9665 genotypes with 19502 annotations displayed
of selected term and subterms
|
Searched Term: abnormal blood homeostasis
|
1500009L16Rikem1(IMPC)Mbp/1500009L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1500009L16Rikem1(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
1700008P02Rikem1(IMPC)J/1700008P02Rikem1(IMPC)J
(C57BL/6NJ-1700008P02Rikem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
1700012B09Riktm1.1(KOMP)Wtsi/1700012B09Riktm1.1(KOMP)Wtsi
(C57BL/6N-1700012B09Riktm1.1(KOMP)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/J)
|
decreased circulating interferon-gamma level
|
J:96123
|
decreased circulating interleukin-12 level
|
J:96123
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/J)
|
decreased circulating interferon-gamma level
|
J:96123
|
decreased circulating interleukin-12 level
|
J:96123
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal circulating cytokine level
|
J:194800
|
1700025G04Rikem1(IMPC)Mbp/1700025G04Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700025G04Rikem1(IMPC)Mbp/Mmucd)
|
increased circulating bilirubin level
|
J:211773
|
1700030J22Rikem1(IMPC)J/1700030J22Rikem1(IMPC)J
(C57BL/6NJ-1700030J22Rikem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
1700034E13Rikem1(IMPC)Mbp/1700034E13Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700034E13Rikem1(IMPC)Mbp/Mmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
1700093K21Rikem1(IMPC)J/1700093K21Rikem1(IMPC)J
(C57BL/6NJ-1700093K21Rikem1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
1700123O20Riktm1a(EUCOMM)Wtsi/1700123O20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd 1700123O20Riktm1a(EUCOMM)Wtsi/WtsiFlmg)
|
increased circulating iron level
|
J:211773
|
2010003K11Rikem1Cya/2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya)
|
increased circulating alanine transaminase level
|
J:326325
|
increased circulating cholesterol level
|
J:326325
|
increased circulating insulin level
|
J:326325
|
increased circulating triglyceride level
|
J:326325
|
increased fasting circulating glucose level
|
J:326325
|
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor Pdgfratm1Sor/Pdgfra+
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
2610318N02Riktm1b(EUCOMM)Wtsi/2610318N02Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2610318N02Riktm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:211773
|
2700054A10Rikem2(IMPC)Mbp/2700054A10Rikem2(IMPC)Mbp
(C57BL/6NCrl-2700054A10Rikem2(IMPC)Mbp/Mmucd)
|
increased circulating phosphate level
|
J:211773
|
2700097O09Riktm1.1(KOMP)Vlcg/2700097O09Riktm1.1(KOMP)Vlcg
(C57BL/6N-2700097O09Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
3425401B19Rikem2(IMPC)Ccpcz/3425401B19Rikem2(IMPC)Ccpcz
(C57BL/6NCrl-3425401B19Rikem2(IMPC)Ccpcz/Ph)
|
decreased circulating potassium level
|
J:211773
|
4833411C07Rikem1Cecad/4833411C07Rikem1Cecad
(C57BL/6N-4833411C07Rikem1Cecad)
|
increased circulating glucose level
|
J:285483
|
4833420G17Rikem1(IMPC)Mbp/4833420G17Rikem1(IMPC)Mbp
(C57BL/6NCrl-4833420G17Rikem1(IMPC)Mbp/Mmucd)
|
increased circulating bilirubin level
|
J:211773
|
4921509C19Riktm1.1(KOMP)Vlcg/4921509C19Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4921509C19Riktm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
4930404H24Riktm1a(KOMP)Wtsi/4930404H24Riktm1a(KOMP)Wtsi
(C57BL/6N-4930404H24Riktm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
4931414P19Rikem1Lych/4931414P19Rikem1Lych
(involves: C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:275266
|
4931429L15Riktm1a(EUCOMM)Wtsi/4931429L15Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4931429L15Riktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
4933402N03Riktm2a(KOMP)Wtsi/4933402N03Riktm2a(KOMP)Wtsi
(C57BL/6N-4933402N03Riktm2a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
4933411K16Rikem1(IMPC)J/4933411K16Rikem1(IMPC)J
(C57BL/6NJ-4933411K16Rikem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
4933428G20Riktm1.1(KOMP)Vlcg/4933428G20Riktm1.1(KOMP)Vlcg
(C57BL/6N-4933428G20Riktm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
4933430I17Riktm1b(EUCOMM)Wtsi/4933430I17Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1b(EUCOMM)Wtsi/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Rik+
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
6430548M08Rikem1(IMPC)Mbp/6430548M08Rikem1(IMPC)Mbp
(C57BL/6N-6430548M08Rikem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+ Trpc5tm1.1Mfre/Trpc5tm1.1Mfre
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N * SJL)
|
decreased circulating luteinizing hormone level
|
J:277600
|
decreased circulating prolactin level
|
J:277600
|
a/a Hps6ru/Hps6ru
(B6.Cg-Hps6ru)
|
increased bleeding time
|
J:7327
|
a/a Rab27aash/Rab27aash
(involves: C3H/HeSnJ * C57BL/6J)
|
increased bleeding time
|
J:77395
|
a/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
decreased circulating glucose level
|
J:168271
|
A1cftm1b(EUCOMM)Hmgu/A1cftm1b(EUCOMM)Hmgu
(B6N(Cg)-A1cftm1b(EUCOMM)Hmgu/J)
|
increased circulating sodium level
|
J:211773
|
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA)
|
abnormal blood homeostasis
|
J:281365
|
decreased circulating glucose level
|
J:281365
|
decreased circulating insulin level
|
J:281365
|
decreased circulating ketone body level
|
J:281365
|
decreased fasting circulating glucose level
|
J:281365
|
increased circulating cholesterol level
|
J:281365
|
increased circulating triglyceride level
|
J:281365
|
A830018L16Rikem1(IMPC)Mbp/A830018L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-A830018L16Rikem1(IMPC)Mbp/MbpMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Atm1Brd/Atm1Brd Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Ypel4tm1a(EUCOMM)Wtsi/WtsiIeg)
|
increased circulating erythropoietin level
|
J:313842
|
Aw-J/Aw-J
(C57BL/6J-Aw-J/J)
|
decreased circulating pituitary hormone level
|
J:52183
|
Ay/a
(involves: KK)
|
hyperglycemia
|
J:26460
|
increased circulating insulin level
|
J:26460
|
Ay/a Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
hyperglycemia
|
J:177084
|
increased circulating cholesterol level
|
J:177084
|
increased circulating insulin level
|
J:177084
|
increased circulating leptin level
|
J:177084
|
increased circulating triglyceride level
|
J:177084
|
Ay/a Apoetm1Unc/Apoetm1Unc Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
increased circulating cholesterol level
|
J:177084
|
increased circulating leptin level
|
J:177084
|
Ay/a Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK)
|
decreased circulating glucose level
|
J:168271
|
Ay/A
(involves: C57BL/6)
|
increased circulating leptin level
|
J:131039
|
Aadacl4em1(IMPC)Ccpcz/Aadacl4em1(IMPC)Ccpcz
(C57BL/6NCrl-Aadacl4em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Aasdhem1(IMPC)Tcp/Aasdhem1(IMPC)Tcp
(C57BL/6N-Aasdhem1(IMPC)Tcp/Cmmr)
|
increased circulating alanine transaminase level
|
J:211773
|
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Abca1mpc227H/Abca1mpc227H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating cholesterol level
|
J:234901
|
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1Blt/Abca1tm1Blt
(C57BL/6-Abca1tm1Blt)
|
abnormal platelet physiology
|
J:95088
|
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
decreased circulating cholesterol level
|
J:61679
|
decreased circulating HDL cholesterol level
|
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
decreased circulating cholesterol level
|
J:60210,
J:61679
|
decreased circulating HDL cholesterol level
|
J:60210,
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ)
|
decreased circulating HDL cholesterol level
|
J:89906
|
decreased circulating phytosterol level
|
J:87209
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
Abca1tm1Jp/Abca1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1Jp/Abca1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
decreased circulating LDL cholesterol level
|
J:98093
|
increased circulating triglyceride level
|
J:98093
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
decreased circulating LDL cholesterol level
|
J:107802
|
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:64390
|
decreased circulating HDL cholesterol level
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:68431,
J:64390
|
decreased circulating estradiol level
|
J:64390
|
decreased circulating HDL cholesterol level
|
J:68431,
J:64390
|
decreased circulating progesterone level
|
J:64390
|
Abca1tm2Jp/Abca1+ Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
abnormal circulating protein level
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca1tm2Jp/Abca1tm2Jp Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
abnormal circulating protein level
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca2em1(IMPC)J/Abca2em1(IMPC)J
(C57BL/6NJ-Abca2em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Abca3tm1Frm/Abca3tm1Frm
(involves: 129S/SvEv)
|
cyanosis
|
J:120296
|
Abca3tm1Holz/Abca3tm1Holz
(involves: 129S6/SvEvTac * C57BL/6)
|
cyanosis
|
J:122736
|
Abca3tm1Nina/Abca3tm1Nina
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:121155
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
abnormal cardiac thrombosis
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
abnormal cardiac thrombosis
|
J:99152
|
Abca6tm2b(KOMP)Wtsi/Abca6tm2b(KOMP)Wtsi
(C57BL/6N-Abca6tm2b(KOMP)Wtsi/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:96865
|
decreased circulating HDL cholesterol level
|
J:96865
|
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Abca8btm1a(EUCOMM)Wtsi/Abca8btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:269226
|
decreased circulating HDL cholesterol level
|
J:269226
|
decreased circulating LDL cholesterol level
|
J:269226
|
decreased circulating triglyceride level
|
J:269226
|
Abca13tm1b(EUCOMM)Wtsi/Abca13tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca13tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Abca16em1(IMPC)J/Abca16em1(IMPC)J
(C57BL/6NJ-Abca16em1(IMPC)J/J)
|
decreased circulating sodium level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Abca17tm1b(EUCOMM)Wtsi/Abca17tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca17tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating potassium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal blood homeostasis
|
J:15531
|
abnormal circulating alanine transaminase level
|
J:15531
|
abnormal circulating alkaline phosphatase level
|
J:15531
|
abnormal circulating aspartate transaminase level
|
J:15531
|
abnormal circulating bilirubin level
|
J:15531
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal circulating enzyme level
|
J:114411
|
decreased circulating cholesterol level
|
J:114411
|
increased circulating alanine transaminase level
|
J:114411,
J:175015
|
increased circulating aspartate transaminase level
|
J:114411
|
increased circulating bilirubin level
|
J:114411
|
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
|
abnormal circulating enzyme level
|
J:105357
|
increased circulating alanine transaminase level
|
J:100491,
J:217802
|
increased circulating alkaline phosphatase level
|
J:105357,
J:217802
|
increased circulating aspartate transaminase level
|
J:100491,
J:217802
|
increased circulating bilirubin level
|
J:105357,
J:217802
|
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
|
decreased circulating calcium level
|
J:199949
|
increased circulating phosphate level
|
J:199949
|
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
|
increased circulating alanine transaminase level
|
J:217802
|
increased circulating alkaline phosphatase level
|
J:217802
|
increased circulating aspartate transaminase level
|
J:217802
|
increased circulating bilirubin level
|
J:217802
|
Abcb4tm1Bor/Abcb4tm1Bor Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased circulating alanine transaminase level
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
|
increased circulating alanine transaminase level
|
J:215915
|
increased circulating alkaline phosphatase level
|
J:215915
|
increased circulating bilirubin level
|
J:215915
|
Abcb4tm1Bor/Abcb4tm1Bor Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased circulating alanine transaminase level
|
J:100491
|
increased circulating aspartate transaminase level
|
J:100491
|
Abcb7tm1Mdf/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))
|
abnormal circulating enzyme level
|
J:106838
|
Abcb11tm1a(EUCOMM)Hmgu/Abcb11tm1a(EUCOMM)Hmgu
(C57BL/6N-Abcb11tm1a(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating aspartate transaminase level
|
J:165965
|
increased circulating potassium level
|
J:165965
|
Abcb11tm1b(EUCOMM)Hmgu/Abcb11+
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
|
abnormal blood homeostasis
|
J:107822
|
increased circulating bilirubin level
|
J:107822
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(FVB.129P2-Abcc2tm1Ahs)
|
increased circulating bilirubin level
|
J:216646
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(B6.129P2(FVB)-Abcc2tm1Ahs)
|
increased circulating bilirubin level
|
J:208127
|
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating alkaline phosphatase level
|
J:134950
|
increased circulating bilirubin level
|
J:134950
|
increased circulating cholesterol level
|
J:134950
|
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating bilirubin level
|
J:114229
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
abnormal blood homeostasis
|
J:117326
|
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:105062
|
increased circulating creatinine level
|
J:105062
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
decreased circulating glucose level
|
J:208932
|
increased circulating glucose level
|
J:208932
|
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:79352
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:61356
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
|
decreased circulating glucose level
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc8tm1Jbry/Abcc8tm1Jbry Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ)
|
decreased circulating glucose level
|
J:179577
|
increased circulating glucose level
|
J:179577
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
|
hypoglycemia
|
J:71840
|
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Abcd3tm1Safe/Abcd3tm1Safe
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal blood homeostasis
|
J:217065
|
Abce1tm1b(EUCOMM)Hmgu/Abce1+
(C57BL/6N-Abce1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating creatinine level
|
J:211773
|
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:122438
|
Abcg2em1Omw/Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw)
|
increased blood uric acid level
|
J:292268
|
increased circulating glucose level
|
J:292268
|
increased circulating insulin level
|
J:292268
|
increased circulating insulin-like growth factor I level
|
J:292268
|
increased circulating potassium level
|
J:292268
|
Abcg2tm1.1(KOMP)Vlcg/Abcg2tm1.1(KOMP)Vlcg
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Abcg2tm1Ahs/Abcg2tm1Ahs
(either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))
|
increased circulating bilirubin level
|
J:80519
|
Abcg2tm1Ahs/Abcg2tm1Ahs
(FVB.129P2-Abcg2tm1Ahs/Tac)
|
increased blood uric acid level
|
J:220924
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: C57BL/6 * DBA * SJL)
|
decreased circulating cholesterol level
|
J:215443
|
increased circulating phytosterol level
|
J:215443
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Tg(CAG-cre/Esr1*)5Amc/?
(involves: C57BL/6 * CBA * SJL)
|
decreased circulating cholesterol level
|
J:215443
|
increased circulating phytosterol level
|
J:215443
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Tg(Vil1-cre)997Gum/?
(involves: C57BL/6 * SJL)
|
increased circulating phytosterol level
|
J:215443
|
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:87209
|
increased circulating phytosterol level
|
J:87209
|
increased circulating triglyceride level
|
J:87209
|
increased circulating VLDL triglyceride level
|
J:87209
|
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
|
abnormal circulating cholesterol level
|
J:157223
|
abnormal circulating lipid level
|
J:157223
|
abnormal platelet activation
|
J:157223
|
decreased platelet aggregation
|
J:157223
|
increased bleeding time
|
J:157223
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating sodium level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:94759
|
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:94759
|
increased circulating free fatty acids level
|
J:192806
|
increased circulating phytosterol level
|
J:94759
|
increased circulating triglyceride level
|
J:94759
|
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:199570
|
increased circulating aspartate transaminase level
|
J:199570
|
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:160725
|
decreased circulating triglyceride level
|
J:160725
|
Abhd5tm1Rze/Abhd5tm1Rze Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating free fatty acids level
|
J:197835
|
decreased circulating glucose level
|
J:197835
|
decreased circulating insulin level
|
J:197835
|
decreased circulating triglyceride level
|
J:197835
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
decreased circulating insulin level
|
J:234876
|
decreased circulating resistin level
|
J:234876
|
increased circulating insulin level
|
J:215257
|
Abhd6tm1c(EUCOMM)Hmgu/Abhd6tm1c(EUCOMM)Hmgu Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6N * CD-1)
|
increased circulating insulin level
|
J:215257
|
Abhd8tm1b(EUCOMM)Wtsi/Abhd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Abhd8tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:294591
|
decreased circulating insulin level
|
J:294591
|
Abhd12bem1(IMPC)J/Abhd12bem1(IMPC)J
(C57BL/6NJ-Abhd12bem1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Abhd17cem1(IMPC)Mbp/Abhd17cem1(IMPC)Mbp
(C57BL/6N-Abhd17cem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating alanine transaminase level
|
J:211773
|
Abi2tm1b(EUCOMM)Wtsi/Abi2tm1b(EUCOMM)Wtsi
(C57BL/6N-Abi2tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Abi3bptm1e.1(KOMP)Mbp/Abi3bptm1e.1(KOMP)Mbp
(C57BL/6N-Abi3bptm1e.1(KOMP)Mbp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Abtb1em1(IMPC)Ccpcz/Abtb1em1(IMPC)Ccpcz
(C57BL/6N-Abtb1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Acacatm1Jkus/Acacatm1Jkus Tg(Fabp1-cre)1Mmt/0
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
increased circulating aspartate transaminase level
|
J:118861
|
Acacatm2Sjw/Acacatm2Sjw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
|
decreased circulating free fatty acids level
|
J:110200
|
decreased circulating ketone body level
|
J:110200
|
hyperglycemia
|
J:110200
|
increased circulating free fatty acids level
|
J:110200
|
increased circulating insulin level
|
J:110200
|
Acacbtm1.2Lowl/Acacbtm1.2Lowl
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating insulin level
|
J:159285
|
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
|
decreased circulating free fatty acids level
|
J:68427
|
decreased circulating glucose level
|
J:68427
|
decreased circulating leptin level
|
J:68427
|
increased circulating ketone body level
|
J:68427
|
increased circulating triglyceride level
|
J:68427
|
Acad8m1Ytc/Acad8m1Ytc
(involves: C57BL/6)
|
abnormal circulating amino acid level
|
J:222356
|
abnormal circulating enzyme level
|
J:222356
|
decreased circulating carnitine level
|
J:222356
|
Acad12tm1b(EUCOMM)Wtsi/Acad12tm1b(EUCOMM)Wtsi
(C57BL/6N-Acad12tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
hypoglycemia
|
J:51660
|
increased circulating carnitine level
|
J:72193
|
increased circulating free fatty acids level
|
J:51660
|
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:115759
|
decreased circulating glucose level
|
J:115759
|
increased circulating carnitine level
|
J:115759
|
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ)
|
decreased circulating carnitine level
|
J:14707
|
decreased circulating glycine level
|
J:14707
|
hypoglycemia
|
J:14707
|
increased circulating HDL cholesterol level
|
J:164460
|
AcadsHdlq8-C57BL/6J/AcadsHdlq8-C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
AcadsHdlq8-NZB/BlNJ/AcadsHdlq8-NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Acadvlem1(IMPC)H/Acadvlem1(IMPC)H
(C57BL/6NTac-Acadvlem1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Acadvltm1Uab/Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating carnitine level
|
J:72193
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
|
hypoglycemia
|
J:106714
|
Acadvltm1Zkhu/Acadvltm1Zkhu Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
decreased circulating glucose level
|
J:208711
|
Acap1tm1.1(KOMP)Vlcg/Acap1tm1.1(KOMP)Vlcg
(B6N(Cg)-Acap1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Acbd3tm1b(EUCOMM)Hmgu/Acbd3+
(C57BL/6N-Acbd3tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Acdacd/Acdacd
(DW/J-Acdacd Pou1f1+)
|
decreased circulating corticosterone level
|
J:18027
|
Ace2em1(ACE2)Yowa/Ace2em1(ACE2)Yowa
(C57BL/6-Ace2em1(ACE2)Yowa)
|
abnormal circulating cytokine level
|
J:288243
|
increased circulating interferon-gamma level
|
J:288243
|
increased circulating interleukin-9 level
|
J:288243
|
Ace2tm1Cof/Y
(129S6/SvEvTac-Ace2tm1Cof)
|
increased circulating angiotensin II level
|
J:113108
|
Ace2tm1Hira/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating angiotensin II level
|
J:135766
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
increased circulating angiotensin II level
|
J:100334
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
increased circulating angiotensin II level
|
J:100334
|
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating creatinine level
|
J:33018
|
Acetm1Keb/Acetm5Keb
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating renin level
|
J:89512
|
Acetm1Mcf/Acetm1Mcf
(Not Specified)
|
increased blood urea nitrogen level
|
J:32114
|
Acetm1Unc/Acetm1Unc
(involves: 129P2/OlaHsd)
|
decreased circulating angiotensin II level
|
J:100334
|
Acetm1Unc/Acetm1Unc Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
decreased circulating angiotensin II level
|
J:100334
|
Acetm1Unc/Acetm1Unc Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
decreased circulating angiotensin II level
|
J:100334
|
Acetm8.1Keb/Acetm8.1Keb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal circulating protein level
|
J:163902
|
decreased circulating angiotensin II level
|
J:163902
|
Acetm9Keb/Acetm9Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating angiotensinogen level
|
J:185888
|
decreased circulating angiotensinogen level
|
J:185888
|
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6)
|
abnormal platelet physiology
|
J:132775
|
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd)
|
abnormal circulating chemokine level
|
J:162629
|
Ackr3tm1.1Twb/Ackr3tm1.1Twb
(involves: 129S/SvEv * BALB/cJ * C57BL/6)
|
cyanosis
|
J:167833
|
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal atrial thrombosis
|
J:136246
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal circulating chemokine level
|
J:166490
|
Acmsdtm1b(EUCOMM)Hmgu/Acmsdtm1b(EUCOMM)Hmgu
(C57BL/6N-Acmsdtm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating bilirubin level
|
J:211773
|
Acot5tm1a(KOMP)Wtsi/Acot5tm1a(KOMP)Wtsi
(C57BL/6N-Acot5tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Acot7tm1.1Mwol/Acot7tm1.1Mwol Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal circulating lipid level
|
J:203753
|
increased circulating free fatty acids level
|
J:203753
|
increased circulating triglyceride level
|
J:203753
|
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating cholesterol level
|
J:182660
|
decreased circulating glucose level
|
J:182660
|
decreased circulating HDL cholesterol level
|
J:182660
|
increased circulating triglyceride level
|
J:182660
|
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N)
|
increased circulating cholesterol level
|
J:335836
|
increased circulating phospholipid level
|
J:335836
|
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6)
|
decreased circulating free fatty acids level
|
J:183258
|
decreased circulating ketone body level
|
J:183258
|
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J)
|
increased circulating alanine transaminase level
|
J:174942
|
increased circulating alkaline phosphatase level
|
J:174942
|
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J)
|
hyperlipidemia
|
J:35794
|
Acox3em1(IMPC)J/Acox3em1(IMPC)J
(C57BL/6NJ-Acox3em1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
Acp6em1(IMPC)Hmgu/Acp6+
(C57BL/6NCrl-Acp6em1(IMPC)Hmgu/Ieg)
|
increased circulating serum albumin level
|
J:211773
|
Acsbg1tm1Mld/Acsbg1tm1Mld
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating testosterone level
|
J:150391
|
Acsf3em1(IMPC)Hmgu/Acsf3em1(IMPC)Hmgu
(C57BL/6NCrl-Acsf3em1(IMPC)Hmgu/Ieg)
|
increased circulating iron level
|
J:211773
|
Acsl1tm1Rcol/Acsl1tm1Rcol Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glycerol level
|
J:162996
|
hyperlipidemia
|
J:162996
|
hypoglycemia
|
J:162996
|
increased circulating free fatty acids level
|
J:162996
|
increased circulating triglyceride level
|
J:162996
|
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Acsm2tm1.1(KOMP)Vlcg/Acsm2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsm2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak/Jsak)
|
abnormal blood homeostasis
|
J:146647
|
abnormal circulating free fatty acids level
|
J:146647
|
decreased circulating leptin level
|
J:146647
|
hypoglycemia
|
J:146647
|
Acss2em22Gpt/Acss2em22Gpt
(C57BL/6JGpt-Acss2em22Gpt/Gpt)
|
decreased blood urea nitrogen level
|
J:346990
|
decreased circulating creatinine level
|
J:346990
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased circulating ketone body level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Camk2a-cre)#Szi/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Hsp70-1-cre)6Arge/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac Insrtm1Dac/Insrtm1Dac Tg(Syn1-cre)671Jxm/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:160212
|
decreased circulating free fatty acids level
|
J:160212
|
decreased circulating HDL cholesterol level
|
J:160212
|
decreased circulating insulin level
|
J:160212
|
decreased circulating LDL cholesterol level
|
J:160212
|
decreased circulating leptin level
|
J:160212
|
decreased fasting circulating glucose level
|
J:160212
|
Actc1tm1Jll/Actc1tm1Jll Tg(Myh6-Actg2)1Jll/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
abnormal cardiac thrombosis
|
J:40165
|
Actg2em1(IMPC)J/Actg2em1(IMPC)J
(C57BL/6NJ-Actg2em1(IMPC)J/J)
|
increased circulating creatinine level
|
J:211773
|
Actl6aem1(IMPC)J/Actl6a+
(C57BL/6NJ-Actl6aem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Actl10tm1a(EUCOMM)Wtsi/Actl10tm1a(EUCOMM)Wtsi
(C57BL/6N-Actl10tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Actn4tm1Mrpk/Actn4tm1Mrpk
(involves: 129 * C57BL/6)
|
abnormal blood urea nitrogen level
|
J:83911
|
Actr6tm1a(EUCOMM)Wtsi/Actr6+
(C57BL/6N-Actr6tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
Actr8tm1.1(KOMP)Vlcg/Actr8+
(B6N(Cg)-Actr8tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Acvr1tm1.1(KOMP)Vlcg/Acvr1+
(C57BL/6N-Acvr1tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating total protein level
|
J:211773
|
Acvr2atm1Zuk/Acvr2atm1Zuk
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6))
|
suppressed circulating follicle stimulating hormone level
|
J:23924
|
Acvr2btm1Enl/Acvr2btm1Enl
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))
|
cyanosis
|
J:42018
|
Acvrl1tm1Enl/Acvrl1+
(B6.Cg-Acvrl1tm1Enl)
|
decreased circulating angiotensin II level
|
J:226550
|
increased circulating adrenaline level
|
J:226550
|
increased circulating noradrenaline level
|
J:226550
|
Acy1em1(IMPC)J/Acy1em1(IMPC)J
(C57BL/6NJ-Acy1em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Acy3em1(IMPC)J/Acy3em1(IMPC)J
(C57BL/6NJ-Acy3em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Acyp1em1(IMPC)J/Acyp1em1(IMPC)J
(C57BL/6NJ-Acyp1em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Ad/Ad
(involves: Chr 7 marker stock * Wild stock)
|
increased circulating insulin level
|
J:6095
|
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock)
|
increased circulating insulin level
|
J:6095
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6)
|
cyanosis
|
J:25085
|
decreased circulating serum albumin level
|
J:25085
|
decreased circulating total protein level
|
J:25085
|
Adatm1Vlr/Adatm1Vlr
(either: 129P2/OlaHsd-Adatm1Vlr or (involves: (129P2/OlaHsd * FVB/N))
|
cyanosis
|
J:26731
|
Adad1em1(IMPC)J/Adad1+
(C57BL/6NJ-Adad1em1(IMPC)J/J)
|
decreased circulating iron level
|
J:211773
|
Adad2em1(IMPC)J/Adad2em1(IMPC)J
(C57BL/6NJ-Adad2em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Adam10tm1Beni/Adam10tm1Beni Adam17tm1.1Srj/Adam17tm1.1Srj Tg(Pf4-icre)Q3Rsko/0
(involves: 129/Sv * 129S/SvEv * C57BL/6)
|
abnormal platelet physiology
|
J:165863
|
Adam10tm1Beni/Adam10tm1Beni Tg(Pf4-icre)Q3Rsko/0
(involves: 129/Sv * C57BL/6)
|
abnormal platelet physiology
|
J:165863
|
Adam17m1Btlr/Adam17m1Btlr
(C57BL/6J-Adam17m1Btlr)
|
decreased circulating tumor necrosis factor level
|
J:166602
|
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv)
|
abnormal platelet physiology
|
J:165863
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating interleukin-17 level
|
J:144795
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl Sox9tm3(cre)Crm/Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
|
abnormal circulating chemokine level
|
J:229771
|
Adam17tm1Bbl/Adam17tm1Bbl Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd)
|
decreased circulating tumor necrosis factor level
|
J:139846
|
Adam17tm1Bbl/Adam17tm1Bbl Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased circulating tumor necrosis factor level
|
J:139846
|
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * DBA/1J)
|
cyanosis
|
J:68672
|
Adam29em1Otin/Adam29em1Otin
(C57BL/6-Adam29em1Otin)
|
decreased circulating phosphate level
|
J:353244
|
Adam33tm1b(EUCOMM)Hmgu/Adam33tm1b(EUCOMM)Hmgu
(C57BL/6N-Adam33tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen)
|
decreased circulating interleukin-10 level
|
J:301741
|
increased circulating interleukin-1 beta level
|
J:301741
|
increased circulating interleukin-6 level
|
J:301741
|
Adamts13s/Adamts13s
(129.B6-Adamts13s)
|
increased susceptibility to induced thrombosis
|
J:148975
|
Adamts13tm1Dgi/Adamts13tm1Dgi
(involves: 129X1/SvJ * C57BL/6J * CASA/Rk)
|
abnormal platelet physiology
|
J:101752
|
abnormal thrombosis
|
J:101752
|
increased circulating von Willebrand factor level
|
J:101752
|
Adamts13tm1Dgi/Adamts13tm1Dgi
(B6.129X1-Adamts13tm1Dgi)
|
increased susceptibility to induced thrombosis
|
J:133469
|
Adamts13tm1Dgi/Adamts13tm1Dgi Vwftm1Wgr/Vwftm1Wgr
(B6.129-Adamts13tm1Dgi Vwftm1Wgr)
|
decreased susceptibility to induced thrombosis
|
J:133469
|
Adamts13tm1Myta/Adamts13tm1Myta
(involves: 129S6/SvEvTac)
|
abnormal blood coagulation
|
J:125786
|
abnormal platelet activation
|
J:125786
|
abnormal thrombosis
|
J:125786
|
Adamts15tm1.1(KOMP)Vlcg/Adamts15tm1.1(KOMP)Vlcg
(C57BL/6N-Adamts15tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Adamts16em1(IMPC)H/Adamts16em1(IMPC)H
(C57BL/6N-Adamts16em1(IMPC)H/H)
|
decreased circulating potassium level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Adamtsl2tm1b(KOMP)Wtsi/Adamtsl2tm1b(KOMP)Wtsi
(C57BL/6-Adamtsl2tm1b(KOMP)Wtsi)
|
cyanosis
|
J:221347
|
Adarem1Stsn/Adartm1Olds
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating serum albumin level
|
J:308678
|
increased circulating alkaline phosphatase level
|
J:308678
|
Adarem3Qwan/Adarem3Qwan
(Not Specified)
|
increased circulating interleukin-1 level
|
J:325221
|
increased circulating interleukin-6 level
|
J:325221
|
increased circulating interleukin-17 level
|
J:325221
|
Adartm1b(EUCOMM)Wtsi/Adar+
(B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Adartm1Knk/Adartm1Knk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal circulating enzyme level
|
J:87714
|
hyperglycemia
|
J:87714
|
increased circulating alanine transaminase level
|
J:87714
|
increased circulating alkaline phosphatase level
|
J:87714
|
increased circulating aspartate transaminase level
|
J:87714
|
increased circulating lactate dehydrogenase level
|
J:87714
|
Adartm2Phs/Adartm2Phs
(B6.Cg-Adartm2Phs)
|
abnormal circulating interferon-beta level
|
J:142338
|
increased circulating interferon-alpha level
|
J:142338
|
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
|
decreased circulating carnitine level
|
J:280282
|
decreased circulating free fatty acids level
|
J:280282
|
increased circulating lactate level
|
J:280282
|
Adck2tm1.1(KOMP)Vlcg/Adck2tm1.1(KOMP)Vlcg
(B6N(Cg)-Adck2tm1.1(KOMP)Vlcg/J)
|
increased circulating potassium level
|
J:211773
|
Adcy1tm1b(EUCOMM)Wtsi/Adcy1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy1tm1b(EUCOMM)Wtsi/H)
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Adcy2tm1a(KOMP)Wtsi/Adcy2tm1a(KOMP)Wtsi
(C57BL/6N-Adcy2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating glucose level
|
J:223554
|
decreased circulating insulin level
|
J:223554
|
decreased circulating leptin level
|
J:223554
|
Adcy3tm1Drs/Adcy3tm1Drs
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating renin level
|
J:144961
|
increased circulating creatinine level
|
J:144961
|
Adcy3tm2.1Drs/Adcy3tm2.1Drs Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:281839
|
Adcy6tm1.1(KOMP)Vlcg/Adcy6tm1.1(KOMP)Vlcg
(C57BL/6N-Adcy6tm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Adcy9tm1b(EUCOMM)Wtsi/Adcy9+
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Adcy10tm1Lex/Adcy10tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:103485
|
Adcyap1tm1Eid/Adcyap1tm1Eid
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating adrenaline level
|
J:73702
|
hypoglycemia
|
J:73702
|
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
|
hypoglycemia
|
J:71968
|
increased circulating cholesterol level
|
J:71968
|
increased circulating corticosterone level
|
J:71968
|
increased circulating free fatty acids level
|
J:71968
|
increased circulating insulin level
|
J:71968
|
increased circulating ketone body level
|
J:71968
|
increased circulating triglyceride level
|
J:71968
|
Adcyap1tm1Nms/Adcyap1tm1Nms
(B6.129-Adcyap1tm1Nms)
|
decreased circulating progesterone level
|
J:131950
|
decreased circulating prolactin level
|
J:131950
|
Adcyap1r1tm1Bbt/Adcyap1r1tm1Bbt
(involves: 129 * C57BL/6J)
|
decreased circulating insulin level
|
J:62115
|
increased circulating insulin level
|
J:62115
|
Add2tm1Feb/Add2tm1Feb
(B6.129-Add2tm1Feb)
|
increased circulating bilirubin level
|
J:63047
|
Adgra1tm1.1Zgwg/Adgra1tm1.1Zgwg
(Not Specified)
|
decreased fasting circulating glucose level
|
J:329982
|
Adgrb1tm2a(EUCOMM)Wtsi/Adgrb1tm2a(EUCOMM)Wtsi
(C57BL/6N-Adgrb1tm2a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Adgrb3em1(IMPC)Bay/Adgrb3+
(C57BL/6N-Adgrb3em1(IMPC)Bay/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Adgrf5m1Btlr/Adgrf5m1Btlr
(C57BL/6J-Adgrf5m1Btlr)
|
increased circulating glucose level
|
J:225045
|
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Adgrg5tm1b(EUCOMM)Wtsi/Adgrg5tm1b(EUCOMM)Wtsi
(C57BL/6N-Adgrg5tm1b(EUCOMM)Wtsi/BayMmucd)
|
increased circulating amylase level
|
J:211773
|
Adgrl3Gt(S17-5H1)Sor/Adgrl3Gt(S17-5H1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased circulating calcium level
|
J:259247
|
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg)
|
decreased circulating insulin level
|
J:304292
|
decreased circulating leptin level
|
J:304292
|
Adip1LG/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1)
|
decreased circulating cholesterol level
|
J:153477
|
decreased circulating free fatty acids level
|
J:153477
|
decreased circulating glucose level
|
J:153477
|
decreased circulating triglyceride level
|
J:153477
|
increased circulating leptin level
|
J:153477
|
Adip1SM/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1)
|
decreased circulating cholesterol level
|
J:153477
|
decreased circulating free fatty acids level
|
J:153477
|
decreased circulating glucose level
|
J:153477
|
decreased circulating triglyceride level
|
J:153477
|
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating glucose level
|
J:111346
|
Adipoqtm1Far/Adipoqtm1Far Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating glucose level
|
J:111346
|
decreased circulating leptin level
|
J:111346
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hyperglycemia
|
J:77479,
J:103106
|
increased circulating free fatty acids level
|
J:77479
|
increased circulating glucose level
|
J:106599
|
increased circulating insulin level
|
J:77479
|
increased circulating osteocalcin level
|
J:199264
|
Adipoqtm1Ish/Adipoqtm1Ish Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating glucose level
|
J:199264
|
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating triglyceride level
|
J:77876
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating calcium level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc)
|
increased circulating cholesterol level
|
J:122027
|
increased circulating leptin level
|
J:122027
|
Adipor1tm1Tka/Adipor1tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
hyperglycemia
|
J:117919
|
increased circulating glucose level
|
J:117919
|
increased circulating insulin level
|
J:117919
|
Adipor1tm1Tka/Adipor1tm1Tka Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating glucose level
|
J:117919
|
hyperglycemia
|
J:117919
|
Adipor1tm2Tka/Adipor1tm2Tka Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn)
|
increased circulating glucose level
|
J:159462
|
increased circulating insulin level
|
J:159462
|
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen)
|
decreased circulating cholesterol level
|
J:122027
|
decreased circulating HDL cholesterol level
|
J:122027
|
decreased circulating insulin level
|
J:122027
|
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
hyperglycemia
|
J:117919
|
increased circulating insulin level
|
J:117919
|
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:129554
|
decreased circulating HDL cholesterol level
|
J:129554
|
decreased circulating insulin level
|
J:129554
|
decreased circulating LDL cholesterol level
|
J:129554
|
decreased circulating triglyceride level
|
J:129554
|
decreased circulating VLDL cholesterol level
|
J:129554
|
increased circulating glucose level
|
J:129554
|
Adissptm1c(EUCOMM)Hmgu/Adissptm1c(EUCOMM)Hmgu Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ)
|
increased circulating glucose level
|
J:332979
|
increased fasting circulating glucose level
|
J:332979
|
Adnp2em3(IMPC)Tcp/Adnp2em3(IMPC)Tcp
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Adora1tm1Jgsc/Adora1tm1Jgsc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating creatinine level
|
J:127544
|
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Adora2atm1Map/Adora2atm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased platelet aggregation
|
J:42276
|
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Adora2btm1.1(KOMP)Vlcg/Adora2btm1.1(KOMP)Vlcg
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Adora2btm1Kra/Adora2btm1Kra
(involves: 129 * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:111715
|
Adora3tm1Jbsn/Adora3tm1Jbsn
(B6.129P2-Adora3tm1Jbsn)
|
decreased circulating creatinine level
|
J:82054
|
Adprsem1(IMPC)Wtsi/Adprsem1(IMPC)Wtsi
(C57BL/6N-Adprsem1(IMPC)Wtsi/WtsiIeg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:87718
|
hyperglycemia
|
J:87718
|
increased circulating insulin level
|
J:87718
|
increased circulating leptin level
|
J:87718
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129 * C57BL/6J)
|
decreased circulating testosterone level
|
J:125763
|
increased circulating luteinizing hormone level
|
J:125763
|
Adra2am1Btlr/Adra2am1Btlr
(C57BL/6J-Adra2am1Btlr)
|
decreased circulating glucose level
|
J:267700
|
increased circulating insulin level
|
J:267700
|
Adra2am2Btlr/Adra2am2Btlr
(C57BL/6J-Adra2am2Btlr)
|
decreased circulating glucose level
|
J:267701
|
Adra2atm1.1(KOMP)Vlcg/Adra2atm1.1(KOMP)Vlcg
(C57BL/6N-Adra2atm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ)
|
hypoglycemia
|
J:130781
|
Adra2btm1Gsb/Adra2btm1Gsb
(B6.129-Adra2btm1Gsb)
|
cyanosis
|
J:166788
|
Adrb1tm1Bkk/Adrb1tm1Bkk Adrb2tm1Bkk/Adrb2tm1Bkk Adrb3tm1Lowl/Adrb3tm1Lowl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
|
increased circulating leptin level
|
J:79309
|
Adrb2tm1Kry/Adrb2+ Lepob/Lep+ Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6 * C57BL/10J * FVB)
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Adrb2tm1Kry/Adrb2tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Adrm1Gt(OST128063)Lex/Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:166694
|
increased circulating growth hormone level
|
J:166694
|
Adss2tm1b(EUCOMM)Wtsi/Adss2+
(C57BL/6N-Adss2tm1b(EUCOMM)Wtsi/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased bleeding time
|
J:295059
|
Aebp1tm1Hsro/Aebp1tm1Hsro
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:125333
|
decreased circulating triglyceride level
|
J:125333
|
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Aff3tm1a(EUCOMM)Wtsi/Aff3tm1a(EUCOMM)Wtsi
(C57BL/6N-Aff3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Afmidtm1a(EUCOMM)Wtsi/Afmidtm1a(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1a(EUCOMM)Wtsi/H)
|
hyperglycemia
|
J:226537
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
increased circulating fructosamine level
|
J:226537
|
increased circulating glucose level
|
J:211773,
J:226537
|
Afptm1Ibmm/Afptm1Ibmm
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))
|
decreased circulating progesterone level
|
J:79500
|
increased circulating follicle stimulating hormone level
|
J:79500
|
increased circulating luteinizing hormone level
|
J:79500
|
Afptm2Ibmm/Afptm2Ibmm
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))
|
decreased circulating progesterone level
|
J:79500
|
increased circulating follicle stimulating hormone level
|
J:79500
|
increased circulating luteinizing hormone level
|
J:79500
|
Aftphem1(IMPC)J/Aftph+
(C57BL/6NJ-Aftphem1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Agap1tm1a(EUCOMM)Wtsi/Agap1tm1a(EUCOMM)Wtsi
(C57BL/6N-Agap1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Agap2tm1.1Kye/Agap2tm1.1Kye
(Not Specified)
|
hyperglycemia
|
J:174775
|
Agap2tm1Kye/Agap2tm1Kye Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2)
|
decreased circulating triglyceride level
|
J:174775
|
hyperglycemia
|
J:174775
|
increased circulating insulin level
|
J:174775
|
Agbl4em1(IMPC)Mbp/Agbl4em1(IMPC)Mbp
(C57BL/6NCrl-Agbl4em1(IMPC)Mbp/Mmucd)
|
increased circulating bilirubin level
|
J:211773
|
Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu/Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu
(involves: FVB/N)
|
abnormal hemostasis
|
J:233744
|
abnormal platelet physiology
|
J:233744
|
decreased platelet aggregation
|
J:233744
|
increased bleeding time
|
J:233744
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:82491
|
Agertm1.1Arnd/Agertm1.1Arnd
(B6.129P2-Agertm1.1Arnd)
|
decreased circulating interleukin-6 level
|
J:104998
|
Agertm1.1Hyam/Ager+ Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)
|
hyperglycemia
|
J:116040
|
Agertm1.1Hyam/Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1)
|
abnormal blood homeostasis
|
J:116507
|
increased circulating glucose level
|
J:116507
|
Agertm1.1Hyam/Agertm1.1Hyam Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)
|
decreased circulating creatinine level
|
J:116040
|
hyperglycemia
|
J:116040
|
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
hypoglycemia
|
J:212003
|
increased circulating alanine transaminase level
|
J:212003
|
increased circulating alkaline phosphatase level
|
J:212003
|
increased circulating aspartate transaminase level
|
J:212003
|
increased circulating creatine kinase level
|
J:212003
|
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno)
|
decreased circulating glucose level
|
J:218471
|
decreased fasting circulating glucose level
|
J:218471
|
increased circulating alanine transaminase level
|
J:218471
|
increased circulating alkaline phosphatase level
|
J:218471
|
increased circulating aspartate transaminase level
|
J:218471
|
increased circulating creatine kinase level
|
J:218471
|
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating cholesterol level
|
J:308367
|
Ago2tm1.1Tara/Ago2tm1.1Tara Lepob/Lepob Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased circulating glucose level
|
J:210552
|
decreased circulating insulin level
|
J:210552
|
increased circulating insulin level
|
J:210552
|
Agpat1tm1.1(KOMP)Vlcg/Agpat1+
(B6N(Cg)-Agpat1tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating glucose level
|
J:250301
|
decreased circulating insulin-like growth factor I level
|
J:250301
|
decreased circulating leptin level
|
J:250301
|
hypoglycemia
|
J:250301
|
increased circulating follicle stimulating hormone level
|
J:250301
|
increased circulating luteinizing hormone level
|
J:250301
|
Agpat2em1(IMPC)Ccpcz/Agpat2+
(C57BL/6NCrl-Agpat2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
hyperglycemia
|
J:186035
|
increased circulating glucose level
|
J:186035
|
increased circulating insulin level
|
J:186035
|
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
|
decreased circulating free fatty acids level
|
J:146649
|
decreased circulating leptin level
|
J:146649
|
hyperglycemia
|
J:146649
|
increased circulating cholesterol level
|
J:231617
|
increased circulating glucose level
|
J:231617
|
increased circulating insulin level
|
J:231617,
J:146649
|
increased circulating triglyceride level
|
J:146649
|
Agpat2tm1Garg/Agpat2tm1Garg Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased circulating glucose level
|
J:231617
|
increased circulating insulin level
|
J:231617
|
Agpat3tm1a(EUCOMM)Wtsi/Agpat3+
(B6JTyr;B6N-Agpat3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Agr2tm1.1Lex/Agr2tm1.1Lex
(involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6)
|
decreased circulating serum albumin level
|
J:195573
|
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating ketone body level
|
J:199803
|
decreased circulating VLDL triglyceride level
|
J:199803
|
Agrptm1Mws/Agrptm1Mws
(B6.129S1-Agrptm1Mws)
|
abnormal blood homeostasis
|
J:117539
|
decreased circulating leptin level
|
J:117539
|
increased circulating thyroxine level
|
J:117539
|
increased circulating triiodothyronine level
|
J:117539
|
Agttm1.1Itl/Agttm1.1Itl Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
decreased circulating angiotensinogen level
|
J:178836
|
Agttm1Afu/Agt+
(involves: C57BL/6 * CBA * ICR)
|
abnormal blood homeostasis
|
J:21887
|
decreased circulating angiotensinogen level
|
J:21887
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA * ICR)
|
abnormal blood homeostasis
|
J:73163
|
decreased circulating angiotensinogen level
|
J:21887
|
increased circulating renin level
|
J:73163,
J:36820
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
|
decreased circulating aldosterone level
|
J:46506
|
increased circulating antidiuretic hormone level
|
J:46506
|
Agttm1Afu/Agttm1Afu Tg(Fabp4-Agt)2Mte/0
(involves: C57BL/6 * CBA * DBA/2 * ICR)
|
decreased circulating angiotensinogen level
|
J:73163
|
Agttm1Ii/Agttm1Ii
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating creatinine level
|
J:140022
|
Agttm1Unc/Agt+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating angiotensinogen level
|
J:18272,
J:24156
|
increased circulating renin level
|
J:24156
|
Agttm1Unc/Agttm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating angiotensinogen level
|
J:24156
|
Agttm1Unc/Agttm2Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating angiotensinogen level
|
J:24156
|
Agttm2Unc/Agt+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating angiotensinogen level
|
J:18272,
J:24156
|
Agttm2Unc/Agttm2Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating angiotensinogen level
|
J:24156
|
Agtr1atm1Afu/Agtr1atm1Afu
(involves: C57BL/6 * CBA * ICR)
|
increased circulating renin level
|
J:28041
|
Agtr1atm1Ecl/Agtr1atm1Ecl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal blood homeostasis
|
J:124206
|
decreased circulating angiotensin II level
|
J:124206
|
decreased circulating renin level
|
J:124206
|
increased blood urea nitrogen level
|
J:124206
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr1btm1Cof/Agtr1btm1Cof
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating protein level
|
J:137944
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating protein level
|
J:137944
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating protein level
|
J:137944
|
Agtr2tm1a(EUCOMM)Wtsi/Agtr2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Agtr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:102984
|
increased circulating corticosterone level
|
J:102984
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal circulating insulin level
|
J:105210
|
abnormal circulating leptin level
|
J:105210
|
Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:102984
|
increased circulating corticosterone level
|
J:102984
|
AgtrapGt(XE129)Byg/AgtrapGt(XE129)Byg
(involves: 129P2/OlaHsd)
|
abnormal blood homeostasis
|
J:185854
|
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:263253
|
increased circulating insulin level
|
J:263253
|
increased circulating serum albumin level
|
J:263253
|
increased circulating triglyceride level
|
J:263253
|
Agxt2tm1Lex/Agxt2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating citrulline level
|
J:207876
|
Ahcyl1tm1a(EUCOMM)Wtsi/Ahcyl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ahcyl1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating thyroxine level
|
J:211773
|
Ahi1tm1Jgg/Ahi1+ Lrp6Gt(Ex187)Byg/Lrp6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased circulating creatinine level
|
J:154321
|
Ahi1tm1Jgg/Ahi1tm1Jgg Tg(TCF/Lef1-lacZ)34Efu/0
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating serum albumin level
|
J:154321
|
increased circulating creatinine level
|
J:154321
|
Ahrb-1/Ahrb-1 Aiptm2.1Bra/Aiptm2.1Bra Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Aiptm2.1Bra)
|
abnormal circulating alanine transaminase level
|
J:166864
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra)
|
abnormal circulating hormone level
|
J:126176
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
abnormal atrial thrombosis
|
J:44690
|
abnormal thrombosis
|
J:44690
|
Ahrrtm1b(KOMP)Wtsi/Ahrr+
(B6N(Cg)-Ahrrtm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ahsgtm1Mbl/Ahsgtm1Mbl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:44632
|
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl)
|
decreased circulating free fatty acids level
|
J:78087
|
decreased circulating insulin level
|
J:78087
|
decreased circulating triglyceride level
|
J:78087
|
AI467606tm2b(EUCOMM)Wtsi/AI467606tm2b(EUCOMM)Wtsi
(C57BL/6N-AI467606tm2b(EUCOMM)Wtsi/BayMmucd)
|
increased circulating creatinine level
|
J:211773
|
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N)
|
hyperglycemia
|
J:262001
|
increased circulating insulin level
|
J:262001
|
increased circulating triglyceride level
|
J:262001
|
Aif1tm1.1(KOMP)Wtsi/Aif1tm1.1(KOMP)Wtsi
(C57BL/6N-Aif1tm1.1(KOMP)Wtsi/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
Aifm1tm2Pngr/Y Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased circulating lactate level
|
J:113016
|
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(C57BL/6NJcl-Aifm3em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating LDL cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Aim2em1(IMPC)Ccpcz/Aim2em1(IMPC)Ccpcz
(C57BL/6N-Aim2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Aim2Gt(CSG445)Byg/Aim2Gt(CSG445)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-18 level
|
J:158969
|
Aim2tm1.2Arte/Aim2tm1.2Arte Dnase2atm1Osa/Dnase2atm1Osa Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J)
|
increased circulating interleukin-10 level
|
J:238323
|
increased circulating tumor necrosis factor level
|
J:238323
|
Aim2tm1Ktak/Aim2tm1Ktak
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating interleukin-18 level
|
J:188013
|
Ajap1tm1b(EUCOMM)Hmgu/Ajap1tm1b(EUCOMM)Hmgu
(B6N(Cg)-Ajap1tm1b(EUCOMM)Hmgu/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Ajubaem1(IMPC)H/Ajubaem1(IMPC)H
(C57BL/6N-Ajubaem1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ak4em1(IMPC)Kmpc/Ak4em1(IMPC)Kmpc
(C57BL/6NTac-Ak4em1(IMPC)Kmpc/Kmpc)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ak7em1(IMPC)Ccpcz/Ak7+
(C57BL/6NCrl-Ak7em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating potassium level
|
J:211773
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6)
|
decreased circulating insulin level
|
J:190017
|
Akap5tm1Gsm/Akap5tm1Gsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:190017
|
Akap5tm1Jsco/Akap5tm1Jsco Tg(Ins2-cre)25Mgn/0
(involves: 129S * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:190017
|
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased circulating insulin level
|
J:190017
|
Akap7tm2b(EUCOMM)Hmgu/Akap7tm2b(EUCOMM)Hmgu
(C57BL/6N-Akap7tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Akap8Gt(XG068)Byg/Akap8Gt(XG068)Byg Fignfi/Fignfi
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6)
|
cyanosis
|
J:116474
|
Akap8lem1(IMPC)J/Akap8lem1(IMPC)J
(C57BL/6NJ-Akap8lem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(B6JTyr;B6N-Akap9tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
increased circulating fructosamine level
|
J:175295
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating glucose level
|
J:213427
|
decreased circulating HDL cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
decreased circulating serum albumin level
|
J:213427
|
decreased circulating total protein level
|
J:213427
|
increased circulating alkaline phosphatase level
|
J:213427
|
Akip1em1Cya/Akip1em1Cya
(C57BL/6N-Akip1em1Cya)
|
decreased bleeding time
|
J:326919
|
decreased prothrombin time
|
J:326919
|
Akp3tm1Jlm/Akp3tm1Jlm
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating triglyceride level
|
J:86263
|
Akr1b1tm1Tona/Akr1b1tm1Tona
(involves: 129S/SvEv * C57BL/6)
|
increased circulating calcium level
|
J:114187
|
increased circulating magnesium level
|
J:114187
|
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129)
|
increased circulating glycerol level
|
J:208505
|
increased circulating insulin level
|
J:208505
|
increased circulating leptin level
|
J:208505
|
increased circulating triglyceride level
|
J:208505
|
Akr1b7tm1.1Fth/Akr1b7tm1.1Fth
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating progesterone level
|
J:123295
|
increased circulating progesterone level
|
J:123295
|
Akr1b8tm1.1(KOMP)Vlcg/Akr1b8tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1b8tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Akr1c18tm1Mni/Akr1c18tm1Mni
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating progesterone level
|
J:129608
|
Akr1d1tm1.1(KOMP)Vlcg/Akr1d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1d1tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
decreased circulating leptin level
|
J:149156
|
hyperglycemia
|
J:149156
|
increased circulating insulin level
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ)
|
hyperglycemia
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
increased circulating insulin level
|
J:149156
|
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
decreased circulating leptin level
|
J:182721
|
decreased circulating thyroxine level
|
J:182721
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:71491
|
increased circulating insulin level
|
J:71491
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd)
|
hyperglycemia
|
J:160759
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb)
|
decreased circulating glucose level
|
J:155432
|
increased circulating insulin level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb)
|
decreased circulating cholesterol level
|
J:155432
|
increased circulating glucose level
|
J:155432
|
increased circulating insulin level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
hyperglycemia
|
J:160759
|
Akt2tm1.2Mbb/Akt2tm1.2Mbb Lepob/Lepob Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:155432
|
Akt2tm1Hem/Akt2tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:114675
|
increased circulating insulin level
|
J:114675
|
Akt2tm1Hem/Akt2tm1Hem
(involves: 129P2/OlaHsd)
|
increased circulating testosterone level
|
J:185012
|
Akt2tm1Hem/Akt2tm1Hem Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating testosterone level
|
J:114675
|
hyperglycemia
|
J:114675
|
increased circulating insulin level
|
J:114675
|
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg)
|
decreased circulating insulin level
|
J:84606
|
hyperglycemia
|
J:84606
|
increased circulating insulin level
|
J:84606
|
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ)
|
decreased circulating leptin level
|
J:149156
|
increased circulating insulin level
|
J:149156
|
Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * C57BL/6 * DBA/1LacJ)
|
decreased circulating insulin level
|
J:149156
|
Aktiptm1b(EUCOMM)Hmgu/Aktiptm1b(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr)
|
increased circulating triglyceride level
|
J:211773
|
Albem8Mvw/Albem8Mvw
(C57BL/6J-Albem8Mvw/MvwJ)
|
decreased circulating serum albumin level
|
J:101977
|
Albem12Mvw/Albem12Mvw Fcgrttm1Dcr/Fcgrttm1Dcr Tg(FCGRT)32Dcr/Tg(FCGRT)32Dcr
(B6.Cg-Tg(FCGRT)32Dcr Albem12Mvw Fcgrttm1Dcr/MvwJ)
|
decreased circulating serum albumin level
|
J:101977
|
AlbMhdabcl001/AlbMhdabcl001
(C3HeB/FeJ-AlbMhdabcl001/Ieg)
|
decreased circulating calcium level
|
J:183993
|
increased circulating alkaline phosphatase level
|
J:183993
|
AlbMhdabcl002/Alb+
(C3HeB/FeJ-AlbMhdabcl002)
|
decreased circulating calcium level
|
J:183993
|
decreased circulating serum albumin level
|
J:82809
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal circulating glucose level
|
J:197607
|
Aldh1a2tm1Dll/Aldh1a2tm1Dll
(Not Specified)
|
cyanosis
|
J:81969
|
Aldh1a2tm1Dll/Aldh1a2tm1Ipc
(involves: CD-1)
|
cyanosis
|
J:81969
|
Aldh1a3tm1.1Pcn/Aldh1a3tm1.1Pcn
(involves: 129/Sv * C57BL/6)
|
cyanosis
|
J:90261
|
Aldh1a3tm1b(KOMP)Wtsi/Aldh1a3+
(B6N(Cg)-Aldh1a3tm1b(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
hyperglycemia
|
J:232360
|
Aldh1b1tm1Vvas/Aldh1b1tm1Vvas
(B6J.Cg-Aldh1b1tm1Vvas)
|
increased fasting circulating glucose level
|
J:228677
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh2tm1a(EUCOMM)Wtsi/Ieg)
|
increased circulating free fatty acids level
|
J:165965
|
Aldh2tm1Dmro/Aldh2+
(B6.129-Aldh2tm1Dmro)
|
abnormal circulating hormone level
|
J:261952
|
Aldh7a1tm1d(EUCOMM)Hmgu/Aldh7a1tm1d(EUCOMM)Hmgu
(B6(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu)
|
increased circulating noradrenaline level
|
J:298561
|
Aldh16a1tm1a(EUCOMM)Wtsi/Aldh16a1tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh16a1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating sodium level
|
J:211773
|
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg
(C57BL/6N-Aldoctm1.1(KOMP)Vlcg)
|
decreased circulating cholesterol level
|
J:346664
|
decreased circulating HDL cholesterol level
|
J:346664
|
decreased circulating triglyceride level
|
J:346664
|
increased circulating triglyceride level
|
J:346664
|
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:346664
|
decreased circulating LDL cholesterol level
|
J:346664
|
decreased circulating triglyceride level
|
J:346664
|
Alg2tm1.1(KOMP)Vlcg/Alg2+
(B6N(Cg)-Alg2tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Alg8em1(IMPC)J/Alg8+
(C57BL/6NJ-Alg8em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Alktm1.1Rhp/Alktm1.1Rhp
(involves: 129 * C57BL/6N)
|
decreased circulating testosterone level
|
J:226955
|
Alktm2.1Ics/Alk+
(B6N.129S2(Cg)-Alktm2.1Ics)
|
increased circulating alkaline phosphatase level
|
J:226655
|
Alkbh6tm1b(EUCOMM)Hmgu/Alkbh6tm1b(EUCOMM)Hmgu
(C57BL/6N-Alkbh6tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J)
|
decreased fasting circulating glucose level
|
J:198968
|
increased circulating insulin level
|
J:198968
|
increased circulating leptin level
|
J:198968
|
Alkbh8tm1b(EUCOMM)Hmgu/Alkbh8tm1b(EUCOMM)Hmgu
(C57BL/6N-Alkbh8tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Alms1bbb/Alms1bbb
(C57BL/6JSfdAnu-Alms1bbb/Anu)
|
hyperglycemia
|
J:104190
|
increased circulating insulin level
|
J:104190
|
Alms1foz/Alms1foz
(involves: NOD)
|
hyperglycemia
|
J:107058
|
increased circulating insulin level
|
J:107058
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
hyperglycemia
|
J:100403
|
increased circulating cholesterol level
|
J:100403
|
increased circulating insulin level
|
J:100403
|
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
|
abnormal circulating cholesterol level
|
J:118221
|
increased circulating HDL cholesterol level
|
J:118221
|
increased circulating insulin level
|
J:118221
|
increased circulating leptin level
|
J:118221
|
increased circulating triglyceride level
|
J:118221
|
Alms1m3Btlr/Alms1m3Btlr
(C57BL/6J-Alms1m3Btlr)
|
increased circulating insulin level
|
J:264649
|
increased fasting circulating glucose level
|
J:264649
|
Alms1tm1b(EUCOMM)Hmgu/Alms1tm1b(EUCOMM)Hmgu
(C57BL/6N-Alms1tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J)
|
increased circulating leptin level
|
J:104825
|
increased circulating VLDL cholesterol level
|
J:104825
|
Alox12tm1Fun/Alox12tm1Fun
(involves: 129S2/SvPas * C57BL/6)
|
increased platelet aggregation
|
J:46896
|
increased susceptibility to induced thrombosis
|
J:46896
|
Alpk1em1Dlka/Alpk1em1Dlka Crb1rd8/Crb1rd8
(involves: C57BL/6N)
|
abnormal circulating chemokine level
|
J:344848
|
increased circulating CXCL10 level
|
J:344848
|
AlplALPLD1/?
(involves: C3HeB/FeJ)
|
decreased circulating alkaline phosphatase level
|
J:68708,
J:187875
|
AlplBAP023/AlplBAP023
(C3HeB/FeJ-AlplBAP023)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
Alplem1(IMPC)Ccpcz/Alpl+
(C57BL/6NCrl-Alplem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
AlplHpp/Alpl+
(involves: BALB/cAnN * C3H/HeH)
|
decreased circulating alkaline phosphatase level
|
J:82809,
J:122319
|
AlplHpp/AlplHpp
(involves: BALB/cAnN * C3H/HeH)
|
decreased circulating alkaline phosphatase level
|
J:122319
|
AlplMhdabap020/AlplMhdabap020
(C3HeB/FeJ-AlplMhdabap020/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
AlplMhdabap26/AlplMhdabap26
(C3HeB/FeJ-AlplMhdabap26)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
AlplMhdabap27/AlplMhdabap27
(C3HeB/FeJ-AlplMhdabap27)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
AlplMhdabap32/AlplMhdabap32
(C3HeB/FeJ-AlplMhdabap32)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
AlplSAP007/AlplSAP007
(C3HeB/FeJ-AlplSAP007)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
decreased circulating alkaline phosphatase level
|
J:39015
|
Alpltm1Sor/Alpltm1Sor
(either: (involves: 129S7/SvEvBrd-Alpltm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal blood homeostasis
|
J:28394
|
Als2clem1(IMPC)J/Als2clem1(IMPC)J
(C57BL/6NJ-Als2clem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Altretm1.1Hbgl/Altretm1.1Hbgl Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:342907
|
Alx1tm1Crm/Alx1tm1Crm
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:33716
|
Alx3tm1Hubr/Alx3+
(involves: 129P2/OlaHsd)
|
increased circulating glucose level
|
J:166436
|
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd)
|
increased circulating insulin level
|
J:166436
|
increased fasting circulating glucose level
|
J:166436
|
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating cholesterol level
|
J:90370
|
increased circulating alkaline phosphatase level
|
J:90370
|
Amer1tm1.2Nbar/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL)
|
cyanosis
|
J:173242
|
Amfrtm1a(KOMP)Wtsi/Amfrtm1a(KOMP)Wtsi
(B6JTyr;B6N-Amfrtm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Amhtm1Bhr/Amhtm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
suppressed circulating follicle stimulating hormone level
|
J:58577
|
Amhr2tm3(cre)Bhr/Amhr2+ Artm1Chc/Y
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating testosterone level
|
J:118270
|
Amhr2tm3(cre)Bhr/Amhr2+ Fsttm1Zuk/Fsttm2Zuk
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating testosterone level
|
J:89081
|
increased circulating follicle stimulating hormone level
|
J:89081
|
increased circulating luteinizing hormone level
|
J:89081
|
Amhr2tm3(cre)Bhr/Amhr2+ Nr5a1tm1Klp/Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased circulating estradiol level
|
J:145805
|
decreased circulating testosterone level
|
J:91352
|
increased circulating follicle stimulating hormone level
|
J:145805
|
Amhr2tm3(cre)Bhr/Amhr2+ Smad1tm2Rob/Smad1tm2.1Rob Smad5tm1Huy/Smad5tm1Huy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
suppressed circulating follicle stimulating hormone level
|
J:157310
|
Amhr2tm3(cre)Bhr/Amhr2+ Smad1tm2Rob/Smad1tm2Rob Smad5tm1Huy/Smad5tm1Huy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
suppressed circulating follicle stimulating hormone level
|
J:157310
|
Amhr2tm3(cre)Bhr/Amhr2+ Smad1tm2Rob/Smad1tm2Rob Smad5tm1Huy/Smad5tm1Zuk
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
suppressed circulating follicle stimulating hormone level
|
J:157310
|
Amhr2tm3(cre)Bhr/Amhr2+ Smad2tm1Cxd/Smad2tm1.1Mwst Smad3tm1Par/Smad3tm1Zuk
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:142827
|
increased circulating luteinizing hormone level
|
J:142827
|
Amhr2tm3(cre)Bhr/Amhr2+ Smad4tm1Rob/Smad4tm1.1Rob
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating progesterone level
|
J:108954
|
Ampd2m4521Dajl/Ampd2m4521Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
increased circulating cholesterol level
|
J:149088
|
increased circulating LDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Ampd2tm1b(EUCOMM)Hmgu/Ampd2+
(C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H)
|
increased circulating potassium level
|
J:211773
|
Ampd2tm1b(EUCOMM)Hmgu/Ampd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Anapc1em1(IMPC)J/Anapc1+
(C57BL/6NJ-Anapc1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Anapc2tm1Kna/Anapc2tm2Kna Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating bilirubin level
|
J:87782
|
Anapc13tm2b(EUCOMM)Wtsi/Anapc13+
(C57BL/6N-Anapc13tm2b(EUCOMM)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Anapc15tm1.1(KOMP)Vlcg/Anapc15+
(B6N(Cg)-Anapc15tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Angel1tm1(NCOM)Cmhd/Angel1tm1(NCOM)Cmhd
(C57BL/6N-Angel1tm1(NCOM)Cmhd/2Tcp)
|
decreased circulating creatinine level
|
J:165965
|
Angptl1tm4b(KOMP)Wtsi/Angptl1tm4b(KOMP)Wtsi
(C57BL/6N-Angptl1tm4b(KOMP)Wtsi/Kmpc)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Angptl3hypl/Angptl3hypl
(involves: KK/Snk)
|
decreased circulating cholesterol level
|
J:75358
|
decreased circulating free fatty acids level
|
J:75358
|
decreased circulating HDL cholesterol level
|
J:75358
|
decreased circulating LDL cholesterol level
|
J:75358
|
decreased circulating triglyceride level
|
J:75358
|
decreased circulating VLDL cholesterol level
|
J:75358
|
Angptl3tm1Akos/Angptl3tm1Akos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl3tm1Akos/Angptl3tm1Akos Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj)
|
decreased circulating cholesterol level
|
J:107479
|
decreased circulating free fatty acids level
|
J:107479
|
decreased circulating triglyceride level
|
J:107479
|
decreased circulating VLDL cholesterol level
|
J:107479
|
Angptl3tm1Lex/Angptl3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm1Lex/Angptl3tm1Lex Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:149912
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm1Lex/Angptl3tm1Lex Ldlrtm1Her/Ldlrtm1Her
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:149912
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm2b(KOMP)Wtsi/Angptl3tm2b(KOMP)Wtsi
(C57BL/6N-Angptl3tm2b(KOMP)Wtsi/Ccpcz)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Angptl4Gt(OST352973)Lex/Angptl4Gt(OST352973)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:122968
|
decreased circulating VLDL cholesterol level
|
J:122968
|
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl4tm1b(EUCOMM)Hmgu/Angptl4tm1b(EUCOMM)Hmgu
(C57BL/6N-Angptl4tm1b(EUCOMM)Hmgu/H)
|
decreased circulating triglyceride level
|
J:211773
|
Angptl4tm1Lex/Angptl4+
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:149912
|
Angptl4tm1Lex/Angptl4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:122968
|
decreased circulating triglyceride level
|
J:149912
|
decreased circulating VLDL cholesterol level
|
J:122968
|
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:97552
|
increased circulating cholesterol level
|
J:97552
|
increased circulating free fatty acids level
|
J:97552
|
increased circulating insulin level
|
J:97552
|
increased circulating leptin level
|
J:97552
|
Angptl8tm1(KOMP)Vlcg/Angptl8+
(involves: C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:217262
|
Angptl8tm1(KOMP)Vlcg/Angptl8tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:217262
|
decreased circulating VLDL triglyceride level
|
J:217262
|
Angptl8tm1Lex/Angptl8tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:161922,
J:187261
|
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased blood urea nitrogen level
|
J:199427
|
increased circulating alanine transaminase level
|
J:199427
|
increased circulating aspartate transaminase level
|
J:199427
|
increased circulating bilirubin level
|
J:199427
|
Ank1M1Btlr/Ank1+
(C57BL/6J-Ank1m1Btlr)
|
increased circulating bilirubin level
|
J:203831
|
Ank1M1Btlr/Ank1M1Btlr
(C57BL/6J-Ank1m1Btlr)
|
increased circulating bilirubin level
|
J:203831
|
increased circulating erythropoietin level
|
J:203831
|
Ank1nb/Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1)
|
abnormal cardiac thrombosis
|
J:62355
|
increased circulating bilirubin level
|
J:162532
|
Ank1Rbc2/Ank1Rbc2
(involves: 129S1/Sv * BALB/c)
|
increased circulating bilirubin level
|
J:148127
|
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
|
increased circulating free fatty acids level
|
J:222913
|
increased circulating glucose level
|
J:222913
|
Ank2tm3.1Bnt/Ank2+
(B6.129(C)-Ank2tm3.1Bnt/J)
|
increased circulating glucose level
|
J:222913
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
decreased circulating insulin level
|
J:222913
|
increased circulating free fatty acids level
|
J:222913
|
increased circulating glucose level
|
J:222913
|
Anktm1.1Ejr/Anktm1.1Ejr
(B6.129-Anktm1.1Ejr)
|
abnormal circulating enzyme level
|
J:168526
|
increased circulating alkaline phosphatase level
|
J:168526
|
Ankhd1tm1a(KOMP)Wtsi/Ankhd1tm1a(KOMP)Wtsi
(C57BL/6N-Ankhd1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Ankib1tm1b(EUCOMM)Hmgu/Ankib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ankib1tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ankrd11tm1b(EUCOMM)Wtsi/Ankrd11+
(C57BL/6N-Ankrd11tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ankrd11Yod/Ankrd11+
(involves: BALB/cAnNCrl * C3H/HeH)
|
decreased circulating leptin level
|
J:136455
|
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating free fatty acids level
|
J:130984
|
increased circulating insulin level
|
J:130984
|
increased circulating leptin level
|
J:130984
|
increased circulating triglyceride level
|
J:130984
|
Ankrd28em1(IMPC)J/Ankrd28em1(IMPC)J
(C57BL/6NJ-Ankrd28em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ankrd60em1(IMPC)J/Ankrd60em1(IMPC)J
(C57BL/6NJ-Ankrd60em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Ano1tm1Bdh/Ano1tm1Bdh
(involves: 129S1/Sv)
|
cyanosis
|
J:138613
|
Ano1tm2Jrr/Ano1tm2Jrr Tg(Cdh16-cre)91Igr/0
(involves: 129S6/SvEvTac * ICR)
|
increased circulating aldosterone level
|
J:210158
|
increased circulating renin level
|
J:210158
|
Ano3em2(IMPC)Mbp/Ano3em2(IMPC)Mbp
(C57BL/6N-Ano3em2(IMPC)Mbp/Mmucd)
|
decreased circulating alanine transaminase level
|
J:211773
|
Ano5em1Huyi/Ano5+
(C57BL/6N-Ano5em1Huyi)
|
increased circulating alkaline phosphatase level
|
J:294237
|
Ano5em1Huyi/Ano5em1Huyi
(C57BL/6N-Ano5em1Huyi)
|
increased circulating alkaline phosphatase level
|
J:294237
|
increased circulating creatine kinase level
|
J:294237
|
Ano5em2Huyi/Ano5em2Huyi
(C57BL/6-Ano5em2Huyi)
|
increased circulating alkaline phosphatase level
|
J:336715
|
Ano5tm1Lrk/Ano5tm1Lrk
(involves: C57BL/6)
|
increased circulating creatine kinase level
|
J:235810
|
Ano6tm1.2Lyj/Ano6tm1.2Lyj
(involves: 129X1/SvJ * C57BL/6)
|
abnormal platelet physiology
|
J:188263
|
decreased susceptibility to induced thrombosis
|
J:188263
|
increased bleeding time
|
J:188263
|
Ano6tm1Avor/Ano6tm1Avor
(involves: 129)
|
increased bleeding time
|
J:260534
|
Ano8em1(IMPC)J/Ano8em1(IMPC)J
(C57BL/6NJ-Ano8em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Anp32btm1Mak/Anp32btm1Mak
(C.129P2(B6)-Anp32btm1Mak)
|
decreased circulating bilirubin level
|
J:227403
|
decreased circulating cholesterol level
|
J:227403
|
decreased circulating HDL cholesterol level
|
J:227403
|
decreased circulating total protein level
|
J:227403
|
Antkmttm1.1(KOMP)Vlcg/Antkmttm1.1(KOMP)Vlcg
(C57BL/6N-Antkmttm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Antxr2em1(IMPC)Wtsi/Antxr2em1(IMPC)Wtsi
(C57BL/6N-Antxr2em1(IMPC)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
anx/anx
(B6C3Fe a/a-anx/J)
|
hypoglycemia
|
J:7689
|
increased blood urea nitrogen level
|
J:7689
|
increased blood uric acid level
|
J:7689
|
increased circulating alkaline phosphatase level
|
J:7689
|
increased circulating cholesterol level
|
J:7689
|
anx/anx Tyro3m1/Tyro3m1
(involves: C3HeB/FeJLe * C57BL/6J)
|
abnormal platelet activation
|
J:241666
|
Anxa1em1(IMPC)Ccpcz/Anxa1em1(IMPC)Ccpcz
(C57BL/6NCrl-Anxa1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating iron level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
|
increased circulating insulin level
|
J:115806
|
Anxa2tm1Kah/Anxa2tm1Kah
(involves: 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:87621
|
increased susceptibility to induced thrombosis
|
J:87621
|
Anxa6tm1(NCOM)Cmhd/Anxa6tm1(NCOM)Cmhd
(C57BL/6N-Anxa6tm1(NCOM)Cmhd/Tcp)
|
increased circulating sodium level
|
J:165965
|
Anxa7tm1Ngl/Anxa7tm1Ngl
(involves: 129S2/SvPas)
|
abnormal platelet aggregation
|
J:91188
|
Aoc1tm1b(EUCOMM)Hmgu/Aoc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aoc1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Aopeptm1b(KOMP)Wtsi/Aopeptm1b(KOMP)Wtsi
(C57BL/6N-Aopeptm1b(KOMP)Wtsi/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ap1artm2b(EUCOMM)Hmgu/Ap1artm2b(EUCOMM)Hmgu
(C57BL/6N-Ap1artm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Ap1g1fgt/Ap1g1fgt
(C57BL/6-Ap1g1fgt/KjnBoc)
|
decreased circulating thyroxine level
|
J:230572
|
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:226582
|
decreased circulating serum albumin level
|
J:226582
|
increased circulating cholesterol level
|
J:226582
|
Ap1s2em1(IMPC)Mbp/Ap1s2em1(IMPC)Mbp
(C57BL/6N-Ap1s2em1(IMPC)Mbp/MbpMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Ap2a1em1(IMPC)J/Ap2a1em1(IMPC)J
(C57BL/6NJ-Ap2a1em1(IMPC)J/Mmjax)
|
decreased circulating creatinine level
|
J:211773
|
Ap2a2em1(IMPC)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2em1(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ap3b1pe-rim2/Ap3b1pe-rim2
(involves: B10.A(R201) * C57BL/10Slc)
|
abnormal platelet dense granule physiology
|
J:42685
|
decreased platelet aggregation
|
J:42685
|
Ap3b1pe/Ap3b1pe
(involves: C3H/He)
|
abnormal blood coagulation
|
J:7327
|
abnormal platelet dense granule physiology
|
J:7327
|
increased bleeding time
|
J:7327
|
Ap3b1pe/Ap3b1pe
(B6.C3-Ap3b1pe/J)
|
abnormal platelet activation
|
J:221384
|
decreased platelet aggregation
|
J:221384
|
increased bleeding time
|
J:7327
|
Ap3b1tm1Sms/Ap3b1tm1Sms
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased bleeding time
|
J:66256
|
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J)
|
decreased platelet aggregation
|
J:29151
|
increased bleeding time
|
J:29151
|
Ap3d1mh/Ap3d1mh
(B6.C3-Grxcr1pi)
|
increased bleeding time
|
J:88018
|
Ap3s1tm1b(EUCOMM)Hmgu/Ap3s1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ap3s1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ap3s2tm1b(EUCOMM)Hmgu/Ap3s2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ap3s2tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ap4e1em1(IMPC)J/Ap4e1+
(C57BL/6NJ-Ap4e1em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ap4e1em1(IMPC)J/Ap4e1em1(IMPC)J
(C57BL/6NJ-Ap4e1em1(IMPC)J/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Ap4e1em2(IMPC)Mbp/Ap4e1em2(IMPC)Mbp
(C57BL/6NCrl-Ap4e1em2(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg)
|
increased circulating amylase level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Ap4m1tm1b(EUCOMM)Wtsi/Ap4m1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap4m1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Ap5m1em1(IMPC)Mbp/Ap5m1em1(IMPC)Mbp
(C57BL/6N-Ap5m1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski)
|
decreased circulating interleukin-12 level
|
J:176742
|
decreased circulating tumor necrosis factor level
|
J:176742
|
Apbb1ipem1(IMPC)Ccpcz/Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Apbb2tm1.1(KOMP)Vlcg/Apbb2+
(C57BL/6N-Apbb2tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
ApcMin/Apc+
(involves: AKR/J * C57BL/6J)
|
hyperlipidemia
|
J:10209
|
ApcMin/Apc+
(C57BL/6J-ApcMin)
|
increased circulating free fatty acids level
|
J:86036
|
increased circulating triglyceride level
|
J:86036
|
Apctm1Kk/Apctm1Kk Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased circulating tumor necrosis factor level
|
J:128606
|
Apctm1Tno/Apctm1Tno Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * ICR)
|
increased blood urea nitrogen level
|
J:95502
|
Apctm2.1Cip/Apctm2.1Cip Lect2tm1Ymg/Lect2tm1Ymg Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
abnormal circulating enzyme level
|
J:184496
|
Apctm2Rak/Apc+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased circulating cholesterol level
|
J:234310
|
increased circulating triglyceride level
|
J:234310
|
Apctm2Tno/Apc+
(involves: C57BL/6J)
|
hyperlipidemia
|
J:86036
|
increased circulating cholesterol level
|
J:86036
|
increased circulating free fatty acids level
|
J:86036
|
increased circulating triglyceride level
|
J:86036
|
Apex1tm1Cur/Apex1+
(involves: 129S1/Sv)
|
increased circulating interleukin-1 alpha level
|
J:119957
|
increased circulating interleukin-10 level
|
J:119957
|
Apiptm1b(EUCOMM)Wtsi/Apiptm1b(EUCOMM)Wtsi
(C57BL/6N-Apiptm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Apmapem1(IMPC)J/Apmapem1(IMPC)J
(C57BL/6NJ-Apmapem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs)
|
decreased circulating glucose level
|
J:247647
|
decreased circulating leptin level
|
J:247647
|
increased circulating leptin level
|
J:247647
|
Apoa1tm1(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81908
|
Apoa1tm1Bres/Apoa1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:40819
|
decreased circulating HDL cholesterol level
|
J:40819
|
decreased circulating LDL cholesterol level
|
J:40819
|
decreased circulating VLDL cholesterol level
|
J:40819
|
increased circulating triglyceride level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres Tg(Mt1-CETP)#Tall/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Unc/Apoa1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:2109
|
decreased circulating HDL cholesterol level
|
J:2109
|
Apoa1tm1Unc/Apoa1+
(B6.129P2-Apoa1tm1Unc)
|
decreased circulating cholesterol level
|
J:22986
|
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc/J)
|
decreased circulating cholesterol level
|
J:114205
|
decreased circulating HDL cholesterol level
|
J:114205
|
decreased circulating phospholipid level
|
J:114205
|
increased circulating cholesterol level
|
J:114205
|
increased circulating triglyceride level
|
J:114205
|
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:2109
|
decreased circulating HDL cholesterol level
|
J:2109
|
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc)
|
decreased circulating cholesterol level
|
J:22986
|
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:129136
|
decreased circulating HDL cholesterol level
|
J:129136
|
decreased circulating phospholipid level
|
J:129136
|
Apoa1tm1Unc/Apoa1tm1Unc Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc)
|
decreased circulating cholesterol level
|
J:85174
|
decreased circulating HDL cholesterol level
|
J:85174
|
decreased circulating LDL cholesterol level
|
J:85174
|
decreased circulating VLDL cholesterol level
|
J:85174
|
increased circulating triglyceride level
|
J:85174
|
Apoa1tm1Unc/Apoa1tm1Unc Tg(APOA1)1Rub/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:129136
|
increased circulating HDL cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Apoa1tm1Unc/Apoa1tm1Unc Tg(APOA2)3Rub/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Apoa1tm2(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81908
|
decreased circulating HDL cholesterol level
|
J:81908
|
Apoa2b/?
(involves: KK * RR)
|
increased circulating cholesterol level
|
J:99474
|
Apoa2tm1Bres/Apoa2+ Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
decreased circulating free fatty acids level
|
J:37250
|
decreased circulating glucose level
|
J:37250
|
decreased circulating HDL cholesterol level
|
J:37250
|
decreased circulating insulin level
|
J:37250
|
Apoa2tm1Bres/Apoa2tm1Bres Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
decreased circulating HDL cholesterol level
|
J:37250
|
Apoa4tm1Bres/Apoa4tm1Bres
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased circulating cholesterol level
|
J:43015
|
decreased circulating HDL cholesterol level
|
J:43015
|
decreased circulating triglyceride level
|
J:43015
|
decreased circulating VLDL triglyceride level
|
J:43015
|
Apoa5tm1Hgc/Apoa5+
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating VLDL cholesterol level
|
J:72092
|
Apoa5tm1Hgc/Apoa5tm1Hgc
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating triglyceride level
|
J:72092
|
increased circulating VLDL cholesterol level
|
J:72092
|
Apobtm1.1Zc/Apob+
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:65191
|
decreased circulating VLDL cholesterol level
|
J:65191
|
Apobtm1.1Zc/Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:65191
|
decreased circulating LDL cholesterol level
|
J:65191
|
decreased circulating triglyceride level
|
J:65191
|
decreased circulating VLDL cholesterol level
|
J:65191
|
Apobtm1Mae/Apob+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating apolipoprotein level
|
J:113171,
J:36426
|
decreased circulating cholesterol level
|
J:113171
|
Apobtm1Mae/Apobtm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating apolipoprotein level
|
J:36426
|
abnormal circulating HDL cholesterol level
|
J:36426
|
decreased circulating cholesterol level
|
J:36426
|
decreased circulating LDL cholesterol level
|
J:36426
|
decreased circulating VLDL cholesterol level
|
J:36426
|
Apobtm1Sgy/Apobtm1Sgy
(involves: 129/Sv * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:33830
|
decreased circulating triglyceride level
|
J:33830
|
Apobtm1Sgy/Apobtm1Sgy Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:41510
|
increased circulating triglyceride level
|
J:41510
|
increased circulating VLDL cholesterol level
|
J:41510
|
Apobtm1Unc/Apob+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:16352
|
decreased circulating HDL cholesterol level
|
J:16352
|
decreased circulating triglyceride level
|
J:16352
|
Apobtm1Unc/Apobtm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:16352
|
decreased circulating HDL cholesterol level
|
J:16352
|
decreased circulating triglyceride level
|
J:16352
|
Apobtm1Zc/Apob+
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating HDL cholesterol level
|
J:76047
|
decreased circulating LDL cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
decreased circulating VLDL cholesterol level
|
J:76047
|
Apobtm1Zc/Apobtm1.1Zc
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating HDL cholesterol level
|
J:76047
|
decreased circulating LDL cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
decreased circulating VLDL cholesterol level
|
J:76047
|
Apobtm1Zc/Apobtm1Zc
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
Apobtm2Sgy/Apobtm2Sgy
(involves: 129/Sv * C57BL/6)
|
increased circulating LDL cholesterol level
|
J:33830
|
increased circulating triglyceride level
|
J:33830
|
Apobtm2Sgy/Apobtm2Sgy Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41510
|
increased circulating HDL cholesterol level
|
J:41510
|
increased circulating triglyceride level
|
J:41510
|
increased circulating VLDL cholesterol level
|
J:41510
|
increased circulating VLDL triglyceride level
|
J:41510
|
Apobtm2Sgy/Apobtm2Sgy Apoetm1Unc/Apoetm1Unc Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:133453
|
decreased circulating HDL cholesterol level
|
J:133453
|
hyperglycemia
|
J:133453
|
increased circulating cholesterol level
|
J:133453
|
increased circulating free fatty acids level
|
J:133453
|
increased circulating insulin level
|
J:133453
|
increased circulating triglyceride level
|
J:133453
|
increased circulating VLDL cholesterol level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:227165
|
increased circulating insulin level
|
J:227165
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:133453
|
decreased circulating HDL cholesterol level
|
J:133453
|
increased circulating cholesterol level
|
J:133453
|
increased circulating free fatty acids level
|
J:133453
|
increased circulating insulin level
|
J:133453
|
increased circulating LDL cholesterol level
|
J:133453
|
increased circulating triglyceride level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:141333
|
increased circulating insulin level
|
J:141333
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
abnormal fasting circulating glucose level
|
J:227165
|
increased circulating cholesterol level
|
J:227165
|
increased circulating insulin level
|
J:227165
|
Apobtm2Sgy/Apobtm4Sgy
(involves: 129/Sv * 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:46549
|
Apobtm3Sgy/Apob+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:23315
|
decreased circulating HDL cholesterol level
|
J:23315
|
Apobtm5Sgy/Apobtm5Sgy
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:51549
|
decreased circulating VLDL cholesterol level
|
J:51549
|
Apobec1tm1Chan/Apobec1tm1Chan
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:36051
|
Apobec1tm1Chan/Apobec1tm1Chan Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating cholesterol level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Chan/Apobec1tm1Chan Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating triglyceride level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Chan/Apobec1tm1Chan Tg(CETP)5203Tall/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating HDL cholesterol level
|
J:48202
|
decreased circulating triglyceride level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Fggtm1Fjc/Fggtm1Fjc Ldlrtm1Her/Ldlrtm1Her
(B6.129-Fggtm1Fjc Apobec1tm1Ddsn Ldlrtm1Her)
|
abnormal blood coagulation
|
J:132734
|
increased circulating LDL cholesterol level
|
J:132734
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:49125
|
increased circulating LDL cholesterol level
|
J:49125
|
increased circulating triglyceride level
|
J:49125
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Ldlrtm1Her/Ldlrtm1Her
(B6.129-Apobec1tm1Ddsn Ldlrtm1Her)
|
abnormal blood coagulation
|
J:132734
|
decreased partial thromboplastin time
|
J:132734
|
decreased prothrombin time
|
J:132734
|
increased circulating antithrombin level
|
J:132734
|
increased circulating LDL cholesterol level
|
J:132734
|
increased circulating prothrombin level
|
J:132734
|
Apobec1tm1Ishi/Apobec1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41982
|
Apobec1tm1Ishi/Apobec1tm1Ishi Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41982
|
increased circulating triglyceride level
|
J:41982
|
Apobec1tm1Rub/Apobec1tm1Rub
(involves: C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:74021
|
increased circulating LDL cholesterol level
|
J:74021
|
Apobec1tm1Rub/Apobec1tm1Rub Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:79196
|
decreased circulating LDL cholesterol level
|
J:79196
|
increased circulating HDL cholesterol level
|
J:79196
|
increased circulating triglyceride level
|
J:79196
|
increased circulating VLDL triglyceride level
|
J:79196
|
Apoc1tm1Lmh/Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:22858
|
increased circulating cholesterol level
|
J:22858
|
increased circulating triglyceride level
|
J:22858
|
Apoc1tm2Lmh/Apoc1tm2Lmh Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:28261
|
Apoc2em1Arem/Apoc2+
(involves: C57BL/6 * FVB/NJ)
|
increased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em1Arem/Apoc2em1Arem
(involves: C57BL/6 * FVB/NJ)
|
abnormal blood homeostasis
|
J:227332
|
abnormal circulating cholesterol level
|
J:227332
|
decreased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em2Arem/Apoc2+
(involves: C57BL/6 * CBA)
|
increased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em2Arem/Apoc2em2Arem
(involves: C57BL/6 * CBA)
|
abnormal blood homeostasis
|
J:227332
|
abnormal circulating cholesterol level
|
J:227332
|
decreased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc3tm1Unc/Apoc3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating HDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
Apoc3tm1Unc/Apoc3+
(involves: 129)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating HDL cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J)
|
abnormal blood homeostasis
|
J:105136
|
decreased circulating triglyceride level
|
J:105136
|
increased circulating glucose level
|
J:105136
|
increased circulating ketone body level
|
J:105136
|
increased circulating leptin level
|
J:105136
|
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Apoeshl/Apoeshl
(KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(C3.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(C.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(B6.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(involves: C3H/He * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoeshl
(involves: BALB/c * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoeshl
(involves: C57BL/6 * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoetm1Unc
(involves: 129P2/OlaHsd * KOR)
|
increased circulating cholesterol level
|
J:54051
|
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating cholesterol level
|
J:136987
|
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga Igs7tm1(tetO-Apoe)Gaga/0
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating cholesterol level
|
J:136987
|
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperlipidemia
|
J:48565
|
increased circulating cholesterol level
|
J:67282,
J:48565
|
increased circulating triglyceride level
|
J:67282,
J:48565
|
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased circulating cholesterol level
|
J:60590
|
increased circulating LDL cholesterol level
|
J:60590
|
increased circulating VLDL cholesterol level
|
J:60590
|
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:104859
|
Apoetm1.1Mae/Apoetm1.1Mae Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased circulating cholesterol level
|
J:219838
|
decreased circulating glucose level
|
J:219838
|
decreased circulating insulin level
|
J:219838
|
decreased circulating triglyceride level
|
J:219838
|
Apoetm1Bres/Apoe+
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased circulating cholesterol level
|
J:2809
|
Apoetm1Bres/Apoetm1Bres
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal circulating LDL cholesterol level
|
J:2809
|
increased circulating cholesterol level
|
J:2809,
J:42426
|
increased circulating VLDL cholesterol level
|
J:2809
|
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)
|
decreased circulating HDL cholesterol level
|
J:42927
|
increased circulating cholesterol level
|
J:42927
|
increased circulating triglyceride level
|
J:42927
|
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:29950
|
Apoetm1Bres/Apoetm1Bres
(B6.129P2-Apoetm1Bres)
|
abnormal circulating cholesterol level
|
J:68574
|
Apoetm1Bres/Apoetm1Bres Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Apoetm1Bres Esr1tm1Ksk)
|
abnormal circulating cholesterol level
|
J:68574
|
Apoetm1Bres/Apoetm1Bres Fn1tm1Bwg/Fn1tm1Bwg
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating VLDL cholesterol level
|
J:90917
|
Apoetm1Bres/Apoetm1Bres Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:40921
|
increased circulating phospholipid level
|
J:40921
|
Apoetm1Bres/Apoetm1Bres Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)
|
decreased circulating HDL cholesterol level
|
J:42927
|
Apoetm1Khw/Apoetm1Khw
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:75681
|
increased circulating LDL cholesterol level
|
J:75681
|
increased circulating triglyceride level
|
J:75681
|
increased circulating VLDL cholesterol level
|
J:75681
|
Apoetm1Khw/Apoetm1Khw Tg(Mx1-cre)29-4Her/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:75681
|
increased circulating LDL cholesterol level
|
J:75681
|
increased circulating triglyceride level
|
J:75681
|
increased circulating VLDL cholesterol level
|
J:75681
|
Apoetm1Khw/Apoetm1Khw Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Khw Tg(Mx1-cre)29-4Her)
|
abnormal circulating lipid level
|
J:196923
|
hyperlipidemia
|
J:196923
|
increased circulating cholesterol level
|
J:196923
|
increased circulating VLDL cholesterol level
|
J:196923
|
Apoetm1Lmh/Apoe+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:22347
|
increased circulating HDL cholesterol level
|
J:22347
|
increased circulating VLDL cholesterol level
|
J:22347
|
Apoetm1Lmh/Apoetm1Lmh
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:22347
|
increased circulating HDL cholesterol level
|
J:22347
|
increased circulating VLDL cholesterol level
|
J:22347
|
Apoetm1Lmh/Apoetm1Lmh Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating HDL cholesterol level
|
J:117317
|
increased circulating LDL cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Apoetm1Lmh/Apoetm1Lmh Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
abnormal circulating enzyme level
|
J:90547
|
abnormal circulating protein level
|
J:90547
|
decreased circulating cholesterol level
|
J:90547
|
decreased circulating LDL cholesterol level
|
J:90547
|
decreased circulating triglyceride level
|
J:90547
|
decreased circulating VLDL cholesterol level
|
J:90547
|
increased circulating cholesterol level
|
J:117317
|
increased circulating factor VIII level
|
J:90547,
J:117317
|
increased circulating HDL cholesterol level
|
J:117317
|
increased circulating LDL cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
increased circulating von Willebrand factor level
|
J:90547
|
Apoetm1Rraf/Apoetm1Rraf Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Rraf Tg(Mx1-cre)29-4Her)
|
abnormal circulating cholesterol level
|
J:196923
|
decreased circulating VLDL cholesterol level
|
J:196923
|
hyperlipidemia
|
J:196923
|
increased circulating cholesterol level
|
J:196923
|
Apoetm1Unc/Apoe+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating triglyceride level
|
J:16573
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal circulating cholesterol level
|
J:73202
|
abnormal glomerular capillary thrombosis
|
J:125978
|
decreased circulating glucose level
|
J:73202
|
decreased circulating HDL cholesterol level
|
J:91058
|
decreased circulating homocysteine level
|
J:73202
|
decreased circulating triglyceride level
|
J:93987
|
hyperlipidemia
|
J:101576
|
increased circulating cholesterol level
|
J:104609,
J:97385,
J:125978,
J:91058,
J:101576,
J:73202,
J:133606
|
increased circulating HDL cholesterol level
|
J:226403
|
increased circulating LDL cholesterol level
|
J:91058,
J:101576,
J:93987
|
increased circulating triglyceride level
|
J:91058,
J:101576,
J:73202
|
increased circulating VLDL cholesterol level
|
J:91058,
J:101576,
J:93987
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:16573
|
hyperlipidemia
|
J:80689
|
increased circulating cholesterol level
|
J:40136,
J:41510,
J:16573,
J:80689
|
increased circulating LDL cholesterol level
|
J:16573
|
increased circulating triglyceride level
|
J:16573,
J:80689
|
increased circulating VLDL cholesterol level
|
J:41510,
J:16573
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating corticosterone level
|
J:101973
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
decreased circulating leptin level
|
J:60585
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr)
|
increased circulating cholesterol level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:75567
|
decreased circulating HDL cholesterol level
|
J:75567
|
increased circulating cholesterol level
|
J:75567
|
increased circulating phospholipid level
|
J:75567
|
Apoetm1Unc/Apoetm1Unc Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:338121
|
increased circulating triglyceride level
|
J:338121
|
Apoetm1Unc/Apoetm1Unc Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * SJL)
|
increased circulating cholesterol level
|
J:101788
|
increased circulating LDL cholesterol level
|
J:101788
|
increased circulating triglyceride level
|
J:101788
|
increased circulating VLDL cholesterol level
|
J:101788
|
Apoetm1Unc/Apoetm1Unc Cbstm1Unc/Cbstm1Unc Tg(Mt1-CBS)25Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
increased circulating homocysteine level
|
J:168131
|
increased circulating methionine level
|
J:168131
|
increased circulating tumor necrosis factor level
|
J:168131
|
Apoetm1Unc/Apoetm1Unc Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
decreased circulating triglyceride level
|
J:61672
|
Apoetm1Unc/Apoetm1Unc Crptm1Hjf/Crptm1Hjf
(B6.Cg-Crptm1Hjf Apoetm1Unc)
|
decreased circulating HDL cholesterol level
|
J:170409
|
decreased circulating triglyceride level
|
J:170409
|
increased circulating HDL cholesterol level
|
J:170409
|
Apoetm1Unc/Apoetm1Unc Csf1op/Csf1op
(involves: 129P2/OlaHsd * C3HeB/Fe * C57BL/6)
|
increased circulating cholesterol level
|
J:40136
|
Apoetm1Unc/Apoetm1Unc Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:184647
|
decreased circulating insulin level
|
J:184647
|
increased circulating C-reactive protein level
|
J:184647
|
increased circulating cholesterol level
|
J:184647
|
increased circulating glucose level
|
J:184647
|
increased circulating interleukin-6 level
|
J:184647
|
increased circulating LDL cholesterol level
|
J:184647
|
increased circulating triglyceride level
|
J:184647
|
increased circulating tumor necrosis factor level
|
J:184647
|
increased circulating VLDL cholesterol level
|
J:184647
|
Apoetm1Unc/Apoetm1Unc Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc)
|
decreased circulating cholesterol level
|
J:102223
|
decreased circulating glucose level
|
J:102223
|
decreased circulating triglyceride level
|
J:102223
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr)
|
increased circulating cholesterol level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
decreased circulating cholesterol level
|
J:121671
|
Apoetm1Unc/Apoetm1Unc Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
decreased circulating HDL cholesterol level
|
J:91058
|
increased circulating cholesterol level
|
J:200141,
J:91058
|
increased circulating LDL cholesterol level
|
J:91058
|
increased circulating triglyceride level
|
J:91058
|
increased circulating VLDL cholesterol level
|
J:91058
|
Apoetm1Unc/Apoetm1Unc Hdl5C57BL/6J/Hdl5C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq19C57BL/6J/Hdlq19C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq86C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq86C3H/HeJ/Hdlq86C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq91C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hsd11b1tm1Lex/Hsd11b1tm1Lex
(B6.129-Hsd11b1tm1Lex Apoetm1Unc)
|
hyperlipidemia
|
J:199430
|
Apoetm1Unc/Apoetm1Unc Il1r1tm1Imx/Il1r1tm1Imx
(B6.129-Il1r1tm1Imx Apoetm1Unc)
|
decreased circulating interleukin-6 level
|
J:148173
|
Apoetm1Unc/Apoetm1Unc Il1rntm1Dih/Il1rntm1Dih
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased circulating cholesterol level
|
J:132570
|
Apoetm1Unc/Apoetm1Unc Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal arterial thrombosis
|
J:105858
|
abnormal blood coagulation
|
J:105858
|
abnormal circulating cholesterol level
|
J:105858
|
abnormal circulating cytokine level
|
J:105858
|
decreased circulating VLDL cholesterol level
|
J:105858
|
increased circulating interferon-gamma level
|
J:105858
|
increased circulating interleukin-12 level
|
J:105858
|
increased circulating LDL cholesterol level
|
J:105858
|
Apoetm1Unc/Apoetm1Unc Klf15tm1Jain/Klf15tm1Jain
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
increased circulating cholesterol level
|
J:203920
|
increased circulating triglyceride level
|
J:203920
|
Apoetm1Unc/Apoetm1Unc Lcattm1Hgc/Lcattm1Hgc
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:75567
|
Apoetm1Unc/Apoetm1Unc Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal thrombosis
|
J:95598
|
decreased circulating troponin level
|
J:95598
|
Apoetm1Unc/Apoetm1Unc Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased circulating cholesterol level
|
J:59491
|
Apoetm1Unc/Apoetm1Unc Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:130923
|
Apoetm1Unc/Apoetm1Unc Lipgtm1Tq/Lipgtm1Tq
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
increased circulating cholesterol level
|
J:93987
|
increased circulating HDL cholesterol level
|
J:93987
|
increased circulating LDL cholesterol level
|
J:93987
|
increased circulating phospholipid level
|
J:93987
|
increased circulating triglyceride level
|
J:93987
|
increased circulating VLDL cholesterol level
|
J:93987
|
Apoetm1Unc/Apoetm1Unc Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:151434
|
abnormal circulating lipid level
|
J:151434
|
hyperlipidemia
|
J:151434
|
increased circulating cholesterol level
|
J:151434
|
increased circulating triglyceride level
|
J:151434
|
increased susceptibility to induced thrombosis
|
J:151434
|
Apoetm1Unc/Apoetm1Unc Msr1tm1Csk/Msr1tm1Csk
(either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR))
|
increased circulating cholesterol level
|
J:39079
|
Apoetm1Unc/Apoetm1Unc Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating glucose level
|
J:143903
|
increased circulating triglyceride level
|
J:143903
|
Apoetm1Unc/Apoetm1Unc Nhdlq11C3H/HeJ/Nhdlq11C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq11C3H/HeJ/Nhdlq11C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq12C3H/HeJ/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq12C57BL/6J/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc Apoetm1Unc)
|
increased circulating creatinine level
|
J:60670
|
Apoetm1Unc/Apoetm1Unc Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c)
|
increased circulating VLDL cholesterol level
|
J:104996
|
Apoetm1Unc/Apoetm1Unc Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Apoetm1Unc Pik3cgtm1Dwu)
|
decreased circulating cholesterol level
|
J:121582
|
Apoetm1Unc/Apoetm1Unc Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv * B6.129P2-Apoetm1Unc/J)
|
increased circulating cholesterol level
|
J:97471
|
Apoetm1Unc/Apoetm1Unc Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Pnhdlc6C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Ptgdrtm1Dgen/Ptgdrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:192168
|
increased circulating triglyceride level
|
J:192168
|
Apoetm1Unc/Apoetm1Unc Rag2tm1Fwa/Rag2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased circulating cholesterol level
|
J:59156
|
decreased circulating HDL cholesterol level
|
J:59156
|
Apoetm1Unc/Apoetm1Unc Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased circulating cholesterol level
|
J:59156
|
decreased circulating HDL cholesterol level
|
J:59156
|
Apoetm1Unc/Apoetm1Unc Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129-Serpine1tm1Mlg Apoetm1Unc)
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:228944
|
Apoetm1Unc/Apoetm1Unc Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:61147
|
decreased circulating VLDL cholesterol level
|
J:61147
|
Apoetm1Unc/Apoetm1Unc Soat2tm1Far/Soat2tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81836
|
increased circulating HDL cholesterol level
|
J:81836
|
increased circulating triglyceride level
|
J:81836
|
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:103051
|
increased circulating triglyceride level
|
J:103051
|
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1tm1Rit
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:103051
|
increased circulating triglyceride level
|
J:103051
|
Apoetm1Unc/Apoetm1Unc Tg(APOC1)1Bres/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
hyperlipidemia
|
J:80689
|
increased circulating cholesterol level
|
J:80689
|
increased circulating LDL cholesterol level
|
J:80689
|
increased circulating triglyceride level
|
J:80689
|
increased circulating VLDL cholesterol level
|
J:80689
|
increased circulating VLDL triglyceride level
|
J:80689
|
Apoetm1Unc/Apoetm1Unc Tg(CAG-IL1RN)1Cga/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)
|
decreased circulating serum amyloid protein level
|
J:132570
|
Apoetm1Unc/Apoetm1Unc Tg(CAG-IL1RN)2Cga/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)
|
decreased circulating serum amyloid protein level
|
J:132570
|
Apoetm1Unc/Apoetm1Unc Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Apoetm1Unc Tg(CMV-Serpine1)1Dgi)
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal circulating cholesterol level
|
J:130658
|
abnormal circulating protein level
|
J:130658
|
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal circulating apolipoprotein E level
|
J:130658
|
increased circulating cholesterol level
|
J:130658
|
Apoetm1Unc/Apoetm1Unc Tg(NOS3)2Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating cholesterol level
|
J:80701
|
Apoetm1Unc/Apoetm1Unc Tg(NOS3)3Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating cholesterol level
|
J:80701
|
Apoetm1Unc/Apoetm1Unc Thbs4tm1Olsa/Thbs4tm1Olsa
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating interleukin-10 level
|
J:345752
|
increased circulating tumor necrosis factor level
|
J:345752
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating LDL cholesterol level
|
J:41705
|
decreased circulating VLDL cholesterol level
|
J:74417
|
decreased circulating VLDL triglyceride level
|
J:74417
|
increased circulating cholesterol level
|
J:41705
|
increased circulating HDL cholesterol level
|
J:74417
|
increased circulating triglyceride level
|
J:74417
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:146721
|
Apoetm2(APOE_i2)Sfu/Apoetm2(APOE_i2)Sfu
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:104859
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating lipid level
|
J:151284
|
decreased circulating HDL cholesterol level
|
J:74417
|
decreased circulating triglyceride level
|
J:74417
|
increased circulating VLDL cholesterol level
|
J:74417
|
increased circulating VLDL triglyceride level
|
J:74417
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:146721
|
increased circulating cholesterol level
|
J:146721
|
increased circulating triglyceride level
|
J:146721
|
Apoetm3(APOE_i3)Sfu/Apoetm3(APOE_i3)Sfu
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:104859
|
Apoetm4Mae/Apoetm4Mae
(129S6/SvEvTac-Apoetm4Mae)
|
abnormal circulating lipid level
|
J:172417
|
increased circulating cholesterol level
|
J:172417
|
increased circulating HDL cholesterol level
|
J:172417
|
increased circulating triglyceride level
|
J:172417
|
increased circulating VLDL cholesterol level
|
J:172417
|
Apoftm1(KOMP)Vlcg/Apof+
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:185314
|
increased circulating HDL cholesterol level
|
J:185314
|
Apoftm1(KOMP)Vlcg/Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:185314
|
Apohtm1Krl/Apohtm1Krl
(involves: 129/Sv * C57BL/6)
|
abnormal blood homeostasis
|
J:68990
|
Apol6em1Hsul/Apol6em1Hsul
(Not Specified)
|
decreased circulating cholesterol level
|
J:344362
|
decreased circulating HDL cholesterol level
|
J:344362
|
decreased circulating triglyceride level
|
J:344362
|
increased circulating free fatty acids level
|
J:344362
|
Apomtm1.1(KOMP)Vlcg/Apomtm1.1(KOMP)Vlcg
(C57BL/6N-Apomtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Apomtm1Cchr/Apomtm1Cchr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:130647
|
decreased circulating triglyceride level
|
J:130647
|
Apomtm1Stf/Apomtm1Stf
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:138581
|
Apootm1b(KOMP)Wtsi/Y
(C57BL/6N-Apootm1b(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Apptm1.1Wevn/Apptm1.1Wevn
(B6.129S6(FVB)-Apptm1.1Wevn)
|
increased susceptibility to induced thrombosis
|
J:241632
|
Apptm1b(KOMP)Wtsi/App+
(C57BL/6N-Apptm1b(KOMP)Wtsi/Ics)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Apptm1Ck/Apptm1Ck Psen1tm1Mpm/Psen1tm1Mpm
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
increased circulating corticosterone level
|
J:191170
|
Apptm1Dbo/Apptm1Dbo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to induced thrombosis
|
J:241632
|
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:211794
|
increased fasting circulating glucose level
|
J:211794
|
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * Black Swiss)
|
increased blood urea nitrogen level
|
J:111451
|
Aptxtm1b(EUCOMM)Hmgu/Aptxtm1b(EUCOMM)Hmgu
(B6N(Cg)-Aptxtm1b(EUCOMM)Hmgu/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Aqp1tm1Ask/Aqp1tm1Ask
(involves: C57BL/6J)
|
increased blood osmolality
|
J:45888
|
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Aqp2cph/Aqp2cph
(C57BL/6J-Aqp2cph)
|
increased blood osmolality
|
J:109463
|
increased blood urea nitrogen level
|
J:9451,
J:109463
|
Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased blood urea nitrogen level
|
J:121445
|
Aqp2tm1.1Ask/Aqp2tm1.1Ask
(involves: C57BL/6J * FVB/N)
|
increased blood urea nitrogen level
|
J:94003
|
Aqp2tm1Ask/Aqp2tm1Ask
(involves: C57BL/6J)
|
increased blood osmolality
|
J:94003
|
increased blood urea nitrogen level
|
J:94003
|
Aqp3tm1Ask/Aqp3tm1Ask
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:61675
|
increased blood osmolality
|
J:61675
|
Aqp3tm2b(EUCOMM)Wtsi/Aqp3tm2b(EUCOMM)Wtsi
(C57BL/6N-Aqp3tm2b(EUCOMM)Wtsi/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating insulin level
|
J:125011
|
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun)
|
decreased circulating glycerol level
|
J:95278
|
hypoglycemia
|
J:95278
|
Aqp8tm1Ask/Aqp8tm1Ask
(involves: 129/Sv * C57BL/6 * CD-1)
|
increased circulating cholesterol level
|
J:104681
|
increased circulating triglyceride level
|
J:104681
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn
(involves: 129S1/Sv * C57BL/6)
|
increased circulating glycerol level
|
J:123742
|
increased circulating triglyceride level
|
J:123742
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J)
|
decreased circulating glucose level
|
J:123742
|
increased circulating glycerol level
|
J:123742
|
Aqp11sjds/Aqp11sjds
(involves: BALB/cRl)
|
increased blood urea nitrogen level
|
J:169660
|
increased circulating creatinine level
|
J:169660
|
Aqp11sjds/Aqp11tm1Lex
(involves: 129S5/SvEvBrd * BALB/cRl * C57BL/6 * CD-1)
|
increased blood urea nitrogen level
|
J:169660
|
Aqp11tm1.1Nlsn/Aqp11tm1.1Nlsn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
decreased blood urea nitrogen level
|
J:194939
|
decreased circulating free fatty acids level
|
J:194939
|
decreased circulating glycerol level
|
J:194939
|
decreased circulating ketone body level
|
J:194939
|
decreased circulating triglyceride level
|
J:194939
|
increased circulating aspartate transaminase level
|
J:194939
|
increased circulating HDL cholesterol level
|
J:194939
|
Aqp11tm1Lex/Aqp11tm1Lex
(129S5/SvEvBrd-Aqp11tm1Lex)
|
increased blood urea nitrogen level
|
J:100522
|
Aqp11tm1Lex/Aqp11tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6 * CD-1)
|
increased blood urea nitrogen level
|
J:169660
|
Aqp12tm1.1(KOMP)Vlcg/Aqp12tm1.1(KOMP)Vlcg
(C57BL/6N-Aqp12tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Artm1.1Chc/Y
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased circulating testosterone level
|
J:89886
|
increased circulating luteinizing hormone level
|
J:89886
|
Artm1.1Jdz/Y
(B6.129X1-Artm1.1Jdz)
|
decreased circulating testosterone level
|
J:123057
|
Artm1.1Jdz/Y
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating testosterone level
|
J:122327
|
Artm1.1Verh/Y
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)
|
increased circulating luteinizing hormone level
|
J:100799
|
Artm1Chc/Y Plekha5Tg(AMH-cre)1Flor/Plekha5+
(involves: 129S/SvEv * C57BL/6 * SJL)
|
decreased circulating testosterone level
|
J:89886,
J:118270
|
increased circulating follicle stimulating hormone level
|
J:89886
|
increased circulating luteinizing hormone level
|
J:89886
|
Artm1Chc/Y Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
decreased circulating testosterone level
|
J:98775,
J:118270,
J:81789
|
hyperglycemia
|
J:98775
|
increased circulating glucose level
|
J:98775
|
increased circulating insulin level
|
J:98775
|
increased circulating leptin level
|
J:98775
|
increased circulating triglyceride level
|
J:98775
|
Artm1Reb/Y
(involves: 129S4/SvJaeSor)
|
increased circulating follicle stimulating hormone level
|
J:90393
|
increased circulating luteinizing hormone level
|
J:90393
|
increased circulating pituitary hormone level
|
J:90393
|
increased circulating testosterone level
|
J:90393
|
Artm1Reb/Y Tg(Amh-cre)8815Reb/?
(involves: 129S4/SvJaeSor * FVB/N)
|
increased circulating follicle stimulating hormone level
|
J:90393
|
increased circulating luteinizing hormone level
|
J:90393
|
increased circulating pituitary hormone level
|
J:90393
|
increased circulating testosterone level
|
J:90393
|
Artm1Verh/Y Plekha5Tg(AMH-cre)1Flor/Plekha5+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:88169
|
Artm1Verh/Y Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:196857
|
increased circulating insulin level
|
J:196857
|
increased circulating triglyceride level
|
J:196857
|
Artm3.1(AR)Ska/Y
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased circulating testosterone level
|
J:170092
|
Artm3.1(AR)Ska/Y Tg(KLKB1-cre/ERT2)1Pcn/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased circulating testosterone level
|
J:170092
|
Artm4(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
abnormal blood homeostasis
|
J:114552
|
decreased circulating follicle stimulating hormone level
|
J:104360
|
decreased circulating testosterone level
|
J:114552
|
increased blood urea nitrogen level
|
J:114552
|
increased circulating creatinine level
|
J:114552
|
increased circulating luteinizing hormone level
|
J:104360
|
increased circulating potassium level
|
J:114552
|
Artm4(AR)Dmr/Ar+
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating testosterone level
|
J:114552
|
Arb2aem2(IMPC)Ccpcz/Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph)
|
increased circulating aspartate transaminase level
|
J:211773
|
Aregtm2c(EUCOMM)Hmgu/Aregtm2c(EUCOMM)Hmgu Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
decreased blood oxygen saturation level
|
J:224904
|
Aregtm2c(EUCOMM)Hmgu/Aregtm2c(EUCOMM)Hmgu Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
decreased blood oxygen saturation level
|
J:224904
|
Arel1tm1b(EUCOMM)Hmgu/Arel1tm1b(EUCOMM)Hmgu
(C57BL/6N-Arel1tm1b(EUCOMM)Hmgu/Mhzh)
|
increased fasting circulating glucose level
|
J:211773
|
Arf2tm1.1(KOMP)Wtsi/Arf2tm1.1(KOMP)Wtsi
(B6N(Cg)-Arf2tm1.1(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Arfgef3em1(IMPC)Hmgu/Arfgef3+
(C57BL/6NCrl-Arfgef3em1(IMPC)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
hyperglycemia
|
J:216529
|
increased circulating insulin level
|
J:216529
|
Arg1tm1Ekoe/Arg1tm1Ekoe
(involves: 129P2/OlaHsd)
|
abnormal blood homeostasis
|
J:183882
|
Arg1tm1Rki/Arg1tm1Rki
(Not Specified)
|
abnormal circulating amino acid level
|
J:83263
|
decreased circulating ornithine level
|
J:83263
|
decreased circulating proline level
|
J:83263
|
increased circulating ammonia level
|
J:83263
|
increased circulating arginine level
|
J:83263
|
increased circulating citrulline level
|
J:83263
|
increased circulating histidine level
|
J:83263
|
Arg2tm1Weo/Arg2+
(involves: C57BL/6J)
|
increased circulating arginine level
|
J:67353
|
Arg2tm1Weo/Arg2tm1Weo
(involves: C57BL/6J)
|
increased circulating arginine level
|
J:67353
|
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Arhgap18tm1a(KOMP)Wtsi/Arhgap18tm1a(KOMP)Wtsi
(B6JTyr;B6N-Arhgap18tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:175295
|
Arhgap22tm1a(KOMP)Wtsi/Arhgap22tm1a(KOMP)Wtsi
(C57BL/6N-Arhgap22tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Arhgap23tm1b(EUCOMM)Wtsi/Arhgap23tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap23tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Arhgap26tm1b(EUCOMM)Hmgu/Arhgap26tm1b(EUCOMM)Hmgu
(C57BL/6N-Arhgap26tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating phosphate level
|
J:211773
|
Arhgap29em1(IMPC)J/Arhgap29+
(C57BL/6NJ-Arhgap29em1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Arhgap30tm1a(EUCOMM)Wtsi/Arhgap30tm1a(EUCOMM)Wtsi
(C57BL/6N-Arhgap30tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Arhgap42em1(IMPC)H/Arhgap42em1(IMPC)H
(C57BL/6NTac-Arhgap42em1(IMPC)H/H)
|
decreased circulating total protein level
|
J:211773
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
|
abnormal blood homeostasis
|
J:57995
|
decreased circulating serum albumin level
|
J:57995
|
increased blood urea nitrogen level
|
J:57995
|
increased circulating cholesterol level
|
J:57995
|
increased circulating creatinine level
|
J:57995
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
increased circulating interleukin-5 level
|
J:140671
|
Arhgef2em1(IMPC)Mbp/Arhgef2em1(IMPC)Mbp
(C57BL/6N-Arhgef2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Arhgef3tm1(KOMP)Wtsi/Arhgef3tm1(KOMP)Wtsi
(C57BL/6N-Arhgef3tm1(KOMP)Wtsi/DkrsJ)
|
abnormal platelet physiology
|
J:241286
|
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating total protein level
|
J:165965
|
Arhgef6tm2e.1(EUCOMM)Wtsi/Arhgef6tm2e.1(EUCOMM)Wtsi
(C57BL/6N-Arhgef6tm2e.1(EUCOMM)Wtsi/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Arhgef10tm1.1(KOMP)Vlcg/Arhgef10tm1.1(KOMP)Vlcg
(B6N(Cg)-Arhgef10tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Arhgef18tm1b(KOMP)Mbp/Arhgef18+
(C57BL/6N-Arhgef18tm1b(KOMP)Mbp/H)
|
increased circulating amylase level
|
J:211773
|
Arhgef38tm1a(KOMP)Wtsi/Arhgef38tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef38tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Arid1bem1(IMPC)Tcp/Arid1b+
(C57BL/6NCrl-Arid1bem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Arid1bem1Hzhu/Arid1b+
(C57BL/6J-Arid1bem1Hzhu)
|
decreased circulating insulin-like growth factor I level
|
J:256668
|
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J)
|
increased circulating insulin level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Arid3cem1(IMPC)J/Arid3cem1(IMPC)J
(C57BL/6NJ-Arid3cem1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Arid4btm1Alb/Arid4btm1.1Mywu Tg(Amh-cre)8815Reb/0
(involves: 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
increased circulating follicle stimulating hormone level
|
J:233398
|
increased circulating luteinizing hormone level
|
J:233398
|
Arid5atm1Rnis/Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis)
|
decreased circulating interleukin-6 level
|
J:197418
|
decreased circulating tumor necrosis factor level
|
J:197418
|
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor
(involves: 129S4/SvJaeSor)
|
increased blood urea nitrogen level
|
J:117491
|
Arih1em3Gpt/Arih1em3Gpt Lyz2em1(icre)Gpt/Lyz2+
(C57BL/6JGpt-Arih1em3Gpt Lyz2em1(icre)Gpt)
|
decreased circulating interferon-beta level
|
J:330879
|
decreased circulating interleukin-6 level
|
J:330879
|
Ark2cGt(P9-3F)Sor/Ark2cGt(P9-3F)Sor Tg(Hlxb9-GFP)1Tmj/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
cyanosis
|
J:198828
|
increased circulating lactate level
|
J:198828
|
Arl5ctm1.1(KOMP)Vlcg/Arl5ctm1.1(KOMP)Vlcg
(C57BL/6N-Arl5ctm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Arl6tm2Vcs/Arl6tm2Vcs
(B6.129-Arl6tm2Vcs)
|
cyanosis
|
J:257068
|
Arl8btm1.1(NCOM)Mfgc/Arl8b+
(C57BL/6N-Arl8btm1.1(NCOM)Mfgc/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Arl13btm1c(EUCOMM)Wtsi/Arl13btm1c(EUCOMM)Wtsi Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6J * C57BL/6N * ICR)
|
increased blood urea nitrogen level
|
J:240795
|
Arl14em1(IMPC)J/Arl14em1(IMPC)J
(C57BL/6NJ-Arl14em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Arl15em1(IMPC)H/Arl15+
(C57BL/6N-Arl15em1(IMPC)H/H)
|
increased circulating creatinine level
|
J:211773
|
Armc2tm1b(EUCOMM)Hmgu/Armc2+
(C57BL/6N-Armc2tm1b(EUCOMM)Hmgu/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Armc3em1(IMPC)J/Armc3+
(C57BL/6NJ-Armc3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Armc5tm1Stra/Armc5+
(involves: 129 * C57BL/6N * Swiss)
|
decreased circulating corticosterone level
|
J:244906
|
increased circulating corticosterone level
|
J:244906
|
Armcx3tm1.1Eso/Y Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:345411
|
decreased circulating glucose level
|
J:345411
|
increased circulating insulin level
|
J:345411
|
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr)
|
increased circulating insulin level
|
J:268298
|
increased fasting circulating glucose level
|
J:268298
|
Arnttm1.1Gonz/Arnttm1.1Gonz Tg(Vil1-cre)20Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased circulating iron level
|
J:189504
|
Arpc1btm1a(EUCOMM)Wtsi/Arpc1btm1a(EUCOMM)Wtsi
(C57BL/6N-Arpc1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Arpc4tm1a(EUCOMM)Wtsi/Arpc4+
(B6JTyr;B6N-Arpc4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Arpc5ltm1.1(KOMP)Vlcg/Arpc5l+
(B6N(Cg)-Arpc5ltm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Arr3em1(IMPC)J/Arr3em1(IMPC)J
(C57BL/6NJ-Arr3em1(IMPC)J/J)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Arrb1tm1Jse/Arrb1tm1Jse Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:159121
|
Arrb2tm1.1(KOMP)Vlcg/Arrb2+
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Arrb2tm1.1(KOMP)Vlcg/Arrb2tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating tumor necrosis factor level
|
J:112607
|
increased circulating interleukin-6 level
|
J:112607
|
Arrdc1tm1.1(KOMP)Vlcg/Arrdc1+
(B6N(Cg)-Arrdc1tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Arrdc1tm1.1(KOMP)Vlcg/Arrdc1tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrdc1tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Arrdc3Gt(CSE151)Byg/Arrdc3+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating adrenaline level
|
J:179646
|
decreased circulating glucose level
|
J:179646
|
increased circulating ketone body level
|
J:179646
|
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:179646
|
decreased circulating insulin level
|
J:179646
|
decreased circulating leptin level
|
J:179646
|
decreased circulating triglyceride level
|
J:179646
|
decreased circulating triiodothyronine level
|
J:179646
|
increased circulating ketone body level
|
J:179646
|
Arrdc5tm1b(EUCOMM)Wtsi/Arrdc5tm1b(EUCOMM)Wtsi
(C57BL/6N-Arrdc5tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
Art1tm1b(EUCOMM)Wtsi/Art1tm1b(EUCOMM)Wtsi
(C57BL/6N-Art1tm1b(EUCOMM)Wtsi/Tcp)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating sodium level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
ArtlesC57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating insulin level
|
J:70961
|
ArtlesCAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
decreased circulating insulin level
|
J:70961
|
Arv1tm1.2Geno/Arv1+
(involves: C57BL/6 * C57BL/6J)
|
increased circulating cholesterol level
|
J:263695
|
increased circulating HDL cholesterol level
|
J:263695
|
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:263695
|
decreased circulating HDL cholesterol level
|
J:263695
|
decreased circulating lactate dehydrogenase level
|
J:263695
|
decreased circulating leptin level
|
J:263695
|
decreased circulating triglyceride level
|
J:263695
|
decreased fasting circulating glucose level
|
J:263695
|
increased blood urea nitrogen level
|
J:263695
|
increased circulating alkaline phosphatase level
|
J:263695
|
increased circulating ghrelin level
|
J:263695
|
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
abnormal circulating lipid level
|
J:241193
|
decreased circulating cholesterol level
|
J:241193
|
decreased circulating HDL cholesterol level
|
J:241193
|
decreased circulating leptin level
|
J:241193
|
decreased fasting circulating glucose level
|
J:241193
|
hypoglycemia
|
J:241193
|
Arvcftm1e(EUCOMM)Wtsi/Arvcftm1e(EUCOMM)Wtsi
(C57BL/6N-Arvcftm1e(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Arxtm1Gldn/Arxtm1Gldn Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL)
|
hyperglycemia
|
J:177838
|
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI)
|
hypoglycemia
|
J:86206
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:285931
|
increased blood urea nitrogen level
|
J:285931
|
increased circulating alanine transaminase level
|
J:285931
|
increased circulating aspartate transaminase level
|
J:285931
|
increased circulating creatine kinase level
|
J:285931
|
increased circulating CXCL10 level
|
J:285931
|
increased circulating lactate dehydrogenase level
|
J:285931
|
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
|
abnormal circulating chemokine level
|
J:232306
|
increased circulating interleukin-12b level
|
J:232306
|
Asb1em1(IMPC)Ccpcz/Asb1em1(IMPC)Ccpcz
(C57BL/6N-Asb1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Asb5em1(IMPC)Ccpcz/Asb5em1(IMPC)Ccpcz
(C57BL/6N-Asb5em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Asb18em1(IMPC)J/Asb18em1(IMPC)J
(C57BL/6NJ-Asb18em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Ascc3tm1a(EUCOMM)Hmgu/Ascc3+
(C57BL/6N-Ascc3tm1a(EUCOMM)Hmgu/Ics)
|
decreased circulating phosphate level
|
J:165965
|
increased circulating phosphate level
|
J:165965
|
Ascl5em1(IMPC)Ccpcz/Ascl5em1(IMPC)Ccpcz
(C57BL/6NCrl-Ascl5em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatine kinase level
|
J:211773
|
Asf1atm1b(KOMP)Wtsi/Asf1a+
(B6N(Cg)-Asf1atm1b(KOMP)Wtsi/2J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Asgr1Mhdabap005/Asgr1Mhdabap005
(C3HeB/FeJ-Asgr1Mhdabap005/Ieg)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Asgr1tm1Sau/Asgr1tm1Sau
(B6.129S4-Asgr1tm1Sau)
|
decreased bleeding time
|
J:136946
|
Asgr2tm1Her/Asgr2tm1Her St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm Asgr2tm1Her)
|
abnormal blood coagulation
|
J:136946
|
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+
(C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
|
increased circulating interleukin-6 level
|
J:208213
|
increased circulating tumor necrosis factor level
|
J:208213
|
Ash2ltm1b(EUCOMM)Wtsi/Ash2l+
(C57BL/6N-Ash2ltm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Asic1em1(IMPC)Mbp/Asic1em1(IMPC)Mbp
(C57BL/6N-Asic1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
decreased circulating alanine transaminase level
|
J:180208
|
decreased circulating arginine level
|
J:180208
|
decreased circulating aspartate transaminase level
|
J:180208
|
increased circulating ammonia level
|
J:180208
|
increased circulating citrulline level
|
J:180208
|
Asltm1Wjc/Asltm1Wjc
(involves: 129S7/SvEvBrd)
|
abnormal circulating amino acid level
|
J:101658
|
decreased circulating arginine level
|
J:101658
|
increased circulating ammonia level
|
J:101658
|
increased circulating citrulline level
|
J:101658
|
increased circulating glutamine level
|
J:101658
|
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:320329
|
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Asphd1em1(IMPC)Ccpcz/Asphd1em1(IMPC)Ccpcz
(C57BL/6NCrl-Asphd1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aspntm1b(EUCOMM)Hmgu/Aspntm1b(EUCOMM)Hmgu
(C57BL/6N-Aspntm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aspscr1tm1.1Jsbo/Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn/0
(B6.Cg-Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn)
|
decreased circulating insulin level
|
J:308358
|
decreased fasting circulating glucose level
|
J:308358
|
increased circulating insulin level
|
J:308358
|
increased fasting circulating glucose level
|
J:308358
|
Ass1bar/Ass1bar
(FVB.BAR-Ass1bar)
|
abnormal circulating amino acid level
|
J:165341
|
increased circulating ammonia level
|
J:165341
|
Ass1bar/Ass1bar
(B6.BAR-Ass1bar)
|
abnormal circulating amino acid level
|
J:165341
|
increased circulating ammonia level
|
J:165341
|
increased circulating citrulline level
|
J:165341
|
Ass1bar/Ass1fold
(involves: C57BL/6Ei * C57BL/6J * OF1 * P/J)
|
abnormal circulating amino acid level
|
J:165341
|
increased circulating ammonia level
|
J:165341
|
increased circulating citrulline level
|
J:165341
|
Ass1fold/Ass1fold
(B6Ei.P-Ass1fold/GrsrJ)
|
abnormal circulating amino acid level
|
J:165341
|
increased circulating ammonia level
|
J:165341
|
increased circulating citrulline level
|
J:165341
|
Ass1tm1.1Ekoe/Ass1tm1.1Ekoe Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal circulating amino acid level
|
J:203474
|
decreased circulating arginine level
|
J:203474
|
decreased circulating ornithine level
|
J:203474
|
decreased circulating taurine level
|
J:203474
|
increased circulating citrulline level
|
J:203474
|
increased circulating ornithine level
|
J:203474
|
increased circulating taurine level
|
J:203474
|
Ass1tm1Bay/Ass1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating citrulline level
|
J:18326
|
Ass1tm1Bay/Ass1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal circulating amino acid level
|
J:18326
|
decreased circulating arginine level
|
J:18326
|
increased circulating ammonia level
|
J:18326
|
increased circulating citrulline level
|
J:18326
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(B6Dnk;B6Brd;B6N-Asxl1tm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased circulating glucose level
|
J:175295
|
increased blood uric acid level
|
J:175295
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating iron level
|
J:165965
|
Asxl2tm1b(EUCOMM)Hmgu/Asxl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Asxl2tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Atad2btm1b(EUCOMM)Hmgu/Atad2btm1b(EUCOMM)Hmgu
(C57BL/6N-Atad2btm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Atad3atm1a(KOMP)Wtsi/Atad3a+
(C57BL/6N-Atad3atm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ate1tm1Avar/Ate1tm2.1Avar Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:155421
|
Atf2Tg(Gzma-Klra1)7Wum/Atf2+
(involves: C57BL/6)
|
decreased circulating interferon-gamma level
|
J:61178
|
Atf2tm1b(EUCOMM)Hmgu/Atf2+
(C57BL/6N-Atf2tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Atf2tm1Nicj/Atf2tm1Nicj
(B6.129P2-Atf2tm1Nicj)
|
cyanosis
|
J:123909
|
Atf2tm1Sis/Atf2tm1Sis
(either: (involves: C57BL/6 * CBA) or (involves: BALB/c * C57BL/6 * CBA) or (involves: C57BL/6 * CBA * ICR))
|
cyanosis
|
J:55657
|
Atf2tm2Nicj/Atf2tm2Nicj
(B6.129P2-Atf2tm2Nicj)
|
cyanosis
|
J:123909
|
Atf3tm1.2Kitab/Atf3tm1.2Kitab Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating glucose level
|
J:231262
|
Atf4tm1(KOMP)Mbp/Atf4+
(C57BL/6NCrl-Atf4tm1(KOMP)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Atf4tm1Kry/Atf4tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6J * FVB)
|
decreased circulating glucose level
|
J:152695
|
Atf4tm1Tow/Atf4+ Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
decreased circulating glucose level
|
J:152695
|
increased circulating insulin level
|
J:152695
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
decreased circulating glucose level
|
J:152695
|
increased circulating insulin level
|
J:152695
|
Atg2bem1(IMPC)J/Atg2bem1(IMPC)J
(C57BL/6NJ-Atg2bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Atg3tm1Kmts/Atg3tm1Kmts
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal circulating amino acid level
|
J:215884
|
Atg4btm1b(EUCOMM)Hmgu/Atg4btm1b(EUCOMM)Hmgu
(C57BL/6N-Atg4btm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Atg5tm1Myok/Atg5tm1Myok Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased blood urea nitrogen level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating amino acid level
|
J:104491
|
Atg7em1(IMPC)Ccpcz/Atg7+
(C57BL/6N-Atg7em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Atg7tm1.1Tchi/Atg7tm1.1Tchi
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal circulating amino acid level
|
J:100199
|
Atg7tm1Tchi/Atg7tm1Tchi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased blood urea nitrogen level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi Lyz2tm1(cre)Ifo/Lyz2+ Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi Sqstm1tm1Keta/Sqstm1tm1Keta Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj)
|
increased circulating alanine transaminase level
|
J:130839
|
increased circulating alkaline phosphatase level
|
J:130839
|
increased circulating aspartate transaminase level
|
J:130839
|
Atg7tm1Tchi/Atg7tm1Tchi Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal circulating enzyme level
|
J:100199
|
increased circulating alanine transaminase level
|
J:130839,
J:100199
|
increased circulating alkaline phosphatase level
|
J:130839,
J:100199
|
increased circulating aspartate transaminase level
|
J:130839,
J:100199
|
Atg9btm1b(KOMP)Mbp/Atg9btm1b(KOMP)Mbp
(C57BL/6N-Atg9btm1b(KOMP)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Atg16l1tm1.1Mvlc/Atg16l1tm1.1Mvlc
(C57BL/6-Atg16l1tm1.1Mvlc)
|
increased circulating interleukin-1 beta level
|
J:206931
|
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1+
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating serum albumin level
|
J:175295
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi Tg(Vil1-cre)997Gum/?
(involves: C57BL/6J * C57BL/6N * SJL)
|
abnormal circulating interleukin level
|
J:221019
|
increased circulating interleukin-1 beta level
|
J:221019
|
increased circulating interleukin-6 level
|
J:221019
|
Ath9FVB/NCr/Ath9C57BL/6J
(involves: C57BL/6J * FVB/NCr)
|
increased circulating HDL cholesterol level
|
J:76127
|
Ath9FVB/NCr/Ath9FVB/NCr
(involves: C57BL/6J * FVB/NCr)
|
increased circulating HDL cholesterol level
|
J:76127
|
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc)
|
decreased circulating leptin level
|
J:222034
|
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Atoh1tm1Hzo/Atoh1tm1Hzo
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:44241
|
Atoh1tm2Hzo/Atoh1tm2Hzo
(Not Specified)
|
cyanosis
|
J:60393
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * Black Swiss)
|
increased circulating corticosterone level
|
J:117414
|
Atp2a1tm1Dhm/Atp2a1tm1Dhm
(involves: CD-1)
|
cyanosis
|
J:82947
|
Atp2a2tm1.1Iemr/Atp2a2tm1.1Iemr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
increased circulating noradrenaline level
|
J:157143
|
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
(C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Atp2b1tm1b(KOMP)Wtsi/Atp2b1+
(C57BL/6N-Atp2b1tm1b(KOMP)Wtsi/Tcp)
|
decreased circulating calcium level
|
J:211773
|
Atp4am1Btlr/Atp4am1Btlr
(involves: C57BL/6J)
|
decreased circulating iron level
|
J:179090
|
increased circulating erythropoietin level
|
J:179090
|
Atp4am1Btlr/Atp4atm1Ges
(involves: 129X1/SvJ * Black Swiss * C57BL/6J)
|
decreased circulating iron level
|
J:179090
|
Atp4atm1.1Ocalv/Atp4atm1.1Ocalv
(involves: 129S6/SvEv * C57BL/6J * C57BL/6NCrl)
|
decreased circulating ferritin level
|
J:235360
|
increased circulating gastrin level
|
J:235360
|
Atp4atm1Ges/Atp4atm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating gastrin level
|
J:63470
|
Atp4btm1Ird/Atp4btm1Ird
(either: (involves: 129S4/SvJae * BALB/cCrSlc) or (involves: 129S4/SvJae * C57BL/6))
|
increased circulating gastrin level
|
J:74022
|
Atp5f1bem1(IMPC)Ccpcz/Atp5f1b+
(C57BL/6NCrl-Atp5f1bem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Atp5if1tm1a(EUCOMM)Wtsi/Atp5if1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atp5if1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating alkaline phosphatase level
|
J:175295
|
Atp5mc2tm2b(EUCOMM)Hmgu/Atp5mc2+
(C57BL/6N-Atp5mc2tm2b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Atp5mgtm1b(EUCOMM)Hmgu/Atp5mg+
(C57BL/6N-Atp5mgtm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Atp5mktm1b(EUCOMM)Wtsi/Atp5mktm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mktm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Atp6ap2em1Nira/Y
(C57BL/6J-Atp6ap2em1Nira)
|
decreased circulating angiotensinogen level
|
J:324587
|
Atp6ap2tm1.1Aich/Atp6ap2+ Tg(Six2-EGFP/cre)1Amc/0
(involves: C57BL/6 * CD-1)
|
increased circulating creatinine level
|
J:228872
|
Atp6ap2tm1.1Aich/Atp6ap2tm1.1Aich Tg(Hoxb7-cre)5526Cmb/0
(involves: C57BL/6)
|
increased circulating creatinine level
|
J:223201
|
Atp6ap2tm1.1Ics/Y Tg(NPHS2-cre)295Lbh/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased circulating serum albumin level
|
J:232697
|
increased blood urea nitrogen level
|
J:232697
|
increased circulating cholesterol level
|
J:232697
|
increased circulating creatinine level
|
J:232697
|
Atp6v0a1tm1b(EUCOMM)Hmgu/Atp6v0a1+
(C57BL/6N-Atp6v0a1tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating potassium level
|
J:211773
|
Atp6v0a4tm1.1Fekf/Atp6v0a4tm1.1Fekf
(involves: C57BL/6)
|
hypokalemia
|
J:188593
|
increased blood osmolality
|
J:188593
|
increased blood urea nitrogen level
|
J:188593
|
Atp6v0d1em1Nju/Atp6v0d1em1Nju Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased circulating leptin level
|
J:346448
|
decreased circulating triglyceride level
|
J:346448
|
increased circulating aspartate transaminase level
|
J:346448
|
increased circulating cholesterol level
|
J:346448
|
increased circulating free fatty acids level
|
J:346448
|
Atp6v0d2tm1Ywc/Atp6v0d2tm1Ywc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating type I collagen C-terminal telopeptide level
|
J:117744
|
Atp6v1b1tm1.1(KOMP)Vlcg/Atp6v1b1tm1.1(KOMP)Vlcg
(C57BL/6N-Atp6v1b1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Atp6v1b1tm1Choo/Atp6v1b1tm1Choo
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating bicarbonate level
|
J:101414
|
Atp6v1b2tm1b(KOMP)Wtsi/Atp6v1b2+
(C57BL/6N-Atp6v1b2tm1b(KOMP)Wtsi/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Atp6v1hem1Xhd/Atp6v1h+
(involves: C57BL/6)
|
decreased circulating phosphate level
|
J:239439
|
increased circulating alkaline phosphatase level
|
J:239439
|
increased circulating calcium level
|
J:239439
|
Atp7aMo-br/Y
(involves: C57BL)
|
decreased circulating copper level
|
J:5462
|
Atp7aMo-ms/Y
(involves: CBA/Kw)
|
decreased circulating ceruloplasmin level
|
J:14875
|
Atp7bm1Btlr/Atp7bm1Btlr
(C57BL/6J-Atp7bm1Btlr)
|
abnormal circulating bilirubin level
|
J:255002
|
Atp7btx/Atp7btx
(DL-Atp7btx)
|
decreased circulating copper level
|
J:7102
|
increased circulating copper level
|
J:19226
|
Atp7btx/Atp7btx
(involves: C57BL/6 * DL)
|
decreased circulating copper level
|
J:7102
|
Atp8a1tm1a(EUCOMM)Wtsi/Atp8a1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atp8a1tm1a(EUCOMM)Wtsi/H)
|
increased blood urea nitrogen level
|
J:165965
|
Atp8a2em1(IMPC)J/Atp8a2+
(C57BL/6NJ-Atp8a2em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Atp8a2wl/Atp8a2wl
(Not Specified)
|
abnormal circulating amino acid level
|
J:5108
|
abnormal circulating tyrosine level
|
J:5108
|
hypoglycemia
|
J:14851
|
increased circulating phenylalanine level
|
J:5108
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Atp8b1tm1Nbf/Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae)
|
increased circulating aspartate transaminase level
|
J:89817
|
increased circulating bilirubin level
|
J:89817
|
Atp8b1tm1Nbf/Atp8b1tm1Nbf Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:215915
|
increased circulating alkaline phosphatase level
|
J:215915
|
increased circulating bilirubin level
|
J:215915
|
Atp8b2tm1a(KOMP)Wtsi/Atp8b2tm1a(KOMP)Wtsi
(C57BL/6N-Atp8b2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
increased circulating bilirubin level
|
J:171924
|
Atp11cem1(IMPC)J/Y
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Atp11cem1(IMPC)J/Atp11cem1(IMPC)J
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
increased circulating bilirubin level
|
J:171925
|
Atp12atm1Ges/Atp12atm1Ges
(involves: Black Swiss)
|
decreased circulating potassium level
|
J:45707
|
Atp13a3em1(IMPC)J/Atp13a3em1(IMPC)J
(C57BL/6NJ-Atp13a3em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Atpaf1em1Cya/Atpaf1em1Cya
(involves: C57BL/6N)
|
increased circulating lactate level
|
J:347150
|
Atrtm1b(KOMP)Wtsi/Atr+
(B6N(Cg)-Atrtm1b(KOMP)Wtsi/2J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Atriptm1b(KOMP)Wtsi/Atrip+
(B6N(Cg)-Atriptm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Atxn1tm1Hzo/Atxn1+ Atxn1ltm2.1Hzo/Atxn1ltm2.1Hzo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:178303
|
Atxn1tm1Hzo/Atxn1tm1Hzo Atxn1ltm2.1Hzo/Atxn1l+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:178303
|
Atxn1tm1Hzo/Atxn1tm1Hzo Atxn1ltm2.1Hzo/Atxn1ltm2.1Hzo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:178303
|
Atxn1ltm2.1Hzo/Atxn1ltm2.1Hzo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:178303
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:135320
|
increased circulating cholesterol level
|
J:135320
|
increased circulating insulin level
|
J:135320
|
Atxn3tm1a(KOMP)Wtsi/Atxn3tm1a(KOMP)Wtsi
(C57BL/6N-Atxn3tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Atxn7l2em1(IMPC)Mbp/Atxn7l2em1(IMPC)Mbp
(C57BL/6NCrl-Atxn7l2em1(IMPC)Mbp/Mmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
AU021092tm1b(KOMP)Wtsi/AU021092+
(C57BL/6N-AU021092tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating calcium level
|
J:211773
|
AU021092tm1b(KOMP)Wtsi/AU021092tm1b(KOMP)Wtsi
(C57BL/6N-AU021092tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Auhem1(IMPC)Tcp/Auhem1(IMPC)Tcp
(C57BL/6NCrl-Auhem1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Aurkaip1em1(IMPC)Bay/Aurkaip1+
(C57BL/6N-Aurkaip1em1(IMPC)Bay/Bay)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Avptm1b(EUCOMM)Wtsi/Avp+
(C57BL/6N-Avptm1b(EUCOMM)Wtsi/H)
|
increased circulating total protein level
|
J:211773
|
Avptm1Lja/Avp+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating hormone level
|
J:148012
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal circulating corticosterone level
|
J:110099
|
decreased circulating atrial natriuretic factor
|
J:110099
|
Avpr1btm1Gzt/Avpr1btm1Gzt
(involves: 129 * C57BL/6J)
|
decreased circulating adrenocorticotropin level
|
J:87707
|
decreased circulating corticosterone level
|
J:87707
|
Avpr1btm1Wsy/Avpr1btm1Wsy
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating testosterone level
|
J:94939
|
Avpr2tm1Jwe/Y
(involves: 129S1/Sv * 129X1/SvJ * CF-1)
|
hypoglycemia
|
J:66094
|
increased circulating sodium level
|
J:66094
|
AW112010em2Flv/AW112010em2Flv
(involves: C57BL/6N)
|
decreased circulating interleukin-6 level
|
J:267975
|
decreased circulating interleukin-12b level
|
J:267975
|
Awat2em1(IMPC)Mbp/Awat2em1(IMPC)Mbp
(C57BL/6NCrl-Awat2em1(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Axin2tm1b(KOMP)Wtsi/Axin2+
(C57BL/6N-Axin2tm1b(KOMP)Wtsi/Bay)
|
increased blood urea nitrogen level
|
J:211773
|
Axltm1Grl/Axltm1Grl Mertktm1Grl/Mertktm1Grl Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal brain thrombosis
|
J:70420
|
abnormal thrombosis
|
J:70420
|
increased circulating tumor necrosis factor level
|
J:70420
|
Azin2Gt(IST12418H6)Tigm/Azin2Gt(IST12418H6)Tigm
(involves: C57BL/6N)
|
decreased circulating insulin level
|
J:204392
|
B2mtm1b(EUCOMM)Wtsi/B2m+
(C57BL/6N-B2mtm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating phosphate level
|
J:211773
|
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
decreased circulating serum albumin level
|
J:110885
|
B4galnt2tm1Jbl/B4galnt2tm1Jbl
(involves: 129S1/Sv)
|
increased circulating alkaline phosphatase level
|
J:217719
|
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating thyroxine level
|
J:37846
|
B4galt5em1(IMPC)Tcp/B4galt5+
(C57BL/6NCrl-B4galt5em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N)
|
abnormal platelet physiology
|
J:223526
|
Bace2tm1b(EUCOMM)Wtsi/Bace2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bace2tm1b(EUCOMM)Wtsi/Orl)
|
increased circulating calcium level
|
J:211773
|
Bach1tm1.1(KOMP)Vlcg/Bach1+
(B6N(Cg)-Bach1tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bach2tm1a(EUCOMM)Wtsi/Bach2tm1a(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
decreased circulating insulin level
|
J:133563
|
increased circulating glucose level
|
J:133563
|
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ)
|
abnormal circulating glucose level
|
J:133563
|
increased circulating insulin level
|
J:133563
|
Badtm1Sjk/Badtm1Sjk Tg(Ins2-Mirc13)E4Biat/0
(involves: 129X1/SvJ * C57BL/6N)
|
hyperglycemia
|
J:314874
|
Bag2em1(IMPC)J/Bag2em1(IMPC)J
(C57BL/6NJ-Bag2em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased circulating cholesterol level
|
J:144416
|
decreased circulating insulin level
|
J:144416
|
decreased circulating triglyceride level
|
J:144416
|
hypoglycemia
|
J:144416
|
increased circulating ketone body level
|
J:144416
|
Bag3tm1b(EUCOMM)Hmgu/Bag3+
(C57BL/6N-Bag3tm1b(EUCOMM)Hmgu/H)
|
decreased blood urea nitrogen level
|
J:211773
|
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating interleukin-6 level
|
J:83559
|
Baiap2tm1b(KOMP)Wtsi/Baiap2+
(C57BL/6N-Baiap2tm1b(KOMP)Wtsi/Tcp)
|
decreased circulating calcium level
|
J:211773
|
Baiap2l1tm1Zgh/Baiap2l1tm1Zgh
(B6.Cg-Baiap2l1tm1Zgh)
|
increased circulating insulin level
|
J:238622
|
increased fasting circulating glucose level
|
J:238622
|
Baiap2l2tm1a(EUCOMM)Hmgu/Baiap2l2tm1a(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1a(EUCOMM)Hmgu/Ics)
|
increased circulating bilirubin level
|
J:211773
|
Bak1tm1Thsn/Bak1tm1Thsn
(B6.129-Bak1tm1Thsn)
|
abnormal platelet physiology
|
J:149205
|
Bak1tm1Thsn/Bak1tm1Thsn Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn)
|
abnormal platelet physiology
|
J:149205
|
Banpem1(IMPC)J/Banp+
(C57BL/6NJ-Banpem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Bap1tm1.1Geno/Bap1tm1.1Geno Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal cardiac thrombosis
|
J:187380
|
BAP008/BAP008
(C3HeB/FeJ-BAP008)
|
increased circulating alkaline phosphatase level
|
J:183993
|
BAP011/BAP011
(C3HeB/FeJ-BAP011)
|
increased circulating alkaline phosphatase level
|
J:183993
|
BAP013/BAP013
(C3HeB/FeJ-BAP013)
|
increased circulating alkaline phosphatase level
|
J:183993
|
BAP028/BAP028
(C3HeB/FeJ-BAP028)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
BAP029/BAP029
(C3HeB/FeJ-BAP029)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
BAP030/BAP030
(C3HeB/FeJ-BAP030)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
BAP031/BAP031
(C3HeB/FeJ-BAP031)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
Barx2tm1b(EUCOMM)Hmgu/Barx2tm1b(EUCOMM)Hmgu
(C57BL/6N-Barx2tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Baz1btm1Ska/Baz1b+
(involves: C57BL/6 * CBA)
|
increased circulating calcium level
|
J:149990
|
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating glucose level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
Baz2aem1(IMPC)Tcp/Baz2aem1(IMPC)Tcp
(C57BL/6NCrl-Baz2aem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Baz2bem1(IMPC)Wtsi/Baz2bem1(IMPC)Wtsi
(C57BL/6N-Baz2bem1(IMPC)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Baz2bem1Hzhu/Baz2bem1Hzhu
(involves: 129 * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:326413
|
decreased circulating aspartate transaminase level
|
J:326413
|
Bbs1tm1Vcs/Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating leptin level
|
J:128532
|
Bbs2tm1.1Huss/Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6)
|
increased circulating alanine transaminase level
|
J:296033
|
increased circulating leptin level
|
J:296033
|
increased circulating triglyceride level
|
J:296033
|
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
|
abnormal blood homeostasis
|
J:134093
|
abnormal circulating hormone level
|
J:134093
|
abnormal circulating lipid level
|
J:134093
|
abnormal circulating mineral level
|
J:134093
|
increased blood urea nitrogen level
|
J:134093
|
increased circulating alanine transaminase level
|
J:134093
|
increased circulating alkaline phosphatase level
|
J:134093
|
increased circulating aspartate transaminase level
|
J:134093
|
increased circulating bilirubin level
|
J:134093
|
increased circulating cholesterol level
|
J:134093
|
increased circulating creatine kinase level
|
J:134093
|
increased circulating glucose level
|
J:134093
|
increased circulating HDL cholesterol level
|
J:134093
|
increased circulating insulin level
|
J:134093
|
increased circulating lactate dehydrogenase level
|
J:134093
|
increased circulating LDL cholesterol level
|
J:134093
|
increased circulating leptin level
|
J:134093
|
increased circulating magnesium level
|
J:134093
|
increased circulating sodium level
|
J:134093
|
increased circulating VLDL cholesterol level
|
J:134093
|
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bbs7tm1b(EUCOMM)Wtsi/Bbs7+
(B6N(Cg)-Bbs7tm1b(EUCOMM)Wtsi/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Bbs9em1(IMPC)Bay/Bbs9+
(C57BL/6N-Bbs9em1(IMPC)Bay/Bay)
|
increased circulating HDL cholesterol level
|
J:211773
|
Bbs10tm1.1(KOMP)Vlcg/Bbs10+
(B6N(Cg)-Bbs10tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating antidiuretic hormone level
|
J:227230
|
increased circulating leptin level
|
J:227230
|
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating free fatty acids level
|
J:189019
|
decreased circulating interleukin-6 level
|
J:189019
|
decreased circulating tumor necrosis factor level
|
J:189019
|
increased circulating glucose level
|
J:189019
|
increased circulating leptin level
|
J:189019
|
BC048562tm1b(KOMP)Wtsi/BC048562tm1b(KOMP)Wtsi
(C57BL/6N-BC048562tm1b(KOMP)Wtsi/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Bcar3em1(IMPC)Mbp/Bcar3em1(IMPC)Mbp
(C57BL/6N-Bcar3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Bcat2m1Ytc/Bcat2m1Ytc
(C57BL/6J-Bcat2m1Ytc)
|
abnormal circulating amino acid level
|
J:87589
|
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N)
|
abnormal circulating amino acid level
|
J:129967
|
decreased circulating free fatty acids level
|
J:129967
|
decreased circulating glucose level
|
J:129967
|
decreased circulating insulin level
|
J:129967
|
decreased circulating ketone body level
|
J:129967
|
decreased circulating leptin level
|
J:129967
|
decreased circulating resistin level
|
J:129967
|
BCH001/BCH001
(C3HeB/FeJ-BCH001)
|
increased circulating calcium level
|
J:183993
|
BCH005/BCH005
(C3HeB/FeJ-BCH005)
|
increased circulating calcium level
|
J:183993
|
BCH012/BCH012
(C3HeB/FeJ-BCH012)
|
increased circulating calcium level
|
J:183993
|
Bckdhbem1(IMPC)J/Bckdhbem1(IMPC)J
(CByJ.B6-Bckdhbem1(IMPC)J)
|
abnormal circulating amino acid level
|
J:344897
|
decreased circulating alanine level
|
J:344897
|
increased circulating leucine level
|
J:344897
|
increased circulating valine level
|
J:344897
|
BckdkGt(OST79912)Lex/BckdkGt(OST79912)Lex
(involves: 129S5/SvEvBrd)
|
abnormal circulating amino acid level
|
J:238065
|
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
|
abnormal circulating amino acid level
|
J:117564
|
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
abnormal circulating glucose level
|
J:181308
|
abnormal circulating insulin level
|
J:181308
|
increased circulating leptin level
|
J:181308
|
Bcl2tm1Mpin/Bcl2tm1Mpin
(involves: 129S2/SvPas * C57BL/6)
|
increased blood urea nitrogen level
|
J:34326
|
increased circulating creatinine level
|
J:34326
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
increased blood urea nitrogen level
|
J:15224,
J:22552
|
increased circulating creatinine level
|
J:15224,
J:22552
|
Bcl2l1Plt16/Bcl2l1+
(involves: BALB/c * C57BL/6)
|
abnormal platelet physiology
|
J:149205
|
Bcl2l1Plt20/Bcl2l1+
(involves: BALB/c * C57BL/6)
|
abnormal platelet physiology
|
J:149205
|
Bcl2l1Plt20/Bcl2l1Plt20
(involves: BALB/c * C57BL/6)
|
abnormal platelet physiology
|
J:149205
|
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo)
|
abnormal platelet physiology
|
J:149205
|
Bcl2l2Gt(ROSA)41Sor/Bcl2l2Gt(ROSA)41Sor
(involves: 129S5/SvEvBrd)
|
increased circulating follicle stimulating hormone level
|
J:46386
|
Bcl2l11em1(IMPC)H/Bcl2l11em1(IMPC)H
(C57BL/6NTac-Bcl2l11em1(IMPC)H/H)
|
increased circulating potassium level
|
J:211773
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
increased blood urea nitrogen level
|
J:58641
|
Bcl2l15tm1b(EUCOMM)Hmgu/Bcl2l15tm1b(EUCOMM)Hmgu
(C57BL/6N-Bcl2l15tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Bcl6tm1Gdba/Bcl6tm1Gdba Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
decreased circulating free fatty acids level
|
J:271078
|
decreased circulating insulin level
|
J:271078
|
decreased circulating triglyceride level
|
J:271078
|
decreased fasting circulating glucose level
|
J:271078
|
increased circulating leptin level
|
J:271078
|
Bcl7cem1(IMPC)J/Bcl7cem1(IMPC)J
(C57BL/6NJ-Bcl7cem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Bcl11atm1Mbu/Bcl11atm1Mbu Eportm1.1(EGFP/icre)Uk/Epor+ Tg(HBB)8.1Gvs/0
(involves: 129 * BALB/cJ * FVB/N)
|
increased circulating erythropoietin level
|
J:196405
|
Bcl11atm1Mbu/Bcl11atm1Mbu Klf1tm1Nimr/Klf1+ Tg(HBB)8.1Gvs/0
(involves: 129P2/OlaHsd * FVB)
|
increased circulating erythropoietin level
|
J:196405
|
Bcl11atm1Pwt/Bcl11atm1Pwt Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased circulating interferon-alpha level
|
J:207383
|
Bcl11btm1.1(KOMP)Vlcg/Bcl11b+
(B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Bclaf1tm1b(EUCOMM)Wtsi/Bclaf1tm1b(EUCOMM)Wtsi
(B6N(Cg)-Bclaf1tm1b(EUCOMM)Wtsi/J)
|
cyanosis
|
J:211773
|
Bco1tm1Dnp/Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating alanine transaminase level
|
J:128383
|
increased circulating cholesterol level
|
J:128383
|
increased circulating free fatty acids level
|
J:128383
|
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal blood homeostasis
|
J:166153
|
Bcorl1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Bcorl1em1(IMPC)Tcp/Cmmr)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Bcorl1em1(IMPC)Tcp/Bcorl1em1(IMPC)Tcp
(C57BL/6NCrl-Bcorl1em1(IMPC)Tcp/Cmmr)
|
decreased circulating cholesterol level
|
J:211773
|
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
|
increased blood urea nitrogen level
|
J:23804
|
increased circulating alanine transaminase level
|
J:23804
|
increased circulating aspartate transaminase level
|
J:23804
|
increased circulating lactate dehydrogenase level
|
J:23804
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
increased circulating lactate level
|
J:189652
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
|
decreased circulating arginine level
|
J:273501
|
decreased circulating glucose level
|
J:273501
|
increased circulating alanine transaminase level
|
J:273501
|
increased circulating alkaline phosphatase level
|
J:273501
|
increased circulating citrulline level
|
J:273501
|
increased circulating ornithine level
|
J:273501
|
Bdkrb1em1(IMPC)H/Bdkrb1em1(IMPC)H
(B6N;B6NTac-Bdkrb1em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
(B6.129S7-Bdkrb2tm1Jfh)
|
decreased blood urea nitrogen level
|
J:121339
|
increased blood urea nitrogen level
|
J:121339
|
increased circulating creatinine level
|
J:121339
|
Bdnftm1Par/Bdnf+
(B6.129S1-Bdnftm1Par)
|
increased circulating insulin level
|
J:59077
|
Bdnftm3Jae/Bdnftm3Jae Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J)
|
increased circulating glucose level
|
J:71969
|
increased circulating insulin level
|
J:71969
|
increased circulating leptin level
|
J:71969
|
Bdt3DBA/2J/Bdt3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased circulating leptin level
|
J:104825
|
increased circulating VLDL cholesterol level
|
J:104825
|
Becn1tm1b(KOMP)Wtsi/Becn1+
(C57BL/6N-Becn1tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Becn1tm1Ebr/Becn1tm1Ebr Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased blood urea nitrogen level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Becn2tm1.1Blev/Becn2+
(B6.Cg-Becn2tm1.1Blev)
|
increased circulating glucose level
|
J:203842
|
Bend7tm1b(EUCOMM)Wtsi/Bend7tm1b(EUCOMM)Wtsi
(C57BL/6N-Bend7tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6)
|
increased circulating insulin level
|
J:231585
|
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J)
|
decreased circulating insulin level
|
J:42700
|
Bglap/Bglap2tm3.1Kry/Bglap/Bglap2tm3.1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
decreased circulating testosterone level
|
J:170888
|
Bglap/Bglap2tm3.1Kry/Bglap/Bglap2tm3.1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
decreased circulating testosterone level
|
J:170888
|
Bglu1C57BL/6Slc/Bglu1C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu1C57BL/6Slc/Bglu1C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu2C57BL/6Slc/Bglu2C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu2C57BL/6Slc/Bglu2C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc)
|
hyperglycemia
|
J:62933
|
Bglu3C3H/HeJ/Bglu3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating glucose level
|
J:108422
|
Bglu3C3H/HeJ/Bglu3C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating glucose level
|
J:108422
|
Bglu4NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu7NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu8NZB/BlNJ/Bglu8NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu8NZW/LacJ/Bglu8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu10NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bglu11NZB/BlNJ/Bglu11NZB/BlNJ Bglu9NZB/BlNJ/Bglu9NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating glucose level
|
J:138463
|
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(B6N(Cg)-Bhlhe40tm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(C57BL/6N-Bhlhe40tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating lipid level
|
J:177569
|
decreased circulating cholesterol level
|
J:177569
|
decreased circulating HDL cholesterol level
|
J:177569
|
decreased circulating phospholipid level
|
J:177569
|
increased circulating alanine transaminase level
|
J:177569
|
Bhmttm1b(EUCOMM)Hmgu/Bhmttm1b(EUCOMM)Hmgu
(C57BL/6N-Bhmttm1b(EUCOMM)Hmgu/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
Bicc1jcpk-bpk/Bicc1jcpk-bpk
(BALB/c-Bicc1jcpk-bpk)
|
increased blood urea nitrogen level
|
J:13276
|
Bicc1m1Btlr/Bicc1m1Btlr
(C57BL/6J-Bicc1m1Btlr)
|
increased blood urea nitrogen level
|
J:132744
|
Bicralem1(IMPC)J/Bicralem1(IMPC)J
(C57BL/6NJ-Bicralem1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
Bin2tm1.1Beni/Bin2tm1.1Beni Tg(Pf4-icre)Q3Rsko/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal platelet activation
|
J:302510
|
abnormal platelet physiology
|
J:302510
|
decreased platelet aggregation
|
J:302510
|
decreased susceptibility to induced thrombosis
|
J:302510
|
increased bleeding time
|
J:302510
|
Birc6em1(IMPC)Ccpcz/Birc6+
(C57BL/6N-Birc6em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatine kinase level
|
J:211773
|
Bivmtm1b(KOMP)Wtsi/Bivmtm1b(KOMP)Wtsi
(C57BL/6N-Bivmtm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Blcapem1(IMPC)J/Blcapem1(IMPC)J
(C57BL/6NJ-Blcapem1(IMPC)J/J)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bloc1s1tm1a(EUCOMM)Hmgu/Bloc1s1+
(C57BL/6N-Bloc1s1tm1a(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:165965
|
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2+
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Bloc1s4cno/Bloc1s4cno
(C3H/HeJ-Bloc1s4cno)
|
abnormal platelet dense granule physiology
|
J:61187
|
decreased platelet aggregation
|
J:61187
|
increased bleeding time
|
J:61187
|
Bloc1s4em1(IMPC)Mbp/Bloc1s4em1(IMPC)Mbp
(C57BL/6NCrl-Bloc1s4em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating total protein level
|
J:211773
|
Bloc1s5mu/Bloc1s5mu
(involves: STOCK t)
|
abnormal platelet physiology
|
J:29151
|
decreased platelet aggregation
|
J:29151
|
increased bleeding time
|
J:29151
|
Bloc1s5mu/Bloc1s5mu
(CHMU/Le)
|
abnormal platelet dense granule physiology
|
J:29151
|
decreased platelet aggregation
|
J:29151
|
increased bleeding time
|
J:29151
|
Bloc1s6em1(IMPC)Mbp/Bloc1s6em1(IMPC)Mbp
(C57BL/6N-Bloc1s6em1(IMPC)Mbp/MbpMmucd)
|
increased circulating serum albumin level
|
J:211773
|
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
|
abnormal blood homeostasis
|
J:4098
|
abnormal platelet activation
|
J:7327,
J:221384
|
abnormal platelet physiology
|
J:221384
|
decreased platelet aggregation
|
J:221384
|
increased bleeding time
|
J:7327
|
Bltp1tm1b(EUCOMM)Hmgu/Bltp1+
(C57BL/6N-Bltp1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating glucose level
|
J:211773
|
Bltp3bem1(IMPC)J/Bltp3bem1(IMPC)J
(C57BL/6NJ-Bltp3bem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N)
|
increased circulating insulin level
|
J:237631
|
increased fasting circulating glucose level
|
J:237631
|
Blvrbtm1(KOMP)Wtsi/Blvrbtm1(KOMP)Wtsi
(C57BL/6N-Blvrbtm1(KOMP)Wtsi/Nju)
|
increased circulating creatinine level
|
J:211773
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:177865
|
decreased circulating insulin level
|
J:177865
|
decreased circulating VLDL triglyceride level
|
J:177865
|
hyperglycemia
|
J:177865
|
increased circulating cholesterol level
|
J:177865
|
increased circulating free fatty acids level
|
J:177865
|
increased circulating HDL cholesterol level
|
J:177865
|
increased circulating LDL cholesterol level
|
J:177865
|
increased circulating triglyceride level
|
J:177865
|
increased circulating VLDL cholesterol level
|
J:177865
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129)
|
abnormal circulating protein level
|
J:155089
|
decreased circulating progesterone level
|
J:151819
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
abnormal circulating adrenaline level
|
J:125921
|
abnormal circulating protein level
|
J:191844
|
abnormal venous thrombosis
|
J:191844
|
decreased circulating adrenaline level
|
J:125921
|
decreased circulating noradrenaline level
|
J:125921
|
decreased prothrombin time
|
J:191844
|
hypercoagulability
|
J:191844
|
increased circulating factor VIII level
|
J:191844
|
increased circulating fibrinogen level
|
J:191844
|
increased circulating osteocalcin level
|
J:97108
|
increased partial thromboplastin time
|
J:191844
|
increased susceptibility to induced thrombosis
|
J:191844
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased circulating glucose level
|
J:135933
|
increased blood urea nitrogen level
|
J:135933
|
increased circulating alanine transaminase level
|
J:135933
|
increased circulating aspartate transaminase level
|
J:135933
|
Bmal1tm2Bra/Bmal1tm2Bra Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR)
|
hyperglycemia
|
J:162641
|
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased circulating testosterone level
|
J:286451
|
Bmp4tm1Blh/Bmp4+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:173500
|
Bmp6em1(IMPC)Ccpcz/Bmp6em1(IMPC)Ccpcz
(C57BL/6N-Bmp6em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Bmp7tm1.1Dgra/Bmp7tm1.1Dgra H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * CBA/J)
|
increased circulating hydroxyproline level
|
J:302309
|
Bmp10tm3b(EUCOMM)Hmgu/Bmp10+
(C57BL/6N-Bmp10tm3b(EUCOMM)Hmgu/Ics)
|
decreased circulating creatinine level
|
J:211773
|
Bmpr1bem1(IMPC)Mbp/Bmpr1bem1(IMPC)Mbp
(C57BL/6NCrl-Bmpr1bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating phosphate level
|
J:211773
|
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
abnormal lung thrombosis
|
J:158116
|
Bms1tm1b(EUCOMM)Hmgu/Bms1+
(C57BL/6N-Bms1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating sodium level
|
J:211773
|
Bmyctm1Mpo/Bmyctm1Mpo
(involves: 129S7/SvEvBrd * C57BL/6N)
|
increased circulating luteinizing hormone level
|
J:191587
|
Bnc1em1(IMPC)H/Bnc1em1(IMPC)H
(C57BL/6NTac-Bnc1em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Bnip2tm1b(EUCOMM)Wtsi/Bnip2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bnip2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Bnip5tm1.1(KOMP)Vlcg/Bnip5tm1.1(KOMP)Vlcg
(C57BL/6N-Bnip5tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Boctm1b(KOMP)Wtsi/Boctm1b(KOMP)Wtsi
(C57BL/6N-Boctm1b(KOMP)Wtsi/H)
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Bodwt1C3H/HeJ/Bodwt1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:106521
|
increased circulating HDL cholesterol level
|
J:106521
|
increased circulating triglyceride level
|
J:106521
|
Bodwt1C3H/HeJ/Bodwt1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:106521
|
increased circulating HDL cholesterol level
|
J:106521
|
increased circulating triglyceride level
|
J:106521
|
Bola2tm1(KOMP)Wtsi/Bola2tm1(KOMP)Wtsi
(C57BL/6N-Bola2tm1(KOMP)Wtsi/Nju)
|
decreased circulating iron level
|
J:211773
|
Borcs6tm1.1(KOMP)Vlcg/Borcs6+
(B6N(Cg)-Borcs6tm1.1(KOMP)Vlcg/J)
|
increased circulating calcium level
|
J:211773
|
bpck/bpck
(B6C3Fe a/a-bpck/J)
|
increased blood urea nitrogen level
|
J:144929
|
Bpgmm1Pgrs/Bpgmm1Pgrs
(involves: C57BL/6 * C57BL/10J)
|
increased blood oxygen capacity
|
J:301620
|
increased circulating erythropoietin level
|
J:301620
|
Bpgmtm1a(KOMP)Wtsi/Bpgmtm1a(KOMP)Wtsi
(C57BL/6N-Bpgmtm1a(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Bpitm1.1Buls/Bpitm1.1Buls
(involves: BALB/cJ * C57BL/6J)
|
abnormal circulating interleukin level
|
J:346703
|
decreased circulating interferon-gamma level
|
J:346703
|
Bpifb1tm1b(KOMP)Wtsi/Bpifb1tm1b(KOMP)Wtsi
(C57BL/6N-Bpifb1tm1b(KOMP)Wtsi/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
BPL001/BPL001
(C3HeB/FeJ-BPL001)
|
decreased circulating phosphate level
|
J:183993
|
BPL002/BPL002
(C3HeB/FeJ-BPL002)
|
decreased circulating phosphate level
|
J:183993
|
BPL003/BPL003
(C3HeB/FeJ-BPL003)
|
decreased circulating phosphate level
|
J:183993
|
BPL004/BPL004
(C3HeB/FeJ-BPL004)
|
decreased circulating phosphate level
|
J:183993
|
BPL005/BPL005
(C3HeB/FeJ-BPL005)
|
decreased circulating phosphate level
|
J:183993
|
BPL006/BPL006
(C3HeB/FeJ-BPL006)
|
decreased circulating phosphate level
|
J:183993
|
BPL007/BPL007
(C3HeB/FeJ-BPL007)
|
decreased circulating phosphate level
|
J:183993
|
BPL008/BPL008
(C3HeB/FeJ-BPL008)
|
decreased circulating phosphate level
|
J:183993
|
BPL009/BPL009
(C3HeB/FeJ-BPL009)
|
decreased circulating phosphate level
|
J:183993
|
BPL010/BPL010
(C3HeB/FeJ-BPL010)
|
decreased circulating phosphate level
|
J:183993
|
BPL011/BPL011
(C3HeB/FeJ-BPL011)
|
decreased circulating phosphate level
|
J:183993
|
BPL012/BPL012
(C3HeB/FeJ-BPL012)
|
decreased circulating phosphate level
|
J:183993
|
BPL013/BPL013
(C3HeB/FeJ-BPL013)
|
decreased circulating phosphate level
|
J:183993
|
BPL014/BPL014
(C3HeB/FeJ-BPL014)
|
decreased circulating phosphate level
|
J:183993
|
Bpnt1tm1Yrk/Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating apolipoprotein E level
|
J:194247
|
abnormal circulating apolipoprotein level
|
J:194247
|
abnormal circulating enzyme level
|
J:194247
|
abnormal circulating protein level
|
J:194247
|
decreased circulating serum albumin level
|
J:194247
|
increased circulating alanine transaminase level
|
J:194247
|
increased circulating alkaline phosphatase level
|
J:194247
|
increased circulating aspartate transaminase level
|
J:194247
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating noradrenaline level
|
J:170095
|
Braftm1Cpri/Braftm1Cpri Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr)
|
increased circulating thyroid-stimulating hormone level
|
J:168249
|
increased circulating thyroxine level
|
J:168249
|
Braftm1Mmcm/Braf+ Tg(Tg-cre/ERT2)#Mmcm/0
(involves: 129P2/OlaHsd)
|
decreased circulating thyroxine level
|
J:172205
|
increased circulating thyroid-stimulating hormone level
|
J:172205
|
Braftm1Sva/Braftm1.1Sva Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
hypoglycemia
|
J:121660
|
Braftm1Tumg/Braf+ Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA)
|
cyanosis
|
J:216228
|
Braftm1Wds/Braftm1.1Wds Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
hypoglycemia
|
J:121660
|
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
|
abnormal blood homeostasis
|
J:159964
|
abnormal circulating lipid level
|
J:159964
|
decreased circulating glucose level
|
J:159964
|
increased circulating cholesterol level
|
J:159964
|
increased circulating glucagon level
|
J:159964
|
increased circulating insulin level
|
J:159964
|
increased circulating interleukin-1 beta level
|
J:159964
|
increased circulating leptin level
|
J:159964
|
increased circulating triglyceride level
|
J:159964
|
increased circulating tumor necrosis factor level
|
J:159964
|
Brd7tm2a(EUCOMM)Wtsi/Brd7+
(Not Specified)
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased blood uric acid level
|
J:175295
|
Brd9em1(IMPC)Tcp/Brd9+
(C57BL/6N-Brd9em1(IMPC)Tcp/Cmmr)
|
increased circulating HDL cholesterol level
|
J:211773
|
Brdttm1a(EUCOMM)Wtsi/Brdttm1a(EUCOMM)Wtsi
(C57BL/6-Brdttm1a(EUCOMM)Wtsi)
|
decreased circulating testosterone level
|
J:232496
|
Brf1tm1Arte/Brf1tm1Arte
(Not Specified)
|
increased circulating alanine transaminase level
|
J:285667
|
increased circulating alkaline phosphatase level
|
J:285667
|
increased circulating bilirubin level
|
J:285667
|
Brip1em1(IMPC)J/Brip1em1(IMPC)J
(C57BL/6NJ-Brip1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Brms1tm1.1(KOMP)Vlcg/Brms1+
(B6N(Cg)-Brms1tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Brpf3tm1a(EUCOMM)Wtsi/Brpf3+
(B6JTyr;B6N-Brpf3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating growth hormone level
|
J:44242
|
increased circulating insulin level
|
J:44242
|
increased circulating leptin level
|
J:44242
|
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb)
|
increased circulating insulin level
|
J:134021
|
increased circulating leptin level
|
J:134021
|
Brwd1em1(IMPC)Tcp/Brwd1em1(IMPC)Tcp
(C57BL/6N-Brwd1em1(IMPC)Tcp/Cmmr)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Bsbob3SPRET/EiJ/? Bsbob4SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
|
increased circulating cholesterol level
|
J:90614
|
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor)
|
increased circulating cholesterol level
|
J:211072
|
increased circulating insulin level
|
J:211072
|
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:183701
|
decreased circulating glucose level
|
J:183701
|
decreased circulating glycerol level
|
J:183701
|
decreased circulating leptin level
|
J:183701
|
decreased circulating triglyceride level
|
J:183701
|
increased circulating free fatty acids level
|
J:183701
|
increased circulating glucose level
|
J:183701
|
increased circulating glycerol level
|
J:183701
|
increased circulating insulin level
|
J:183701
|
increased circulating triglyceride level
|
J:183701
|
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased circulating leptin level
|
J:173404
|
increased circulating cholesterol level
|
J:211072,
J:173404
|
increased circulating glucose level
|
J:173404
|
increased circulating insulin level
|
J:211072,
J:173404
|
increased circulating triglyceride level
|
J:173404
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno)
|
decreased circulating free fatty acids level
|
J:200947
|
decreased circulating leptin level
|
J:200947
|
decreased circulating triglyceride level
|
J:200947
|
hyperglycemia
|
J:200947
|
increased circulating glucose level
|
J:200947
|
increased circulating HDL cholesterol level
|
J:200947
|
increased circulating insulin level
|
J:200947
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
|
decreased circulating complement protein level
|
J:287636
|
Bsndtm1.1Suc/Bsndtm1.1Suc
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating sodium level
|
J:175265
|
hypokalemia
|
J:175265
|
increased circulating bicarbonate level
|
J:175265
|
Bsndtm1Suc/Bsndtm1Suc
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating creatinine level
|
J:175265
|
hypokalemia
|
J:175265
|
increased circulating aldosterone level
|
J:175265
|
increased circulating bicarbonate level
|
J:175265
|
Bsxtm1Tre/Bsxtm1Tre Lepob/Lepob
(B6.Cg-Lepob Bsxtm1Tre)
|
hyperglycemia
|
J:122746
|
increased circulating insulin level
|
J:122746
|
Btbd1tm1a(KOMP)Wtsi/Btbd1tm1a(KOMP)Wtsi
(C57BL/6N-Btbd1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:211773
|
Btbd2em1(IMPC)Mbp/Btbd2em1(IMPC)Mbp
(C57BL/6N-Btbd2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
Btbd9Gt(RRE078)Byg/Btbd9Gt(RRE078)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating iron level
|
J:187433
|
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Btbd16tm2b(EUCOMM)Hmgu/Btbd16tm2b(EUCOMM)Hmgu
(C57BL/6N-Btbd16tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating triglyceride level
|
J:211773
|
Btctm1Dcl/Btctm1Dcl Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal atrial thrombosis
|
J:83820
|
Btdtm1Bwol/Btdtm1Bwol
(B6.Cg-Btdtm1Bwol)
|
increased circulating ammonia level
|
J:168391
|
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp
(B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J)
|
increased fasting circulating glucose level
|
J:211773
|
Btktm1Wk/Btktm1Wk Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet physiology
|
J:86448
|
decreased platelet aggregation
|
J:86448
|
Btrctm1b(KOMP)Wtsi/Btrctm1b(KOMP)Wtsi
(C57BL/6N-Btrctm1b(KOMP)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Btrctm1Paga/Btrctm1Paga Fbxw11tm1Ybn/Fbxw11tm1Ybn Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased circulating interleukin-1 beta level
|
J:206654
|
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
hypoglycemia
|
J:234643
|
Bub1btm1Jvd/Bub1btm1Jvd Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
hypoglycemia
|
J:234643
|
Bud23em2(IMPC)H/Bud23+
(C57BL/6N-Bud23em2(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
Bwt1HRS/J/Bwt1HRS/J Find1C57BLKS/J/Find1C57BLKS/J
(involves: C57BLKS/J * HRS/J)
|
increased circulating glucose level
|
J:100832
|
Byslem1(IMPC)Ccpcz/Bysl+
(C57BL/6N-Byslem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
C1dem1(IMPC)H/C1d+
(C57BL/6NTac-C1dem1(IMPC)H/H)
|
increased circulating serum albumin level
|
J:211773
|
C1galt1em1(IMPC)Hmgu/C1galt1+
(C57BL/6N-C1galt1em1(IMPC)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
C1galt1ptl1/C1galt1ptl1
(C57BL/6-C1galt1ptl1)
|
increased blood urea nitrogen level
|
J:115272
|
increased circulating creatinine level
|
J:115272
|
C1galt1tm1.1Rpmc/C1galt1tm1.1Rpmc Mgat1tm2Jxm/Mgat1tm2Jxm Tg(Zp3-cre)1Gwh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating testosterone level
|
J:173879
|
increased circulating follicle stimulating hormone level
|
J:173879
|
C1galt1tm1.1Staka/C1galt1tm1.2Staka Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA * DBA/2)
|
increased bleeding time
|
J:202276
|
C1qatm1b(EUCOMM)Wtsi/C1qatm1b(EUCOMM)Wtsi
(B6N(Cg)-C1qatm1b(EUCOMM)Wtsi/3J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
C1qcem1(IMPC)J/C1qcem1(IMPC)J
(C57BL/6NJ-C1qcem1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
C1ql3em1(IMPC)H/C1ql3em1(IMPC)H
(C57BL/6NTac-C1ql3em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex)
|
increased circulating cholesterol level
|
J:344722
|
increased circulating ketone body level
|
J:344722
|
C1qtnf1em1(IMPC)Mbp/C1qtnf1em1(IMPC)Mbp
(C57BL/6N-C1qtnf1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
|
decreased circulating free fatty acids level
|
J:241403
|
decreased circulating triglyceride level
|
J:241403
|
increased circulating insulin level
|
J:241403
|
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex)
|
decreased circulating cholesterol level
|
J:282612
|
decreased circulating HDL cholesterol level
|
J:282612
|
decreased circulating LDL cholesterol level
|
J:282612
|
increased circulating free fatty acids level
|
J:282612
|
increased circulating glycerol level
|
J:282612
|
increased circulating triglyceride level
|
J:282612
|
increased circulating VLDL cholesterol level
|
J:282612
|
increased circulating VLDL triglyceride level
|
J:282612
|
C1qtnf3tm2b(EUCOMM)Wtsi/C1qtnf3tm2b(EUCOMM)Wtsi
(C57BL/6N-C1qtnf3tm2b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6JSmoc-C1qtnf4em1Smoc/Smoc)
|
increased circulating interleukin-6 level
|
J:302282
|
increased circulating interleukin-18 level
|
J:302282
|
increased circulating tumor necrosis factor level
|
J:302282
|
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating insulin level
|
J:237401
|
decreased fasting circulating glucose level
|
J:237401
|
C1qtnf5tm1.1(KOMP)Vlcg/C1qtnf5+
(B6N(Cg)-C1qtnf5tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased circulating complement protein level
|
J:227217
|
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg)
|
decreased circulating glucose level
|
J:244352
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
increased circulating insulin level
|
J:212299
|
increased circulating leptin level
|
J:212299
|
increased circulating resistin level
|
J:212299
|
C2cd2em1(IMPC)J/C2cd2em1(IMPC)J
(C57BL/6NJ-C2cd2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
C2cd4bem1(IMPC)Wtsi/C2cd4bem1(IMPC)Wtsi
(C57BL/6N-C2cd4bem1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
decreased circulating adrenaline level
|
J:284780
|
decreased circulating free fatty acids level
|
J:284780
|
increased fasting circulating glucose level
|
J:284780
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:152533
|
decreased circulating interleukin-6 level
|
J:166640,
J:152533
|
decreased circulating tumor necrosis factor level
|
J:152533
|
increased circulating alanine transaminase level
|
J:152533
|
increased circulating bilirubin level
|
J:152533
|
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
|
abnormal blood homeostasis
|
J:113463
|
C3tm1Crr/C3tm1Crr
(B6;129S4-C3tm1Crr/J)
|
decreased circulating free fatty acids level
|
J:214214
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae)
|
abnormal blood coagulation
|
J:44715
|
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6)
|
decreased circulating glucose level
|
J:60633,
J:58966
|
decreased circulating insulin level
|
J:60633
|
decreased circulating leptin level
|
J:60633,
J:58966
|
decreased circulating triglyceride level
|
J:60633
|
increased circulating free fatty acids level
|
J:60633,
J:58966
|
C3tm1Hrc/C3tm1Hrc
(involves: 129)
|
decreased circulating insulin level
|
J:87945
|
decreased circulating leptin level
|
J:87945
|
increased circulating free fatty acids level
|
J:87945
|
C3tm1Hrc/C3tm1Hrc Cd55tm1Song/Cd55tm1Song Cr1ltm1Hmo/Cr1ltm1Hmo
(involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
abnormal platelet physiology
|
J:138410
|
C3tm1Hrc/C3tm1Hrc Cd55tm1Song/Cd55tm1Song Cr1ltm1Hmo/Cr1ltm1Hmo Vsig4tm1Gne/Vsig4tm1Gne
(involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6N)
|
abnormal platelet physiology
|
J:138410
|
C3tm1Hrc/C3tm1Hrc Lepob/Lepob
(involves: 129 * C57BL/6)
|
decreased circulating insulin level
|
J:80546
|
increased circulating free fatty acids level
|
J:80546
|
C3ar1tm1Cge/C3ar1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:166640
|
C3ar1tm1Cge/C3ar1tm1Cge
(B6.129S4(C)-C3ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
decreased circulating phospholipid level
|
J:214214
|
C3ar1tm1Cge/C3ar1tm1Cge C5ar1tm1Cge/C5ar1tm1Cge
(B6.Cg-C3ar1tm1Cge C5ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
decreased circulating phospholipid level
|
J:214214
|
C3ar1tm1Raw/C3ar1tm1Raw
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:68807
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
increased circulating interleukin-1 beta level
|
J:93791
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae)
|
abnormal blood coagulation
|
J:44715
|
C4bptm1b(KOMP)Wtsi/C4bptm1b(KOMP)Wtsi
(C57BL/6N-C4bptm1b(KOMP)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
C4bptm1Raw/C4bptm1Raw
(B6.129-C4bptm1Raw)
|
increased circulating interleukin-6 level
|
J:244020
|
C5ar1tm1Cge/C5ar1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:166640
|
C5ar1tm1Cge/C5ar1tm1Cge
(B6.129S4(Cg)-C5ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6)
|
increased circulating alanine transaminase level
|
J:152533
|
increased circulating bilirubin level
|
J:152533
|
increased circulating insulin level
|
J:123294
|
C9tm1.1(KOMP)Vlcg/C9tm1.1(KOMP)Vlcg
(B6N(Cg)-C9tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
C9orf72tm1.1(KOMP)Mbp/C9orf72tm1.1(KOMP)Mbp
(C57BL/6N-C9orf72tm1.1(KOMP)Mbp/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
|
abnormal circulating interleukin level
|
J:240357
|
decreased circulating interleukin-2 level
|
J:240357
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal circulating cytokine level
|
J:240357
|
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal circulating cytokine level
|
J:240357
|
CA001/CA001+
(C3HeB/FeJ-CA001)
|
decreased circulating calcium level
|
J:163957
|
cab/cab
(STOCK Cacna1smdg)
|
cyanosis
|
J:6195
|
hypoglycemia
|
J:7797
|
Cab39em1(IMPC)Tcp/Cab39+
(C57BL/6NCrl-Cab39em1(IMPC)Tcp/Cmmr)
|
increased blood urea nitrogen level
|
J:211773
|
Cabcoco1tm1a(KOMP)Wtsi/Cabcoco1tm1a(KOMP)Wtsi
(C57BL/6N-Cabcoco1tm1a(KOMP)Wtsi/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Cacfd1tm1Lex/Cacfd1tm1Lex
(B6;129S5-Cacfd1tm1Lex/Mmucd)
|
increased circulating cholesterol level
|
J:171883
|
increased circulating triglyceride level
|
J:171883
|
Cachd1em1(IMPC)J/Cachd1+
(C57BL/6NJ-Cachd1em1(IMPC)J/J)
|
increased circulating calcium level
|
J:211773
|
Cacna1btm1b(KOMP)Wtsi/Cacna1btm1b(KOMP)Wtsi
(C57BL/6N-Cacna1btm1b(KOMP)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA)
|
decreased circulating glucagon level
|
J:105212
|
decreased circulating insulin level
|
J:105212
|
decreased circulating leptin level
|
J:105212
|
decreased circulating triglyceride level
|
J:105212
|
Cacna1ctm3Hfm/Cacna1ctm3Hfm Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:84919
|
increased circulating glucose level
|
J:84919
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating insulin level
|
J:72316
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6)
|
decreased circulating glucagon level
|
J:95377
|
increased circulating glucose level
|
J:95377
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6)
|
hyperglycemia
|
J:95636
|
increased circulating glucose level
|
J:101873
|
Cacna1ftm1.1(KOMP)Vlcg/Y
(C57BL/6N-Cacna1ftm1.1(KOMP)Vlcg/Ucd)
|
increased circulating creatinine level
|
J:211773
|
Cacna1ftm1.1(KOMP)Vlcg/Cacna1ftm1.1(KOMP)Vlcg
(C57BL/6N-Cacna1ftm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Cacna1stm1.1(KOMP)Vlcg/Cacna1s+
(B6N(Cg)-Cacna1stm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Cacna1stm1.1(KOMP)Vlcg/Cacna1stm1.1(KOMP)Vlcg
(B6N(Cg)-Cacna1stm1.1(KOMP)Vlcg/J)
|
cyanosis
|
J:211773
|
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cacnb2tm1.1(KOMP)Vlcg/Cacnb2tm1.1(KOMP)Vlcg
(C57BL/6N-Cacnb2tm1.1(KOMP)Vlcg/Tcp)
|
increased circulating glucose level
|
J:211773
|
Cacng3tm1Dgen/Cacng3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
Cacybptm1b(EUCOMM)Wtsi/Cacybp+
(C57BL/6N-Cacybptm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Cadps2em1(IMPC)Rbrc/Cadps2em1(IMPC)Rbrc
(C57BL/6NJcl-Cadps2em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Calcatm1Rfg/Calcatm1Rfg
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating calcium level
|
J:80827
|
Calcatm1Rfg/Calcatm1Rfg
(involves: Black Swiss)
|
abnormal circulating magnesium level
|
J:80827
|
Calcoco1em1(IMPC)H/Calcoco1em1(IMPC)H
(C57BL/6N-Calcoco1em1(IMPC)H/H)
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Calcrem1(IMPC)Rbrc/Calcrem1(IMPC)Rbrc
(C57BL/6NJcl-Calcrem1(IMPC)Rbrc/Rbrc)
|
abnormal circulating alkaline phosphatase level
|
J:211773
|
abnormal circulating calcium level
|
J:211773
|
Calcrtm1Rda/Calcrtm1Rda Tg(CMV-cre)1Cgn/0
(B6.Cg-Calcrtm1Rda Tg(CMV-cre)1Cgn)
|
abnormal circulating calcium level
|
J:150982
|
abnormal circulating hormone level
|
J:150982
|
Camk1tm2b(EUCOMM)Hmgu/Camk1tm2b(EUCOMM)Hmgu
(C57BL/6N-Camk1tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Camk1dem1(IMPC)Mbp/Camk1dem1(IMPC)Mbp
(C57BL/6NCrl-Camk1dem1(IMPC)Mbp/Mmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6)
|
decreased circulating leptin level
|
J:136219
|
Camkmttm1b(EUCOMM)Wtsi/Camkmttm1b(EUCOMM)Wtsi
(C57BL/6N-Camkmttm1b(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Camsap1em1(IMPC)J/Camsap1+
(C57BL/6NJ-Camsap1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3+
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased circulating thyroxine level
|
J:211773
|
Cand1em1(IMPC)Mbp/Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Cand2tm1a(EUCOMM)Wtsi/Cand2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cand2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:211773
|
decreased circulating thyroxine level
|
J:211773
|
Candy/Candy
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Candy2/Candy2
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Candy3/Candy3
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Candy4/Candy4
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Candy5/Candy5
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:163957
|
increased circulating phosphate level
|
J:163957
|
Cant1tm1b(EUCOMM)Hmgu/Cant1+
(C57BL/6N-Cant1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:165965
|
Capn1tm1.1Arte/Capn1tm1.1Arte Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
abnormal platelet physiology
|
J:189100
|
Capn1tm1Ahc/Capn1tm1Ahc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal blood coagulation
|
J:67798
|
abnormal platelet dense granule physiology
|
J:67798
|
abnormal platelet physiology
|
J:67798
|
decreased platelet aggregation
|
J:67798
|
Capn3tm1.1Hiso/Capn3tm1.1Hiso
(B6.129P2-Capn3tm1.1Hiso)
|
increased circulating creatine kinase level
|
J:163711
|
Capn10tm1b(EUCOMM)Wtsi/Capn10tm1b(EUCOMM)Wtsi
(C57BL/6N-Capn10tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Capn12tm1b(EUCOMM)Hmgu/Capn12tm1b(EUCOMM)Hmgu
(C57BL/6N-Capn12tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating amylase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Caprin1tm1Mtok/Caprin1tm1Mtok
(involves: 129S6/SvEvTac * C57BL/6)
|
cyanosis
|
J:164650
|
Capza2tm1b(KOMP)Wtsi/Capza2+
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Car2n/Car2n
(involves: C57BL/6J * DBA/2J)
|
decreased circulating bicarbonate level
|
J:19268
|
Car2tm1(KOMP)Vlcg/Car2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal blood pH regulation
|
J:216402
|
decreased circulating bicarbonate level
|
J:216402
|
hypokalemia
|
J:216402
|
Car4tm1b(EUCOMM)Wtsi/Car4+
(C57BL/6N-Car4tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating calcium level
|
J:211773
|
Car5atm1Sly/Car5atm1Sly
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating ammonia level
|
J:196135
|
Car5atm1Sly/Car5atm1Sly Car5btm1Sly/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:196135
|
increased circulating ammonia level
|
J:196135
|
Car5atm1Sly/Car5atm1Sly Car5btm1Sly/Car5btm1Sly
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:196135
|
increased circulating ammonia level
|
J:196135
|
Car6em1(IMPC)Ccpcz/Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Car7tm1b(KOMP)Wtsi/Car7+
(B6N(Cg)-Car7tm1b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Card11em1(IMPC)Ccpcz/Card11em1(IMPC)Ccpcz
(C57BL/6NCrl-Card11em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
|
decreased circulating interleukin-4 level
|
J:132226
|
decreased circulating interleukin-5 level
|
J:132226
|
Carftm1.1(KOMP)Vlcg/Carftm1.1(KOMP)Vlcg
(B6N(Cg)-Carftm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Carmil2tm1b(KOMP)Mbp/Carmil2tm1b(KOMP)Mbp
(C57BL/6N-Carmil2tm1b(KOMP)Mbp/Orl)
|
increased circulating glucose level
|
J:211773
|
Cartpttm1Amgn/Cartpttm1Amgn
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating insulin level
|
J:103911
|
Casc3tm1.1(KOMP)Vlcg/Casc3+
(C57BL/6NCrl-Casc3tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased blood urea nitrogen level
|
J:211773
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:115310
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating interleukin-1 alpha level
|
J:22964
|
decreased circulating interleukin-1 beta level
|
J:22964
|
decreased circulating interleukin-6 level
|
J:22964
|
decreased circulating tumor necrosis factor level
|
J:22964
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(B6.129S2(NOD)-Casp1tm1Sesh Casp4del)
|
decreased circulating interleukin-1 alpha level
|
J:193522
|
decreased circulating interleukin-1 beta level
|
J:193522
|
decreased circulating interleukin-18 level
|
J:193522
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del Tg(Casp4)#Gne/0
(involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)
|
decreased circulating interleukin-1 beta level
|
J:193522
|
decreased circulating interleukin-18 level
|
J:193522
|
Casp1tm1Sesh/Casp1tm1Sesh Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating interleukin-18 level
|
J:191055
|
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6)
|
decreased circulating interleukin-1 alpha level
|
J:193522
|
decreased circulating interleukin-1 beta level
|
J:193522
|
decreased circulating interleukin-18 level
|
J:193522
|
Casp4tm1b(KOMP)Wtsi/Casp4tm1b(KOMP)Wtsi
(C57BL/6N-Casp4tm1b(KOMP)Wtsi/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Casp4tm1Yuan/Casp4tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased circulating interleukin-1 alpha level
|
J:46167
|
decreased circulating interleukin-1 beta level
|
J:46167
|
Casp8em1Hbz/Casp8em1Hbz
(involves: C57BL/6)
|
decreased circulating alanine transaminase level
|
J:342732
|
decreased circulating aspartate transaminase level
|
J:342732
|
Casp8tm1Clie/Casp8tm1Clie Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal circulating enzyme level
|
J:218665
|
increased circulating alkaline phosphatase level
|
J:218665
|
increased circulating bilirubin level
|
J:218665
|
Casp8tm1Clie/Casp8tm1Clie Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating alanine transaminase level
|
J:160521
|
increased circulating aspartate transaminase level
|
J:160521
|
increased circulating bilirubin level
|
J:160521
|
Casp8tm1Clie/Casp8tm1Clie Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal circulating enzyme level
|
J:218665
|
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6)
|
increased circulating interleukin-18 level
|
J:144912
|
Casp14em1(IMPC)Ccpcz/Casp14em1(IMPC)Ccpcz
(C57BL/6N-Casp14em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
Casq1tm1b(EUCOMM)Wtsi/Casq1tm1b(EUCOMM)Wtsi
(C57BL/6N-Casq1tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
CasrBCH002/CasrBCH002
(C3HeB/FeJ-CasrBCH002)
|
decreased circulating phosphate level
|
J:183993
|
increased circulating calcium level
|
J:183993
|
CasrBCH003/CasrBCH003
(C3HeB/FeJ-CasrBCH003)
|
increased circulating calcium level
|
J:183993
|
CasrBCH004/CasrBCH004
(C3HeB/FeJ-CasrBCH004)
|
increased circulating calcium level
|
J:183993
|
CasrBCH007/CasrBCH007
(C3HeB/FeJ-CasrBCH007)
|
increased circulating calcium level
|
J:183993
|
CasrBCH011/CasrBCH011
(C3HeB/FeJ-CasrBCH011)
|
increased circulating calcium level
|
J:183993
|
CasrBCH013/CasrBCH013
(C3HeB/FeJ-CasrBCH013)
|
increased circulating calcium level
|
J:183993
|
CasrNuf/Casr+
(either: (involves: 102/El * 102/H * C3H/He) or (involves: 102/El * C3H/He * C3H/HeH))
|
decreased circulating calcium level
|
J:92612
|
decreased circulating parathyroid hormone level
|
J:92612
|
increased circulating phosphate level
|
J:92612
|
CasrNuf/CasrNuf
(involves: 102/El * C3H/He)
|
decreased circulating calcium level
|
J:92612
|
decreased circulating parathyroid hormone level
|
J:92612
|
increased circulating phosphate level
|
J:92612
|
Casrtm1b(KOMP)Mbp/Casr+
(C57BL/6N-Casrtm1b(KOMP)Mbp/Tcp)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Casrtm1Ces/Casr+
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating calcium level
|
J:29900
|
increased circulating magnesium level
|
J:29900
|
increased circulating parathyroid hormone level
|
J:29900
|
Casrtm1Ces/Casrtm1Ces
(involves: 129X1/SvJ * Black Swiss)
|
decreased circulating phosphate level
|
J:71056
|
increased circulating calcium level
|
J:29900
|
increased circulating magnesium level
|
J:29900
|
increased circulating parathyroid hormone level
|
J:29900
|
Casrtm1Wch/Casr+ Tg(PTH-cre)4167Slib/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
increased circulating calcium level
|
J:180651
|
increased circulating parathyroid hormone level
|
J:180651
|
Casrtm1Wch/Casrtm1Wch Tg(PTH-cre)4167Slib/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
increased circulating calcium level
|
J:180651
|
increased circulating parathyroid hormone level
|
J:180651
|
Casttm1.1(KOMP)Vlcg/Casttm1.1(KOMP)Vlcg
(B6N(Cg)-Casttm1.1(KOMP)Vlcg/2J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Catb/Catb
(Not Specified)
|
decreased circulating cholesterol level
|
J:5205,
J:5351
|
decreased circulating triglyceride level
|
J:5205,
J:5351
|
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal blood homeostasis
|
J:75192
|
abnormal circulating free fatty acids level
|
J:75192
|
decreased circulating leptin level
|
J:75192
|
increased circulating CXCL10 level
|
J:115914
|
increased circulating interferon-gamma level
|
J:115914
|
increased circulating interleukin-6 level
|
J:115914
|
increased circulating triglyceride level
|
J:75192
|
increased circulating tumor necrosis factor level
|
J:115914
|
increased circulating VLDL triglyceride level
|
J:75192
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
increased circulating insulin level
|
J:84260
|
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
|
abnormal circulating amino acid level
|
J:182288
|
hyperglycemia
|
J:182288
|
increased blood urea nitrogen level
|
J:182288
|
increased circulating glycerol level
|
J:182288
|
increased circulating insulin level
|
J:182288
|
Cav1tm1Pesch/Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn)
|
decreased circulating glucose level
|
J:182288
|
decreased circulating glycerol level
|
J:182288
|
Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
increased circulating creatine kinase level
|
J:69965
|
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating hormone level
|
J:143425
|
abnormal circulating lipid level
|
J:143425
|
decreased circulating leptin level
|
J:143425
|
hyperlipidemia
|
J:143425
|
increased circulating free fatty acids level
|
J:143425
|
increased circulating insulin level
|
J:143425
|
increased circulating triglyceride level
|
J:143425
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating free fatty acids level
|
J:94416
|
decreased circulating insulin level
|
J:94416
|
decreased circulating leptin level
|
J:94416
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating free fatty acids level
|
J:121012
|
decreased circulating insulin level
|
J:121012
|
decreased circulating leptin level
|
J:121012
|
decreased circulating triglyceride level
|
J:121012
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
abnormal circulating lipoprotein level
|
J:236022
|
decreased circulating cholesterol level
|
J:236022
|
decreased circulating glucose level
|
J:236022
|
decreased circulating glycerol level
|
J:236022
|
decreased circulating iron level
|
J:236022
|
decreased circulating serum albumin level
|
J:236022
|
increased blood urea nitrogen level
|
J:236022
|
Cbr2tm1b(EUCOMM)Hmgu/Cbr2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cbr2tm1b(EUCOMM)Hmgu/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
Cbstm1Unc/Cbs+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating homocysteine level
|
J:23321
|
Cbstm1Unc/Cbs+
(B6.129P2-Cbstm1Unc/J)
|
increased circulating homocysteine level
|
J:64885,
J:166184
|
Cbstm1Unc/Cbs+
(involves: 129P2/OlaHsd)
|
increased circulating homocysteine level
|
J:112538
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating homocysteine level
|
J:105571,
J:190486,
J:23321
|
increased circulating progesterone level
|
J:114850
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating homocysteine level
|
J:150548
|
Cbstm1Unc/Cbstm1Unc
(B6.129P2-Cbstm1Unc/J)
|
abnormal circulating amino acid level
|
J:166184
|
decreased circulating taurine level
|
J:166184
|
increased circulating homocysteine level
|
J:166184
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd)
|
increased circulating homocysteine level
|
J:112538
|
Cbstm1Unc/Cbstm1Unc Tg(CBS)11181Eri/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal blood homeostasis
|
J:165612
|
abnormal circulating amino acid level
|
J:165612
|
abnormal circulating homocysteine level
|
J:165612
|
decreased bleeding time
|
J:165612
|
hypercoagulability
|
J:165612
|
Cbstm1Unc/Cbstm1Unc Tg(Mt1-CBS)25Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal circulating homocysteine level
|
J:150548
|
Cbstm1Unc/Cbstm1Unc Tg(Mt1-CBS*I278T)1Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal circulating homocysteine level
|
J:150548
|
Cbstm1Unc/Cbstm1Unc Tg(Mt1-CBS*S466L)EB86Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
increased circulating homocysteine level
|
J:150548,
J:168131
|
increased circulating methionine level
|
J:168131
|
Cbx1em1(IMPC)Ccpcz/Cbx1+
(C57BL/6NCrl-Cbx1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatinine level
|
J:211773
|
Cbx5tm1a(EUCOMM)Wtsi/Cbx5tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx5tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cc2d1atm1.1Thkn/Cc2d1atm1.1Thkn Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
cyanosis
|
J:236761
|
Cc2d1atm1.2Thkn/Cc2d1atm1.2Thkn
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)
|
cyanosis
|
J:236761
|
Cc2d1btm1a(KOMP)Wtsi/Cc2d1b+
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating phosphate level
|
J:165965
|
Cc2d1btm1a(KOMP)Wtsi/Cc2d1btm1a(KOMP)Wtsi
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J)
|
increased circulating insulin level
|
J:228688
|
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
|
decreased circulating leptin level
|
J:220560
|
increased circulating glucose level
|
J:220560
|
Ccdc18tm1a(EUCOMM)Wtsi/Ccdc18tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc18tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ccdc28bem1Jlba/Ccdc28bem1Jlba
(C57BL/6J-Ccdc28bem1Jlba)
|
increased circulating glucose level
|
J:325766
|
Ccdc32em1(IMPC)J/Ccdc32+
(C57BL/6NJ-Ccdc32em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Ccdc40em1(IMPC)J/Ccdc40em1(IMPC)J
(C57BL/6NJ-Ccdc40em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Ccdc50em2Gpt/Ccdc50em2Gpt
(C57BL/6J-Ccdc50em2Gpt)
|
increased circulating interferon-beta level
|
J:345495
|
Ccdc50tm1b(EUCOMM)Hmgu/Ccdc50tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccdc50tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ccdc51em1(IMPC)J/Ccdc51em1(IMPC)J
(C57BL/6NJ-Ccdc51em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Ccdc57tm1a(EUCOMM)Wtsi/Ccdc57+
(B6JTyr;B6N-Ccdc57tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Ccdc77tm1a(EUCOMM)Wtsi/Ccdc77tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc77tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Ccdc78em1(IMPC)J/Ccdc78em1(IMPC)J
(C57BL/6NJ-Ccdc78em1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
decreased circulating insulin level
|
J:189183
|
increased circulating free fatty acids level
|
J:189183
|
increased circulating glucose level
|
J:189183
|
increased circulating leptin level
|
J:189183
|
Ccdc88bem1(IMPC)Tcp/Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Ccdc90bem1(IMPC)J/Ccdc90bem1(IMPC)J
(C57BL/6NJ-Ccdc90bem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6NCrl-Ccdc92tm1a(KOMP)Mbp/MbpMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp)
|
decreased circulating cholesterol level
|
J:332421
|
decreased circulating interleukin-1 beta level
|
J:332421
|
decreased circulating interleukin-18 level
|
J:332421
|
decreased circulating LDL cholesterol level
|
J:332421
|
decreased circulating leptin level
|
J:332421
|
decreased circulating triglyceride level
|
J:332421
|
Ccdc92tm1b(KOMP)Mbp/Ccdc92tm1b(KOMP)Mbp
(C57BL/6N-Ccdc92tm1b(KOMP)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Ccdc103em4(IMPC)H/Ccdc103+
(C57BL/6N-Ccdc103em4(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Ccdc117em1(IMPC)J/Ccdc117em1(IMPC)J
(C57BL/6NJ-Ccdc117em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Ccdc120tm1.1(KOMP)Vlcg/Ccdc120tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Ccdc122tm1a(KOMP)Wtsi/Ccdc122tm1a(KOMP)Wtsi
(C57BL/6N-Ccdc122tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Ccdc127tm1b(EUCOMM)Wtsi/Ccdc127tm1b(EUCOMM)Wtsi
(C57BL/6N-Ccdc127tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Ccdc198em1Iad/Ccdc198em1Iad
(FVB.Cg-Pde6b+ Tyrc-ch Ccdc198em1Iad/J)
|
decreased circulating ferritin level
|
J:337480
|
Cckartm1b(EUCOMM)Hmgu/Cckartm1b(EUCOMM)Hmgu
(C57BL/6N-Cckartm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Cckbrtm1Kpn/Cckbrtm1Kpn
(involves: 129S2/SvPas)
|
increased circulating gastrin level
|
J:49320
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal circulating iron level
|
J:142455
|
decreased circulating ferritin level
|
J:142455
|
decreased circulating unsaturated transferrin level
|
J:142455
|
increased circulating gastrin level
|
J:142455,
J:35876
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae)
|
increased circulating gastrin level
|
J:101985
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased circulating interferon-gamma level
|
J:155025
|
increased circulating interleukin-10 level
|
J:155025
|
increased circulating tumor necrosis factor level
|
J:155025
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
decreased circulating free fatty acids level
|
J:110277
|
decreased circulating insulin level
|
J:110277
|
increased circulating glucose level
|
J:126512
|
increased circulating insulin level
|
J:126512
|
increased circulating leptin level
|
J:126512
|
Ccl2tm1Rol/Ccl2tm1Rol Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased circulating triglyceride level
|
J:75837
|
increased circulating VLDL cholesterol level
|
J:75837
|
Ccl3em1(IMPC)H/Ccl3em1(IMPC)H
(C57BL/6N-Ccl3em1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Ccl9tm1(KOMP)Vlcg/Ccl9tm1(KOMP)Vlcg
(C57BL/6N-Ccl9tm1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ccl25em1(IMPC)H/Ccl25em1(IMPC)H
(C57BL/6N-Ccl25em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Ccl28em1(IMPC)Ccpcz/Ccl28em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccl28em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ccnitm1Jro/Ccnitm1Jro
(involves: 129S4/SvJaeSor)
|
increased circulating creatinine level
|
J:115356
|
Ccnqtm1.1(KOMP)Vlcg/Ccnq+
(C57BL/6N-Ccnqtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Ccnt1em1(IMPC)J/Ccnt1em1(IMPC)J
(C57BL/6NJ-Ccnt1em1(IMPC)J/Mmjax)
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:224589
|
decreased circulating free fatty acids level
|
J:224589
|
decreased circulating triglyceride level
|
J:224589
|
Ccpg1tm1b(EUCOMM)Hmgu/Ccpg1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae)
|
increased blood urea nitrogen level
|
J:115119
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
abnormal circulating chemokine level
|
J:169909
|
decreased circulating interferon-gamma level
|
J:169909
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating alanine transaminase level
|
J:61542
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd)
|
decreased circulating alanine transaminase level
|
J:311042
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * BALB/c)
|
decreased circulating creatinine level
|
J:162714
|
Ccr2tm1Mae/Ccr2tm1Mae Msmpem1Jzx/Msmpem1Jzx
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:311042
|
Ccr3tm1Cge/Ccr3tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
abnormal hemostasis
|
J:115273
|
decreased circulating interleukin-4 level
|
J:115273
|
Cd1d1em1(IMPC)H/Cd1d1em1(IMPC)H
(C57BL/6NTac-Cd1d1em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc)
|
increased blood urea nitrogen level
|
J:121187
|
Cd1d1tm1Luc/Cd1d1tm1Luc Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Cd1d1tm1Luc Ldlrtm1Her)
|
decreased circulating VLDL cholesterol level
|
J:110061
|
Cd2apem1Irgu/Cd2apem1Irgu
(C57BL/6-Cd2apem1Irgu)
|
decreased circulating serum albumin level
|
J:294238
|
increased blood urea nitrogen level
|
J:294238
|
increased circulating creatinine level
|
J:294238
|
Cd2aptm1Shaw/Cd2aptm1Shaw
(involves: 129X1/SvJ)
|
decreased circulating serum albumin level
|
J:57971
|
increased blood urea nitrogen level
|
J:57971
|
increased circulating creatinine level
|
J:57971
|
Cd5ltm1b(KOMP)Mbp/Cd5ltm1b(KOMP)Mbp
(C57BL/6N-Cd5ltm1b(KOMP)Mbp/H)
|
decreased circulating glucose level
|
J:211773
|
Cd14tm1Smg/Cd14tm1Smg
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:32729
|
decreased circulating tumor necrosis factor level
|
J:32729
|
Cd19tm1(cre)Cgn/Cd19+ Il10tm1Roer/Il10tm1Roer
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-10 level
|
J:151551
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
decreased circulating interferon-gamma level
|
J:136210
|
decreased circulating interleukin-4 level
|
J:136210
|
decreased circulating interleukin-6 level
|
J:136210
|
decreased circulating interleukin-10 level
|
J:136210
|
decreased circulating tumor necrosis factor level
|
J:136210
|
Cd22tm1b(EUCOMM)Wtsi/Cd22tm1b(EUCOMM)Wtsi
(C57BL/6N-Cd22tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Cd24atm1Pjln/Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
increased erythrocyte sedimentation rate
|
J:76695
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:95353
|
decreased circulating interleukin-4 level
|
J:95353
|
Cd33tm1.1(KOMP)Vlcg/Cd33tm1.1(KOMP)Vlcg
(B6N(Cg)-Cd33tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cd33tm1Avrk/Cd33tm1Avrk
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating aspartate transaminase level
|
J:83728
|
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating triglyceride level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
decreased fasting circulating glucose level
|
J:56081
|
increased circulating cholesterol level
|
J:56081
|
increased circulating HDL cholesterol level
|
J:56081
|
increased circulating ketone body level
|
J:126461
|
increased circulating leptin level
|
J:126461
|
increased circulating triglyceride level
|
J:56081
|
increased circulating VLDL triglyceride level
|
J:56081
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal circulating lipid level
|
J:87372
|
decreased susceptibility to induced thrombosis
|
J:136325
|
increased circulating free fatty acids level
|
J:87372
|
increased circulating ketone body level
|
J:87372
|
increased circulating triglyceride level
|
J:87372
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
decreased circulating glucose level
|
J:220343
|
decreased circulating triglyceride level
|
J:220343
|
Cd38em1(IMPC)Ccpcz/Cd38em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd38em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Cd38tm1Okam/Cd38tm1Okam
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:52933
|
Cd40tm1Kik/Cd40tm1Kik
(B6.129P2-Cd40tm1Kik/J)
|
decreased platelet aggregation
|
J:108988
|
Cd40lgtm1Imx/Y
(B6.129S2-Cd40lgtm1Imx/J)
|
decreased platelet aggregation
|
J:108988
|
Cd40lgtm1Imx/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thrombosis
|
J:103954
|
decreased platelet aggregation
|
J:103954
|
increased bleeding time
|
J:103954
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6)
|
abnormal blood coagulation
|
J:75152
|
Cd44tm1Hbg/Cd44tm1Hbg Tg(TNF)197Gkl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating interleukin-1 level
|
J:97992
|
increased circulating interleukin-6 level
|
J:97992
|
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak)
|
abnormal circulating cytokine level
|
J:69351
|
increased circulating interferon-gamma level
|
J:69351
|
increased circulating interleukin-2 level
|
J:69351
|
increased circulating tumor necrosis factor level
|
J:69351
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating chemokine level
|
J:155691
|
decreased blood urea nitrogen level
|
J:114341
|
decreased circulating creatinine level
|
J:114341
|
decreased circulating tumor necrosis factor level
|
J:155691
|
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl)
|
abnormal platelet physiology
|
J:98979
|
Cd47tm1Fpl/Cd47tm1Fpl
(C.129S7-Cd47tm1Fpl)
|
abnormal platelet physiology
|
J:98979
|
Cd52em1(IMPC)Ccpcz/Cd52em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd52em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating glucose level
|
J:211773
|
Cd55tm1b(EUCOMM)Hmgu/Cd55tm1b(EUCOMM)Hmgu
(C57BL/6N-Cd55tm1b(EUCOMM)Hmgu/BayMmucd)
|
decreased circulating phosphate level
|
J:211773
|
Cd55btm1a(KOMP)Wtsi/Cd55btm1a(KOMP)Wtsi
(C57BL/6N-Cd55btm1a(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129/Sv * C57BL/6)
|
hemoglobinemia
|
J:70419
|
Cd59btm1Jha/Cd59btm1Jha
(involves: 129/Sv * C57BL/6)
|
abnormal platelet physiology
|
J:82330
|
hemoglobinemia
|
J:82330
|
Cd84tm1b(KOMP)Mbp/Cd84tm1b(KOMP)Mbp
(B6N(Cg)-Cd84tm1b(KOMP)Mbp/J)
|
increased circulating sodium level
|
J:211773
|
Cd151tm1Lka/Cd151tm1Lka
(C57BL/6-Cd151tm1Lka)
|
increased bleeding time
|
J:91605
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal circulating cytokine level
|
J:224919
|
Cd180tm1Kmiy/Cd180tm1Kmiy Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
abnormal blood urea nitrogen level
|
J:137066
|
Cd200tm1a(KOMP)Wtsi/Cd200tm1a(KOMP)Wtsi
(C57BL/6N-Cd200tm1a(KOMP)Wtsi/H)
|
decreased circulating calcium level
|
J:165965
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
|
decreased blood urea nitrogen level
|
J:217719
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
decreased circulating bilirubin level
|
J:217719
|
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6 * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:153503
|
Cd209etm1b(KOMP)Wtsi/Cd209etm1b(KOMP)Wtsi
(C57BL/6N-Cd209etm1b(KOMP)Wtsi/Wtsi)
|
increased circulating serum albumin level
|
J:211773
|
Cd248tm1.1(KOMP)Vlcg/Cd248tm1.1(KOMP)Vlcg
(C57BL/6N-Cd248tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Cd276tm2b(EUCOMM)Hmgu/Cd276tm2b(EUCOMM)Hmgu
(C57BL/6N-Cd276tm2b(EUCOMM)Hmgu/Orl)
|
increased circulating total protein level
|
J:211773
|
Cd300etm1.1(KOMP)Vlcg/Cd300etm1.1(KOMP)Vlcg
(C57BL/6N-Cd300etm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Cd300ld2em1(IMPC)Wtsi/Cd300ld2em1(IMPC)Wtsi
(C57BL/6N-Cd300ld2em1(IMPC)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Cd300ldem1(IMPC)Wtsi/Cd300ldem1(IMPC)Wtsi
(C57BL/6N-Cd300ldem1(IMPC)Wtsi/WtsiIeg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Cd320Gt(CC0426)Wtsi/Cd320Gt(CC0426)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating homocysteine level
|
J:199961
|
Cdan1tm1b(KOMP)Wtsi/Cdan1+
(C57BL/6N-Cdan1tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Cdc20tm1.1(KOMP)Vlcg/Cdc20+
(B6N(Cg)-Cdc20tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cdc20bem1(IMPC)Wtsi/Cdc20bem1(IMPC)Wtsi
(C57BL/6N-Cdc20bem1(IMPC)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Cdc34tm1.1(KOMP)Mbp/Cdc34+
(B6N(Cg)-Cdc34tm1.1(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cdc37em1(IMPC)J/Cdc37+
(C57BL/6NJ-Cdc37em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cdc42tm1b(EUCOMM)Hmgu/Cdc42+
(C57BL/6N-Cdc42tm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cdc42tm1Brak/Cdc42tm1Brak Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet activation
|
J:160792
|
abnormal platelet dense granule physiology
|
J:160792
|
abnormal platelet physiology
|
J:160792
|
increased bleeding time
|
J:160792
|
increased platelet aggregation
|
J:160792
|
increased susceptibility to induced thrombosis
|
J:160792
|
Cdc42ep3em1(IMPC)Mbp/Cdc42ep3em1(IMPC)Mbp
(C57BL/6NCrl-Cdc42ep3em1(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Cdc73Gt(RRE190)Byg/Cdc73+
(B6.129P2-Cdc73Gt(RRE190)Byg)
|
increased circulating calcium level
|
J:243366
|
increased circulating parathyroid hormone level
|
J:243366
|
Cdc73tm1Btt/Cdc73+ Tg(PTH-cre)4167Slib/0
(Not Specified)
|
increased circulating calcium level
|
J:243366
|
Cdc73tm1Btt/Cdc73tm1Btt Tg(PTH-cre)4167Slib/0
(Not Specified)
|
increased circulating calcium level
|
J:243366
|
Cdca5tm1.1(KOMP)Vlcg/Cdca5+
(B6N(Cg)-Cdca5tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cdca7lem1(IMPC)Mbp/Cdca7lem1(IMPC)Mbp
(C57BL/6NCrl-Cdca7lem1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Cdca8tm1a(KOMP)Wtsi/Cdca8+
(C57BL/6N-Cdca8tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:175295
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Cdh4tm1b(EUCOMM)Wtsi/Cdh4tm1b(EUCOMM)Wtsi
(B6N(Cg)-Cdh4tm1b(EUCOMM)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cdh9tm1b(KOMP)Wtsi/Cdh9tm1b(KOMP)Wtsi
(C57BL/6N-Cdh9tm1b(KOMP)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Cdh11em1(IMPC)Mbp/Cdh11em1(IMPC)Mbp
(C57BL/6N-Cdh11em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cdh18em1(IMPC)J/Cdh18em1(IMPC)J
(C57BL/6NJ-Cdh18em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Cdh20em1(IMPC)J/Cdh20em1(IMPC)J
(C57BL/6NJ-Cdh20em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cdin1em1(IMPC)J/Cdin1+
(C57BL/6NJ-Cdin1em1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Cdipttm1b(EUCOMM)Wtsi/Cdipt+
(C57BL/6N-Cdipttm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating lactate dehydrogenase level
|
J:211773
|
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating follicle stimulating hormone level
|
J:54534
|
decreased circulating insulin level
|
J:54534
|
decreased circulating progesterone level
|
J:54534
|
hyperglycemia
|
J:54534
|
Cdk5tm1Kul/Cdk5tm1Kul
(involves: 129S4/SvJae * C57BL/6)
|
cyanosis
|
J:64289
|
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik)
|
decreased circulating glucose level
|
J:220703
|
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3+
(C57BL/6N-Cdk5rap3tm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA)
|
decreased circulating cholesterol level
|
J:272566
|
decreased circulating triglyceride level
|
J:272566
|
decreased fasting circulating glucose level
|
J:272566
|
hypoglycemia
|
J:272566
|
increased circulating alanine transaminase level
|
J:272566
|
increased circulating bilirubin level
|
J:272566
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased circulating insulin level
|
J:281075
|
increased circulating glucose level
|
J:281075
|
Cdk12em1(IMPC)Tcp/Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Cdk14tm1a(KOMP)Wtsi/Cdk14tm1a(KOMP)Wtsi
(C57BL/6N-Cdk14tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
Cdk15tm1b(KOMP)Wtsi/Cdk15tm1b(KOMP)Wtsi
(B6N(Cg)-Cdk15tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Cdk18em1(IMPC)J/Cdk18em1(IMPC)J
(C57BL/6NJ-Cdk18em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
decreased circulating glucose level
|
J:195460
|
decreased circulating insulin level
|
J:195460
|
increased circulating leptin level
|
J:195460
|
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn)
|
increased circulating glucose level
|
J:178248
|
Cdkl2tm1b(EUCOMM)Hmgu/Cdkl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cdkl2tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating potassium level
|
J:211773
|
Cdkl4tm1.1(KOMP)Vlcg/Cdkl4tm1.1(KOMP)Vlcg
(B6N(Cg)-Cdkl4tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased circulating testosterone level
|
J:115443
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv)
|
decreased circulating testosterone level
|
J:115443
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1btm1Kin/Cdkn1b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating glucose level
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1b+ Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
hyperglycemia
|
J:96047
|
hyperlipidemia
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating glucose level
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
hyperlipidemia
|
J:96047
|
increased circulating insulin level
|
J:96047
|
Cdkn1ctm1Kat/Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:61190
|
Cdkn1ctm1Kat/Cdkn1ctm1Kat
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:61190
|
Cdkn2aipem1(IMPC)J/Cdkn2aipem1(IMPC)J
(C57BL/6NJ-Cdkn2aipem1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating testosterone level
|
J:68829
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
decreased circulating testosterone level
|
J:68829
|
increased circulating follicle stimulating hormone level
|
J:68829
|
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:68829
|
Cdkn3em1(IMPC)J/Cdkn3em1(IMPC)J
(C57BL/6NJ-Cdkn3em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cdo1tm1.1Mhst/Cdo1tm1.1Mhst
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:182195
|
decreased circulating insulin-like growth factor I level
|
J:182195
|
increased circulating cysteine level
|
J:182195
|
Cdo1tm1Mhst/Cdo1tm1Mhst Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
abnormal blood homeostasis
|
J:186922
|
decreased circulating cysteine level
|
J:186922
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating triglyceride level
|
J:181979
|
increased circulating insulin level
|
J:181979
|
increased circulating leptin level
|
J:181979
|
Ceacam3em1(IMPC)Wtsi/Ceacam3em1(IMPC)Wtsi
(C57BL/6N-Ceacam3em1(IMPC)Wtsi/WtsiCnrm)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Ceacam16tm1.1(KOMP)Wtsi/Ceacam16tm1.1(KOMP)Wtsi
(B6N(Cg)-Ceacam16tm1.1(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ceacam23em1(IMPC)Wtsi/Ceacam23em1(IMPC)Wtsi
(C57BL/6N-Ceacam23em1(IMPC)Wtsi/WtsiOulu)
|
increased circulating HDL cholesterol level
|
J:211773
|
Cebpam4443Dajl/Cebpam4443Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
increased circulating cholesterol level
|
J:149088
|
increased circulating HDL cholesterol level
|
J:149088
|
increased circulating LDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Cebpatm1.1(Cebpb)Ylee/Cebpatm1.1(Cebpb)Ylee
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating leptin level
|
J:77646
|
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating serum albumin level
|
J:28320
|
hypoglycemia
|
J:28320
|
increased circulating tyrosine level
|
J:28320
|
Cebpatm1Gonz/Cebpatm1Gonz Lepob/Lepob Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating cholesterol level
|
J:93579
|
decreased circulating HDL cholesterol level
|
J:93579
|
decreased circulating insulin level
|
J:93579
|
decreased circulating LDL cholesterol level
|
J:93579
|
increased circulating free fatty acids level
|
J:93579
|
increased circulating glucose level
|
J:93579
|
increased circulating VLDL cholesterol level
|
J:93579
|
Cebpatm1Gonz/Cebpatm1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N)
|
increased circulating free fatty acids level
|
J:93579
|
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hypoglycemia
|
J:35795
|
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
|
decreased circulating glucose level
|
J:163725
|
increased circulating alanine transaminase level
|
J:163725
|
increased circulating aspartate transaminase level
|
J:163725
|
increased circulating triglyceride level
|
J:163725
|
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating insulin level
|
J:120098
|
increased circulating glucose level
|
J:120098
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
hypoglycemia
|
J:136134
|
Cebpbtm1.1Elgaz/Cebpbtm1.1Elgaz Lyz2em1.1(cre)Elgaz/Lyz2+
(BALB/cJ-Cebpbtm1.1Elgaz Lyz2em1.1Elgaz/Elgaz)
|
decreased circulating interleukin-10 level
|
J:247885
|
increased circulating interleukin-6 level
|
J:247885
|
increased circulating tumor necrosis factor level
|
J:247885
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Ins2Akita/Ins2Akita Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)
|
decreased circulating insulin level
|
J:156725
|
increased circulating glucose level
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Leprdb/Leprdb Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J)
|
hyperglycemia
|
J:156725
|
increased circulating insulin level
|
J:156725
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal circulating free fatty acids level
|
J:52286
|
decreased circulating free fatty acids level
|
J:62132,
J:52286
|
decreased circulating insulin level
|
J:62132
|
decreased circulating interleukin-12 level
|
J:25215
|
decreased circulating leptin level
|
J:62132
|
decreased circulating triglyceride level
|
J:52286
|
hypoglycemia
|
J:62132,
J:52286
|
increased circulating corticosterone level
|
J:52286
|
increased circulating interleukin-6 level
|
J:25215
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1)
|
hypoglycemia
|
J:49673
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6)
|
increased circulating glucose level
|
J:117502
|
increased circulating triglyceride level
|
J:117502
|
Cebpbtm2.1Acle/Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased circulating interleukin-6 level
|
J:155795
|
Cebpdtm1Pfj/Cebpd+
(involves: 129S1/Sv)
|
decreased circulating lactate level
|
J:116932
|
Cebpdtm1Pfj/Cebpdtm1Pfj
(involves: 129S1/Sv)
|
decreased blood uric acid level
|
J:116932
|
decreased circulating lactate level
|
J:116932
|
Cecr2tm2b(EUCOMM)Hmgu/Cecr2+
(C57BL/6N-Cecr2tm2b(EUCOMM)Hmgu/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Celtm1Dyh/Celtm1Dyh Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:124658
|
decreased circulating insulin level
|
J:124658
|
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Celsr3tm1Agof/Celsr3tm1Agof
(either: CD-1.129P2-Celsr3tm1Agof or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
cyanosis
|
J:98367
|
Cemip2tm1.1Cya/Cemip2tm1.1Cya Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
increased circulating hyaluronic acid level
|
J:317425
|
Cenpetm1b(EUCOMM)Hmgu/Cenpe+
(C57BL/6N-Cenpetm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating lipase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cenphtm1b(EUCOMM)Hmgu/Cenph+
(C57BL/6N-Cenphtm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cep19tm1b(EUCOMM)Hmgu/Cep19tm1b(EUCOMM)Hmgu
(C57BL/6N-Cep19tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac)
|
increased circulating glucose level
|
J:206667
|
increased circulating triglyceride level
|
J:206667
|
Cep43tm1b(EUCOMM)Hmgu/Cep43+
(C57BL/6N-Cep43tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cep57l1tm1b(KOMP)Wtsi/Cep57l1+
(B6N(Cg)-Cep57l1tm1b(KOMP)Wtsi/2J)
|
increased fasting circulating glucose level
|
J:211773
|
Cep126tm1b(KOMP)Mbp/Cep126tm1b(KOMP)Mbp
(C57BL/6N-Cep126tm1b(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cep135em1(IMPC)J/Cep135+
(C57BL/6NJ-Cep135em1(IMPC)J/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cep295nltm1.1(KOMP)Vlcg/Cep295nltm1.1(KOMP)Vlcg
(B6N(Cg)-Cep295nltm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Cept1tm1.1Sem/Cept1tm1.1Sem Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:249456
|
Cers5tm2b(KOMP)Mbp/Cers5tm2b(KOMP)Mbp
(B6N(Cg)-Cers5tm2b(KOMP)Mbp/J)
|
increased circulating sodium level
|
J:211773
|
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
|
decreased circulating insulin level
|
J:215519
|
decreased circulating leptin level
|
J:215519
|
Ces1dem1(IMPC)Mbp/Ces1dem1(IMPC)Mbp
(C57BL/6NCrl-Ces1dem1(IMPC)Mbp/Mmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac)
|
abnormal circulating lipid level
|
J:158743
|
decreased circulating cholesterol level
|
J:158743
|
decreased circulating free fatty acids level
|
J:158743
|
decreased circulating glucose level
|
J:158743
|
decreased circulating glycerol level
|
J:158743
|
decreased circulating triglyceride level
|
J:158743
|
decreased circulating VLDL cholesterol level
|
J:158743
|
decreased circulating VLDL triglyceride level
|
J:158743
|
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating apolipoprotein E level
|
J:262803
|
abnormal circulating apolipoprotein level
|
J:262803
|
decreased fasting circulating glucose level
|
J:262803
|
hyperlipidemia
|
J:262803
|
increased circulating cholesterol level
|
J:262803
|
increased circulating free fatty acids level
|
J:262803
|
increased circulating insulin level
|
J:262803
|
increased circulating phospholipid level
|
J:262803
|
increased circulating triglyceride level
|
J:262803
|
increased circulating VLDL cholesterol level
|
J:262803
|
increased circulating VLDL triglyceride level
|
J:262803
|
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg)
|
decreased circulating triglyceride level
|
J:335459
|
increased circulating alanine transaminase level
|
J:335459
|
increased circulating aspartate transaminase level
|
J:335459
|
increased circulating insulin level
|
J:335459
|
Cfap36tm1a(EUCOMM)Wtsi/Cfap36tm1a(EUCOMM)Wtsi
(C57BL/6N-Cfap36tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Cfap44tm1a(EUCOMM)Wtsi/Cfap44tm1a(EUCOMM)Wtsi
(C57BL/6N-Cfap44tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Cfap61tm2a(EUCOMM)Wtsi/Cfap61tm2a(EUCOMM)Wtsi
(C57BL/6N-Cfap61tm2a(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Cfap107em1(IMPC)J/Cfap107em1(IMPC)J
(C57BL/6NJ-Cfap107em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Cfap119tm1b(EUCOMM)Hmgu/Cfap119tm1b(EUCOMM)Hmgu
(C57BL/6N-Cfap119tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cfbtm1.1(KOMP)Wtsi/Cfbtm1.1(KOMP)Wtsi
(C57BL/6N-Cfbtm1.1(KOMP)Wtsi/J)
|
decreased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cfbtm1Hrc/Cfb+ Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129S/Sv * C57BL/6)
|
decreased circulating complement protein level
|
J:78193
|
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6)
|
abnormal blood coagulation
|
J:240426
|
abnormal blood homeostasis
|
J:240426
|
abnormal brain thrombosis
|
J:240426
|
abnormal glomerular capillary thrombosis
|
J:240426
|
abnormal hepatic portal vein thrombosis
|
J:240426
|
abnormal kidney thrombosis
|
J:240426
|
abnormal kidney venous thrombosis
|
J:240426
|
abnormal lung thrombosis
|
J:240426
|
abnormal thrombosis
|
J:240426
|
decreased circulating complement protein level
|
J:240426
|
increased blood urea nitrogen level
|
J:240426
|
Cfhtm1Mbo/Cfh+
(involves: 129/Sv * C57BL/6)
|
decreased circulating complement protein level
|
J:78193
|
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6)
|
decreased circulating complement protein level
|
J:78193
|
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129)
|
decreased circulating complement protein level
|
J:125860,
J:131403
|
Cfhtm1Mbo/Cfhtm1Mbo Cfitm1Mcp/Cfitm1Mcp
(involves: 129/Sv * C57BL/6)
|
abnormal circulating protein level
|
J:131403
|
Cfhtm1Mbo/Cfhtm1Mbo Tg(CAG-Cfh*)#Mcp/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal circulating complement protein level
|
J:125860
|
abnormal kidney thrombosis
|
J:125860
|
increased blood urea nitrogen level
|
J:125860
|
Cfitm1b(EUCOMM)Hmgu/Cfitm1b(EUCOMM)Hmgu
(C57BL/6N-Cfitm1b(EUCOMM)Hmgu/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Cfitm1Mcp/Cfitm1Mcp
(involves: 129/Sv * C57BL/6)
|
decreased circulating complement protein level
|
J:131403
|
Cfl1tm1.1Wit/Cfl1tm1.1Wit Tg(NPHS2-cre)295Lbh/0
(involves: 129 * C57BL/6 * SJL)
|
increased circulating creatinine level
|
J:165315
|
Cgatm1Sac/Cgatm1Sac
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating follicle stimulating hormone level
|
J:28450
|
decreased circulating luteinizing hormone level
|
J:28450
|
decreased circulating testosterone level
|
J:28450
|
decreased circulating thyroid-stimulating hormone level
|
J:28450
|
Cgastm1a(EUCOMM)Hmgu/Cgastm1a(EUCOMM)Hmgu
(C57BL/6N-Cgastm1a(EUCOMM)Hmgu)
|
decreased circulating interferon-alpha level
|
J:201167
|
decreased circulating interferon-beta level
|
J:201167
|
Cgntm1b(KOMP)Wtsi/Cgntm1b(KOMP)Wtsi
(B6N(Cg)-Cgntm1b(KOMP)Wtsi/J)
|
cyanosis
|
J:211773
|
Cgnl1em1(IMPC)Mbp/Cgnl1em1(IMPC)Mbp
(C57BL/6NCrl-Cgnl1em1(IMPC)Mbp/Mmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Cgref1em1(IMPC)J/Cgref1em1(IMPC)J
(C57BL/6NJ-Cgref1em1(IMPC)J/Mmjax)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Cgrrf1tm1b(KOMP)Wtsi/Cgrrf1tm1b(KOMP)Wtsi
(C57BL/6N-Cgrrf1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Chaf1btm1b(EUCOMM)Hmgu/Chaf1b+
(C57BL/6N-Chaf1btm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating calcium level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:153908
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:153908
|
Chchd10em1(IMPC)H/Chchd10em1(IMPC)H
(C57BL/6N-Chchd10em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Chchd10em1(IMPC)Mbp/Chchd10em1(IMPC)Mbp
(C57BL/6NCrl-Chchd10em1(IMPC)Mbp/Mmucd)
|
increased circulating phosphate level
|
J:211773
|
Chct1tm1b(EUCOMM)Wtsi/Chct1tm1b(EUCOMM)Wtsi
(C57BL/6N-Chct1tm1b(EUCOMM)Wtsi/Bay)
|
increased circulating calcium level
|
J:211773
|
Chd2tm1b(EUCOMM)Hmgu/Chd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Chd2tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Chd3em1(IMPC)J/Chd3em1(IMPC)J
(C57BL/6NJ-Chd3em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
decreased circulating follicle stimulating hormone level
|
J:174086
|
decreased circulating luteinizing hormone level
|
J:174086
|
Chd7tm2a(EUCOMM)Wtsi/Chd7+
(involves: 129S5/SvEvBrd * C57BL/6N)
|
abnormal circulating enzyme level
|
J:330596
|
abnormal circulating lipoprotein level
|
J:330596
|
decreased circulating alanine transaminase level
|
J:330596
|
decreased circulating total protein level
|
J:330596
|
increased blood uric acid level
|
J:330596
|
increased circulating alkaline phosphatase level
|
J:330596
|
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi)
|
abnormal circulating lipid level
|
J:330596
|
abnormal circulating lipoprotein level
|
J:330596
|
abnormal circulating mineral level
|
J:330596
|
abnormal circulating protein level
|
J:330596
|
decreased circulating aspartate transaminase level
|
J:330596
|
decreased circulating calcium level
|
J:330596
|
decreased circulating cholesterol level
|
J:330596
|
decreased circulating free fatty acids level
|
J:330596
|
decreased circulating glycerol level
|
J:330596
|
decreased circulating insulin level
|
J:330596
|
decreased circulating magnesium level
|
J:330596
|
decreased circulating potassium level
|
J:330596
|
decreased circulating serum albumin level
|
J:330596
|
decreased circulating triglyceride level
|
J:330596
|
increased blood urea nitrogen level
|
J:330596
|
Chd9tm1a(EUCOMM)Wtsi/Chd9tm1a(EUCOMM)Wtsi
(C57BL/6N-Chd9tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Chdhem1Rmps/Chdhem1Rmps
(C57BL/6N-Chdhem1Rmps)
|
increased circulating homocysteine level
|
J:286033
|
Chdhtm1b(KOMP)Mbp/Chdhtm1b(KOMP)Mbp
(C57BL/6N-Chdhtm1b(KOMP)Mbp/Tcp)
|
decreased circulating alanine transaminase level
|
J:211773
|
Chek2tm1b(EUCOMM)Hmgu/Chek2tm1b(EUCOMM)Hmgu
(B6N(Cg)-Chek2tm1b(EUCOMM)Hmgu/J)
|
increased circulating sodium level
|
J:211773
|
Chfrtm1a(KOMP)Wtsi/Chfrtm1a(KOMP)Wtsi
(C57BL/6NCrl-Chfrtm1a(KOMP)Wtsi/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Chgatm1Skmt/Chga+
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating adrenaline level
|
J:99805
|
increased circulating noradrenaline level
|
J:99805
|
Chgatm1Skmt/Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating adrenaline level
|
J:99805
|
increased circulating noradrenaline level
|
J:99805
|
Chic2tm1b(EUCOMM)Wtsi/Chic2+
(C57BL/6N-Chic2tm1b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Chldq1MRL/MpJ/Chldq1MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq1MRL/MpJ/Chldq1SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq2MRL/MpJ/Chldq2MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq2MRL/MpJ/Chldq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq3MRL/MpJ/Chldq3MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033,
J:123776
|
increased circulating HDL cholesterol level
|
J:106033,
J:123776
|
Chldq3MRL/MpJ/Chldq3SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq4MRL/MpJ/Chldq4MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq4MRL/MpJ/Chldq4SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq7NZB/BlNJ/Chldq7NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq7NZB/BlNJ/Chldq7RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq9NZB/BlNJ/Chldq9RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating HDL cholesterol level
|
J:123776
|
Chldq9RF/J/Chldq9RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating HDL cholesterol level
|
J:123776
|
Chldq12NZB/BlNJ/Chldq12NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating cholesterol level
|
J:123776
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq12NZB/BlNJ/Chldq12RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating cholesterol level
|
J:123776
|
increased circulating HDL cholesterol level
|
J:123776
|
Chlq1BALB/cJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:104331
|
Chlq1DBA/2J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
abnormal circulating corticosterone level
|
J:104331
|
Chlq2C57BL/6J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:104331
|
Chlq3C3H/HeJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating leptin level
|
J:104331
|
Chlq4C3H/HeJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating thyroxine level
|
J:104331
|
Chlq5C57BL/6J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:104331
|
Chlq6C3H/HeJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:104331
|
Chlq7BALB/cJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating thyroxine level
|
J:104331
|
Chlq8C3H/HeJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating thyroxine level
|
J:104331
|
Chlq10C3H/HeJ/? Chlq11C3H/HeJ/? Chlq9BALB/cJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:111693
|
Chlq10DBA/2J/? Chlq11DBA/2J/? Chlq9BALB/cJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:111693
|
Chlq10DBA/2J/? Chlq11DBA/2J/? Chlq9C57BL/6J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:111693
|
Chlq11DBA/2J/? Chlq12DBA/2J/? Chlq5BALB/cJ/? Chlq9C57BL/6J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
decreased circulating insulin-like growth factor I level
|
J:111693
|
Chlq13DBA/2J/? Chlq14DBA/2J/? Chlq15C3H/HeJ/? Chlq5C57BL/6J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:111693
|
Chlq15C3H/HeJ/? Chlq16BALB/cJ/? Chlq17BALB/cJ/? Chlq18C3H/HeJ/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
increased circulating insulin-like growth factor I level
|
J:111693
|
Chmp4ctm1b(EUCOMM)Wtsi/Chmp4ctm1b(EUCOMM)Wtsi
(C57BL/6N-Chmp4ctm1b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Chn1em1(IMPC)J/Chn1+
(C57BL/6NJ-Chn1em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Chohd2/Chohd2+
(C3HeB/FeJ-Chohd2/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd3/Chohd3+
(C3HeB/FeJ-Chohd3/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd4/Chohd4+
(C3HeB/FeJ-Chohd4/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd5/Chohd5+
(C3HeB/FeJ-Chohd5/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Chohd6/Chohd6+
(C3HeB/FeJ-Chohd6/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
chohr1/chohr1
(C3HeB/FeJ-chohr1/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
chohr2/chohr2
(C3HeB/FeJ-chohr2/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
chohr3/chohr3
(C3HeB/FeJ-chohr3/Ieg)
|
increased blood urea nitrogen level
|
J:94145
|
increased circulating cholesterol level
|
J:94145
|
increased circulating creatinine level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Chol6CAST/Ei/Chol6CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
abnormal circulating cholesterol level
|
J:83460
|
increased circulating cholesterol level
|
J:83460
|
Chol7129S1/SvImJ/Chol7129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol7129S1/SvImJ/Chol7CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol8129S1/SvImJ/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol8CAST/Ei/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol9129S1/SvImJ/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol9CAST/Ei/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol10129S1/SvImJ/Chol10129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol10129S1/SvImJ/Chol10RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol11129S1/SvImJ/Chol11129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol11129S1/SvImJ/Chol11RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chp2tm1b(KOMP)Mbp/Chp2+
(B6N(Cg)-Chp2tm1b(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Chrdtm1Emdr/Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
cyanosis
|
J:83662
|
Chrdl1em1(IMPC)H/Chrdl1em1(IMPC)H
(C57BL/6NTac-Chrdl1em1(IMPC)H/H)
|
increased fasting circulating glucose level
|
J:211773
|
Chrm3tm1Jwe/Chrm3+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating insulin level
|
J:91888
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating glucagon level
|
J:91888
|
decreased circulating glucose level
|
J:91888
|
decreased circulating insulin level
|
J:91888,
J:67919
|
decreased circulating leptin level
|
J:67919
|
decreased circulating triglyceride level
|
J:67919
|
Chrm3tm2.1Jwe/Chrm3tm2.1Jwe Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
decreased circulating glucose level
|
J:158245
|
Chrna7tm1b(EUCOMM)Hmgu/Chrna7tm1b(EUCOMM)Hmgu
(C57BL/6N-Chrna7tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Chrnb2tm1b(EUCOMM)Hmgu/Chrnb2+
(C57BL/6N-Chrnb2tm1b(EUCOMM)Hmgu/H)
|
increased circulating aspartate transaminase level
|
J:211773
|
Chrngtm1Mtak/Chrngtm1Mtak
(involves: 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:99894
|
Chst2em1(IMPC)Mbp/Chst2em1(IMPC)Mbp
(C57BL/6N-Chst2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Chst8tm1.1Jub/Chst8tm1.1Jub
(B6.129X1-Chst8tm1.1Jub)
|
increased circulating follicle stimulating hormone level
|
J:135143
|
increased circulating luteinizing hormone level
|
J:135143
|
increased circulating testosterone level
|
J:135143
|
Chst8tm1b(KOMP)Mbp/Chst8tm1b(KOMP)Mbp
(C57BL/6N-Chst8tm1b(KOMP)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Chst10tm1Mifu/Chst10tm1Mifu
(involves: 129)
|
increased circulating estrogen level
|
J:195651
|
Chtf18tm1b(KOMP)Wtsi/Chtf18+
(B6N(Cg)-Chtf18tm1b(KOMP)Wtsi/J)
|
increased circulating bilirubin level
|
J:211773
|
Chuktm1Mpa/Chuktm1Mpa Ikbkbtm2Cgn/Ikbkbtm2Cgn Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased circulating alanine transaminase level
|
J:137861
|
increased circulating bilirubin level
|
J:137861
|
Chuktm1Mpa/Chuktm1Mpa Tg(KRT14-cre)1Cgn/?
(involves: C57BL/6)
|
decreased circulating free fatty acids level
|
J:122320
|
CiartGt(IST11761C7)Tigm/CiartGt(IST11761C7)Tigm
(C57BL/6-CiartGt(IST11761C7)Tigm)
|
increased circulating corticosterone level
|
J:209571
|
Cib2tm1b(EUCOMM)Wtsi/Cib2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cib2tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Cib3em1(IMPC)H/Cib3em1(IMPC)H
(C57BL/6N-Cib3em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Cideatm1b(EUCOMM)Hmgu/Cideatm1b(EUCOMM)Hmgu
(C57BL/6N-Cideatm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ)
|
abnormal circulating glucose level
|
J:85229
|
decreased circulating triglyceride level
|
J:85229
|
Cidebtm1Pli/Cidebtm1Pli
(Not Specified)
|
decreased circulating free fatty acids level
|
J:126556
|
decreased circulating leptin level
|
J:126556
|
decreased circulating triglyceride level
|
J:126556
|
Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel)
|
abnormal circulating lipid level
|
J:226899
|
increased circulating alanine transaminase level
|
J:226899
|
increased circulating free fatty acids level
|
J:226899
|
increased circulating insulin level
|
J:226899
|
increased circulating triglyceride level
|
J:226899
|
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka)
|
decreased circulating glucose level
|
J:140863
|
decreased circulating leptin level
|
J:140863
|
Cidectm1Pli/Cidectm1Pli
(Not Specified)
|
abnormal blood homeostasis
|
J:140122
|
decreased circulating free fatty acids level
|
J:140122
|
decreased circulating ketone body level
|
J:140122
|
decreased circulating leptin level
|
J:140122
|
decreased circulating triglyceride level
|
J:140122
|
Cidectm1Pli/Cidectm1Pli Lepob/Lepob
(involves: C57BL/10J)
|
decreased circulating free fatty acids level
|
J:140122
|
decreased circulating triglyceride level
|
J:140122
|
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal circulating glucose level
|
J:106081
|
Ciitatm1Wrth/Ciitatm1Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating type I collagen C-terminal telopeptide level
|
J:233241
|
Cimip2btm1(KOMP)Wtsi/Cimip2btm1(KOMP)Wtsi
(C57BL/6N-Cimip2btm1(KOMP)Wtsi/Nju)
|
increased blood urea nitrogen level
|
J:211773
|
Cimip6tm1b(KOMP)Wtsi/Cimip6tm1b(KOMP)Wtsi
(C57BL/6N-Cimip6tm1b(KOMP)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Cinptm1.1(KOMP)Vlcg/Cinp+
(B6N(Cg)-Cinptm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cirbilem1Cya/Cirbilem1Cya
(Not Specified)
|
increased circulating lactate dehydrogenase level
|
J:301260
|
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H)
|
decreased circulating amylase level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating aspartate transaminase level
|
J:165965
|
increased circulating phosphate level
|
J:165965
|
Cittm1a(KOMP)Wtsi/Cit+
(B6JTyr;B6N-Cittm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:165965
|
Clca2em1(IMPC)Mbp/Clca2em1(IMPC)Mbp
(C57BL/6NCrl-Clca2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Clcn2em1Uis/Clcn2+
(C57BL/6N-Clcn2em1Uis)
|
increased circulating aldosterone level
|
J:282228
|
Clcn2tm1Tjj/Clcn2tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating renin level
|
J:282228
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating glucose level
|
J:80901
|
Clcn7tm1.1Mjec/Clcn7+
(involves: 129S/SvEv * C57BL/6 * DBA/2J)
|
increased circulating alkaline phosphatase level
|
J:203761
|
Clcn7tm1.1Teti/Clcn7+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating parathyroid hormone level
|
J:203761
|
Clcnkatm1b(EUCOMM)Hmgu/Clcnkatm1b(EUCOMM)Hmgu
(C57BL/6N-Clcnkatm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Clcnkbem1Haca/Clcnkbem1Haca
(C57BL/6-Clcnkbem1Haca)
|
decreased circulating potassium level
|
J:259681
|
increased circulating renin level
|
J:259681
|
Clcnkbtm1.1Doel/Clcnkbtm1.1Doel
(involves: 129S1/Sv * 129X1/SvJ)
|
alkalemia
|
J:259639
|
hypokalemia
|
J:259639
|
Cldn2tm1Lex/Y
(B6J.129S5-Cldn2tm1Lex)
|
increased blood urea nitrogen level
|
J:237065
|
increased circulating creatinine level
|
J:237065
|
Cldn3em1(IMPC)H/Cldn3em1(IMPC)H
(C57BL/6N-Cldn3em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cldn4tm1.1Jhou/Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek)
|
increased circulating aldosterone level
|
J:216399
|
increased circulating bicarbonate level
|
J:216399
|
increased circulating potassium level
|
J:216399
|
Cldn4tm1.1Yham/Cldn4tm1.1Yham
(B6.129S2-Cldn4tm1.1Yham)
|
decreased circulating calcium level
|
J:195766
|
Cldn7tm1Yche/Cldn7tm1Yche
(involves: C57BL/6)
|
increased blood urea nitrogen level
|
J:155363
|
increased circulating aldosterone level
|
J:155363
|
Cldn8tm1.1Jhou/Cldn8tm1.1Jhou Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn8tm1.1Jhou Tg(Aqp2-cre)1Dek)
|
decreased circulating potassium level
|
J:220813
|
hypokalemia
|
J:220813
|
increased circulating aldosterone level
|
J:220813
|
increased circulating bicarbonate level
|
J:220813
|
Cldn10tm1.1Dmu/Cldn10tm1.1Dmu Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL)
|
abnormal circulating mineral level
|
J:188580
|
increased blood urea nitrogen level
|
J:188580
|
increased circulating magnesium level
|
J:188580
|
increased circulating phosphate level
|
J:188580
|
Cldn11em1(IMPC)H/Cldn11em1(IMPC)H
(C57BL/6N-Cldn11em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
abnormal circulating non-HDL cholesterol level
|
J:279934
|
decreased circulating free fatty acids level
|
J:279934
|
decreased circulating total protein level
|
J:279934
|
decreased circulating triglyceride level
|
J:279934
|
decreased fasting circulating glucose level
|
J:279934
|
increased circulating creatinine level
|
J:279934
|
increased circulating glucose level
|
J:279934
|
Cldn13em1(IMPC)J/Cldn13em1(IMPC)J
(C57BL/6NJ-Cldn13em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn13tm1.1(KOMP)Vlcg/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cldn16tm1.1Dmu/Cldn16tm1.1Dmu
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased circulating magnesium level
|
J:159706
|
increased circulating parathyroid hormone level
|
J:159706
|
Cldn17em#Prso/Cldn17em#Prso
(C57BL/6-Cldn17em#Prso)
|
abnormal circulating protein level
|
J:325994
|
decreased circulating sodium level
|
J:325994
|
increased circulating bicarbonate level
|
J:325994
|
Cldn19tm1.1(KOMP)Vlcg/Cldn19tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn19tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cldn23em1(IMPC)J/Cldn23em1(IMPC)J
(C57BL/6NJ-Cldn23em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cldnd2tm1b(EUCOMM)Hmgu/Cldnd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cldnd2tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating calcium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Clec1btm1.1Arte/Clec1btm1.1Arte Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
abnormal blood coagulation
|
J:217963
|
abnormal platelet physiology
|
J:181715
|
Clec1btm1.1Ksi/Clec1btm1.1Ksi
(involves: C57BL/6)
|
abnormal platelet activation
|
J:165898
|
decreased platelet aggregation
|
J:165898
|
Clec1btm1.2Arte/Clec1btm1.2Arte
(involves: 129 * C57BL/6)
|
abnormal platelet physiology
|
J:181754
|
Clec1btm1.2Arte/Clec1btm1.2Arte
(Not Specified)
|
decreased platelet aggregation
|
J:181715
|
Clec1btm1Mlkn/Clec1btm1Mlkn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal platelet activation
|
J:162815
|
Clec2dtm1.1Mgil/Clec2dtm1.1Mgil
(C57BL/6-Clec2dtm1.1Mgil)
|
decreased circulating parathyroid hormone level
|
J:143122
|
increased circulating calcium level
|
J:143122
|
Clec2htm1.1Apma/Clec2htm1.1Apma
(B6(Cg)-Clec2htm1.1Apma)
|
increased circulating creatinine level
|
J:322835
|
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating interleukin level
|
J:217720
|
increased circulating interleukin-4 level
|
J:217720
|
increased circulating interleukin-10 level
|
J:217720
|
increased circulating interleukin-17 level
|
J:217720
|
increased circulating interleukin-23 level
|
J:217720
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-17 level
|
J:203159
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating interleukin-17 level
|
J:203159
|
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
|
increased circulating alanine transaminase level
|
J:200968
|
increased circulating aspartate transaminase level
|
J:200968
|
Clec7atm1Gdb/Clec7atm1Gdb
(B6.129S6-Clec7atm1Gdb)
|
abnormal circulating interleukin level
|
J:179011
|
decreased circulating interleukin-17 level
|
J:179011
|
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL)
|
hyperglycemia
|
J:214528
|
Clic1tm1.1Breit/Clic1tm1.1Breit
(involves: 129 * C57BL/6J)
|
abnormal platelet activation
|
J:158394
|
decreased platelet aggregation
|
J:158394
|
increased bleeding time
|
J:158394
|
Clic4tm1.1Aidi/Clic4tm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating interleukin-6 level
|
J:175404
|
decreased circulating tumor necrosis factor level
|
J:175404
|
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating glucose level
|
J:160186
|
decreased circulating insulin level
|
J:160186
|
decreased circulating leptin level
|
J:160186
|
increased circulating glucagon level
|
J:160186
|
Clip3tm1.1Ics/Clip3tm1.1Ics
(involves: C57BL/6)
|
cyanosis
|
J:194894
|
Clk1tm1a(EUCOMM)Wtsi/Clk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Clk1tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating calcium level
|
J:165965
|
Clmptm1Lex/Clmptm1Lex
(B6;129S5-Clmptm1Lex/Mmucd)
|
abnormal blood homeostasis
|
J:171883
|
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda)
|
increased blood osmolality
|
J:160849
|
increased circulating potassium level
|
J:160849
|
Cln8em1(IMPC)Mbp/Cln8em1(IMPC)Mbp
(C57BL/6N-Cln8em1(IMPC)Mbp/MbpMmucd)
|
increased circulating phosphate level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Clockm1Jt/Clock+
(involves: C57BL/6)
|
abnormal circulating protein level
|
J:155089
|
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt)
|
decreased circulating corticosterone level
|
J:98343
|
increased circulating cholesterol level
|
J:98343
|
increased circulating glucose level
|
J:98343
|
increased circulating leptin level
|
J:98343
|
increased circulating triglyceride level
|
J:98343
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6)
|
decreased circulating estradiol level
|
J:92343
|
decreased circulating luteinizing hormone level
|
J:92343
|
decreased circulating progesterone level
|
J:92343
|
increased circulating estradiol level
|
J:92343
|
increased circulating progesterone level
|
J:92343
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J)
|
hyperglycemia
|
J:162641
|
Clockm1Jt/Clockm1Jt Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)
|
decreased circulating glucose level
|
J:135847
|
decreased circulating insulin level
|
J:135847
|
increased circulating cholesterol level
|
J:135847
|
increased circulating free fatty acids level
|
J:135847
|
increased circulating glucose level
|
J:135847
|
increased circulating insulin level
|
J:135847
|
increased circulating triglyceride level
|
J:135847
|
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Clpstm1Lowe/Clpstm1Lowe
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating triglyceride level
|
J:75167
|
increased circulating cholesterol level
|
J:75167
|
Clpstm2.1Lowe/Clpstm2.1Lowe
(B6.129X1-Clpstm2.1Lowe)
|
decreased circulating HDL cholesterol level
|
J:159587
|
increased circulating cholesterol level
|
J:159587
|
Clptm1lem1(IMPC)J/Clptm1lem1(IMPC)J
(C57BL/6NJ-Clptm1lem1(IMPC)J/Mmjax)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Clstn3tm1b(EUCOMM)Hmgu/Clstn3tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
|
decreased circulating glucose level
|
J:293885
|
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating carnitine level
|
J:148522
|
increased circulating ketone body level
|
J:148522
|
increased circulating methionine level
|
J:148752
|
increased circulating sodium level
|
J:148752
|
increased circulating tyrosine level
|
J:148752
|
Clutm1b(EUCOMM)Hmgu/Clutm1b(EUCOMM)Hmgu
(C57BL/6N-Clutm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Cluhtm1.1Eir/Cluhtm1.1Eir Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL)
|
abnormal circulating amino acid level
|
J:249661
|
decreased fasting circulating glucose level
|
J:249661
|
hypoglycemia
|
J:249661
|
increased circulating alanine transaminase level
|
J:249661
|
increased circulating lysine level
|
J:249661
|
increased circulating methionine level
|
J:249661
|
increased circulating proline level
|
J:249661
|
increased circulating serine level
|
J:249661
|
increased circulating threonine level
|
J:249661
|
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased fasting circulating glucose level
|
J:249661
|
Clvs1tm1.1(KOMP)Vlcg/Clvs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Clvs1tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Clybltm1b(EUCOMM)Hmgu/Clybltm1b(EUCOMM)Hmgu
(C57BL/6N-Clybltm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Cmahem1(IMPC)Hmgu/Cmahem1(IMPC)Hmgu
(C57BL/6NCrl-Cmahem1(IMPC)Hmgu/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cmklr2tm1.1Dgen/Cmklr2tm1.1Dgen
(involves: C57BL/6J)
|
increased circulating estradiol level
|
J:273922
|
increased circulating LDL cholesterol level
|
J:273922
|
Cmpk1tm1b(EUCOMM)Wtsi/Cmpk1+
(C57BL/6N-Cmpk1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating iron level
|
J:211773
|
Cmpk2tm1b(KOMP)Wtsi/Cmpk2tm1b(KOMP)Wtsi
(C57BL/6N-Cmpk2tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Cmtm7em1(IMPC)J/Cmtm7em1(IMPC)J
(C57BL/6NJ-Cmtm7em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cmtr2tm1.1(KOMP)Vlcg/Cmtr2+
(B6N(Cg)-Cmtr2tm1.1(KOMP)Vlcg/2J)
|
decreased circulating creatinine level
|
J:211773
|
Cnbptm1b(KOMP)Wtsi/Cnbp+
(B6N(Cg)-Cnbptm1b(KOMP)Wtsi/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Cnga3tm1.1(KOMP)Vlcg/Cnga3tm1.1(KOMP)Vlcg
(C57BL/6N-Cnga3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Cnih2tm1b(KOMP)Wtsi/Cnih2tm1b(KOMP)Wtsi
(B6N(Cg)-Cnih2tm1b(KOMP)Wtsi/J)
|
decreased circulating calcium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cnmdtm1Ska/Cnmdtm1Ska
(involves: C57BL/6 * CBA)
|
decreased circulating alkaline phosphatase level
|
J:81137
|
Cnn1tm1Tkhi/Cnn1tm1Tkhi
(involves: 129S/SvEv * C57BL/6)
|
increased circulating alkaline phosphatase level
|
J:77112
|
Cnnm2tm1.1Hmik/Cnnm2+
(involves: C57BL * C57BL/6J * DBA)
|
decreased circulating magnesium level
|
J:303151
|
Cnnm2tm1Hmik/Cnnm2tm1Hmik Tg(Six2-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased circulating magnesium level
|
J:303151
|
Cnnm4tm1a(EUCOMM)Wtsi/Cnnm4tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating magnesium level
|
J:207520
|
Cnnm4tm1b(EUCOMM)Wtsi/Cnnm4tm1b(EUCOMM)Wtsi
(involves: C57BL * C57BL/6N * DBA)
|
decreased circulating magnesium level
|
J:303151
|
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
|
decreased circulating glucose level
|
J:180033
|
decreased circulating triglyceride level
|
J:180033
|
decreased fasting circulating glucose level
|
J:180033
|
Cnot4tm1b(EUCOMM)Wtsi/Cnot4+
(C57BL/6N-Cnot4tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
|
abnormal circulating glucose level
|
J:274297
|
abnormal circulating insulin level
|
J:274297
|
abnormal circulating lipid level
|
J:274297
|
increased circulating ketone body level
|
J:274297
|
Cnpy1tm1(KOMP)Wtsi/Cnpy1tm1(KOMP)Wtsi
(C57BL/6N-Cnpy1tm1(KOMP)Wtsi/Nju)
|
decreased circulating serum albumin level
|
J:211773
|
Cnpy2em1(IMPC)Wtsi/Cnpy2em1(IMPC)Wtsi
(C57BL/6N-Cnpy2em1(IMPC)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli)
|
decreased circulating alanine transaminase level
|
J:277868
|
decreased circulating triglyceride level
|
J:277868
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased circulating adrenocorticotropin level
|
J:89722
|
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating insulin level
|
J:93697
|
decreased circulating leptin level
|
J:93697
|
Cnr1tm1Zim/Cnr1tm1Zim
(involves: 129 * C57BL/6J)
|
decreased circulating progesterone level
|
J:144423
|
increased circulating corticosterone level
|
J:144423
|
increased circulating estradiol level
|
J:144423
|
Cntn5em1(IMPC)Mbp/Cntn5em1(IMPC)Mbp
(C57BL/6N-Cntn5em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Coasyem1(IMPC)H/Coasy+
(C57BL/6NTac-Coasyem1(IMPC)H/H)
|
increased circulating potassium level
|
J:211773
|
Cog2tm1a(KOMP)Wtsi/Cog2+
(B6JTyr;B6N-Cog2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating creatinine level
|
J:175295
|
increased circulating triglyceride level
|
J:175295
|
Cog3tm1b(EUCOMM)Hmgu/Cog3+
(C57BL/6N-Cog3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating insulin level
|
J:211773
|
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cog8em1(IMPC)J/Cog8+
(C57BL/6NJ-Cog8em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Col1a1Aga2/Col1a1+
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased circulating alkaline phosphatase level
|
J:129569
|
increased circulating parathyroid hormone level
|
J:129569
|
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
|
abnormal blood gas level
|
J:185988
|
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
increased circulating leptin level
|
J:187378
|
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:166568
|
decreased circulating insulin level
|
J:166568
|
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating enzyme level
|
J:174049
|
increased circulating alanine transaminase level
|
J:174049
|
increased circulating alkaline phosphatase level
|
J:174049
|
increased circulating amylase level
|
J:174049
|
increased circulating aspartate transaminase level
|
J:174049
|
increased circulating lactate dehydrogenase level
|
J:174049
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
decreased circulating glucose level
|
J:217463
|
increased circulating alanine transaminase level
|
J:217463
|
increased circulating serum albumin level
|
J:217463
|
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:211215
|
decreased circulating insulin level
|
J:211215
|
increased circulating osteocalcin level
|
J:211215
|
Col1a1tm2(tetO-LIN28B)Gqda/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
hypoglycemia
|
J:177113
|
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
decreased circulating alanine transaminase level
|
J:213764,
J:210545
|
decreased circulating cholesterol level
|
J:213764
|
decreased circulating interleukin-6 level
|
J:210545
|
increased circulating cholesterol level
|
J:210545
|
increased circulating triglyceride level
|
J:210545
|
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
increased circulating glucose level
|
J:177113
|
increased circulating insulin level
|
J:177113
|
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased circulating amylase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Col2a1tm1Dshh/Col2a1tm1Dshh
(involves: 129S6/SvEvTac * C57BL/6J)
|
cyanosis
|
J:212712
|
Col4a1deltaex40/Col4a1+
(B6.129S-Col4a1deltaex40)
|
cyanosis
|
J:215446
|
Col4a1deltaex40/Col4a1+
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating creatine kinase level
|
J:172720
|
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
increased blood urea nitrogen level
|
J:240798
|
Col4a2em1(IMPC)Wtsi/Col4a2+
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Col4a3tm1.1Rkl/Col4a3+
(involves: C57BL/6)
|
increased circulating creatinine level
|
J:167404
|
Col4a3tm1b(EUCOMM)Wtsi/Col4a3tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a3tm1b(EUCOMM)Wtsi/H)
|
decreased circulating amylase level
|
J:211773
|
Col4a3tm1Dec/Col4a3tm1Dec
(involves: 129X1/SvJ * C57BL/6)
|
increased blood urea nitrogen level
|
J:37963
|
Col4a3tm1Dec/Col4a3tm1Dec
(129-Col4a3tm1Dec/J)
|
increased blood urea nitrogen level
|
J:158731
|
increased circulating creatinine level
|
J:158731
|
Col4a3tm1Dec/Col4a3tm1Dec
(B6.129X1-Col4a3tm1Dec)
|
increased circulating creatinine level
|
J:167404
|
Col4a3tm1Dec/Col4a3tm1Dec Itga1tm1Gdnr/Itga1tm1Gdnr
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c)
|
increased circulating total protein level
|
J:91620
|
Col4a3tm1Dec/Col4a3tm1Dec Sostdc1tm1Myan/Sostdc1tm1Myan
(involves: 129X1/SvJ)
|
increased blood urea nitrogen level
|
J:158731
|
increased circulating creatinine level
|
J:158731
|
Col4a3tm1Jhm/Col4a3tm1Jhm
(involves: 129S1/Sv * 129X1/SvJ)
|
increased blood urea nitrogen level
|
J:37017
|
increased circulating creatinine level
|
J:37017
|
uremia
|
J:37017
|
Col4a3tm1Jhm/Col4a3tm1Jhm Lamb2em1Jhm/Lamb2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
increased blood urea nitrogen level
|
J:280129
|
Col4a4m1Btlr/Col4a4m1Btlr
(C57BL/6J-Col4a4m1Btlr)
|
increased blood urea nitrogen level
|
J:170552,
J:158794
|
increased circulating creatinine level
|
J:158794
|
uremia
|
J:158794
|
Col4a4m1H/Col4a4m1H
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating serum albumin level
|
J:285510
|
increased blood urea nitrogen level
|
J:285510
|
increased circulating creatinine level
|
J:285510
|
Col4a5em1Keha/Y
(C57BL/6J-Col4a5em1Keha)
|
decreased circulating total protein level
|
J:283613
|
increased blood urea nitrogen level
|
J:283613
|
increased circulating creatinine level
|
J:283613
|
Col4a5tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col4a5tm1Yseg/Y
(B6.Cg-Col4a5tm1Yseg)
|
increased blood urea nitrogen level
|
J:102306
|
Col4a5tm1Yseg/Col4a5+
(B6.Cg-Col4a5tm1Yseg)
|
increased blood urea nitrogen level
|
J:102306
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating insulin level
|
J:171817
|
hyperglycemia
|
J:171817
|
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi)
|
decreased circulating insulin-like growth factor I level
|
J:278926
|
Col6a3em1(IMPC)Kmpc/Col6a3em1(IMPC)Kmpc
(C57BL/6NTac-Col6a3em1(IMPC)Kmpc/Kmpc)
|
increased circulating LDL cholesterol level
|
J:211773
|
Col9a2tm1b(EUCOMM)Wtsi/Col9a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col9a2tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col9a3em1(IMPC)Tcp/Col9a3em1(IMPC)Tcp
(C57BL/6N-Col9a3em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Col11a2tm1b(KOMP)Wtsi/Col11a2+
(C57BL/6N-Col11a2tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Col16a1em1(IMPC)J/Col16a1em1(IMPC)J
(C57BL/6NJ-Col16a1em1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Col17a1em1(IMPC)Mbp/Col17a1em1(IMPC)Mbp
(C57BL/6N-Col17a1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Col18a1tm1Hms/Col18a1tm1Hms
(B6.129S4-Col18a1tm1Hms)
|
abnormal circulating enzyme level
|
J:167008
|
increased circulating triglyceride level
|
J:167008
|
increased circulating VLDL triglyceride level
|
J:167008
|
Col18a1tm1Hms/Col18a1tm1Hms
(involves: 129S4/SvJae * C57BL/6J * C57BL/6JOlaHsd)
|
increased circulating creatinine level
|
J:92842
|
Col25a1tm1.1Tiwa/Col25a1tm1.1Tiwa
(B6.Cg-Col25a1tm1.1Tiwa)
|
cyanosis
|
J:206855
|
Colec10em2(IMPC)Tcp/Colec10em2(IMPC)Tcp
(C57BL/6NCrl-Colec10em2(IMPC)Tcp/Tcp)
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Colec11tm1Lex/Colec11tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal blood urea nitrogen level
|
J:234934
|
Colgalt2tm1.1Hwei/Colgalt2tm1.1Hwei
(involves: C57BL/6J)
|
increased circulating alanine transaminase level
|
J:310468
|
increased circulating interleukin-1 beta level
|
J:310468
|
increased circulating interleukin-4 level
|
J:310468
|
increased circulating interleukin-6 level
|
J:310468
|
increased circulating interleukin-9 level
|
J:310468
|
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Comttm1b(EUCOMM)Wtsi/Comttm1b(EUCOMM)Wtsi
(C57BL/6N-Comttm1b(EUCOMM)Wtsi/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Comttm1Kara/Comttm1Kara
(involves: 129S4/SvJaeSor)
|
abnormal blood homeostasis
|
J:137276
|
Copg1em1Geha/Copg1em1Geha
(involves: C57BL/6)
|
decreased circulating interferon-gamma level
|
J:345528
|
Copg1tm1a(EUCOMM)Wtsi/Copg1+
(C57BL/6N-Copg1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
Coq6tm1b(EUCOMM)Hmgu/Coq6+
(C57BL/6N-Coq6tm1b(EUCOMM)Hmgu/Ics)
|
increased fasting circulating glucose level
|
J:211773
|
Coq6tm1b(EUCOMM)Hmgu/Coq6+
(B6N(Cg)-Coq6tm1b(EUCOMM)Hmgu/J)
|
increased circulating sodium level
|
J:211773
|
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
hyperlipidemia
|
J:249129
|
Coq8btm1b(EUCOMM)Hmgu/Coq8b+
(B6N(Cg)-Coq8btm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Coq8btm1c(EUCOMM)Hmgu/Coq8btm1c(EUCOMM)Hmgu Tg(NPHS2-cre)295Lbh/0
(involves: C3H * C57BL/6 * C57BL/6N * SJL)
|
decreased circulating serum albumin level
|
J:294296
|
increased blood urea nitrogen level
|
J:294296
|
increased circulating serum albumin level
|
J:294296
|
Coro1ctm1d(KOMP)Wtsi/Coro1ctm1d(KOMP)Wtsi
(involves: C57BL/6N)
|
increased circulating alkaline phosphatase level
|
J:290447
|
Corttm1Ldl/Corttm1Ldl
(involves: C57BL/6J)
|
decreased circulating prolactin level
|
J:179095
|
increased circulating adrenocorticotropin level
|
J:179095
|
increased circulating ghrelin level
|
J:179095
|
increased circulating glucose level
|
J:179095
|
increased circulating growth hormone level
|
J:179095
|
Cox7a2lem1(IMPC)J/Cox7a2lem1(IMPC)J
(C57BL/6NJ-Cox7a2lem1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Cox7ctm1b(KOMP)Mbp/Cox7c+
(B6N(Cg)-Cox7ctm1b(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Cox10em1(IMPC)Bay/Cox10+
(C57BL/6N-Cox10em1(IMPC)Bay/Bay)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cox15tm1.1(KOMP)Vlcg/Cox15+
(C57BL/6N-Cox15tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Cox19tm1b(EUCOMM)Hmgu/Cox19+
(C57BL/6N-Cox19tm1b(EUCOMM)Hmgu/Tcp)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Cpm1Btlr/Cpm1Btlr
(C57BL/6J-Cpm1Btlr)
|
decreased circulating iron level
|
J:173078
|
Cptm1b(KOMP)Wtsi/Cptm1b(KOMP)Wtsi
(B6N(Cg)-Cptm1b(KOMP)Wtsi/J)
|
decreased circulating iron level
|
J:211773
|
Cptm1Hrs/Cptm1Hrs
(involves: 129X1/SvJ * Black Swiss)
|
decreased circulating ceruloplasmin level
|
J:57730
|
increased circulating ferritin level
|
J:57730
|
Cptm1Hrs/Cptm1Hrs Hephsla/Hephsla
(involves: 129X1/SvJ)
|
decreased circulating iron level
|
J:196540
|
Cptm1Samd/Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating iron level
|
J:78092
|
increased circulating unsaturated transferrin level
|
J:78092
|
Cptm1Yos/Cptm1Yos
(involves: 129P2/OlaHsd * BALB/c)
|
decreased circulating iron level
|
J:79916
|
Cpa1tm1.1Satom/Cpa1tm1.1Satom
(involves: C57BL/6NCrl * FVB/N)
|
increased circulating amylase level
|
J:300042
|
increased circulating hydroxyproline level
|
J:300042
|
Cpa1tm1Satom/Cpa1tm1Satom
(involves: C57BL/6NCrl)
|
decreased circulating amylase level
|
J:300042
|
Cpa5em1(IMPC)J/Cpa5em1(IMPC)J
(C57BL/6NJ-Cpa5em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Cpaptm1a(EUCOMM)Wtsi/Cpaptm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cpaptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:194085
|
Cpaptm1a(EUCOMM)Wtsi/Cpaptm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cpaptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Cpb1tm1.1(KOMP)Vlcg/Cpb1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cpb1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cpb2tm1Efp/Cpb2+ Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Cpb2tm1Efp/Cpb2+ Plgtm1Dco/Plgtm1Dco
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Cpb2tm1Efp/Cpb2tm1Efp
(B6.129-Cpb2tm1Efp)
|
abnormal blood coagulation
|
J:80114
|
Cpb2tm1Efp/Cpb2tm1Efp Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Cpb2tm1Efp/Cpb2tm1Efp Plgtm1Dco/Plgtm1Dco
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Cpb2tm1Jcmm/Cpb2tm1Jcmm
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thrombolysis
|
J:102729
|
Cpb2tm1Mng/Cpb2tm1Mng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:73713,
J:107340
|
Cpdem1(IMPC)J/Cpd+
(C57BL/6NJ-Cpdem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Cpefat/Cpefat
(involves: HRS/J)
|
hyperglycemia
|
J:10872
|
hypoglycemia
|
J:13651
|
increased circulating insulin level
|
J:13651,
J:10872
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
decreased circulating adrenocorticotropin level
|
J:40372
|
decreased circulating gastrin level
|
J:52393
|
hyperglycemia
|
J:10872
|
increased circulating cholesterol level
|
J:19043,
J:18161
|
increased circulating growth hormone level
|
J:40372
|
increased circulating HDL cholesterol level
|
J:19043,
J:18161
|
increased circulating insulin level
|
J:24436,
J:10872
|
increased circulating LDL cholesterol level
|
J:19043
|
increased circulating pituitary hormone level
|
J:40372,
J:38227
|
increased circulating triglyceride level
|
J:19043
|
increased circulating triiodothyronine level
|
J:80698
|
increased circulating VLDL cholesterol level
|
J:19043
|
Cpefat/Cpefat Find1HRS/J/Find1HRS/J
(involves: C57BLKS/J * HRS/J)
|
increased circulating glucose level
|
J:100832
|
Cpefat/Cpefat Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J)
|
decreased circulating insulin level
|
J:100832
|
increased circulating cholesterol level
|
J:100832
|
increased circulating glucose level
|
J:100832
|
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
increased circulating glucose level
|
J:95741
|
increased circulating insulin level
|
J:95741
|
increased circulating leptin level
|
J:95741
|
Cpeb3em1Gaoxu/Cpeb3em1Gaoxu
(C57BL/6J-Cpeb3em1Gaoxu)
|
decreased circulating estradiol level
|
J:323073
|
increased circulating follicle stimulating hormone level
|
J:323073
|
Cpeb4tm1b(EUCOMM)Wtsi/Cpeb4+
(C57BL/6N-Cpeb4tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating calcium level
|
J:211773
|
Cpgi5563tm1.1(NCC)Wcs/Cpgi5563tm1.1(NCC)Wcs
(C57BL/6N-Cpgi5563tm1.1(NCC)Wcs/Wtsi)
|
decreased circulating amylase level
|
J:277622
|
decreased circulating cholesterol level
|
J:277622
|
decreased circulating triglyceride level
|
J:277622
|
Cplx4em1(IMPC)H/Cplx4em1(IMPC)H
(C57BL/6NTac-Cplx4em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cpn1tm1b(KOMP)Wtsi/Cpn1tm1b(KOMP)Wtsi
(B6N(Cg)-Cpn1tm1b(KOMP)Wtsi/2J)
|
increased circulating calcium level
|
J:211773
|
CpoxRbc16/Cpox+
(involves: C57BL/6)
|
increased circulating ferritin level
|
J:244493
|
Cps1em1(IMPC)H/Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H)
|
decreased circulating potassium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cps1tm1Mw/Cps1tm1Mw
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating ammonia level
|
J:52334
|
Cpsf4lem1(IMPC)J/Cpsf4lem1(IMPC)J
(C57BL/6NJ-Cpsf4lem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac))
|
decreased circulating glucose level
|
J:101934
|
increased circulating free fatty acids level
|
J:101934
|
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
increased circulating glucose level
|
J:148205
|
increased circulating insulin level
|
J:148205
|
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6)
|
hyperlipidemia
|
J:109455
|
increased circulating triglyceride level
|
J:109455
|
Cpt2tm1b(KOMP)Wtsi/Cpt2+
(C57BL/6N-Cpt2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating phosphate level
|
J:211773
|
Cq1C57BL/6J/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq1KK/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq1KK/Cq1KK
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2KK
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2KK Cq3C57BL/6J/Cq3C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:108417
|
Cq3C57BL/6J/?
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:108417
|
Cq4C57BL/6J/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:87328
|
Cq4KK-A(y)/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:87328
|
Cq5KK-A(y)/Cq5KK-A(y)
(involves: KK-Ay * RR)
|
increased circulating cholesterol level
|
J:87328
|
Cq6C57BL/6J/Cq6RR
(involves: C57BL/6J * RR)
|
increased circulating cholesterol level
|
J:94251
|
Cq6RR/Cq6RR
(involves: C57BL/6J * RR)
|
increased circulating cholesterol level
|
J:94251
|
Cr1ltm1Hmo/Cr1l+
(involves: 129X1/SvJ)
|
increased blood urea nitrogen level
|
J:105466
|
Cracdltm1b(KOMP)Wtsi/Cracdltm1b(KOMP)Wtsi
(C57BL/6N-Cracdltm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Crattm1.1Pbrc/Crattm1.1Pbrc Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
decreased circulating free fatty acids level
|
J:184778
|
decreased circulating triglyceride level
|
J:184778
|
increased circulating glucose level
|
J:184778
|
Crb3tm1.2Lprs/Crb3tm1.2Lprs
(B6(Cg)-Crb3tm1.2Lprs)
|
cyanosis
|
J:228786
|
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp)
|
decreased circulating free fatty acids level
|
J:208570
|
decreased circulating glucose level
|
J:208570
|
decreased circulating insulin level
|
J:208570
|
decreased circulating leptin level
|
J:208570
|
Creb1tm3Gsc/Creb1+ Gprc6atm1.1Kry/Gprc6a+ Tg(Cyp17a1-icre)AJako/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased circulating testosterone level
|
J:170888
|
Creb1tm3Gsc/Creb1tm3Gsc Tg(Cyp17a1-icre)AJako/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased circulating testosterone level
|
J:170888
|
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac)
|
decreased circulating insulin level
|
J:345514
|
decreased circulating leptin level
|
J:345514
|
decreased fasting circulating glucose level
|
J:345514
|
Creb3l1tm1e(EUCOMM)Wtsi/Creb3l1+
(C57BL/6N-Creb3l1tm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Creb3l3tm1.1Sad/Creb3l3tm1.1Sad
(involves: 129 * C57BL/6 * FVB/N)
|
decreased circulating serum amyloid protein level
|
J:140018
|
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA)
|
decreased circulating free fatty acids level
|
J:75361
|
increased circulating insulin level
|
J:75361
|
increased circulating leptin level
|
J:75361
|
Crebbptm1Few/Crebbp+
(Not Specified)
|
decreased circulating glucagon level
|
J:91133
|
increased circulating glucose level
|
J:91133
|
increased circulating insulin level
|
J:91133
|
Crebbptm1Few/Crebbptm1Few
(Not Specified)
|
decreased circulating glucagon level
|
J:91133
|
increased circulating glucose level
|
J:91133
|
increased circulating insulin level
|
J:91133
|
CrebrfGt(YHD319)Byg/CrebrfGt(YHD319)Byg
(B6.129P2-CrebrfGt(YHD319)Byg)
|
decreased circulating corticosterone level
|
J:192857
|
decreased circulating prolactin level
|
J:192857
|
Creg1em1Yal/Creg1em1Yal Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
abnormal circulating enzyme level
|
J:263073
|
increased circulating alanine transaminase level
|
J:263073
|
increased circulating alkaline phosphatase level
|
J:263073
|
increased circulating aspartate transaminase level
|
J:263073
|
increased circulating insulin level
|
J:263073
|
increased fasting circulating glucose level
|
J:263073
|
Creg2em1(IMPC)J/Creg2em1(IMPC)J
(C57BL/6NJ-Creg2em1(IMPC)J/Mmjax)
|
decreased fasting circulating glucose level
|
J:211773
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal circulating corticosterone level
|
J:23082
|
abnormal circulating glucose level
|
J:23082
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating adrenaline level
|
J:105629
|
abnormal circulating corticosterone level
|
J:90690,
J:72196,
J:102987,
J:105629,
J:54256
|
abnormal circulating glucose level
|
J:102987,
J:105629
|
abnormal circulating hormone level
|
J:90690
|
abnormal circulating noradrenaline level
|
J:105629
|
decreased circulating adrenaline level
|
J:102987
|
decreased circulating corticosterone level
|
J:105629
|
decreased circulating leptin level
|
J:105629
|
increased circulating interleukin-6 level
|
J:72196
|
Crhtm2.1Maj/Crhtm2.1Maj Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased circulating adrenocorticotropin level
|
J:238330
|
decreased circulating corticosterone level
|
J:238330
|
Crhtm2.2Maj/Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:238330
|
Crhr1tm2.3Jde/Crhr1tm2.3Jde
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac)
|
decreased circulating corticosterone level
|
J:187372
|
Crhr1tm2Jde/Crhr1tm2Jde
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating corticosterone level
|
J:187372
|
Crhr1tm2Wrst/Crhr1tm2Wrst Tg(Camk2a-cre)159Kln/0
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:85745
|
increased circulating corticosterone level
|
J:85745
|
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:83683
|
decreased circulating free fatty acids level
|
J:83683
|
decreased circulating triglyceride level
|
J:83683
|
cri/cri
(involves: DBA/2J)
|
abnormal circulating mineral level
|
J:15349
|
abnormal circulating potassium level
|
J:15349
|
decreased circulating potassium level
|
J:15349
|
Crispld2tm1.1(KOMP)Vlcg/Crispld2+
(C57BL/6N-Crispld2tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Crlf2em1(IMPC)Mbp/Crlf2em1(IMPC)Mbp
(C57BL/6N-Crlf2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Crls1tm1Geno/Crls1tm1Geno Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
increased fasting circulating glucose level
|
J:266083
|
Crpem1Wuy/Crpem1Wuy
(C57BL/6-Crpem1Wuy)
|
abnormal circulating aspartate transaminase level
|
J:341658
|
increased circulating alanine transaminase level
|
J:341658
|
Crptm1Hjf/Crp+
(C57BL/6-Crptm1Hjf)
|
decreased circulating C-reactive protein level
|
J:170409
|
Crptm1Hjf/Crptm1Hjf
(C57BL/6-Crptm1Hjf)
|
decreased circulating C-reactive protein level
|
J:170409
|
Crptm1Hjf/Crptm1Hjf Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crptm1Hjf Ldlrtm1Her)
|
decreased circulating LDL cholesterol level
|
J:170409
|
decreased circulating VLDL cholesterol level
|
J:170409
|
increased circulating cholesterol level
|
J:170409
|
increased circulating triglyceride level
|
J:170409
|
Crppaem2Mbp/Crppaem2Mbp Myf5tm3(cre)Sor/Myf5+
(B6.Cg-Myf5tm3(cre)Sor Crppaem2Mbp)
|
increased circulating creatine kinase level
|
J:324289
|
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:142448
|
hyperglycemia
|
J:142448
|
increased circulating insulin level
|
J:142448
|
increased circulating triglyceride level
|
J:142448
|
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
decreased circulating corticosterone level
|
J:151618
|
Crtc2tm1Mmy/Crtc2tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:157556
|
decreased fasting circulating glucose level
|
J:157556
|
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating free fatty acids level
|
J:167211
|
decreased circulating insulin level
|
J:167211
|
decreased circulating leptin level
|
J:167211
|
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Cry1em1(IMPC)H/Cry1em1(IMPC)H
(C57BL/6N-Cry1em1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Cry1tm1Jhjh/Cry1tm1Jhjh Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:159504
|
increased circulating interleukin-6 level
|
J:159504
|
increased circulating tumor necrosis factor level
|
J:159504
|
Crybb2tm1Itl/Crybb2tm1Itl
(C57BL/6-Crybb2tm1Itl)
|
decreased circulating progesterone level
|
J:220082
|
increased circulating estradiol level
|
J:220082
|
Crybg1tm1b(KOMP)Wtsi/Crybg1+
(C57BL/6N-Crybg1tm1b(KOMP)Wtsi/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Crygstm1b(KOMP)Wtsi/Crygstm1b(KOMP)Wtsi
(B6N(Cg)-Crygstm1b(KOMP)Wtsi/2J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Crymtm1Sasu/Crymtm1Sasu
(129S6.Cg-Crymtm1Sasu)
|
decreased circulating thyroxine level
|
J:119707
|
decreased circulating triiodothyronine level
|
J:119707
|
Csf1Mhdabap25/Csf1Mhdabap25
(C3HeB/FeJ-Csf1Mhdabap25)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
Csf1op/Csf1op
(C57BL/6J-Csf1op)
|
decreased circulating phosphate level
|
J:5634
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
decreased circulating testosterone level
|
J:34371
|
Csf1op/Csf1op
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal circulating calcium level
|
J:5634
|
decreased circulating phosphate level
|
J:5634
|
decreased circulating testosterone level
|
J:34371
|
Csf1op/Csf1op Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:117880
|
Csf1rtm1Ers/Csf1rtm1Ers
(involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)
|
abnormal circulating cytokine level
|
J:73663
|
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating progesterone level
|
J:86386
|
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
|
increased circulating free fatty acids level
|
J:102499
|
increased circulating glucose level
|
J:145518
|
increased circulating leptin level
|
J:102499
|
increased circulating triglyceride level
|
J:102499
|
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating glucose level
|
J:142440
|
decreased circulating insulin level
|
J:142440
|
Csf2tm1Mlg/Csf2tm1Mlg Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli)
|
hyperglycemia
|
J:145518
|
Csf3em1(IMPC)H/Csf3em1(IMPC)H
(C57BL/6NTac-Csf3em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Csgalnact1tm1.1Nari/Csgalnact1tm1.1Nari Csgalnact2tm1.2Staka/Csgalnact2tm1.2Staka
(involves: C57BL/6J)
|
cyanosis
|
J:256718
|
Csktm2b(EUCOMM)Hmgu/Csk+
(C57BL/6N-Csktm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Csmd1em1(IMPC)Wtsi/Csmd1em1(IMPC)Wtsi
(C57BL/6N-Csmd1em1(IMPC)Wtsi/WtsiIeg)
|
increased circulating creatinine level
|
J:211773
|
Csmd3em1(IMPC)Mbp/Csmd3em1(IMPC)Mbp
(C57BL/6NCrl-Csmd3em1(IMPC)Mbp/Mmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Csnk1g2em1Xidw/Csnk1g2em1Xidw
(Not Specified)
|
abnormal circulating protein level
|
J:298682
|
decreased circulating testosterone level
|
J:298682
|
increased circulating follicle stimulating hormone level
|
J:298682
|
increased circulating luteinizing hormone level
|
J:298682
|
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Csnk1g3tm1a(EUCOMM)Wtsi/Csnk1g3tm1a(EUCOMM)Wtsi
(C57BL/6N-Csnk1g3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating cholesterol level
|
J:184220
|
increased circulating HDL cholesterol level
|
J:184220
|
increased circulating LDL cholesterol level
|
J:184220
|
Cspp1em1(IMPC)J/Cspp1em1(IMPC)J
(C57BL/6NJ-Cspp1em1(IMPC)J/Mmjax)
|
decreased circulating creatinine level
|
J:211773
|
Cst6em1(IMPC)Ccpcz/Cst6+
(C57BL/6NCrl-Cst6em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Cstbtm1b(EUCOMM)Wtsi/Cstbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cstbtm1b(EUCOMM)Wtsi/Orl)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ct45atm1e(KOMP)Wtsi/Y
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ct45atm1e(KOMP)Wtsi/Ct45atm1e(KOMP)Wtsi
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ctdsp1tm1b(EUCOMM)Wtsi/Ctdsp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ctdsp1tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ctdspltm1.1(KOMP)Mbp/Ctdspltm1.1(KOMP)Mbp
(C57BL/6N-Ctdspltm1.1(KOMP)Mbp/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
|
decreased circulating free fatty acids level
|
J:176727
|
hyperglycemia
|
J:176727
|
increased circulating cholesterol level
|
J:176727
|
increased circulating insulin level
|
J:176727
|
increased circulating leptin level
|
J:176727
|
Cthtm1Iish/Cth+
(B6.129-Cthtm1Iish/Iish)
|
increased circulating homocysteine level
|
J:166184
|
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish/Iish)
|
abnormal circulating amino acid level
|
J:166184
|
decreased circulating creatinine level
|
J:166184
|
decreased circulating taurine level
|
J:166184
|
increased blood urea nitrogen level
|
J:166184
|
increased circulating alanine transaminase level
|
J:166184
|
increased circulating alkaline phosphatase level
|
J:166184
|
increased circulating aspartate transaminase level
|
J:166184
|
increased circulating homocysteine level
|
J:166184
|
increased circulating serum albumin level
|
J:166184
|
increased circulating triglyceride level
|
J:166184
|
Cthtm1Liwu/Cth+
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased circulating cysteine level
|
J:140705
|
increased circulating homocysteine level
|
J:140705
|
Cthtm1Liwu/Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased circulating cysteine level
|
J:140705
|
increased circulating homocysteine level
|
J:140705
|
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli)
|
increased circulating glucose level
|
J:192096
|
Ctnnb1tm1Mmt/Ctnnb1+ Krastm4Tyj/Kras+ Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased circulating estradiol level
|
J:186144
|
decreased circulating progesterone level
|
J:186144
|
increased circulating follicle stimulating hormone level
|
J:186144
|
increased circulating luteinizing hormone level
|
J:186144
|
Ctnnb1tm1Mmt/Ctnnb1+ Ptentm1Hwu/Ptentm1Hwu Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased circulating estradiol level
|
J:186144
|
decreased circulating progesterone level
|
J:186144
|
increased circulating follicle stimulating hormone level
|
J:186144
|
increased circulating luteinizing hormone level
|
J:186144
|
Ctr9tm1b(EUCOMM)Wtsi/Ctr9+
(C57BL/6N-Ctr9tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde)
|
hyperglycemia
|
J:153355
|
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde)
|
hyperglycemia
|
J:153355
|
Ctsctm1Ley/Ctsctm1Ley
(B6.129X1-Ctsctm1Ley)
|
decreased circulating interleukin-6 level
|
J:131520
|
increased circulating interleukin-6 level
|
J:88160
|
Ctsdtm1b(EUCOMM)Wtsi/Ctsd+
(C57BL/6N-Ctsdtm1b(EUCOMM)Wtsi/Ics)
|
increased circulating aspartate transaminase level
|
J:211773
|
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
abnormal thrombosis
|
J:28201
|
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:108745
|
increased circulating interleukin-18 level
|
J:108745
|
Ctsktm1Psa/Ctsktm1Psa Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
decreased circulating thyroxine level
|
J:83877
|
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr)
|
hyperglycemia
|
J:153355
|
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Ctsotm2b(KOMP)Wtsi/Ctsotm2b(KOMP)Wtsi
(C57BL/6N-Ctsotm2b(KOMP)Wtsi/Cnrm)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae)
|
hyperglycemia
|
J:153355
|
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae)
|
hyperglycemia
|
J:153355
|
Ctsstm1Hap/Ctsstm1Hap Dmdmdx/Dmdmdx
(involves: 129S2/SvPas * C57BL/10ScSn)
|
increased circulating creatine kinase level
|
J:230788
|
Ctsstm1Hap/Ctsstm1Hap Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her)
|
decreased circulating cholesterol level
|
J:82520
|
decreased circulating LDL cholesterol level
|
J:82520
|
Cttnbp2nlem1(IMPC)J/Cttnbp2nlem1(IMPC)J
(C57BL/6NJ-Cttnbp2nlem1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
Ctu1em1(IMPC)J/Ctu1+
(C57BL/6NJ-Ctu1em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N)
|
hyperkalemia
|
J:229424
|
increased circulating aldosterone level
|
J:229424
|
increased circulating magnesium level
|
J:229424
|
increased circulating phosphate level
|
J:229424
|
Cul4atm1b(EUCOMM)Hmgu/Cul4atm1b(EUCOMM)Hmgu
(C57BL/6N-Cul4atm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cul9em1(IMPC)Ccpcz/Cul9em1(IMPC)Ccpcz
(C57BL/6N-Cul9em1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Cux1tm1Ejn/Cux1tm1Ejn Cys1cpk/Cys1cpk
(involves: 129S4/SvJae * C57BL/6)
|
increased blood urea nitrogen level
|
J:142805
|
Cux1tm1Mbu/Cux1tm1Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:71407
|
Cux1tm2Ejn/Cux1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating testosterone level
|
J:74660
|
Cux1tm2Ejn/Cux1tm2Ejn
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating testosterone level
|
J:74660
|
Cwc22em1(IMPC)Mbp/Cwc22+
(C57BL/6NCrl-Cwc22em1(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Cwc27tm1Lex/Cwc27tm1Lex
(B6;129S5-Cwc27tm1Lex/Mmucd)
|
abnormal blood homeostasis
|
J:171883
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs Ldlrtm1Her/Ldlr+
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J)
|
decreased circulating cholesterol level
|
J:95279
|
decreased circulating LDL cholesterol level
|
J:95279
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs Ldlrtm1Her/Ldlrtm1Her
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J)
|
decreased circulating cholesterol level
|
J:95279
|
decreased circulating LDL cholesterol level
|
J:95279
|
Cxcl5em1(IMPC)Kmpc/Cxcl5em1(IMPC)Kmpc
(C57BL/6NTac-Cxcl5em1(IMPC)Kmpc/Kmpc)
|
increased circulating alanine transaminase level
|
J:211773
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
|
abnormal circulating chemokine level
|
J:162629
|
decreased circulating interleukin-6 level
|
J:162629
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal circulating chemokine level
|
J:162629
|
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cxcl14em1(IMPC)H/Cxcl14em1(IMPC)H
(C57BL/6NTac-Cxcl14em1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:126841
|
decreased circulating glucose level
|
J:126841
|
decreased circulating insulin level
|
J:126841
|
Cxcl16tm1Syon/Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon)
|
decreased circulating interferon-gamma level
|
J:155199
|
decreased circulating interleukin-4 level
|
J:155199
|
Cxcl17tm1b(EUCOMM)Wtsi/Cxcl17tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl17tm1b(EUCOMM)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Cxcr1tm1a(EUCOMM)Wtsi/Cxcr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2+
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating thyroxine level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:19570
|
Cxcr3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:101679
|
Cxcr3tm1Raks/Cxcr3tm1Raks
(B6.129P2-Cxcr3tm1Raks)
|
decreased blood urea nitrogen level
|
J:152790
|
decreased circulating creatinine level
|
J:152790
|
Cxcr4em1(IMPC)Mbp/Cxcr4+
(C57BL/6NCrl-Cxcr4em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating creatinine level
|
J:211773
|
Cxxc4em1(IMPC)J/Cxxc4em1(IMPC)J
(C57BL/6NJ-Cxxc4em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Cyb5d2tm1.1(KOMP)Wtsi/Cyb5d2tm1.1(KOMP)Wtsi
(B6N(Cg)-Cyb5d2tm1.1(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Cyb5r3tm1b(KOMP)Wtsi/Cyb5r3+
(C57BL/6N-Cyb5r3tm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
decreased circulating insulin level
|
J:91486
|
hyperlipidemia
|
J:91486
|
increased circulating glucose level
|
J:91486
|
Cyb561tm1a(EUCOMM)Wtsi/Cyb561tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating calcium level
|
J:165965
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
increased circulating iron level
|
J:165965
|
Cyb561tm1a(EUCOMM)Wtsi/Cyb561tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cyb561tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating amylase level
|
J:175295
|
increased circulating fructosamine level
|
J:175295
|
increased circulating magnesium level
|
J:175295
|
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Cyb561a3tm2b(EUCOMM)Hmgu/Cyb561a3tm2b(EUCOMM)Hmgu
(C57BL/6N-Cyb561a3tm2b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Cyb561d2tm1b(EUCOMM)Wtsi/Cyb561d2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561d2tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating sodium level
|
J:211773
|
Cybatm1a(EUCOMM)Wtsi/Cybatm1a(EUCOMM)Wtsi
(C57BL/6N-Cybatm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating amylase level
|
J:211773
|
Cybbtm1.1Abk/Cybbtm1.1Abk Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk)
|
decreased circulating insulin level
|
J:245699
|
decreased circulating LDL cholesterol level
|
J:245699
|
decreased fasting circulating glucose level
|
J:245699
|
increased circulating HDL cholesterol level
|
J:245699
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased blood urea nitrogen level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:175295
|
decreased circulating glucose level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Cybrd1tm1b(EUCOMM)Hmgu/Cybrd1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cybrd1tm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Cygbtm1b(EUCOMM)Wtsi/Cygbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cygbtm1b(EUCOMM)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
Cyldtm1.1Gmos/Cyldtm1.1Gmos
(involves: BALB/cJ)
|
cyanosis
|
J:162840
|
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal circulating serum albumin level
|
J:114972
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
increased circulating alanine transaminase level
|
J:163973
|
increased circulating aspartate transaminase level
|
J:163973
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating alanine transaminase level
|
J:122409
|
increased circulating aspartate transaminase level
|
J:122409
|
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
increased circulating alanine transaminase level
|
J:163973
|
increased circulating aspartate transaminase level
|
J:163973
|
Cyp1a2tm1Gonz/Cyp1a2tm1Gonz
(involves: 129S4/SvJae)
|
cyanosis
|
J:25724
|
Cyp1atm1Dwn/Cyp1atm1Dwn
(B6.129-Cyp1atm1Dwn)
|
increased circulating alanine transaminase level
|
J:122409
|
increased circulating aspartate transaminase level
|
J:122409
|
Cyp2a12em1Utr/Cyp2a12em1Utr Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2a12em1Utr Cyp2c70em1Utr)
|
decreased circulating cholesterol level
|
J:302190
|
increased circulating alanine transaminase level
|
J:302190
|
increased circulating alkaline phosphatase level
|
J:302190
|
Cyp2ab1tm1b(KOMP)Wtsi/Cyp2ab1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp2ab1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Cyp2b10tm1a(KOMP)Wtsi/Cyp2b10tm1a(KOMP)Wtsi
(C57BL/6N-Cyp2b10tm1a(KOMP)Wtsi)
|
abnormal blood homeostasis
|
J:339440
|
increased circulating alanine transaminase level
|
J:339440
|
Cyp2c23Gt(OST85045)Lex/Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex)
|
decreased circulating aldosterone level
|
J:204734
|
increased circulating sodium level
|
J:204734
|
Cyp2c23tm1b(EUCOMM)Hmgu/Cyp2c23tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp2c23tm1b(EUCOMM)Hmgu/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Cyp2c70em1Sjka/Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka)
|
increased circulating alanine transaminase level
|
J:330641
|
increased circulating alkaline phosphatase level
|
J:330641
|
increased circulating aspartate transaminase level
|
J:330641
|
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr)
|
increased circulating alanine transaminase level
|
J:302190
|
increased circulating alkaline phosphatase level
|
J:302190
|
increased circulating cholesterol level
|
J:302190
|
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte)
|
decreased circulating cholesterol level
|
J:241121
|
decreased circulating HDL cholesterol level
|
J:241121
|
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
|
abnormal blood homeostasis
|
J:143909
|
Cyp2j5tm1Dcz/Cyp2j5tm1Dcz
(129S/SvEv-Cyp2j5tm1Dcz)
|
decreased circulating estrogen level
|
J:146047
|
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating phosphate level
|
J:223194
|
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cyp4f16tm1b(KOMP)Wtsi/Cyp4f16tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4f16tm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Cyp7a1tm1b(EUCOMM)Wtsi/Cyp7a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7a1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Cyp8b1tm1Rus/Cyp8b1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:100246
|
Cyp11a1tm1.1Bcc/Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc)
|
increased circulating adrenocorticotropin level
|
J:191801
|
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6)
|
abnormal circulating potassium level
|
J:78062
|
abnormal circulating sodium level
|
J:78062
|
decreased circulating aldosterone level
|
J:78062
|
decreased circulating corticosterone level
|
J:78062
|
increased circulating adrenocorticotropin level
|
J:78062
|
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified)
|
abnormal circulating hormone level
|
J:133007
|
decreased circulating corticosterone level
|
J:133007
|
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating corticosterone level
|
J:147610
|
decreased circulating insulin level
|
J:147610
|
decreased circulating renin level
|
J:147610
|
hypokalemia
|
J:147610
|
increased circulating adrenocorticotropin level
|
J:147610
|
Cyp11b2tm1Hsk/Cyp11b2tm1Hsk
(involves: 129S6/SvEvTac)
|
decreased circulating aldosterone level
|
J:99269
|
increased circulating angiotensin II level
|
J:99269
|
increased circulating corticosterone level
|
J:99269
|
increased circulating potassium level
|
J:99269
|
increased circulating renin level
|
J:99269
|
Cyp11b2tm2Hsk/Cyp11b2tm2Hsk
(involves: 129S6/SvEvTac)
|
hypokalemia
|
J:147672
|
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju)
|
decreased circulating phosphate level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cyp17a1tm1Vpap/Cyp17a1+
(chimera involves: 129X1/SvJ * C57BL/6)
|
decreased circulating testosterone level
|
J:100434
|
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating dihydrotestosterone level
|
J:70204
|
increased circulating follicle stimulating hormone level
|
J:48086,
J:63458,
J:56358
|
increased circulating luteinizing hormone level
|
J:48086,
J:63458,
J:56358
|
increased circulating prolactin level
|
J:70204
|
increased circulating testosterone level
|
J:48086,
J:70204,
J:56358
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac)
|
increased circulating cholesterol level
|
J:65805
|
increased circulating HDL cholesterol level
|
J:65805
|
increased circulating insulin level
|
J:65805
|
increased circulating leptin level
|
J:65805
|
increased circulating triglyceride level
|
J:65805
|
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating estradiol level
|
J:114305,
J:70359
|
increased circulating cholesterol level
|
J:82070
|
increased circulating glucose level
|
J:82070
|
increased circulating testosterone level
|
J:114305,
J:70359,
J:82070,
J:68190
|
increased circulating triglyceride level
|
J:82070
|
Cyp20a1tm1a(EUCOMM)Wtsi/Cyp20a1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cyp20a1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Cyp24a1tm1Star/Cyp24a1tm1Star
(involves: 129S4/SvJae)
|
increased circulating calcium level
|
J:63457
|
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:48127
|
increased circulating cholesterol level
|
J:115373
|
increased circulating triglyceride level
|
J:115373
|
increased circulating VLDL cholesterol level
|
J:115373
|
increased circulating VLDL triglyceride level
|
J:115373
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J)
|
decreased circulating phosphate level
|
J:223194
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased circulating phosphate level
|
J:223194
|
Cyp27b1tm1b(EUCOMM)Hmgu/Cyp27b1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp27b1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Cyp27b1tm1Dgo/Cyp27b1tm1Dgo
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
abnormal blood homeostasis
|
J:70030
|
decreased circulating calcium level
|
J:70030
|
decreased circulating phosphate level
|
J:70030
|
increased circulating alkaline phosphatase level
|
J:70030
|
increased circulating parathyroid hormone level
|
J:70030
|
Cyp27b1tm1Star/Cyp27b1tm1Star
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood homeostasis
|
J:71928
|
decreased circulating calcium level
|
J:78635,
J:71928
|
decreased circulating phosphate level
|
J:71928
|
increased circulating alkaline phosphatase level
|
J:71928
|
increased circulating parathyroid hormone level
|
J:71928
|
Cyp39a1em1(IMPC)Ccpcz/Cyp39a1em1(IMPC)Ccpcz
(C57BL/6N-Cyp39a1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Cyriaem1(IMPC)Hmgu/Cyriaem1(IMPC)Hmgu
(C57BL/6NCrl-Cyriaem1(IMPC)Hmgu/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Cyribm1Ivdi/Cyribm1Ivdi
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased circulating interleukin-6 level
|
J:282597
|
increased circulating interleukin-10 level
|
J:282597
|
increased circulating tumor necrosis factor level
|
J:282597
|
Cyribtm1b(KOMP)Wtsi/Cyrib+
(C57BL/6N-Cyribtm1b(KOMP)Wtsi/Tcp)
|
decreased circulating sodium level
|
J:211773
|
Cyribtm1c(KOMP)Wtsi/Cyribtm1d(KOMP)Wtsi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)
|
abnormal circulating chemokine level
|
J:282597
|
increased circulating CXCL10 level
|
J:282597
|
increased circulating interleukin-6 level
|
J:282597
|
increased circulating interleukin-10 level
|
J:282597
|
increased circulating tumor necrosis factor level
|
J:282597
|
Cys1cpk/Cys1cpk
(B6(Cg)-Cys1cpk/J)
|
increased blood urea nitrogen level
|
J:9290,
J:6718
|
Cys1cpk/Cys1cpk
(B6(Cg)-Cys1cpk/JUnc)
|
increased blood urea nitrogen level
|
J:7202
|
increased circulating creatinine level
|
J:7202
|
Cys1cpk/Cys1cpk
(involves: C57BL/6J * CD-1)
|
increased blood urea nitrogen level
|
J:33739
|
Cys1cpk/Cys1cpk
(C.B6(Cg)-Cys1cpk)
|
increased blood urea nitrogen level
|
J:99616
|
Cys1cpk/Cys1cpk
(D2J.B6(Cg)-Cys1cpk)
|
increased blood urea nitrogen level
|
J:99620
|
increased circulating creatinine level
|
J:99620
|
Cystm1tm1b(EUCOMM)Hmgu/Cystm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cystm1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi)
|
decreased circulating glucose level
|
J:272118
|
decreased circulating triglyceride level
|
J:272118
|
Cyth4em1(IMPC)Ccpcz/Cyth4em1(IMPC)Ccpcz
(C57BL/6NCrl-Cyth4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating iron level
|
J:211773
|
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
D7Ertd443etm2a(KOMP)Wtsi/D7Ertd443etm2a(KOMP)Wtsi
(C57BL/6N-D7Ertd443etm2a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Daam1Gt(RRT390)Byg/Daam1Gt(RRT390)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:167714
|
Daam1tm1b(EUCOMM)Hmgu/Daam1+
(C57BL/6N-Daam1tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
Daam2tm1a(KOMP)Wtsi/Daam2tm1a(KOMP)Wtsi
(C57BL/6N-Daam2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Daam2tm1b(KOMP)Wtsi/Daam2tm1b(KOMP)Wtsi
(C57BL/6N-Daam2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Dab2tm2.1Xxx/Dab2tm2.2Xxx Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:205046
|
increased circulating LDL cholesterol level
|
J:205046
|
Dach1tm1b(KOMP)Wtsi/Dach1+
(B6N(Cg)-Dach1tm1b(KOMP)Wtsi/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Dach1tm1Krs/Dach1tm1Krs
(involves: 129P2/OlaHsd)
|
cyanosis
|
J:81143
|
Dach1tm1Mrd/Dach1tm1Mrd
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:67361
|
Dach1tm1Mrd/Dach1tm1Mrd
(involves: 129S7/SvEvBrd * C57BL/6)
|
cyanosis
|
J:67361
|
Dact3tm1b(KOMP)Wtsi/Dact3tm1b(KOMP)Wtsi
(C57BL/6N-Dact3tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Dag1tm1.1Swin/Dag1tm1.1Swin Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
increased circulating creatine kinase level
|
J:187750
|
Dag1tm1.1Swin/Dag1tm1.1Swin Dmdmdx/Dmdmdx
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
increased circulating creatine kinase level
|
J:187750
|
Dag1tm2Kcam/Dag1tm2Kcam Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
increased circulating creatine kinase level
|
J:78838
|
DaoG181R/DaoG181R
(DDY-Dao1G181R)
|
decreased circulating glutamic acid level
|
J:21994
|
decreased circulating glycine level
|
J:21994
|
decreased circulating taurine level
|
J:21994
|
increased circulating alanine level
|
J:21994
|
increased circulating serine level
|
J:21994
|
Daotm1Ttsu/Daotm1Ttsu
(129S/SvEv-Daotm1Ttsu)
|
increased circulating serine level
|
J:228710
|
Dap3em1(IMPC)J/Dap3+
(C57BL/6NJ-Dap3em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Daptm1a(KOMP)Mbp/Daptm1a(KOMP)Mbp
(C57BL/6N-Daptm1a(KOMP)Mbp/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Dars2tm1a(KOMP)Wtsi/Dars2+
(C57BL/6N-Dars2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
DatdDBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal circulating protein level
|
J:70962
|
Dbhtm1Rpa/Dbhtm1Rpa
(either: (involves: 129S7/SvEvBrd * 129/SvCpj) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
absent circulating adrenaline
|
J:24414
|
absent circulating noradrenaline
|
J:24414
|
increased circulating corticosterone level
|
J:97566
|
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J)
|
decreased circulating glucagon level
|
J:85772
|
decreased circulating glucose level
|
J:85772
|
increased circulating corticosterone level
|
J:85772
|
increased circulating insulin level
|
J:85772
|
Dbitm1Smdp/Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp)
|
increased circulating cholesterol level
|
J:168744
|
Dbil5tm1(KOMP)Wtsi/Dbil5tm1(KOMP)Wtsi
(C57BL/6N-Dbil5tm1(KOMP)Wtsi/Nju)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dbm1A/J/Dbm1A/J Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
increased circulating glucose level
|
J:112869
|
increased circulating insulin level
|
J:112869
|
Dbm2C57BL/6J/?
(involves: A/J * C57BL/6J)
|
increased circulating glucose level
|
J:112869
|
Dbm3C57BL/6J/? Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:112869
|
Dbm4C57BL/6J/? Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:112869
|
Dbn1em1(IMPC)Bay/Dbn1em1(IMPC)Bay
(C57BL/6N-Dbn1em1(IMPC)Bay/Bay)
|
increased circulating phosphate level
|
J:211773
|
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating calcium level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ucd)
|
increased circulating phosphate level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Rbrc)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Dbndd2tm1b(EUCOMM)Wtsi/Dbndd2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dbndd2tm1b(EUCOMM)Wtsi/Tcp)
|
decreased circulating creatinine level
|
J:211773
|
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Dbptm1Schb/Dbptm1Schb Hlftm1Schb/Hlftm1Schb Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased circulating aldosterone level
|
J:164398
|
increased circulating alanine transaminase level
|
J:129710
|
Dbsq3C3H/HeJ/Dbsq3C3H/HeJ Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS)
|
increased circulating glucose level
|
J:116038
|
Dbsq3C57BLKS/J/Dbsq3C3H/HeJ Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS)
|
increased circulating glucose level
|
J:116038
|
Dbsty1NZO/HlLt/Dbsty1NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
increased circulating insulin level
|
J:65256
|
Dbsty1NZO/HlLt/Dbsty1NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
increased circulating insulin level
|
J:65256
|
Dbsty4NZO/HlLt/Dbsty4NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
Dbsty4NZO/HlLt/Dbsty4NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
|
hyperglycemia
|
J:65256
|
Dbttm1Geh/Dbttm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal circulating amino acid level
|
J:119973
|
decreased circulating alanine level
|
J:119973
|
decreased circulating glutamic acid level
|
J:119973
|
decreased circulating glutamine level
|
J:119973
|
Dbttm1Geh/Dbttm1Geh Tg(tetO-DBT)525AGeh/0 Tg(Cebpb-tTA)5Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI)
|
abnormal circulating amino acid level
|
J:119973
|
Dbttm1Geh/Dbttm1Geh Tg(tetO-DBT)A1Geh/0 Tg(Cebpb-tTA)5Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI)
|
abnormal circulating amino acid level
|
J:119973
|
Dbx1tm1Tmj/Dbx1tm1Tmj
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:165285
|
Dcaf5em1(IMPC)Ccpcz/Dcaf5em1(IMPC)Ccpcz
(C57BL/6NCrl-Dcaf5em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Dcaf7tm1b(EUCOMM)Wtsi/Dcaf7+
(C57BL/6N-Dcaf7tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating total protein level
|
J:211773
|
Dcaf8em1(IMPC)Ccpcz/Dcaf8em1(IMPC)Ccpcz
(C57BL/6N-Dcaf8em1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Dcaf11tm1d(KOMP)Wtsi/Dcaf11tm1d(KOMP)Wtsi
(B6(Cg)-Dcaf11tm1d(KOMP)Wtsi)
|
decreased circulating insulin level
|
J:351189
|
Dcaf15tm1a(EUCOMM)Hmgu/Dcaf15tm1a(EUCOMM)Hmgu
(C57BL/6NCrl-Dcaf15tm1a(EUCOMM)Hmgu/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dcakdtm1b(EUCOMM)Hmgu/Dcakdtm1b(EUCOMM)Hmgu
(C57BL/6N-Dcakdtm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Dcbld2tm1a(KOMP)Wtsi/Dcbld2tm1a(KOMP)Wtsi
(C57BL/6N-Dcbld2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Dclk1tm1a(EUCOMM)Wtsi/Dclk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Dcp2tm1Smoc/Dcp2tm1Smoc Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating testosterone level
|
J:292283
|
increased circulating follicle stimulating hormone level
|
J:292283
|
increased circulating luteinizing hormone level
|
J:292283
|
Dcttm1b(KOMP)Mbp/Dcttm1b(KOMP)Mbp
(C57BL/6N-Dcttm1b(KOMP)Mbp/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Dctn1tm1a(EUCOMM)Wtsi/Dctn1+
(C57BL/6N-Dctn1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Dctn4em1(IMPC)Wtsi/Dctn4+
(C57BL/6N-Dctn4em1(IMPC)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Dcun1d5em1(IMPC)H/Dcun1d5em1(IMPC)H
(C57BL/6N-Dcun1d5em1(IMPC)H/H)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dcxtm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Dcxtm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ddah1tm1.1Geno/Ddah1tm1.1Geno
(Not Specified)
|
abnormal circulating amino acid level
|
J:234529
|
Ddah1tm1.1Yjch/Ddah1tm1.1Yjch
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal circulating amino acid level
|
J:182373
|
Ddah1tm1Pval/Ddah1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating amino acid level
|
J:121719
|
Ddah1tm1Yjch/Ddah1tm1Yjch Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C57BL/6J)
|
abnormal circulating amino acid level
|
J:168130
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(involves: 129 * C57BL/6 * SJL)
|
decreased circulating aldosterone level
|
J:175630
|
increased circulating creatinine level
|
J:175630
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn)
|
decreased circulating aldosterone level
|
J:175630
|
increased circulating creatinine level
|
J:175630
|
Ddit3tm1.1(KOMP)Vlcg/Ddit3tm1.1(KOMP)Vlcg
(C57BL/6N-Ddit3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng)
|
decreased blood urea nitrogen level
|
J:134371
|
decreased circulating estradiol level
|
J:134371
|
decreased circulating progesterone level
|
J:134371
|
decreased circulating testosterone level
|
J:134371
|
increased circulating glucose level
|
J:134371
|
Ddx6em1(IMPC)Mbp/Ddx6+
(C57BL/6N-Ddx6em1(IMPC)Mbp/Ucd)
|
increased circulating total protein level
|
J:211773
|
Ddx20tm1Yosa/Ddx20+
(involves: 129/Sv * C57BL/6)
|
decreased circulating adrenocorticotropin level
|
J:136021
|
Ddx39atm1b(KOMP)Wtsi/Ddx39a+
(C57BL/6N-Ddx39atm1b(KOMP)Wtsi/Bay)
|
increased circulating phosphate level
|
J:211773
|
Ddx42tm1b(EUCOMM)Wtsi/Ddx42+
(C57BL/6N-Ddx42tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating thyroxine level
|
J:211773
|
Ddx46em1Caox/Ddx46+
(involves: C57BL/6J)
|
increased circulating interferon-beta level
|
J:271836
|
Ddx51tm1a(KOMP)Wtsi/Ddx51+
(C57BL/6N-Ddx51tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Ddx60tm1b(EUCOMM)Wtsi/Ddx60tm1b(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating interferon-beta level
|
J:228452
|
increased circulating interferon-alpha level
|
J:228452
|
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh)
|
decreased circulating glucose level
|
J:151622
|
Decr2tm1b(EUCOMM)Wtsi/Decr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Decr2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating creatinine level
|
J:211773
|
Defb14tm1b(KOMP)Wtsi/Defb14tm1b(KOMP)Wtsi
(C57BL/6N-Defb14tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:211773
|
Defb20tm1b(EUCOMM)Hmgu/Defb20tm1b(EUCOMM)Hmgu
(C57BL/6N-Defb20tm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Degs1Gt(OST368559)Lex/Degs1Gt(OST368559)Lex
(involves: 129S5/SvEvBrd)
|
increased circulating alanine transaminase level
|
J:203554
|
increased circulating alkaline phosphatase level
|
J:203554
|
increased circulating bilirubin level
|
J:203554
|
Del(1)1Brk/Del(1)1Brk
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal circulating iron level
|
J:100202
|
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating thyroxine level
|
J:205165
|
decreased circulating triiodothyronine level
|
J:205165
|
increased circulating thyroid-stimulating hormone level
|
J:205165
|
Del(3Bglap2-Bglap)2Kry/Del(3Bglap2-Bglap)2Kry
(involves: 129S7/SvEvBrd)
|
decreased circulating insulin level
|
J:126780
|
decreased circulating testosterone level
|
J:170888
|
increased circulating estradiol level
|
J:170888
|
increased circulating glucose level
|
J:126780
|
increased circulating luteinizing hormone level
|
J:170888
|
increased circulating triglyceride level
|
J:126780
|
Del(3Bglap2-Bglap)2Kry/Del(3Bglap2-Bglap)2Kry Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased circulating insulin level
|
J:145998
|
Del(6Dlx6-Dlx5)1Tlu/+ Mef2ctm1Eno/Mef2c+
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:122483
|
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv)
|
abnormal circulating calcium level
|
J:133151
|
increased circulating parathyroid hormone level
|
J:136038,
J:133151
|
Del(6Slco1b2-Slco1a5)1Nki/+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:163765
|
increased circulating bilirubin level
|
J:163765
|
increased circulating HDL cholesterol level
|
J:163765
|
increased circulating triglyceride level
|
J:163765
|
Del(7)Tyrc-3H/Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH)
|
decreased circulating glucose level
|
J:5063
|
hypoglycemia
|
J:5063
|
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating free fatty acids level
|
J:227939
|
increased circulating insulin level
|
J:227939
|
Del(7Hmx3-Hmx2)2Tlu/Del(7Hmx3-Hmx2)2Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
decreased circulating growth hormone level
|
J:92940
|
Del(7Saa1-Saa2)1Itl/Del(7Saa1-Saa2)1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased circulating cholesterol level
|
J:165605
|
increased circulating phospholipid level
|
J:165605
|
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:109005
|
decreased circulating HDL cholesterol level
|
J:109005
|
decreased circulating triglyceride level
|
J:109005
|
Del(11Irf1-D11Mit23)1Rub/+
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
decreased circulating carnitine level
|
J:60187
|
increased circulating VLDL triglyceride level
|
J:60187
|
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
decreased circulating carnitine level
|
J:60187
|
increased circulating free fatty acids level
|
J:60187
|
increased circulating triglyceride level
|
J:60187
|
increased circulating VLDL triglyceride level
|
J:60187
|
Del(11Jmjd6-Mettl23)1Flv/Del(11Jmjd6-Mettl23)1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal blood homeostasis
|
J:86771
|
cyanosis
|
J:86771
|
Del(11Nme2-Nme1)1Zou/Del(11Nme2-Nme1)1Zou
(involves: 129 * C57BL/6)
|
abnormal circulating iron level
|
J:146219
|
abnormal circulating protein level
|
J:146219
|
decreased circulating iron level
|
J:146219
|
Del(12Bdkrb2-Bdkrb1)1Mki/Del(12Bdkrb2-Bdkrb1)1Mki
(involves: C57BL/6J)
|
decreased blood urea nitrogen level
|
J:121339
|
increased blood urea nitrogen level
|
J:121339
|
increased circulating creatinine level
|
J:121339
|
Del(17Abcg1-Cbs)2Yah/+
(B6.129P2-Del(17Abcg1-Cbs)2Yah)
|
increased circulating homocysteine level
|
J:154298
|
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating cholesterol level
|
J:80679
|
increased circulating cholesterol level
|
J:80679
|
increased circulating phytosterol level
|
J:80679
|
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal circulating chemokine level
|
J:194295
|
increased circulating alanine transaminase level
|
J:194295
|
increased circulating interleukin-1 alpha level
|
J:194295
|
increased circulating interleukin-6 level
|
J:194295
|
increased circulating interleukin-10 level
|
J:194295
|
increased circulating tumor necrosis factor level
|
J:194295
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA * DBA/2)
|
increased blood urea nitrogen level
|
J:65025
|
increased circulating creatinine level
|
J:65025
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
decreased circulating glucose level
|
J:92536
|
increased blood urea nitrogen level
|
J:103743
|
increased circulating insulin level
|
J:92536
|
increased circulating lactate level
|
J:103743
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased circulating glucose level
|
J:199416
|
Dele1em2(IMPC)Ccpcz/Dele1em2(IMPC)Ccpcz
(C57BL/6N-Dele1em2(IMPC)Ccpcz/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA)
|
abnormal circulating lipid level
|
J:276600
|
decreased circulating HDL cholesterol level
|
J:276600
|
increased circulating VLDL triglyceride level
|
J:276600
|
Dennd6bem1(IMPC)Hmgu/Dennd6bem1(IMPC)Hmgu
(C57BL/6NCrl-Dennd6bem1(IMPC)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Denrtm1b(KOMP)Wtsi/Denr+
(C57BL/6N-Denrtm1b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Depdc5tm1b(EUCOMM)Hmgu/Depdc5+
(C57BL/6N-Depdc5tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Deptortm1.1Mala/Deptortm1.1Mala Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA)
|
decreased fasting circulating glucose level
|
J:275931
|
Derl2tm1.2Hpl/Derl2tm1.2Hpl
(involves: BALB/cJ)
|
hypoglycemia
|
J:170650
|
Deup1tm1.1(KOMP)Vlcg/Deup1tm1.1(KOMP)Vlcg
(C57BL/6N-Deup1tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating glucose level
|
J:111346
|
decreased circulating leptin level
|
J:111346
|
Dgat1tm1Ryyo/Dgat1tm1Ryyo
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:155626
|
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:88742
|
decreased circulating triglyceride level
|
J:88742
|
hypoglycemia
|
J:88742
|
Dgat2l6tm1b(KOMP)Wtsi/Dgat2l6tm1b(KOMP)Wtsi
(C57BL/6N-Dgat2l6tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Dgkdem1(IMPC)H/Dgkd+
(C57BL/6NTac-Dgkdem1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Dgkeem1(IMPC)Tcp/Dgkeem1(IMPC)Tcp
(C57BL/6NCrl-Dgkeem1(IMPC)Tcp/Tcp)
|
decreased circulating creatinine level
|
J:211773
|
Dgkhem1(IMPC)J/Dgkhem1(IMPC)J
(C57BL/6NJ-Dgkhem1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
Dgkiem1(IMPC)Wtsi/Dgkiem1(IMPC)Wtsi
(C57BL/6N-Dgkiem1(IMPC)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:295189,
J:211773
|
Dgkkem1(IMPC)Ics/Y
(C57BL/6N-Dgkkem1(IMPC)Ics/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating ferritin level
|
J:293120
|
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
decreased circulating glucose level
|
J:294620
|
decreased circulating serum albumin level
|
J:294620
|
increased circulating alanine transaminase level
|
J:294620
|
increased circulating aspartate transaminase level
|
J:294620
|
increased circulating cholesterol level
|
J:294620
|
Dhcr7tm1Fdp/Dhcr7tm1Fdp
(involves: 129S4/SvJae)
|
cyanosis
|
J:68084
|
Dhcr7tm1Gst/Dhcr7tm1Gst
(B6.129P2-Dhcr7tm1Gst)
|
increased circulating corticosterone level
|
J:93296
|
Dhcr7tm1Gst/Dhcr7tm1Gst Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
|
decreased circulating cholesterol level
|
J:141730
|
Dhcr24tm1a(EUCOMM)Wtsi/Dhcr24+
(B6JTyr;B6N-Dhcr24tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:175295
|
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:304449
|
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:87402
|
decreased circulating cholesterol level
|
J:87402
|
Dhfrtm1b(EUCOMM)Wtsi/Dhfr+
(C57BL/6N-Dhfrtm1b(EUCOMM)Wtsi/Tcp)
|
decreased circulating creatinine level
|
J:211773
|
Dhhtm1Amc/Dhhtm1Amc
(involves: 129S1/Sv * C57BL/6J * Swiss Webster)
|
decreased circulating testosterone level
|
J:65900
|
increased circulating luteinizing hormone level
|
J:65900
|
Dhrs2tm1a(KOMP)Wtsi/Dhrs2tm1a(KOMP)Wtsi
(C57BL/6N-Dhrs2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Dhrs7bem1(IMPC)Mbp/Dhrs7b+
(C57BL/6NCrl-Dhrs7bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dhtkd1tm1Mmgu/Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:288186
|
decreased circulating glycerol level
|
J:288186
|
decreased circulating triglyceride level
|
J:288186
|
increased circulating phospholipid level
|
J:288186
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:267178
|
increased circulating creatine kinase level
|
J:267178
|
increased circulating insulin level
|
J:267178
|
increased circulating insulin-like growth factor I level
|
J:267178
|
increased circulating lactate dehydrogenase level
|
J:267178
|
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dhx33tm1b(KOMP)Wtsi/Dhx33+
(C57BL/6N-Dhx33tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating thyroxine level
|
J:211773
|
Dhx40tm1(NCOM)Cmhd/Dhx40tm1(NCOM)Cmhd
(C57BL/6N-Dhx40tm1(NCOM)Cmhd/Tcp)
|
decreased circulating cholesterol level
|
J:165965
|
Dhx58tm1Aki/Dhx58tm1Aki
(involves: 129/Sv * C57BL/6)
|
decreased circulating interferon-beta level
|
J:156867
|
Dhx58tm1Gnb/Dhx58tm1Gnb
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating interferon-gamma level
|
J:146113
|
increased circulating interleukin-12 level
|
J:146113
|
Diaph2tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Diaph2tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating phosphate level
|
J:211773
|
Diaph3tm1b(KOMP)Mbp/Diaph3+
(C57BL/6N-Diaph3tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Dibg1129S6/SvEvTac/Dibg1129S6/SvEvTac
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:142949
|
Dicer1tm1b(EUCOMM)Wtsi/Dicer1+
(C57BL/6N-Dicer1tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dicer1tm1Bdh/Dicer1tm1Bdh Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129)
|
decreased circulating progesterone level
|
J:142113
|
Dicer1tm1Smr/Dicer1tm1Smr Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal atrial thrombosis
|
J:131962
|
abnormal ventricular thrombosis
|
J:131962
|
Dido1tm3Cmar/Dido1tm3.1Cmar Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
increased circulating alanine transaminase level
|
J:328215
|
increased circulating aspartate transaminase level
|
J:328215
|
increased circulating cholesterol level
|
J:328215
|
Dio1tm1Vag/Dio1tm1Vag
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:104508
|
increased circulating thyroxine level
|
J:104508
|
increased circulating triiodothyronine level
|
J:104508
|
Dio2tm1Acb/Dio2tm1Acb Tg(Cga-cre)3Sac/0
(involves: C57BL/6J * SJL)
|
increased circulating thyroid-stimulating hormone level
|
J:197623
|
increased circulating thyroxine level
|
J:197623
|
Dio2tm1Vag/Dio2tm1Vag
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:72958
|
increased circulating thyroxine level
|
J:72958
|
Dio3tm1Dmst/Dio3tm1Dmst Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating thyroxine level
|
J:218350
|
increased circulating triiodothyronine level
|
J:218350
|
Dio3tm1Stg/Dio3tm1Stg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating thyroid-stimulating hormone level
|
J:105434
|
decreased circulating thyroxine level
|
J:105434
|
decreased circulating triiodothyronine level
|
J:105434
|
increased circulating thyroid-stimulating hormone level
|
J:105434
|
Dip2atm2b(KOMP)Wtsi/Dip2atm2b(KOMP)Wtsi
(C57BL/6N-Dip2atm2b(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Dip2btm1a(EUCOMM)Wtsi/Dip2b+
(B6JTyr;B6N-Dip2btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:175295
|
Dipk1atm1a(EUCOMM)Wtsi/Dipk1atm1a(EUCOMM)Wtsi
(C57BL/6N-Dipk1atm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Diwg1C57BL/6/Diwg1C57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:142949
|
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Dkk3tm1Cni/Dkk3tm1Cni Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Dlec1tm1b(EUCOMM)Wtsi/Dlec1tm1b(EUCOMM)Wtsi
(C57BL/6N-Dlec1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
Dlg1Gt(gt1.8geo)1Ber/Dlg1Gt(gt1.8geo)1Ber
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
cyanosis
|
J:67360
|
Dlg4tm1e(EUCOMM)Wtsi/Dlg4tm1e(EUCOMM)Wtsi
(C57BL/6N-Dlg4tm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating sodium level
|
J:211773
|
Dlg4tm2.1Grnt/Dlg4tm2.1Grnt
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating corticosterone level
|
J:175436
|
Dlg5tm1Vv/Dlg5tm1Vv
(involves: 129 * C57BL/6)
|
increased blood urea nitrogen level
|
J:124940
|
Dlgap2em1(IMPC)Mhzh/Dlgap2em1(IMPC)Mhzh
(C57BL/6N-Dlgap2em1(IMPC)Mhzh/Mhzh)
|
increased fasting circulating glucose level
|
J:211773
|
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating glucose level
|
J:211773
|
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J))
|
hyperlipidemia
|
J:77909
|
increased circulating cholesterol level
|
J:77909
|
Dll1m1Mhda/Dll1+
(C3HeB/FeJ-Dll1m1Mhda)
|
decreased circulating cholesterol level
|
J:150183
|
decreased circulating triglyceride level
|
J:150183
|
increased blood uric acid level
|
J:150183
|
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos)
|
decreased blood uric acid level
|
J:150183
|
decreased circulating cholesterol level
|
J:150183
|
decreased circulating total protein level
|
J:150183
|
decreased circulating triglyceride level
|
J:150183
|
Dlx2tm1Fsh/Dlx2tm1Fsh
(Not Specified)
|
cyanosis
|
J:102348
|
Dlx2tm1Jlr/Dlx2tm1Jlr
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * CD-1))
|
cyanosis
|
J:29443
|
Dlx3em1(IMPC)Mbp/Dlx3+
(C57BL/6N-Dlx3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Dlx4em1(IMPC)J/Dlx4em1(IMPC)J
(C57BL/6NJ-Dlx4em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Dmbt1tm2Qaa/Dmbt1tm2Qaa Tg(ATP6V1B1-cre)45Rnel/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased circulating bicarbonate level
|
J:167156
|
Dmbt1tm2Qaa/Dmbt1tm2Qaa Tg(Hoxb7-cre)5526Cmb/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating bicarbonate level
|
J:167156
|
Dmbx1tm1Sse/Dmbx1tm1Sse
(involves: ICR)
|
decreased circulating leptin level
|
J:125193
|
Dmbx1tm1Sse/Dmbx1tm1Sse Lepob/Lepob
(involves: ICR)
|
abnormal circulating glucose level
|
J:125193
|
Dmdem1(IMPC)Hmgu/Y
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Dmdem1(IMPC)Hmgu/Dmdem1(IMPC)Hmgu
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dmdem1Wehi/Y
(BALB/c-Dmdem1Wehi)
|
increased circulating aspartate transaminase level
|
J:353371
|
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
|
increased circulating creatine kinase level
|
J:285447
|
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno)
|
increased circulating creatine kinase level
|
J:285447
|
Dmdem#Tve/Y
(involves: C57BL/6 * CBA)
|
increased circulating creatine kinase level
|
J:275476
|
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal circulating pyruvate kinase level
|
J:7361
|
increased circulating creatine kinase level
|
J:7361
|
Dmdmdx/Y
(involves: 129S4/SvJae * C57BL/10ScSn)
|
abnormal circulating pyruvate kinase level
|
J:48851
|
Dmdmdx/Y Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
abnormal circulating pyruvate kinase level
|
J:48851
|
Dmdmdx/Y Terctm1Rdp/Terc+
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
increased circulating creatine kinase level
|
J:167294
|
Dmdmdx/Y Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
increased circulating creatine kinase level
|
J:167294
|
Dmdmdx/Dmd+
(involves: 129S4/SvJae * C57BL/10ScSn)
|
abnormal circulating pyruvate kinase level
|
J:48851
|
Dmdmdx/Dmd+ Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/10ScSn)
|
abnormal circulating pyruvate kinase level
|
J:48851
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal circulating pyruvate kinase level
|
J:7361
|
increased circulating creatine kinase level
|
J:7361,
J:226314
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx)
|
abnormal circulating pyruvate kinase level
|
J:7361
|
increased circulating creatine kinase level
|
J:18080,
J:7361,
J:152524
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J)
|
increased circulating creatine kinase level
|
J:226314
|
Dmdtm1Kmf/Y
(involves: C57BL/6)
|
increased circulating creatine kinase level
|
J:233298
|
Dmp1tm1.1(KOMP)Vlcg/Dmp1tm1.1(KOMP)Vlcg
(C57BL/6N-Dmp1tm1.1(KOMP)Vlcg/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dmp1tm1Mis/Dmp1tm1Mis
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal circulating protein level
|
J:115339
|
decreased circulating calcium level
|
J:115339
|
decreased circulating phosphate level
|
J:184352,
J:115339
|
increased circulating parathyroid hormone level
|
J:115339
|
Dmwdem1(IMPC)J/Dmwdem1(IMPC)J
(C57BL/6NJ-Dmwdem1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating cholesterol level
|
J:211773
|
Dmxl2tm1c(EUCOMM)Wtsi/Dmxl2+ Tg(Nes-cre)1Atp/0
(involves: C57BL/6N * FVB/N)
|
decreased circulating testosterone level
|
J:217623
|
increased circulating luteinizing hormone level
|
J:217623
|
Dnaaf2tm1.1(KOMP)Vlcg/Dnaaf2+
(B6N(Cg)-Dnaaf2tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dnah1tm1b(EUCOMM)Hmgu/Dnah1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dnah1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Dnah5tm1b(KOMP)Wtsi/Dnah5+
(C57BL/6N-Dnah5tm1b(KOMP)Wtsi/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dnaja1tm1.1(KOMP)Vlcg/Dnaja1+
(C57BL/6N-Dnaja1tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Dnaja4tm1b(KOMP)Wtsi/Dnaja4tm1b(KOMP)Wtsi
(C57BL/6N-Dnaja4tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Dnajb3tm1.1(KOMP)Vlcg/Dnajb3tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb3tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnajb7tm1.1(KOMP)Vlcg/Dnajb7tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb7tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg)
|
hypoglycemia
|
J:226674
|
increased circulating glucagon level
|
J:226674
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg)
|
abnormal circulating glucose level
|
J:226674
|
decreased circulating insulin level
|
J:226674
|
hypoglycemia
|
J:226674
|
increased circulating glucagon level
|
J:226674
|
Dnajb11tm1b(EUCOMM)Wtsi/Dnajb11+
(C57BL/6N-Dnajb11tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dnajb12tm1.1(KOMP)Vlcg/Dnajb12+
(C57BL/6N-Dnajb12tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Dnajb14em1(IMPC)J/Dnajb14+
(C57BL/6NJ-Dnajb14em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Dnajc2em1(IMPC)J/Dnajc2+
(C57BL/6NJ-Dnajc2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh)
|
hyperglycemia
|
J:98194
|
increased circulating insulin level
|
J:98194
|
Dnajc5gtm1.1(KOMP)Vlcg/Dnajc5g+
(C57BL/6N-Dnajc5gtm1.1(KOMP)Vlcg/J)
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnajc7tm1.2Neg/Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:225381
|
Dnajc9tm1.1(KOMP)Vlcg/Dnajc9+
(C57BL/6N-Dnajc9tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Dnajc13em1(IMPC)J/Dnajc13+
(C57BL/6NJ-Dnajc13em1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
Dnajc14tm1.1(KOMP)Vlcg/Dnajc14tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajc14tm1.1(KOMP)Vlcg/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
|
decreased circulating free fatty acids level
|
J:204025
|
decreased circulating triglyceride level
|
J:204025
|
Dnajc15tm1b(KOMP)Wtsi/Dnajc15tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc15tm1b(KOMP)Wtsi/Bay)
|
increased circulating glucose level
|
J:211773
|
Dnajc17tm1a(EUCOMM)Hmgu/Dnajc17+
(C57BL/6N-Dnajc17tm1a(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:165965
|
Dnajc17tm1b(EUCOMM)Hmgu/Dnajc17+
(C57BL/6N-Dnajc17tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating fructosamine level
|
J:211773
|
Dnajc19tm1a(EUCOMM)Hmgu/Dnajc19tm1a(EUCOMM)Hmgu
(C57BL/6N-Dnajc19tm1a(EUCOMM)Hmgu/H)
|
increased circulating glucose level
|
J:165965
|
Dnajc30tm1.1(KOMP)Vlcg/Dnajc30tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajc30tm1.1(KOMP)Vlcg/J)
|
increased circulating calcium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * CD-1)
|
decreased blood urea nitrogen level
|
J:110060
|
decreased circulating creatinine level
|
J:110060
|
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6)
|
increased circulating creatinine level
|
J:277126
|
Dnase1l2em1(IMPC)J/Dnase1l2em1(IMPC)J
(C57BL/6NJ-Dnase1l2em1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ieg)
|
increased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/H)
|
increased blood urea nitrogen level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Orl)
|
increased circulating calcium level
|
J:211773
|
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Dnase2atm1Osa/Dnase2atm1Osa Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:114982
|
increased circulating interleukin-10 level
|
J:238323
|
increased circulating interleukin-18 level
|
J:114982
|
increased circulating tumor necrosis factor level
|
J:238323,
J:114982
|
Dnase2atm1Osa/Dnase2atm2Osa Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal blood homeostasis
|
J:114982
|
increased circulating interleukin-18 level
|
J:114982
|
increased circulating tumor necrosis factor level
|
J:114982
|
Dnase2btm1a(EUCOMM)Hmgu/Dnase2btm1a(EUCOMM)Hmgu
(C57BL/6N-Dnase2btm1a(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:165965
|
Dnertm3b(EUCOMM)Hmgu/Dnertm3b(EUCOMM)Hmgu
(C57BL/6N-Dnertm3b(EUCOMM)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Dnm1tm1Pdc/Dnm1tm1Pdc Dnm3tm1.2Pdc/Dnm3tm1.2Pdc
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
cyanosis
|
J:175247
|
Dnm1lPy/Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH)
|
increased circulating alanine transaminase level
|
J:161510
|
increased circulating aspartate transaminase level
|
J:161510
|
Dnm2tm1.1(KOMP)Vlcg/Dnm2+
(C57BL/6N-Dnm2tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Dnpeptm1e(EUCOMM)Wtsi/Dnpeptm1e(EUCOMM)Wtsi
(C57BL/6N-Dnpeptm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Dntttm2b(KOMP)Wtsi/Dntttm2b(KOMP)Wtsi
(C57BL/6N-Dntttm2b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Dock1tm1Jfco/Dock1tm1Jfco
(involves: 129/Sv * C57BL/6)
|
cyanosis
|
J:143342
|
Dock2tm1b(EUCOMM)Wtsi/Dock2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dock2tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Dock6em1(IMPC)J/Dock6+
(C57BL/6NJ-Dock6em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Dock7m/Dock7m
(B6.D(Cg)-Dock7m)
|
increased bleeding time
|
J:45425
|
Dock9em1(IMPC)J/Dock9em1(IMPC)J
(C57BL/6NJ-Dock9em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam)
|
decreased circulating insulin level
|
J:133566
|
decreased circulating leptin level
|
J:133566
|
Dop1btm1a(EUCOMM)Wtsi/Dop1btm1a(EUCOMM)Wtsi
(C57BL/6N-Dop1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Dp(17Abcg1-Cbs)1Yah/0
(B6.129P2-Dp(17Abcg1-Cbs1)1Yah)
|
decreased circulating homocysteine level
|
J:154298
|
Dpf3em1(IMPC)J/Dpf3em1(IMPC)J
(C57BL/6NJ-Dpf3em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Dph6tm1a(KOMP)Wtsi/Dph6tm1a(KOMP)Wtsi
(C57BL/6N-Dph6tm1a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Dpm2tm1b(EUCOMM)Hmgu/Dpm2+
(C57BL/6N-Dpm2tm1b(EUCOMM)Hmgu/H)
|
increased circulating total protein level
|
J:211773
|
Dpp4tm1Nwa/Dpp4tm1Nwa
(C57BL/6-Dpp4tm1Nwa)
|
increased circulating glucagon level
|
J:62709
|
increased circulating insulin level
|
J:62709
|
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Dpp9tm1a(EUCOMM)Hmgu/Dpp9+
(C57BL/6N-Dpp9tm1a(EUCOMM)Hmgu/Cnrm)
|
decreased circulating phosphate level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Dpp9tm1b(EUCOMM)Hmgu/Dpp9+
(C57BL/6N-Dpp9tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating iron level
|
J:211773
|
Dppa2tm1.1Yam/Dppa2tm1.1Yam Dppa4tm1Yam/Dppa4tm1Yam
(involves: 129S4/SvJae)
|
cyanosis
|
J:178324
|
Dpy19l3tm1a(EUCOMM)Wtsi/Dpy19l3tm1a(EUCOMM)Wtsi
(C57BL/6N-Dpy19l3tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating free fatty acids level
|
J:165965
|
Dpy30tm1a(KOMP)Wtsi/Dpy30+
(C57BL/6N-Dpy30tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating sodium level
|
J:211773
|
Draxintm1Lex/Draxintm1Lex
(B6;129S5-Draxintm1Lex/Mmucd)
|
decreased circulating insulin level
|
J:171883
|
Drc7em1(IMPC)J/Drc7em1(IMPC)J
(C57BL/6NJ-Drc7em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Tg(Nes-cre)1Kln/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating insulin-like growth factor I level
|
J:194227
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Tg(Prl-cre)1Mrub/?
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased circulating prolactin level
|
J:194227
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating estrogen level
|
J:41857
|
decreased circulating growth hormone level
|
J:41857
|
increased circulating adrenocorticotropin level
|
J:110599
|
increased circulating corticosterone level
|
J:110599
|
increased circulating pituitary hormone level
|
J:110599
|
increased circulating prolactin level
|
J:41857
|
Drd2tm1Low/Drd2tm1Low
(either: B6.129S2-Drd2tm1Low or (involves: 129S2/SvPas * C57BL/6))
|
increased circulating prolactin level
|
J:41858
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
|
decreased circulating growth hormone level
|
J:106832
|
decreased circulating insulin-like growth factor I level
|
J:106832
|
increased circulating prolactin level
|
J:106832
|
Drd2tm1Mok/Drd2tm1Mok
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
abnormal circulating hormone level
|
J:97838
|
Drd3tm1Stl/Drd3tm1Stl
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating leptin level
|
J:89345
|
Drg2tm1a(EUCOMM)Wtsi/Drg2tm1a(EUCOMM)Wtsi
(C57BL/6N-Drg2tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating phosphate level
|
J:165965
|
Droshatm1Litt/Droshatm1Litt Tg(Six2-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * CD-1)
|
cyanosis
|
J:321428
|
DrsiC3H/HeNCrl/DrsiC3H/HeNCrl
(B6.C3-(D7Mit56-D7Mit230))
|
increased circulating total protein level
|
J:89623
|
Dsc3tm1b(EUCOMM)Wtsi/Dsc3+
(C57BL/6N-Dsc3tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Dscc1tm1a(KOMP)Wtsi/Dscc1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Dscc1tm1a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:175295
|
Dsetm1b(EUCOMM)Hmgu/Dse+
(C57BL/6N-Dsetm1b(EUCOMM)Hmgu/H)
|
increased circulating aspartate transaminase level
|
J:211773
|
Dsg1cem1(IMPC)Mbp/Dsg1cem1(IMPC)Mbp
(C57BL/6N-Dsg1cem1(IMPC)Mbp/Ucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dsg2tm1b(EUCOMM)Wtsi/Dsg2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dsg2tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
|
decreased circulating leptin level
|
J:219200
|
Dsttm1b(EUCOMM)Wtsi/Dst+
(C57BL/6N-Dsttm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Dtnbp1sdy/Dtnbp1sdy
(involves: DBA/2J)
|
abnormal platelet physiology
|
J:85123,
J:323340
|
decreased platelet aggregation
|
J:85123
|
increased bleeding time
|
J:1958
|
Dtnbp1sdy/Dtnbp1sdy
(DBA/2J-Dtnbp1sdy/J)
|
increased bleeding time
|
J:14267
|
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dtx1em1(IMPC)H/Dtx1em1(IMPC)H
(C57BL/6N-Dtx1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Dtx3lem1(IMPC)H/Dtx3lem1(IMPC)H
(C57BL/6N-Dtx3lem1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Dtx4em1(IMPC)Ccpcz/Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J)
|
decreased circulating insulin-like growth factor I level
|
J:121821
|
decreased circulating thyroxine level
|
J:121821
|
increased circulating thyroid-stimulating hormone level
|
J:121821
|
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating thyroxine level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dusp1tm1(KOMP)Wtsi/Dusp1tm1(KOMP)Wtsi
(C57BL/6N-Dusp1tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas)
|
abnormal circulating alanine transaminase level
|
J:118832
|
increased blood urea nitrogen level
|
J:118832
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating cholesterol level
|
J:129718
|
decreased circulating free fatty acids level
|
J:129718
|
decreased circulating triglyceride level
|
J:129718
|
increased circulating interleukin-6 level
|
J:118833
|
increased circulating interleukin-10 level
|
J:118833
|
increased circulating tumor necrosis factor level
|
J:118833
|
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating interferon-gamma level
|
J:126383
|
increased circulating interleukin-6 level
|
J:126383
|
increased circulating interleukin-10 level
|
J:126383
|
increased circulating tumor necrosis factor level
|
J:126383
|
Dusp3tm1a(KOMP)Wtsi/Dusp3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Dusp3tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:175295
|
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Dusp4tm1a(EUCOMM)Wtsi/Dusp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Dusp4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
decreased circulating sodium level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Dusp7tm1(KOMP)Wtsi/Dusp7tm1(KOMP)Wtsi
(C57BL/6N-Dusp7tm1(KOMP)Wtsi/Nju)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi)
|
increased circulating interleukin-1 beta level
|
J:301503
|
increased circulating interleukin-6 level
|
J:301503
|
increased circulating tumor necrosis factor level
|
J:301503
|
Dusp11tm1b(EUCOMM)Wtsi/Dusp11tm1b(EUCOMM)Wtsi
(C57BL/6N-Dusp11tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating aspartate transaminase level
|
J:211773
|
Dusp16em1(IMPC)Tcp/Dusp16em1(IMPC)Tcp
(C57BL/6NCrl-Dusp16em1(IMPC)Tcp/Tcp)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Dusp18em1(IMPC)J/Dusp18em1(IMPC)J
(C57BL/6NJ-Dusp18em1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
|
increased circulating interferon-gamma level
|
J:213253
|
increased circulating interleukin-6 level
|
J:213253
|
increased circulating interleukin-17 level
|
J:213253
|
increased circulating tumor necrosis factor level
|
J:213253
|
Dusp26em1Jhxia/Dusp26em1Jhxia Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:279111
|
increased circulating aspartate transaminase level
|
J:279111
|
increased circulating glucose level
|
J:279111
|
increased fasting circulating glucose level
|
J:279111
|
Dusp26tm1a(KOMP)Wtsi/Dusp26tm1a(KOMP)Wtsi
(C57BL/6N-Dusp26tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating magnesium level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Dvl2tm1Awb/Dvl2tm1Awb
(either: 129S6/SvEvTac-Dvl2tm1Awb or (involves: 129S6/SvEvTac * NIH Swiss))
|
cyanosis
|
J:79834
|
Dvl3tm1Awb/Dvl3tm1Awb
(129S6/SvEvTac-Dvl3tm1Awb)
|
cyanosis
|
J:142392
|
Dvl3tm1Awb/Dvl3tm1Awb
(involves: 129S6/SvEvTac * Black Swiss)
|
cyanosis
|
J:142392
|
Dymem1(IMPC)Tcp/Dymem1(IMPC)Tcp
(C57BL/6N-Dymem1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Dync1i2tm1a(EUCOMM)Wtsi/Dync1i2+
(C57BL/6N-Dync1i2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating sodium level
|
J:175295
|
Dynll1tm1(KOMP)Wtsi/Dynll1+
(C57BL/6N-Dynll1tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Dyrk1btm1b(EUCOMM)Wtsi/Dyrk1b+
(C57BL/6N-Dyrk1btm1b(EUCOMM)Wtsi/Ics)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating creatine kinase level
|
J:83126,
J:171870
|
Dytnem1(IMPC)J/Dytnem1(IMPC)J
(C57BL/6NJ-Dytnem1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
E2f1tm1Meg/E2f1tm1Meg E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
decreased circulating growth hormone level
|
J:138289
|
decreased circulating insulin-like growth factor I level
|
J:138289
|
decreased circulating leptin level
|
J:138289
|
decreased circulating triglyceride level
|
J:138289
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating insulin level
|
J:89720
|
decreased circulating glucose level
|
J:89720
|
decreased circulating insulin level
|
J:89720
|
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
abnormal atrial thrombosis
|
J:75765
|
abnormal cardiac thrombosis
|
J:75765
|
E130308A19Rikem1(IMPC)J/E130308A19Rikem1(IMPC)J
(C57BL/6NJ-E130308A19Rikem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
E130311K13Rikem1(IMPC)J/E130311K13Rikem1(IMPC)J
(C57BL/6NJ-E130311K13Rikem1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Ebf1em1(IMPC)Mbp/Ebf1+
(C57BL/6N-Ebf1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating serum albumin level
|
J:211773
|
Ebi3Gt716Lex/Ebi3Gt716Lex Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
abnormal circulating interleukin level
|
J:134148
|
increased circulating interleukin-17 level
|
J:134148
|
Ebi3tm1Nkma/Ebi3tm1Nkma Faslpr/Faslpr
(MRL.Cg-Ebi3tm1Nkma Faslpr)
|
abnormal blood homeostasis
|
J:181669
|
decreased blood urea nitrogen level
|
J:181669
|
decreased circulating creatinine level
|
J:181669
|
decreased circulating interferon-gamma level
|
J:181669
|
increased circulating interleukin-4 level
|
J:181669
|
Ecel1em1Hiki/Ecel1em1Hiki
(involves: C57BL/6)
|
cyanosis
|
J:262090
|
Ecel1tm1Jroh/Ecel1tm1Jroh
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:56300
|
Echdc1em1(IMPC)J/Echdc1em1(IMPC)J
(C57BL/6NJ-Echdc1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:346664
|
increased circulating LDL cholesterol level
|
J:346664
|
increased circulating triglyceride level
|
J:346664
|
increased circulating VLDL cholesterol level
|
J:346664
|
increased circulating VLDL triglyceride level
|
J:346664
|
Eci3tm1b(EUCOMM)Wtsi/Eci3tm1b(EUCOMM)Wtsi
(C57BL/6N-Eci3tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Ecpasem1(IMPC)J/Ecpasem1(IMPC)J
(C57BL/6NJ-Ecpasem1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Ecrg4tm1b(EUCOMM)Hmgu/Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating cholesterol level
|
J:211773
|
Ecscrtm1a(KOMP)Wtsi/Ecscrtm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:236657
|
increased circulating glycerol level
|
J:236657
|
increased circulating triglyceride level
|
J:236657
|
Edc3em1(IMPC)Tcp/Edc3+
(C57BL/6NCrl-Edc3em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Edem1em1(IMPC)Kmpc/Edem1em1(IMPC)Kmpc
(C57BL/6NTac-Edem1em1(IMPC)Kmpc/Kmpc)
|
increased circulating calcium level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Edn1tm1Utj/Edn1+
(involves: 129X1/SvJ * ICR)
|
abnormal blood gas level
|
J:60070
|
Edn1tm1Ywa/Edn1tm1Ywa Tg(Aqp2-cre)1Dek/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating antidiuretic hormone level
|
J:104785
|
decreased circulating sodium level
|
J:104785
|
Edn2tm1.1Nat/Edn2tm1.1Nat Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
acidemia
|
J:201436
|
decreased circulating glucose level
|
J:201436
|
increased circulating bicarbonate level
|
J:201436
|
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac)
|
abnormal blood homeostasis
|
J:201436
|
acidemia
|
J:201436
|
decreased circulating glucose level
|
J:201436
|
decreased circulating triiodothyronine level
|
J:201436
|
increased blood urea nitrogen level
|
J:201436
|
increased blood uric acid level
|
J:201436
|
increased circulating bicarbonate level
|
J:201436
|
increased circulating erythropoietin level
|
J:201436
|
increased circulating ketone body level
|
J:201436
|
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating progesterone level
|
J:215159
|
Ednratm2Ywa/Ednratm2Ywa Tg(Aqp2-cre)1Dek/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating antidiuretic hormone level
|
J:101241
|
Ednrbtm1.1Nrd/Ednrb+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood pH regulation
|
J:226561
|
decreased circulating lactate level
|
J:226561
|
Ednrbtm1Yko/Ednrbtm1Yko Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
abnormal blood homeostasis
|
J:135711
|
Ednrbtm1Ywa/Ednrbs
(involves: 129S/SvEv)
|
abnormal blood gas level
|
J:60070
|
Eea1tm1b(EUCOMM)Hmgu/Eea1tm1b(EUCOMM)Hmgu
(C57BL/6N-Eea1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Eepd1em1(IMPC)J/Eepd1em1(IMPC)J
(C57BL/6NJ-Eepd1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Efcab7em1(IMPC)J/Efcab7em1(IMPC)J
(C57BL/6NJ-Efcab7em1(IMPC)J/Mmjax)
|
decreased circulating total protein level
|
J:211773
|
Efna4tm1.1(KOMP)Vlcg/Efna4tm1.1(KOMP)Vlcg
(C57BL/6N-Efna4tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Efna5tm1b(EUCOMM)Wtsi/Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Egfem1em1(IMPC)J/Egfem1em1(IMPC)J
(C57BL/6NJ-Egfem1em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Egfrtm1Mag/Egfrtm1Mag
(involves: 129S2/SvPas * CD-1)
|
increased blood urea nitrogen level
|
J:26833
|
increased circulating creatinine level
|
J:26833
|
Egfrtm1Msi/Egfrtm1Msi Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating tumor necrosis factor level
|
J:125912
|
Egfrtm1Msi/Egfrtm1Msi Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating tumor necrosis factor level
|
J:125912
|
Egfrtm1Rdk/Egfrtm1Rdk
(involves: 129X1/SvJ * Black Swiss)
|
cyanosis
|
J:41158
|
Egln1Gt(RRG405)Byg/Egln1Gt(RRG405)Byg P4htmtm1Jomy/P4htmtm1Jomy
(Not Specified)
|
decreased circulating erythropoietin level
|
J:213191
|
Egln1tm1Kael/Egln1tm1Kael Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
increased circulating erythropoietin level
|
J:132718
|
Egln1tm2Fong/Egln1tm2Fong Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating erythropoietin level
|
J:132720
|
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss)
|
decreased circulating adrenaline level
|
J:136034
|
decreased circulating noradrenaline level
|
J:136034
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129)
|
abnormal circulating progesterone level
|
J:35132
|
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi)
|
abnormal circulating alanine transaminase level
|
J:128421
|
abnormal circulating tumor necrosis factor level
|
J:128421
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
abnormal circulating alanine transaminase level
|
J:105638
|
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating testosterone level
|
J:45064
|
Egr2tm2(cre)Pch/Egr2+ Phox2btm4Jbr/Phox2b+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
alkalemia
|
J:176573
|
Eh/Eh
(B6By.Cg-Eh/J)
|
cyanosis
|
J:121991
|
Ehd2tm1.1Cbm/Ehd2tm1.1Cbm
(B6N.129(Cg)-Ehd2tm1.1Cbm)
|
decreased circulating free fatty acids level
|
J:285350
|
Ehfem1(IMPC)Kmpc/Ehfem1(IMPC)Kmpc
(C57BL/6NTac-Ehfem1(IMPC)Kmpc/Kmpc)
|
decreased fasting circulating glucose level
|
J:211773
|
Ehhadhtm1b(KOMP)Wtsi/Ehhadhtm1b(KOMP)Wtsi
(C57BL/6NTac-Ehhadhtm1b(KOMP)Wtsi/H)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ)
|
increased circulating free fatty acids level
|
J:207678
|
increased circulating glucose level
|
J:207678
|
increased circulating insulin level
|
J:207678
|
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Nju)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Eid2bem1(IMPC)J/Eid2b+
(C57BL/6NJ-Eid2bem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Eif2ak2em1(IMPC)Mbp/Eif2ak2em1(IMPC)Mbp
(C57BL/6N-Eif2ak2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Eif2ak3tm1.1Drc/Eif2ak3tm1.1Drc Tg(Ela1-cre)16Eps/0
(involves: 129S6/SvEvTac)
|
increased circulating amylase level
|
J:129974
|
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
|
decreased circulating insulin level
|
J:76661
|
hyperglycemia
|
J:76661
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
decreased circulating insulin level
|
J:70005
|
hyperglycemia
|
J:70005
|
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating amino acid level
|
J:92545
|
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc)
|
abnormal circulating amino acid level
|
J:92545
|
Eif2b5tm1a(EUCOMM)Wtsi/Eif2b5+
(C57BL/6N-Eif2b5tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating glucose level
|
J:165965
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating insulin level
|
J:70004
|
hypoglycemia
|
J:70004
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd)
|
hypoglycemia
|
J:144954
|
Eif3kem1(IMPC)Hmgu/Eif3k+
(C57BL/6NCrl-Eif3kem1(IMPC)Hmgu/Ieg)
|
increased circulating total protein level
|
J:211773
|
Eif4e2tm1.1Nso/Eif4e2tm1.1Nso
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:188802
|
Eif4e3tm1a(KOMP)Wtsi/Eif4e3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eif4e3tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating calcium level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c)
|
decreased circulating leptin level
|
J:72217
|
hypoglycemia
|
J:72217
|
Eif4g1em1(IMPC)Hmgu/Eif4g1+
(C57BL/6NCrl-Eif4g1em1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Eif4g2tm1b(KOMP)Wtsi/Eif4g2+
(C57BL/6N-Eif4g2tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Elapor1tm1b(EUCOMM)Hmgu/Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating glucose level
|
J:211773
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
|
increased circulating interleukin-1 beta level
|
J:184388
|
increased circulating interleukin-6 level
|
J:184388
|
increased circulating interleukin-12 level
|
J:184388
|
increased circulating tumor necrosis factor level
|
J:184388
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating interleukin-1 beta level
|
J:184388
|
increased circulating interleukin-6 level
|
J:184388
|
increased circulating interleukin-12 level
|
J:184388
|
increased circulating tumor necrosis factor level
|
J:184388
|
Elavl1tm1b(EUCOMM)Hmgu/Elavl1+
(C57BL/6N-Elavl1tm1b(EUCOMM)Hmgu/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Elk1tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Elk1tm1.1(KOMP)Vlcg/J)
|
increased circulating insulin level
|
J:211773
|
Elk3em1(IMPC)Ics/Elk3+
(C57BL/6N-Elk3em1(IMPC)Ics/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(C57BL/6N-Elk4tm1a(EUCOMM)Wtsi/H)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating fructosamine level
|
J:165965
|
decreased circulating glycerol level
|
J:165965
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating sodium level
|
J:165965
|
Ell2tm1a(EUCOMM)Wtsi/Ell2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ell2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ell2tm1b(EUCOMM)Wtsi/Ell2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ell2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Elmo1tm1a(EUCOMM)Wtsi/Elmo1tm1a(EUCOMM)Wtsi
(C57BL/6N-Elmo1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating glucose level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
increased blood urea nitrogen level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Elntm1Dyl/Eln+
(B6.129-Elntm1Dyl)
|
increased circulating renin level
|
J:86535
|
Elof1tm1.1(KOMP)Vlcg/Elof1+
(B6N(Cg)-Elof1tm1.1(KOMP)Vlcg/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Elovl5em1(IMPC)Tcp/Elovl5em1(IMPC)Tcp
(C57BL/6NCrl-Elovl5em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(B6;129S5-Elovl6Gt(OST222498)Lex/Orl)
|
decreased circulating cholesterol level
|
J:82809
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:130031
|
decreased circulating leptin level
|
J:130031
|
Elovl6tm1b(EUCOMM)Hmgu/Elovl6tm1b(EUCOMM)Hmgu
(C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Elp6em1(IMPC)J/Elp6+
(C57BL/6NJ-Elp6em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Elpt2C57BL/6/Elpt2C57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating leptin level
|
J:142949
|
Elpt3129S6/SvEvTac/Elpt3129S6/SvEvTac
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating leptin level
|
J:142949
|
ElptC57BL/6J/?
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos)
|
increased circulating leptin level
|
J:83539
|
ElptC57BL/6J/ElptC57BL/6J HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos)
|
increased circulating insulin level
|
J:83539
|
Emc4tm1(KOMP)Wtsi/Emc4+
(C57BL/6N-Emc4tm1(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Emc10tm1b(EUCOMM)Wtsi/Emc10tm1b(EUCOMM)Wtsi
(C57BL/6N-Emc10tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Emcnem1(IMPC)Wtsi/Emcnem1(IMPC)Wtsi
(C57BL/6N-Emcnem1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Emdem1(IMPC)Kmpc/Y
(C57BL/6NTac-Emdem1(IMPC)Kmpc/Kmpc)
|
increased circulating phosphate level
|
J:211773
|
Emdem1(IMPC)Kmpc/Emdem1(IMPC)Kmpc
(C57BL/6NTac-Emdem1(IMPC)Kmpc/Kmpc)
|
increased circulating phosphate level
|
J:211773
|
Emg1tm1.1(KOMP)Wtsi/Emg1+
(C57BL/6N-Emg1tm1.1(KOMP)Wtsi/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Emid1tm1a(EUCOMM)Wtsi/Emid1tm1a(EUCOMM)Wtsi
(C57BL/6N-Emid1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
Emilin1tm1Gmb/Emilin1tm1Gmb
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased platelet aggregation
|
J:226863
|
increased prothrombin time
|
J:226863
|
Emilin1tm1Gmb/Emilin1tm1Gmb Emilin2tm1.2Jhp/Emilin2tm1.2Jhp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:226863
|
decreased platelet aggregation
|
J:226863
|
Emilin2tm1.2Jhp/Emilin2tm1.2Jhp
(involves: C57BL/6)
|
abnormal blood coagulation
|
J:226863
|
decreased platelet aggregation
|
J:226863
|
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Eml3em1(IMPC)J/Eml3+
(C57BL/6NJ-Eml3em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
EnamAbte2/Enam+
(C3HeB/FeJ-EnamAbte2)
|
decreased circulating cholesterol level
|
J:220423
|
decreased circulating transferrin level
|
J:220423
|
decreased circulating triglyceride level
|
J:220423
|
Enamabte/Enam+
(C3HeB/FeJ-Enamabte)
|
decreased circulating cholesterol level
|
J:220423
|
decreased circulating transferrin level
|
J:220423
|
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Endovem1(IMPC)Mbp/Endovem1(IMPC)Mbp
(C57BL/6NCrl-Endovem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
increased circulating insulin level
|
J:225402
|
increased circulating triglyceride level
|
J:225402
|
increased fasting circulating glucose level
|
J:225402
|
Enkurem1(IMPC)Mbp/Enkur+
(C57BL/6N-Enkurem1(IMPC)Mbp/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Enpp1asj-2J/Enpp1asj-2J
(BALB/cJ-Enpp1asj-2J/GrsrJ)
|
abnormal circulating calcium level
|
J:215824
|
abnormal circulating mineral level
|
J:215824
|
abnormal circulating phosphate level
|
J:215824
|
decreased circulating phosphate level
|
J:215824
|
Enpp1asj/Enpp1+
(C57BL/6J-Enpp1asj/GrsrJ)
|
decreased circulating phosphate level
|
J:201689
|
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ)
|
decreased circulating phosphate level
|
J:201689
|
Enpp1em1(IMPC)Ccpcz/Enpp1em1(IMPC)Ccpcz
(C57BL/6NCrl-Enpp1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Enpp1ttw/Enpp1ttw
(involves: ICR)
|
decreased circulating phosphate level
|
J:43357
|
Enpp2tm1Lex/Enpp2+
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased circulating interleukin-6 level
|
J:103485
|
decreased circulating tumor necrosis factor level
|
J:103485
|
Enpp4em1(IMPC)Ics/Enpp4em1(IMPC)Ics
(C57BL/6N-Enpp4em1(IMPC)Ics/Ics)
|
increased circulating phosphate level
|
J:211773
|
Enpp5tm1b(KOMP)Mbp/Enpp5tm1b(KOMP)Mbp
(C57BL/6N-Enpp5tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
Ensaem1(IMPC)J/Ensaem1(IMPC)J
(C57BL/6NJ-Ensaem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating glycerol level
|
J:165965
|
Entpd1tm1b(EUCOMM)Wtsi/Entpd1+
(C57BL/6N-Entpd1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating sodium level
|
J:211773
|
Entpd1tm1Djp/Entpd1tm1Djp
(involves: 129 * C57BL/6)
|
abnormal platelet physiology
|
J:76092
|
Entpd1tm1Djp/Entpd1tm1Djp
(B6.129-Entpd1tm1Djp)
|
decreased platelet aggregation
|
J:143010
|
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas)
|
decreased platelet aggregation
|
J:57505
|
increased bleeding time
|
J:57505
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating serum albumin level
|
J:163795
|
hypoglycemia
|
J:163795
|
increased circulating alanine transaminase level
|
J:163795
|
increased circulating alkaline phosphatase level
|
J:163795
|
increased circulating bilirubin level
|
J:163795
|
Entpd6tm1a(KOMP)Wtsi/Entpd6tm1a(KOMP)Wtsi
(C57BL/6N-Entpd6tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Entr1em1(IMPC)Mbp/Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Eomestm1b(EUCOMM)Wtsi/Eomes+
(C57BL/6N-Eomestm1b(EUCOMM)Wtsi/H)
|
decreased circulating creatinine level
|
J:211773
|
Ep300tm1Reck/Ep300+
(involves: 129P2/OlaHsd)
|
cyanosis
|
J:85949
|
Epas1tm1.1Fsl/Epas1tm1.1Fsl
(involves: C57BL/6 * C57BL/6NTac)
|
increased circulating erythropoietin level
|
J:199595
|
Epas1tm1Mcs/Epas1tm1Mcs Hif1atm3Rsjo/Hif1atm3Rsjo Vhltm1Jae/Vhltm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)
|
decreased circulating erythropoietin level
|
J:186085
|
Epas1tm1Mcs/Epas1tm1Mcs Vhltm1Jae/Vhltm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * 129X1/SvJ * CD-1)
|
decreased circulating erythropoietin level
|
J:186085
|
Epas1tm1Pec/Epas1tm1Pec
(involves: 129/Sv * Swiss)
|
cyanosis
|
J:77480
|
Epas1tm1Rus/Epas1tm1Rus
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased circulating noradrenaline level
|
J:50964
|
Epas1tm1Yms/Epas1tm1Yms Tg(Vil1-cre)20Syr/0
(B6.Cg-Epas1tm1Yms Tg(Vil1-cre)20Syr)
|
decreased circulating iron level
|
J:189504
|
Epb41tm1Cnby/Epb41tm1Cnby
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
increased circulating aspartate transaminase level
|
J:77852
|
increased circulating creatine kinase level
|
J:77852
|
Epb41l1tm1b(EUCOMM)Wtsi/Epb41l1tm1b(EUCOMM)Wtsi
(C57BL/6N-Epb41l1tm1b(EUCOMM)Wtsi/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Epb41l4atm1b(KOMP)Mbp/Epb41l4atm1b(KOMP)Mbp
(C57BL/6N-Epb41l4atm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
Epb41l5tm1a(EUCOMM)Hmgu/Epb41l5+
(C57BL/6N-Epb41l5tm1a(EUCOMM)Hmgu/H)
|
decreased circulating glycerol level
|
J:165965
|
Epc1tm1a(EUCOMM)Wtsi/Epc1+
(Not Specified)
|
increased circulating creatine kinase level
|
J:175295
|
EpcamGt(RST556)Byg/EpcamGt(RST556)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thrombosis
|
J:155941
|
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Epha3tm1Abn/Epha3tm1Abn
(involves: 129S1/Sv * 129S1/SvImJ)
|
cyanosis
|
J:119874
|
Epha5tm1b(NCOM)Mfgc/Epha5tm1b(NCOM)Mfgc
(C57BL/6N-Epha5tm1b(NCOM)Mfgc/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Ephb4em1(IMPC)Bay/Ephb4+
(C57BL/6N-Ephb4em1(IMPC)Bay/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
epi/?
(involves: CBA/J)
|
decreased circulating glucose level
|
J:5421
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
hypoglycemia
|
J:173769
|
increased circulating cholesterol level
|
J:173769
|
increased circulating free fatty acids level
|
J:173769
|
increased circulating ketone body level
|
J:173769
|
increased circulating triglyceride level
|
J:173769
|
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:204966
|
Eppinem1(IMPC)Mbp/Eppinem1(IMPC)Mbp
(C57BL/6N-Eppinem1(IMPC)Mbp/MbpMmucd)
|
increased circulating creatinine level
|
J:211773
|
Eps8l2tm1b(EUCOMM)Wtsi/Eps8l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eps8l2tm1b(EUCOMM)Wtsi/H)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eps15tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Eps15tm1c(KOMP)Wtsi/Eps15tm1c(KOMP)Wtsi Eps15l1tm2.1Noff/Eps15l1tm2.1Noff Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
increased circulating iron level
|
J:272122
|
Eps15l1em1(IMPC)J/Eps15l1em1(IMPC)J
(C57BL/6NJ-Eps15l1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Epxtm1b(EUCOMM)Wtsi/Epxtm1b(EUCOMM)Wtsi
(C57BL/6N-Epxtm1b(EUCOMM)Wtsi/Orl)
|
increased circulating triglyceride level
|
J:211773
|
Erap1tm2b(EUCOMM)Wtsi/Erap1tm2b(EUCOMM)Wtsi
(C57BL/6N-Erap1tm2b(EUCOMM)Wtsi/Kmpc)
|
decreased circulating serum albumin level
|
J:211773
|
Erbb2tm4(Erbb2)Mul/Erbb2tm1Haus
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
cyanosis
|
J:94397
|
Erbb3tm1Cbm/Erbb3tm1Cbm
(either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))
|
cyanosis
|
J:43515
|
Erbb3tm2Cbm/Erbb3tm2Cbm
(either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))
|
cyanosis
|
J:43515
|
Erc1tm1b(EUCOMM)Hmgu/Erc1+
(C57BL/6N-Erc1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ercc1tm1Dwm/Ercc1tm1Dwm Tg(Ttr-Ercc1)17Dwm/0
(involves: 129P2/OlaHsd * BALB/c)
|
increased circulating lactate level
|
J:106084
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating glucose level
|
J:117488
|
decreased circulating insulin level
|
J:117488
|
decreased circulating insulin-like growth factor I level
|
J:117488
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating amino acid level
|
J:76608
|
Ercc3tm1b(NCOM)Mfgc/Ercc3+
(C57BL/6N-Ercc3tm1b(NCOM)Mfgc/Tcp)
|
increased circulating potassium level
|
J:211773
|
Ercc5tm2b(EUCOMM)Hmgu/Ercc5+
(C57BL/6N-Ercc5tm2b(EUCOMM)Hmgu/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Ercc6tm1Gvh/Ercc6tm1Gvh Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
|
hypoglycemia
|
J:122013
|
Ercc8em1(IMPC)H/Ercc8em1(IMPC)H
(C57BL/6N-Ercc8em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Erfetm1Lex/Erfetm1Lex
(B6;129S5-Erfetm1Lex/Mmucd)
|
decreased circulating iron level
|
J:211331
|
Erfetm1Lex/Erfetm1Lex Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased circulating iron level
|
J:211331
|
Ergic2em1(IMPC)Hmgu/Ergic2+
(C57BL/6N-Ergic2em1(IMPC)Hmgu/Ieg)
|
increased circulating iron level
|
J:211773
|
Erlin1em1(IMPC)Tcp/Erlin1em1(IMPC)Tcp
(C57BL/6N-Erlin1em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Erlin2tm1a(EUCOMM)Wtsi/Erlin2tm1a(EUCOMM)Wtsi
(C57BL/6N-Erlin2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
Ermnem1(IMPC)H/Ermnem1(IMPC)H
(C57BL/6N-Ermnem1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ermp1tm1.1(KOMP)Vlcg/Ermp1tm1.1(KOMP)Vlcg
(C57BL/6N-Ermp1tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ern1tm1Rjk/Ern1tm2.1Rjk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:171230
|
Ero1bGt(P077G11)Wrst/Ero1b+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1b+ Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc)
|
increased circulating glucose level
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:158805
|
Errfi1tm1.1Jwj/Errfi1tm1.1Jwj
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
cyanosis
|
J:153715
|
Esco1tm1(KOMP)Wtsi/Esco1tm1(KOMP)Wtsi
(C57BL/6N-Esco1tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Espnltm1b(KOMP)Wtsi/Espnltm1b(KOMP)Wtsi
(C57BL/6N-Espnltm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Esr1tm1.1Gust/Esr1tm1.1Gust
(B6.129X1-Esr1tm1.1Gust)
|
increased circulating glucose level
|
J:186230
|
Esr1tm1.1Ics/Esr1tm1.1Ics
(involves: C57BL/6NTac)
|
decreased circulating progesterone level
|
J:206373
|
increased circulating follicle stimulating hormone level
|
J:206373
|
increased circulating luteinizing hormone level
|
J:206373
|
Esr1tm1.1Lja/Esr1+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
decreased circulating progesterone level
|
J:79228
|
Esr1tm1.1Lja/Esr1tm1.1Mma
(involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:128135
|
increased circulating estradiol level
|
J:128135
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating estradiol level
|
J:171276
|
increased circulating luteinizing hormone level
|
J:171276
|
increased circulating testosterone level
|
J:171276
|
Esr1tm1.1Ohl/Esr1tm1.1Ohl
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating estradiol level
|
J:171276
|
increased circulating luteinizing hormone level
|
J:171276
|
increased circulating testosterone level
|
J:171276
|
Esr1tm1.2Awo/Esr1tm1.2Awo Kiss1tm1.1(cre)Uboe/Kiss1+
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating luteinizing hormone level
|
J:167285
|
increased circulating luteinizing hormone level
|
J:167285
|
Esr1tm1.2Awo/Esr1tm1.2Awo Tg(Cga-cre)1Awo/0
(involves: C57BL/6 * SJL)
|
decreased circulating luteinizing hormone level
|
J:152925
|
increased circulating estradiol level
|
J:152925
|
increased circulating luteinizing hormone level
|
J:152925
|
Esr1tm1.2Mma/Esr1tm1.2Mma Tg(Cyp17a1-icre)AJako/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased circulating luteinizing hormone level
|
J:151908
|
increased circulating testosterone level
|
J:151908
|
Esr1tm1Arnal/Esr1tm1Arnal
(involves: C57BL/6)
|
increased circulating estradiol level
|
J:171276
|
increased circulating luteinizing hormone level
|
J:171276
|
increased circulating testosterone level
|
J:171276
|
Esr1tm1Geog/Esr1tm1Geog
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating estradiol level
|
J:135981
|
increased circulating luteinizing hormone level
|
J:135981
|
increased circulating testosterone level
|
J:135981
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:62222,
J:114164
|
decreased circulating osteocalcin level
|
J:62222
|
increased circulating cholesterol level
|
J:66077
|
increased circulating estradiol level
|
J:112080
|
increased circulating HDL cholesterol level
|
J:66077
|
increased circulating leptin level
|
J:66077
|
increased circulating testosterone level
|
J:36658
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased circulating estradiol level
|
J:152738
|
decreased circulating prolactin level
|
J:64639
|
decreased circulating testosterone level
|
J:152738
|
increased circulating estradiol level
|
J:72221
|
increased circulating glucose level
|
J:151012
|
increased circulating testosterone level
|
J:152738
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased circulating estradiol level
|
J:84989
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
increased circulating luteinizing hormone level
|
J:59105
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:62222
|
decreased circulating osteocalcin level
|
J:62222
|
increased circulating cholesterol level
|
J:66077
|
increased circulating HDL cholesterol level
|
J:66077
|
increased circulating leptin level
|
J:66077
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased circulating follicle stimulating hormone level
|
J:84989
|
Esr1tm1Ksk/Esr1tm1Ksk Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased circulating follicle stimulating hormone level
|
J:84989
|
decreased circulating luteinizing hormone level
|
J:84989
|
increased circulating estradiol level
|
J:84989
|
Esr1tm1Syeh/Esr1tm1Syeh Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129X1/SvJ * FVB/N)
|
increased circulating testosterone level
|
J:147000
|
Esr1tm2Ksk/Esr1tm2Ksk
(involves: C57BL/6)
|
increased circulating luteinizing hormone level
|
J:118736
|
Esr1tm3.1Ksk/Esr1tm3.1Ksk
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating estradiol level
|
J:176459
|
Esr1tm4.2Ksk/Esr1tm4.2Ksk
(involves: C57BL/6 * C57BL/6NTac * CBA)
|
increased circulating luteinizing hormone level
|
J:191182
|
increased circulating testosterone level
|
J:191182
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating insulin-like growth factor I level
|
J:110416
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating luteinizing hormone level
|
J:118736
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
decreased circulating glucose level
|
J:151012
|
increased circulating glucose level
|
J:151012
|
Esrp2tm1(KOMP)Vlcg/Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating serum albumin level
|
J:228040
|
Esrratm1.1(KOMP)Vlcg/Esrratm1.1(KOMP)Vlcg
(C57BL/6N-Esrratm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Esrrgtm1Rev/Esrrgtm1Rev
(either: (involves: 129) or (involves: C57BL/6) or (involves: ICR))
|
increased circulating lactate level
|
J:129851
|
Esyt3tm1b(EUCOMM)Wtsi/Esyt3tm1b(EUCOMM)Wtsi
(C57BL/6N-Esyt3tm1b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Ethe1tm1.1Zev/Ethe1tm1.1Zev
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal blood homeostasis
|
J:146537
|
increased circulating lactate level
|
J:146537
|
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood uric acid level
|
J:211773
|
Etv6em3Knic/Etv6+
(involves: C57BL/6J)
|
impaired blood coagulation
|
J:342774
|
Evc2em1(IMPC)Mbp/Evc2em1(IMPC)Mbp
(C57BL/6N-Evc2em1(IMPC)Mbp/MbpMmucd)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Evi5tm1a(KOMP)Wtsi/Evi5tm1a(KOMP)Wtsi
(C57BL/6N-Evi5tm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Evltm1b(KOMP)Wtsi/Evltm1b(KOMP)Wtsi
(C57BL/6N-Evltm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Ewsr1tm1b(EUCOMM)Wtsi/Ewsr1+
(C57BL/6N-Ewsr1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Exoc3tm2b(EUCOMM)Hmgu/Exoc3+
(C57BL/6N-Exoc3tm2b(EUCOMM)Hmgu/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Exoc3tm2c(EUCOMM)Hmgu/Exoc3tm2c(EUCOMM)Hmgu Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * C57BL/6N)
|
abnormal platelet physiology
|
J:302300
|
abnormal thrombosis
|
J:302300
|
decreased bleeding time
|
J:302300
|
decreased platelet aggregation
|
J:302300
|
decreased platelet dense granule secretion
|
J:302300
|
increased platelet dense granule secretion
|
J:302300
|
increased susceptibility to induced thrombosis
|
J:302300
|
Exoc3l2em1(IMPC)J/Exoc3l2+
(C57BL/6N-Exoc3l2em1(IMPC)J/J)
|
increased circulating serum albumin level
|
J:211773
|
Exoc3l2tm1b(KOMP)Wtsi/Exoc3l2+
(C57BL/6N-Exoc3l2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Exoc4em1(IMPC)J/Exoc4+
(C57BL/6NJ-Exoc4em1(IMPC)J/J)
|
increased circulating sodium level
|
J:211773
|
Exoc6hbd/Exoc6hbd
(AB.Cg-Exoc6hbd)
|
increased circulating iron level
|
J:8251
|
Exoc6tm1b(EUCOMM)Wtsi/Exoc6+
(C57BL/6N-Exoc6tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Exoc6bem1(IMPC)Hmgu/Exoc6b+
(C57BL/6NCrl-Exoc6bem1(IMPC)Hmgu/Ieg)
|
decreased circulating glucose level
|
J:211773
|
Exosc3tm1.1(KOMP)Vlcg/Exosc3+
(C57BL/6N-Exosc3tm1.1(KOMP)Vlcg/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Exosc8tm1.1(KOMP)Vlcg/Exosc8+
(C57BL/6N-Exosc8tm1.1(KOMP)Vlcg/J)
|
increased circulating insulin level
|
J:211773
|
Exph5tm1b(EUCOMM)Wtsi/Exph5tm1b(EUCOMM)Wtsi
(C57BL/6N-Exph5tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating potassium level
|
J:211773
|
Extl1em1Caox/Extl1em1Caox Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA)
|
increased circulating interleukin-6 level
|
J:333437
|
increased circulating interleukin-17 level
|
J:333437
|
increased circulating tumor necrosis factor level
|
J:333437
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased circulating insulin level
|
J:148348
|
Eya1bor/Eya1bor
(C3HeB/FeJ-Eya1bor)
|
increased blood urea nitrogen level
|
J:54408
|
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju)
|
increased circulating glucose level
|
J:211773
|
Ezh2tm1a(EUCOMM)Wtsi/Ezh2+
(C57BL/6N-Ezh2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:175295
|
F2tm1b(EUCOMM)Hmgu/F2+
(C57BL/6N-F2tm1b(EUCOMM)Hmgu/H)
|
increased circulating fructosamine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
F2tm1Jld/F2tm1Sjd
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal blood coagulation
|
J:144572
|
increased bleeding time
|
J:144572
|
F2tm1Jld/F2tm1Sjd Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal blood coagulation
|
J:144572
|
increased bleeding time
|
J:144572
|
F2tm1Sjd/F2tm1Sjd
(involves: 129P2/OlaHsd * Black Swiss)
|
impaired blood coagulation
|
J:48273
|
F2tm2Jld/F2+
(B6.129P2-F2tm2Jld)
|
abnormal circulating protein level
|
J:174629
|
decreased susceptibility to induced thrombosis
|
J:174629
|
increased bleeding time
|
J:174629
|
F2rtm1Ajc/F2rtm1Ajc
(B6.129S4-F2rtm1Ajc)
|
abnormal circulating protein level
|
J:217458
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-18 level
|
J:102762
|
F2rl2tm1Cgh/F2rl2tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal platelet physiology
|
J:49283
|
decreased susceptibility to induced thrombosis
|
J:80154
|
increased bleeding time
|
J:80154
|
F2rl3tm1.1Cgh/F2rl3tm1.1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to induced thrombosis
|
J:80154
|
increased bleeding time
|
J:80154
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal blood coagulation
|
J:91165
|
decreased circulating interleukin-1 beta level
|
J:91165
|
decreased circulating interleukin-6 level
|
J:91165
|
decreased circulating tumor necrosis factor level
|
J:91165
|
F3tm1Dco/F3tm1Dco Tg(F3)1Nmk/0
(B6.Cg-F3tm1Dco Tg(F3)1Nmk)
|
abnormal blood coagulation
|
J:88245
|
F3tm1Dwr/F3+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood coagulation
|
J:99260
|
abnormal thrombosis
|
J:99260
|
decreased partial thromboplastin time
|
J:99260
|
increased circulating factor IX level
|
J:99260
|
increased circulating factor VIII level
|
J:99260
|
increased circulating factor XI level
|
J:99260
|
F3tm1Dwr/F3tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal atrial thrombosis
|
J:99260
|
abnormal cardiac thrombosis
|
J:99260
|
abnormal thrombosis
|
J:99260
|
abnormal ventricular thrombosis
|
J:99260
|
F3tm1Fct/F3tm1Fct
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal blood coagulation
|
J:216519
|
F3tm1Jld/F3+
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
abnormal blood coagulation
|
J:33831
|
F5tm2Dgi/F5+
(B6.129S2-F5tm2Dgi)
|
abnormal blood coagulation
|
J:66260
|
abnormal thrombosis
|
J:66260
|
F5tm2Dgi/F5tm2Dgi
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:66260
|
abnormal thrombosis
|
J:66260
|
F5tm2Dgi/F5tm2Dgi
(B6.129S2-F5tm2Dgi)
|
abnormal blood coagulation
|
J:66260
|
F5tm2Dgi/F5tm2Dgi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thrombosis
|
J:62716
|
F5tm2Dgi/F5tm2Dgi Proztm1Gjb/Proz+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal thrombosis
|
J:62716
|
F5tm2Dgi/F5tm2Dgi Proztm1Gjb/Proztm1Gjb
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal thrombosis
|
J:62716
|
F7tm1(tTA,tetO-F7)Edr/F7tm1(tTA,tetO-F7)Edr
(B6.129X1-F7tm1(tTA,tetO-F7)Edr)
|
abnormal blood coagulation
|
J:144540
|
abnormal circulating protein level
|
J:144540
|
increased partial thromboplastin time
|
J:144540
|
increased prothrombin time
|
J:144540
|
F7tm1Pec/F7+ Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:61481
|
F7tm1Pec/F7+ Tfpitm1Gjb/Tfpitm1Gjb
(involves: 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:89395
|
F7tm1Pec/F7tm1Pec Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:61481
|
F8tm1.1Rmnt/F8tm1.1Rmnt Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca * SJL)
|
decreased circulating factor VIII level
|
J:212401
|
F8tm1.1Rmnt/F8tm1.1Rmnt Tg(Cdh5-cre)7Mlia/0
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
decreased circulating factor VIII level
|
J:212401
|
F8tm1.1Rmnt/F8tm1.1Rmnt Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * SJL)
|
decreased circulating factor VIII level
|
J:212401
|
F8tm1Kaz/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood coagulation
|
J:24941,
J:36698
|
F8tm1Kaz/F8tm1Kaz
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood coagulation
|
J:36698
|
F8tm2Kaz/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood coagulation
|
J:24941,
J:36698
|
F8tm2Kaz/Y
(involves: 129S4/SvJae)
|
abnormal blood coagulation
|
J:176909
|
F8tm2Kaz/Y Tg(Alb-F8)EBmre/0
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal blood coagulation
|
J:176909
|
F9em1Dlli/Y
(involves: C57BL/6J)
|
increased partial thromboplastin time
|
J:262204
|
F9em3Dlli/Y
(involves: C57BL/6J)
|
abnormal blood coagulation
|
J:262204
|
increased partial thromboplastin time
|
J:262204
|
F9tm1Dws/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:44497
|
F9tm1Dws/Y
(involves: 129P2/OlaHsd)
|
abnormal blood coagulation
|
J:166332
|
increased bleeding time
|
J:166332
|
F9tm1Dws/F9tm1Dws
(involves: 129P2/OlaHsd)
|
abnormal blood coagulation
|
J:166332
|
increased bleeding time
|
J:166332
|
F9tm1Emg/Y
(involves: 129S/SvEv * C57BL/6J)
|
abnormal blood coagulation
|
J:48501
|
increased bleeding time
|
J:48501
|
F9tm1Emg/F9+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal blood coagulation
|
J:48501
|
F9tm1Ver/F9tm1Ver
(involves: 129/Sv * C57BL/6)
|
abnormal blood coagulation
|
J:43590
|
increased bleeding time
|
J:43590
|
F9tm2(F9)Dws/F9tm2(F9)Dws
(involves: 129S6/SvEvTac * C57BL/6)
|
increased bleeding time
|
J:92964
|
F9tm3Dws/Y
(B6.129P2-F9tm3Dws)
|
abnormal blood coagulation
|
J:166332
|
increased bleeding time
|
J:166332
|
F9tm3Dws/F9tm3Dws
(B6.129P2-F9tm3Dws)
|
increased bleeding time
|
J:166332
|
F10tm1b(EUCOMM)Hmgu/F10+
(C57BL/6N-F10tm1b(EUCOMM)Hmgu/H)
|
decreased circulating creatinine level
|
J:211773
|
F10tm1Ccmt/F10tm1Ccmt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased bleeding time
|
J:145092
|
F11tm1Gjb/F11tm1Gjb
(involves: 129X1/SvJ * C57BL/6)
|
decreased platelet aggregation
|
J:100529
|
increased partial thromboplastin time
|
J:40270
|
F11tm1Gjb/F11tm1Gjb Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thrombosis
|
J:67398
|
F12tm1Fjc/F12tm1Fjc
(involves: 129X1/SvJ * C57BL/6)
|
increased partial thromboplastin time
|
J:238837
|
F13a1tm1Akic/F13a1tm1Akic
(involves: 129P2/OlaHsd * Black Swiss)
|
increased bleeding time
|
J:222849
|
F13a1tm1Gdi/F13a1tm1Gdi
(involves: 129P2/OlaHsd * CBA/Ca)
|
abnormal blood coagulation
|
J:87293
|
increased bleeding time
|
J:87293
|
F13btm1Akic/F13btm1Akic
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased bleeding time
|
J:222849
|
Fa2hem1(IMPC)Mbp/Fa2hem1(IMPC)Mbp
(C57BL/6NCrl-Fa2hem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Faahem1(IMPC)H/Faahem1(IMPC)H
(C57BL/6NTac-Faahem1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Faap100em1Jzc/Faap100em1Jzc
(involves: C57BL/6J * ICR)
|
increased circulating follicle stimulating hormone level
|
J:339060
|
Fabp1tm1b(EUCOMM)Hmgu/Fabp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fabp1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating bilirubin level
|
J:211773
|
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:87278
|
Fabp2em1(IMPC)Hmgu/Fabp2em1(IMPC)Hmgu
(C57BL/6N-Fabp2em1(IMPC)Hmgu/Ieg)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto)
|
abnormal circulating lipid level
|
J:64975
|
decreased circulating cholesterol level
|
J:64975
|
increased circulating glycerol level
|
J:64975
|
increased circulating insulin level
|
J:64975
|
increased circulating leptin level
|
J:64975
|
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating glucose level
|
J:167535
|
increased circulating free fatty acids level
|
J:167535
|
increased circulating triglyceride level
|
J:167535
|
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
hypoglycemia
|
J:54614
|
increased circulating free fatty acids level
|
J:54614
|
Fabp3tm1Jshr/Fabp3+
(B6.129-Fabp3tm1Jshr)
|
decreased circulating glucose level
|
J:102858
|
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating insulin level
|
J:57864
|
decreased circulating triglyceride level
|
J:37027
|
hypoglycemia
|
J:37027
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota)
|
decreased circulating glucose level
|
J:111878
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:217245
|
increased circulating free fatty acids level
|
J:217245
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
decreased circulating cholesterol level
|
J:111878
|
decreased circulating glucose level
|
J:111878
|
decreased circulating insulin level
|
J:111878
|
decreased circulating triglyceride level
|
J:111878
|
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota)
|
decreased circulating glucose level
|
J:81609
|
decreased circulating leptin level
|
J:81609
|
Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(involves: 129 * C57BL/6J * C57BL/10J * SJL)
|
decreased circulating glucose level
|
J:81609
|
increased circulating insulin level
|
J:81609
|
Fabp6tm1Lbal/Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal)
|
decreased circulating cholesterol level
|
J:195544
|
decreased circulating triglyceride level
|
J:195544
|
Faddtm1Mpa/Faddtm1Mpa Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating alanine transaminase level
|
J:118336
|
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
abnormal circulating lipid level
|
J:186265
|
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Fads2tm1Wst/Fads2tm1Wst
(involves: 129P2/OlaHsd)
|
abnormal platelet physiology
|
J:140341
|
decreased platelet aggregation
|
J:140341
|
decreased susceptibility to induced thrombosis
|
J:140341
|
increased bleeding time
|
J:140341
|
Fads3tm1b(EUCOMM)Hmgu/Fads3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fads3tm1b(EUCOMM)Hmgu/Wtsi)
|
decreased circulating phosphate level
|
J:211773
|
Fads6tm1b(EUCOMM)Wtsi/Fads6tm1b(EUCOMM)Wtsi
(C57BL/6N-Fads6tm1b(EUCOMM)Wtsi/Ieg)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Faf1em1(IMPC)H/Faf1em1(IMPC)H
(C57BL/6NTac-Faf1em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Faf2tm1Tfji/Faf2tm1Tfji Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * CBA * DBA)
|
decreased circulating free fatty acids level
|
J:235325
|
decreased circulating phospholipid level
|
J:235325
|
decreased circulating triglyceride level
|
J:235325
|
decreased circulating VLDL triglyceride level
|
J:235325
|
increased circulating alkaline phosphatase level
|
J:235325
|
increased circulating aspartate transaminase level
|
J:235325
|
increased circulating phospholipid level
|
J:235325
|
Fahtm1Mgo/Fahtm1Mgo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal circulating aspartate transaminase level
|
J:16046
|
hypoglycemia
|
J:16046
|
increased circulating creatinine level
|
J:16046
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT)
|
increased circulating tyrosine level
|
J:77295
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
|
abnormal circulating amino acid level
|
J:27735
|
increased circulating aspartate transaminase level
|
J:27735
|
increased circulating bilirubin level
|
J:27735
|
increased circulating tyrosine level
|
J:27735
|
Fahtm1Mgo/Fahtm1Mgo Hgdaku/Hgd+
(involves: 129S7/SvEvBrd * NB)
|
increased circulating tyrosine level
|
J:77295
|
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating alanine transaminase level
|
J:164184
|
Fam3aem1Cya/Fam3aem1Cya
(involves: C57BL/6)
|
increased circulating alanine transaminase level
|
J:295206
|
increased circulating aspartate transaminase level
|
J:295206
|
increased circulating glutamate dehydrogenase level
|
J:295206
|
Fam3btm1Bkht/Fam3btm1Bkht
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:167823
|
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
|
increased circulating free fatty acids level
|
J:258290
|
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal circulating protein level
|
J:185208
|
decreased circulating phosphate level
|
J:185208
|
increased circulating parathyroid hormone level
|
J:185208
|
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi Tg(Col1a1-cre)2Bek/0
(involves: 129S6/SvEvTac * CD-1)
|
decreased circulating phosphate level
|
J:225679
|
Fam20ctm1Lex/Fam20ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating calcium level
|
J:186384
|
decreased circulating phosphate level
|
J:186384
|
increased circulating alkaline phosphatase level
|
J:186384
|
Fam43aem1(IMPC)J/Fam43aem1(IMPC)J
(C57BL/6NJ-Fam43aem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Fam53aem1(IMPC)Ccpcz/Fam53aem1(IMPC)Ccpcz
(C57BL/6N-Fam53aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Fam53btm1b(EUCOMM)Hmgu/Fam53btm1b(EUCOMM)Hmgu
(C57BL/6N-Fam53btm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating fructosamine level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
(C57BL/6N-Fam72atm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
Fam81bem1(IMPC)J/Fam81bem1(IMPC)J
(C57BL/6NJ-Fam81bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fam83gtm1a(EUCOMM)Wtsi/Fam83gtm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Fam83hem1(IMPC)Ccpcz/Fam83hem1(IMPC)Ccpcz
(C57BL/6N-Fam83hem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
Fam83hem2(IMPC)Ccpcz/Fam83h+
(C57BL/6NCrl-Fam83hem2(IMPC)Ccpcz/Ccpcz)
|
increased circulating glucose level
|
J:211773
|
Fam110btm1a(EUCOMM)Wtsi/Fam110b+
(C57BL/6N-Fam110btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased blood urea nitrogen level
|
J:165965
|
Fam114a1em1(IMPC)J/Fam114a1em1(IMPC)J
(C57BL/6NJ-Fam114a1em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Fam117btm1a(EUCOMM)Wtsi/Fam117btm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased blood urea nitrogen level
|
J:165965
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Fam120aem1(IMPC)J/Fam120aem1(IMPC)J
(C57BL/6NJ-Fam120aem1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fam120cem1(IMPC)Ccpcz/Y
(C57BL/6NCrl-Fam120cem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
Fam161atm1b(KOMP)Wtsi/Fam161atm1b(KOMP)Wtsi
(C57BL/6N-Fam161atm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Fam168aem1(IMPC)J/Fam168aem1(IMPC)J
(C57BL/6NJ-Fam168aem1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Fam171a1em1(IMPC)J/Fam171a1em1(IMPC)J
(C57BL/6NJ-Fam171a1em1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
Fam184btm2b(EUCOMM)Wtsi/Fam184btm2b(EUCOMM)Wtsi
(C57BL/6N-Fam184btm2b(EUCOMM)Wtsi/Tcp)
|
increased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Fam185aem1(IMPC)Ccpcz/Fam185aem1(IMPC)Ccpcz
(C57BL/6N-Fam185aem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fam199xem1(IMPC)Mbp/Fam199xem1(IMPC)Mbp
(C57BL/6N-Fam199xem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Fam210atm1b(EUCOMM)Wtsi/Fam210a+
(C57BL/6N-Fam210atm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Fam210btm1b(KOMP)Mbp/Fam210btm1b(KOMP)Mbp
(C57BL/6N-Fam210btm1b(KOMP)Mbp/Ucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Fam217btm1.1(KOMP)Vlcg/Fam217btm1.1(KOMP)Vlcg
(C57BL/6N-Fam217btm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating glucose level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Fam222aem1(IMPC)J/Fam222aem1(IMPC)J
(C57BL/6NJ-Fam222aem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Fam234btm1a(EUCOMM)Wtsi/Fam234btm1a(EUCOMM)Wtsi
(C57BL/6N-Fam234btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating calcium level
|
J:165965
|
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi)
|
increased blood urea nitrogen level
|
J:242198
|
Fancd2em1(IMPC)Hmgu/Fancd2+
(C57BL/6NCrl-Fancd2em1(IMPC)Hmgu/Ieg)
|
increased circulating iron level
|
J:211773
|
Fancftm1Nki/Fancftm1Nki
(involves: 129P2/OlaHsd * FVB)
|
increased circulating follicle stimulating hormone level
|
J:180025
|
increased circulating luteinizing hormone level
|
J:180025
|
Fanclgcd/Fanclgcd
(involves: C57BL/6J * CBA/J)
|
increased circulating follicle stimulating hormone level
|
J:13553
|
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Farp1tm1b(EUCOMM)Hmgu/Farp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Farp1tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Farp2tm1a(KOMP)Wtsi/Farp2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Farp2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:175295
|
Fars2em1(IMPC)J/Fars2+
(C57BL/6NJ-Fars2em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Farsatm2a(EUCOMM)Wtsi/Farsa+
(C57BL/6N-Farsatm2a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating sodium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal circulating protein level
|
J:27634
|
increased circulating serum albumin level
|
J:28885
|
increased circulating total protein level
|
J:28885
|
Faslpr/Faslpr
(MRL-Faslpr)
|
increased blood urea nitrogen level
|
J:126261
|
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL)
|
increased blood urea nitrogen level
|
J:45448
|
Faslpr/Faslpr Ifngtm1Ts/Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr)
|
increased blood urea nitrogen level
|
J:123834
|
Faslpr/Faslpr Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased circulating creatinine level
|
J:39600
|
Faslpr/Faslpr Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)
|
decreased circulating creatinine level
|
J:39600
|
Faslpr/Faslpr Il27ratm1Mak/Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr)
|
decreased blood urea nitrogen level
|
J:122148
|
decreased circulating creatinine level
|
J:122148
|
increased circulating interleukin-4 level
|
J:122148
|
increased circulating interleukin-5 level
|
J:122148
|
Faslpr/Faslpr Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * MRL)
|
abnormal blood homeostasis
|
J:42666
|
Faslpr/Faslpr Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * MRL)
|
increased blood urea nitrogen level
|
J:45448
|
Faslpr/Faslpr Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased circulating interferon-alpha level
|
J:113557
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
decreased circulating alanine transaminase level
|
J:135830
|
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:153501
|
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:153501
|
Fasntm1Sem/Fasntm1Sem Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal blood homeostasis
|
J:127793
|
decreased circulating cholesterol level
|
J:127793
|
decreased circulating glucose level
|
J:127793
|
decreased circulating insulin level
|
J:127793
|
increased circulating free fatty acids level
|
J:127793
|
increased circulating glucagon level
|
J:127793
|
Fasntm1Sem/Fasntm1Sem Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating free fatty acids level
|
J:127482
|
increased circulating glucose level
|
J:127482
|
increased circulating insulin level
|
J:127482
|
increased circulating triglyceride level
|
J:127482
|
Fastkd5em1(IMPC)J/Fastkd5em1(IMPC)J
(C57BL/6NJ-Fastkd5em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fbgl1KK/Ta/Fbgl1KK/Ta
(involves: BALB/c * KK/Ta)
|
hyperglycemia
|
J:88209
|
Fbgl2KK/Ta/Fbgl2KK/Ta
(involves: BALB/c * KK/Ta)
|
hyperglycemia
|
J:88209
|
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to induced thrombosis
|
J:96831
|
Fbln7tm1.1Hiya/Fbln7tm1.1Hiya
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating creatinine level
|
J:271278
|
increased blood urea nitrogen level
|
J:271278
|
Fbn1em1Chop/Fbn1+
(C57BL/6-Fbn1em1Chop)
|
decreased circulating leptin level
|
J:251851
|
Fbn1tm1Rmz/Fbn1tm1Rmz
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal arterial thrombosis
|
J:43199
|
Fbn2em1(IMPC)Rbrc/Fbn2em1(IMPC)Rbrc
(C57BL/6NJcl-Fbn2em1(IMPC)Rbrc/Rbrc)
|
decreased circulating amylase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fbp1m1Btlr/Fbp1m1Btlr
(C57BL/6J-Fbp1m1Btlr)
|
hypoglycemia
|
J:267693
|
Fbrsem1(IMPC)J/Fbrs+
(C57BL/6NJ-Fbrsem1(IMPC)J/Mmjax)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Fbxl3em1(IMPC)Ccpcz/Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fbxl5tm1Kei/Fbxl5tm1Kei Ireb2tm1Roua/Ireb2tm1Roua
(B6.129-Fbxl5tm1Kei Ireb2tm1Roua)
|
decreased circulating unsaturated transferrin level
|
J:176655
|
increased circulating iron level
|
J:176655
|
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
abnormal blood coagulation
|
J:176655
|
abnormal circulating enzyme level
|
J:176655
|
decreased circulating unsaturated transferrin level
|
J:176655
|
increased circulating alanine transaminase level
|
J:176655
|
increased circulating aspartate transaminase level
|
J:176655
|
increased circulating iron level
|
J:176655
|
increased circulating lactate dehydrogenase level
|
J:176655
|
increased partial thromboplastin time
|
J:176655
|
increased prothrombin time
|
J:176655
|
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Fbxo2tm1b(EUCOMM)Wtsi/Fbxo2tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo2tm1b(EUCOMM)Wtsi/Nju)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbxo7tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating iron level
|
J:272313
|
increased circulating bilirubin level
|
J:272313
|
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Fbxo11tm2b(EUCOMM)Wtsi/Fbxo11+
(C57BL/6N-Fbxo11tm2b(EUCOMM)Wtsi/H)
|
decreased circulating iron level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fbxo30tm1b(KOMP)Wtsi/Fbxo30+
(C57BL/6N-Fbxo30tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Fbxo33tm1b(EUCOMM)Wtsi/Fbxo33tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo33tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Fbxo41tm1.1(KOMP)Vlcg/Fbxo41tm1.1(KOMP)Vlcg
(C57BL/6N-Fbxo41tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Fbxo42em1(IMPC)J/Fbxo42+
(C57BL/6NJ-Fbxo42em1(IMPC)J/Mmjax)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Fbxo48em1(IMPC)J/Fbxo48em1(IMPC)J
(C57BL/6NJ-Fbxo48em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai Tg(Amh-cre)8815Reb/0
(involves: 129 * C57BL/6 * C57BL/6J * FVB/N)
|
decreased circulating testosterone level
|
J:289161
|
Fbxw8Gt(RRT057)Byg/Fbxw8Gt(RRT057)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:130238
|
Fbxw8tm1b(EUCOMM)Hmgu/Fbxw8+
(C57BL/6N-Fbxw8tm1b(EUCOMM)Hmgu/Nju)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Fbxw15em1(IMPC)Ccpcz/Fbxw15em1(IMPC)Ccpcz
(C57BL/6N-Fbxw15em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating phosphate level
|
J:211773
|
Fbxw18em1(IMPC)Ccpcz/Fbxw18+
(C57BL/6N-Fbxw18em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating sodium level
|
J:211773
|
Fcer1atm1Ftl/Fcer1atm1Ftl
(CBy.129S2-Fcer1atm1Ftl)
|
decreased circulating interleukin-4 level
|
J:120702
|
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c)
|
reduced thrombolysis
|
J:47138
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet activation
|
J:118488
|
decreased platelet aggregation
|
J:112819
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd)
|
decreased platelet aggregation
|
J:165893
|
Fcgbptm1b(EUCOMM)Wtsi/Fcgbptm1b(EUCOMM)Wtsi
(C57BL/6N-Fcgbptm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N)
|
abnormal glomerular capillary thrombosis
|
J:179175
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk)
|
abnormal glomerular capillary thrombosis
|
J:179175
|
Fcgr3tm1b(EUCOMM)Hmgu/Fcgr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fcgr3tm1b(EUCOMM)Hmgu/H)
|
decreased circulating creatine kinase level
|
J:211773
|
Fcgr4tm1Rav/Fcgr4tm1Rav Tg(Ctsk-cre)1Rda/0
(involves: C57BL/6)
|
abnormal circulating protein level
|
J:197378
|
Fcgrttm1Dcr/Fcgrttm1Dcr
(B6.129X1-Fcgrttm1Dcr/DcrJ)
|
decreased circulating serum albumin level
|
J:110885
|
Fcgrttm1Dcr/Fcgrttm1Dcr Tg(CAG-FCGRT)276Dcr/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
increased circulating serum albumin level
|
J:110885
|
Fcgrttm1Esw/Fcgrttm1Esw Tg(Tek-cre)1Ywa/0
(B6.Cg-Tg(Tek-cre)1Ywa Fcgrttm1Esw)
|
decreased circulating serum albumin level
|
J:146640
|
Fcho2tm1b(EUCOMM)Hmgu/Fcho2+
(C57BL/6N-Fcho2tm1b(EUCOMM)Hmgu/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Fcmrtm1.2Khl/Fcmrtm1.2Khl
(involves: C57BL/6)
|
decreased circulating alanine transaminase level
|
J:174871
|
Fcrl2em1(IMPC)H/Fcrl2em1(IMPC)H
(C57BL/6NTac-Fcrl2em1(IMPC)H/H)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Fdxacb1tm1.1(KOMP)Vlcg/Fdxacb1tm1.1(KOMP)Vlcg
(C57BL/6N-Fdxacb1tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c)
|
abnormal circulating enzyme level
|
J:2021
|
increased circulating alkaline phosphatase level
|
J:2021
|
increased circulating bilirubin level
|
J:2021
|
Fechm1Pas/Fechtm1.1(FECH*)Emi
(involves: 129 * BALB/cJ * C57BL/6J)
|
increased circulating bilirubin level
|
J:239515
|
Fermt3tm1.1Efp/Fermt3tm1.1Efp
(involves: C57BL/6)
|
abnormal platelet activation
|
J:227094
|
abnormal platelet physiology
|
J:227094
|
decreased platelet aggregation
|
J:227094
|
decreased susceptibility to induced thrombosis
|
J:227094
|
increased bleeding time
|
J:227094
|
Fermt3tm1Ref/Fermt3tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet activation
|
J:133659
|
abnormal thrombosis
|
J:133659
|
decreased platelet aggregation
|
J:133659
|
increased bleeding time
|
J:133659
|
Fezf2em1(IMPC)Hmgu/Fezf2em1(IMPC)Hmgu
(C57BL/6NCrl-Fezf2em1(IMPC)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Ffal1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating free fatty acids level
|
J:84091
|
Ffaq2NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating free fatty acids level
|
J:138463
|
Ffaq3NZB/BlNJ/Ffaq3NZB/BlNJ Ffaq4NZB/BlNJ/Ffaq4NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating free fatty acids level
|
J:138463
|
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating hormone level
|
J:141957
|
abnormal circulating insulin level
|
J:141957
|
decreased circulating glucagon level
|
J:141957
|
decreased circulating triglyceride level
|
J:141957
|
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified)
|
abnormal circulating triglyceride level
|
J:129843
|
decreased circulating insulin level
|
J:129843
|
Ffar1tm1Lex/Ffar1tm1Lex
(involves: C57BL/6 * C57BL/6J)
|
increased circulating glucose level
|
J:200805
|
Ffar2tm1b(EUCOMM)Hmgu/Ffar2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ffar2tm1b(EUCOMM)Hmgu/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ffar2tm1Fmgb/Ffar2tm1Fmgb
(involves: 129S/SvEv)
|
decreased circulating insulin level
|
J:191508
|
Ffar2tm1Lex/Ffar2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal circulating free fatty acids level
|
J:138134
|
Ffar2tm1Soff/Ffar2tm1Soff
(B6.129-Ffar2tm1Soff)
|
increased circulating insulin level
|
J:227939
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:157383
|
increased circulating tumor necrosis factor level
|
J:157383
|
Ffar2tm2Soff/Ffar2tm2Soff Ffar3tm2.1Soff/Ffar3tm2.1Soff Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating free fatty acids level
|
J:227939
|
increased circulating insulin level
|
J:227939
|
Ffar3tm1Gzt/Ffar3tm1Gzt
(involves: C57BL/6)
|
decreased circulating noradrenaline level
|
J:172798
|
increased circulating ketone body level
|
J:172798
|
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating leptin level
|
J:143567
|
Ffar3tm1Soff/Ffar3tm1Soff
(B6.129-Ffar3tm1Soff)
|
increased circulating insulin level
|
J:227939
|
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
|
increased circulating alanine transaminase level
|
J:182599
|
increased circulating cholesterol level
|
J:182599
|
increased circulating glucose level
|
J:182599
|
increased circulating HDL cholesterol level
|
J:182599
|
increased circulating insulin level
|
J:182599
|
increased circulating LDL cholesterol level
|
J:182599
|
increased circulating leptin level
|
J:182599
|
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1)
|
abnormal blood coagulation
|
J:36591
|
decreased circulating fibrinogen level
|
J:28436
|
decreased platelet aggregation
|
J:28436
|
impaired blood coagulation
|
J:28436
|
Fgatm1Jld/Fgatm1Jld
(B6.129P2-Fgatm1Jld)
|
decreased circulating fibrinogen level
|
J:28436
|
decreased platelet aggregation
|
J:28436
|
impaired blood coagulation
|
J:28436
|
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal blood coagulation
|
J:63750
|
Fgatm1Jld/Fgatm1Jld Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss * CF-1)
|
abnormal blood coagulation
|
J:36591
|
Fgatm1Jld/Fgatm1Jld Vwftm1Wgr/Vwftm1Wgr
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:63750
|
Fgbtm1.1(KOMP)Vlcg/Fgb+
(C57BL/6N-Fgbtm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
Fgd3em1(IMPC)Ccpcz/Fgd3em1(IMPC)Ccpcz
(C57BL/6N-Fgd3em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating creatinine level
|
J:211773
|
Fgd4tm1a(EUCOMM)Wtsi/Fgd4tm1a(EUCOMM)Wtsi
(C57BL/6N-Fgd4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Fgf2tm1b(EUCOMM)Wtsi/Fgf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Fgf2tm1b(EUCOMM)Wtsi/H)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Fgf8tm1Mrc/Fgf8tm3Mrc
(involves: 129 * C57BL/6)
|
cyanosis
|
J:87304
|
Fgf9Eks/Fgf9Eks
(involves: C57BL/6J * DBA/2J)
|
cyanosis
|
J:77537
|
Fgf9tm1Dor/Fgf9tm1Dor
(involves: 129S6/SvEvTac * C57BL/6)
|
cyanosis
|
J:69852
|
Fgf10tm1b(EUCOMM)Wtsi/Fgf10+
(C57BL/6N-Fgf10tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fgf14em1(IMPC)Ccpcz/Fgf14em1(IMPC)Ccpcz
(C57BL/6N-Fgf14em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fgf18tm1Dor/Fgf18tm1Dor
(involves: 129X1/SvJ * C57BL/6J)
|
cyanosis
|
J:75879
|
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating glucose level
|
J:150831
|
decreased circulating ketone body level
|
J:150831
|
hypoglycemia
|
J:150831
|
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
|
abnormal blood homeostasis
|
J:157309
|
increased circulating cholesterol level
|
J:157309
|
increased circulating glucose level
|
J:157309
|
increased circulating insulin level
|
J:157309
|
increased circulating leptin level
|
J:157309
|
increased circulating triglyceride level
|
J:157309
|
Fgf21tm1Fdl/Fgf21tm1Fdl
(B6.Cg-Fgf21tm1Fdl)
|
decreased circulating growth hormone level
|
J:184999
|
decreased circulating insulin-like growth factor I level
|
J:184999
|
increased circulating growth hormone level
|
J:184999
|
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit)
|
abnormal circulating free fatty acids level
|
J:157334
|
decreased circulating free fatty acids level
|
J:157334
|
increased circulating free fatty acids level
|
J:157334
|
increased circulating ketone body level
|
J:157334
|
Fgf22tm1b(EUCOMM)Hmgu/Fgf22tm1b(EUCOMM)Hmgu
(C57BL/6N-Fgf22tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
Fgf23em1(IMPC)Ccpcz/Fgf23+
(C57BL/6NCrl-Fgf23em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating iron level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Fgf23tm1.1Kew/Fgf23+
(B6.129-Fgf23tm1.1Kew)
|
decreased circulating phosphate level
|
J:180061
|
increased circulating alkaline phosphatase level
|
J:180061
|
Fgf23tm1.1Kew/Fgf23tm1.1Kew
(B6.129-Fgf23tm1.1Kew)
|
decreased circulating phosphate level
|
J:180061
|
increased circulating alkaline phosphatase level
|
J:180061
|
Fgf23tm1Blan/Fgf23tm1Blan
(Not Specified)
|
increased circulating alkaline phosphatase level
|
J:94041
|
increased circulating phosphate level
|
J:94041
|
Fgf23tm1Blan/Fgf23tm1Blan
(involves: 129/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:121006
|
decreased circulating serum albumin level
|
J:121006
|
hypoglycemia
|
J:121006
|
increased blood urea nitrogen level
|
J:121006
|
increased circulating alkaline phosphatase level
|
J:121006
|
increased circulating calcium level
|
J:121006
|
increased circulating phosphate level
|
J:121006
|
Fgf23tm1Blan/Fgf23tm1Blan
(involves: 129 * C57BL/6)
|
increased circulating phosphate level
|
J:173962
|
Fgf23tm1Blan/Fgf23tm1Blan PhexHyp/Y
(Not Specified)
|
increased circulating phosphate level
|
J:94041
|
Fgf23tm1Blan/Fgf23tm1Blan Sfrp4tm1.1Blan/Sfrp4tm1.1Blan
(involves: 129 * C57BL/6)
|
increased circulating phosphate level
|
J:173962
|
Fgf23tm1Blan/Fgf23tm1Blan Vdrtm1Rge/Vdrtm1Rge
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating alkaline phosphatase level
|
J:121006
|
increased circulating parathyroid hormone level
|
J:121006
|
Fgf23tm1Sliu/Fgf23+ PhexHyp/Y
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating phosphate level
|
J:110579
|
Fgf23tm1Sliu/Fgf23tm1Sliu
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating calcium level
|
J:110579
|
abnormal circulating phosphate level
|
J:110579
|
decreased circulating parathyroid hormone level
|
J:110579
|
Fgf23tm1Sliu/Fgf23tm1Sliu PhexHyp/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating calcium level
|
J:110579
|
abnormal circulating phosphate level
|
J:110579
|
decreased circulating parathyroid hormone level
|
J:110579
|
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
abnormal blood urea nitrogen level
|
J:88172
|
decreased circulating parathyroid hormone level
|
J:88172
|
decreased circulating triglyceride level
|
J:88172
|
hypoglycemia
|
J:88172
|
increased circulating calcium level
|
J:88172
|
increased circulating cholesterol level
|
J:88172
|
increased circulating phosphate level
|
J:88172
|
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N)
|
hypoglycemia
|
J:72517
|
Fgfrl1tm1True/Fgfrl1tm1True
(B6.129S6-Fgfrl1tm1True)
|
cyanosis
|
J:130254
|
Fggtm1Fjc/Fggtm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:64396
|
Fggtm1Jld/Fggtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
decreased platelet aggregation
|
J:36873
|
increased bleeding time
|
J:36873
|
Fggtm1Lord/Fgg+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:129828
|
abnormal thrombolysis
|
J:129828
|
decreased circulating fibrinogen level
|
J:129828
|
Fggtm1Lord/Fggtm1Lord
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:129828
|
abnormal thrombolysis
|
J:129828
|
abnormal thrombosis
|
J:129828
|
decreased circulating fibrinogen level
|
J:129828
|
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:199844
|
decreased circulating free fatty acids level
|
J:199844
|
decreased circulating HDL cholesterol level
|
J:199844
|
hyperglycemia
|
J:199844
|
Fgl2tm1Pam/Fgl2tm1Pam
(involves: 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:99453
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
increased circulating creatinine level
|
J:130895
|
Fglu2KK/?
(involves: C57BL/6J * KK-Ay)
|
hyperglycemia
|
J:81517
|
FgluKK/TaJcl/FgluKK/TaJcl
(involves: C57BL/6Jcl * KK.B6-Ay/Jcl)
|
hyperglycemia
|
J:51880
|
Fhip1bem1(IMPC)Tcp/Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Fhip2aem1(IMPC)J/Fhip2aem1(IMPC)J
(C57BL/6NJ-Fhip2aem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:302658
|
decreased circulating LDL cholesterol level
|
J:302658
|
increased circulating alanine transaminase level
|
J:302658
|
increased circulating aspartate transaminase level
|
J:302658
|
Fhl1tm1a(EUCOMM)Wtsi/Fhl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fhl1tm1a(EUCOMM)Wtsi/H)
|
decreased circulating cholesterol level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Ficdtm1b(EUCOMM)Hmgu/Ficdtm1b(EUCOMM)Hmgu
(C57BL/6N-Ficdtm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
Firrmtm1a(EUCOMM)Hmgu/Firrm+
(C57BL/6N-Firrmtm1a(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating cholesterol level
|
J:165965
|
increased circulating HDL cholesterol level
|
J:165965
|
Firrmtm1b(EUCOMM)Hmgu/Firrm+
(C57BL/6N-Firrmtm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
Fis1tm1.1Itl/Fis1tm1.1Itl Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NTac * FVB)
|
increased circulating interferon-beta level
|
J:290485
|
increased circulating interleukin-6 level
|
J:290485
|
increased circulating interleukin-12b level
|
J:290485
|
increased circulating interleukin-13 level
|
J:290485
|
Fis1tm1b(EUCOMM)Hmgu/Fis1+
(C57BL/6N-Fis1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
Fitm2tm1.1Dls/Fitm2tm1.1Dls Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating insulin level
|
J:212437
|
increased circulating tumor necrosis factor level
|
J:212437
|
Fkbp4tm1Shou/Fkbp4tm1Shou
(involves: 129S/SvEv)
|
increased circulating testosterone level
|
J:120960
|
Fkbp5tm1Dvds/Fkbp5tm1Dvds
(involves: 129X1/SvJ * C57BL/6 * Swiss Webster)
|
decreased circulating corticosterone level
|
J:177683
|
Fkbp8tm1Kei/Fkbp8tm1Kei
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:132961
|
Fkbp9tm1a(EUCOMM)Hmgu/Fkbp9tm1a(EUCOMM)Hmgu
(C57BL/6N-Fkbp9tm1a(EUCOMM)Hmgu/Ics)
|
decreased circulating alanine transaminase level
|
J:165965
|
decreased circulating aspartate transaminase level
|
J:165965
|
decreased circulating sodium level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
Fkbp10tm2a(EUCOMM)Wtsi/Fkbp10+
(C57BL/6N-Fkbp10tm2a(EUCOMM)Wtsi/Ics)
|
decreased circulating amylase level
|
J:165965
|
Fkrptm1Itl/Fkrptm1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
increased circulating alanine transaminase level
|
J:164448
|
increased circulating creatine kinase level
|
J:164448
|
Fktntm1Kcam/Fktntm1Kcam Myf5tm3(cre)Sor/Myf5+
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
increased circulating creatine kinase level
|
J:187144
|
Fktntm1Kcam/Fktntm1Kcam Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129S/SvEv * C57BL/6 * CBA)
|
increased circulating creatine kinase level
|
J:187144
|
Fktntm1Kcam/Fktntm1Kcam Tg(Ckmm-cre)5Khn/?
(involves: 129S/SvEv * FVB)
|
increased circulating creatine kinase level
|
J:187144
|
Fktntm3.1Ttd/Fktntm3.1Ttd Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased circulating creatine kinase level
|
J:198535
|
Fktntm3.1Ttd/Fktntm3.1Ttd Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
increased circulating creatine kinase level
|
J:198535
|
Flcntm1Baba/Flcntm1.1Lss Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * FVB/N * ICR * SJL)
|
increased blood urea nitrogen level
|
J:130978
|
Flcntm1Btt/Flcntm1Btt Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJaeSor * C57BL/6 * ICR)
|
increased blood urea nitrogen level
|
J:143922
|
Flnatm1.1Caw/Y H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
cyanosis
|
J:118252
|
Flnatm1.2Caw/Flna+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thrombosis
|
J:118252
|
Flnbtm1b(KOMP)Wtsi/Flnb+
(C57BL/6N-Flnbtm1b(KOMP)Wtsi/H)
|
increased circulating serum albumin level
|
J:211773
|
Flt3m1Btlr/Flt3m1Btlr
(C57BL/6J-Flt3m1Btlr)
|
decreased circulating interferon-alpha level
|
J:159599
|
decreased circulating interferon-gamma level
|
J:159599
|
decreased circulating interleukin-12 level
|
J:159599
|
increased circulating interleukin-6 level
|
J:159599
|
increased circulating tumor necrosis factor level
|
J:159599
|
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J)
|
cyanosis
|
J:287134
|
Flvcr2tm1a(EUCOMM)Hmgu/Flvcr2+
(C57BL/6N-Flvcr2tm1a(EUCOMM)Hmgu/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Flywch1tm1b(EUCOMM)Hmgu/Flywch1+
(C57BL/6N-Flywch1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe)
|
decreased circulating cholesterol level
|
J:223365
|
decreased circulating glucose level
|
J:223365
|
decreased circulating HDL cholesterol level
|
J:223365
|
decreased circulating LDL cholesterol level
|
J:223365
|
decreased fasting circulating glucose level
|
J:223365
|
Fn1tm1Ref/Fn1tm1Ref Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to induced thrombosis
|
J:82373
|
Fnbp1em1(IMPC)J/Fnbp1em1(IMPC)J
(C57BL/6NJ-Fnbp1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Fndc3aem1(IMPC)Tcp/Fndc3aem1(IMPC)Tcp
(C57BL/6N-Fndc3aem1(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
Fndc4tm1.1(KOMP)Vlcg/Fndc4tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc4tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Fndc5em21Gpt/Fndc5em21Gpt
(C57BL/6JGpt-Fndc5em21Cd/Gpt)
|
abnormal circulating enzyme level
|
J:247171
|
abnormal circulating lipid level
|
J:247171
|
Fndc7tm1.1(KOMP)Vlcg/Fndc7tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc7tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Fnip1em1(IMPC)Ccpcz/Fnip1+
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Fnip1em1(IMPC)Ccpcz/Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Fnip2tm1a(KOMP)Wtsi/Fnip2tm1a(KOMP)Wtsi
(C57BL/6N-Fnip2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Folr1tm1.1(KOMP)Vlcg/Folr1+
(C57BL/6N-Folr1tm1.1(KOMP)Vlcg/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Folr1tm1Fnn/Folr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating homocysteine level
|
J:57765
|
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased circulating tumor necrosis factor level
|
J:175064
|
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased circulating interleukin-6 level
|
J:175064
|
increased circulating interleukin-10 level
|
J:175064
|
increased circulating tumor necrosis factor level
|
J:175064
|
Fostm7Wag/Fostm7Wag Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating interleukin-6 level
|
J:175064
|
increased circulating interleukin-10 level
|
J:175064
|
increased circulating tumor necrosis factor level
|
J:175064
|
Fosl2tm2Wag/Fosl2tm2Wag Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased circulating glucose level
|
J:211215
|
decreased circulating osteocalcin level
|
J:211215
|
Foxa1tm1Gsc/Foxa1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating insulin level
|
J:53312
|
decreased circulating glucagon level
|
J:53312
|
hypoglycemia
|
J:53312
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
hyperglycemia
|
J:143476
|
Foxa1tm1Stf/Foxa1+
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:138581
|
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified)
|
decreased circulating glucagon level
|
J:57493
|
decreased circulating insulin level
|
J:57493
|
decreased circulating triglyceride level
|
J:57493
|
hypoglycemia
|
J:57493
|
increased circulating cortisol level
|
J:57493
|
increased circulating growth hormone level
|
J:57493
|
Foxa2tm1.1Stf/Foxa2tm1.1Stf Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln)
|
decreased circulating free fatty acids level
|
J:155391
|
decreased circulating glucose level
|
J:155391
|
decreased circulating insulin level
|
J:155391
|
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating free fatty acids level
|
J:95662
|
increased circulating triglyceride level
|
J:95662
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
decreased circulating glucagon level
|
J:70409
|
hypoglycemia
|
J:70409
|
increased circulating insulin level
|
J:70409
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
decreased circulating glucagon level
|
J:96332
|
hypoglycemia
|
J:96332
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:93473
|
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk)
|
decreased circulating cholesterol level
|
J:216477
|
decreased circulating leptin level
|
J:216477
|
decreased fasting circulating glucose level
|
J:72595
|
Foxd2em1(IMPC)Hmgu/Foxd2+
(C57BL/6NCrl-Foxd2em1(IMPC)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Foxd2em1(IMPC)Hmgu/Foxd2em1(IMPC)Hmgu
(C57BL/6NCrl-Foxd2em1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Foxe1tm1Rdl/Foxe1tm1Rdl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating levels of thyroid hormone
|
J:48970
|
increased circulating thyroid-stimulating hormone level
|
J:48970
|
Foxg1tm1M/Foxg1tm1M
(involves: 129S1/Sv * C57BL/6J)
|
cyanosis
|
J:26720
|
Foxi2tm1.1(KOMP)Vlcg/Foxi2tm1.1(KOMP)Vlcg
(C57BL/6N-Foxi2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Foxj3tm1a(EUCOMM)Wtsi/Foxj3tm1a(EUCOMM)Wtsi
(C57BL/6N-Foxj3tm1a(EUCOMM)Wtsi/BayMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Foxk2tm1.2Sven/Foxk2tm1.2Sven
(B6.Cg-Foxk2tm1.2Sven)
|
decreased circulating lactate level
|
J:273343
|
increased circulating insulin level
|
J:273343
|
Foxl2tm1Gpil/Foxl2tm1Gpil
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6J) or (involves: 129S6/SvEvTac * NIHS-BC))
|
decreased circulating insulin-like growth factor I level
|
J:90371
|
Foxl2tm2.1Tre/Foxl2tm2.1Tre Gnrhrtm1.1(cre)Uboe/Gnrhr+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating follicle stimulating hormone level
|
J:204036
|
decreased circulating luteinizing hormone level
|
J:204036
|
increased circulating luteinizing hormone level
|
J:204036
|
Foxn1nu/Foxn1nu
(involves: BALB/c)
|
abnormal circulating cytokine level
|
J:50903
|
decreased circulating alanine transaminase level
|
J:50903
|
decreased circulating interleukin-2 level
|
J:50903
|
decreased circulating interleukin-6 level
|
J:50903
|
decreased circulating tumor necrosis factor level
|
J:50903
|
Foxn1nu/Foxn1nu
(involves: CD-1)
|
abnormal circulating gonadotropin level
|
J:106251
|
decreased circulating follicle stimulating hormone level
|
J:106251
|
decreased circulating luteinizing hormone level
|
J:106251
|
Foxo1tm1b(EUCOMM)Wtsi/Foxo1+
(C57BL/6N-Foxo1tm1b(EUCOMM)Wtsi/J)
|
increased circulating bilirubin level
|
J:211773
|
Foxo1tm1Rdp/Foxo1tm1.1Rdp Foxo3tm1Rdp/Foxo3tm1.1Rdp Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal circulating hormone level
|
J:232961
|
decreased circulating luteinizing hormone level
|
J:232961
|
increased circulating estradiol level
|
J:232961
|
suppressed circulating follicle stimulating hormone level
|
J:232961
|
Foxo1tm1Rdp/Foxo1tm1.1Rdp Foxo3tm1Rdp/Foxo3tm1.1Rdp Ptentm1Hwu/Ptentm1Hwu Tg(CYP19A1-cre)1Jri/0
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal circulating hormone level
|
J:232961
|
decreased circulating luteinizing hormone level
|
J:232961
|
suppressed circulating follicle stimulating hormone level
|
J:232961
|
Foxo1tm1Rdp/Foxo1tm1.1Rdp Foxo3tm1Rdp/Foxo3tm1.1Rdp Tg(CYP19A1-cre)1Jri/0
(involves: 129S6/SvEvTac)
|
abnormal circulating hormone level
|
J:232961
|
decreased circulating luteinizing hormone level
|
J:232961
|
increased circulating estradiol level
|
J:232961
|
suppressed circulating follicle stimulating hormone level
|
J:232961
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:215526
|
hyperglycemia
|
J:215526
|
Foxo1tm1Rdp/Foxo1tm1Rdp Irs1tm1Mfw/Irs1tm1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)
|
decreased circulating cholesterol level
|
J:137845
|
decreased circulating free fatty acids level
|
J:137845
|
decreased circulating HDL cholesterol level
|
J:137845
|
decreased circulating triglyceride level
|
J:137845
|
Foxo1tm1Whb/Foxo1+ Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating glucose level
|
J:79560
|
Foxo1tm1Whb/Foxo1+ Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased circulating glucose level
|
J:109010
|
increased circulating insulin level
|
J:109010
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified)
|
decreased circulating cholesterol level
|
J:179687
|
decreased circulating free fatty acids level
|
J:179687
|
decreased circulating triglyceride level
|
J:179687
|
decreased circulating VLDL triglyceride level
|
J:179687
|
increased circulating glucose level
|
J:179687
|
increased circulating insulin level
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac)
|
decreased circulating tumor necrosis factor level
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac Insrtm1Dac/Insr+
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac Leprdb/Leprdb
(B6.Cg-Foxo1tm2.1Dac Leprdb)
|
increased circulating insulin level
|
J:179687
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating follicle stimulating hormone level
|
J:84269
|
increased circulating luteinizing hormone level
|
J:84269
|
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
|
decreased circulating cholesterol level
|
J:236585
|
decreased circulating glucose level
|
J:236585
|
decreased circulating insulin level
|
J:236585
|
decreased fasting circulating glucose level
|
J:236585
|
Foxp2tm2.2Woen/Foxp2+
(involves: C57BL/6 * C57BL/6J)
|
abnormal circulating mineral level
|
J:150425
|
increased circulating ferritin level
|
J:150425
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal atrial thrombosis
|
J:11262
|
Foxp3tm1Kuch/? Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:123352
|
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
increased circulating interferon-gamma level
|
J:117165
|
increased circulating interleukin-4 level
|
J:117165
|
increased circulating interleukin-5 level
|
J:117165
|
increased circulating interleukin-6 level
|
J:117165
|
increased circulating interleukin-10 level
|
J:117165
|
increased circulating tumor necrosis factor level
|
J:117165
|
Foxp3tm1Tch/Y Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Foxp3tm1Tch)
|
increased circulating interferon-gamma level
|
J:117165
|
Foxp3tm2.1(EGFP/cre)Shori/Y Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
decreased circulating lipase level
|
J:234397
|
FpliC57BL/6J/?
(involves: C57BL/6J * KK-Ay)
|
increased circulating insulin level
|
J:81517
|
Fpr3tm1b(EUCOMM)Hmgu/Fpr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fpr3tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
fpw/fpw
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:151726
|
decreased circulating interleukin-1 alpha level
|
J:151726
|
decreased circulating interleukin-6 level
|
J:151726
|
decreased circulating leptin level
|
J:151726
|
increased circulating interleukin-10 level
|
J:151726
|
increased circulating tumor necrosis factor level
|
J:151726
|
Frey1tm1.1(KOMP)Vlcg/Frey1tm1.1(KOMP)Vlcg
(C57BL/6N-Frey1tm1.1(KOMP)Vlcg/Mmucd)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Frktm1Liu/Frktm1Liu
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating triiodothyronine level
|
J:77207
|
Frmd4aem1(IMPC)J/Frmd4a+
(C57BL/6NJ-Frmd4aem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Frrs1tm1a(EUCOMM)Wtsi/Frrs1+
(C57BL/6N-Frrs1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Fryltm1b(KOMP)Wtsi/Fryl+
(C57BL/6N-Fryltm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
Fsbpem1(IMPC)J/Fsbpem1(IMPC)J
(C57BL/6NJ-Fsbpem1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Fsd2em1(IMPC)Mbp/Fsd2em1(IMPC)Mbp
(C57BL/6N-Fsd2em1(IMPC)Mbp/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
Fshbtm1Zuk/Fshbtm1Zuk
(either: 129S/SvEv or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased circulating follicle stimulating hormone level
|
J:38099
|
decreased circulating progesterone level
|
J:38099
|
increased circulating luteinizing hormone level
|
J:38099
|
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg
(C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Fshrtm1Mha/Fshrtm1Mha
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:61909
|
increased circulating luteinizing hormone level
|
J:61909
|
Fshrtm1Saco/Fshr+
(involves: C57BL/6)
|
decreased circulating testosterone level
|
J:50933
|
increased circulating follicle stimulating hormone level
|
J:50933
|
Fshrtm1Saco/Fshr+
(involves: 129)
|
decreased circulating progesterone level
|
J:65577
|
increased circulating testosterone level
|
J:65577
|
Fshrtm1Saco/Fshr+
(involves: 129T2/SvEmsJ)
|
abnormal thrombosis
|
J:81460
|
decreased circulating estradiol level
|
J:81460,
J:89713
|
decreased circulating progesterone level
|
J:81460
|
increased circulating follicle stimulating hormone level
|
J:81460
|
increased circulating luteinizing hormone level
|
J:81460
|
increased circulating testosterone level
|
J:81460,
J:89713
|
Fshrtm1Saco/Fshrtm1Saco
(involves: C57BL/6)
|
decreased circulating testosterone level
|
J:61957,
J:50933
|
increased circulating follicle stimulating hormone level
|
J:50933
|
Fshrtm1Saco/Fshrtm1Saco
(involves: 129)
|
decreased circulating estradiol level
|
J:70933,
J:65577
|
decreased circulating progesterone level
|
J:65577
|
decreased circulating testosterone level
|
J:70680
|
increased circulating follicle stimulating hormone level
|
J:70933
|
increased circulating luteinizing hormone level
|
J:70933
|
increased circulating testosterone level
|
J:70933,
J:65577
|
Fsttm1Zuk/Fsttm1Zuk
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:23925
|
Fsttm1Zuk/Fsttm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6)
|
cyanosis
|
J:23925
|
Fstl1tm1.1Ning/Fstl1tm1.1Ning
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
cyanosis
|
J:171347
|
Fstl1tm1.2Mvdh/Fstl1tm1.2Mvdh
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
cyanosis
|
J:176532
|
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fstl1tm2.1(cre/ERT2)Mvdh/Fstl1tm2.1(cre/ERT2)Mvdh
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:176532
|
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased circulating insulin level
|
J:119526
|
Fth1tm1.1Lck/Fth1tm1.1Lck Tg(Mx1-cre)1Cgn/0
(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn)
|
increased circulating alanine transaminase level
|
J:166515
|
increased circulating aspartate transaminase level
|
J:166515
|
increased circulating iron level
|
J:166515
|
Fth1tm1Cbea/Fth1+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating ferritin level
|
J:70685
|
Ftl1em1(IMPC)Rbrc/Ftl1em1(IMPC)Rbrc
(C57BL/6NJcl-Ftl1em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating iron level
|
J:211773
|
Ftl1tm1.1Ruvi/Ftl1tm1.1Ruvi
(involves: 129 * C57BL/6)
|
increased circulating iron level
|
J:244236
|
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating insulin level
|
J:152163
|
increased circulating cholesterol level
|
J:152163
|
increased circulating glucagon level
|
J:152163
|
increased circulating glucose level
|
J:152163
|
increased circulating HDL cholesterol level
|
J:152163
|
increased circulating leptin level
|
J:152163
|
increased circulating triglyceride level
|
J:152163
|
Ftotm1.1Pzg/Ftotm1.1Pzg Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
|
decreased circulating insulin-like growth factor I level
|
J:166984
|
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:166984
|
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:166984
|
Ftotm1a(EUCOMM)Wtsi/Ftotm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ftotm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating iron level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Ftotm1Urt/Ftotm1Urt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating hormone level
|
J:147471
|
decreased circulating leptin level
|
J:147471
|
increased circulating adrenaline level
|
J:147471
|
Ftsj1tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Ftsj1tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
Ftsj1tm1b(EUCOMM)Wtsi/Ftsj1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ftsj1tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating phosphate level
|
J:211773
|
Fundc2tm1Qim/Fundc2tm1Qim
(involves: C57BL/6)
|
decreased susceptibility to induced thrombosis
|
J:301680
|
Fut4em1(IMPC)Ics/Fut4em1(IMPC)Ics
(C57BL/6N-Fut4em1(IMPC)Ics/Ics)
|
decreased circulating creatinine level
|
J:211773
|
Fxyd4tm1Grt/Fxyd4tm1Grt
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
increased circulating potassium level
|
J:78904
|
Fyttd1em1(IMPC)J/Fyttd1em1(IMPC)J
(C57BL/6NJ-Fyttd1em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Fzd1tm1.1Nat/Fzd1tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
cyanosis
|
J:165556
|
Fzd3tm1Nat/Fzd3tm1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:79213
|
Fzd4tm1Nat/Fzd4tm1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating progesterone level
|
J:115734
|
Fzd8em1(IMPC)Bay/Fzd8em1(IMPC)Bay
(C57BL/6N-Fzd8em1(IMPC)Bay/Bay)
|
decreased circulating bilirubin level
|
J:211773
|
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating alanine transaminase level
|
J:209000
|
decreased circulating aspartate transaminase level
|
J:209000
|
decreased circulating insulin level
|
J:209000
|
increased circulating free fatty acids level
|
J:209000
|
increased circulating glycerol level
|
J:225236
|
G2e3em1(IMPC)Tcp/G2e3em1(IMPC)Tcp
(C57BL/6NCrl-G2e3em1(IMPC)Tcp/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
G3bp1tm1b(KOMP)Wtsi/G3bp1+
(C57BL/6N-G3bp1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
G6pc1em1Jyc/G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
hypoglycemia
|
J:320697
|
increased blood uric acid level
|
J:320697
|
increased circulating cholesterol level
|
J:320697
|
increased circulating triglyceride level
|
J:320697
|
G6pc1tm1.1Ics/G6pc1tm1.1Ics Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood homeostasis
|
J:195257
|
increased blood uric acid level
|
J:195257
|
increased circulating cholesterol level
|
J:195257
|
increased circulating triglyceride level
|
J:195257
|
G6pc1tm1.1Ics/G6pc1tm1.1Ics Tg(Kap-cre/ERT2)64.9Ics/0
(involves: 129S2/SvPas * FVB/N)
|
increased blood uric acid level
|
J:238264
|
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae)
|
decreased circulating glucose level
|
J:33212
|
increased blood uric acid level
|
J:33212
|
increased circulating cholesterol level
|
J:33212
|
increased circulating triglyceride level
|
J:33212
|
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
abnormal blood homeostasis
|
J:155990
|
hypoglycemia
|
J:155990
|
increased blood uric acid level
|
J:155990
|
increased circulating cholesterol level
|
J:155990
|
increased circulating triglyceride level
|
J:155990
|
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating glucose level
|
J:141593
|
decreased circulating triglyceride level
|
J:141593
|
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:117664
|
increased circulating glucagon level
|
J:117664
|
Gab1tm1Gsf/Gab1tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating free fatty acids level
|
J:98318
|
decreased circulating glucose level
|
J:98318
|
decreased circulating insulin level
|
J:98318
|
decreased circulating triglyceride level
|
J:98318
|
Gabarapl2tm1b(EUCOMM)Hmgu/Gabarapl2+
(C57BL/6N-Gabarapl2tm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet)
|
increased circulating luteinizing hormone level
|
J:115850
|
increased circulating prolactin level
|
J:115850
|
Gabra2em1(IMPC)H/Gabra2em1(IMPC)H
(C57BL/6N-Gabra2em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Gad1tm1Mrc/Gad1tm1Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:43954
|
Gad1tm1Oba/Gad1tm1Oba
(involves: C57BL/6 * CBA)
|
cyanosis
|
J:40978
|
Gad2tm1b(EUCOMM)Wtsi/Gad2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gad2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya)
|
increased circulating glucose level
|
J:88785
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
abnormal circulating insulin level
|
J:105628
|
Galtm1Wyn/Galtm1Wyn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucocorticoid level
|
J:84420
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
decreased circulating insulin-like growth factor I level
|
J:165361
|
Galk2tm1b(EUCOMM)Hmgu/Galk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Galk2tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased circulating serum albumin level
|
J:128982
|
increased bleeding time
|
J:128982
|
Galnt2tm1.2Mrl/Galnt2tm1.2Mrl
(involves: C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:251899
|
Galnt3tcal/Galnt3tcal
(involves: C3H * C57BL/6J)
|
abnormal circulating protein level
|
J:187064
|
increased circulating phosphate level
|
J:187064
|
Galnt3tm1.1Cfg/Galnt3tm1.1Cfg
(involves: C57BL/6)
|
increased circulating bilirubin level
|
J:217719
|
Galnt3tm1Mjec/Galnt3tm1Mjec
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating alkaline phosphatase level
|
J:151805
|
decreased circulating parathyroid hormone level
|
J:151805
|
increased circulating calcium level
|
J:151805
|
increased circulating phosphate level
|
J:151805
|
Galnt11tm1Kgth/Galnt11tm1Kgth
(B6NHsd.Cg-Galnt11tm1Kgth)
|
increased blood urea nitrogen level
|
J:287843
|
increased circulating LDL cholesterol level
|
J:287843
|
Galnt18tm1b(KOMP)Wtsi/Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Galr2em1(IMPC)H/Galr2em1(IMPC)H
(C57BL/6NTac-Galr2em1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
Gamttm1Isb/Gamttm1Isb
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating creatinine level
|
J:90367
|
Gar1tm1a(EUCOMM)Wtsi/Gar1+
(C57BL/6N-Gar1tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating sodium level
|
J:165965
|
increased circulating sodium level
|
J:165965
|
Garin1bem1(IMPC)Ccpcz/Garin1bem1(IMPC)Ccpcz
(C57BL/6N-Garin1bem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
abnormal cardiac thrombosis
|
J:244087
|
Gas6tm1.1(KOMP)Vlcg/Gas6tm1.1(KOMP)Vlcg
(C57BL/6N-Gas6tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gas6tm1Hiar/Gas6tm1Hiar
(B6.129P2-Gas6tm1Hiar)
|
abnormal circulating serum albumin level
|
J:112430
|
Gas6tm1Pec/Gas6tm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet dense granule physiology
|
J:77462
|
decreased platelet aggregation
|
J:77462
|
decreased susceptibility to induced thrombosis
|
J:77462
|
Gasttm1(INS)Ez/Gast+
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:99270
|
Gasttm1(INS)Ez/Gast+ Ins2Akita/Ins2+
(involves: 129S4/SvJae * C57BL/6NSlc)
|
abnormal circulating glucose level
|
J:99270
|
Gasttm1Lcs/Gasttm1Lcs
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased circulating iron level
|
J:142455
|
increased circulating unsaturated transferrin level
|
J:142455
|
Gata1tm6Sho/Gata1tm6Sho
(involves: 129S1/Sv * BALB/c)
|
abnormal hemostasis
|
J:115273
|
decreased circulating interleukin-4 level
|
J:115273
|
decreased circulating interleukin-13 level
|
J:115273
|
Gata2tm1Sac/Gata2tm1Sac Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
decreased circulating follicle stimulating hormone level
|
J:108963
|
decreased circulating thyroid-stimulating hormone level
|
J:108963
|
Gata3tm1Jeng/Gata3tm1Jeng
(involves: 129S7/SvEvBrd)
|
abnormal blood coagulation
|
J:28393
|
Gata4tm1.1Jmol/Gata4tm1.1Jmol
(involves: 129 * C57BL/6)
|
decreased circulating testosterone level
|
J:308912
|
Gata4tm1.1Sad/Gata4tm1.1Sad Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
decreased circulating anti-Mullerian hormone level
|
J:173711
|
Gata4tm1.1Sad/Gata4tm1.2Sad Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
decreased blood oxygen saturation level
|
J:231793
|
Gata4tm1.2Wtp/Gata4+
(B6.Cg-Gata4tm1.2Wtp)
|
decreased circulating estradiol level
|
J:173711
|
Gata6tm2Msp/Gata6tm2Msp Tg(Tagln-cre)1Jjl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
cyanosis
|
J:107814
|
Gatad2btm1b(EUCOMM)Hmgu/Gatad2b+
(C57BL/6N-Gatad2btm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
decreased circulating cholesterol level
|
J:191142
|
decreased circulating glucose level
|
J:191142
|
decreased circulating insulin level
|
J:191142
|
decreased circulating leptin level
|
J:191142
|
decreased circulating triglyceride level
|
J:191142
|
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
(C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Gba1em1(IMPC)H/Gba1+
(C57BL/6N-Gba1em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Gba1tm1.1Pmis/Gba1tm1.1Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal circulating chemokine level
|
J:167081
|
abnormal circulating cytokine level
|
J:167081
|
decreased circulating HDL cholesterol level
|
J:167081
|
decreased circulating interleukin-1 alpha level
|
J:167081
|
decreased circulating interleukin-1 beta level
|
J:167081
|
decreased circulating interleukin-6 level
|
J:167081
|
decreased circulating tumor necrosis factor level
|
J:167081
|
increased circulating aspartate transaminase level
|
J:167081
|
increased circulating interferon-gamma level
|
J:167081
|
increased circulating interleukin-2 level
|
J:167081
|
increased circulating interleukin-3 level
|
J:167081
|
increased circulating interleukin-9 level
|
J:167081
|
increased circulating interleukin-10 level
|
J:167081
|
increased circulating interleukin-13 level
|
J:167081
|
Gba1tm1.1Pmis/Gba1tm1.2Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal circulating chemokine level
|
J:167081
|
abnormal circulating cytokine level
|
J:167081
|
decreased circulating HDL cholesterol level
|
J:167081
|
decreased circulating interleukin-1 alpha level
|
J:167081
|
decreased circulating interleukin-1 beta level
|
J:167081
|
decreased circulating interleukin-6 level
|
J:167081
|
decreased circulating tumor necrosis factor level
|
J:167081
|
increased circulating aspartate transaminase level
|
J:167081
|
increased circulating interferon-gamma level
|
J:167081
|
increased circulating interleukin-2 level
|
J:167081
|
increased circulating interleukin-3 level
|
J:167081
|
increased circulating interleukin-9 level
|
J:167081
|
increased circulating interleukin-10 level
|
J:167081
|
increased circulating interleukin-13 level
|
J:167081
|
Gba1tm1Nsb/Gba1tm1Nsb
(involves: 129S/SvEv * C57BL/6)
|
cyanosis
|
J:1100
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:76409
|
increased circulating alanine transaminase level
|
J:76409
|
increased circulating aspartate transaminase level
|
J:76409
|
Gba2tm1a(EUCOMM)Wtsi/Gba2tm1a(EUCOMM)Wtsi
(C57BL/6N-Gba2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:175295
|
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd)
|
decreased circulating glucose level
|
J:176889
|
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd)
|
decreased fasting circulating glucose level
|
J:226481
|
increased circulating creatine kinase level
|
J:226481
|
Gbp2tm1b(KOMP)Wtsi/Gbp2tm1b(KOMP)Wtsi
(C57BL/6N-Gbp2tm1b(KOMP)Wtsi/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Gbp5tm1Tigm/Gbp5tm1Tigm
(B6.Cg-Gbp5tm1Tigm)
|
decreased circulating interleukin-1 beta level
|
J:183942
|
decreased circulating interleukin-18 level
|
J:183942
|
Gbp7em1(IMPC)J/Gbp7em1(IMPC)J
(C57BL/6NJ-Gbp7em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gbx1tm1b(KOMP)Wtsi/Gbx1tm1b(KOMP)Wtsi
(C57BL/6N-Gbx1tm1b(KOMP)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
(B6.129-Gbx2tm1.1Mrt)
|
cyanosis
|
J:100584
|
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Gcdhtm2b(EUCOMM)Hmgu/Gcdhtm2b(EUCOMM)Hmgu
(C57BL/6N-Gcdhtm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys)
|
decreased circulating insulin level
|
J:154694
|
increased circulating glucose level
|
J:154694
|
Gcgrem1Tshu/Gcgrem1Tshu
(involves: C57BL/6J)
|
decreased fasting circulating glucose level
|
J:279017
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
decreased fasting circulating glucose level
|
J:300368
|
increased circulating glucagon level
|
J:300368
|
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating insulin level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
decreased circulating glucose level
|
J:176507
|
decreased circulating insulin level
|
J:176507
|
increased circulating glucagon level
|
J:176507,
J:73926
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal circulating amino acid level
|
J:251829
|
decreased circulating glucose level
|
J:81772
|
decreased circulating insulin level
|
J:251829
|
decreased circulating leptin level
|
J:81772
|
hypoglycemia
|
J:251829,
J:81772
|
increased circulating glucagon level
|
J:251829,
J:81772
|
increased circulating LDL cholesterol level
|
J:81772
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
decreased circulating insulin level
|
J:208604
|
increased circulating glucagon level
|
J:208604
|
Gcgrtm1Mjch/Gcgrtm1Mjch Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
abnormal circulating amino acid level
|
J:251829
|
decreased circulating insulin level
|
J:251829
|
hypoglycemia
|
J:251829
|
increased circulating glucagon level
|
J:251829
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
decreased circulating glucose level
|
J:208604
|
decreased circulating insulin level
|
J:208604
|
hypoglycemia
|
J:208604
|
increased circulating glucagon level
|
J:208604
|
Gckem1(IMPC)H/Gck+
(C57BL/6NTac-Gckem1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
GckGena348/Gck+
(involves: BALB/c * C3H/He)
|
hyperglycemia
|
J:82809,
J:79719,
J:90389
|
GckGena348/GckGena348
(involves: BALB/c * C3H/He)
|
hyperglycemia
|
J:90389
|
GckGls006/Gck+
(C3HeB/FeJ-GckGls006)
|
decreased circulating insulin level
|
J:189544
|
hyperglycemia
|
J:189544
|
increased circulating glucose level
|
J:189544
|
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006)
|
hyperglycemia
|
J:137483,
J:189544
|
increased circulating glucose level
|
J:189544
|
GckHlb62/?
(C57BL/6J-GckHlb62/J)
|
hyperglycemia
|
J:214141,
J:82961
|
Gckm1Rge/Gck+
(involves: C3HeB/FeJ)
|
hyperglycemia
|
J:162903
|
increased circulating insulin level
|
J:162903
|
Gckm1Rge/Gckm1Rge
(involves: C3HeB/FeJ)
|
hyperglycemia
|
J:162903
|
GckRgsc149/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc149/Gck+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
GckRgsc210/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc210/GckRgsc210
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
GckRgsc236/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc272/Gck+
(involves: C57BL/6J * DBA/2J)
|
decreased circulating insulin level
|
J:88919
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc341/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc392/Gck+
(involves: C57BL/6J * DBA/2J)
|
decreased circulating insulin level
|
J:88919
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc392/GckRgsc392
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
GckRgsc475/Gck+
(involves: C57BL/6J * DBA/2J)
|
decreased circulating insulin level
|
J:88919
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc552/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc553/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc702/Gck+
(involves: C57BL/6J * DBA/2J)
|
decreased circulating insulin level
|
J:88919
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc702/GckRgsc702
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
GckRgsc735/Gck+
(involves: C57BL/6J * DBA/2J)
|
hyperglycemia
|
J:88919
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc960/Gck+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
GckSgrd-2Nwu/Gck+
(C57BL/6J-GckSgrd-2Nwu)
|
hyperglycemia
|
J:196563
|
GckSgrd-2Nwu/GckSgrd-2Nwu
(C57BL/6J-GckSgrd-2Nwu)
|
decreased circulating insulin level
|
J:196563
|
hyperglycemia
|
J:196563
|
GckSgrd/Gck+
(C57BL/6J-GckSgrd)
|
decreased circulating insulin level
|
J:196563
|
hyperglycemia
|
J:196563
|
GckSgrd/GckSgrd-2Nwu
(C57BL/6J-GckSgrd/GckSgrd-2Nwu)
|
decreased circulating insulin level
|
J:196563
|
hyperglycemia
|
J:196563
|
GckSgrd/GckSgrd
(C57BL/6J-GckSgrd)
|
decreased circulating insulin level
|
J:196563
|
hyperglycemia
|
J:196563
|
Gcktm1.1Mgn/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:51826
|
Gcktm1.1Mgn/Gcktm1.1Mgn
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating glucose level
|
J:51826
|
Gcktm1.1Mgn/Gcktm1.1Mgn
(129S6/SvEvTac-Gcktm1.1Mgn)
|
increased circulating glucose level
|
J:51826
|
Gcktm1.1Mgn/Gcktm1.1Mgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased circulating glucose level
|
J:51826
|
increased circulating insulin level
|
J:51826
|
Gcktm1.1Mgn/Gcktm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased circulating insulin level
|
J:51826
|
hyperglycemia
|
J:51826
|
Gcktm1.2Mgn/Gck+
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:51826
|
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating insulin level
|
J:51826
|
hyperglycemia
|
J:51826
|
increased circulating free fatty acids level
|
J:51826
|
Gcktm1Efr/Gck+
(involves: 129P2/OlaHsd * C57BL/6)
|
hyperglycemia
|
J:28756
|
Gcktm1Hrt/Gck+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating glucose level
|
J:105247
|
increased fasting circulating glucose level
|
J:250069
|
Gcktm1Mgn/Gcktm1Mgn
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating glucose level
|
J:51826
|
Gcktm1Tka/Gck+
(involves: 129X1/SvJ * ICR)
|
hyperglycemia
|
J:30334
|
Gcktm1Tka/Gck+ Irs1tm1Tka/Irs1tm1Tka
(involves: 129X1/SvJ * C57BL/6 * CBA * ICR)
|
increased circulating insulin level
|
J:38899
|
Gcktm1Tka/Gcktm1Tka
(involves: 129X1/SvJ * ICR)
|
decreased circulating insulin level
|
J:30334
|
hyperglycemia
|
J:30334
|
Gcktm1Ts/Gck+
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))
|
hyperglycemia
|
J:29255
|
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))
|
abnormal circulating cholesterol level
|
J:29255
|
increased circulating triglyceride level
|
J:29255
|
Gcktm1Ydor/Gck+ Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6 * C57BL/6J * CD-1)
|
hypoglycemia
|
J:302600
|
Gcktm1Ydor/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased fasting circulating glucose level
|
J:302600
|
hypoglycemia
|
J:302600
|
increased circulating insulin level
|
J:302600
|
Gcktm2Mgn/Gck+
(129S6/SvEvTac-Gcktm2Mgn)
|
hyperglycemia
|
J:121910
|
Gcktm2Mgn/Gck+
(B6.129S6-Gcktm2Mgn)
|
hyperglycemia
|
J:121910
|
Gcktm2Mgn/Gcktm2Mgn
(129S6/SvEvTac-Gcktm2Mgn)
|
hyperglycemia
|
J:121910
|
Gcktm3Mgn/Gck+
(B6.129S6-Gcktm3Mgn)
|
hypoglycemia
|
J:121910
|
Gcktm3Mgn/Gck+
(129S6/SvEvTac-Gcktm3Mgn)
|
hypoglycemia
|
J:121910
|
Gcktm3Mgn/Gcktm3Mgn
(129S6/SvEvTac-Gcktm3Mgn)
|
abnormal circulating insulin level
|
J:121910
|
decreased circulating glucose level
|
J:121910
|
hypoglycemia
|
J:121910
|
Gckrem1(IMPC)H/Gckrem1(IMPC)H
(C57BL/6NTac-Gckrem1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Gckrtm1Bms/Gckrtm1Bms
(involves: 129S1/Sv * C57BL/6)
|
increased circulating glucose level
|
J:58949
|
increased circulating insulin level
|
J:58949
|
Gckrtm1Jfg/Gckrtm1Jfg
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating insulin level
|
J:61183
|
Gclctm1Tdal/Gclctm1Tdal Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:202376
|
increased circulating aspartate transaminase level
|
J:202376
|
Gclmtm1Tdal/Gclmtm1Tdal
(involves: 129 * C57BL/6J)
|
decreased circulating cysteine level
|
J:80927
|
Gclmtm1Tjka/Gclmtm1Tjka
(B6.129-Gclmtm1Tjka)
|
increased circulating alanine transaminase level
|
J:125009
|
Gcm2tm1.2Malx/Gcm2tm1.2Malx
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6N)
|
decreased circulating calcium level
|
J:213334
|
decreased circulating parathyroid hormone level
|
J:213334
|
increased circulating phosphate level
|
J:213334
|
Gcm2tm1Kry/Gcm2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased circulating calcium level
|
J:78067,
J:63291
|
decreased circulating phosphate level
|
J:63291
|
Gcn1em1(IMPC)J/Gcn1+
(C57BL/6NJ-Gcn1em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Gcnt1em1(IMPC)Ccpcz/Gcnt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Gcnt1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating iron level
|
J:211773
|
Gcnt2tm1Tmu/Gcnt2tm1Tmu
(involves: 129S2/SvPas * C57BL/6)
|
increased blood urea nitrogen level
|
J:100533
|
increased circulating creatinine level
|
J:100533
|
Gcnt4tm1.1Jxm/Gcnt4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating thyroxine level
|
J:149909
|
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Gdap2em1(IMPC)Wtsi/Gdap2em1(IMPC)Wtsi
(C57BL/6N-Gdap2em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating thyroxine level
|
J:211773
|
Gde1tm1b(EUCOMM)Hmgu/Gde1+
(C57BL/6N-Gde1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Gdf9tm1Zuk/Gdf9tm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
increased circulating follicle stimulating hormone level
|
J:35782
|
increased circulating luteinizing hormone level
|
J:35782
|
Gdf10tm2b(KOMP)Wtsi/Gdf10tm2b(KOMP)Wtsi
(C57BL/6N-Gdf10tm2b(KOMP)Wtsi/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
Gdf11tm2b(EUCOMM)Hmgu/Gdf11+
(C57BL/6N-Gdf11tm2b(EUCOMM)Hmgu/Bay)
|
increased circulating total protein level
|
J:211773
|
Gdf15tm1Sjl/Gdf15tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased bleeding time
|
J:195443
|
increased platelet aggregation
|
J:195443
|
increased susceptibility to induced thrombosis
|
J:195443
|
Gdf15tm1Sjl/Gdf15tm1Sjl Leprdb/Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J)
|
hyperglycemia
|
J:202996
|
increased circulating creatinine level
|
J:202996
|
increased circulating HDL cholesterol level
|
J:202996
|
Gdpd2tm1a(KOMP)Wtsi/Y
(C57BL/6N-Gdpd2tm1a(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Gemin4em1(IMPC)Ics/Gemin4+
(C57BL/6N-Gemin4em1(IMPC)Ics/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Gena327/Gena327+
(involves: BALB/c * C3H/HeH)
|
increased circulating triglyceride level
|
J:82809,
J:79719
|
Gena341/Gena341
(Not Specified)
|
decreased circulating alkaline phosphatase level
|
J:163957
|
decreased circulating phosphate level
|
J:163957
|
Gena346/Gena346+
(involves: BALB/c * C3H/HeH)
|
hyperglycemia
|
J:169366
|
Gena360/Gena360+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:82809,
J:79719
|
decreased circulating HDL cholesterol level
|
J:82809,
J:79719
|
Gena381/Gena381+
(involves: BALB/c * C3H/HeH)
|
increased circulating alkaline phosphatase level
|
J:169366
|
Gena382/Gena382+
(involves: BALB/c * C3H/HeH)
|
decreased circulating alanine transaminase level
|
J:169366
|
decreased circulating aspartate transaminase level
|
J:169366
|
Gena383/Gena383+
(involves: BALB/c * C3H/HeH)
|
increased circulating sodium level
|
J:163957,
J:79719,
J:169366
|
Gena391/Gena391+
(involves: BALB/c * C3H/He)
|
abnormal circulating glucose level
|
J:82809
|
increased circulating HDL cholesterol level
|
J:82809
|
increased circulating triglyceride level
|
J:82809
|
Gena396/Gena396+
(involves: BALB/c * C3H/HeH)
|
hyperglycemia
|
J:169366
|
Gena397/Gena397+
(involves: BALB/c * C3H/HeH)
|
hypoglycemia
|
J:169366
|
Gfertm1.1Crg/Gfertm1.1Crg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:227242
|
Gfi1btm1b(EUCOMM)Hmgu/Gfi1b+
(C57BL/6N-Gfi1btm1b(EUCOMM)Hmgu/H)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Gfm1tm1a(EUCOMM)Wtsi/Gfm1+
(C57BL/6N-Gfm1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:175295
|
Gfpt1tm1b(EUCOMM)Wtsi/Gfpt1+
(C57BL/6N-Gfpt1tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gfpt2tm1b(EUCOMM)Wtsi/Gfpt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gfpt2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating serum albumin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Gfraltm1Lex/Gfraltm1Lex
(B6.129S5-Gfraltm1Lex)
|
abnormal circulating triglyceride level
|
J:254140
|
Gfustm1Jbl/Gfustm1Jbl
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating creatinine level
|
J:82239
|
Gga1Gt(AN0619)Wtsi/Gga1Gt(AN0619)Wtsi
(B6J.129P2-Gga1Gt(AN0619)Wtsi)
|
abnormal circulating enzyme level
|
J:184229
|
hypoglycemia
|
J:184229
|
Gga1Gt(AN0619)Wtsi/Gga1Gt(AN0619)Wtsi Gga3Gt(RRC067)Byg/Gga3Gt(RRC067)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating enzyme level
|
J:184229
|
hypoglycemia
|
J:184229
|
Gga2Gt(IST10483E10)Tigm/Gga2Gt(IST10483E10)Tigm
(involves: C57BL/6J * C57BL/6N)
|
hypoglycemia
|
J:184229
|
Gga3Gt(RRC067)Byg/Gga3Gt(RRC067)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating enzyme level
|
J:184229
|
hypoglycemia
|
J:184229
|
Ggcxtm1.1Kry/Ggcxtm1.1Kry Tg(BGLAP-cre)1Clem/0
(involves: FVB/NJ)
|
decreased circulating osteocalcin level
|
J:264734
|
Ggcxtm1.1Kry/Ggcxtm1.1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB/N)
|
abnormal circulating osteocalcin level
|
J:264734
|
hypoglycemia
|
J:264734
|
Ggcxtm1Sinos/Ggcxtm1Sinos Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ggcxtm1Sinos Speer6-ps1Tg(Alb-cre)21Mgn)
|
impaired blood coagulation
|
J:212951
|
increased bleeding time
|
J:212951
|
Ggnbp2tm1b(KOMP)Wtsi/Ggnbp2+
(C57BL/6N-Ggnbp2tm1b(KOMP)Wtsi/Tcp)
|
decreased circulating total protein level
|
J:211773
|
Ggps1tm1b(EUCOMM)Wtsi/Ggps1+
(C57BL/6N-Ggps1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ggt1tm1Zuk/Ggt1tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating cysteine level
|
J:34309
|
decreased circulating estradiol level
|
J:65574
|
decreased circulating follicle stimulating hormone level
|
J:65574
|
decreased circulating insulin-like growth factor I level
|
J:65574
|
decreased circulating testosterone level
|
J:65574
|
increased circulating growth hormone level
|
J:65574
|
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1)
|
increased circulating ghrelin level
|
J:89518
|
Ghtm1.1(KOMP)Vlcg/Ghtm1.1(KOMP)Vlcg
(C57BL/6N-Ghtm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA)
|
increased circulating glucose level
|
J:173909
|
Ghrtm1.1Jero/Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero)
|
decreased circulating insulin-like growth factor I level
|
J:155335
|
increased circulating growth hormone level
|
J:155335
|
Ghrtm1.1Masp/Ghrtm1.1Masp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating insulin-like growth factor I level
|
J:152627
|
decreased circulating triglyceride level
|
J:152627
|
increased circulating free fatty acids level
|
J:152627
|
increased circulating growth hormone level
|
J:152627
|
increased circulating insulin level
|
J:152627
|
Ghrtm1Arge/Ghrtm1Arge
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66913
|
increased circulating growth hormone level
|
J:66913
|
Ghrtm1b(KOMP)Wtsi/Ghr+
(C57BL/6N-Ghrtm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6N)
|
increased circulating insulin-like growth factor I level
|
J:206358
|
increased circulating interleukin-6 level
|
J:206358
|
increased circulating leptin level
|
J:206358
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd)
|
decreased circulating insulin-like growth factor I level
|
J:155335
|
increased circulating growth hormone level
|
J:155335
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal circulating lipid level
|
J:105686
|
decreased circulating cholesterol level
|
J:105686
|
decreased circulating estradiol level
|
J:79216
|
decreased circulating glucose level
|
J:105686
|
decreased circulating HDL cholesterol level
|
J:105686
|
decreased circulating insulin level
|
J:105686,
J:110613
|
decreased circulating insulin-like growth factor I level
|
J:53777,
J:44604,
J:60207,
J:63459
|
decreased circulating LDL cholesterol level
|
J:105686
|
decreased circulating luteinizing hormone level
|
J:53777
|
decreased circulating testosterone level
|
J:53777,
J:105921
|
decreased circulating triglyceride level
|
J:105686
|
decreased circulating VLDL cholesterol level
|
J:105686
|
decreased fasting circulating glucose level
|
J:110613
|
increased circulating corticosterone level
|
J:105686
|
increased circulating growth hormone level
|
J:44604
|
increased circulating leptin level
|
J:105686
|
increased circulating prolactin level
|
J:53777
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
decreased circulating glucose level
|
J:103286
|
decreased circulating insulin level
|
J:103286
|
decreased circulating thyroxine level
|
J:103286
|
decreased circulating triiodothyronine level
|
J:103286
|
increased circulating corticosterone level
|
J:103286
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal blood homeostasis
|
J:107763
|
decreased circulating glucagon level
|
J:107763
|
decreased circulating glucose level
|
J:107763
|
decreased circulating insulin level
|
J:107763
|
decreased circulating insulin-like growth factor I level
|
J:107763
|
hypoglycemia
|
J:107763
|
increased circulating creatine kinase level
|
J:107763
|
increased circulating serum albumin level
|
J:107763
|
Ghrtm1Mwat/Ghrtm1Mwat
(involves: 129X1/SvJ * C57BL)
|
decreased circulating insulin-like growth factor I level
|
J:95149
|
hyperglycemia
|
J:95149
|
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL)
|
decreased circulating insulin-like growth factor I level
|
J:95149
|
hyperglycemia
|
J:95149
|
Ghrhtm1b(EUCOMM)Wtsi/Ghrhtm1b(EUCOMM)Wtsi
(C57BL/6N-Ghrhtm1b(EUCOMM)Wtsi/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:91828
|
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit)
|
decreased circulating growth hormone level
|
J:3735
|
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit/J)
|
decreased circulating glucose level
|
J:95779
|
decreased circulating insulin-like growth factor I level
|
J:95779
|
increased circulating insulin level
|
J:95779
|
Ghrhrlit/Ghrhrlit Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating glucose level
|
J:95779
|
decreased circulating insulin-like growth factor I level
|
J:95779
|
increased circulating glucose level
|
J:95779
|
increased circulating insulin level
|
J:95779
|
increased circulating leptin level
|
J:95779
|
Ghrhrtm1.1(KOMP)Vlcg/Ghrhr+
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ghrltm1Mko/Ghrltm1Mko
(B6.Cg-Ghrltm1Mko)
|
decreased circulating glucose level
|
J:121019
|
increased circulating insulin level
|
J:121019
|
Ghsrtm1Lowl/Ghsrtm1Lowl
(involves: C57BL/6J)
|
decreased circulating glucose level
|
J:104704
|
Ghsrtm1Rgs/Ghsrtm1Rgs
(involves: 129 * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:89243
|
Gigyf2tm1b(EUCOMM)Wtsi/Gigyf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gigyf2tm1b(EUCOMM)Wtsi/Bay)
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:160090
|
decreased circulating interleukin-4 level
|
J:160090
|
Gimap6tm1a(KOMP)Wtsi/Gimap6tm1a(KOMP)Wtsi
(C57BL/6N-Gimap6tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Gins2tm1b(EUCOMM)Wtsi/Gins2+
(C57BL/6N-Gins2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating lipase level
|
J:211773
|
Giptm1Nina/Giptm1Nina
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:298236
|
Giprtm1Thor/Giprtm1Thor
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating insulin level
|
J:88159
|
increased circulating glucose level
|
J:88159
|
Giprtm1Thor/Giprtm1Thor Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased circulating insulin level
|
J:88159
|
increased circulating glucose level
|
J:88159
|
Giprtm1Yse/Giprtm1Yse
(involves: 129P2/Ola * C57BL/6J)
|
decreased circulating insulin level
|
J:59087
|
hyperglycemia
|
J:59087
|
Git1tm1Bcb/Git1tm1Bcb
(involves: 129 * C57BL/6)
|
cyanosis
|
J:158935
|
Gja1tm1Dlg/Gja1tm1Dlg Tg(Tek-cre)1Ywa/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal blood homeostasis
|
J:71092
|
abnormal circulating hormone level
|
J:71092
|
Gja1tm1Kdr/Gja1tm1Kdr
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:24121
|
Gja5tm2.1Kwi/Gja5tm2.1Kwi
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased circulating renin level
|
J:205109
|
Gja8Aey69/Gja8Aey69 H3c14Aey69/H3c14Aey69
(C3HeB/FeJ)
|
hypolipidemia
|
J:277247
|
Gja8tm1b(EUCOMM)Hmgu/Gja8tm1b(EUCOMM)Hmgu
(C57BL/6N-Gja8tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
Gjd4tm1.1(KOMP)Vlcg/Gjd4tm1.1(KOMP)Vlcg
(C57BL/6N-Gjd4tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Gje1em1(IMPC)H/Gje1em1(IMPC)H
(C57BL/6NTac-Gje1em1(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hypoglycemia
|
J:43449,
J:100255
|
increased circulating glycerol level
|
J:43449
|
Gktm1Wjc/Gk+
(involves: 129S7/SvEvBrd)
|
decreased circulating glucose level
|
J:148831
|
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(C57BL/6N-Gkn2tm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Glatm1Kul/Y Tg(CAG-A4GALT)#Sais/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms)
|
increased blood urea nitrogen level
|
J:206001
|
Glatm1Kul/Glatm1Kul Tg(CAG-A4GALT)#Sais/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms)
|
increased blood urea nitrogen level
|
J:206001
|
GldcGt(EUCG0001d02)Hmgu/GldcGt(EUCG0001d02)Hmgu
(B6.129P2-GldcGt(EUCG0001d02)Hmgu)
|
increased circulating glycine level
|
J:221782
|
Glg1tm1a(KOMP)Wtsi/Glg1+
(C57BL/6N-Glg1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Glis2tm1Amj/Glis2tm1Amj
(involves: 129P2/OlaHsd * C57BL/6)
|
increased blood urea nitrogen level
|
J:134208
|
increased circulating creatinine level
|
J:134208
|
Glis3tm1.2Chan/Glis3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:177082
|
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:177082
|
hyperglycemia
|
J:177082
|
increased circulating glucose level
|
J:177082
|
increased circulating ketone body level
|
J:177082
|
Glis3tm1Amj/Glis3tm1Amj
(involves: 129 * C57BL/6)
|
hyperglycemia
|
J:148994
|
increased circulating insulin level
|
J:148994
|
Glis3tm1Hiha/Glis3tm1Hiha
(involves: C57BL/6 * CBA)
|
increased circulating glucose level
|
J:150077
|
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating alanine transaminase level
|
J:208774
|
increased circulating aspartate transaminase level
|
J:208774
|
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd)
|
decreased circulating glucose level
|
J:171883
|
increased circulating alkaline phosphatase level
|
J:171883
|
Glo1Gt(VICTR48)1493Lex/Glo1Gt(VICTR48)1493Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:82809
|
hyperglycemia
|
J:82809
|
Glp1rtm1.2Stof/Glp1rtm1.2Stof
(Not Specified)
|
abnormal circulating insulin level
|
J:203834
|
Glp1rtm1b(KOMP)Mbp/Glp1rtm1b(KOMP)Mbp
(C57BL/6N-Glp1rtm1b(KOMP)Mbp/H)
|
increased fasting circulating glucose level
|
J:211773
|
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating insulin level
|
J:36918,
J:206563
|
increased circulating glucose level
|
J:36918,
J:206563
|
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:88159
|
increased circulating glucose level
|
J:88159
|
Glp1rtm1Ddr/Glp1rtm1Ddr
(B6.129-Glp1rtm1Ddr)
|
increased circulating glucose level
|
J:200805
|
Glra2tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra2tm1b(KOMP)Wtsi/H)
|
increased circulating amylase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
Glra4tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra4tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Glrbem1(IMPC)Tcp/Glrb+
(C57BL/6NCrl-Glrbem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Glrx3tm1.1(KOMP)Vlcg/Glrx3+
(B6N(Cg)-Glrx3tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gls001/Gls001+
(C3HeB/FeJ-Gls001)
|
hyperglycemia
|
J:137483
|
Gls2em1Xen/Gls2em1Xen
(involves: C57BL/6NTac)
|
decreased fasting circulating glucose level
|
J:271619
|
increased circulating glucagon level
|
J:271619
|
increased circulating glutamine level
|
J:271619
|
Gls007/Gls007+
(C3HeB/FeJ-Gls007)
|
hyperglycemia
|
J:137483
|
Glt8d2tm1a(KOMP)Wtsi/Glt8d2tm1a(KOMP)Wtsi
(C57BL/6N-Glt8d2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
glu5/glu5
(Not Specified)
|
hyperglycemia
|
J:85113
|
Gluchos3C3H/HeH/Gluchos3C57BL/6J
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating insulin level
|
J:106692
|
Gluchos3C57BL/6J/Gluchos3C57BL/6J
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating insulin level
|
J:106692
|
Glud1tm1.1Pma/Glud1tm1.1Pma Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL)
|
decreased circulating insulin level
|
J:145558
|
Glultm1.1Geno/Glultm1.1Geno Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * DBA)
|
increased circulating ammonia level
|
J:221031
|
Glultm3Whla/Glultm1Whla Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased circulating glutamine level
|
J:161082
|
Glultm3Whla/Glultm1Whla Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased circulating glucose level
|
J:162067
|
Glultm3Whla/Glultm3Whla Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased circulating glucose level
|
J:162067
|
Glyctkem1(IMPC)J/Glyctkem1(IMPC)J
(C57BL/6NJ-Glyctkem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gm2aem1(IMPC)H/Gm2aem1(IMPC)H
(C57BL/6NTac-Gm2aem1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Gm94tm1b(KOMP)Wtsi/Gm94+
(C57BL/6N-Gm94tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
Gm1043em1(IMPC)Wtsi/Gm1043em1(IMPC)Wtsi
(C57BL/6NCrl-Gm1043em1(IMPC)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
Gm5127em1(IMPC)J/Y
(C57BL/6NJ-Gm5127em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Gm5127em1(IMPC)J/Gm5127em1(IMPC)J
(C57BL/6NJ-Gm5127em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Gm5134tm1a(EUCOMM)Hmgu/Gm5134tm1a(EUCOMM)Hmgu
(C57BL/6N-Gm5134tm1a(EUCOMM)Hmgu/H)
|
decreased circulating triglyceride level
|
J:165965
|
Gm12610em1Rwan/Gm12610em1Rwan
(C57BL/6-Gm12610em1Rwan)
|
decreased circulating creatinine level
|
J:359024
|
Gm20646em1(IMPC)Wtsi/Gm20646em1(IMPC)Wtsi
(C57BL/6N-Gm20646em1(IMPC)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
increased circulating alanine transaminase level
|
J:341056
|
increased circulating aspartate transaminase level
|
J:341056
|
increased circulating insulin level
|
J:341056
|
increased circulating triglyceride level
|
J:341056
|
Gm41610em1Scrp/Gm41610em1Scrp
(C57BL/6-Gm41610em1Scrp)
|
decreased partial thromboplastin time
|
J:302605
|
increased circulating interleukin-5 level
|
J:302605
|
increased circulating interleukin-13 level
|
J:302605
|
Gmdstm1a(KOMP)Wtsi/Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Gmeb2em1(IMPC)J/Gmeb2+
(C57BL/6NJ-Gmeb2em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
Gmiptm1b(KOMP)Wtsi/Gmiptm1b(KOMP)Wtsi
(C57BL/6N-Gmiptm1b(KOMP)Wtsi/BayMmucd)
|
decreased circulating fructosamine level
|
J:211773
|
Gmnctm1b(KOMP)Wtsi/Gmnc+
(C57BL/6N-Gmnctm1b(KOMP)Wtsi/Wtsi)
|
increased circulating sodium level
|
J:211773
|
Gmnntm1Tjm/Gmnntm1Tjm Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)
|
increased circulating erythropoietin level
|
J:171741
|
Gmppaem1(IMPC)Tcp/Gmppaem1(IMPC)Tcp
(C57BL/6N-Gmppaem1(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Gmppatm1d(EUCOMM)Wtsi/Gmppatm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal blood homeostasis
|
J:305791
|
Gna11em1Mman/Gna11+
(C57BL/6NCrl-Gna11em1Mman)
|
decreased circulating calcium level
|
J:280180
|
decreased circulating parathyroid hormone level
|
J:280180
|
Gna11em1Mman/Gna11em1Mman
(C57BL/6NCrl-Gna11em1Mman)
|
decreased circulating calcium level
|
J:280180
|
decreased circulating parathyroid hormone level
|
J:280180
|
increased circulating phosphate level
|
J:280180
|
Gna11tm1a(EUCOMM)Wtsi/Gna11tm1a(EUCOMM)Wtsi
(C57BL/6N-Gna11tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating amylase level
|
J:165965
|
decreased circulating phosphate level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating calcium level
|
J:165965
|
Gna11tm1Soff/Gna11+ Gnaqtm2Soff/Gnaqtm2Soff Tg(PTH-cre)4167Slib/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating calcium level
|
J:116986
|
increased circulating parathyroid hormone level
|
J:116986
|
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd)
|
increased circulating triglyceride level
|
J:172091
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaq+ Tg(PTH-cre)4167Slib/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating calcium level
|
J:116986
|
increased circulating parathyroid hormone level
|
J:116986
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(PTH-cre)4167Slib/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating parathyroid hormone level
|
J:116986
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tg-cre)1Soff/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating thyroxine level
|
J:127484
|
increased circulating thyroid-stimulating hormone level
|
J:127484
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA * FVB/N)
|
abnormal blood coagulation
|
J:99597
|
abnormal platelet physiology
|
J:99597
|
decreased platelet aggregation
|
J:99597
|
increased bleeding time
|
J:99597
|
Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal blood coagulation
|
J:99597
|
abnormal platelet physiology
|
J:99597
|
increased bleeding time
|
J:99597
|
Gna13tm2.2Soff/Gna13tm2.2Soff Tg(EIIa-cre)C5379Lmgd/?
(involves: FVB)
|
abnormal blood coagulation
|
J:99597
|
abnormal platelet physiology
|
J:99597
|
increased bleeding time
|
J:99597
|
Gnai2tm1Lbi/Gnai2+ Tg(WTbeta2)4Wjk/0
(B6.Cg-Gnai2tm1Lbi Tg(WTbeta2)4Wjk)
|
cyanosis
|
J:125581
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased circulating interferon-gamma level
|
J:121471
|
increased circulating interleukin-4 level
|
J:121471
|
increased circulating interleukin-5 level
|
J:121471
|
Gnao1tm1b(EUCOMM)Hmgu/Gnao1+
(C57BL/6N-Gnao1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Gnao1tm3Lbi/Gnao1tm3Lbi
(involves: 129S7/SvEvBrd)
|
decreased circulating glucose level
|
J:168245
|
increased circulating insulin level
|
J:168245
|
Gnao1tm4Lbi/Gnao1tm4Lbi Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
increased circulating insulin level
|
J:169627
|
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv * C57BL/6)
|
abnormal platelet physiology
|
J:118488,
J:42882
|
increased bleeding time
|
J:42882
|
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv)
|
decreased platelet aggregation
|
J:114266
|
Gnaqtm2.1Soff/Gnaqtm2.1Soff
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal blood coagulation
|
J:77461
|
GnasOedsml/Gnas+
(Not Specified)
|
decreased circulating calcium level
|
J:91717
|
increased circulating parathyroid hormone level
|
J:91717
|
increased circulating phosphate level
|
J:91717
|
Gnastm1Kel/Gnas+
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating glucagon level
|
J:91703
|
decreased circulating glucose level
|
J:91703
|
decreased circulating insulin level
|
J:91703
|
Gnastm1Kel/Gnas+
(involves: 129S2/SvPas)
|
increased circulating ghrelin level
|
J:184320
|
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
|
abnormal blood homeostasis
|
J:106729
|
decreased circulating calcium level
|
J:49340
|
decreased circulating cholesterol level
|
J:60971
|
decreased circulating glucose level
|
J:106729
|
decreased circulating insulin level
|
J:106729
|
decreased circulating triglyceride level
|
J:60971
|
increased circulating parathyroid hormone level
|
J:49340
|
Gnastm2.1Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating parathyroid hormone level
|
J:97229
|
decreased circulating phosphate level
|
J:97229
|
Gnastm2Jop/Gnas+
(involves: 129S/SvEv)
|
decreased circulating leptin level
|
J:182868
|
Gnastm3Lsw/Gnastm3Lsw Ren1tm2(cre)Gom/Ren1+
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating aldosterone level
|
J:118076
|
decreased circulating renin level
|
J:118076
|
Gnastm3Lsw/Gnastm3Lsw Tg(Col2a1-cre)1Rsjo/0
(involves: 129S6/SvEvTac * FVB/N)
|
cyanosis
|
J:97230
|
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1)
|
increased circulating glucose level
|
J:99237
|
increased circulating insulin level
|
J:99237
|
increased circulating leptin level
|
J:99237
|
increased circulating triglyceride level
|
J:99237
|
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac)
|
abnormal blood homeostasis
|
J:233851
|
Gnastm5.1Lsw/Gnastm5.1Lsw H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
cyanosis
|
J:254756
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
decreased circulating insulin level
|
J:102504
|
hypoglycemia
|
J:102504
|
increased circulating glucagon level
|
J:102504
|
increased circulating triglyceride level
|
J:102504
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Fabp4-cre)1Abel/0
(involves: FVB)
|
decreased circulating free fatty acids level
|
J:159612
|
decreased circulating insulin level
|
J:159612
|
decreased circulating leptin level
|
J:159612
|
decreased circulating triglyceride level
|
J:159612
|
hypoglycemia
|
J:159612
|
increased circulating corticosterone level
|
J:159612
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Slc5a2-cre)1Tauc/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood homeostasis
|
J:233851
|
decreased circulating calcium level
|
J:233851
|
increased circulating parathyroid hormone level
|
J:233851
|
Gnaztm1Lfb/Gnaztm1Lfb
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
decreased platelet aggregation
|
J:77282
|
decreased susceptibility to induced thrombosis
|
J:77282
|
Gnb1lem1(IMPC)Tcp/Gnb1l+
(C57BL/6NCrl-Gnb1lem1(IMPC)Tcp/Tcp)
|
decreased circulating calcium level
|
J:211773
|
Gnb1lGt(OST35527)Lex/Gnb1l+
(B6;129S5-Gnb1lGt(OST35527)Lex/Orl)
|
increased circulating bilirubin level
|
J:82809
|
Gnb2em1(IMPC)J/Gnb2em1(IMPC)J
(C57BL/6NJ-Gnb2em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Gnb4em1(IMPC)H/Gnb4em1(IMPC)H
(C57BL/6NTac-Gnb4em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gnetm1Dar/Gnetm1Dar
(involves: C57BL/6J)
|
increased blood urea nitrogen level
|
J:122172
|
Gnetm1Sngi/Gnetm1Sngi Tg(ACTB-GNE*D176V)9Sngi/0
(involves: C57BL/6)
|
increased circulating creatine kinase level
|
J:117854
|
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N)
|
decreased circulating leptin level
|
J:92791
|
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N)
|
decreased circulating leptin level
|
J:92791
|
Gng7tm1Lex/Gng7tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating insulin level
|
J:103485
|
Gng12em1(IMPC)J/Gng12em1(IMPC)J
(C57BL/6NJ-Gng12em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Gng12em1(IMPC)Tcp/Gng12em1(IMPC)Tcp
(C57BL/6NCrl-Gng12em1(IMPC)Tcp/Cmmr)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Gng13tm1.1(KOMP)Vlcg/Gng13+
(C57BL/6N-Gng13tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating glucose level
|
J:211773
|
Gngt2em1(IMPC)Bay/Gngt2em1(IMPC)Bay
(C57BL/6N-Gngt2em1(IMPC)Bay/BayMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
|
decreased circulating glucose level
|
J:147857
|
increased circulating alanine transaminase level
|
J:147857,
J:146081
|
increased circulating cholesterol level
|
J:147857
|
increased circulating methionine level
|
J:147857
|
GnptabGt(OST97730)Lex/GnptabGt(OST97730)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal circulating enzyme level
|
J:127156
|
Gnptabtm1Kkol/Gnptabtm1Kkol
(involves: 129 * C57BL/6)
|
increased circulating type I collagen C-terminal telopeptide level
|
J:202751
|
Gnptgem1(IMPC)Mbp/Gnptgem1(IMPC)Mbp
(C57BL/6N-Gnptgem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gnrh1hpg/Gnrh1hpg
(involves: 101/H * C3H/HeH)
|
decreased circulating follicle stimulating hormone level
|
J:5877
|
Gnrh1tm1.1Hjn/Gnrh1tm1.1Hjn
(involves: C57BL/6)
|
increased circulating estradiol level
|
J:170674
|
increased circulating luteinizing hormone level
|
J:170674
|
increased circulating progesterone level
|
J:170674
|
GnrhrGt(181A6)Cmhd/GnrhrGt(181A6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating estradiol level
|
J:158384
|
decreased circulating follicle stimulating hormone level
|
J:158384
|
decreased circulating luteinizing hormone level
|
J:158384
|
decreased circulating progesterone level
|
J:158384
|
decreased circulating testosterone level
|
J:158384
|
Gnrhrhh/Gnrhrhh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating hormone level
|
J:96941
|
decreased circulating dihydrotestosterone level
|
J:96941
|
decreased circulating follicle stimulating hormone level
|
J:96941
|
decreased circulating progesterone level
|
J:96941
|
decreased circulating testosterone level
|
J:96941
|
Gnrhrhh/Gnrhrhh
(involves: C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:211771
|
decreased circulating gonadotropin level
|
J:211771
|
decreased circulating luteinizing hormone level
|
J:211771
|
Gnrhrtm1(GNRHR1)Xen/Gnrhrtm1(GNRHR1)Xen
(involves: C57BL/6 * C57BL/6JOlaHsd)
|
decreased circulating luteinizing hormone level
|
J:199193
|
decreased circulating testosterone level
|
J:199193
|
increased circulating estradiol level
|
J:199193
|
Gnrhrtm1.1(cre)Uboe/Gnrhr+ Tgfbr3tm1.1Hlin/Tgfbr3tm1.1Hlin Tgfbr3lem2Djb/Tgfbr3lem2Djb
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N)
|
increased circulating follicle stimulating hormone level
|
J:316383
|
Gnrhrtm1.1Bhr/Gnrhrtm1.1Bhr
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
decreased circulating follicle stimulating hormone level
|
J:211771
|
decreased circulating gonadotropin level
|
J:211771
|
decreased circulating luteinizing hormone level
|
J:211771
|
Gnrhrtm2.1(GNRHR)Djb/Gnrhrtm2.1(GNRHR)Djb
(involves: 129 * C57BL/6J * FVB/N)
|
decreased circulating follicle stimulating hormone level
|
J:324870
|
decreased circulating luteinizing hormone level
|
J:324870
|
Golga3tm1b(EUCOMM)Hmgu/Golga3tm1b(EUCOMM)Hmgu
(C57BL/6N-Golga3tm1b(EUCOMM)Hmgu/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Golga5tm1b(KOMP)Wtsi/Golga5tm1b(KOMP)Wtsi
(C57BL/6N-Golga5tm1b(KOMP)Wtsi/J)
|
increased circulating bilirubin level
|
J:211773
|
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glomerular capillary thrombosis
|
J:151282
|
Golph3em1(IMPC)Tcp/Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Golt1atm1b(KOMP)Wtsi/Golt1atm1b(KOMP)Wtsi
(C57BL/6N-Golt1atm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Gopctm1e.1(EUCOMM)Wtsi/Gopc+
(C57BL/6N-Gopctm1e.1(EUCOMM)Wtsi/Tcp)
|
decreased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Gorasp1tm1b(KOMP)Wtsi/Gorasp1+
(C57BL/6N-Gorasp1tm1b(KOMP)Wtsi/Orl)
|
decreased circulating creatinine level
|
J:211773
|
Gosr2tm1b(EUCOMM)Hmgu/Gosr2+
(C57BL/6N-Gosr2tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
Got1tm1b(EUCOMM)Hmgu/Got1+
(C57BL/6N-Got1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating glucose level
|
J:211773
|
Gp1batm1Ware/Gp1batm1Ware
(involves: 129S1/Sv * 129X1/SvJ)
|
increased bleeding time
|
J:63389
|
Gp1bbtm1Frla/Gp1bbtm1Frla
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to induced thrombosis
|
J:135065
|
increased bleeding time
|
J:135065
|
Gp1bbtm1Ware/Gp1bbtm1Ware
(Not Specified)
|
increased bleeding time
|
J:93756
|
Gp1bbtm2Frla/Gp1bbtm2Frla
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to induced thrombosis
|
J:135065
|
increased bleeding time
|
J:135065
|
Gp5tm1Drp/Gp5tm1Drp
(involves: 129X1/SvJ * C57BL/6J)
|
decreased bleeding time
|
J:58516
|
Gp6tm1Beni/Gp6tm1Beni
(involves: 129 * C57BL/6)
|
abnormal blood coagulation
|
J:217963
|
increased bleeding time
|
J:217963
|
Gp6tm1Beni/Gp6tm1Beni Clec1btm1.1Arte/Clec1btm1.1Arte Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
increased bleeding time
|
J:217963
|
Gp6tm1Ware/Gp6tm1Ware
(involves: Black Swiss)
|
abnormal blood coagulation
|
J:85315
|
abnormal platelet activation
|
J:85315
|
decreased platelet aggregation
|
J:85315
|
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating cholesterol level
|
J:134068
|
decreased circulating triglyceride level
|
J:134068
|
increased circulating ketone body level
|
J:134068
|
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:84541
|
decreased circulating HDL cholesterol level
|
J:84541
|
decreased circulating insulin level
|
J:84541
|
decreased circulating triglyceride level
|
J:84541
|
decreased circulating VLDL triglyceride level
|
J:84541
|
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:213618
|
decreased circulating glucose level
|
J:213618
|
increased circulating alanine transaminase level
|
J:213618
|
increased circulating aspartate transaminase level
|
J:213618
|
increased circulating cholesterol level
|
J:213618
|
Gpatch4em1(IMPC)Ccpcz/Gpatch4em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpatch4em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Gpbar1tm1.1(KOMP)Vlcg/Gpbar1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpbar1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Gpbar1tm1.2Auw/Gpbar1tm1.2Auw
(involves: 129 * C57BL/6J)
|
increased circulating insulin level
|
J:152388
|
Gpbar1tm1Ktan/Gpbar1tm1Ktan
(involves: 129X1/SvJ * C57BL/6N)
|
increased circulating cholesterol level
|
J:114971
|
Gpbp1tm1b(EUCOMM)Wtsi/Gpbp1+
(C57BL/6N-Gpbp1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
Gpc3tm1Arge/Y
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
hypoglycemia
|
J:75054
|
Gpc4tm2b(EUCOMM)Wtsi/Y
(C57BL/6N-Gpc4tm2b(EUCOMM)Wtsi/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Gpc4tm2b(EUCOMM)Wtsi/Gpc4tm2b(EUCOMM)Wtsi
(C57BL/6N-Gpc4tm2b(EUCOMM)Wtsi/J)
|
increased circulating bilirubin level
|
J:211773
|
Gpcpd1em1(IMPC)Tcp/Gpcpd1+
(C57BL/6N-Gpcpd1em1(IMPC)Tcp/Tcp)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
hyperglycemia
|
J:345630
|
Gpd1em1(IMPC)Hmgu/Gpd1em1(IMPC)Hmgu
(C57BL/6NCrl-Gpd1em1(IMPC)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka)
|
decreased circulating insulin level
|
J:124766
|
increased circulating cholesterol level
|
J:124766
|
increased circulating thyroxine level
|
J:87244
|
increased circulating triiodothyronine level
|
J:87244
|
Gpd2tm1Tka/Gpd2tm1Tka Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct)
|
abnormal circulating amino acid level
|
J:124766
|
decreased circulating insulin level
|
J:124766
|
hypoglycemia
|
J:124766
|
increased blood urea nitrogen level
|
J:124766
|
increased circulating alkaline phosphatase level
|
J:124766
|
increased circulating ammonia level
|
J:124766
|
increased circulating free fatty acids level
|
J:124766
|
increased circulating glycerol level
|
J:124766
|
Gper1em1(IMPC)Hmgu/Gper1em1(IMPC)Hmgu
(C57BL/6NCrl-Gper1em1(IMPC)Hmgu/Ieg)
|
decreased circulating potassium level
|
J:211773
|
Gper1tm1.1Lmlf/Gper1tm1.1Lmlf
(B6.129-Gper1tm1.1Lmlf)
|
decreased circulating glucagon level
|
J:146345
|
decreased circulating insulin-like growth factor I level
|
J:146345
|
increased circulating glucose level
|
J:146345
|
Gpi1b-m1Neu/Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu)
|
increased circulating bilirubin level
|
J:35956
|
increased circulating glucose level
|
J:35956
|
Gpi1b-m2Neu/Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu)
|
increased circulating bilirubin level
|
J:35956
|
increased circulating glucose level
|
J:35956
|
Gpihbp1tm1Sgy/Gpihbp1tm1Sgy
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:129764
|
increased circulating cholesterol level
|
J:129764
|
increased circulating triglyceride level
|
J:129764
|
increased circulating VLDL cholesterol level
|
J:129764
|
Gpld1tm1.1(KOMP)Vlcg/Gpld1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpld1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gpn1em1(IMPC)J/Gpn1+
(C57BL/6NJ-Gpn1em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Gpnmbtm1.1(KOMP)Vlcg/Gpnmb+
(C57BL/6N-Gpnmbtm1.1(KOMP)Vlcg/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Gpr3tm1Cled/Gpr3tm1Cled
(either: B6.129-Gpr3tm1Cled or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
increased circulating follicle stimulating hormone level
|
J:105182
|
Gpr4tm1Witt/Gpr4tm1Witt
(either: B6.129X1-Gpr4tm1Witt or (involves: 129X1/SvJ * C57BL/6))
|
cyanosis
|
J:118276
|
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen)
|
increased circulating cholesterol level
|
J:111942
|
increased circulating glucose level
|
J:111942
|
increased circulating HDL cholesterol level
|
J:111942
|
increased circulating LDL cholesterol level
|
J:111942
|
Gpr21tm1Dgen/Gpr21tm1Dgen
(B6.129P2-Gpr21tm1Dgen)
|
abnormal circulating chemokine level
|
J:181127
|
decreased circulating serum amyloid protein level
|
J:181127
|
Gpr22tm1b(KOMP)Wtsi/Gpr22tm1b(KOMP)Wtsi
(C57BL/6N-Gpr22tm1b(KOMP)Wtsi/H)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6)
|
abnormal circulating hormone level
|
J:189617
|
decreased circulating ghrelin level
|
J:189617
|
increased circulating cholesterol level
|
J:189617
|
increased circulating glucose level
|
J:189617
|
increased circulating insulin level
|
J:189617
|
increased circulating leptin level
|
J:189617
|
increased circulating triglyceride level
|
J:189617
|
Gpr27tm1Tac/Gpr27tm1Tac
(B6.129S-Gpr27tm1Tac)
|
decreased circulating insulin level
|
J:286854
|
Gpr39tm1Dgen/Gpr39tm1Dgen
(B6.129P2-Gpr39tm1Dgen)
|
decreased circulating insulin level
|
J:151806
|
increased circulating glucose level
|
J:151806
|
Gpr39tm1Lex/Gpr39tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:124913
|
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating insulin level
|
J:302257
|
increased circulating leptin level
|
J:302257
|
increased circulating triglyceride level
|
J:302257
|
Gpr63tm1.1(KOMP)Vlcg/Gpr63tm1.1(KOMP)Vlcg
(C57BL/6N-Gpr63tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Gpr68tm1.1Aha/Gpr68tm1.1Aha
(B6.129(C)-Gpr68tm1.1Aha)
|
decreased circulating insulin level
|
J:189192
|
Gpr68tm1Aha/Gpr68tm1Aha
(B6.129-Gpr68tm1Aha)
|
decreased circulating glucagon level
|
J:189192
|
decreased circulating glucose level
|
J:189192
|
decreased circulating insulin level
|
J:189192
|
Gpr82tm1Shbg/Y
(C3Fe.Cg-Gpr82tm1Shbg)
|
decreased circulating glucose level
|
J:301613
|
decreased circulating insulin level
|
J:301613
|
decreased circulating VLDL cholesterol level
|
J:301613
|
decreased fasting circulating glucose level
|
J:301613
|
Gpr82tm1Shbg/Gpr82tm1Shbg
(C3Fe.Cg-Gpr82tm1Shbg)
|
decreased circulating insulin level
|
J:301613
|
decreased circulating VLDL cholesterol level
|
J:301613
|
Gpr84tm1.1(KOMP)Vlcg/Gpr84tm1.1(KOMP)Vlcg
(C57BL/6N-Gpr84tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Gpr87tm1.1(KOMP)Vlcg/Gpr87tm1.1(KOMP)Vlcg
(C57BL/6N-Gpr87tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gpr101em7036Tac/Y
(C57BL/6NTac-Gpr101em7036Tac)
|
increased circulating insulin level
|
J:347398
|
increased circulating tumor necrosis factor level
|
J:347398
|
Gpr119tm1Tjkw/Gpr119tm1Tjkw
(C57BL/6J-Gpr119tm1Tjkw)
|
decreased circulating insulin level
|
J:244912
|
Gpr142tm1Lex/Gpr142tm1Lex
(B6.129S-Gpr142tm1Lex)
|
abnormal circulating glucose level
|
J:249154
|
abnormal circulating hormone level
|
J:249154
|
abnormal circulating insulin level
|
J:249154
|
abnormal circulating non-HDL cholesterol level
|
J:249154
|
decreased circulating insulin level
|
J:249154
|
increased fasting circulating glucose level
|
J:249154
|
Gpr146em1(IMPC)H/Gpr146em1(IMPC)H
(C57BL/6NTac-Gpr146em1(IMPC)H/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Gpr176tm1b(EUCOMM)Hmgu/Gpr176tm1b(EUCOMM)Hmgu
(C57BL/6N-Gpr176tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Gpr182tm2c(KOMP)Wtsi/Gpr182tm2c(KOMP)Wtsi Tg(Cdh5-cre/ERT2)1Rha/0
(B6.Cg-Gpr182tm2c(KOMP)Wtsi Tg(Cdh5-cre/ERT2)1Rha)
|
abnormal circulating chemokine level
|
J:305796
|
increased circulating CXCL10 level
|
J:305796
|
Gpr183tm1Lex/Gpr183tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal circulating interferon-beta level
|
J:211122
|
increased circulating interferon-alpha level
|
J:211122
|
increased circulating interferon-gamma level
|
J:211122
|
Gprasp2em1(IMPC)J/Gprasp2em1(IMPC)J
(C57BL/6NJ-Gprasp2em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gprc5ctm1Yhir/Gprc5ctm1Yhir
(B6.Cg-Gprc5ctm1Yhir)
|
increased circulating alkaline phosphatase level
|
J:176063
|
increased circulating lactate dehydrogenase level
|
J:176063
|
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating hormone level
|
J:144372
|
abnormal circulating phosphate level
|
J:144372
|
decreased circulating insulin level
|
J:144372
|
decreased circulating testosterone level
|
J:144372
|
increased circulating estradiol level
|
J:144372
|
increased circulating glucose level
|
J:144372
|
Gprin1em1(IMPC)H/Gprin1em1(IMPC)H
(C57BL/6N-Gprin1em1(IMPC)H/H)
|
increased circulating iron level
|
J:211773
|
Gpsm1tm1.1Lajb/Gpsm1+ Pkd1tm1.1Fqi/Pkd1tm1.1Fqi
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:193175
|
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb Pkd1tm1.1Fqi/Pkd1tm1.1Fqi
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:193175
|
increased circulating creatinine level
|
J:193175
|
Gpx1tm1Ysh/Gpx1tm1Ysh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal platelet physiology
|
J:41169
|
Gpx3tm1Jlos/Gpx3+
(B6N.Cg-Gpx3tm1Jlos)
|
decreased bleeding time
|
J:183744
|
increased platelet aggregation
|
J:183744
|
Gpx3tm1Jlos/Gpx3tm1Jlos
(B6N.Cg-Gpx3tm1Jlos)
|
abnormal blood homeostasis
|
J:183744
|
decreased bleeding time
|
J:183744
|
increased platelet aggregation
|
J:183744
|
increased susceptibility to induced thrombosis
|
J:183744
|
Gramd1bem1Pton/Gramd1bem1Pton
(involves: C57BL/6N)
|
decreased circulating corticosterone level
|
J:266462
|
Gramd1ctm1a(KOMP)Wtsi/Gramd1ctm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Gramd1ctm1a(KOMP)Wtsi/JMmucd)
|
decreased circulating corticosterone level
|
J:347902
|
increased circulating cortisol level
|
J:347902
|
Gramd1ctm1b(KOMP)Wtsi/Gramd1ctm1b(KOMP)Wtsi
(C57BL/6N-Gramd1ctm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB)
|
increased circulating insulin level
|
J:213603
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv)
|
increased circulating insulin level
|
J:213603
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:208498
|
Grcc10tm1.1(KOMP)Vlcg/Grcc10tm1.1(KOMP)Vlcg
(C57BL/6N-Grcc10tm1.1(KOMP)Vlcg/J)
|
cyanosis
|
J:211773
|
Grem1tm1Azun/Grem1tm1Azun
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
cyanosis
|
J:90991
|
Grem2em1(IMPC)Bay/Grem2+
(C57BL/6N-Grem2em1(IMPC)Bay/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Grem2em1Stpg/Grem2em1Stpg
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J)
|
abnormal circulating hormone level
|
J:318711
|
Grhl3tm1a(EUCOMM)Wtsi/Grhl3+
(C57BL/6N-Grhl3tm1a(EUCOMM)Wtsi/Ics)
|
decreased blood urea nitrogen level
|
J:165965
|
decreased circulating alkaline phosphatase level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating calcium level
|
J:165965
|
increased circulating glucose level
|
J:165965
|
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal blood homeostasis
|
J:181969
|
Gria1em1(IMPC)H/Gria1em1(IMPC)H
(C57BL/6N-Gria1em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Gria1em1(IMPC)Hmgu/Gria1em1(IMPC)Hmgu
(C57BL/6N-Gria1em1(IMPC)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Gria1tm1Lex/Gria1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased glycosylated hemoglobin level
|
J:82809
|
increased blood urea nitrogen level
|
J:82809
|
Gria2em1(IMPC)H/Gria2+
(C57BL/6NTac-Gria2em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Grid2Lc/Grid2+
(involves: C57BL/6 * CBA)
|
increased circulating adrenocorticotropin level
|
J:44206
|
increased circulating corticosterone level
|
J:44206
|
Grik3em1(IMPC)Mbp/Grik3em1(IMPC)Mbp
(C57BL/6N-Grik3em1(IMPC)Mbp/MbpMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Grin1tm1.1Phs/Grin1tm1.1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:75497
|
Grin1tm1Cur/Grin1tm1.1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:75497
|
Grin1tm1Cur/Grin1tm1Cur
(involves: 129S1/Sv * C57BL/6)
|
cyanosis
|
J:66345
|
Grin1tm1Nak/Grin1tm1Nak
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
cyanosis
|
J:38582
|
Grin1tm1Stl/Grin1tm1Stl
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
cyanosis
|
J:17384
|
Grin1tm2Slab/Grin1tm1.1Slab
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:82670
|
Grin2dtm1a(EUCOMM)Wtsi/Grin2dtm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating sodium level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Grin3btm1b(KOMP)Wtsi/Grin3btm1b(KOMP)Wtsi
(C57BL/6N-Grin3btm1b(KOMP)Wtsi/H)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Grip1eb/Grip1eb
(involves: ATEB/Le * C57BL/6J)
|
abnormal blood coagulation
|
J:64538
|
Grm3tm1b(KOMP)Wtsi/Grm3tm1b(KOMP)Wtsi
(C57BL/6N-Grm3tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J)
|
abnormal circulating hormone level
|
J:268827
|
increased circulating antidiuretic hormone level
|
J:268827
|
increased circulating ghrelin level
|
J:268827
|
gro22/gro22
(Not Specified)
|
decreased circulating cholesterol level
|
J:85113
|
Grpel1tm1c(EUCOMM)Wtsi/Grpel1tm1c(EUCOMM)Wtsi Tg(ACTA1-cre/ERT2)97.16Mtz/0
(involves: C57BL/6N)
|
decreased circulating glucose level
|
J:330869
|
Grtp1tm1b(EUCOMM)Hmgu/Grtp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Grtp1tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Grxcr1em1(IMPC)J/Grxcr1em1(IMPC)J
(C57BL/6NJ-Grxcr1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Gsdmetm1b(KOMP)Wtsi/Gsdmetm1b(KOMP)Wtsi
(C57BL/6N-Gsdmetm1b(KOMP)Wtsi/Wtsi)
|
increased circulating fructosamine level
|
J:211773
|
Gse1tm1a(EUCOMM)Wtsi/Gse1+
(C57BL/6N-Gse1tm1a(EUCOMM)Wtsi/H)
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating total protein level
|
J:165965
|
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
decreased circulating glycerol level
|
J:175295
|
Gsk3atm1b(EUCOMM)Hmgu/Gsk3atm1b(EUCOMM)Hmgu
(C57BL/6N-Gsk3atm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gsk3atm1Dral/Gsk3atm1Dral Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd)
|
increased circulating corticosterone level
|
J:200517
|
increased circulating interleukin-6 level
|
J:200517
|
Gsk3btm1Jrw/Gsk3b+
(involves: 129 * C57BL/6J)
|
decreased circulating glucose level
|
J:135659
|
decreased circulating insulin level
|
J:135659
|
Gsk3btm1Jrw/Gsk3b+ Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
abnormal circulating glucose level
|
J:135659
|
abnormal circulating insulin level
|
J:135659
|
Gsk3btm1Jrw/Gsk3b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal circulating glucose level
|
J:135659
|
increased circulating glucose level
|
J:135659
|
increased circulating insulin level
|
J:135659
|
Gsk3btm2Jrw/Gsk3btm2Jrw Irs2tm1Mfw/Irs2tm1Mfw Tg(Ins2-cre)23Herr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating glucose level
|
J:135659
|
increased circulating insulin level
|
J:135659
|
Gskiptm1.2Ekn/Gskiptm1.2Ekn
(B6.129P2(Cg)-Gskiptm1.2Ekn)
|
cyanosis
|
J:228948
|
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal platelet activation
|
J:24346
|
increased bleeding time
|
J:24346
|
Gsta4tm1Pzim/Gsta4tm1Pzim
(involves: 129S1/Sv * 129S6/SvEvTac)
|
increased circulating alanine transaminase level
|
J:87983
|
increased circulating aspartate transaminase level
|
J:87983
|
Gstcdtm1b(EUCOMM)Wtsi/Gstcdtm1b(EUCOMM)Wtsi
(C57BL/6N-Gstcdtm1b(EUCOMM)Wtsi/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating potassium level
|
J:211773
|
Gstk1tm1Pgb/Gstk1tm1Pgb
(BALB/c-Gstk1tm1Pgb)
|
decreased circulating triglyceride level
|
J:177201
|
Gstm5em1(IMPC)Mbp/Gstm5em1(IMPC)Mbp
(C57BL/6N-Gstm5em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Gstm6tm1b(EUCOMM)Hmgu/Gstm6tm1b(EUCOMM)Hmgu
(C57BL/6N-Gstm6tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Gstt1tm1a(EUCOMM)Hmgu/Gstt1tm1a(EUCOMM)Hmgu
(Not Specified)
|
increased circulating glucose level
|
J:165965
|
Gstz1tm3b(EUCOMM)Hmgu/Gstz1tm3b(EUCOMM)Hmgu
(C57BL/6N-Gstz1tm3b(EUCOMM)Hmgu/BayMmucd)
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Gsx2tm1Ssp/Gsx2tm1Ssp
(involves: 129S2/SvPas)
|
cyanosis
|
J:44324
|
Gt(ROSA)26Sortm1(B4galt1)Clib/Gt(ROSA)26Sortm1(B4galt1)Clib Tg(Nes-cre)Wme/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased circulating interleukin-6 level
|
J:209737
|
Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/Gt(ROSA)26Sor+ Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:134336
|
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J)
|
abnormal circulating glucagon level
|
J:146650
|
abnormal circulating glucose level
|
J:146650
|
decreased circulating glucagon level
|
J:146650
|
decreased circulating insulin level
|
J:146650
|
hyperglycemia
|
J:146650
|
increased circulating glucagon level
|
J:146650
|
Gt(ROSA)26Sortm1(CAG-LMNA*)Cyh/Gt(ROSA)26Sor+ Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6JNarl * FVB)
|
increased circulating creatine kinase level
|
J:284048
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+ Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
decreased circulating glucose level
|
J:292094
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Secisbp2tm1.1Amdu/Secisbp2tm1.2Amdu
(B6(129S4)-Gt(ROSA)26Sortm1(cre/ERT2)Tyj Secisbp2tm1.1Amdu Secisbp2tm1.2Amdu)
|
increased circulating thyroid-stimulating hormone level
|
J:251875
|
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+ Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd)
|
increased circulating alanine transaminase level
|
J:92789
|
increased circulating aspartate transaminase level
|
J:92789
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
decreased circulating insulin level
|
J:201507
|
decreased circulating osteocalcin level
|
J:201507
|
decreased circulating testosterone level
|
J:201507
|
hyperglycemia
|
J:201507
|
increased circulating glucose level
|
J:201507
|
increased circulating resistin level
|
J:201507
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+ Cd79atm3(cre/ERT2)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal circulating chemokine level
|
J:208904
|
increased circulating interferon-gamma level
|
J:208904
|
increased circulating interleukin-6 level
|
J:208904
|
increased circulating interleukin-10 level
|
J:208904
|
increased circulating tumor necrosis factor level
|
J:208904
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:210493
|
hyperglycemia
|
J:210493
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA)
|
decreased fasting circulating glucose level
|
J:210493
|
increased circulating insulin level
|
J:210493
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Trp53tm1Brn/Trp53tm1Brn Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
hyperglycemia
|
J:210493
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
hyperglycemia
|
J:210493
|
Gt(ROSA)26Sortm1(Gphb5)Lmac/Gt(ROSA)26Sor+
(Not Specified)
|
decreased circulating cholesterol level
|
J:96633
|
decreased circulating glucose level
|
J:96633
|
decreased circulating insulin level
|
J:96633
|
increased circulating thyroxine level
|
J:96633
|
increased circulating triiodothyronine level
|
J:96633
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+
(Not Specified)
|
hyperglycemia
|
J:170965
|
increased circulating insulin level
|
J:170965
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+ Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N)
|
abnormal circulating hormone level
|
J:169459
|
decreased circulating glucose level
|
J:169459
|
decreased circulating growth hormone level
|
J:169459
|
decreased circulating insulin level
|
J:169459
|
decreased circulating insulin-like growth factor I level
|
J:169459
|
increased circulating leptin level
|
J:169459
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating insulin level
|
J:144715
|
increased circulating glucagon level
|
J:144715
|
increased circulating glucose level
|
J:144715
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
hyperglycemia
|
J:210493
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Lepob/Lepob Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
|
hyperglycemia
|
J:237232
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
|
hyperglycemia
|
J:237232
|
increased circulating insulin level
|
J:237232
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurog3-cre)C1Able/0
(involves: 129S4/SvJaeSor)
|
hyperglycemia
|
J:190530
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cytokine level
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+ Lyz2tm1(cre)Ifo/Lyz2+ Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating interferon-gamma level
|
J:260047
|
increased circulating interleukin-6 level
|
J:260047
|
increased circulating tumor necrosis factor level
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+ Tg(S100A8-cre,-EGFP)1Ilw/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal circulating cytokine level
|
J:260047
|
increased circulating interleukin-18 level
|
J:260047
|
Gt(ROSA)26Sortm1(ptxA)Cgh/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
hypoglycemia
|
J:130781
|
increased circulating insulin level
|
J:130781
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)
|
decreased circulating insulin level
|
J:194290
|
decreased fasting circulating glucose level
|
J:194290
|
hypoglycemia
|
J:194290
|
increased circulating free fatty acids level
|
J:194290
|
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+ Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB/N)
|
decreased circulating thyroxine level
|
J:209418
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv Tg(Agrp-cre)1Gsb/?
(involves: C57BL/6 * FVB/N)
|
decreased circulating adrenaline level
|
J:133218
|
decreased circulating glucose level
|
J:133218
|
decreased circulating insulin level
|
J:133218
|
decreased circulating noradrenaline level
|
J:133218
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased circulating interleukin-17 level
|
J:205858
|
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sor+ Hfetm2Nca/Hfetm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)
|
increased circulating iron level
|
J:133221
|
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sortm1(Tfrc*)Nca
(involves: 129S4/SvJae * FVB/N)
|
increased circulating iron level
|
J:133221
|
Gt(ROSA)26Sortm1.1(Alb-PCSK9)Mby/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6N)
|
increased circulating cholesterol level
|
J:280156
|
increased circulating LDL cholesterol level
|
J:280156
|
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:166829
|
decreased circulating LDL cholesterol level
|
J:166829
|
increased circulating free fatty acids level
|
J:166829
|
increased circulating HDL cholesterol level
|
J:166829
|
increased circulating leptin level
|
J:166829
|
increased circulating triglyceride level
|
J:166829
|
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:166829
|
decreased circulating LDL cholesterol level
|
J:166829
|
decreased circulating leptin level
|
J:166829
|
increased circulating free fatty acids level
|
J:166829
|
increased circulating HDL cholesterol level
|
J:166829
|
increased circulating insulin level
|
J:166829
|
increased circulating triglyceride level
|
J:166829
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:286108
|
decreased fasting circulating glucose level
|
J:286108
|
Gt(ROSA)26Sortm1Fia/Gt(ROSA)26Sor+ Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased circulating growth hormone level
|
J:138868
|
Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
increased circulating erythropoietin level
|
J:192055
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal circulating cytokine level
|
J:207306
|
increased circulating interferon-gamma level
|
J:207306
|
increased circulating interleukin-2 level
|
J:207306
|
increased circulating interleukin-4 level
|
J:207306
|
increased circulating interleukin-6 level
|
J:207306
|
increased circulating interleukin-10 level
|
J:207306
|
increased circulating tumor necrosis factor level
|
J:207306
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+ Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR)
|
abnormal circulating cytokine level
|
J:207306
|
increased circulating interferon-gamma level
|
J:207306
|
increased circulating interleukin-2 level
|
J:207306
|
increased circulating interleukin-4 level
|
J:207306
|
increased circulating interleukin-6 level
|
J:207306
|
increased circulating interleukin-10 level
|
J:207306
|
increased circulating tumor necrosis factor level
|
J:207306
|
Gt(ROSA)26Sortm2(OVA/EGFP)Dwir/Gt(ROSA)26Sor+ Tg(TcraTcrb)1100Mjb/0 Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased circulating alanine transaminase level
|
J:173806
|
Gt(ROSA)26Sortm2(SNCA*119)Djmo/Gt(ROSA)26Sortm2(SNCA*119)Djmo 7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+
(involves: 129 * C57BL/6)
|
increased circulating noradrenaline level
|
J:150777
|
Gt(ROSA)26Sortm2.1(CAG-PSTPIP1*)Dtg/Gt(ROSA)26Sor+
(involves: BALB/cJ * C57BL/6)
|
increased circulating interleukin-1 alpha level
|
J:196002
|
increased circulating interleukin-1 beta level
|
J:196002
|
increased circulating tumor necrosis factor level
|
J:196002
|
Gt(ROSA)26Sortm3(CAG-Il17a)Awai/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased circulating interleukin-17 level
|
J:144710
|
Gt(ROSA)26Sortm3(H1/tetO-RNAi:Mir143)Jcbr/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:176266
|
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+ Tg(Col1a1-cre)1Ack/0
(involves: FVB/N)
|
increased circulating osteocalcin level
|
J:208766
|
increased circulating type I collagen C-terminal telopeptide level
|
J:208766
|
Gt(ROSA)26Sortm8(RNAi:Crhr1)Rkuhn/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating corticosterone level
|
J:151155
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/? Tnfaip3tm1Homy/Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
abnormal circulating cytokine level
|
J:212681
|
abnormal circulating interleukin level
|
J:212681
|
increased circulating interferon-gamma level
|
J:212681
|
increased circulating interleukin-1 beta level
|
J:212681
|
increased circulating interleukin-6 level
|
J:212681
|
increased circulating tumor necrosis factor level
|
J:212681
|
Gt(ROSA)26Sortm31(H1/tetO-RNAi:Insr)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
hyperglycemia
|
J:151686
|
Gtf2a1lem1(IMPC)J/Gtf2a1lem1(IMPC)J
(C57BL/6NJ-Gtf2a1lem1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Gtf2e2tm1b(EUCOMM)Wtsi/Gtf2e2+
(C57BL/6N-Gtf2e2tm1b(EUCOMM)Wtsi/H)
|
increased circulating creatinine level
|
J:211773
|
Gtf2ird1em1(IMPC)Ccpcz/Gtf2ird1em1(IMPC)Ccpcz
(C57BL/6NCrl-Gtf2ird1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1Tg(Alb1-Myc)166.8Sst
(involves: C57BL/6J * CBA/J)
|
increased circulating corticosterone level
|
J:190478
|
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating corticosterone level
|
J:182346
|
Gtpbp10tm1b(KOMP)Mbp/Gtpbp10tm1b(KOMP)Mbp
(C57BL/6N-Gtpbp10tm1b(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Guca2btm1Lorz/Guca2btm1Lorz
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating sodium level
|
J:86148
|
Gucy1a1tm1.1Dko/Gucy1a1tm1.1Dko
(involves: C57BL/6)
|
abnormal platelet aggregation
|
J:110362
|
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal platelet activation
|
J:121321
|
Gucy1b1tm1Zhen/Gucy1b1tm1Zhen Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal platelet physiology
|
J:177066
|
decreased platelet aggregation
|
J:177066
|
decreased susceptibility to induced thrombosis
|
J:177066
|
increased bleeding time
|
J:177066
|
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar)
|
increased circulating insulin level
|
J:178241
|
increased circulating leptin level
|
J:178241
|
Guf1tm1.1Nju/Guf1tm1.1Nju
(involves: 129 * C57BL/6 * FVB/N)
|
increased circulating testosterone level
|
J:333298
|
Guloem1(IMPC)Ccpcz/Guloem1(IMPC)Ccpcz
(C57BL/6NCrl-Guloem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gulosfx/Gulosfx
(BALB/cBy-Gulosfx/J)
|
decreased circulating alkaline phosphatase level
|
J:66648
|
decreased circulating calcium level
|
J:66648
|
decreased circulating insulin-like growth factor I level
|
J:66648
|
decreased circulating phosphate level
|
J:66648
|
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:59931
|
increased circulating cholesterol level
|
J:59931
|
Gulp1tm1.2Kimj/Gulp1tm1.2Kimj
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating type I collagen C-terminal telopeptide level
|
J:340688
|
Gusbmps/Gusbmps
(involves: C57BL/6By)
|
decreased circulating cholesterol level
|
J:13923
|
Gy/Y
(involves: C3H/Sn * C57BL/6Ei)
|
decreased circulating calcium level
|
J:88352
|
decreased circulating potassium level
|
J:88352
|
Gy/Y
(involves: 101/H * C3H/HeH)
|
decreased circulating phosphate level
|
J:8335
|
increased circulating alkaline phosphatase level
|
J:8335
|
Gy/Y
(B6.Cg-Gy)
|
decreased circulating phosphate level
|
J:17152
|
Gy/Y
(involves: 101/H * C3H/HeH * C3H/HeSnJ * C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
Gy/Gy
(B6.Cg-Gy)
|
decreased circulating phosphate level
|
J:17152
|
Gy/Gy
(involves: 101/H * C3H/HeH * C3H/HeSnJ * C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
Gy/Gy+
(involves: 101/H * C3H/HeH)
|
decreased circulating phosphate level
|
J:8335
|
Gypcem1(IMPC)Rbrc/Gypcem1(IMPC)Rbrc
(C57BL/6NJcl-Gypcem1(IMPC)Rbrc/Rbrc)
|
decreased glycosylated hemoglobin level
|
J:211773
|
Gys2m1Btlr/Gys2m1Btlr
(C57BL/6J-Gys2m1Btlr)
|
decreased fasting circulating glucose level
|
J:265256
|
Gys2m2Btlr/Gys2m2Btlr
(C57BL/6J-Gys2m2Btlr)
|
decreased fasting circulating glucose level
|
J:265257
|
Gys2tm1.1Arte/Gys2tm1.1Arte
(Not Specified)
|
decreased circulating glucose level
|
J:208923
|
decreased circulating insulin level
|
J:208923
|
Gys2tm1.1Pro/Gys2tm1.1Pro Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal circulating ketone body level
|
J:162043
|
decreased circulating glucose level
|
J:162043
|
decreased circulating insulin level
|
J:162043
|
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Gys2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295,
J:165965
|
decreased circulating glycerol level
|
J:175295
|
increased circulating calcium level
|
J:165965
|
increased circulating sodium level
|
J:165965
|
increased circulating total protein level
|
J:165965
|
Gzf1em1(IMPC)Tcp/Gzf1+
(C57BL/6NCrl-Gzf1em1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Gzf1em1(IMPC)Tcp/Gzf1em1(IMPC)Tcp
(C57BL/6NCrl-Gzf1em1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
H1f8tm1b(KOMP)Wtsi/H1f8tm1b(KOMP)Wtsi
(C57BL/6N-H1f8tm1b(KOMP)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
H1f10tm1.1(KOMP)Vlcg/H1f10+
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
H1f10tm1.1(KOMP)Vlcg/H1f10tm1.1(KOMP)Vlcg
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)
|
increased circulating thyroid-stimulating hormone level
|
J:113509
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)
|
increased circulating glucose level
|
J:59245
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA)
|
increased circulating glucose level
|
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
|
abnormal atrial thrombosis
|
J:88055
|
cyanosis
|
J:88055
|
H2-T24em1(IMPC)Wtsi/H2-T24em1(IMPC)Wtsi
(C57BL/6N-H2-T24em1(IMPC)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
H2g7/H2g7 Ins2tm1Jja/Ins2tm1Jja Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased circulating glucose level
|
J:111874
|
H2ab3em1(IMPC)Wtsi/H2ab3em1(IMPC)Wtsi
(C57BL/6N-H2ab3em1(IMPC)Wtsi/WtsiOulu)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
H2az1em1(IMPC)J/H2az1+
(C57BL/6NJ-H2az1em1(IMPC)J/Mmjax)
|
decreased circulating total protein level
|
J:211773
|
H3f3btm1.1(KOMP)Mbp/H3f3btm1.1(KOMP)Mbp
(C57BL/6N-H3f3btm1.1(KOMP)Mbp/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
H4c2em1(IMPC)Bay/H4c2em1(IMPC)Bay
(C57BL/6N-H4c2em1(IMPC)Bay/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ)
|
decreased circulating free fatty acids level
|
J:292236
|
decreased circulating insulin level
|
J:292236
|
decreased fasting circulating glucose level
|
J:292236
|
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating corticosterone level
|
J:189132,
J:108281
|
decreased circulating glucose level
|
J:189132
|
H6pdtm1Pmst/H6pdtm1Pmst Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:189132
|
H13tm1b(KOMP)Wtsi/H13+
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Haaotm2b(KOMP)Mbp/Haaotm2b(KOMP)Mbp
(C57BL/6N-Haaotm2b(KOMP)Mbp/Ucd)
|
increased circulating glucose level
|
J:211773
|
Hacd2tm1a(EUCOMM)Hmgu/Hacd2tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
hypoglycemia
|
J:333944
|
increased circulating lactate level
|
J:333944
|
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg)
|
decreased circulating glucose level
|
J:179084
|
decreased circulating ketone body level
|
J:179084
|
increased circulating free fatty acids level
|
J:179084
|
increased circulating insulin level
|
J:179084
|
increased circulating triglyceride level
|
J:179084
|
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
decreased circulating glucose level
|
J:166803
|
increased circulating insulin level
|
J:166803
|
Hadhatm1Jib/Hadha+
(involves: 129X1/SvJ * NIH Black Swiss)
|
increased circulating free fatty acids level
|
J:101304
|
increased circulating insulin level
|
J:101304
|
Hadhatm1Jib/Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss)
|
abnormal blood homeostasis
|
J:69846
|
decreased circulating carnitine level
|
J:69846
|
hypoglycemia
|
J:69846
|
increased blood urea nitrogen level
|
J:69846
|
increased circulating alanine transaminase level
|
J:69846
|
increased circulating bilirubin level
|
J:69846
|
increased circulating carnitine level
|
J:69846
|
Hadhbem1(IMPC)Bay/Hadhb+
(C57BL/6N-Hadhbem1(IMPC)Bay/BayMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan)
|
decreased circulating glucose level
|
J:117738
|
Hamp/Hamp2tm1.1(HAMP)Bjs/Hamp/Hamp2tm1.1(HAMP)Bjs
(involves: 129 * NTac:NIHBS)
|
increased circulating iron level
|
J:203898
|
Hamp/Hamp2tm1.1(HAMP)Bjs/Hamp/Hamp2tm1.1(HAMP)Bjs
(involves: 129 * NTac:NIHBS)
|
increased circulating iron level
|
J:203898
|
Hamptm1.1(HAMP)Bjs/Hamptm1.1(HAMP)Bjs
(involves: 129 * NTac:NIHBS)
|
increased circulating iron level
|
J:203898
|
Hamptm1Svl/Hamptm1Svl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating iron level
|
J:119004
|
increased circulating ferritin level
|
J:119004
|
Hamptm2.1Svl/Hamptm2.1Svl
(involves: FVB/N)
|
increased circulating iron level
|
J:211683
|
Hand1tm1Eno/Hand1tm2Eno Tg(Myh6-cre)2182Mds/0
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
cyanosis
|
J:94514
|
Hap1tm1b(KOMP)Wtsi/Hap1+
(C57BL/6N-Hap1tm1b(KOMP)Wtsi/J)
|
increased blood urea nitrogen level
|
J:211773
|
Hap1tm1Hay/Hap1tm1Hay
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating leptin level
|
J:76174
|
Has3tm1b(EUCOMM)Wtsi/Has3tm1b(EUCOMM)Wtsi
(C57BL/6N-Has3tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm2(HBG1,HBD,HBB*)Ryan
(Not Specified)
|
increased circulating bilirubin level
|
J:148521
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating bilirubin level
|
J:30155
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased circulating erythropoietin level
|
J:185154
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+
(B6;129-Hbb-b1tm1Unc Hbb-b2tm1Unc/J)
|
increased circulating erythropoietin level
|
J:211331
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd)
|
increased circulating bilirubin level
|
J:97548
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+ Tg(HBB*)L2Pai/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating bilirubin level
|
J:97548
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+ Tmprss6tm1Otin/Tmprss6+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal circulating erythropoietin level
|
J:185154
|
Hbb-b1tm1Unc/Hbb-b1+ Hbb-b2tm1Unc/Hbb-b2+ Tmprss6tm1Otin/Tmprss6tm1Otin
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased circulating erythropoietin level
|
J:185154
|
Hbbd3th/Hbb+ Tg(HBB-AR-HBA2,-HBB*)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster)
|
increased circulating alanine transaminase level
|
J:94190
|
increased circulating aspartate transaminase level
|
J:94190
|
Hbbd3th/Hbbd3th Tg(HBB-AR-HBA2,-HBB*)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster)
|
increased circulating alanine transaminase level
|
J:94190
|
increased circulating aspartate transaminase level
|
J:94190
|
Hbbd4/Hbb+
(involves: 101/H)
|
increased blood oxygen capacity
|
J:7972
|
Hbbd4/Hbbd4
(involves: 101/H)
|
increased blood oxygen capacity
|
J:7972
|
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Hctm1b(EUCOMM)Wtsi/Hctm1b(EUCOMM)Wtsi
(C57BL/6N-Hctm1b(EUCOMM)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Hcar1em1(IMPC)Ccpcz/Hcar1em1(IMPC)Ccpcz
(C57BL/6N-Hcar1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Hccstm1Tcc/Hccs+ Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
abnormal atrial thrombosis
|
J:143285
|
Hcfc1em1Poche/Y
(C57BL/6J-Hcfc1em1Poche)
|
increased circulating homocysteine level
|
J:317822
|
Hcfc2fkls/Hcfc2fkls
(involves: C57BL/6J)
|
decreased circulating interferon-alpha level
|
J:251008
|
decreased circulating interferon-beta level
|
J:251008
|
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:111432
|
Hdac2tm1.2Eno/Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1)
|
cyanosis
|
J:123173
|
Hdac3tm1Swh/Hdac3tm1.1Swh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating glucagon level
|
J:134288
|
decreased circulating insulin level
|
J:134288
|
hypoglycemia
|
J:134288
|
increased circulating alanine transaminase level
|
J:134288
|
increased circulating cholesterol level
|
J:134288
|
increased circulating LDL cholesterol level
|
J:134288
|
increased circulating triglyceride level
|
J:134288
|
Hdac4em1(IMPC)Ccpcz/Hdac4+
(C57BL/6N-Hdac4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Hdac6tm1.1Pmt/Hdac6tm1.1Pmt
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-10 level
|
J:228570
|
Hdac7tm1b(EUCOMM)Hmgu/Hdac7+
(C57BL/6N-Hdac7tm1b(EUCOMM)Hmgu/Kmpc)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Hdac10tm1.1(KOMP)Mbp/Hdac10tm1.1(KOMP)Mbp
(C57BL/6N-Hdac10tm1.1(KOMP)Mbp/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Hdac11em1(IMPC)Kmpc/Hdac11em1(IMPC)Kmpc
(C57BL/6NTac-Hdac11em1(IMPC)Kmpc/Kmpc)
|
increased circulating alanine transaminase level
|
J:211773
|
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased circulating insulin level
|
J:85774
|
increased circulating leptin level
|
J:85774
|
Hddc2em1(IMPC)H/Hddc2em1(IMPC)H
(C57BL/6NTac-Hddc2em1(IMPC)H/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Hddc3tm1.1(KOMP)Vlcg/Hddc3tm1.1(KOMP)Vlcg
(C57BL/6N-Hddc3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Hdgfl1em1(IMPC)Tcp/Hdgfl1+
(C57BL/6NCrl-Hdgfl1em1(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
Hdgfl2tm1Lex/Hdgfl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating alkaline phosphatase level
|
J:171883
|
Hdl1C57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl2CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl3C57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl4CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:84091
|
increased circulating LDL cholesterol level
|
J:84091
|
Hdl6DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:84091
|
Hdl7DBA/2J/Hdl7DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdl34C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:38473
|
Hdl35C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdl36C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdl40C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdlcl1C57BL/6J/Hdlcl1C57BL/6J
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:94548
|
Hdlcl2C57BL/6J/Hdlcl2PERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:94548
|
Hdlq2NZB/BlNJ/Hdlq2NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Hdlq2NZB/BlNJ/Hdlq2SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Hdlq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707
|
Hdlq4NZB/BlNJ/Hdlq4SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707
|
Hdlq5C57BL/6J/Hdlq5C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq5NZB/BlNJ/Hdlq5NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq6C57BL/6J/Hdlq6C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq6NZB/BlNJ/Hdlq6NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq7C57BL/6J/Hdlq7C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq7C57BL/6J/Hdlq7C57BL/6J Hdlq9C57BL/6J/Hdlq9C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq7NZB/BlNJ/Hdlq7NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq10CAST/Ei/Hdlq10DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq11DBA/2J/Hdlq11CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq11DBA/2J/Hdlq11DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq12DBA/2J/Hdlq12CAST/EiJ
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq12DBA/2J/Hdlq12DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq13129S1/SvImJ/Hdlq13129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq13129S1/SvImJ/Hdlq13CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq14129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq14C57BL/6J/Hdlq14C57BL/6J Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:88486
|
Hdlq15129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089,
J:88486
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq58C57BL/6J/Hdlq58C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq60129S1/SvImJ/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq60C57BL/6J/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15C57BL/6J/Hdlq15C57BL/6J Hdlq19129S1/SvImJ/Hdlq19129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:88486
|
Hdlq16129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq17129S1/SvImJ/Hdlq17C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq18129S1/SvImJ/Hdlq18C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18C57BL/6J/Hdlq18C57BL/6J Hdlq59C57BL/6J/Hdlq59C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:144089
|
Hdlq20NZB/BlNJ/Hdlq20NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq20NZB/BlNJ/Hdlq20SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq21NZB/BlNJ/Hdlq21NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq21NZB/BlNJ/Hdlq21SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq22NZB/BlNJ/Hdlq22NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq22NZB/BlNJ/Hdlq22SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq23NZB/BlNJ/Hdlq23NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq23NZB/BlNJ/Hdlq23SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq24NZB/BlNJ/Hdlq24NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq24NZB/BlNJ/Hdlq24SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq25NZB/BlNJ/Hdlq25NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq25NZB/BlNJ/Hdlq25SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq26NZB/BlNJ/Hdlq26NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq27NZB/BlNJ/Hdlq27NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq28NZB/BlNJ/Hdlq28NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq28NZB/BlNJ/Hdlq28SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq29NZB/BlNJ/Hdlq29NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq29NZB/BlNJ/Hdlq29SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq30NZB/BlNJ/Hdlq30NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq30NZB/BlNJ/Hdlq30SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq31NZB/BlNJ/Hdlq31NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq31NZB/BlNJ/Hdlq31SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq32NZB/BlNJ/Hdlq32NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq33PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq34PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq35PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq37PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq37PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq40A/J/Hdlq40C57BL/6J Hdlq41A/J/?
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42A/J/Hdlq42A/J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42A/J/Hdlq42C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42C57BL/6J/Hdlq42C57BL/6J Hdlq44A/J/Hdlq44A/J
(involves: A/J * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:114073
|
Hdlq43C57BL/6J/Hdlq43C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq44A/J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq44C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq44C57BL/6J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq45A/J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq45C57BL/6J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq46C57BL/6J/Hdlq46C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq47C57BL/6J/Hdlq47C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq48C57BL/6J/Hdlq48C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq49A/J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq49C57BL/6J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq50A/J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq50C57BL/6J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq51A/J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq51C57BL/6J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq52129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq53129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq54129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq55129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq56C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq57129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq67129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq83PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq83PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq89RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq90RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq92C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq99129S1/SvImJ/Hdlq99129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq99129S1/SvImJ/Hdlq99RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq102129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Heatr3tm1a(EUCOMM)Hmgu/Heatr3+
(C57BL/6N-Heatr3tm1a(EUCOMM)Hmgu/Ics)
|
increased circulating glycerol level
|
J:165965
|
Hecaem1(IMPC)J/Hecaem1(IMPC)J
(C57BL/6NJ-Hecaem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hectd1tm1b(EUCOMM)Hmgu/Hectd1+
(C57BL/6N-Hectd1tm1b(EUCOMM)Hmgu/Nju)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Hectd3tm1Lex/Hectd3tm1Lex
(FVB.129S5(B6)-Hectd3tm1Lex)
|
decreased circulating interferon-beta level
|
J:266602
|
decreased circulating interleukin-1 beta level
|
J:266602
|
decreased circulating interleukin-6 level
|
J:266602
|
decreased circulating tumor necrosis factor level
|
J:266602
|
Hecw1tm2b(EUCOMM)Hmgu/Hecw1tm2b(EUCOMM)Hmgu
(C57BL/6N-Hecw1tm2b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Hellstm1a(EUCOMM)Wtsi/Hellstm1a(EUCOMM)Wtsi
(C57BL/6N-Hellstm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J)
|
hypoglycemia
|
J:107145
|
Helz2tm1Tesa/Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa)
|
decreased circulating insulin level
|
J:218127
|
decreased fasting circulating glucose level
|
J:218127
|
increased circulating leptin level
|
J:218127
|
Hephem1(IMPC)Ccpcz/Y
(C57BL/6NCrl-Hephem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating iron level
|
J:211773
|
Hephem1(IMPC)Ccpcz/Hephem1(IMPC)Ccpcz
(C57BL/6NCrl-Hephem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Herpud1tm1Kame/Herpud1tm1Kame
(B6CrSlc.129-Herpud1tm1Kame)
|
increased circulating glucose level
|
J:210654
|
Hexbtm1b(EUCOMM)Hmgu/Hexbtm1b(EUCOMM)Hmgu
(C57BL/6N-Hexbtm1b(EUCOMM)Hmgu/H)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased circulating interleukin-4 level
|
J:87617
|
Hfetm1.1Wsr/Hfetm1.1Wsr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating iron level
|
J:132134,
J:132141
|
Hfetm1Gfn/Hfetm1Gfn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating iron level
|
J:68025
|
Hfetm1Wsr/Hfetm1Wsr Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating iron level
|
J:132134
|
Hfetm2Nca/Hfetm2Nca
(involves: 129S6/SvEvTac)
|
increased circulating iron level
|
J:133221
|
Hfetm2Nca/Hfetm2Nca Tg(Ttr-Hfe)1Nca/0
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating iron level
|
J:133221
|
Hgdtm1a(KOMP)Wtsi/Hgdtm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal blood homeostasis
|
J:287389
|
Hgdtm1c(KOMP)Wtsi/Hgdtm1c(KOMP)Wtsi Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal blood homeostasis
|
J:287389
|
Hgsnatem4(IMPC)Tcp/Hgsnatem4(IMPC)Tcp
(C57BL/6NCrl-Hgsnatem4(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Hgsnattm1a(EUCOMM)Wtsi/Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
increased blood urea nitrogen level
|
J:235361
|
increased circulating alanine transaminase level
|
J:235361
|
Hibadhtm1b(EUCOMM)Wtsi/Hibadhtm1b(EUCOMM)Wtsi
(C57BL/6N-Hibadhtm1b(EUCOMM)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Hibadhtm1b(EUCOMM)Wtsi/Hibadhtm1b(EUCOMM)Wtsi
(C57BL/6N-Hibadhtm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Hif1atm1Stom/Hif1atm1Stom Tg(Vil1-cre)20Syr/0
(B6.Cg-Hif1atm1Stom Tg(Vil1-cre)20Syr)
|
decreased circulating insulin level
|
J:325395
|
Hif1atm3Rsjo/Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating glucose level
|
J:152724
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased circulating creatine kinase level
|
J:97761
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:143384
|
Hif1atm3Rsjo/Hif1atm3Rsjo Vhltm1Jae/Vhltm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)
|
increased circulating erythropoietin level
|
J:186085
|
Hif1antm1.1Rsjo/Hif1antm1.1Rsjo Tg(Nes-cre)1Wme/0
(involves: 129 * C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:160941
|
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo)
|
abnormal circulating hormone level
|
J:160941
|
decreased circulating cholesterol level
|
J:160941
|
decreased circulating glucose level
|
J:160941
|
decreased circulating HDL cholesterol level
|
J:160941
|
decreased circulating insulin level
|
J:160941
|
decreased circulating LDL cholesterol level
|
J:160941
|
decreased circulating triglyceride level
|
J:160941
|
decreased circulating VLDL triglyceride level
|
J:160941
|
increased circulating cholesterol level
|
J:160941
|
Hikeshi1R/Hikeshi1R
(involves: BALB/cRl * C3H/Rl * C57BL/10Rl)
|
cyanosis
|
J:105164
|
Hilpdatm1Xen/Hilpdatm1Xen
(C57BL/6-Hilpdatm1Xen)
|
increased circulating HDL cholesterol level
|
J:301866
|
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating glucagon level
|
J:237329
|
decreased circulating triglyceride level
|
J:237329
|
increased circulating alanine transaminase level
|
J:237329
|
increased circulating cholesterol level
|
J:237329
|
increased circulating corticosterone level
|
J:237329
|
increased circulating insulin level
|
J:237329
|
increased circulating leptin level
|
J:237329
|
increased circulating serum albumin level
|
J:237329
|
Hip1em1(IMPC)Hmgu/Hip1em1(IMPC)Hmgu
(C57BL/6N-Hip1em1(IMPC)Hmgu/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Hipk3tm1b(EUCOMM)Hmgu/Hipk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Hipk3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Hipk4tm1b(KOMP)Mbp/Hipk4tm1b(KOMP)Mbp
(C57BL/6N-Hipk4tm1b(KOMP)Mbp/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
hipr/hipr
(involves: C57BL/6J)
|
increased circulating corticosterone level
|
J:196485
|
Hivep1tm1(KOMP)Mbp/Hivep1+
(C57BL/6N-Hivep1tm1(KOMP)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Hjvtm1b(KOMP)Wtsi/Hjvtm1b(KOMP)Wtsi
(C57BL/6N-Hjvtm1b(KOMP)Wtsi/J)
|
increased circulating iron level
|
J:211773
|
Hjvtm1Kpan/Hjvtm1Kpan Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating unsaturated transferrin level
|
J:231428
|
increased circulating ferritin level
|
J:231428
|
increased circulating iron level
|
J:231428
|
Hjvtm1Nca/Hjvtm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased circulating iron level
|
J:100178
|
Hk1dea/Hk1dea
(A/J-Hk1dea/J)
|
increased circulating bilirubin level
|
J:72146
|
Hlb206/?
(C57BL/6J-Hlb206)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb211/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb212/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb216/?
(C57BL/6J-Hlb216)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb237/?
(C57BL/6J-Hlb237)
|
decreased circulating cholesterol level
|
J:82961
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb239/?
(involves: 129 * C57BL/6)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb240/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb241/?
(C57BL/6J-hlb241/J)
|
decreased circulating HDL cholesterol level
|
J:82961
|
increased circulating cholesterol level
|
J:82961
|
hlb242/?
(C57BL/6J-hlb242/J)
|
increased circulating cholesterol level
|
J:82961
|
hlb243/hlb243
(C57BL/6J-hlb243/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb245/?
(C57BL/6J-Hlb245/J)
|
increased circulating cholesterol level
|
J:82961
|
Hlb250/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb252/?
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:82961
|
decreased circulating HDL cholesterol level
|
J:82961
|
hlb258/?
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal blood coagulation
|
J:82961
|
decreased circulating fibrinogen level
|
J:82961
|
Hlb280/?
(C57BL/6J-Hlb280/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb289/?
(C57BL/6J-Hlb289/J)
|
hyperglycemia
|
J:82961
|
Hlb290/?
(C57BL/6J-Hlb290/J)
|
hyperglycemia
|
J:82961
|
Hlb295/?
(C57BL/6J-Hlb295)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb299/?
(C57BL/6J-Hlb299/J)
|
increased circulating cholesterol level
|
J:82961
|
Hlb300/?
(C57BL/6J-Hlb300)
|
increased circulating cholesterol level
|
J:82961
|
hlb388/hlb388
(C57BL/6J-hlb388/J)
|
increased circulating HDL cholesterol level
|
J:77944
|
Hlb395/?
(C57BL/6J-Hlb395)
|
increased circulating triglyceride level
|
J:82961
|
Hlb396/?
(C57BL/6J-Hlb396)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb397/?
(C57BL/6J-Hlb397/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb437/?
(C57BL/6J-hlb437/J)
|
hyperglycemia
|
J:77944
|
Hlb446/?
(C57BL/6J-Hlb446/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb476/?
(C57BL/6J-Hlb476/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb477/Hlb477
(C57BL/6J-Hlb477/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb497/hlb497
(C57BL/6J-hlb497/J)
|
increased circulating triglyceride level
|
J:82961
|
hlb505/?
(C57BL/6J-hlb505/J)
|
increased circulating triglyceride level
|
J:77944
|
Hlb529/?
(C57BL/6J-Hlb529/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb560/?
(C57BL/6J-hlb560/J)
|
increased circulating triglyceride level
|
J:77944
|
Hlb561/?
(C57BL/6J-Hlb561/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb586/?
(C57BL/6J-Hlb586/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb589/?
(C57BL/6J-Hlb589/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb592/?
(C57BL/6J-Hlb592/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb594/?
(C57BL/6J-Hlb594/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlcsem1(IMPC)J/Hlcs+
(C57BL/6NJ-Hlcsem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Hltftm1.2Geno/Hltftm1.2Geno
(B6.129S2-Hltftm1.2Geno)
|
hypoglycemia
|
J:203735
|
Hlxtm1Rph/Hlxtm1Rph
(FVB.129P2-Hlxtm1Rph)
|
decreased circulating serum albumin level
|
J:119681
|
Hmga1tm1Brun/Hmga1+
(Not Specified)
|
decreased circulating insulin level
|
J:99652
|
Hmga1tm1Brun/Hmga1tm1Brun
(Not Specified)
|
decreased circulating insulin level
|
J:99652
|
Hmgb1tm1.1Dltg/Hmgb1tm1.1Dltg Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N)
|
increased circulating amylase level
|
J:225260
|
increased circulating interleukin-6 level
|
J:225260
|
increased circulating lactate dehydrogenase level
|
J:225260
|
increased circulating tumor necrosis factor level
|
J:225260
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased circulating interleukin-1 beta level
|
J:205499
|
increased circulating interleukin-18 level
|
J:205499
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased circulating interleukin-1 beta level
|
J:205499
|
increased circulating interleukin-18 level
|
J:205499
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating interleukin-1 beta level
|
J:205499
|
increased circulating interleukin-18 level
|
J:205499
|
Hmgb1tm1Meb/Hmgb1tm1Meb
(involves: 129P2/OlaHsd * BALB/c)
|
hypoglycemia
|
J:55880
|
Hmgcltm2Gam/Hmgcltm2Gam Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hmgcltm2Gam Speer6-ps1Tg(Alb-cre)21Mgn)
|
hypoglycemia
|
J:204294
|
increased circulating ammonia level
|
J:204294
|
increased circulating carnitine level
|
J:204294
|
Hmgcrem1Bcgen/Hmgcrem1Bcgen
(Not Specified)
|
increased circulating triglyceride level
|
J:299971
|
Hmgcrem1Bcgen/Hmgcrem1Bcgen Usp20em1Gpt/Usp20em1Gpt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA)
|
increased circulating triglyceride level
|
J:299971
|
Hmgcrtm2Ishi/Hmgcrtm2Ishi Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal circulating apolipoprotein level
|
J:201488
|
abnormal circulating lipoprotein level
|
J:201488
|
decreased circulating cholesterol level
|
J:201488
|
decreased circulating LDL cholesterol level
|
J:201488
|
decreased circulating triglyceride level
|
J:201488
|
hypoglycemia
|
J:201488
|
increased circulating alanine transaminase level
|
J:201488
|
increased circulating aspartate transaminase level
|
J:201488
|
increased circulating bilirubin level
|
J:201488
|
increased circulating cholesterol level
|
J:201488
|
increased circulating free fatty acids level
|
J:201488
|
increased circulating LDL cholesterol level
|
J:201488
|
increased circulating phospholipid level
|
J:201488
|
Hmgcs1em1(IMPC)J/Hmgcs1+
(C57BL/6NJ-Hmgcs1em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Hmgcs2em1(IMPC)Tcp/Hmgcs2+
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp)
|
abnormal circulating ketone body level
|
J:326918
|
Hmgcs2em1(IMPC)Tcp/Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp)
|
decreased circulating ketone body level
|
J:326918
|
Hmgn1em1(IMPC)Ics/Hmgn1em1(IMPC)Ics
(C57BL/6N-Hmgn1em1(IMPC)Ics/Ics)
|
decreased circulating creatinine level
|
J:211773
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
decreased circulating corticosterone level
|
J:199604
|
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(B6.Cg-Hmgn3tm1.2Mbus)
|
decreased circulating insulin level
|
J:153774
|
increased circulating glucose level
|
J:153774
|
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating corticosterone level
|
J:199604
|
increased circulating glucose level
|
J:199604
|
increased circulating testosterone level
|
J:199604
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:148498
|
Hmox1tm1.1Hes/Hmox1tm1.1Hes Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased circulating free fatty acids level
|
J:214639
|
Hmox1tm1.1Hes/Hmox1tm1.1Hes Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)
|
decreased circulating alanine transaminase level
|
J:214639
|
decreased circulating aspartate transaminase level
|
J:214639
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c)
|
abnormal thrombosis
|
J:54684
|
increased circulating alanine transaminase level
|
J:153083
|
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating iron level
|
J:79254
|
increased blood urea nitrogen level
|
J:62437
|
increased circulating ferritin level
|
J:79254
|
Hmox2tm1Poss/Hmox2tm1Poss
(B6.129S2-Hmox2tm1Poss)
|
abnormal circulating protein level
|
J:91075
|
Hmtb1A/J/Hmtb1A/J
(C57BL/6J-Chr 5A/J/Na)
|
abnormal thrombosis
|
J:114074
|
decreased bleeding time
|
J:114074
|
Hmtb1A/J/Hmtb1C57BL/6J Hmtb3A/J/Hmtb3C57BL/6J
(involves: C57BL/6J-Chr 5A/J * C57BL/6J-Chr 17A/J)
|
abnormal blood coagulation
|
J:114074
|
abnormal thrombosis
|
J:114074
|
Hmtb2A/J/Hmtb2A/J
(C57BL/6J-Chr 11A/J/Na)
|
abnormal blood coagulation
|
J:114074
|
Hmtb3A/J/Hmtb3A/J
(C57BL/6J-Chr 17A/J/Na)
|
abnormal blood coagulation
|
J:114074
|
decreased bleeding time
|
J:114074
|
Hmtb4C57BL/6J/Hmtb4C57BL/6J
(involves: A/J * C57BL/6J)
|
abnormal thrombosis
|
J:139651
|
Hmtb5C57BL/6J/Hmtb5C57BL/6J
(involves: A/J * C57BL/6J)
|
increased bleeding time
|
J:139651
|
Hmtb6A/J/Hmtb6C57BL/6J
(involves: A/J * C57BL/6J)
|
abnormal thrombosis
|
J:139651
|
Hmtb8C57BL/6J/Hmtb8C57BL/6J
(involves: A/J * C57BL/6J)
|
abnormal thrombosis
|
J:139651
|
Hmtb9C57BL/6J/Hmtb9C57BL/6J
(involves: A/J * C57BL/6J)
|
abnormal thrombosis
|
J:139651
|
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:47008
|
decreased circulating insulin-like growth factor I level
|
J:47008
|
hyperglycemia
|
J:47008
|
increased circulating growth hormone level
|
J:47008
|
Hnf1atm1.1Ylee/Hnf1atm2Ylee
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:81639
|
hyperglycemia
|
J:81639
|
Hnf1atm1.1Ylee/Hnf1atm2Ylee Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:81639
|
hyperglycemia
|
J:81639
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
abnormal circulating amino acid level
|
J:31627
|
decreased blood uric acid level
|
J:31627
|
decreased circulating arginine level
|
J:31627
|
decreased circulating lysine level
|
J:31627
|
increased circulating alanine transaminase level
|
J:31627
|
increased circulating ammonia level
|
J:31627
|
increased circulating aspartate transaminase level
|
J:31627
|
increased circulating bilirubin level
|
J:31627
|
increased circulating cholesterol level
|
J:31627
|
increased circulating glucose level
|
J:48230
|
increased circulating hydroxyproline level
|
J:31627
|
increased circulating phenylalanine level
|
J:31627
|
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
|
abnormal circulating amino acid level
|
J:31627
|
decreased blood uric acid level
|
J:31627
|
decreased circulating arginine level
|
J:31627
|
decreased circulating lysine level
|
J:31627
|
increased circulating alanine transaminase level
|
J:31627
|
increased circulating ammonia level
|
J:31627
|
increased circulating aspartate transaminase level
|
J:31627
|
increased circulating bilirubin level
|
J:31627
|
increased circulating cholesterol level
|
J:31627
|
increased circulating hydroxyproline level
|
J:31627
|
increased circulating phenylalanine level
|
J:31627
|
Hnf1btm1Mya/Hnf1btm3Mya Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
increased circulating bilirubin level
|
J:75935
|
increased circulating cholesterol level
|
J:75935
|
increased circulating triglyceride level
|
J:75935
|
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N)
|
decreased circulating insulin level
|
J:306082
|
hyperglycemia
|
J:306082
|
increased fasting circulating glucose level
|
J:306082
|
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N)
|
decreased circulating cholesterol level
|
J:67396
|
decreased circulating HDL cholesterol level
|
J:67396
|
decreased circulating triglyceride level
|
J:67396
|
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz Tg(Ins2-cre)25Mgn/0
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:108652
|
Hnf4atm1b(EUCOMM)Hmgu/Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hnf4atm2.1Mwei/Hnf4atm2.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
decreased circulating cholesterol level
|
J:106993
|
decreased circulating free fatty acids level
|
J:106993
|
decreased circulating iron level
|
J:106993
|
decreased circulating triglyceride level
|
J:106993
|
hypokalemia
|
J:106993
|
increased circulating bilirubin level
|
J:106993
|
increased circulating ketone body level
|
J:106993
|
Hnrnpa2b1tm1.1Caox/Hnrnpa2b1tm1.1Caox Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
decreased circulating interferon-beta level
|
J:283622
|
Hnrnpabtm2b(EUCOMM)Hmgu/Hnrnpab+
(C57BL/6N-Hnrnpabtm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Hnrnpctm1b(EUCOMM)Hmgu/Hnrnpc+
(C57BL/6N-Hnrnpctm1b(EUCOMM)Hmgu/J)
|
decreased circulating serum albumin level
|
J:211773
|
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased blood urea nitrogen level
|
J:116112
|
increased circulating aspartate transaminase level
|
J:116112
|
increased circulating tumor necrosis factor level
|
J:116112
|
Hoga1tm2a(KOMP)Wtsi/Hoga1tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal blood homeostasis
|
J:231386
|
Hom1A/Ph/Hom1A/Ph
(involves: A/Ph * C57BL/10ScSnPh)
|
increased circulating testosterone level
|
J:5336,
J:5301
|
Hook3tm1b(NCOM)Mfgc/Hook3tm1b(NCOM)Mfgc
(C57BL/6N-Hook3tm1b(NCOM)Mfgc/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Hoxa1tm1Ipc/Hoxa1tm1Ipc
(involves: 129S2/SvPas * C57BL/6)
|
cyanosis
|
J:23837
|
Hoxa2tm1b(EUCOMM)Wtsi/Hoxa2+
(C57BL/6N-Hoxa2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Hoxa5tm1Rob/Hoxa5tm1Rob
(129S(Cg)-Hoxa5tm1Rob)
|
cyanosis
|
J:45341
|
increased circulating estradiol level
|
J:182519
|
increased circulating thyroid-stimulating hormone level
|
J:84449
|
Hoxc12tm1.1(KOMP)Vlcg/Hoxc12tm1.1(KOMP)Vlcg
(C57BL/6N-Hoxc12tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Hptm1Skl/Hptm1Skl
(involves: 129P2/OlaHsd * C57BL/6J)
|
hemoglobinemia
|
J:49888
|
Hptm1Skl/Hptm1Skl Hpxtm1Altr/Hpxtm1Altr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)
|
abnormal blood homeostasis
|
J:80539
|
abnormal circulating protein level
|
J:80539
|
Hpcaem1(IMPC)H/Hpcaem1(IMPC)H
(C57BL/6NTac-Hpcaem1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Hpcal1em1Ylzg/Hpcal1em1Ylzg
(C57BL/6J-Hpcal1em1Ylzg)
|
increased circulating alanine level
|
J:331711
|
increased circulating aspartate transaminase level
|
J:331711
|
Hpdhty/Hpdhty
(ICRIII)
|
decreased circulating tyrosine level
|
J:14313,
J:11113
|
Hpgdtm1Ljm/Hpgdtm1Ljm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating progesterone level
|
J:130001
|
hph1/hph1
(involves: C57BL/6 * CBA/Ca)
|
increased circulating phenylalanine level
|
J:9146
|
HpnHlb320/?
(C57BL/6J-HpnHlb320/J)
|
decreased circulating HDL cholesterol level
|
J:82961
|
increased circulating cholesterol level
|
J:82961
|
HpnHlb320/Hpn+
(involves: C57BL/6J * C57L/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
HpnHlb320/HpnHlb320
(C57BL/6J-HpnHlb320/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
increased circulating alkaline phosphatase level
|
J:187708
|
HpnHlb320/HpnHlb320
(involves: C57BL/6J * C57L/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
Hpntm1Qwu/Hpntm1Qwu
(involves: 129X1/SvJ * NIH Swiss)
|
increased circulating alkaline phosphatase level
|
J:45393
|
Hprt1tm1(AGT)Asku/Y Tg(REN)64071Sig/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating angiotensinogen level
|
J:143791
|
increased circulating angiotensin II level
|
J:143791
|
Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6)
|
hyperglycemia
|
J:159291
|
Hprt1tm1(Ins2-HBEGF)Herr/Hprt1tm1(Ins2-HBEGF)Herr
(involves: 129 * C57BL/6)
|
hyperglycemia
|
J:159291
|
Hprt1tm1(Pck1-cre)Vhh/Hprt1+ Tg(CAG-lacZ,-Miox)#Ysk/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased blood urea nitrogen level
|
J:266834
|
increased circulating creatinine level
|
J:266834
|
Hprt1tm2(AGT)Asku/Y Tg(REN)64071Sig/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating angiotensinogen level
|
J:143791
|
increased circulating angiotensin II level
|
J:143791
|
Hps1ep/Hps1ep
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal circulating enzyme level
|
J:6219
|
abnormal platelet physiology
|
J:7327,
J:42484
|
increased bleeding time
|
J:7327
|
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J)
|
increased bleeding time
|
J:7327
|
Hps3coa-6J/Hps3coa-6J
(C3H/HeJ-Hps3coa-6J/J)
|
abnormal blood coagulation
|
J:63693
|
increased bleeding time
|
J:63693
|
Hps3coa/Hps3coa
(involves: C57BL/10J)
|
abnormal platelet dense granule physiology
|
J:9300
|
decreased platelet aggregation
|
J:9300
|
increased bleeding time
|
J:9300
|
Hps4le/Hps4le
(B6.C3-Pde6brd1 Hps4le)
|
abnormal platelet physiology
|
J:11990
|
increased bleeding time
|
J:7327
|
Hps4le/Hps4le Pde6brd1/Pde6brd1
(B6.C3-Pde6brd1 Hps4le/J)
|
abnormal platelet activation
|
J:221384
|
decreased platelet aggregation
|
J:221384
|
Hps5ru2-mr/Hps5ru2-mr
(B6.Cg-Hps5ru2-mr/Re)
|
increased bleeding time
|
J:7327
|
Hpse2Gt(OST411605)Lex/Hpse2Gt(OST411605)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating glucose level
|
J:219597
|
decreased circulating serum albumin level
|
J:219597
|
increased circulating alkaline phosphatase level
|
J:219597
|
Hpxtm1Altr/Hpxtm1Altr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased circulating haptoglobin level
|
J:58821
|
Hrem1(IMPC)H/Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating amylase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Hrastm2Xbr/Hrastm2Xbr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased circulating angiotensin II level
|
J:137729
|
Hrgtm1Wja/Hrgtm1Wja
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thrombolysis
|
J:134621
|
decreased bleeding time
|
J:134621
|
decreased prothrombin time
|
J:134621
|
increased circulating fibrinogen level
|
J:134621
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
decreased circulating insulin level
|
J:107191
|
increased circulating free fatty acids level
|
J:107191
|
increased circulating leptin level
|
J:107191
|
Hrh2tm1Wtn/Hrh2tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating gastrin level
|
J:62871
|
Hrh2tm1Yfks/Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating gastrin level
|
J:102252
|
Hrh3tm1.1Jhwa/Hrh3tm1.1Jhwa
(involves: C57BL/6 * C57BL/6NTac)
|
increased circulating glucose level
|
J:174155
|
Hrh3tm1Kot/Hrh3tm1Kot
(involves: 129X1/SvJ * C57BL/6N)
|
increased circulating insulin level
|
J:80824
|
increased circulating leptin level
|
J:80824
|
Hrnrem1(IMPC)Wtsi/Hrnrem1(IMPC)Wtsi
(C57BL/6N-Hrnrem1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating serum albumin level
|
J:211773
|
Hs2st1tm1.1Je/Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating triglyceride level
|
J:158299
|
Hs3st3a1tm1(KOMP)Vlcg/Hs3st3a1tm1(KOMP)Vlcg
(C57BL/6N-Hs3st3a1tm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Hsd3b7tm1Rus/Hsd3b7tm1Rus
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating triglyceride level
|
J:122973
|
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd)
|
decreased circulating corticosterone level
|
J:189059
|
Hsd11b1tm1.2Tuck/Hsd11b1tm1.2Tuck
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating insulin level
|
J:203302
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1+
(involves: C57BL/6Jcl * C57BL/6N)
|
increased circulating corticosterone level
|
J:214146
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N)
|
increased circulating corticosterone level
|
J:214146
|
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating corticosterone level
|
J:189059
|
decreased circulating insulin level
|
J:189059
|
increased circulating HDL cholesterol level
|
J:189059
|
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
abnormal circulating cholesterol level
|
J:72402
|
decreased circulating glucose level
|
J:37960,
J:45085
|
decreased circulating triglyceride level
|
J:72402
|
increased circulating cholesterol level
|
J:72402
|
increased circulating HDL cholesterol level
|
J:72402
|
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko)
|
decreased circulating LDL cholesterol level
|
J:89080
|
increased circulating HDL cholesterol level
|
J:89080
|
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
decreased circulating aldosterone level
|
J:53391
|
decreased circulating potassium level
|
J:53391
|
Hsd17b1tm1.1(KOMP)Vlcg/Hsd17b1tm1.1(KOMP)Vlcg
(C57BL/6N-Hsd17b1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)
|
abnormal circulating androgen level
|
J:301756
|
increased circulating dihydrotestosterone level
|
J:301756
|
increased circulating luteinizing hormone level
|
J:301756
|
increased circulating progesterone level
|
J:301756
|
increased circulating testosterone level
|
J:301756
|
Hsd17b4em1(IMPC)Tcp/Hsd17b4+
(C57BL/6NCrl-Hsd17b4em1(IMPC)Tcp/Tcp)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Hsd17b8em1(IMPC)J/Hsd17b8em1(IMPC)J
(C57BL/6NJ-Hsd17b8em1(IMPC)J/J)
|
increased fasting circulating glucose level
|
J:211773
|
Hsf1tm1.1(KOMP)Vlcg/Hsf1+
(C57BL/6N-Hsf1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Hsf2tm1b(KOMP)Wtsi/Hsf2tm1b(KOMP)Wtsi
(C57BL/6N-Hsf2tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bptm1a(EUCOMM)Hmgu
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm)
|
decreased circulating glucose level
|
J:165965
|
increased circulating glucose level
|
J:165965
|
increased circulating HDL cholesterol level
|
J:165965
|
Hsf4tm1b(KOMP)Wtsi/Hsf4tm1b(KOMP)Wtsi
(C57BL/6N-Hsf4tm1b(KOMP)Wtsi/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Hsf5em1(IMPC)J/Hsf5em1(IMPC)J
(C57BL/6NJ-Hsf5em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Hsp90aa1tm1(KOMP)Wtsi/Hsp90aa1tm1(KOMP)Wtsi
(C57BL/6N-Hsp90aa1tm1(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Hspa4ltm1Imad/Hspa4ltm1Imad
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased blood urea nitrogen level
|
J:114659
|
increased circulating calcium level
|
J:114659
|
increased circulating sodium level
|
J:114659
|
Hspa5tm1.1(KOMP)Vlcg/Hspa5+
(C57BL/6N-Hspa5tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hspa5tm1Aoe/Hspa5tm1Aoe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:131209
|
Hspb1tm1.1(KOMP)Vlcg/Hspb1tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb1tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
Hspb3tm1.1(KOMP)Vlcg/Hspb3tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb3tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Hspb7tm1.1Yty/Hspb7tm1.1Yty Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
increased circulating creatine kinase level
|
J:246267
|
Hspb8em1(IMPC)J/Hspb8em1(IMPC)J
(C57BL/6NJ-Hspb8em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Hspb8tm1.1Depr/Hspb8tm1.1Depr
(B.129-Hspb8tm1.1Depr)
|
decreased circulating interleukin-6 level
|
J:186292
|
htd/htd
(C3H/HeJ-htd/J)
|
decreased circulating thyroxine level
|
J:68094
|
decreased circulating triiodothyronine level
|
J:68094
|
increased circulating corticosterone level
|
J:68094
|
Htr1ftm1.1(KOMP)Vlcg/Htr1ftm1.1(KOMP)Vlcg
(C57BL/6N-Htr1ftm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Htr2btm1Kry/Htr2btm1Kry Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:284574
|
Htr2ctm1Arte/Y
(involves: C57BL/6)
|
increased circulating corticosterone level
|
J:228775
|
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke)
|
increased circulating leptin level
|
J:147514
|
Htr2ctm1Jul/Y
(B6.129S-Htr2ctm1Jul)
|
hyperglycemia
|
J:50262
|
increased circulating insulin level
|
J:50262
|
increased circulating leptin level
|
J:50262
|
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk)
|
decreased circulating cholesterol level
|
J:142503
|
decreased circulating glucose level
|
J:142503
|
decreased circulating insulin level
|
J:142503
|
decreased circulating insulin-like growth factor I level
|
J:142503
|
decreased circulating leptin level
|
J:142503
|
decreased circulating triglyceride level
|
J:142503
|
increased circulating ghrelin level
|
J:142503
|
increased circulating growth hormone level
|
J:142503
|
Htr2ctm2Jke/Y Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
hyperglycemia
|
J:207704
|
increased circulating glucagon level
|
J:207704
|
increased circulating glucose level
|
J:207704
|
increased circulating insulin level
|
J:207704
|
Htr2ctm2Jke/Y Tg(Pomc-cre/ERT2)#Jke/0
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating glucagon level
|
J:207704
|
increased circulating glucose level
|
J:207704
|
increased circulating insulin level
|
J:207704
|
Htr2ctm2Jke/Y Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J)
|
hyperglycemia
|
J:207704
|
Htr2ctm2Jke/Htr2ctm2Jke Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
hyperglycemia
|
J:207704
|
increased circulating glucagon level
|
J:207704
|
increased circulating glucose level
|
J:207704
|
increased circulating insulin level
|
J:207704
|
Htr2ctm2Jke/Htr2ctm2Jke Tg(Pomc-cre/ERT2)#Jke/0
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating glucagon level
|
J:207704
|
increased circulating glucose level
|
J:207704
|
increased circulating insulin level
|
J:207704
|
Htr3atm1Ckn/Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
increased blood urea nitrogen level
|
J:90942
|
Htr4tm1Dgen/Htr4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased blood urea nitrogen level
|
J:101679
|
Htr7tm1b(KOMP)Wtsi/Htr7tm1b(KOMP)Wtsi
(C57BL/6N-Htr7tm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
hubb/hubb
(involves: ICR)
|
abnormal circulating bilirubin level
|
J:8170
|
increased circulating bilirubin level
|
J:8170
|
Hunktm1b(EUCOMM)Wtsi/Hunktm1b(EUCOMM)Wtsi
(C57BL/6N-Hunktm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating glucose level
|
J:211773
|
Huwe1tm1Wgu/Y Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:182446
|
hyperglycemia
|
J:182446
|
increased circulating glucose level
|
J:182446
|
Huwe1tm1Wgu/Y Tg(Ins2-cre)23Herr/0 Trp53tm1Thl/Trp53tm1Thl
(involves: C57BL/6J * CBA/J)
|
hyperglycemia
|
J:182446
|
Hyal2tm1.1Bfla/Hyal2tm1.1Bfla
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased circulating hyaluronic acid level
|
J:146040
|
increased circulating lactate dehydrogenase level
|
J:146040
|
Hyal3tm1.1(KOMP)Vlcg/Hyal3tm1.1(KOMP)Vlcg
(C57BL/6N-Hyal3tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Hyal6em1(IMPC)H/Hyal6em1(IMPC)H
(C57BL/6NTac-Hyal6em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Hycc1em1(IMPC)Ccpcz/Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
hydro/?
(involves: Mlac:ICR)
|
decreased circulating calcium level
|
J:207131
|
increased circulating phosphate level
|
J:207131
|
HypchNZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom)
|
increased circulating cholesterol level
|
J:83735
|
HypismC57BL/6J/HypismPERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating insulin level
|
J:94548
|
Hyplip2MRL/MpJ/Hyplip2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating HDL cholesterol level
|
J:92871
|
increased circulating cholesterol level
|
J:92871
|
Hypn2C57BL/6/Hypn2C57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:142949
|
Hypn3C57BL/6/Hypn3C57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:142949
|
HypnC57BL/6/?
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos)
|
increased circulating insulin level
|
J:83539
|
HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:142949
|
Iah1tm1b(EUCOMM)Hmgu/Iah1tm1b(EUCOMM)Hmgu
(C57BL/6N-Iah1tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Iapptm1Sgm/Iapptm1Sgm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:50042
|
Ibtkem1(IMPC)Hmgu/Ibtkem1(IMPC)Hmgu
(C57BL/6N-Ibtkem1(IMPC)Hmgu/Ieg)
|
increased circulating serum albumin level
|
J:211773
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay/J)
|
increased circulating glucose level
|
J:118466
|
Icam1tm1Jcgr/Icam1tm1Jcgr Ldlrtm1Her/Ldlrtm1Her Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:69597
|
Icostm1Tkan/Icostm1Tkan
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:95353
|
decreased circulating interleukin-4 level
|
J:95353
|
Id2tm2b(EUCOMM)Wtsi/Id2+
(C57BL/6N-Id2tm2b(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Id4tm1Vdr/Id4tm1Vdr Tg(MMTV-cre)1Mam/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating estradiol level
|
J:213955
|
decreased circulating estrogen level
|
J:213955
|
IdeGt(OST132429)Lex/IdeGt(OST132429)Lex
(involves: 129S5/SvEvBrd * C57BL/6-Tyrc)
|
hyperglycemia
|
J:82747
|
increased circulating insulin level
|
J:82747
|
Idetm1a(EUCOMM)Wtsi/Idetm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Idetm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
increased circulating amylase level
|
J:175295
|
Idh1tm1Mak/Idh1tm1Mak Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:186700
|
Idh1tm2Mak/Idh1tm2Mak Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:186700
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal blood homeostasis
|
J:282516
|
Iduaem1(IMPC)Hmgu/Iduaem1(IMPC)Hmgu
(C57BL/6NCrl-Iduaem1(IMPC)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Iduatm1Clk/Iduatm1Clk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating enzyme level
|
J:138341
|
Ier3ip1em1(IMPC)J/Ier3ip1+
(C57BL/6NJ-Ier3ip1em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1)
|
decreased circulating insulin level
|
J:336782
|
hyperglycemia
|
J:336782
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased circulating insulin level
|
J:336782
|
hyperglycemia
|
J:336782
|
increased circulating glucose level
|
J:336782
|
increased fasting circulating glucose level
|
J:336782
|
Ier5lem1(IMPC)J/Ier5lem1(IMPC)J
(C57BL/6NJ-Ier5lem1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
If1l/If1l
(involves: BALB/c)
|
abnormal circulating interferon level
|
J:5113
|
Ifi27l2atm1.1(KOMP)Vlcg/Ifi27l2atm1.1(KOMP)Vlcg
(C57BL/6N-Ifi27l2atm1.1(KOMP)Vlcg/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Ifi35em1Hhl/Ifi35em1Hhl
(C57BL/6-Ifi35em1Hhl)
|
decreased circulating interleukin-6 level
|
J:298909
|
decreased circulating tumor necrosis factor level
|
J:298909
|
Ifi204tm1.1Cjul/Ifi204tm1.1Cjul
(B6.129(Cg)-Ifi204tm1.1Cjul)
|
decreased circulating interferon-beta level
|
J:270123
|
decreased circulating interleukin-1 beta level
|
J:270123
|
decreased circulating interleukin-6 level
|
J:270123
|
decreased circulating tumor necrosis factor level
|
J:270123
|
Ifih1em1(IMPC)Wtsi/Ifih1em1(IMPC)Wtsi
(C57BL/6N-Ifih1em1(IMPC)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:211773
|
Ifit2tm1.1Ebsb/Ifit2tm1.1Ebsb
(B6NCrl.129P2(C)-Ifit2tm1.1Ebsb)
|
decreased circulating interleukin-1 beta level
|
J:199862
|
decreased circulating interleukin-6 level
|
J:199862
|
decreased circulating interleukin-12b level
|
J:199862
|
decreased circulating tumor necrosis factor level
|
J:199862
|
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
abnormal circulating testosterone level
|
J:192287
|
decreased circulating corticosterone level
|
J:192287
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas)
|
increased circulating alanine transaminase level
|
J:144400
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased circulating interleukin-12 level
|
J:54482
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased circulating interleukin-6 level
|
J:168781
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-beta level
|
J:61048
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B6.129P2-Ifnb1tm1Tl)
|
decreased circulating interferon-alpha level
|
J:172226
|
decreased circulating interferon-beta level
|
J:172226
|
Ifnb1tm2.1Lien/Ifnb1tm2.1Lien Tyrc-2J/Tyrc-2J Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-alpha level
|
J:172226
|
decreased circulating interferon-beta level
|
J:172226
|
Ifngtm1.1Hayg/Ifngtm1.1Hayg
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal circulating cytokine level
|
J:220784
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
abnormal circulating cytokine level
|
J:47459
|
increased circulating interleukin-6 level
|
J:47459
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
abnormal circulating cytokine level
|
J:47459
|
increased circulating interleukin-6 level
|
J:47459
|
Ifngtm1Ts/Ifngtm1Ts Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129-Ifngtm1Ts Tgfb1tm1Doe)
|
increased circulating alanine transaminase level
|
J:69346
|
Ifngtm1Yiw/Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw)
|
abnormal circulating interferon level
|
J:91691
|
Ifngtm1Yiw/Ifngtm1Yiw
(C.129X1-Ifngtm1Yiw)
|
abnormal circulating interferon level
|
J:91691
|
increased circulating alanine transaminase level
|
J:91691
|
Ifngr1tm1.1Rost/Ifngr1tm1.1Rost
(involves: BALB/cJ * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:152785
|
decreased circulating interleukin-12 level
|
J:152785
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
decreased circulating tumor necrosis factor level
|
J:17878
|
increased circulating interferon-gamma level
|
J:314959
|
increased circulating interleukin-1 beta level
|
J:314959
|
increased circulating interleukin-6 level
|
J:174397
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
abnormal circulating chemokine level
|
J:152785
|
decreased circulating interleukin-12 level
|
J:152785
|
decreased circulating osteocalcin level
|
J:233116
|
Ifngr1tm1Agt/Ifngr1tm1Agt Tg(GZMB-Tax)#Lera/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating calcium level
|
J:147601
|
Ifnl3em1Mtba/Ifnl3em1Mtba
(involves: C57BL/6)
|
abnormal circulating interferon level
|
J:287260
|
Ifnl3tm1.1(KOMP)Vlcg/Ifnl3tm1.1(KOMP)Vlcg
(C57BL/6N-Ifnl3tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Ift20tm1.1Gjp/Ift20tm1.1Gjp Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)
|
increased blood urea nitrogen level
|
J:141071
|
Ift25tm1a(EUCOMM)Wtsi/Ift25+
(B6JTyr;B6N-Ift25tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Ift25tm1a(EUCOMM)Wtsi/Ift25tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cyanosis
|
J:184749
|
Ift25tm1b(EUCOMM)Wtsi/Ift25tm1b(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cyanosis
|
J:184749
|
Ift27tm1b(EUCOMM)Hmgu/Ift27tm1b(EUCOMM)Hmgu
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
cyanosis
|
J:215449
|
Ift43tm1b(EUCOMM)Hmgu/Ift43+
(C57BL/6N-Ift43tm1b(EUCOMM)Hmgu/Bay)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Ift80tm1a(KOMP)Wtsi/Ift80tm1a(KOMP)Wtsi
(C57BL/6N-Ift80tm1a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw)
|
decreased circulating glucose level
|
J:95813
|
increased circulating alkaline phosphatase level
|
J:73583
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw)
|
increased circulating alkaline phosphatase level
|
J:73583
|
Igf1tm1.1Dlr/Igf1tm1.1Dlr
(involves: C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:69518
|
increased circulating growth hormone level
|
J:69518
|
increased circulating insulin level
|
J:69518
|
Igf1tm1.1Dlr/Igf1tm1.1Dlr Tg(Ttr-IGF1)1Sykr/0
(FVB.Cg-Igf1tm1.1Dlr Tg(Ttr-IGF1)1Sykr)
|
decreased circulating insulin level
|
J:157350
|
increased circulating insulin-like growth factor I level
|
J:157350
|
Igf1tm1.1Nros/Igf1tm1.1Nros
(involves: BALB/c * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:159167
|
Igf1tm1Arge/Igf1+ Liftm1Stw/Liftm1Stw
(involves: 129S/SvEv * 129S1/Sv * C57BL/6 * MF1)
|
increased circulating insulin-like growth factor I level
|
J:87585
|
increased circulating leptin level
|
J:87585
|
Igf1tm1Arge/Igf1tm1Arge
(involves: 129S/SvEv * DBA * MF1)
|
increased circulating growth hormone level
|
J:66913
|
Igf1tm1Dlr/Igf1tm1Dlr Tg(Alb1-cre)1Dlr/0
(involves: 129/Sv * C57BL/6J * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:155733
|
increased circulating leptin level
|
J:155733
|
Igf1tm1Dlr/Igf1tm1Dlr Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased circulating insulin-like growth factor I level
|
J:121798,
J:55718
|
increased circulating growth hormone level
|
J:121798
|
Igf1tm1Dlr/Igf1tm1Dlr Tg(Serpina1e-cre/ERT)1Sykr/0
(involves: 129/Sv * C57BL/6J * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:155733
|
increased circulating insulin level
|
J:155733
|
increased circulating leptin level
|
J:155733
|
Igf1tm2.1Arge/Igf1tm2.1Arge
(involves: 129S/SvEv * C57BL/6J * CBA)
|
decreased circulating insulin-like growth factor I level
|
J:142247
|
Igf1tm2Arge/Igf1tm2.1Arge
(involves: 129S/SvEv * C57BL/6J * CBA)
|
decreased circulating insulin-like growth factor I level
|
J:142247
|
Igf1tm2Arge/Igf1tm2.1Arge Tg(SERPINA1-cre)1Arge/0
(involves: 129S/SvEv * C57BL/6J * CBA)
|
decreased circulating insulin-like growth factor I level
|
J:142247
|
Igf1tm2Arge/Igf1tm2Arge
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:142247
|
Igf1tm2Arge/Igf1tm2Arge Tg(SERPINA1-cre)1Arge/0
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:142247
|
Igf1tm2Ts/Igf1tm2Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating glucose level
|
J:37969
|
decreased circulating growth hormone level
|
J:37969
|
Igf1rtm1.1Mhz/Igf1rtm1.1Mhz Tg(Ins2-cre)25Mgn/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:121640
|
Igf1rtm1Arge/Igf1rtm1Arge
(involves: 129S/SvEv)
|
cyanosis
|
J:15108
|
Igf1rtm1Jcbr/Igf1rtm1Jcbr Tg(Fabp4-cre)1Abel/?
(involves: C57BL/6 * FVB/N)
|
increased circulating glucose level
|
J:141321
|
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640,
J:94512
|
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ
(B6.C3-(D6Mit93-D6Mit150))
|
decreased circulating insulin-like growth factor I level
|
J:112375,
J:99471
|
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ Igf1sl4C3H/HeJ/Igf1sl4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ Igf1sl4C57BL/6J/Igf1sl4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl1C3H/HeJ/Igf1sl1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl1C3H/HeJ/Igf1sl1C57BL/6J Igf1sl4C3H/HeJ/Igf1sl4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl1C3H/HeJ/Igf1sl1C57BL/6J Igf1sl4C57BL/6J/Igf1sl4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl2C3H/HeJ/Igf1sl2C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl2C3H/HeJ/Igf1sl2C3H/HeJ
(B6.C3H-Igf1sl2C3H/HeJ)
|
increased circulating total protein level
|
J:111677
|
Igf1sl2C3H/HeJ/Igf1sl2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating total protein level
|
J:66640
|
Igf1sl3C3H/HeJ/Igf1sl3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating insulin-like growth factor I level
|
J:66640
|
Igf1sl3C3H/HeJ/Igf1sl3C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating insulin-like growth factor I level
|
J:66640
|
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal circulating hormone level
|
J:77413
|
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini)
|
decreased circulating cholesterol level
|
J:271356
|
decreased circulating free fatty acids level
|
J:271356
|
decreased circulating glucose level
|
J:271356
|
decreased circulating insulin level
|
J:271356
|
decreased circulating triglyceride level
|
J:271356
|
decreased fasting circulating glucose level
|
J:271356
|
Igf2rtm1Arge/Igf2r+
(involves: 129)
|
abnormal circulating hormone level
|
J:34584
|
Igf2rtm1Arge/Igf2rtm1Arge
(involves: 129)
|
abnormal circulating hormone level
|
J:34584
|
Igf2rtm1Stw/Igf2r+
(involves: 129S1/Sv * C57BL/6)
|
abnormal circulating hormone level
|
J:22124
|
cyanosis
|
J:22124
|
Igf2rtm2Arge/Igf2r+
(involves: 129)
|
abnormal circulating hormone level
|
J:34584
|
Igf2rtm2Arge/Igf2rtm2Arge
(involves: 129)
|
abnormal circulating hormone level
|
J:34584
|
Igfalstm1b(KOMP)Wtsi/Igfalstm1b(KOMP)Wtsi
(C57BL/6N-Igfalstm1b(KOMP)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Igfbp3tm1Jep/Igfbp3tm1Jep Igfbp4tm1Jep/Igfbp4tm1Jep Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating glucose level
|
J:112029
|
decreased circulating insulin-like growth factor I level
|
J:112029
|
increased circulating insulin level
|
J:112029
|
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:168345
|
increased circulating glucose level
|
J:168345
|
increased circulating insulin level
|
J:168345
|
Igfbp3q1DU6i/Igfbp3q1DBA/2
(involves: DBA/2J * DU6i)
|
abnormal circulating protein level
|
J:68837
|
Igfbp3q1DU6i/Igfbp3q1DU6i
(involves: DBA/2J * DU6i)
|
abnormal circulating protein level
|
J:68837
|
Igfbp3q2DBA/2/Igfbp3q2DU6i
(involves: DBA/2 * DU6i)
|
abnormal circulating protein level
|
J:68837
|
Igfbp3q2DU6i/Igfbp3q2DU6i
(involves: DBA/2 * DU6i)
|
abnormal circulating protein level
|
J:68837
|
Igfbp6em1(IMPC)J/Igfbp6em1(IMPC)J
(C57BL/6NJ-Igfbp6em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Igh-7tm1Led/Igh-7tm1Led Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal circulating complement protein level
|
J:161523
|
Ighmtm1Cgn/Ighm+ Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
increased circulating glucose level
|
J:91865
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
(B6.BKS-Ighmbp2nmd-2J/J)
|
increased circulating creatine kinase level
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
increased circulating creatine kinase level
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J Tg(Eno2-Ighmbp2)17Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
increased circulating creatine kinase level
|
J:90418
|
Igktm1.1Cog/Igktm1.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased blood uric acid level
|
J:135758
|
decreased circulating phosphate level
|
J:135758
|
Igktm1.1Cog/Igktm1.2Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased blood uric acid level
|
J:135758
|
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
decreased circulating insulin level
|
J:287584
|
Igs2tm1(CAG-Ptgs2os)Scrp/Igs2tm1(CAG-Ptgs2os)Scrp
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:325487
|
increased circulating interleukin-10 level
|
J:325487
|
Igs86tm1Low/Igs86tm1Low
(B6.129S4-Igs86tm1Low)
|
increased circulating glucose level
|
J:194013
|
increased circulating insulin level
|
J:194013
|
increased circulating leptin level
|
J:194013
|
Igs86tm1Low/Igs86tm1Low Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:194013
|
increased circulating insulin level
|
J:194013
|
increased circulating leptin level
|
J:194013
|
Igsf1tm1Zuk/Y
(either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
decreased circulating thyroid-stimulating hormone level
|
J:190867
|
decreased circulating triiodothyronine level
|
J:190867
|
Igsf9em1(IMPC)J/Igsf9em1(IMPC)J
(C57BL/6NJ-Igsf9em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Igsf11tm1b(KOMP)Wtsi/Igsf11tm1b(KOMP)Wtsi
(C57BL/6N-Igsf11tm1b(KOMP)Wtsi/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Igtptm1Gvw/Igtptm1Gvw
(involves: 129S1/Sv * C57BL/6)
|
increased circulating interferon-gamma level
|
J:59891
|
increased circulating interleukin-12b level
|
J:59891
|
Iigp1cem1(IMPC)Hmgu/Iigp1cem1(IMPC)Hmgu
(C57BL/6N-Iigp1cem1(IMPC)Hmgu/Ieg)
|
increased circulating phosphate level
|
J:211773
|
Iigp1cem1Btlr/Iigp1cem1Btlr
(C57BL/6J-Iigp1cem1Btlr)
|
increased circulating alanine transaminase level
|
J:333470
|
increased circulating triglyceride level
|
J:333470
|
Ikbipem1Bcgen/Ikbipem1Bcgen Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased circulating interleukin-6 level
|
J:282971
|
increased circulating tumor necrosis factor level
|
J:282971
|
Ikbkbtm2Mka/Ikbkbtm2.1Mka Tg(Vil-cre)1Mka/0
(involves: 129/Sv * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:83313
|
Ikbketm1Dgen/Ikbketm1Dgen
(B6.129P2-Ikbketm1Dgen)
|
decreased circulating glucose level
|
J:171942
|
decreased circulating leptin level
|
J:171942
|
Ikbkgtm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased circulating alanine transaminase level
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating alanine transaminase level
|
J:160521
|
increased circulating aspartate transaminase level
|
J:160521
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased circulating alanine transaminase level
|
J:151485
|
increased circulating tumor necrosis factor level
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: FVB/N)
|
increased circulating alanine transaminase level
|
J:160521
|
increased circulating aspartate transaminase level
|
J:160521
|
increased circulating glutamate dehydrogenase level
|
J:160521
|
Ikbkgtm1.1Dwat/Y Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased circulating alanine transaminase level
|
J:202106
|
increased circulating aspartate transaminase level
|
J:202106
|
increased circulating bilirubin level
|
J:202106
|
increased circulating lactate dehydrogenase level
|
J:202106
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:118336
|
increased circulating alanine transaminase level
|
J:118336
|
Ikzf2em2(IMPC)H/Ikzf2em2(IMPC)H
(C57BL/6NTac-Ikzf2em2(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood urea nitrogen level
|
J:81805
|
increased circulating creatinine level
|
J:81805
|
Il1atm1b(EUCOMM)Wtsi/Il1atm1b(EUCOMM)Wtsi
(C57BL/6N-Il1atm1b(EUCOMM)Wtsi/J)
|
decreased circulating serum albumin level
|
J:211773
|
Il1atm1Yiw/Il1atm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating interleukin-1 alpha level
|
J:47429
|
Il1atm1Yiw/Il1atm1Yiw Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:47429
|
decreased circulating interleukin-1 alpha level
|
J:47429
|
decreased circulating interleukin-1 beta level
|
J:47429
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:27234
|
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:47429
|
decreased circulating interleukin-1 beta level
|
J:47429
|
Il1r1em1Qizh/Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh)
|
increased circulating interleukin-6 level
|
J:338375
|
increased circulating tumor necrosis factor level
|
J:338375
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129 * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:43088
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased blood urea nitrogen level
|
J:112999
|
decreased circulating creatinine level
|
J:112999
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
decreased circulating interleukin-6 level
|
J:125570
|
decreased circulating interleukin-18 level
|
J:125570
|
increased circulating insulin level
|
J:108634
|
increased circulating insulin-like growth factor I level
|
J:108634
|
increased circulating interleukin-1 beta level
|
J:125570
|
increased circulating interleukin-18 level
|
J:125570
|
increased circulating leptin level
|
J:108634
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:42373
|
decreased circulating serum amyloid protein level
|
J:42373
|
Il1r2tm1.2Mchc/Il1r2tm1.2Mchc
(involves: BALB/cJ * C57BL/6J * C57BL/6NTac)
|
increased circulating interleukin-1 alpha level
|
J:347877
|
increased circulating interleukin-6 level
|
J:347877
|
Il1r2tm1Yiw/Il1r2tm1Yiw Il1rntm1Yiw/Il1rntm1Yiw
(B6.129-Il1r2tm1Yiw Il1rntm1Yiw)
|
increased circulating tumor necrosis factor level
|
J:274653
|
Il1rntm1Dih/Il1rntm1Dih
(B6.129S-Il1rntm1Dih)
|
decreased circulating cholesterol level
|
J:76336
|
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating cholesterol level
|
J:76336
|
decreased circulating interleukin-1 level
|
J:36387
|
increased circulating interleukin-6 level
|
J:61600
|
increased circulating serum amyloid protein level
|
J:61600
|
Il2tm1.1Kasm/Il2tm1.1Kasm Ndor1Tg(UBC-cre/ERT2)1Ejb/?
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating interleukin-17 level
|
J:190168
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
increased circulating bilirubin level
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
abnormal circulating cytokine level
|
J:190168
|
decreased circulating interferon-gamma level
|
J:190168
|
decreased circulating interleukin-4 level
|
J:190168
|
decreased circulating interleukin-13 level
|
J:190168
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating interleukin-17 level
|
J:120176
|
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Il2rgtm1Wjl/Il2rgtm1Wjl Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
hyperglycemia
|
J:138005
|
Il4tm1Cgn/Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn)
|
increased circulating glucose level
|
J:95105
|
Il4tm1Kopf/Il4tm1Kopf Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal circulating complement protein level
|
J:161523
|
Il4tm2Nnt/Il4tm2Nnt Tgfb1tm1Doe/Tgfb1tm1Doe
(C.Cg-Tgfb1tm1Doe Il4tm2Nnt)
|
increased circulating alanine transaminase level
|
J:69346
|
Il4i1tm1b(EUCOMM)Wtsi/Il4i1+
(C57BL/6N-Il4i1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating lipase level
|
J:211773
|
Il4i1tm1b(EUCOMM)Wtsi/Il4i1tm1b(EUCOMM)Wtsi
(C57BL/6N-Il4i1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating potassium level
|
J:211773
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ)
|
abnormal circulating cytokine level
|
J:133518
|
abnormal circulating interferon-gamma level
|
J:133518
|
increased circulating interleukin-4 level
|
J:133518
|
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch)
|
increased circulating interleukin-4 level
|
J:152376
|
Il5tm1.1(icre)Lky/Il5+
(C57BL/6-Il5tm1.1(icre)Lky)
|
decreased circulating interleukin-5 level
|
J:206097
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:105633
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
decreased circulating interleukin-12 level
|
J:79314
|
increased circulating interleukin-10 level
|
J:79314
|
Il6ratm1.1(IL6R)Csk/Il6ratm1.1(IL6R)Csk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating serum amyloid protein level
|
J:207264
|
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:188445
|
decreased circulating tumor necrosis factor level
|
J:188445
|
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating interleukin-1 beta level
|
J:188445
|
decreased circulating tumor necrosis factor level
|
J:188445
|
increased circulating interleukin-6 level
|
J:166367
|
increased circulating tumor necrosis factor level
|
J:166367
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:188445
|
decreased circulating tumor necrosis factor level
|
J:188445
|
increased circulating aspartate transaminase level
|
J:202764
|
Il6sttm1b(KOMP)Mbp/Il6st+
(C57BL/6N-Il6sttm1b(KOMP)Mbp/J)
|
increased circulating bilirubin level
|
J:211773
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased circulating interleukin-6 level
|
J:168781
|
Il6sttm1Ern/Il6sttm1Ern Stat3tm1Aki/Stat3+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
decreased circulating interleukin-6 level
|
J:168781
|
Il6sttm1Ern/Il6sttm1Ern Tiraptm1.1Pjh/Tiraptm1.1Pjh
(involves: 129S1/Sv)
|
decreased circulating interleukin-6 level
|
J:168781
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * CD-1)
|
decreased circulating calcium level
|
J:88710
|
increased circulating parathyroid hormone level
|
J:88710
|
Il9em1(IMPC)Mbp/Il9em1(IMPC)Mbp
(C57BL/6NCrl-Il9em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-10 level
|
J:151551
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating enzyme level
|
J:110238
|
abnormal circulating protein level
|
J:110238
|
abnormal circulating serum albumin level
|
J:93577
|
decreased circulating cholesterol level
|
J:129479
|
decreased circulating creatinine level
|
J:93577
|
decreased circulating insulin level
|
J:129479
|
decreased circulating iron level
|
J:15222
|
increased circulating cholesterol level
|
J:129479
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd)
|
increased circulating interleukin-12 level
|
J:118833
|
increased circulating tumor necrosis factor level
|
J:118833
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
increased circulating interferon-gamma level
|
J:157787
|
increased circulating interleukin-1 alpha level
|
J:157787
|
increased circulating interleukin-1 beta level
|
J:157787,
J:139972
|
increased circulating interleukin-2 level
|
J:157787
|
increased circulating interleukin-6 level
|
J:157787,
J:139972
|
increased circulating interleukin-12 level
|
J:157787
|
increased circulating interleukin-17 level
|
J:157787
|
increased circulating tumor necrosis factor level
|
J:157787
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn)
|
abnormal circulating interleukin-6 level
|
J:191723
|
abnormal circulating interleukin-12b level
|
J:191723
|
Il10ratm1.1Jack/Il10ratm1.1Jack Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased circulating interferon-gamma level
|
J:157787
|
increased circulating interleukin-1 alpha level
|
J:157787
|
increased circulating interleukin-1 beta level
|
J:157787
|
increased circulating interleukin-2 level
|
J:157787
|
increased circulating interleukin-12 level
|
J:157787
|
increased circulating interleukin-17 level
|
J:157787
|
increased circulating tumor necrosis factor level
|
J:157787
|
Il10ratm1.2Jack/Il10ratm1.2Jack
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)
|
increased circulating interferon-gamma level
|
J:157787
|
increased circulating interleukin-1 alpha level
|
J:157787
|
increased circulating interleukin-1 beta level
|
J:157787
|
increased circulating interleukin-2 level
|
J:157787
|
increased circulating interleukin-6 level
|
J:157787
|
increased circulating interleukin-12 level
|
J:157787
|
increased circulating interleukin-17 level
|
J:157787
|
increased circulating tumor necrosis factor level
|
J:157787
|
Il10ratm1b(KOMP)Wtsi/Il10ratm1b(KOMP)Wtsi
(C57BL/6N-Il10ratm1b(KOMP)Wtsi/Orl)
|
decreased blood urea nitrogen level
|
J:211773
|
Il10rbtm1a(KOMP)Wtsi/Il10rbtm1a(KOMP)Wtsi
(C57BL/6N-Il10rbtm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Il10rbtm1Agt/Il10rbtm1Agt Tg(Cd4-TGFBR2)16Flv/?
(involves: 129S2/SvPas * C3H * C57BL/6)
|
increased circulating interferon-gamma level
|
J:134156
|
increased circulating interleukin-6 level
|
J:134156
|
increased circulating tumor necrosis factor level
|
J:134156
|
Il11tm1Moto/Il11tm1Moto
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
increased circulating leptin level
|
J:345337
|
Il11tm2.1Moto/Il11tm2.1Moto Tg(BGLAP-cre)1Clem/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * FVB/NJ)
|
abnormal circulating interleukin level
|
J:345337
|
decreased circulating osteocalcin level
|
J:345337
|
Il12atm1b(EUCOMM)Hmgu/Il12atm1b(EUCOMM)Hmgu
(C57BL/6N-Il12atm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Il12atm1Cab/Il12atm1Cab
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:54482
|
decreased circulating interleukin-12 level
|
J:54482
|
Il12atm1Cab/Il12atm1Cab
(B6.129S4-Il12atm1Cab)
|
decreased circulating interferon-gamma level
|
J:79552
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
decreased circulating interferon-gamma level
|
J:120806
|
Il12rb1tm1Jm/Il12rb1tm1Jm
(involves: 129S1/Sv * C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:42105
|
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J)
|
increased circulating interleukin-12 level
|
J:120061
|
Il13tm1.1(KOMP)Vlcg/Il13tm1.1(KOMP)Vlcg
(C57BL/6N-Il13tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-13 level
|
J:67965
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129)
|
decreased circulating interleukin-13 level
|
J:67965
|
Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
increased circulating interleukin-5 level
|
J:130488
|
Il13ra2tm1b(EUCOMM)Hmgu/Il13ra2tm1b(EUCOMM)Hmgu
(C57BL/6N-Il13ra2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating potassium level
|
J:211773
|
Il13ra2tm1Gru/Il13ra2tm1Gru
(C.Cg-Il13ra2tm1Gru)
|
decreased circulating interleukin-13 level
|
J:82376
|
Il17rcem1(IMPC)Mbp/Il17rcem1(IMPC)Mbp
(C57BL/6NCrl-Il17rcem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating triglyceride level
|
J:211773
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd)
|
decreased circulating interferon-gamma level
|
J:46514
|
decreased circulating interleukin-18 level
|
J:122588,
J:46514
|
Il18tm1Khe/Il18tm1Khe
(involves: 129P2/OlaHsd)
|
decreased circulating interferon-gamma level
|
J:62263
|
decreased circulating interleukin-18 level
|
J:62263
|
increased circulating tumor necrosis factor level
|
J:62263
|
Il18tm1Khe/Il18tm1Khe
(B6.129P2-Il18tm1Khe)
|
decreased circulating interferon-gamma level
|
J:138759
|
decreased circulating interleukin-6 level
|
J:138759
|
decreased circulating interleukin-18 level
|
J:138759
|
Il18bptm1(KOMP)Vlcg/Il18bptm1(KOMP)Vlcg
(C57BL/6-Il18bptm1(KOMP)Vlcg)
|
increased circulating interferon-gamma level
|
J:255309
|
Il18bptm1.1(KOMP)Vlcg/Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N)
|
abnormal circulating chemokine level
|
J:261967
|
increased circulating alanine transaminase level
|
J:261967
|
increased circulating ferritin level
|
J:261967
|
increased circulating interferon-gamma level
|
J:261967
|
increased circulating interleukin-18 level
|
J:261967
|
Il20ratm1.1(KOMP)Vlcg/Il20ratm1.1(KOMP)Vlcg
(C57BL/6N-Il20ratm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Il20rbem2(IMPC)Mbp/Il20rbem2(IMPC)Mbp
(C57BL/6N-Il20rbem2(IMPC)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Il20rbtm1b(KOMP)Wtsi/Il20rbtm1b(KOMP)Wtsi
(C57BL/6N-Il20rbtm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Il21rtm1Lex/Il21rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating triglyceride level
|
J:103485
|
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd)
|
abnormal circulating cytokine level
|
J:179011
|
decreased circulating interleukin-1 alpha level
|
J:179011
|
decreased circulating interleukin-12 level
|
J:179011
|
decreased circulating interleukin-12b level
|
J:179011
|
decreased circulating tumor necrosis factor level
|
J:179011
|
increased circulating interleukin-17 level
|
J:179011
|
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv)
|
increased circulating alanine transaminase level
|
J:126103
|
increased circulating aspartate transaminase level
|
J:126103
|
Il22ra1tm1a(EUCOMM)Wtsi/Il22ra1tm1a(EUCOMM)Wtsi
(C57BL/6N-Il22ra1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:175295
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
abnormal circulating interleukin level
|
J:216867
|
increased circulating interleukin-17 level
|
J:216867
|
Il23rtm1.1Ngh/Il23rtm1.1Ngh
(involves: C57BL/6)
|
abnormal circulating interleukin level
|
J:216867
|
increased circulating interleukin-17 level
|
J:216867
|
Il23rtm1.1Ngh/Il23rtm1.1Ngh Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating interleukin level
|
J:216867
|
Il23rtm2a(EUCOMM)Wtsi/Il23rtm2a(EUCOMM)Wtsi
(C57BL/6N-Il23rtm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Il24tm1.1(KOMP)Vlcg/Il24tm1.1(KOMP)Vlcg
(C57BL/6N-Il24tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Il25tm1Lex/Il25tm1Lex
(B6;129S5-Il25tm1Lex/Orl)
|
increased circulating triglyceride level
|
J:82809
|
Il27tm1Lex/Il27tm1Lex
(involves: 129S/SvEvBrd)
|
increased circulating interleukin-12b level
|
J:187660
|
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
|
decreased circulating interferon-gamma level
|
J:116610
|
increased circulating alanine transaminase level
|
J:88618
|
increased circulating interferon-gamma level
|
J:88618
|
increased circulating interleukin-1 beta level
|
J:88618
|
increased circulating interleukin-4 level
|
J:88618
|
increased circulating interleukin-6 level
|
J:88618
|
increased circulating interleukin-12 level
|
J:88618
|
increased circulating tumor necrosis factor level
|
J:88618
|
Ildr1Gt(D178D03)Wrst/Ildr1Gt(D178D03)Wrst
(involves: 129S2/SvPas * C57BL/6J * Swiss Webster)
|
abnormal circulating hormone level
|
J:201407
|
Ildr1Gt(D178D03)Wrst/Ildr1Gt(D178D03)Wrst Tg(Cck-EGFP)BJ203Gsat/0
(involves: 129S2/SvPas * C57BL/6J * FVB/NTac * Swiss Webster)
|
abnormal circulating hormone level
|
J:201407
|
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J
(B6.D2-Ildr2Dbsm1-DBA/2J)
|
hyperglycemia
|
J:138216
|
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J Lepob/Lepob
(B6.Cg-Ildr2Dbsm1-DBA/2J Lepob)
|
decreased circulating insulin level
|
J:138216
|
hyperglycemia
|
J:138216
|
Ildr2W87*/Ildr2W87*
(involves: C3HeB/FeJ)
|
decreased circulating insulin level
|
J:138216
|
Ilf3tm1Pnk/Ilf3tm1Pnk
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:99935
|
Ilktm1.1(KOMP)Vlcg/Ilk+
(C57BL/6N-Ilktm1.1(KOMP)Vlcg/J)
|
increased circulating phosphate level
|
J:211773
|
Ilktm1Star/Ilktm1Star Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased blood urea nitrogen level
|
J:129244
|
increased circulating cholesterol level
|
J:129244
|
increased circulating creatinine level
|
J:129286
|
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal circulating apolipoprotein level
|
J:302091
|
abnormal circulating non-HDL cholesterol level
|
J:302091
|
decreased circulating cholesterol level
|
J:302091
|
decreased circulating HDL cholesterol level
|
J:302091
|
decreased circulating LDL cholesterol level
|
J:302091
|
decreased circulating phospholipid level
|
J:302091
|
decreased circulating triglyceride level
|
J:302091
|
decreased circulating VLDL triglyceride level
|
J:302091
|
ImmtGt(AW0256)Wtsi/Immt+
(involves: 129P2/OlaHsd)
|
increased circulating creatine kinase level
|
J:344896
|
increased circulating glucose level
|
J:344896
|
increased circulating lactate dehydrogenase level
|
J:344896
|
increased circulating lactate level
|
J:344896
|
Impactem1(IMPC)Ccpcz/Impactem1(IMPC)Ccpcz
(C57BL/6NCrl-Impactem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Impacttm1.1Casb/Impacttm1.1Casb
(involves: C57BL/6J)
|
decreased fasting circulating glucose level
|
J:279071
|
Impg2em1(IMPC)Mbp/Impg2em1(IMPC)Mbp
(C57BL/6NCrl-Impg2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Inafm1em1(IMPC)Kmpc/Inafm1em1(IMPC)Kmpc
(C57BL/6NTac-Inafm1em1(IMPC)Kmpc/Kmpc)
|
decreased circulating serum albumin level
|
J:211773
|
Ing2tm1.1(KOMP)Vlcg/Ing2+
(C57BL/6N-Ing2tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Ing4em1(IMPC)Tcp/Ing4em1(IMPC)Tcp
(C57BL/6NCrl-Ing4em2(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ing4Gt(XG370)Byg/Ing4Gt(XG370)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating interleukin-6 level
|
J:161381
|
Ing5em1(IMPC)J/Ing5em1(IMPC)J
(C57BL/6NJ-Ing5em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:3315
|
Inhatm1Bay/Inhatm1Bay
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased circulating follicle stimulating hormone level
|
J:84989
|
increased circulating estradiol level
|
J:84989
|
Inhbatm1Zuk/Inhbatm2Zuk
(involves: 129S7/SvEvBrd)
|
decreased circulating estradiol level
|
J:63882
|
decreased circulating progesterone level
|
J:63882
|
hypoglycemia
|
J:63882
|
increased circulating follicle stimulating hormone level
|
J:63882
|
Inhbatm2Zuk/Inhbatm2Zuk
(involves: 129S7/SvEvBrd)
|
abnormal circulating hormone level
|
J:63882
|
Inhbbtm1b(EUCOMM)Hmgu/Inhbbtm1b(EUCOMM)Hmgu
(C57BL/6N-Inhbbtm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Inhbbtm1Grid/Inhbbtm1Grid
(involves: 129S1/Sv * C57BL/6)
|
increased circulating aspartate transaminase level
|
J:19647
|
Inhbbtm1Jae/Inhbbtm1Jae
(either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased circulating follicle stimulating hormone level
|
J:16995
|
Inhbctm1Zuk/Inhbctm1Zuk
(either: (involves: 129S5/SvEvBrd * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased circulating serum albumin level
|
J:110815
|
Inpp5del20/Inpp5del20
(B6.129-Inpp5del20)
|
increased circulating interleukin-6 level
|
J:173266
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:121283
|
abnormal platelet activation
|
J:121283
|
decreased platelet aggregation
|
J:121283
|
increased bleeding time
|
J:121283
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(B6.129P2/OlaHsd-Inpp5dtm1Dmt)
|
increased circulating interleukin-6 level
|
J:173266
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating interleukin-6 level
|
J:117320
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating interleukin-6 level
|
J:78771
|
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd)
|
abnormal blood homeostasis
|
J:139745
|
decreased circulating free fatty acids level
|
J:139745
|
decreased circulating glucose level
|
J:139745
|
decreased circulating insulin level
|
J:139745
|
decreased circulating leptin level
|
J:139745
|
decreased circulating triglyceride level
|
J:139745
|
Inppl1tm1Glas/Inppl1tm1Glas
(involves: C57BL/6J)
|
decreased circulating cholesterol level
|
J:96048
|
decreased circulating free fatty acids level
|
J:96048
|
decreased circulating leptin level
|
J:96048
|
decreased circulating triglyceride level
|
J:96048
|
Ins1tm1.1(cre)Thor/Ins1+ Med15tm1c(KOMP)Wtsi/Med15tm1c(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating insulin level
|
J:355262
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
increased circulating triglyceride level
|
J:40377
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell)
|
increased circulating glucose level
|
J:98583
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Mnt/Ins2tm1Mnt Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal circulating insulin level
|
J:152798
|
hyperglycemia
|
J:152798
|
increased circulating glucose level
|
J:152798
|
Ins1tm1Jja/Ins1tm1Jja Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell)
|
increased circulating glucose level
|
J:98583
|
Ins2Akita/?
(involves: C57BL/6NSlc)
|
decreased circulating insulin level
|
J:130021
|
decreased circulating triglyceride level
|
J:130021
|
hyperglycemia
|
J:130021
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
|
decreased circulating insulin level
|
J:40063
|
hyperglycemia
|
J:40063,
J:125256
|
Ins2Akita/Ins2+
(involves: C3H * C57BL/6NJcl * C57BL/6NSlc)
|
hyperglycemia
|
J:40063
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J)
|
decreased circulating insulin level
|
J:321591
|
hyperglycemia
|
J:99412,
J:76224
|
Ins2Akita/Ins2+
(involves: C57BL/6NSlc)
|
decreased circulating leptin level
|
J:200802
|
increased circulating glucose level
|
J:200802
|
Ins2Akita/Ins2+ Or12d17em1Cya/Or12d17em1Cya
(C57BL/6-Ins2Akita Or12d17em1Cya)
|
decreased circulating insulin level
|
J:321591
|
Ins2Akita/Ins2+ Prf1tm1Sdz/Prf1tm1Sdz Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
hyperglycemia
|
J:138005
|
Ins2Akita/Ins2+ Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc)
|
decreased circulating leptin level
|
J:200802
|
increased circulating glucose level
|
J:200802
|
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita)
|
hyperglycemia
|
J:47883
|
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita/J)
|
hyperglycemia
|
J:76224
|
Ins2Akita/Ins2Akita
(involves: C57BL/6NSlc)
|
decreased circulating insulin level
|
J:156725
|
hyperglycemia
|
J:156725
|
Ins2Akita/Ins2Akita
(C.B6N-Ins2Akita)
|
hyperglycemia
|
J:198186
|
Ins2Akita/Ins2Akita Itga1tm1Gdnr/Itga1tm1Gdnr
(C.Cg-Ins2Akita Itga1tm1Gdnr)
|
hyperglycemia
|
J:198186
|
Ins2Akita/Ins2Akita Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)
|
increased circulating glucose level
|
J:303318
|
Ins2Akita/Ins2Akita Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Ins2Akita Ldlrtm1Her)
|
decreased circulating insulin level
|
J:174983
|
hyperglycemia
|
J:174983
|
increased circulating cholesterol level
|
J:174983
|
increased circulating HDL cholesterol level
|
J:174983
|
increased circulating LDL cholesterol level
|
J:174983
|
increased circulating triglyceride level
|
J:174983
|
increased circulating VLDL cholesterol level
|
J:174983
|
Ins2Akita/Ins2Akita Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(FVB.Cg-Rpl13atm1.1Jesc Ins2Akita)
|
abnormal circulating glucose level
|
J:237822
|
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
|
decreased circulating insulin level
|
J:122098
|
hyperglycemia
|
J:122098,
J:137483
|
increased circulating glucose level
|
J:122098
|
Ins2C95S/Ins2C95S
(C3HeB/FeJ-Ins2C95S)
|
increased circulating glucose level
|
J:122098
|
Ins2em#Arak/Ins2+
(C.129-Rag2tm1Fwa Ins2em#Arak Jak3tm1Tks/Arak)
|
hyperglycemia
|
J:294041
|
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss)
|
increased circulating ketone body level
|
J:94589
|
Insig1em1(IMPC)Ccpcz/Insig1em1(IMPC)Ccpcz
(C57BL/6N-Insig1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified)
|
decreased circulating triglyceride level
|
J:208931
|
Insig1tm1Mbjg/Insig1tm1Mbjg Insig2tm1Mbjg/Insig2tm1Mbjg Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL)
|
decreased circulating triglyceride level
|
J:101203
|
increased circulating cholesterol level
|
J:101203
|
Insl5tm1Imad/Insl5tm1Imad
(129(B6)-Insl5tm1Imad)
|
decreased circulating insulin level
|
J:189146
|
hyperglycemia
|
J:189146
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
cyanosis
|
J:112173
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:112173
|
Insm2em1Tcai/Insm2em1Tcai
(involves: C57BL/6J)
|
abnormal blood homeostasis
|
J:334013
|
decreased circulating insulin level
|
J:334013
|
increased fasting circulating glucose level
|
J:334013
|
Insq2SM/J/?
(involves: A/J * SM/J)
|
increased circulating insulin level
|
J:64138
|
Insq3SM/J/?
(involves: A/J * SM/J)
|
increased circulating insulin level
|
J:64138
|
Insq4SM/J/?
(involves: A/J * SM/J)
|
increased circulating insulin level
|
J:64138
|
Insq5SM/J/?
(involves: A/J * SM/J)
|
decreased circulating insulin level
|
J:64138
|
Insq6C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6)
|
increased circulating insulin level
|
J:61489
|
Insq7C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6)
|
increased circulating insulin level
|
J:61489
|
Insq8C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6)
|
increased circulating insulin level
|
J:61489
|
Insq9C57BL/6/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6)
|
increased circulating insulin level
|
J:61489
|
Insq10129/SvIr/?
(involves: 129S6.129S4(B6)-Insrtm1Dac * C57BL/6)
|
increased circulating insulin level
|
J:61489
|
InsrRgsc294/Insr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
increased circulating insulin level
|
J:133634
|
InsrRgsc824/Insr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
increased circulating insulin level
|
J:133634
|
increased glycosylated hemoglobin level
|
J:133634
|
InsrRgsc1777/Insr+
(involves: C3H * C57BL/6JJcl)
|
hyperglycemia
|
J:133634
|
increased circulating insulin level
|
J:133634
|
Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
increased circulating insulin level
|
J:135659
|
Insrtm1Dac/Insr+
(involves: C3H/HeH * C57BL/6)
|
increased circulating insulin level
|
J:141688
|
Insrtm1Dac/Insr+
(B6.129S4-Insrtm1Dac/J)
|
increased circulating insulin level
|
J:246319
|
Insrtm1Dac/Insr+ Ppp2r2aigt10/Ppp2r2a+
(involves: 129S4/SvJae * C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:246319
|
increased circulating insulin level
|
J:246319
|
Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6)
|
hyperglycemia
|
J:33408
|
increased circulating insulin level
|
J:33408
|
Insrtm1Dac/Insrtm1Dac Insrrtm1Dac/Insrrtm1Dac
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6J)
|
hyperglycemia
|
J:70602
|
increased circulating insulin level
|
J:70602
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L1Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
hyperglycemia
|
J:91350
|
increased circulating glucose level
|
J:91350
|
increased circulating insulin level
|
J:91350
|
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:32538
|
increased circulating free fatty acids level
|
J:32538
|
increased circulating insulin level
|
J:32538
|
increased circulating triglyceride level
|
J:32538
|
Insrtm1Jja/Insrtm1Jja Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2)
|
increased circulating glucose level
|
J:80773
|
Insrtm1Khn/Insrtm1Dac Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6J * FVB)
|
hyperglycemia
|
J:51266
|
increased circulating insulin level
|
J:51266
|
Insrtm1Khn/Insrtm1Khn Leprtm1.1Chua/Leprtm1.1Chua Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
hyperglycemia
|
J:192274
|
increased circulating leptin level
|
J:192274
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)
|
abnormal circulating serum albumin level
|
J:63878
|
decreased circulating free fatty acids level
|
J:63878
|
decreased circulating triglyceride level
|
J:63878
|
hyperglycemia
|
J:63878
|
increased circulating alkaline phosphatase level
|
J:63878
|
increased circulating aspartate transaminase level
|
J:63878
|
increased circulating insulin level
|
J:63878
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased circulating glucose level
|
J:121640
|
hyperglycemia
|
J:121640
|
increased circulating insulin level
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
hyperglycemia
|
J:234643
|
increased circulating insulin level
|
J:234643
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:121640
|
increased circulating insulin level
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
decreased circulating luteinizing hormone level
|
J:64790
|
increased circulating insulin level
|
J:64790
|
increased circulating leptin level
|
J:64790
|
increased circulating triglyceride level
|
J:64790
|
Insrtm1Khn/Insrtm1Khn Tg(Pdgfrb-cre)#Rha/0
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating insulin level
|
J:327000
|
Insrtm1Khn/Insrtm1Khn Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB)
|
hyperglycemia
|
J:169404
|
increased circulating free fatty acids level
|
J:169404
|
increased circulating glucose level
|
J:169404
|
increased circulating insulin level
|
J:169404
|
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc)
|
hyperglycemia
|
J:98723
|
increased circulating insulin level
|
J:98723
|
Insyn2bem1(IMPC)J/Insyn2bem1(IMPC)J
(C57BL/6NJ-Insyn2bem1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Ints9tm1b(KOMP)Wtsi/Ints9+
(C57BL/6N-Ints9tm1b(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Ints10tm1b(KOMP)Wtsi/Ints10+
(C57BL/6N-Ints10tm1b(KOMP)Wtsi/J)
|
decreased circulating creatinine level
|
J:211773
|
Ints12tm1a(EUCOMM)Wtsi/Ints12+
(B6JTyr;B6N-Ints12tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:175295
|
Ints12tm1b(EUCOMM)Wtsi/Ints12+
(C57BL/6N-Ints12tm1b(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:211773
|
Invsinv/Invsinv
(involves: FVB/N)
|
increased blood urea nitrogen level
|
J:132552
|
Ip6k1Gt(OST137568)Lex/Ip6k1Gt(OST137568)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating insulin level
|
J:103485
|
Ip6k1tm1.1Snyd/Ip6k1tm1.1Snyd
(involves: 129X1/SvJ * BALB/c * C57BL/6)
|
decreased circulating insulin level
|
J:132167
|
Ipo7em1(IMPC)Mbp/Ipo7+
(C57BL/6N-Ipo7em1(IMPC)Mbp/Ucd)
|
increased circulating insulin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ipo11tm1.1(KOMP)Vlcg/Ipo11+
(B6N(Cg)-Ipo11tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ipptm1.1(KOMP)Vlcg/Ipptm1.1(KOMP)Vlcg
(C57BL/6N-Ipptm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Iqca1em1(IMPC)J/Iqca1em1(IMPC)J
(C57BL/6NJ-Iqca1em1(IMPC)J/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Iqcetm1b(EUCOMM)Hmgu/Iqcetm1b(EUCOMM)Hmgu
(C57BL/6N-Iqcetm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Iqgap2tm1Vs/Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs)
|
increased circulating aspartate transaminase level
|
J:132670
|
Iqsec3tm3b(KOMP)Wtsi/Iqsec3tm3b(KOMP)Wtsi
(C57BL/6N-Iqsec3tm3b(KOMP)Wtsi/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Irag1em1(IMPC)Ccpcz/Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Irak1tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Irak1tm1b(EUCOMM)Hmgu/Wtsi)
|
increased circulating fructosamine level
|
J:211773
|
Irak2tm1b(EUCOMM)Wtsi/Irak2tm1b(EUCOMM)Wtsi
(C57BL/6N-Irak2tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Irak2tm1Jth/Irak2tm1Jth
(involves: 129 * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:149258
|
decreased circulating tumor necrosis factor level
|
J:149258
|
Irak4tm1Lix/Irak4tm1Lix
(involves: C57BL/6)
|
decreased circulating interleukin-6 level
|
J:125732
|
decreased circulating tumor necrosis factor level
|
J:125732
|
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:76098
|
decreased circulating interleukin-1 level
|
J:76098
|
decreased circulating interleukin-6 level
|
J:76098
|
decreased circulating tumor necrosis factor level
|
J:76098
|
Ireb2tm1.1Eal/Ireb2tm1.1Eal
(B6J.129-Ireb2tm1.1Eal)
|
increased circulating ferritin level
|
J:217335
|
Ireb2tm1Roua/Ireb2tm1Roua
(involves: C57BL/6)
|
increased circulating ferritin level
|
J:67313
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
decreased circulating interleukin-2 level
|
J:110672
|
increased circulating interferon-gamma level
|
J:110672
|
increased circulating interleukin-3 level
|
J:110672
|
increased circulating interleukin-4 level
|
J:110672
|
increased circulating interleukin-5 level
|
J:110672
|
increased circulating interleukin-6 level
|
J:110672
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129)
|
abnormal circulating interleukin-4 level
|
J:84367
|
abnormal circulating interleukin-10 level
|
J:84367
|
decreased circulating interferon-gamma level
|
J:84367
|
increased circulating interleukin-5 level
|
J:84367
|
increased circulating interleukin-6 level
|
J:84367
|
increased circulating interleukin-13 level
|
J:84367
|
Irf1tm1Mak/Irf1tm1Mak
(B6.129S2-Irf1tm1Mak/J)
|
abnormal circulating alanine transaminase level
|
J:111090
|
Irf3em1(IMPC)Mbp/Irf3em1(IMPC)Mbp
(C57BL/6N-Irf3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Irf3tm1Ttg/Irf3tm1Ttg
(involves: 129S/SvEv * C57BL/6J)
|
abnormal circulating interferon level
|
J:98127
|
Irf5tm1Ttg/Irf5tm1Ttg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:97567
|
decreased circulating interleukin-12b level
|
J:97567
|
decreased circulating tumor necrosis factor level
|
J:97567
|
Irf6em1(IMPC)Wtsi/Irf6em1(IMPC)Wtsi
(C57BL/6N-Irf6em1(IMPC)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Irf7M2Btlr/Irf7+
(C57BL/6J-Irf7M2Btlr)
|
decreased circulating interferon-beta level
|
J:217798
|
Irf7M2Btlr/Irf7M2Btlr
(C57BL/6J-Irf7M2Btlr)
|
decreased circulating interferon-beta level
|
J:217798
|
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
(C57BL/6N-Irf8tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Irf9M1Btlr/Irf9+
(C57BL/6J-Irf9M1Btlr)
|
increased circulating interferon-beta level
|
J:236674
|
Irf9M1Btlr/Irf9M1Btlr
(C57BL/6J-Irf9M1Btlr)
|
increased circulating interferon-beta level
|
J:236674
|
Irgm1em1(IMPC)Wtsi/Irgm1em1(IMPC)Wtsi
(C57BL/6N-Irgm1em1(IMPC)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Irgm1tm1Gat/Irgm1tm1Gat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating interferon-gamma level
|
J:87535
|
increased circulating interleukin-12 level
|
J:87535
|
Irgm2em1(IMPC)J/Irgm2em1(IMPC)J
(C57BL/6NJ-Irgm2em1(IMPC)J/J)
|
decreased circulating serum albumin level
|
J:211773
|
Irgqem1(IMPC)J/Irgqem1(IMPC)J
(C57BL/6NJ-Irgqem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Irs1m1Btlr/Irs1m1Btlr
(C57BL/6J-Irs1m1Btlr)
|
increased circulating insulin level
|
J:267531
|
Irs1Sml/Irs1+
(C3.Cg-Irs1Sml H2b/GrsrJ)
|
increased circulating insulin level
|
J:163661
|
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ)
|
decreased circulating glucose level
|
J:163661
|
increased circulating insulin level
|
J:163661
|
Irs1tm1Jos/Irs1+ Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:93415
|
hyperglycemia
|
J:93415
|
Irs1tm1Jos/Irs1tm1Jos
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating insulin level
|
J:21374
|
Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased circulating free fatty acids level
|
J:80976
|
decreased circulating leptin level
|
J:80976
|
decreased circulating triglyceride level
|
J:80976
|
hyperglycemia
|
J:80976
|
increased circulating insulin level
|
J:80976
|
Irs1tm1Jos/Irs1tm1Jos Irs4tm1Lhd/Y
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:80976
|
Irs1tm1Jos/Irs1tm1Jos Irs4tm1Lhd/Irs4tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:80976
|
Irs1tm1Mfw/Irs1tm1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:137845
|
decreased circulating free fatty acids level
|
J:137845
|
decreased circulating HDL cholesterol level
|
J:137845
|
decreased circulating triglyceride level
|
J:137845
|
hyperglycemia
|
J:137845
|
increased circulating glucose level
|
J:137845
|
increased circulating insulin level
|
J:137845
|
Irs1tm1Mfw/Irs1tm2.1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N)
|
increased circulating insulin level
|
J:156999
|
Irs1tm1Tka/Irs1tm1Tka
(Not Specified)
|
increased circulating insulin level
|
J:21373
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased circulating HDL cholesterol level
|
J:47029
|
increased circulating free fatty acids level
|
J:99746
|
increased circulating insulin level
|
J:61479
|
increased circulating triglyceride level
|
J:47029,
J:99746
|
Irs1tm2.1Mfw/Irs1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased circulating insulin level
|
J:156999
|
Irs1tm2.1Mfw/Irs1tm2.1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased circulating insulin level
|
J:156999
|
Irs1tm2.1Mfw/Irs1tm2.1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N)
|
increased circulating insulin level
|
J:156999
|
Irs1tm2Tka/Irs1tm2Tka Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased circulating insulin level
|
J:137846
|
Irs2M1Btlr/Irs2M1Btlr
(C57BL/6J-Irs2M1Btlr)
|
hyperglycemia
|
J:267533
|
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal circulating glucose level
|
J:74303
|
abnormal circulating hormone level
|
J:64791
|
abnormal circulating insulin level
|
J:94000
|
decreased circulating estradiol level
|
J:64791
|
decreased circulating luteinizing hormone level
|
J:64791
|
decreased circulating progesterone level
|
J:64791
|
decreased circulating prolactin level
|
J:64791
|
decreased circulating testosterone level
|
J:64791
|
hyperglycemia
|
J:135659,
J:94000,
J:96047,
J:46134
|
increased circulating insulin level
|
J:135659,
J:46134
|
increased circulating leptin level
|
J:64791
|
Irs2tm1Mfw/Irs2tm1Mfw Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:87249
|
Irs2tm1Mfw/Irs2tm1Mfw Tg(Ins2-Irs2)13Mfw/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating insulin level
|
J:94000
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
hyperglycemia
|
J:99746
|
increased circulating cholesterol level
|
J:99746
|
increased circulating free fatty acids level
|
J:99746
|
increased circulating HDL cholesterol level
|
J:99746
|
increased circulating insulin level
|
J:65485
|
increased circulating triglyceride level
|
J:99746
|
Irs2tm1With/Irs2tm1With Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating glucose level
|
J:97406
|
increased circulating insulin level
|
J:97406
|
increased circulating leptin level
|
J:97406
|
Irs2tm1With/Irs2tm1With Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating glucose level
|
J:97406
|
increased circulating insulin level
|
J:97406
|
increased circulating leptin level
|
J:97406
|
Irs2tm2Mfw/Irs2tm2Mfw Irs4tm1.1Mfw/Y Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:221293
|
increased circulating insulin level
|
J:221293
|
increased circulating leptin level
|
J:221293
|
increased fasting circulating glucose level
|
J:221293
|
Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating glucose level
|
J:93415
|
increased circulating insulin level
|
J:93415
|
increased circulating leptin level
|
J:93415
|
Irs2tm2Mfw/Irs2tm2Mfw Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating glucose level
|
J:221293
|
increased circulating insulin level
|
J:221293
|
increased circulating leptin level
|
J:221293
|
increased fasting circulating glucose level
|
J:221293
|
Irs2tm2Tka/Irs2tm2Tka Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased circulating insulin level
|
J:137846
|
Irs2tm2Tka/Irs2tm2Tka Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:93416
|
increased circulating glucose level
|
J:93416
|
increased circulating leptin level
|
J:93416
|
increased circulating triglyceride level
|
J:93416
|
Irs4tm1.1Mfw/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating glucose level
|
J:221293
|
Irs4tm1Lhd/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating glucose level
|
J:59964
|
Irx1tm1(KOMP)Vlcg/Irx1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
cyanosis
|
J:248919
|
Irx1tm1.1(KOMP)Vlcg/Irx1+
(C57BL/6N-Irx1tm1.1(KOMP)Vlcg/J)
|
increased circulating potassium level
|
J:211773
|
Irx3em2(IMPC)H/Irx3em2(IMPC)H
(C57BL/6N-Irx3em2(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Irx6tm1b(KOMP)Mbp/Irx6tm1b(KOMP)Mbp
(C57BL/6N-Irx6tm1b(KOMP)Mbp/Kmpc)
|
increased circulating phosphate level
|
J:211773
|
Isg20em1Cya/Isg20em1Cya Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6N * ICR)
|
increased blood urea nitrogen level
|
J:343183
|
increased circulating creatinine level
|
J:343183
|
Ism1em1(IMPC)Ccpcz/Ism1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ism1em1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Itchtm1b(EUCOMM)Hmgu/Itchtm1b(EUCOMM)Hmgu
(C57BL/6N-Itchtm1b(EUCOMM)Hmgu/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Itga1tm1Gdnr/Itga1tm1Gdnr
(involves: 129S4/SvJae * BALB/c)
|
increased circulating creatinine level
|
J:91522
|
increased circulating serum albumin level
|
J:91522
|
Itga2tm1.1Eck/Itga2+
(involves: 129P2/OlaHsd)
|
abnormal platelet physiology
|
J:75683
|
decreased platelet aggregation
|
J:75683
|
Itga2tm1.1Eck/Itga2tm1.1Eck
(involves: 129P2/OlaHsd)
|
abnormal platelet aggregation
|
J:75683
|
abnormal platelet physiology
|
J:75683
|
decreased platelet aggregation
|
J:75683
|
Itga2tm1.1Tkun/Itga2tm1.1Tkun Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * SJL)
|
abnormal platelet physiology
|
J:195799
|
decreased platelet aggregation
|
J:195799
|
Itga2tm1Ztr/Itga2tm1Ztr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet physiology
|
J:108331
|
Itga2btm1(GFP/cre)Emam/Itga2btm1(GFP/cre)Emam
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal platelet physiology
|
J:84564
|
Itga2btm1Graf/Itga2b+
(B6.Cg-Itga2btm1Graf)
|
abnormal platelet activation
|
J:123159
|
Itga2btm1Tlr/Itga2b+
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal platelet activation
|
J:63961
|
abnormal platelet aggregation
|
J:63961
|
abnormal platelet physiology
|
J:63961
|
Itga2btm1Tlr/Itga2btm1Tlr
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal blood coagulation
|
J:63961
|
abnormal hemostasis
|
J:63961
|
abnormal platelet activation
|
J:63961
|
abnormal platelet physiology
|
J:63961
|
decreased platelet aggregation
|
J:63961
|
increased bleeding time
|
J:63961
|
Itga7tm1Umr/Itga7tm1Umr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating creatine kinase level
|
J:43840
|
Itga8tm1b(KOMP)Wtsi/Itga8+
(C57BL/6N-Itga8tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Itga11em1(IMPC)H/Itga11em1(IMPC)H
(C57BL/6N-Itga11em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Itgadtm1.1Zimm/Itgadtm1.1Zimm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating interleukin-12 level
|
J:130908
|
Itgalem1(IMPC)H/Itgalem1(IMPC)H
(C57BL/6NTac-Itgalem1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Itgaltm1Mak)
|
increased circulating interleukin-2 level
|
J:123460
|
increased circulating interleukin-10 level
|
J:123460
|
increased circulating tumor necrosis factor level
|
J:123460
|
Itgamtm1Myd/Itgamtm1Myd
(B6.129S4-Itgamtm1Myd)
|
abnormal blood homeostasis
|
J:113463
|
Itgb1tm1Efu/Itgb1tm1Efu Tg(ATP6V1B1-cre)45Rnel/0
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating bicarbonate level
|
J:167156
|
Itgb1tm1Efu/Itgb1tm1Efu Tg(Vil1-cre)997Gum/0
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:119155
|
Itgb1tm1Ref/Itgb1tm1Ref Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal platelet physiology
|
J:118488
|
Itgb1tm1Ross/Itgb1tm1Ross Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal atrial thrombosis
|
J:82534
|
Itgb1tm1Ross/Itgb1tm1Ross Tg(Hoxb7-cre)13Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased blood urea nitrogen level
|
J:149831
|
Itgb1tm2Mlkn/Itgb1tm2Mlkn
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal platelet physiology
|
J:108331
|
Itgb1tm2Son/Itgb1tm2Son
(FVB.129P2-Itgb1tm2Son)
|
cyanosis
|
J:82463
|
Itgb1tm3Mlkn/Itgb1tm3Mlkn Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased circulating noradrenaline level
|
J:108331
|
Itgb2tm1Bay/Itgb2tm1Bay
(B6.129S7-Itgb2tm1Bay/J)
|
increased circulating glucose level
|
J:118466
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating interleukin-3 level
|
J:48542
|
increased circulating interleukin-6 level
|
J:48542
|
Itgb3tm1Aja/Itgb3tm1Aja
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal platelet activation
|
J:148306
|
abnormal platelet dense granule physiology
|
J:148306
|
abnormal platelet physiology
|
J:148306
|
decreased susceptibility to induced thrombosis
|
J:148306
|
increased bleeding time
|
J:148306
|
Itgb3tm1Drp/Itgb3tm1Drp
(Not Specified)
|
abnormal blood coagulation
|
J:73416
|
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr Tg(Pf4-icre)Q3Rsko/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal blood coagulation
|
J:224675
|
abnormal hemostasis
|
J:224675
|
decreased platelet aggregation
|
J:224675
|
increased bleeding time
|
J:224675
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal platelet activation
|
J:52262
|
increased bleeding time
|
J:52262
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas)
|
abnormal platelet physiology
|
J:96049
|
decreased circulating calcium level
|
J:60672
|
Itgb3tm1Hyn/Itgb3tm1Hyn Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:83615
|
increased circulating glucose level
|
J:83615
|
Itgb3tm1Mgin/Itgb3tm1Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal platelet activation
|
J:123968
|
increased bleeding time
|
J:123968
|
Itgb3tm2Mgin/Itgb3tm2Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal platelet activation
|
J:123968
|
abnormal thrombosis
|
J:129707
|
increased bleeding time
|
J:123968
|
Itgb6em1(IMPC)Ccpcz/Itgb6em1(IMPC)Ccpcz
(C57BL/6NCrl-Itgb6em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Itgb8tm1b(KOMP)Wtsi/Itgb8+
(C57BL/6N-Itgb8tm1b(KOMP)Wtsi/BayMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Itgbl1em1(IMPC)Kmpc/Itgbl1em1(IMPC)Kmpc
(C57BL/6NTac-Itgbl1em1(IMPC)Kmpc/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Itln1em1Cya/Itln1em1Cya
(involves: C57BL/6)
|
decreased circulating osteocalcin level
|
J:282124
|
increased circulating interleukin-1 alpha level
|
J:282124
|
increased circulating interleukin-6 level
|
J:282124
|
increased circulating interleukin-10 level
|
J:282124
|
increased circulating tumor necrosis factor level
|
J:282124
|
increased circulating type I collagen C-terminal telopeptide level
|
J:282124
|
Itpr2tm1Kmik/Itpr2tm1Kmik Itpr3tm1Kmik/Itpr3tm1Kmik
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating glucose level
|
J:101380
|
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
|
abnormal circulating hormone level
|
J:144968
|
decreased circulating glucose level
|
J:144968
|
decreased circulating insulin level
|
J:144968
|
decreased circulating insulin-like growth factor I level
|
J:144968
|
decreased circulating leptin level
|
J:144968
|
decreased circulating thyroxine level
|
J:144968
|
decreased circulating triiodothyronine level
|
J:144968
|
Itsn1em1(IMPC)H/Itsn1em1(IMPC)H
(C57BL/6NTac-Itsn1em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Izumo1rtm2a(KOMP)Wtsi/Izumo1rtm2a(KOMP)Wtsi
(C57BL/6N-Izumo1rtm2a(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Jade2em1(IMPC)Tcp/Jade2em1(IMPC)Tcp
(C57BL/6N-Jade2em1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Jag1Ndr/Jag1Ndr
(involves: C3HeB/FeJ * C57BL/6)
|
decreased circulating serum albumin level
|
J:277897
|
increased circulating alkaline phosphatase level
|
J:277897
|
increased circulating aspartate transaminase level
|
J:277897
|
increased circulating bilirubin level
|
J:277897
|
Jag1tm1Frad/Jag1tm1Frad Tg(Tagln-cre)1Her/0
(B6.Cg-Jag1tm1Frad Tg(Tagln-cre)1Her)
|
increased circulating alanine transaminase level
|
J:166890
|
increased circulating alkaline phosphatase level
|
J:166890
|
increased circulating aspartate transaminase level
|
J:166890
|
increased circulating bilirubin level
|
J:166890
|
increased circulating cholesterol level
|
J:166890
|
increased circulating gamma-glutamyl transferase level
|
J:166890
|
increased circulating lactate dehydrogenase level
|
J:166890
|
Jag1tm1Grid/Jag1+ Notch2tm1Grid/Notch2+
(involves: 129S1/Sv * C57BL/6J)
|
increased blood urea nitrogen level
|
J:74574
|
increased circulating alanine transaminase level
|
J:74574
|
increased circulating alkaline phosphatase level
|
J:74574
|
Jag1tm1Grid/Jag1tm2Grid Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
cyanosis
|
J:166769
|
Jag2tm1Grid/Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
cyanosis
|
J:46930
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
abnormal circulating creatinine level
|
J:199153
|
decreased circulating cholesterol level
|
J:199153
|
decreased circulating parathyroid hormone level
|
J:199153
|
decreased circulating phosphate level
|
J:199153
|
decreased circulating serum albumin level
|
J:199153
|
decreased circulating total protein level
|
J:199153
|
hypoglycemia
|
J:199153
|
increased blood uric acid level
|
J:199153
|
increased circulating calcium level
|
J:199153
|
Jak1M1Mhda/Jak1M1Mhda
(C3HeB/FeJ-Jak1M1Mhda/Ieg)
|
decreased circulating phosphate level
|
J:183993
|
increased circulating alkaline phosphatase level
|
J:183993
|
increased circulating calcium level
|
J:183993
|
Jak2tm1.1Ble/Jak2+ Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal blood coagulation
|
J:257910
|
abnormal thrombosis
|
J:257910
|
Jak2tm1.1Jlvl/Jak2tm1.1Jlvl
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating iron level
|
J:163497
|
Jak2tm1Kuw/Jak2tm1Kuw Tg(Gnrh1-cre)35Awo/0
(involves: 129X1/SvJ * CD-1)
|
decreased circulating luteinizing hormone level
|
J:167849
|
Jakmip2em1(IMPC)J/Jakmip2em1(IMPC)J
(C57BL/6NJ-Jakmip2em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Jakmip3em1(IMPC)J/Jakmip3em1(IMPC)J
(C57BL/6NJ-Jakmip3em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Jam2tm1.1(KOMP)Mbp/Jam2tm1.1(KOMP)Mbp
(C57BL/6N-Jam2tm1.1(KOMP)Mbp/J)
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Jam3tm1.1(KOMP)Vlcg/Jam3+
(C57BL/6N-Jam3tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Jam3tm1Lex/Jam3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
cyanosis
|
J:145994
|
Jarid2tm1a(KOMP)Wtsi/Jarid2+
(Not Specified)
|
increased circulating creatinine level
|
J:175295
|
Jmjd4em1(IMPC)Wtsi/Jmjd4em1(IMPC)Wtsi
(C57BL/6N-Jmjd4em1(IMPC)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Jmjd7em1(IMPC)Wtsi/Jmjd7em1(IMPC)Wtsi
(C57BL/6N-Jmjd7em1(IMPC)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Jmjd8em1Kaso/Jmjd8em1Kaso
(C57BL/6-Jmjd8em1Kaso)
|
decreased circulating insulin level
|
J:319518
|
decreased circulating interleukin-1 beta level
|
J:319518
|
Jmjd8tm1.1(KOMP)Vlcg/Jmjd8tm1.1(KOMP)Vlcg
(C57BL/6N-Jmjd8tm1.1(KOMP)Vlcg/J)
|
decreased circulating iron level
|
J:211773
|
Juntm5.1(Junb)Wag/Juntm5.1(Junb)Wag
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:75359
|
Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased circulating interleukin-6 level
|
J:155575
|
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
decreased circulating follicle stimulating hormone level
|
J:53906
|
decreased circulating growth hormone level
|
J:53906
|
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating glucose level
|
J:210545
|
increased circulating cholesterol level
|
J:210545
|
Juptm1.1(KOMP)Vlcg/Jup+
(C57BL/6N-Juptm1.1(KOMP)Vlcg/J)
|
decreased circulating phosphate level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal atrial thrombosis
|
J:38047
|
abnormal cardiac thrombosis
|
J:38047
|
abnormal ventricular thrombosis
|
J:38047
|
KAL003/KAL003
(C3HeB/FeJ-KAL003)
|
increased blood urea nitrogen level
|
J:163957
|
increased circulating potassium level
|
J:163957
|
KAL004/KAL004
(C3HeB/FeJ-KAL004)
|
increased blood urea nitrogen level
|
J:163957
|
increased circulating potassium level
|
J:163957
|
KAL006/KAL006+
(C3HeB/FeJ-KAL006)
|
increased blood urea nitrogen level
|
J:163957
|
increased circulating potassium level
|
J:163957
|
KAL007/KAL007
(C3HeB/FeJ-KAL007)
|
increased blood urea nitrogen level
|
J:163957
|
increased circulating potassium level
|
J:163957
|
Kank1em1(IMPC)Bay/Kank1em1(IMPC)Bay
(C57BL/6N-Kank1em1(IMPC)Bay/BayMmucd)
|
decreased circulating calcium level
|
J:211773
|
Kash5em1(IMPC)J/Kash5em1(IMPC)J
(C57BL/6NJ-Kash5em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Kat2bem1(IMPC)Wtsi/Kat2bem1(IMPC)Wtsi
(C57BL/6N-Kat2bem1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Kat6atm1Avo/Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
cyanosis
|
J:108453
|
Kat8em1(IMPC)Mbp/Kat8+
(C57BL/6N-Kat8em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Katnal2em1(IMPC)Tcp/Katnal2em1(IMPC)Tcp
(C57BL/6N-Katnal2em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
kavh/kavh
(mixed)
|
increased blood urea nitrogen level
|
J:226961
|
Kazntm1a(EUCOMM)Wtsi/Kazntm1a(EUCOMM)Wtsi
(C57BL/6N-Kazntm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
Kbtbd2em1Btlr/Kbtbd2em1Btlr
(Not Specified)
|
increased circulating insulin level
|
J:236520
|
increased fasting circulating glucose level
|
J:236520
|
Kbtbd2em1Btlr/Kbtbd2em1Btlr Pik3r1em1Btlr/Pik3r1em1Btlr
(Not Specified)
|
decreased circulating glucose level
|
J:236520
|
decreased circulating insulin level
|
J:236520
|
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr)
|
decreased circulating leptin level
|
J:236520
|
increased circulating alanine transaminase level
|
J:236520
|
increased circulating aspartate transaminase level
|
J:236520
|
increased circulating insulin level
|
J:236520
|
increased fasting circulating glucose level
|
J:236520
|
Kbtbd7tm1.1(KOMP)Vlcg/Kbtbd7tm1.1(KOMP)Vlcg
(C57BL/6N-Kbtbd7tm1.1(KOMP)Vlcg/J)
|
increased circulating bilirubin level
|
J:211773
|
Kbtbd8em1(IMPC)Tcp/Kbtbd8em1(IMPC)Tcp
(C57BL/6N-Kbtbd8em1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Kcna3tm1Gvd/Kcna3tm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:88651
|
Kcna6tm1Lex/Kcna6tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating triglyceride level
|
J:103485
|
Kcnab3tm1.1(KOMP)Vlcg/Kcnab3tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnab3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Kcnb1tm1Dgen/Kcnb1tm1Dgen
(involves: C57BL/6)
|
hypoglycemia
|
J:129963
|
increased circulating insulin level
|
J:129963
|
Kcnb2em1(IMPC)J/Kcnb2em1(IMPC)J
(C57BL/6NJ-Kcnb2em1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Kcnd3em1(IMPC)J/Kcnd3em1(IMPC)J
(C57BL/6NJ-Kcnd3em1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
Kcne1tm1b(EUCOMM)Hmgu/Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Kcne1tm1Sfh/Kcne1tm1Sfh
(involves: 129S1/Sv)
|
abnormal circulating renin level
|
J:77288
|
hypokalemia
|
J:77288
|
increased blood osmolality
|
J:77288
|
increased circulating aldosterone level
|
J:77288
|
increased circulating sodium level
|
J:77288
|
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:175295
|
increased circulating magnesium level
|
J:175295
|
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi)
|
decreased circulating ferritin level
|
J:230226
|
decreased circulating iron level
|
J:230226
|
increased circulating erythropoietin level
|
J:230226
|
increased circulating magnesium level
|
J:230226
|
Kcne2tm1Gwab/Kcne2tm1Gwab
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating gastrin level
|
J:116518
|
Kcne3tm1.1(KOMP)Vlcg/Kcne3tm1.1(KOMP)Vlcg
(C57BL/6NCrl-Kcne3tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased circulating total protein level
|
J:211773
|
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:210381
|
increased circulating aldosterone level
|
J:210381
|
increased circulating cholesterol level
|
J:210381
|
increased circulating LDL cholesterol level
|
J:210381
|
Kcng2em1(IMPC)Bay/Kcng2em1(IMPC)Bay
(C57BL/6N-Kcng2em1(IMPC)Bay/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Kcng4tm1.1(KOMP)Vlcg/Kcng4tm1.1(KOMP)Vlcg
(C57BL/6N-Kcng4tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3+
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N)
|
decreased circulating glucose level
|
J:271003
|
decreased circulating insulin level
|
J:271003
|
increased circulating insulin level
|
J:271003
|
increased fasting circulating glucose level
|
J:271003
|
Kcnh6em2Jkya/Kcnh6em2Jkya
(involves: C57BL/6N)
|
decreased circulating glucose level
|
J:271003
|
decreased circulating insulin level
|
J:271003
|
increased circulating insulin level
|
J:271003
|
increased fasting circulating glucose level
|
J:271003
|
Kcnh6tm1.1(KOMP)Vlcg/Kcnh6tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnh6tm1.1(KOMP)Vlcg/Tcp)
|
increased circulating calcium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Kcnip1em1(IMPC)H/Kcnip1em1(IMPC)H
(C57BL/6N-Kcnip1em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
Kcnj1tm1Ges/Kcnj1tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating sodium level
|
J:79354
|
Kcnj2tm1Swz/Kcnj2tm1Swz
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
cyanosis
|
J:78077
|
Kcnj6em1(IMPC)H/Kcnj6em1(IMPC)H
(C57BL/6N-Kcnj6em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Kcnj11tm1b(EUCOMM)Wtsi/Kcnj11tm1b(EUCOMM)Wtsi
(C57BL/6N-Kcnj11tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Kcnj11tm1Sse/Kcnj11+ Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:94610
|
increased circulating insulin level
|
J:94610
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse)
|
hypoglycemia
|
J:69163
|
increased circulating atrial natriuretic factor
|
J:106396
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd)
|
decreased circulating insulin level
|
J:49755
|
Kcnj11tm1Sse/Kcnj11tm1Sse Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:94610
|
Kcnj15em1(IMPC)Bay/Kcnj15em1(IMPC)Bay
(C57BL/6N-Kcnj15em1(IMPC)Bay/Bay)
|
increased circulating phosphate level
|
J:211773
|
Kcnk1tm1.1Barh/Kcnk1tm1.1Barh
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating phosphate level
|
J:183234
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased circulating renin level
|
J:131927
|
hypokalemia
|
J:131927
|
increased circulating aldosterone level
|
J:131927
|
Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Kcnk12em1(IMPC)J/Kcnk12em1(IMPC)J
(C57BL/6NJ-Kcnk12em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Kcnk16tm1.1Lex/Kcnk16tm1.1Lex
(B6.129S-Kcnk16tm1.1Lex)
|
abnormal fasting circulating glucose level
|
J:259519
|
Kcnma1em1(IMPC)H/Kcnma1em1(IMPC)H
(C57BL/6N-Kcnma1em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Kcnn4em1(IMPC)Ccpcz/Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatine kinase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Kcnq1tm1Apf/Kcnq1tm1Apf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating gastrin level
|
J:66428
|
Kcnq3em1(IMPC)H/Kcnq3em1(IMPC)H
(C57BL/6N-Kcnq3em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
Kctd1em1(IMPC)J/Kctd1em1(IMPC)J
(C57BL/6NJ-Kctd1em1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Kctd1Mhdahst014/Kctd1+
(C3HeB/FeJ-Kctd1Mhdahst014)
|
increased blood urea nitrogen level
|
J:250423
|
increased circulating amylase level
|
J:250423
|
increased circulating calcium level
|
J:250423
|
increased circulating creatinine level
|
J:250423
|
increased circulating glucose level
|
J:250423
|
increased circulating potassium level
|
J:250423
|
increased circulating serum albumin level
|
J:250423
|
Kctd1tm1c(EUCOMM)Wtsi/Kctd1tm1c(EUCOMM)Wtsi Tg(Six2-EGFP/cre)1Amc/0
(involves: C57BL/6J * C57BL/6N * CD-1)
|
increased blood urea nitrogen level
|
J:344153
|
Kctd5em1(IMPC)J/Kctd5+
(C57BL/6NJ-Kctd5em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Kctd7em2(IMPC)Bay/Kctd7em2(IMPC)Bay
(C57BL/6N-Kctd7em2(IMPC)Bay/BayMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Kctd9em1(IMPC)J/Kctd9em1(IMPC)J
(C57BL/6NJ-Kctd9em1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
Kctd9em1Beij/Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
decreased circulating alanine transaminase level
|
J:281803
|
decreased circulating aspartate transaminase level
|
J:281803
|
Kctd15tm1b(EUCOMM)Wtsi/Kctd15+
(C57BL/6N-Kctd15tm1b(EUCOMM)Wtsi/Ucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Kctd15tm1b(EUCOMM)Wtsi/Kctd15+
(C57BL/6N-Kctd15tm1b(EUCOMM)Wtsi/Ics)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Kctd19em1(IMPC)J/Kctd19em1(IMPC)J
(C57BL/6NJ-Kctd19em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Kdm3atm1.1Jsak/Kdm3atm1.1Jsak
(involves: C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:158258
|
increased circulating glucose level
|
J:158258
|
increased circulating insulin level
|
J:158258
|
increased circulating leptin level
|
J:158258
|
increased circulating triglyceride level
|
J:158258
|
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha)
|
hyperlipidemia
|
J:147295
|
increased circulating cholesterol level
|
J:147295
|
increased circulating free fatty acids level
|
J:147295
|
increased circulating triglyceride level
|
J:147295
|
Kdm3btm1Jxu/Kdm3btm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating estradiol level
|
J:286338
|
decreased circulating insulin-like growth factor I level
|
J:286338
|
Kdm4btm1a(EUCOMM)Wtsi/Kdm4b+
(B6Dnk;B6Brd;B6N-Tyrc-Brd Kdm4btm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating total protein level
|
J:175295
|
increased circulating creatinine level
|
J:175295
|
Kdm4ctm1a(KOMP)Wtsi/Kdm4c+
(C57BL/6N-Kdm4ctm1a(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:165965
|
increased circulating serum albumin level
|
J:165965
|
Kdm5bGt(RRO123)Byg/Kdm5bGt(RRO123)Byg
(FVB.129P2-Kdm5bGt(RRO123)Byg)
|
decreased circulating estradiol level
|
J:218960
|
Kdm5ctm1.2Yshi/Y
(involves: 129 * 129S1/SvImJ * C57BL/6J)
|
increased circulating testosterone level
|
J:262206
|
Kdm6bGt(XB814)Byg/Kdm6bGt(XB814)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:196346
|
Kdm6btm1.1Cdcn/Kdm6btm1.1Cdcn
(involves: C57BL/6)
|
cyanosis
|
J:233350
|
Keg1tm1b(KOMP)Mbp/Keg1tm1b(KOMP)Mbp
(C57BL/6N-Keg1tm1b(KOMP)Mbp/J)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Keltm1Slee/Keltm1Slee
(B6.129X1-Keltm1Slee)
|
decreased erythrocyte magnesium level
|
J:212528
|
decreased erythrocyte potassium level
|
J:212528
|
Keltm1Slee/Keltm1Slee Xktm1Ariv/Y
(B6.Cg-Keltm1Slee Xktm1Ariv)
|
increased erythrocyte sodium level
|
J:212528
|
Khdrbs1tm1Rchd/Khdrbs1tm1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating leptin level
|
J:115775
|
Khdrbs3tm1b(EUCOMM)Hmgu/Khdrbs3tm1b(EUCOMM)Hmgu
(C57BL/6N-Khdrbs3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Kics2tm1b(KOMP)Wtsi/Kics2tm1b(KOMP)Wtsi
(C57BL/6N-Kics2tm1b(KOMP)Wtsi/Nju)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Kif1btm1b(KOMP)Wtsi/Kif1b+
(C57BL/6N-Kif1btm1b(KOMP)Wtsi/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Kif2ctm1.1(KOMP)Vlcg/Kif2c+
(C57BL/6N-Kif2ctm1.1(KOMP)Vlcg/Rbrc)
|
increased circulating triglyceride level
|
J:211773
|
Kif3atm1Gsn/Kif3atm2Gsn Tg(Cdh16-cre)91Igr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR)
|
increased blood urea nitrogen level
|
J:83293
|
Kif3ctm1.1(KOMP)Vlcg/Kif3c+
(C57BL/6N-Kif3ctm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Kif5atm1b(EUCOMM)Wtsi/Kif5atm1b(EUCOMM)Wtsi
(C57BL/6N-Kif5atm1b(EUCOMM)Wtsi/J)
|
cyanosis
|
J:211773
|
Kif5atm1Gsn/Kif5atm1Gsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cyanosis
|
J:82911
|
Kif5btm1Njen/Kif5btm1.1Njen Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)
|
decreased circulating insulin level
|
J:170198
|
hyperglycemia
|
J:170198
|
Kif5ctm1dIcs/Kif5c+
(C57BL/6N-Kif5ctm1dIcs/Ics)
|
increased circulating total protein level
|
J:211773
|
Kif13bGt(AF0005)Wtsi/Kif13bGt(AF0005)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:282570
|
increased circulating HDL cholesterol level
|
J:282570
|
increased circulating LDL cholesterol level
|
J:282570
|
Kif13btm1.1Noh/Kif13btm1.1Noh
(B6.Cg-Kif13btm1.1Noh)
|
increased circulating cholesterol level
|
J:208261
|
increased circulating factor VIII level
|
J:208261
|
increased circulating HDL cholesterol level
|
J:208261
|
increased circulating LDL cholesterol level
|
J:208261
|
Kif13btm1b(EUCOMM)Wtsi/Kif13btm1b(EUCOMM)Wtsi
(C57BL/6N-Kif13btm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Kif18btm1a(EUCOMM)Wtsi/Kif18b+
(C57BL/6N-Kif18btm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Kif21atm1b(EUCOMM)Hmgu/Kif21a+
(C57BL/6N-Kif21atm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Kif21btm1a(KOMP)Wtsi/Kif21btm1a(KOMP)Wtsi
(C57BL/6N-Kif21btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Kif26btm2b(KOMP)Wtsi/Kif26b+
(C57BL/6N-Kif26btm2b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Kifbpem1Hmy/Kifbpem1Hmy
(Not Specified)
|
cyanosis
|
J:253679
|
Kifbpem2Hmy/Kifbpem2Hmy
(Not Specified)
|
cyanosis
|
J:253679
|
Kinem1(IMPC)J/Kin+
(C57BL/6NJ-Kinem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Kiss1tm1Coll/Kiss1tm1Coll
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal circulating estradiol level
|
J:122381
|
decreased circulating estradiol level
|
J:122381
|
decreased circulating follicle stimulating hormone level
|
J:122381
|
decreased circulating luteinizing hormone level
|
J:122381
|
decreased circulating testosterone level
|
J:122381
|
Kiss1tm1Rla/Kiss1tm1Rla
(involves: 129S1/SvImJ)
|
decreased circulating follicle stimulating hormone level
|
J:126704
|
Kiss1rGt1Stei/Kiss1rGt1Stei
(involves: 129S1/SvImJ * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:127450,
J:124098
|
Kiss1rtm1.1(KOMP)Vlcg/Kiss1rtm1.1(KOMP)Vlcg
(C57BL/6N-Kiss1rtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating creatinine level
|
J:211773
|
Kiss1rtm1.1Aeh/Kiss1rtm1.1Aeh Tg(Gnrh1-cre)1Dlc/0
(involves: C57BL/6 * CBA)
|
decreased circulating follicle stimulating hormone level
|
J:206044
|
Kiss1rtm1.1Hjn/Kiss1rtm1.1Hjn Tg(Gnrh1-cre)35Awo/0
(involves: 129 * C57BL/6 * CD-1)
|
decreased circulating follicle stimulating hormone level
|
J:212351
|
decreased circulating luteinizing hormone level
|
J:212351
|
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
abnormal blood homeostasis
|
J:181650
|
decreased circulating cholesterol level
|
J:181650
|
decreased circulating follicle stimulating hormone level
|
J:181650
|
decreased circulating gonadotropin level
|
J:181650
|
decreased circulating luteinizing hormone level
|
J:181650
|
decreased circulating total protein level
|
J:181650
|
decreased circulating triglyceride level
|
J:181650
|
increased blood urea nitrogen level
|
J:181650
|
increased circulating alkaline phosphatase level
|
J:181650
|
increased circulating glucose level
|
J:181650
|
increased circulating serum albumin level
|
J:181650
|
Kiss1rtm1Coll/Kiss1rtm1Coll
(involves: 129S6/SvEvTac)
|
decreased circulating estradiol level
|
J:96442
|
decreased circulating follicle stimulating hormone level
|
J:96442,
J:96108
|
decreased circulating gonadotropin level
|
J:96442
|
decreased circulating luteinizing hormone level
|
J:96442,
J:96108
|
decreased circulating testosterone level
|
J:96442
|
Kiss1rtm1Rla/Kiss1rtm1Rla
(involves: 129S1/SvImJ)
|
decreased circulating follicle stimulating hormone level
|
J:126704
|
decreased circulating testosterone level
|
J:126704
|
KitMhdasco5/KitMhdasco5
(C3HeB/FeJ-KitMhdasco5)
|
decreased circulating cholesterol level
|
J:125831
|
decreased circulating HDL cholesterol level
|
J:125831
|
decreased circulating LDL cholesterol level
|
J:125831
|
Kittm1.1Bsm/Kittm1.1Bsm
(involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)
|
increased circulating luteinizing hormone level
|
J:61141
|
Kittm1Rosay/Kit+ Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hyperglycemia
|
J:168676
|
KitW-sh/KitW-sh Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
abnormal circulating complement protein level
|
J:161523
|
KitW-v/KitW-v
(involves: C57BL/6)
|
increased bleeding time
|
J:7327
|
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1)
|
abnormal circulating histamine level
|
J:197334
|
Kitltm1Pbes/Kitltm1Pbes
(involves: 129S1/Sv * C57BL/6J)
|
abnormal blood homeostasis
|
J:50150
|
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J)
|
abnormal circulating protein level
|
J:229255
|
decreased circulating glucose level
|
J:229255
|
decreased circulating serum albumin level
|
J:229255
|
increased circulating phosphate level
|
J:229255
|
Klkl/Kl+
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin level
|
J:64878
|
hypoglycemia
|
J:64878
|
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
abnormal circulating mineral level
|
J:44109
|
hypoglycemia
|
J:44109
|
increased circulating calcium level
|
J:44109
|
Klkl/Klkl
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating insulin level
|
J:64878
|
hypoglycemia
|
J:64878
|
Klkl/Klkl
(involves: C3H/J * C57BL/6J)
|
decreased circulating insulin level
|
J:66078
|
hypoglycemia
|
J:66078
|
increased circulating noradrenaline level
|
J:102218
|
Klm1Anu/Klm1Anu
(C57BL/6NCrlAnu-Klm1Anu)
|
increased circulating calcium level
|
J:104190
|
Kltm1.1Tel/Kltm1.1Tel Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR)
|
decreased circulating parathyroid hormone level
|
J:201719
|
increased circulating parathyroid hormone level
|
J:201719
|
increased circulating phosphate level
|
J:201719
|
Kltm1.2Tel/Kltm1.2Tel
(involves: C57BL/6 * FVB/N)
|
increased circulating calcium level
|
J:201719
|
increased circulating phosphate level
|
J:201719
|
Kltm1Lex/Kltm1Lex
(B6.129S-Kltm1Lex)
|
increased circulating calcium level
|
J:173962
|
increased circulating phosphate level
|
J:173962
|
Kltm1Lex/Kltm1Lex Sfrp4tm1.1Blan/Sfrp4tm1.1Blan
(involves: 129S/SvEvBrd * C57BL/6)
|
increased circulating phosphate level
|
J:173962
|
Kltm1Yin/Kltm1Yin
(Not Specified)
|
increased circulating calcium level
|
J:86859
|
increased circulating phosphate level
|
J:86859
|
Klbtm1.1Akha/Klbtm1.1Akha
(C57BL/6-Klbtm1.1Akha)
|
abnormal circulating cholesterol level
|
J:195570
|
abnormal circulating glucose level
|
J:195570
|
abnormal circulating insulin level
|
J:195570
|
abnormal circulating ketone body level
|
J:195570
|
abnormal circulating leptin level
|
J:195570
|
decreased circulating cholesterol level
|
J:195570
|
decreased circulating insulin level
|
J:195570
|
Klbtm1.2Sakl/Klb+ Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating cholesterol level
|
J:189018
|
decreased circulating free fatty acids level
|
J:189018
|
decreased circulating glucose level
|
J:189018
|
decreased circulating insulin level
|
J:189018
|
decreased circulating leptin level
|
J:189018
|
decreased circulating triglyceride level
|
J:189018
|
Klbtm1.2Sakl/Klbtm1.2Sakl
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating triglyceride level
|
J:189018
|
Klbtm1.2Sakl/Klbtm1.2Sakl Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
abnormal blood homeostasis
|
J:189018
|
decreased circulating free fatty acids level
|
J:189018
|
Klc2tm1e(EUCOMM)Wtsi/Klc2tm1e(EUCOMM)Wtsi
(C57BL/6N-Klc2tm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Klc3em1(IMPC)J/Klc3em1(IMPC)J
(C57BL/6N-Klc3em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Klf4tm1Khk/Klf4tm1Khk Plekha5Tg(AMH-cre)1Flor/Plekha5+
(involves: C57BL/6 * SJL)
|
decreased circulating testosterone level
|
J:132612
|
Klf7tm1b(EUCOMM)Hmgu/Klf7+
(C57BL/6N-Klf7tm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Klf7tm1Rmz/Klf7tm1Rmz
(involves: 129/Sv * C57BL/6)
|
cyanosis
|
J:99181
|
Klf12tm1b(EUCOMM)Wtsi/Klf12+
(C57BL/6N-Klf12tm1b(EUCOMM)Wtsi/Orl)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Klf14tm1.1(KOMP)Vlcg/Klf14tm1.1(KOMP)Vlcg
(C57BL/6N-Klf14tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Klf14tm1.1Yec/Klf14tm1.1Yec Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:226403
|
Klf15hlb444/?
(C57BL/6J-Klf15hlb444/J)
|
increased circulating triglyceride level
|
J:77944
|
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain)
|
abnormal circulating amino acid level
|
J:129763
|
decreased circulating glucose level
|
J:129763
|
decreased circulating lactate level
|
J:129763
|
hypoglycemia
|
J:129763
|
increased circulating glucagon level
|
J:129763
|
increased circulating ketone body level
|
J:129763
|
Klf16em1(IMPC)J/Klf16+
(C57BL/6NJ-Klf16em1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Klhdc2tm1b(EUCOMM)Hmgu/Klhdc2+
(C57BL/6N-Klhdc2tm1b(EUCOMM)Hmgu/H)
|
increased circulating creatinine level
|
J:211773
|
Klhdc10em1(IMPC)J/Klhdc10em1(IMPC)J
(C57BL/6NJ-Klhdc10em1(IMPC)J/Mmjax)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Klhdc10tm1Hijo/Klhdc10tm1Hijo
(B6J.B6N-Klhdc10tm1Hijo)
|
decreased circulating interleukin-6 level
|
J:251158
|
Klhl3tm1.1Esoh/Klhl3+
(involves: C57BL/6)
|
hyperkalemia
|
J:214330
|
Klhl3tm1.1Esoh/Klhl3tm1.1Esoh
(involves: C57BL/6)
|
hyperkalemia
|
J:214330
|
Klhl3tm1.1Slin/Klhl3+
(Not Specified)
|
acidemia
|
J:284284
|
decreased circulating bicarbonate level
|
J:284284
|
hyperkalemia
|
J:284284
|
increased circulating aldosterone level
|
J:284284
|
Klhl3tm1.1Slin/Klhl3tm1.1Slin
(Not Specified)
|
acidemia
|
J:284284
|
decreased circulating bicarbonate level
|
J:284284
|
hyperkalemia
|
J:284284
|
increased circulating aldosterone level
|
J:284284
|
Klhl3tm1b(KOMP)Wtsi/Klhl3tm1b(KOMP)Wtsi
(C57BL/6N-Klhl3tm1b(KOMP)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Klhl3tm2.1Esoh/Klhl3tm2.1Esoh
(involves: C57BL/6 * C57BL/6J)
|
acidemia
|
J:244278
|
increased circulating potassium level
|
J:244278
|
Klhl5tm1b(EUCOMM)Hmgu/Klhl5tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl5tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Klhl18tm1a(KOMP)Wtsi/Klhl18tm1a(KOMP)Wtsi
(C57BL/6N-Klhl18tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:211773
|
Klhl32em1(IMPC)J/Klhl32em1(IMPC)J
(C57BL/6NJ-Klhl32em1(IMPC)J/Mmjax)
|
decreased fasting circulating glucose level
|
J:211773
|
Klk5tm2b(KOMP)Wtsi/Klk5tm2b(KOMP)Wtsi
(C57BL/6N-Klk5tm2b(KOMP)Wtsi/Ccpcz)
|
increased circulating phosphate level
|
J:211773
|
Klk13em1(IMPC)Ccpcz/Klk13em1(IMPC)Ccpcz
(C57BL/6N-Klk13em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Klk14tm1.1(KOMP)Vlcg/Klk14tm1.1(KOMP)Vlcg
(C57BL/6N-Klk14tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Klkb1tm1Tigm/Klkb1tm1Tigm
(involves: C57BL/6)
|
increased partial thromboplastin time
|
J:168556
|
Klra8Cmv1-r/Klra8Cmv1-r
(C.B6-Klra8Cmv1-r)
|
increased circulating interferon-gamma level
|
J:97203
|
Klra17tm1.1Apma/Klra17tm1.1Apma
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating interferon-alpha level
|
J:152288
|
decreased circulating interleukin-12 level
|
J:152288
|
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka)
|
increased circulating alanine transaminase level
|
J:222503
|
Klrc3em1(IMPC)Wtsi/Klrc3+
(C57BL/6N-Klrc3em1(IMPC)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
increased circulating cholesterol level
|
J:203736
|
increased circulating glucose level
|
J:79719,
J:203736
|
increased circulating insulin level
|
J:203736
|
increased circulating triglyceride level
|
J:203736
|
Kmt2bm1H/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
increased circulating glucose level
|
J:203736
|
increased circulating insulin level
|
J:203736
|
Kmt2btm1Afst/Kmt2b+
(involves: 129P2/OlaHsd)
|
increased circulating glucose level
|
J:203736
|
increased circulating insulin level
|
J:203736
|
Kmt2btm1Afst/Kmt2btm1.1Afst Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:166778
|
Kmt2btm1Afst/Kmt2btm1.1Afst Tg(Gdf9-icre)5092Coo/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
decreased circulating estradiol level
|
J:166778
|
increased circulating follicle stimulating hormone level
|
J:166778
|
increased circulating luteinizing hormone level
|
J:166778
|
Kmt2btm1Afst/Kmt2btm1.1Afst Tg(Zp3-cre)3Mrt/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating follicle stimulating hormone level
|
J:166778
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Tg(Nkx2-1-cre)2Sand/0
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:301083
|
Kmt2dtm1.2(IMPC)Wtsi/Kmt2d+
(C57BL/6N-Kmt2dtm1.2(IMPC)Wtsi/Wtsi)
|
decreased circulating sodium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Kmt2etm1.2(IMPC)Wtsi/Kmt2e+
(C57BL/6N-Kmt2etm1.2(IMPC)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Kmt5btm1a(KOMP)Wtsi/Kmt5b+
(B6JTyr;B6N-Kmt5btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
Kng1tm1Krmc/Kng1tm1Krmc
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * CD-1))
|
abnormal blood coagulation
|
J:130769
|
decreased susceptibility to induced thrombosis
|
J:130769
|
increased partial thromboplastin time
|
J:130769
|
Kng2tm2a(EUCOMM)Wtsi/Kng2tm2a(EUCOMM)Wtsi
(C57BL/6N-Kng2tm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Knstrntm1b(KOMP)Wtsi/Knstrntm1b(KOMP)Wtsi
(C57BL/6N-Knstrntm1b(KOMP)Wtsi/Ics)
|
increased fasting circulating glucose level
|
J:211773
|
Kntc1tm1b(EUCOMM)Hmgu/Kntc1+
(C57BL/6N-Kntc1tm1b(EUCOMM)Hmgu/J)
|
increased fasting circulating glucose level
|
J:211773
|
Kpna1tm1.2Yyo/Kpna1tm1.2Yyo
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:188099
|
decreased circulating progesterone level
|
J:188099
|
increased circulating alanine transaminase level
|
J:188099
|
increased circulating aspartate transaminase level
|
J:188099
|
Kptntm1a(EUCOMM)Wtsi/Kptntm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Kptntm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:175295
|
increased circulating calcium level
|
J:175295
|
increased circulating serum albumin level
|
J:175295
|
increased circulating total protein level
|
J:175295
|
Krastm4Tyj/Kras+ Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp)
|
decreased circulating thyroid-stimulating hormone level
|
J:147732
|
Krastm4Tyj/Kras+ Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased circulating erythropoietin level
|
J:115071
|
Krastm4Tyj/Kras+ Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal hepatic portal vein thrombosis
|
J:116129
|
Kremen1em1(IMPC)Ccpcz/Kremen1em1(IMPC)Ccpcz
(C57BL/6NCrl-Kremen1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Krit1tm1.1(KOMP)Vlcg/Krit1+
(C57BL/6N-Krit1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Krt1tm1Tmm/Krt1tm1Tmm
(involves: 129 * C57BL/6)
|
abnormal circulating interleukin level
|
J:200244
|
increased circulating interleukin-18 level
|
J:200244
|
Krt7tm1b(KOMP)Wtsi/Krt7tm1b(KOMP)Wtsi
(C57BL/6N-Krt7tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Krt9tm1.1(KOMP)Vlcg/Krt9tm1.1(KOMP)Vlcg
(C57BL/6N-Krt9tm1.1(KOMP)Vlcg/J)
|
increased circulating iron level
|
J:211773
|
Krt17tm1.1(KOMP)Vlcg/Krt17+
(C57BL/6N-Krt17tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Krt32em1(IMPC)Kmpc/Krt32em1(IMPC)Kmpc
(C57BL/6NTac-Krt32em1(IMPC)Kmpc/Kmpc)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Krt34em1(IMPC)Ccpcz/Krt34em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt34em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Krt77em1(IMPC)J/Krt77em1(IMPC)J
(C57BL/6NJ-Krt77em1(IMPC)J/J)
|
increased circulating sodium level
|
J:211773
|
Krt80em1(IMPC)J/Krt80em1(IMPC)J
(C57BL/6NJ-Krt80em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Krt87em1(IMPC)Wtsi/Krt87em1(IMPC)Wtsi
(C57BL/6NCrl-Krt87em1(IMPC)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:211773
|
Krtap17-1tm1.1(KOMP)Vlcg/Krtap17-1tm1.1(KOMP)Vlcg
(C57BL/6N-Krtap17-1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Krtcap2em1(IMPC)J/Krtcap2em1(IMPC)J
(C57BL/6NJ-Krtcap2em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Kyem1(IMPC)J/Ky+
(C57BL/6NJ-Kyem1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Kyat1tm1b(KOMP)Wtsi/Kyat1+
(C57BL/6N-Kyat1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Kynuem1(IMPC)J/Kynuem1(IMPC)J
(C57BL/6NJ-Kynuem1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
L3mbtl3em2(IMPC)Tcp/L3mbtl3+
(C57BL/6NCrl-L3mbtl3em2(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Lacc1em1Arkr/Lacc1em1Arkr
(C57BL/6NTac-Lacc1em1Arkr)
|
decreased circulating interleukin-1 beta level
|
J:244365
|
Lacc1em2Arkr/Lacc1em2Arkr
(C57BL/6NTac-Lacc1em2Arkr)
|
decreased circulating interleukin-1 beta level
|
J:244365
|
Lacc1em3Arkr/Lacc1em3Arkr
(C57BL/6NTac-Lacc1em3Arkr)
|
increased circulating interleukin-1 beta level
|
J:244365
|
Lacc1em4Arkr/Lacc1em4Arkr
(C57BL/6NTac-Lacc1em4Arkr)
|
increased circulating interleukin-1 beta level
|
J:244365
|
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased circulating tumor necrosis factor level
|
J:244365
|
increased circulating interleukin-1 beta level
|
J:244365
|
Lactbtm1.1(KOMP)Mbp/Lactbtm1.1(KOMP)Mbp
(C57BL/6N-Lactbtm1.1(KOMP)Mbp/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Lama1tm2b(EUCOMM)Hmgu/Lama1+
(C57BL/6N-Lama1tm2b(EUCOMM)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
Lama2dy/Lama2dy
(B6.129P1-Lama2dy/J)
|
increased circulating prolactin level
|
J:5000
|
Lama4tm1.1(KOMP)Vlcg/Lama4tm1.1(KOMP)Vlcg
(C57BL/6N-Lama4tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lama4tm1Ktry/Lama4tm1Ktry
(either: B6.129X1-Lama4tm1Ktry or (involves: 129X1/SvJ * C57BL/6))
|
abnormal circulating bilirubin level
|
J:74287
|
Lama5mpc205H/Lama5mpc205H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased blood urea nitrogen level
|
J:234901
|
increased circulating creatinine level
|
J:234901
|
Lama5tm1Jhm/Lama5tm2Jhm Tg(SFTPC-rtTA)5Jaw/? Tg(tetO-cre)1Jaw/?
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:104565
|
Lama5tm2Jhm/Lama5tm1Jhm Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased circulating serum albumin level
|
J:185850
|
increased circulating cholesterol level
|
J:185850
|
Lama5tm3Jhm/Lama5tm3Jhm
(involves: 129S1/Sv * 129X1/SvJ)
|
increased blood urea nitrogen level
|
J:128225
|
Lamb2npht/Lamb2npht
(involves: C57BL/6)
|
decreased circulating serum albumin level
|
J:208069
|
decreased circulating total protein level
|
J:208069
|
increased circulating cholesterol level
|
J:208069
|
increased circulating triglyceride level
|
J:208069
|
Lamp1em1(IMPC)Mbp/Lamp1em1(IMPC)Mbp
(C57BL/6N-Lamp1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating phosphate level
|
J:211773
|
Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating troponin T level
|
J:328713
|
Lamp2tm1Amcu/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
decreased fasting circulating glucose level
|
J:215605
|
increased circulating alanine transaminase level
|
J:215605
|
Lamp2tm1Psa/Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))
|
abnormal circulating amino acid level
|
J:64151
|
Lamp5em1(IMPC)J/Lamp5em1(IMPC)J
(C57BL/6NJ-Lamp5em1(IMPC)J/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Lamtor5tm1Lye/Lamtor5tm1Lye Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:258406
|
increased fasting circulating glucose level
|
J:258406
|
Lancl3em1(IMPC)H/Y
(C57BL/6N-Lancl3em1(IMPC)H/H)
|
increased circulating serum albumin level
|
J:211773
|
Laptm4atm1b(EUCOMM)Hmgu/Laptm4atm1b(EUCOMM)Hmgu
(C57BL/6N-Laptm4atm1b(EUCOMM)Hmgu/Ics)
|
increased fasting circulating glucose level
|
J:211773
|
Large1myd/Large1myd
(B6C3Fe a/a-Large1myd/J)
|
increased circulating creatine kinase level
|
J:27793
|
Large1vls/Large1vls
(B6.CAST(Cg)-Large1vls/Pjn)
|
increased circulating creatinine level
|
J:100214
|
Larp1em1(IMPC)Mbp/Larp1+
(C57BL/6N-Larp1em1(IMPC)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Larp4bem1(IMPC)Wtsi/Larp4bem1(IMPC)Wtsi
(C57BL/6N-Larp4bem1(IMPC)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Larp6em1(IMPC)Tcp/Larp6em1(IMPC)Tcp
(C57BL/6NCrl-Larp6em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Lat2tm1Wz/Lat2tm1Wz
(Not Specified)
|
increased circulating interleukin-6 level
|
J:181866
|
increased circulating tumor necrosis factor level
|
J:181866
|
Latem1(IMPC)Ics/Latem1(IMPC)Ics
(C57BL/6N-Latem1(IMPC)Ics/Ics)
|
increased circulating bilirubin level
|
J:211773
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
increased blood urea nitrogen level
|
J:125722
|
Lattm1.1Mal/Lattm1.1Mal Rag1tm1Bal/Rag1tm1Bal
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal platelet dense granule physiology
|
J:125744
|
decreased platelet aggregation
|
J:125744
|
Lattm1Bpay/Lattm1Bpay
(involves: 129S2/SvPas)
|
abnormal platelet aggregation
|
J:103904
|
Lattm2.1Mal/Lattm2.1Mal Rag1tm1Bal/Rag1tm1Bal
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal platelet dense granule physiology
|
J:125744
|
abnormal thrombosis
|
J:125744
|
decreased platelet aggregation
|
J:125744
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal thrombosis
|
J:125744
|
decreased platelet aggregation
|
J:125744
|
Lats1em1(IMPC)H/Lats1em1(IMPC)H
(C57BL/6NTac-Lats1em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Lats1tm1Tx/Lats1tm1Tx
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating growth hormone level
|
J:52536
|
decreased circulating luteinizing hormone level
|
J:52536
|
decreased circulating prolactin level
|
J:52536
|
Lbptm1b(EUCOMM)Hmgu/Lbptm1b(EUCOMM)Hmgu
(C57BL/6N-Lbptm1b(EUCOMM)Hmgu/H)
|
increased circulating fructosamine level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Lbptm1Buru/Lbptm1Buru
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:44878
|
Lbrem1(IMPC)Tcp/Lbrem1(IMPC)Tcp
(C57BL/6N-Lbrem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Lca5lem1(IMPC)Ics/Lca5lem1(IMPC)Ics
(C57BL/6N-Lca5lem1(IMPC)Ics/Ics)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Lcattm1Hgc/Lcat+
(involves: C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:41208
|
decreased circulating cholesterol level
|
J:41208
|
Lcattm1Hgc/Lcattm1Hgc
(involves: C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:41208
|
decreased circulating cholesterol level
|
J:41208
|
decreased circulating HDL cholesterol level
|
J:41208
|
Lcattm1Hgc/Lcattm1Hgc
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:75567
|
decreased circulating HDL cholesterol level
|
J:75567
|
Lcattm1Hgc/Lcattm1Hgc Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:75567
|
decreased circulating glucose level
|
J:89015
|
decreased circulating HDL cholesterol level
|
J:89015,
J:75567
|
decreased circulating insulin level
|
J:89015
|
decreased circulating LDL cholesterol level
|
J:89015
|
increased circulating cholesterol level
|
J:75567
|
increased circulating triglyceride level
|
J:89015,
J:75567
|
increased circulating VLDL cholesterol level
|
J:89015,
J:75567
|
Lcattm1Hgc/Lcattm1Hgc Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating HDL cholesterol level
|
J:93775
|
decreased circulating LDL cholesterol level
|
J:93775
|
decreased circulating triglyceride level
|
J:93775
|
increased circulating cholesterol level
|
J:93775
|
increased circulating phospholipid level
|
J:93775
|
increased circulating VLDL cholesterol level
|
J:93775
|
Lcattm1Nsa/Lcat+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:39237
|
decreased circulating HDL cholesterol level
|
J:39237
|
increased circulating triglyceride level
|
J:39237
|
Lcattm1Nsa/Lcattm1Nsa
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:39237
|
decreased circulating HDL cholesterol level
|
J:39237
|
increased circulating triglyceride level
|
J:39237
|
Lcattm1Nsa/Lcattm1Nsa
(B6.Cg-Lcattm1Nsa)
|
abnormal circulating phospholipid level
|
J:69299
|
decreased circulating cholesterol level
|
J:69299
|
decreased circulating HDL cholesterol level
|
J:69299
|
decreased circulating VLDL cholesterol level
|
J:69299
|
increased circulating triglyceride level
|
J:69299
|
Lce1mtm1b(EUCOMM)Wtsi/Lce1mtm1b(EUCOMM)Wtsi
(C57BL/6N-Lce1mtm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Lch/Lch+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:72447,
J:79719
|
decreased circulating HDL cholesterol level
|
J:72447,
J:79719
|
Lch2/Lch2+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:79719,
J:79307
|
decreased circulating HDL cholesterol level
|
J:79719,
J:79307
|
Lclat1em1(IMPC)Mbp/Lclat1em1(IMPC)Mbp
(C57BL/6N-Lclat1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lclat1tm1Yugs/Lclat1tm1Yugs
(B6.Cg-Lclat1tm1Yugs)
|
decreased circulating glucose level
|
J:163077
|
decreased circulating insulin level
|
J:163077
|
Lcmt1em1(IMPC)Rbrc/Lcmt1+
(C57BL/6NJcl-Lcmt1em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating phosphate level
|
J:211773
|
Lcmt1Gt(CSC099)Byg/Lcmt1Gt(CSC099)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:201873
|
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade)
|
increased circulating cholesterol level
|
J:169355
|
increased circulating insulin level
|
J:169355
|
increased circulating LDL cholesterol level
|
J:169355
|
increased fasting circulating glucose level
|
J:169355
|
Lcn2tm1b(KOMP)Wtsi/Lcn2tm1b(KOMP)Wtsi
(C57BL/6N-Lcn2tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Lcorlem1Jke/Lcorlem1Jke
(C57BL/6NCrl-Lcorlem1Jke)
|
decreased circulating insulin level
|
J:360835
|
decreased circulating insulin-like growth factor I level
|
J:360835
|
Lcp1tm1e.1(KOMP)Wtsi/Lcp1+
(C57BL/6N-Lcp1tm1e.1(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet activation
|
J:162815
|
decreased platelet aggregation
|
J:162815
|
Lcp2tm1Gak/Lcp2tm2Gak Tg(Pf4-icre)Q3Rsko/0 Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal platelet activation
|
J:162815
|
Ldb3tm1Chen/Ldb3tm1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
cyanosis
|
J:72799
|
Ldhaa-m1Neu/Ldhaa-m1Neu
(C3.Cg-Ldhaa-m1Neu)
|
increased circulating bilirubin level
|
J:14326
|
Ldhatm1a(EUCOMM)Wtsi/Ldha+
(B6JTyr;B6N-Ldhatm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
LdlrHlb301/Ldlr+
(C57BL/6J-LdlrHlb301/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
LdlrRgsc366/Ldlr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating cholesterol level
|
J:133634
|
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating lipid level
|
J:67282
|
decreased circulating cholesterol level
|
J:67282
|
decreased circulating HDL cholesterol level
|
J:67282
|
Ldlrtm1b(EUCOMM)Wtsi/Ldlrtm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrtm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating unsaturated transferrin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Ldlrtm1Her/Ldlr+
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:100916
|
Ldlrtm1Her/Ldlr+
(B6.129S7-Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
Ldlrtm1Her/Ldlr+ Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
Ldlrtm1Her/Ldlr+ Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
hyperglycemia
|
J:100916
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating amino acid level
|
J:146932
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating alanine transaminase level
|
J:175559
|
increased circulating cholesterol level
|
J:175559
|
increased circulating free fatty acids level
|
J:175559
|
increased circulating glucose level
|
J:84844
|
increased circulating insulin level
|
J:84844
|
increased circulating LDL cholesterol level
|
J:102291
|
increased circulating triglyceride level
|
J:175559
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd)
|
abnormal circulating cholesterol level
|
J:48202
|
abnormal circulating LDL cholesterol level
|
J:84694
|
increased circulating cholesterol level
|
J:84694,
J:228420,
J:48202
|
increased circulating LDL cholesterol level
|
J:114949,
J:169834,
J:84694
|
increased circulating triglyceride level
|
J:48202
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:96110
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her)
|
abnormal circulating cholesterol level
|
J:100916,
J:130278
|
decreased circulating HDL cholesterol level
|
J:130794
|
decreased circulating interleukin-10 level
|
J:130794
|
hyperglycemia
|
J:100916,
J:130278
|
increased circulating cholesterol level
|
J:61287,
J:135078,
J:137264,
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating insulin level
|
J:130278
|
increased circulating interleukin-1 beta level
|
J:137264
|
increased circulating interleukin-6 level
|
J:137264
|
increased circulating LDL cholesterol level
|
J:130794,
J:72027
|
increased circulating triglyceride level
|
J:130278,
J:137264,
J:72027
|
increased circulating tumor necrosis factor level
|
J:137264
|
increased circulating VLDL cholesterol level
|
J:130278,
J:130794
|
increased circulating VLDL triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J)
|
decreased circulating triglyceride level
|
J:85174
|
increased circulating cholesterol level
|
J:104609,
J:85174
|
increased circulating HDL cholesterol level
|
J:85174
|
increased circulating LDL cholesterol level
|
J:85174,
J:149005
|
increased circulating triglyceride level
|
J:149005
|
increased circulating VLDL cholesterol level
|
J:85174,
J:149005
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA)
|
abnormal circulating protein level
|
J:75567
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:114480
|
increased circulating LDL cholesterol level
|
J:114480
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:29950
|
Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her)
|
abnormal circulating cholesterol level
|
J:72027
|
hyperlipidemia
|
J:72027
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
Ldlrtm1Her/Ldlrtm1Her Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating cholesterol level
|
J:108412
|
increased circulating HDL cholesterol level
|
J:108412
|
increased circulating LDL cholesterol level
|
J:108412
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her
(involves: 129S7/SvEvBrd)
|
abnormal circulating apolipoprotein E level
|
J:67929
|
abnormal circulating apolipoprotein level
|
J:67929
|
increased circulating cholesterol level
|
J:67929
|
increased circulating LDL cholesterol level
|
J:67929
|
increased circulating triglyceride level
|
J:67929
|
increased circulating VLDL cholesterol level
|
J:67929
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating factor VIII level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
increased circulating von Willebrand factor level
|
J:117317
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
abnormal circulating apolipoprotein level
|
J:67929
|
increased circulating cholesterol level
|
J:67929
|
increased circulating LDL cholesterol level
|
J:67929
|
increased circulating triglyceride level
|
J:67929
|
increased circulating VLDL cholesterol level
|
J:67929
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Vldlrtm1Her/Vldlrtm1Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating factor VIII level
|
J:117317
|
Ldlrtm1Her/Ldlrtm1Her Lrpap1tm1Her/Lrpap1tm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:43736
|
increased circulating triglyceride level
|
J:43736
|
Ldlrtm1Her/Ldlrtm1Her Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:142788
|
Ldlrtm1Her/Ldlrtm1Her Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ)
|
abnormal circulating VLDL cholesterol level
|
J:116503
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating HDL cholesterol level
|
J:116503
|
decreased circulating LDL cholesterol level
|
J:116503
|
Ldlrtm1Her/Ldlrtm1Her Mobq6CAST/EiJ/Mobq6CAST/EiJ
(B6.CAST-Mobq6CAST/EiJ)
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating HDL cholesterol level
|
J:116503
|
decreased circulating LDL cholesterol level
|
J:116503
|
decreased circulating VLDL cholesterol level
|
J:116503
|
Ldlrtm1Her/Ldlrtm1Her Npc1m1N/Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c)
|
increased circulating LDL cholesterol level
|
J:104996,
J:130969
|
Ldlrtm1Her/Ldlrtm1Her Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:149005
|
increased circulating HDL cholesterol level
|
J:149005
|
Ldlrtm1Her/Ldlrtm1Her Nr1h3tm1.1Djm/Nr1h3tm1.1Djm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:184536
|
decreased circulating triglyceride level
|
J:184536
|
Ldlrtm1Her/Ldlrtm1Her Nr5a2tm3.1Sjns/Nr5a2tm3.1Sjns
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased circulating LDL cholesterol level
|
J:215556
|
decreased circulating triglyceride level
|
J:215556
|
Ldlrtm1Her/Ldlrtm1Her Olr1tm1Meht/Olr1tm1Meht
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:130794
|
increased circulating interleukin-10 level
|
J:130794
|
increased circulating LDL cholesterol level
|
J:130794
|
increased circulating VLDL cholesterol level
|
J:130794
|
Ldlrtm1Her/Ldlrtm1Her Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
increased circulating LDL cholesterol level
|
J:169834
|
Ldlrtm1Her/Ldlrtm1Her Scd1ab-2J/Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J)
|
abnormal circulating cholesterol level
|
J:130278
|
decreased circulating triglyceride level
|
J:130278
|
decreased circulating VLDL cholesterol level
|
J:130278
|
decreased circulating VLDL triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her Scd1ab-J/Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J)
|
decreased circulating cholesterol level
|
J:130278
|
decreased circulating triglyceride level
|
J:130278
|
decreased circulating VLDL cholesterol level
|
J:130278
|
decreased circulating VLDL triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S-Serpine1tm1Mlg Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:61287
|
Ldlrtm1Her/Ldlrtm1Her Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:61147
|
Ldlrtm1Her/Ldlrtm1Her Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:96110
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC1)1Lmh/?
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:65146
|
increased circulating triglyceride level
|
J:65146
|
increased circulating VLDL cholesterol level
|
J:65146
|
increased circulating VLDL triglyceride level
|
J:65146
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC3)3707Bres/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
increased circulating LDL cholesterol level
|
J:37861
|
increased circulating VLDL cholesterol level
|
J:37861
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC3)3707Bres/? Tg(Mt1-CETP)#Tall/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:37861
|
increased circulating LDL cholesterol level
|
J:37861
|
increased circulating triglyceride level
|
J:37861
|
increased circulating VLDL cholesterol level
|
J:37861
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOM)NCchr/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating triglyceride level
|
J:130647
|
Ldlrtm1Her/Ldlrtm1Her Tg(APPSWE)2576Kha/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:114480
|
increased circulating LDL cholesterol level
|
J:114480
|
Ldlrtm1Her/Ldlrtm1Her Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Ldlrtm1Her Tg(CMV-Serpine1)1Dgi)
|
increased circulating cholesterol level
|
J:61287
|
Ldlrtm1Her/Ldlrtm1Her Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
abnormal circulating cholesterol level
|
J:100916
|
hyperglycemia
|
J:100916
|
Ldlrtm1Her/Ldlrtm1Her Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:76336
|
increased circulating triglyceride level
|
J:76336
|
Ldlrtm1Her/Ldlrtm1Her Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir Ldlrtm1Her)
|
decreased circulating cholesterol level
|
J:102502
|
Ldlrtm1Her/Ldlrtm1Her Wnt16tm2a(EUCOMM)Wtsi/Wnt16tm2a(EUCOMM)Wtsi
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
increased circulating aldosterone level
|
J:344215
|
Ldlrad1tm1b(KOMP)Wtsi/Ldlrad1tm1b(KOMP)Wtsi
(C57BL/6N-Ldlrad1tm1b(KOMP)Wtsi/BayMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Ldlrad4tm1b(EUCOMM)Wtsi/Ldlrad4tm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrad4tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Ldlrap1Gt(OST149604)Lex/Ldlrap1Gt(OST149604)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:102291
|
increased circulating LDL cholesterol level
|
J:102291
|
Ldlrap1tm1Her/Ldlrap1tm1Her
(involves: 129S6/SvEvTac)
|
abnormal circulating LDL cholesterol level
|
J:84694
|
increased circulating cholesterol level
|
J:84694
|
increased circulating LDL cholesterol level
|
J:84694
|
increased circulating triglyceride level
|
J:84694
|
Ldoc1tm1.1Tmki/Y
(B6.129S-Ldoc1tm1.1Tmki)
|
increased circulating progesterone level
|
J:217586
|
lec/lec
(Not Specified)
|
cyanosis
|
J:6726
|
Lefty1tm1b(KOMP)Wtsi/Lefty1+
(C57BL/6N-Lefty1tm1b(KOMP)Wtsi/Bay)
|
increased circulating potassium level
|
J:211773
|
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst)
|
increased circulating cholesterol level
|
J:167736
|
increased circulating glucose level
|
J:167736
|
increased circulating insulin level
|
J:167736
|
increased circulating leptin level
|
J:167736
|
increased circulating triglyceride level
|
J:167736
|
Lepob/Lepob
(involves: C57BL/6J)
|
hyperglycemia
|
J:219118,
J:92558
|
increased circulating corticosterone level
|
J:60001
|
increased circulating insulin level
|
J:92558
|
increased fasting circulating glucose level
|
J:219118
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating glucose level
|
J:5400
|
decreased circulating glucose level
|
J:129554,
J:145998,
J:189019
|
hyperglycemia
|
J:65486,
J:122746,
J:5400
|
hypoglycemia
|
J:5400
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating insulin level
|
J:104171,
J:122746,
J:5400
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161,
J:104171
|
increased circulating VLDL cholesterol level
|
J:18161
|
Lepob/Lepob
(D2.Cg-Lepob/Chua)
|
hyperglycemia
|
J:78850
|
increased circulating insulin level
|
J:78850
|
Lepob/Lepob
(FVB.Cg-Lepob/Chua)
|
hyperglycemia
|
J:78850
|
increased circulating insulin level
|
J:78850
|
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating hormone level
|
J:76479
|
decreased circulating pancreatic peptide level
|
J:76479
|
decreased circulating testosterone level
|
J:107169,
J:76479
|
hyperglycemia
|
J:107169
|
increased circulating cholesterol level
|
J:107169
|
increased circulating corticosterone level
|
J:107169,
J:76479
|
increased circulating insulin level
|
J:107169,
J:76479
|
increased circulating leptin level
|
J:76479
|
increased circulating triglyceride level
|
J:107169
|
Lepob/Lepob
(involves: 129 * C57BL/6)
|
increased circulating insulin level
|
J:121534
|
Lepob/Lepob
(BKS.Cg-Lepob/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating glucose level
|
J:5400
|
hyperglycemia
|
J:5400
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating insulin level
|
J:5400
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161
|
increased circulating VLDL cholesterol level
|
J:18161
|
Lepob/Lepob
(B6.Cg-Lepob/JBomTac)
|
increased circulating triglyceride level
|
J:149091
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
decreased circulating tumor necrosis factor level
|
J:115569
|
hyperglycemia
|
J:7702
|
increased circulating insulin level
|
J:7702
|
Lepob/Lepob
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
Lepob/Lepob
(BTBR.Cg-Lepob)
|
hyperglycemia
|
J:65486
|
Lepob/Lepob
(involves: BTBR * C57BL/6 * V stock)
|
hyperglycemia
|
J:65486
|
increased circulating insulin level
|
J:65486
|
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ)
|
hyperglycemia
|
J:106121,
J:185261
|
increased blood urea nitrogen level
|
J:185261
|
increased circulating insulin level
|
J:106121
|
increased circulating triglyceride level
|
J:106121,
J:185261
|
Lepob/Lepob
(B6.Cg-Lepob/JRj)
|
increased circulating free fatty acids level
|
J:277927
|
Lepob/Lepob Mapk8tm1Wag/Mapk8tm1Wag
(B6.Cg-Lepob Mapk8tm1Wag)
|
decreased circulating glucose level
|
J:80452
|
decreased circulating insulin level
|
J:80452
|
Lepob/Lepob Mir375tm1Stf/Mir375tm1Stf
(B6.Cg-Mir375tm1Stf Lepob)
|
decreased circulating insulin level
|
J:147572
|
increased circulating glucose level
|
J:147572
|
Lepob/Lepob Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae)
|
increased circulating cholesterol level
|
J:231617
|
increased circulating glucose level
|
J:231617
|
increased circulating insulin level
|
J:231617
|
increased circulating triglyceride level
|
J:231617
|
Lepob/Lepob Nfe2l2tm1.1Jgpi/Nfe2l2tm1.1Jgpi Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased circulating glucose level
|
J:208590
|
increased circulating triglyceride level
|
J:208590
|
Lepob/Lepob Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob)
|
hyperglycemia
|
J:208590
|
increased circulating triglyceride level
|
J:208590
|
Lepob/Lepob Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating glucose level
|
J:107169
|
abnormal circulating insulin level
|
J:107169
|
decreased circulating corticosterone level
|
J:107169
|
decreased circulating testosterone level
|
J:107169
|
increased circulating cholesterol level
|
J:107169
|
increased circulating triglyceride level
|
J:107169
|
Lepob/Lepob Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129 * BALB/c * C57BL/10J)
|
decreased circulating free fatty acids level
|
J:102651
|
decreased circulating glucose level
|
J:102651
|
decreased circulating LDL cholesterol level
|
J:102651
|
increased circulating cholesterol level
|
J:102651
|
increased circulating HDL cholesterol level
|
J:102651
|
Lepob/Lepob Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating testosterone level
|
J:76479
|
increased circulating corticosterone level
|
J:76479
|
Lepob/Lepob Nr1i3tm1Dgen/Nr1i3tm1Dgen
(B6.Cg-Nr1i3tm1Dgen Lepob)
|
decreased circulating triglyceride level
|
J:149091
|
Lepob/Lepob Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating corticosterone level
|
J:85176
|
decreased circulating glucose level
|
J:85176
|
increased circulating insulin level
|
J:85176
|
Lepob/Lepob Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:116568
|
increased circulating insulin level
|
J:116568
|
increased circulating triglyceride level
|
J:116568
|
Lepob/Lepob Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
decreased circulating insulin level
|
J:121534
|
hyperglycemia
|
J:121534
|
increased circulating free fatty acids level
|
J:121534
|
increased circulating glucose level
|
J:121534
|
increased circulating insulin level
|
J:121534
|
increased circulating triglyceride level
|
J:121534
|
Lepob/Lepob Ptprvtm1Asmi/Ptprv+
(involves: 129P2/OlaHsd * C57BL/10J)
|
increased circulating insulin level
|
J:145998
|
Lepob/Lepob Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/10J)
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Lepob/Lepob Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating insulin level
|
J:70695
|
Lepob/Lepob Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:189021
|
Lepob/Lepob Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
increased circulating glucose level
|
J:187736
|
Lepob/Lepob Stxbp5lT2dm1/Stxbp5lT2dm1
(B6.Cg-Lepob Chr 16BTNTTF)
|
decreased circulating insulin level
|
J:178002
|
increased circulating glucose level
|
J:178002
|
Lepob/Lepob Stxbp5lT2dm1/Stxbp5lT2dm1 T2dm2C57BL/6J/T2dm2C57BL/6J
(involves: BTBR * C57BL/6J)
|
hyperglycemia
|
J:65486
|
Lepob/Lepob T2dm2BTBR/T2dm2BTBR
(involves: BTBR * C57BL/6J)
|
increased circulating insulin level
|
J:65486
|
Lepob/Lepob T2dm2BTBR/T2dm2C57BL/6J
(involves: BTBR * C57BL/6J)
|
increased circulating insulin level
|
J:65486
|
Lepob/Lepob Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J)
|
decreased circulating insulin level
|
J:210552
|
hyperglycemia
|
J:210552
|
Lepob/Lepob Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:210552
|
increased circulating glucose level
|
J:210552
|
Lepob/Lepob Tg(Pmch-ATXN3*)3Rck/0
(involves: C57BL/6J * FVB/NJ)
|
decreased circulating glucose level
|
J:104264
|
Lepob/Lepob Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:55722
|
Leptm1.1Gvcao/Leptm1.1Gvcao Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NTac)
|
decreased circulating follicle stimulating hormone level
|
J:218720
|
decreased circulating growth hormone level
|
J:218720
|
decreased circulating leptin level
|
J:218720
|
decreased circulating luteinizing hormone level
|
J:218720
|
decreased circulating prolactin level
|
J:218720
|
Leptm1.2Gvcao/Leptm1.2Gvcao
(involves: 129S4/SvJaeSor * FVB/NJ * FVB/NTac)
|
decreased circulating follicle stimulating hormone level
|
J:218720
|
decreased circulating leptin level
|
J:218720
|
decreased circulating prolactin level
|
J:218720
|
Leprbrta/Leprbrta
(C57BL/6JSfdAnu-Leprbrta/Anu)
|
hyperglycemia
|
J:104190
|
Leprdb-3J/Leprdb-3J
(129P3/J-Leprdb-3J/J)
|
hyperglycemia
|
J:6337
|
hypoglycemia
|
J:6337
|
increased circulating glucagon level
|
J:6337
|
increased circulating insulin level
|
J:6337
|
Leprdb-3J/Leprdb-3J
(B6.129-Leprdb-3J)
|
abnormal circulating glucose level
|
J:78850
|
abnormal circulating insulin level
|
J:78850
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLtJ-Leprdb-5J/LtJ)
|
hyperglycemia
|
J:87061
|
increased circulating insulin level
|
J:87061
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
abnormal circulating glucose level
|
J:118305
|
hyperglycemia
|
J:118305
|
increased circulating insulin level
|
J:118305
|
increased circulating leptin level
|
J:118305
|
Leprdb-9J/Leprdb-9J
(involves: C57BL/6 * CBA * SWR)
|
decreased circulating insulin level
|
J:129982
|
hyperglycemia
|
J:129982
|
Leprdb-ad/Leprdb-ad
(Not Specified)
|
increased circulating glucose level
|
J:31691
|
increased circulating insulin level
|
J:31691
|
LeprDb-Btlr/LeprDb-Btlr
(C57BL/6J-LeprDb-Btlr)
|
hyperglycemia
|
J:133632
|
Leprdb-dmpg/Leprdb-dmpg
(involves: B10.D2-H8b/Sn * C57BL/6)
|
hyperglycemia
|
J:83762
|
increased circulating insulin level
|
J:83762
|
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl)
|
increased blood uric acid level
|
J:171755
|
Leprdb-NCSU/Leprdb-NCSU
(involves: CD-1)
|
increased circulating glucose level
|
J:60363
|
increased circulating insulin level
|
J:60363
|
increased circulating leptin level
|
J:60363
|
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating insulin level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating leptin level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased fasting circulating glucose level
|
J:313303
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas)
|
hyperglycemia
|
J:174584
|
increased circulating cholesterol level
|
J:174584
|
increased circulating insulin level
|
J:174584
|
Leprdb-rlpy/Leprdb-rlpy
(involves: NU/J)
|
hyperglycemia
|
J:83762
|
increased circulating insulin level
|
J:83762
|
Leprdb-rtnd/Leprdb-rtnd
(involves: C57BL/6 * CBA/J)
|
hyperglycemia
|
J:83762
|
increased circulating insulin level
|
J:83762
|
Leprdb/Lepr+
(involves: C57BLKS/J)
|
abnormal circulating insulin level
|
J:71934
|
decreased circulating insulin level
|
J:219658
|
increased circulating glucose level
|
J:71934
|
increased circulating leptin level
|
J:219658
|
Leprdb/Lepr+ Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J)
|
abnormal circulating cholesterol level
|
J:186924
|
increased circulating glucose level
|
J:186924
|
increased circulating insulin level
|
J:186924
|
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating insulin level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating leptin level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased fasting circulating glucose level
|
J:313303
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
decreased circulating glucose level
|
J:117919
|
decreased circulating insulin level
|
J:117919
|
hyperglycemia
|
J:106871,
J:117919,
J:104790,
J:96047,
J:232827,
J:210493,
J:106597
|
hyperlipidemia
|
J:96047
|
increased circulating cholesterol level
|
J:232827
|
increased circulating corticosterone level
|
J:89242
|
increased circulating free fatty acids level
|
J:106871,
J:232827
|
increased circulating glucose level
|
J:89242,
J:5010,
J:80996
|
increased circulating insulin level
|
J:104790,
J:232827,
J:106597,
J:89242,
J:5010,
J:80996
|
increased circulating leptin level
|
J:232827,
J:89242
|
increased circulating triglyceride level
|
J:232827
|
increased glycosylated hemoglobin level
|
J:104790
|
Leprdb/Leprdb
(FVB.BKS-Leprdb)
|
abnormal circulating glucose level
|
J:78850
|
hyperglycemia
|
J:78850
|
increased circulating insulin level
|
J:78850
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating lipid level
|
J:18161
|
hyperglycemia
|
J:18161
|
increased circulating cholesterol level
|
J:18161
|
increased circulating glucose level
|
J:82334
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating insulin level
|
J:82334
|
increased circulating interleukin-6 level
|
J:115772
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating leptin level
|
J:115772,
J:82334
|
increased circulating triglyceride level
|
J:18161,
J:82334
|
increased circulating VLDL cholesterol level
|
J:18161
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating glucose level
|
J:43162
|
abnormal circulating lipid level
|
J:18161
|
decreased circulating glucose level
|
J:91813,
J:43162
|
decreased circulating insulin level
|
J:91813,
J:43162
|
decreased circulating triglyceride level
|
J:91813
|
hyperglycemia
|
J:185546,
J:135864
|
increased circulating cholesterol level
|
J:18161
|
increased circulating glucose level
|
J:6323
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161
|
increased circulating VLDL cholesterol level
|
J:18161
|
Leprdb/Leprdb
(involves: C57BL/6 * C57BLKS/J)
|
hyperglycemia
|
J:142218
|
increased circulating glucose level
|
J:164339
|
increased circulating insulin level
|
J:164339
|
increased circulating leptin level
|
J:142218
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl)
|
hyperglycemia
|
J:156725
|
increased circulating insulin level
|
J:156725
|
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj)
|
increased circulating ketone body level
|
J:277927
|
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating insulin level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating leptin level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased fasting circulating glucose level
|
J:313303
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb)
|
hyperglycemia
|
J:346348
|
increased blood urea nitrogen level
|
J:346348
|
increased circulating cholesterol level
|
J:346348
|
increased circulating creatinine level
|
J:346348
|
increased circulating insulin level
|
J:346348
|
increased circulating triglyceride level
|
J:346348
|
Leprdb/Leprdb
(BKS(D)-Leprdb/JOrlRj)
|
abnormal blood homeostasis
|
J:357542
|
hyperglycemia
|
J:357542
|
Leprdb/Leprdb Nos3tm1Unc/Nos3tm1Unc
(BKS.Cg-Leprdb Nos3tm1Unc)
|
hyperglycemia
|
J:135864
|
increased circulating creatinine level
|
J:135864
|
Leprdb/Leprdb Repin1tm1.2Arte/Repin1tm1.2Arte
(involves: BALB/c * C57BL/6 * C57BLKS/J)
|
decreased circulating glucose level
|
J:238672
|
Leprdb/Leprdb Rock1tm1Leiw/Rock1tm1Leiw
(involves: 129S7/SvEvBrd * C57BLKS/J * FVB/N)
|
hyperglycemia
|
J:182287
|
Leprdb/Leprdb Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J)
|
hyperglycemia
|
J:127478
|
increased blood urea nitrogen level
|
J:127478
|
Leprdb/Leprdb Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA)
|
abnormal blood homeostasis
|
J:232827
|
hyperglycemia
|
J:232827
|
increased circulating cholesterol level
|
J:232827
|
increased circulating free fatty acids level
|
J:232827
|
increased circulating insulin level
|
J:232827
|
increased circulating leptin level
|
J:232827
|
increased circulating testosterone level
|
J:232827
|
increased circulating triglyceride level
|
J:232827
|
LeprKK/LeprKK
(involves: C57BL/6J * KK/HlLt)
|
increased circulating glucose level
|
J:53637
|
increased circulating insulin level
|
J:53637
|
increased circulating leptin level
|
J:53637
|
Leprm5Btlr/Leprm5Btlr
(C57BL/6-Leprm5Btlr)
|
increased circulating insulin level
|
J:166105
|
increased circulating leptin level
|
J:166105
|
Leprm7Btlr/Leprm7Btlr
(C57BL/6J-Leprm7Btlr)
|
increased circulating glucose level
|
J:236685
|
LeprTg(Mth11)1Aig/LeprTg(Mth11)1Aig
(involves: Him:OF1)
|
hyperglycemia
|
J:61119
|
increased circulating insulin level
|
J:61119
|
Leprtm1.1Chua/Leprtm1.1Chua
(involves: 129 * C57BL/6)
|
decreased circulating glucose level
|
J:94019
|
Leprtm1.1Chua/Leprtm1.1Chua Ntstm1(cre)Mgmj/Nts+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
increased circulating leptin level
|
J:176657
|
Leprtm1.1Chua/Leprtm1.1Chua Prlhtm1(cre)Smln/Prlh+
(involves: 129 * C57BL/6J)
|
increased circulating insulin level
|
J:215557
|
increased circulating leptin level
|
J:215557
|
Leprtm1.1Chua/Leprtm1.1Chua Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac)
|
abnormal circulating glucose level
|
J:174691
|
increased circulating insulin level
|
J:174691
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB)
|
decreased circulating growth hormone level
|
J:173444
|
increased circulating leptin level
|
J:173444
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Nr5a1-cre)2Lowl/0
(involves: 129 * C57BL/6J * FVB)
|
increased circulating leptin level
|
J:105327
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Nr5a1-cre)2Lowl/0 Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB)
|
increased circulating leptin level
|
J:105327
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Pomc1-cre)16Lowl/0
(involves: 129 * C57BL/6J * FVB)
|
increased circulating leptin level
|
J:106354,
J:105327
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
decreased circulating adrenaline level
|
J:145998
|
decreased circulating noradrenaline level
|
J:145998
|
Leprtm1.1Chua/Leprtm1.2Chua Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating thyroxine level
|
J:183754
|
increased circulating corticosterone level
|
J:183754
|
increased circulating glucose level
|
J:183754
|
increased circulating insulin level
|
J:183754
|
increased circulating leptin level
|
J:183754
|
Leprtm1.2Chua/Leprtm1.2Chua
(involves: 129 * C57BL/6)
|
hyperglycemia
|
J:94019
|
increased circulating insulin level
|
J:94019
|
Leprtm1.2Chua/Leprtm1.2Chua Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating thyroxine level
|
J:183754
|
increased circulating corticosterone level
|
J:183754
|
increased circulating glucose level
|
J:183754
|
increased circulating insulin level
|
J:183754
|
increased circulating leptin level
|
J:183754
|
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Leprtm1Chua/Leprtm1Chua
(involves: 129 * C57BL/6)
|
increased circulating glucose level
|
J:94019
|
increased circulating insulin level
|
J:94019
|
increased circulating leptin level
|
J:94019
|
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J)
|
hyperglycemia
|
J:184572
|
increased circulating cholesterol level
|
J:184572
|
increased circulating glucagon level
|
J:184572
|
increased circulating insulin level
|
J:184572
|
increased circulating leptin level
|
J:184572
|
increased circulating triglyceride level
|
J:184572
|
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ)
|
hyperglycemia
|
J:216393
|
increased circulating insulin level
|
J:216393
|
Leprtm1Jke/Leprtm1Jke Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating cholesterol level
|
J:184572
|
decreased circulating glucose level
|
J:184572
|
decreased circulating insulin level
|
J:184572
|
decreased circulating triglyceride level
|
J:184572
|
increased circulating cholesterol level
|
J:184572
|
increased circulating insulin level
|
J:184572
|
increased circulating leptin level
|
J:184572
|
increased circulating triglyceride level
|
J:184572
|
Leprtm1Mgmj/Leprtm1Mgmj
(B6.129-Leprtm1Mgmj)
|
increased circulating glucose level
|
J:82334
|
increased circulating insulin level
|
J:82334
|
increased circulating leptin level
|
J:82334
|
increased circulating triglyceride level
|
J:82334
|
Leprtm1Rck/Leprtm1.1Rck Tg(Syn1-cre)671Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
hyperglycemia
|
J:72241
|
increased circulating insulin level
|
J:72241
|
increased circulating leptin level
|
J:72241
|
Leprtm1Rck/Leprtm1Rck Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
increased circulating leptin level
|
J:344866
|
Leprtm1Yli/Leprtm1Yli
(B6.129-Leprtm1Yli)
|
abnormal circulating glucose level
|
J:142218
|
increased circulating insulin level
|
J:142218
|
increased circulating leptin level
|
J:142218
|
Leprtm2Mgmj/Lepr+
(B6.Cg-Leprtm2Mgmj)
|
decreased circulating insulin level
|
J:122056
|
Leprtm2Mgmj/Leprtm2Mgmj
(B6.Cg-Leprtm2Mgmj)
|
decreased circulating insulin level
|
J:122056
|
decreased circulating leptin level
|
J:122056
|
Leprtm2Yli/Leprtm2Yli
(B6.129-Leprtm2Yli)
|
abnormal circulating glucose level
|
J:142218
|
increased circulating insulin level
|
J:142218
|
increased circulating leptin level
|
J:142218
|
Leprtm3.1Yli/Leprtm3.1Yli
(B6.129-Leprtm3.1Yli)
|
decreased circulating leptin level
|
J:161732
|
increased circulating glucose level
|
J:161732
|
increased circulating insulin level
|
J:161732
|
increased circulating leptin level
|
J:161732
|
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj)
|
increased circulating glucose level
|
J:164339
|
increased circulating insulin level
|
J:164339
|
Leprtm5Mgmj/Leprtm5Mgmj
(B6.129-Leprtm5Mgmj)
|
increased circulating leptin level
|
J:179119
|
Leprtm5Mgmj/Leprtm5Mgmj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating leptin level
|
J:221245
|
Leprotl1tm1b(EUCOMM)Hmgu/Leprotl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Leprotl1tm1b(EUCOMM)Hmgu/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Letmd1em1(IMPC)Kmpc/Letmd1em1(IMPC)Kmpc
(C57BL/6NTac-Letmd1em1(IMPC)Kmpc/Kmpc)
|
increased fasting circulating glucose level
|
J:211773
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating testosterone level
|
J:313172
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1)
|
increased circulating alanine transaminase level
|
J:116073
|
Lgals3bptm1Megt/Lgals3bptm1Megt
(involves: 129P2/OlaHsd * C57BL/Ka)
|
increased circulating interferon-gamma level
|
J:94936
|
increased circulating interleukin-12 level
|
J:94936
|
Lgals7tm1a(EUCOMM)Wtsi/Lgals7tm1a(EUCOMM)Wtsi
(C57BL/6N-Lgals7tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
Lgals12tm1Ftl/Lgals12tm1Ftl
(B6.129-Lgals12tm1Ftl)
|
decreased circulating leptin level
|
J:180097
|
increased circulating insulin level
|
J:180097
|
Lgmntm1Cptr/Lgmntm1Cptr
(B6.129S6-Lgmntm1Cptr)
|
increased circulating creatinine level
|
J:172774
|
Lgmntm1Ihn/Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:143886
|
Lgr4tm1.2Knis/Lgr4tm1.2Knis
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating creatinine level
|
J:127019
|
Lgr5tm1Ah/Lgr5tm1Ah
(involves: 129S5/SvEvBrd * C57BL/6)
|
cyanosis
|
J:94196
|
Lgr5tm1Ah/Lgr5tm1Ah
(involves: 129S5/SvEvBrd)
|
cyanosis
|
J:127123
|
Lhbtm1Kmr/Lhbtm1Kmr
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating estradiol level
|
J:94719
|
decreased circulating progesterone level
|
J:94719
|
decreased circulating testosterone level
|
J:94719
|
Lhcgrtm1.1Pnara/Lhcgr+
(involves: 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
decreased circulating follicle stimulating hormone level
|
J:203295
|
decreased circulating luteinizing hormone level
|
J:203295
|
increased circulating testosterone level
|
J:203295
|
Lhcgrtm1Hht/Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating testosterone level
|
J:105533,
J:66818
|
increased circulating follicle stimulating hormone level
|
J:105533,
J:66818
|
increased circulating luteinizing hormone level
|
J:105533,
J:66818
|
Lhcgrtm1Zmlei/Lhcgr+
(either: 129X1/SvJ-Lhcgrtm1Zmlei or (involves: 129X1/SvJ * C57BL/6))
|
decreased circulating testosterone level
|
J:66817
|
increased circulating follicle stimulating hormone level
|
J:66817
|
Lhcgrtm1Zmlei/Lhcgrtm1Zmlei
(either: 129X1/SvJ-Lhcgrtm1Zmlei or (involves: 129X1/SvJ * C57BL/6))
|
decreased circulating estradiol level
|
J:66817
|
decreased circulating progesterone level
|
J:66817
|
decreased circulating testosterone level
|
J:66817
|
increased circulating estradiol level
|
J:66817
|
increased circulating follicle stimulating hormone level
|
J:66817
|
increased circulating luteinizing hormone level
|
J:66817
|
Lhfpl4em1(IMPC)H/Lhfpl4+
(C57BL/6NTac-Lhfpl4em1(IMPC)H/H)
|
decreased circulating alanine transaminase level
|
J:211773
|
Lhx1tm1a(EUCOMM)Wtsi/Lhx1+
(C57BL/6N-Lhx1tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Lhx3tm1.1Sjr/Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:169035
|
decreased circulating prolactin level
|
J:169035
|
decreased circulating thyroxine level
|
J:169035
|
Lhx4tm1Ssp/Lhx4tm1Ssp
(involves: 129S2/SvPas * CF-1)
|
abnormal blood gas level
|
J:19373
|
Lhx5tm1Lmgd/Lhx5tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
cyanosis
|
J:55103
|
Lhx9tm1Lmgd/Lhx9tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating estradiol level
|
J:60621
|
decreased circulating testosterone level
|
J:60621
|
increased circulating follicle stimulating hormone level
|
J:60621
|
Liat1tm1.1(KOMP)Vlcg/Liat1tm1.1(KOMP)Vlcg
(B6N(Cg)-Liat1tm1.1(KOMP)Vlcg/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv)
|
decreased circulating adrenocorticotropin level
|
J:34269
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:119777
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6 * MF1)
|
decreased circulating triglyceride level
|
J:87585
|
increased circulating insulin-like growth factor I level
|
J:87585
|
increased circulating leptin level
|
J:87585
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c)
|
increased circulating alanine transaminase level
|
J:136940
|
increased circulating aspartate transaminase level
|
J:136940
|
increased circulating interleukin-6 level
|
J:136940
|
increased circulating serum amyloid protein level
|
J:136940
|
increased circulating tumor necrosis factor level
|
J:136940
|
Lima1tm1.1Blsg/Lima1+
(involves: C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:263730
|
Lima1tm1Blsg/Lima1tm1Blsg Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased circulating cholesterol level
|
J:263730
|
decreased circulating HDL cholesterol level
|
J:263730
|
decreased circulating LDL cholesterol level
|
J:263730
|
decreased circulating VLDL cholesterol level
|
J:263730
|
Limd1em1(IMPC)H/Limd1em1(IMPC)H
(C57BL/6NTac-Limd1em1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Lims1tm1.1Chen/Lims1tm1.1Chen Lims2tm1.1Chen/Lims2tm1.1Chen Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal atrial thrombosis
|
J:167114
|
Lin7ctm1Dsb/Lin7ctm1Dsb
(involves: 129S1/Sv * 129X1/SvJ)
|
increased blood urea nitrogen level
|
J:134806
|
Lin28atm1Egm/Lin28atm1Egm
(involves: 129S/SvEv * C57BL/6NTac)
|
decreased circulating follicle stimulating hormone level
|
J:196313
|
decreased circulating testosterone level
|
J:196313
|
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
increased circulating alanine transaminase level
|
J:270182
|
increased circulating aspartate transaminase level
|
J:270182
|
increased circulating cholesterol level
|
J:270182
|
increased circulating ketone body level
|
J:270182
|
increased circulating LDL cholesterol level
|
J:270182
|
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1)
|
decreased circulating HDL cholesterol level
|
J:68812
|
increased circulating free fatty acids level
|
J:68812
|
increased circulating insulin level
|
J:68812
|
increased circulating LDL cholesterol level
|
J:68812
|
Lipctm1Unc/Lipctm1Unc
(involves: 129)
|
abnormal circulating cholesterol level
|
J:22938
|
abnormal circulating phospholipid level
|
J:22938
|
increased circulating cholesterol level
|
J:22938
|
increased circulating HDL cholesterol level
|
J:22938
|
Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:22938
|
abnormal circulating phospholipid level
|
J:22938
|
increased circulating cholesterol level
|
J:22938
|
increased circulating HDL cholesterol level
|
J:22938
|
Lipctm1Unc/Lipctm1Unc
(B6.129P2-Lipctm1Unc)
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating cholesterol level
|
J:120962
|
increased circulating triglyceride level
|
J:120962
|
Lipetm1b(KOMP)Wtsi/Lipetm1b(KOMP)Wtsi
(C57BL/6N-Lipetm1b(KOMP)Wtsi/Ucd)
|
increased circulating insulin level
|
J:211773
|
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c)
|
abnormal circulating cholesterol level
|
J:82299
|
abnormal circulating free fatty acids level
|
J:82299
|
decreased circulating leptin level
|
J:82299
|
increased circulating glucose level
|
J:82299
|
Lipetm1Ishi/Lipetm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating free fatty acids level
|
J:59889
|
decreased circulating glycerol level
|
J:59889
|
Lipetm1Ishi/Lipetm1Ishi
(B6.129S7-Lipetm1Ishi)
|
increased circulating cholesterol level
|
J:152385
|
increased circulating free fatty acids level
|
J:152385
|
increased circulating glucose level
|
J:152385
|
increased circulating triglyceride level
|
J:152385
|
Lipetm1Ishi/Lipetm1Ishi Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi Lipetm1Ishi)
|
increased circulating cholesterol level
|
J:152385
|
increased circulating free fatty acids level
|
J:152385
|
increased circulating glucose level
|
J:152385
|
increased circulating triglyceride level
|
J:152385
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
decreased circulating leptin level
|
J:133126
|
hyperglycemia
|
J:85540
|
increased circulating insulin level
|
J:85540
|
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd)
|
decreased circulating free fatty acids level
|
J:84822
|
decreased circulating insulin level
|
J:84822
|
decreased circulating triglyceride level
|
J:84822
|
increased circulating glucose level
|
J:84822
|
Lipetm2Rze/Lipetm2Rze Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA)
|
increased circulating glucose level
|
J:144744
|
increased circulating leptin level
|
J:144744
|
Lipgtm1Chan/Lipg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating cholesterol level
|
J:82390
|
increased circulating HDL cholesterol level
|
J:82390
|
Lipgtm1Chan/Lipgtm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating cholesterol level
|
J:82390
|
increased circulating HDL cholesterol level
|
J:82390
|
increased circulating phospholipid level
|
J:82390
|
Lipgtm1Tq/Lipg+
(B6.129S6-Lipgtm1Tq)
|
increased circulating HDL cholesterol level
|
J:81821
|
increased circulating phospholipid level
|
J:81821
|
increased circulating triglyceride level
|
J:81821
|
Lipgtm1Tq/Lipgtm1Tq
(B6.129S6-Lipgtm1Tq)
|
increased circulating cholesterol level
|
J:81821
|
increased circulating HDL cholesterol level
|
J:81821
|
increased circulating phospholipid level
|
J:81821
|
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating cholesterol level
|
J:93987
|
increased circulating HDL cholesterol level
|
J:93987
|
increased circulating phospholipid level
|
J:93987
|
increased circulating triglyceride level
|
J:93987
|
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac)
|
abnormal circulating HDL cholesterol level
|
J:129942
|
Lipilpd1/Lipilpd1
(involves: CD-1)
|
increased circulating triglyceride level
|
J:46789
|
Lipntm1.1(KOMP)Vlcg/Lipntm1.1(KOMP)Vlcg
(C57BL/6N-Lipntm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Lipq1BALB/cJ/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq1C57BL/6By/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq2BALB/cJ/Lipq2BALB/cJ
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq3BALB/cJ/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq3C57BL/6By/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Llcfc1tm1.1(KOMP)Vlcg/Llcfc1tm1.1(KOMP)Vlcg
(C57BL/6N-Llcfc1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
Llgl2tm1b(KOMP)Wtsi/Llgl2+
(C57BL/6N-Llgl2tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lman1Gt(XST010)Byg/Lman1Gt(XST010)Byg
(B6.129-Lman1Gt(XST010)Byg)
|
abnormal circulating protein level
|
J:262681
|
decreased circulating aspartate transaminase level
|
J:262681
|
decreased circulating factor VIII level
|
J:262681
|
Lman1Gt(XST010)Byg/Lman1Gt(XST010)Byg Mcfd2tm1Dgi/Mcfd2tm1Dgi
(B6.129-Mcfd2tm1Dgi Lman1Gt(XST010)Byg)
|
abnormal circulating protein level
|
J:262681
|
decreased circulating aspartate transaminase level
|
J:262681
|
decreased circulating factor VIII level
|
J:262681
|
Lman1tm1c(KOMP)Wtsi/Lman1tm1c(KOMP)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal blood homeostasis
|
J:213133
|
Lman1tm1c(KOMP)Wtsi/Lman1tm1c(KOMP)Wtsi Tg(Tek-cre)12Flv/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal blood homeostasis
|
J:213133
|
Lman2em1(IMPC)Wtsi/Lman2em1(IMPC)Wtsi
(C57BL/6NCrl-Lman2em1(IMPC)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Lmbrd1tm1b(EUCOMM)Hmgu/Lmbrd1+
(C57BL/6N-Lmbrd1tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating glucose level
|
J:211773
|
Lmf1cld/Lmf1cld
(STOCK T/tw73)
|
cyanosis
|
J:7083
|
hyperchylomicronemia
|
J:7083
|
increased circulating cholesterol level
|
J:7083
|
increased circulating triglyceride level
|
J:7083
|
Lmf1Gt(OST195742)Lex/Lmf1Gt(OST195742)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
hyperlipidemia
|
J:223457
|
increased circulating cholesterol level
|
J:223457
|
increased circulating triglyceride level
|
J:223457
|
LmnaDhe/Lmna+
(B6(D2)-LmnaDhe/TyGrsrJ)
|
increased circulating phosphate level
|
J:188496
|
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz)
|
increased circulating alanine transaminase level
|
J:338760
|
increased circulating alkaline phosphatase level
|
J:338760
|
increased circulating aspartate transaminase level
|
J:338760
|
increased circulating cholesterol level
|
J:338760
|
increased circulating LDL cholesterol level
|
J:338760
|
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased circulating carnitine level
|
J:221850
|
decreased circulating lactate level
|
J:221850
|
hypoglycemia
|
J:221850
|
increased circulating creatine kinase level
|
J:221850
|
increased circulating ketone body level
|
J:221850
|
Lmnatm1.1Otin/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:211388
|
decreased circulating glucose level
|
J:177632
|
increased circulating alkaline phosphatase level
|
J:211388
|
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:177632
|
decreased circulating insulin level
|
J:177632
|
decreased circulating leptin level
|
J:177632
|
hypoglycemia
|
J:177632
|
increased circulating growth hormone level
|
J:177632
|
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating glucose level
|
J:95528
|
Lmnatm1Stw/Lmna+
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating insulin level
|
J:75101
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6J)
|
decreased circulating glucose level
|
J:75101
|
decreased circulating triglyceride level
|
J:75101
|
Lmnatm2.1Gbon/Lmnatm2.1Gbon
(involves: 129 * C57BL/6)
|
decreased circulating insulin level
|
J:180603
|
hypoglycemia
|
J:180603
|
Lmnb1tm1a(EUCOMM)Wtsi/Lmnb1+
(B6Dnk;B6Brd;B6N-Tyrc-Brd Lmnb1tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating calcium level
|
J:175295
|
Lmnb2tm1a(KOMP)Wtsi/Lmnb2+
(B6JTyr;B6N-Lmnb2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:175295
|
Lmod3em1(IMPC)Mbp/Lmod3+
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Lmr5CcS5/Dem/Lmr5CcS5/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-12 level
|
J:108764
|
Lmr9BALB/cHeA/Lmr9CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-6 level
|
J:108764
|
Lmr9CcS20/Dem/Lmr9CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-6 level
|
J:108764
|
Lmr11BALB/cHeA/Lmr11CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-6 level
|
J:108764
|
Lmr11CcS20/Dem/Lmr11CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-6 level
|
J:108764
|
Lmr12BALB/cHeA/Lmr12BALB/cHeA Lmr14BALB/cHeA/Lmr14BALB/cHeA
(involves: BALB/cHeA * STS/A)
|
increased circulating tumor necrosis factor level
|
J:108764
|
Lmr12BALB/cHeA/Lmr12CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-4 level
|
J:108764
|
Lmr12CcS16/Dem/Lmr12CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-4 level
|
J:108764
|
Lmr13CcS16/Dem/Lmr13CcS16/Dem Lmr14CcS16/Dem/Lmr14CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
decreased circulating tumor necrosis factor level
|
J:108764
|
Lmr14BALB/cHeA/Lmr14CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interferon-gamma level
|
J:108764
|
Lmr14CcS16/Dem/Lmr14CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interferon-gamma level
|
J:108764
|
Lmr14CcS16/Dem/Lmr14CcS16/Dem Lmr5CcS5/Dem/Lmr5CcS5/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating interleukin-12 level
|
J:108764
|
Lmr15BALB/cHeA/Lmr15CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
decreased circulating interferon-gamma level
|
J:108764
|
Lmr15CcS16/Dem/Lmr15CcS16/Dem
(involves: BALB/cHeA * STS/A)
|
decreased circulating interferon-gamma level
|
J:108764
|
Lmr17BALB/cHeA/Lmr17CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating tumor necrosis factor level
|
J:108764
|
Lmr17CcS20/Dem/Lmr17CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
increased circulating tumor necrosis factor level
|
J:108764
|
Lmr17CcS20/Dem/Lmr17CcS20/Dem Lmr3BALB/cHeA/Lmr3BALB/cHeA
(involves: BALB/cHeA * STS/A)
|
increased circulating interferon-gamma level
|
J:108764
|
Lmtk2em1(IMPC)Mbp/Lmtk2em1(IMPC)Mbp
(C57BL/6N-Lmtk2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc)
|
decreased circulating cholesterol level
|
J:306153
|
decreased circulating HDL cholesterol level
|
J:306153
|
decreased circulating LDL cholesterol level
|
J:306153
|
decreased circulating triglyceride level
|
J:306153
|
Lncenc1em2Smoc/Lncenc1em2Smoc
(C57BL/6J-Lncenc1em2Smoc)
|
decreased circulating triglyceride level
|
J:306153
|
Lnpeptm1Ske/Lnpeptm1Ske
(B6.129S-Lnpeptm1Ske)
|
decreased circulating cholesterol level
|
J:220356
|
increased circulating leptin level
|
J:220356
|
LnpkUl/Lnpk+
(B6EiC3-+ a/LnpkUl A/J)
|
increased bleeding time
|
J:31800
|
Lonp1tm1b(EUCOMM)Hmgu/Lonp1+
(C57BL/6N-Lonp1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating iron level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Lonrf2em2(IMPC)H/Lonrf2em2(IMPC)H
(C57BL/6N-Lonrf2em2(IMPC)H/H)
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Lonrf3tm1a(KOMP)Wtsi/Y
(C57BL/6N-Lonrf3tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Lonrf3tm1a(KOMP)Wtsi/Lonrf3tm1a(KOMP)Wtsi
(C57BL/6N-Lonrf3tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:211773
|
Lore1SS/Lore1SS
(involves: LS * SS)
|
abnormal blood homeostasis
|
J:76104
|
Lore2SS/Lore2SS
(involves: LS * SS)
|
abnormal blood homeostasis
|
J:76104
|
Loxtm1Soin/Loxtm1Soin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:103389
|
Loxl1tm1.1(KOMP)Vlcg/Loxl1+
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Loxl1tm1.1(KOMP)Vlcg/Loxl1tm1.1(KOMP)Vlcg
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J)
|
decreased circulating total protein level
|
J:211773
|
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified)
|
cyanosis
|
J:220689
|
Loxl4tm1.1(KOMP)Vlcg/Loxl4tm1.1(KOMP)Vlcg
(C57BL/6N-Loxl4tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lpar1tm1b(EUCOMM)Wtsi/Lpar1+
(C57BL/6N-Lpar1tm1b(EUCOMM)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Lpar6tm1.1(KOMP)Vlcg/Lpar6tm1.1(KOMP)Vlcg
(C57BL/6N-Lpar6tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Lpcat1Gt(BC0405)Wtsi/Lpcat1Gt(BC0405)Wtsi
(involves: 129P2/OlaHsd * Black Swiss)
|
cyanosis
|
J:161467
|
Lpcat2em1(IMPC)J/Lpcat2em1(IMPC)J
(C57BL/6NJ-Lpcat2em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Lpcat3tm1a(EUCOMM)Wtsi/Lpcat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating glucose level
|
J:220827
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased circulating triglyceride level
|
J:220827
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal circulating apolipoprotein level
|
J:220827
|
decreased circulating triglyceride level
|
J:220827
|
decreased circulating VLDL phospholipid level
|
J:220827
|
decreased circulating VLDL triglyceride level
|
J:220827
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased circulating glucose level
|
J:220827
|
decreased circulating insulin level
|
J:220827
|
decreased circulating triglyceride level
|
J:220827
|
Lpin1fld-2J/Lpin1fld-2J
(C3H/HeJ-Lpin1fld-2J/J)
|
decreased circulating leptin level
|
J:66739
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld/J)
|
increased circulating glucose level
|
J:121022
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld)
|
decreased circulating LDL cholesterol level
|
J:63448
|
decreased circulating leptin level
|
J:66739
|
decreased circulating VLDL cholesterol level
|
J:63448
|
increased circulating HDL cholesterol level
|
J:63448
|
increased circulating insulin level
|
J:63448
|
increased circulating triglyceride level
|
J:82882
|
increased circulating VLDL triglyceride level
|
J:147417
|
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J)
|
decreased circulating free fatty acids level
|
J:189894
|
decreased circulating triglyceride level
|
J:189894
|
decreased fasting circulating glucose level
|
J:189894
|
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating cholesterol level
|
J:30062
|
increased circulating triglyceride level
|
J:30062
|
increased circulating VLDL cholesterol level
|
J:30062
|
increased circulating VLDL triglyceride level
|
J:30062
|
Lpltm1Bres/Lpl+ Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae)
|
abnormal blood homeostasis
|
J:134550
|
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:30062
|
decreased circulating HDL cholesterol level
|
J:30062
|
decreased circulating LDL cholesterol level
|
J:30062
|
increased circulating cholesterol level
|
J:30062
|
increased circulating triglyceride level
|
J:30062
|
increased circulating VLDL cholesterol level
|
J:30062
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6)
|
increased circulating triglyceride level
|
J:90737
|
increased circulating VLDL triglyceride level
|
J:90737
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
increased circulating triglyceride level
|
J:110484
|
Lpltm1Sem/Lpl+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:25652
|
increased circulating HDL cholesterol level
|
J:25652
|
increased circulating phospholipid level
|
J:25652
|
increased circulating triglyceride level
|
J:25652
|
increased circulating VLDL triglyceride level
|
J:25652
|
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:25652
|
hyperlipidemia
|
J:25652
|
increased circulating cholesterol level
|
J:25652
|
increased circulating phospholipid level
|
J:25652
|
increased circulating triglyceride level
|
J:25652
|
Lpptm1b(KOMP)Wtsi/Lpp+
(C57BL/6NCrl-Lpptm1b(KOMP)Wtsi/Ccpcz)
|
increased circulating phosphate level
|
J:211773
|
Lpptm1b(KOMP)Wtsi/Lpptm1b(KOMP)Wtsi
(C57BL/6NCrl-Lpptm1b(KOMP)Wtsi/Ccpcz)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lprq1MRL/MpJ/Lprq1MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating cholesterol level
|
J:53728
|
decreased circulating VLDL cholesterol level
|
J:53728
|
Lprq2MRL/MpJ/Lprq2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating HDL cholesterol level
|
J:53728
|
Lprq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
abnormal circulating protein level
|
J:29072
|
increased circulating HDL cholesterol level
|
J:29072
|
Lprq4NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
abnormal circulating cholesterol level
|
J:29072
|
increased circulating HDL cholesterol level
|
J:29072
|
Lratd2em1(IMPC)Ccpcz/Lratd2em1(IMPC)Ccpcz
(C57BL/6N-Lratd2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Lrbaem1(IMPC)Wtsi/Lrbaem1(IMPC)Wtsi
(C57BL/6N-Lrbaem1(IMPC)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Lrfn2tm1.1Jaru/Lrfn2tm1.1Jaru
(B6.129P2(Cg)-Lrfn2tm1.1Jaru)
|
decreased circulating erythropoietin level
|
J:301285
|
Lrig1tm1a(EUCOMM)Wtsi/Lrig1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating alanine transaminase level
|
J:213427
|
decreased circulating alkaline phosphatase level
|
J:213427
|
decreased circulating aspartate transaminase level
|
J:213427
|
Lrig3em1(IMPC)Ccpcz/Lrig3em1(IMPC)Ccpcz
(C57BL/6NCrl-Lrig3em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Lrig3tm1.1Hhed/Lrig3tm1.1Hhed
(B6.129(Cg)-Lrig3tm1.1Hhed)
|
decreased circulating glycerol level
|
J:242435
|
decreased circulating HDL cholesterol level
|
J:242435
|
decreased circulating insulin level
|
J:242435
|
Lrmdatm1e(EUCOMM)Wtsi/Lrmdatm1e(EUCOMM)Wtsi
(C57BL/6N-1700112E06Riktm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Lrp1tm1.1(KOMP)Wtsi/Lrp1+
(C57BL/6N-Lrp1tm1.1(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lrp1tm2Her/Lrp1tm2Her Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:127398
|
decreased circulating free fatty acids level
|
J:127398
|
decreased circulating glucose level
|
J:127398
|
decreased circulating insulin level
|
J:127398
|
decreased circulating leptin level
|
J:127398
|
Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
abnormal blood homeostasis
|
J:83443
|
increased circulating factor VIII level
|
J:83443
|
increased circulating von Willebrand factor level
|
J:83443
|
Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal circulating protein level
|
J:117317
|
increased circulating factor VIII level
|
J:117317
|
increased circulating von Willebrand factor level
|
J:117317
|
Lrp1tm2Her/Lrp1tm2Her Tg(Syn1-cre)671Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:93329
|
hypoglycemia
|
J:93329
|
Lrp1bem1(IMPC)Hmgu/Lrp1b+
(C57BL/6N-Lrp1bem1(IMPC)Hmgu/Ieg)
|
increased circulating iron level
|
J:211773
|
Lrp2m267Asp/Lrp2m267Asp
(involves: C57BL/6J * FVB/N)
|
abnormal circulating mineral level
|
J:166387
|
Lrp2tm1Her/Lrp2tm1Her
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:34835
|
Lrp2tm1Her/Lrp2tm1Her
(either: (involves: 129S7/SvEvBrd * CD-1) or (involves: 129/SvEmcTer * 129S7/SvEvBrd * C57BL/6N))
|
increased circulating dihydrotestosterone level
|
J:115189
|
increased circulating testosterone level
|
J:115189
|
Lrp2tm1Tew/Lrp2tm1Tew Tg(APOE-cre)VITew/0
(Not Specified)
|
decreased circulating calcium level
|
J:81496
|
increased circulating parathyroid hormone level
|
J:81496
|
Lrp3em1Cya/Lrp3em1Cya
(C57BL/6N-Lrp3em1Cya/Cya)
|
increased circulating cholesterol level
|
J:345338
|
Lrp4mitt/Lrp4mitt
(involves: C57BL/6)
|
cyanosis
|
J:119654
|
Lrp4mte/Lrp4mte
(involves: C57BL/6)
|
cyanosis
|
J:119654
|
Lrp4tm1.1Line/Lrp4tm1.1Line Mnx1tm4(cre)Tmj/Mnx1+ Tg(ACTA1-cre)79Jme/0
(involves: 129S/SvEv * 129S1/Sv * C57BL/6 * C57BL/6J * SJL)
|
cyanosis
|
J:188352
|
Lrp4tm1.1Pg/Lrp4tm1.1Pg
(involves: C57BL/6N)
|
abnormal blood homeostasis
|
J:277372
|
Lrp5tm1Jsak/Lrp5+
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:81174
|
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:81174
|
increased circulating VLDL cholesterol level
|
J:81174
|
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg)
|
decreased circulating glucose level
|
J:182772
|
Lrp6tm1Arma/Lrp6+
(C57BL/6-Lrp6tm1Arma)
|
increased circulating LDL cholesterol level
|
J:210538
|
increased circulating triglyceride level
|
J:210538
|
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma)
|
hyperlipidemia
|
J:210538
|
increased circulating aspartate transaminase level
|
J:210538
|
increased circulating bilirubin level
|
J:210538
|
increased circulating LDL cholesterol level
|
J:210538
|
increased circulating triglyceride level
|
J:210538
|
increased circulating VLDL triglyceride level
|
J:210538
|
Lrpap1tm1Her/Lrpap1tm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal circulating protein level
|
J:43736
|
Lrrc3tm1b(EUCOMM)Hmgu/Lrrc3tm1b(EUCOMM)Hmgu
(C57BL/6N-Lrrc3tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Lrrc4ctm1Lex/Lrrc4ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:171883
|
Lrrc8cem1(IMPC)Mbp/Lrrc8cem1(IMPC)Mbp
(C57BL/6N-Lrrc8cem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Lrrc8dtm1a(EUCOMM)Wtsi/Lrrc8dtm1a(EUCOMM)Wtsi
(C57BL/6N-Lrrc8dtm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lrrc8eem1Bcgen/Lrrc8eem1Bcgen
(C57BL/6N-Lrrc8eem1Bcgen)
|
abnormal circulating cytokine level
|
J:288504
|
decreased circulating interferon-beta level
|
J:288504
|
decreased circulating tumor necrosis factor level
|
J:288504
|
Lrrc19tm1Ryag/Lrrc19tm1Ryag
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating interleukin-6 level
|
J:271376
|
decreased circulating tumor necrosis factor level
|
J:271376
|
Lrrc23tm1a(EUCOMM)Wtsi/Lrrc23tm1a(EUCOMM)Wtsi
(C57BL/6N-Lrrc23tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Lrrc28em1(IMPC)J/Lrrc28em1(IMPC)J
(C57BL/6NJ-Lrrc28em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Lrrc41em1(IMPC)J/Lrrc41em1(IMPC)J
(C57BL/6NJ-Lrrc41em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Lrrc55osem1Caox/Lrrc55osem1Caox
(C57BL/6-Lrrc55osem1Caox)
|
decreased circulating interferon-beta level
|
J:293325
|
Lrrc56em1(IMPC)Tcp/Lrrc56em1(IMPC)Tcp
(C57BL/6N-Lrrc56em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Lrrc78em1(IMPC)J/Lrrc78em1(IMPC)J
(C57BL/6NJ-Lrrc78em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Lrrfip1tm1.1(KOMP)Wtsi/Lrrfip1+
(C57BL/6N-Lrrfip1tm1.1(KOMP)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Lrrk1tm1.1Smo/Lrrk1tm1.1Smo
(involves: 129S/Sv)
|
decreased circulating alkaline phosphatase level
|
J:208677
|
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Lsm1tm1b(EUCOMM)Hmgu/Lsm1+
(C57BL/6N-Lsm1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating sodium level
|
J:211773
|
Lsm1tm1b(EUCOMM)Hmgu/Lsm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Lsm1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lsm3em1Caox/Lsm3em1Caox
(involves: C57BL/6J)
|
increased circulating interferon-alpha level
|
J:262834
|
increased circulating interferon-beta level
|
J:262834
|
increased circulating interleukin-6 level
|
J:262834
|
Lsm8em1(IMPC)Mbp/Lsm8+
(C57BL/6N-Lsm8em1(IMPC)Mbp/MbpMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Lsstm1b(KOMP)Wtsi/Lss+
(C57BL/6N-Lsstm1b(KOMP)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lst1tm1.1(KOMP)Vlcg/Lst1tm1.1(KOMP)Vlcg
(C57BL/6N-Lst1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased circulating interferon-gamma level
|
J:115034
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased circulating interferon-gamma level
|
J:115034
|
Ltatm1.1Sned/Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal circulating tumor necrosis factor level
|
J:109621
|
Ltbp1tm1a(EUCOMM)Wtsi/Ltbp1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ltbp1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating iron level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
increased blood urea nitrogen level
|
J:175295
|
Ltbp1tm1Veto/Ltbp1tm1Veto
(involves: 129 * C57BL/6)
|
cyanosis
|
J:128012
|
Ltbp1tm2Veto/Ltbp1tm2Veto
(involves: 129 * C57BL/6)
|
cyanosis
|
J:128012
|
Ltbp2tm2b(KOMP)Wtsi/Ltbp2tm2b(KOMP)Wtsi
(C57BL/6N-Ltbp2tm2b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Ltftm1Omc/Ltftm1Omc
(either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6))
|
increased circulating iron level
|
J:81005
|
Ltkem1(IMPC)H/Ltkem1(IMPC)H
(C57BL/6NTac-Ltkem1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Ltn1tm1b(EUCOMM)Hmgu/Ltn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ltn1tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
LtryNZB/BlNJ/?
(NZB/BlNJ)
|
decreased circulating luteinizing hormone level
|
J:82664
|
Luc7l3em1(IMPC)J/Luc7l3+
(C57BL/6NJ-Luc7l3em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Lumtm1.1(KOMP)Vlcg/Lum+
(C57BL/6N-Lumtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Lurap1em1(IMPC)J/Lurap1em1(IMPC)J
(C57BL/6NJ-Lurap1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Luzp1tm1Acch/Luzp1tm1Acch
(B6.129P2-Luzp1tm1Acch)
|
cyanosis
|
J:141306
|
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
increased bleeding time
|
J:81387
|
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
increased circulating alanine transaminase level
|
J:291868
|
Ly86tm1a(KOMP)Wtsi/Ly86+
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Lyarem1(IMPC)J/Lyarem1(IMPC)J
(C57BL/6NJ-Lyarem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Lyntm1.1Calo/Lyntm1.1Calo Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal circulating chemokine level
|
J:200745
|
abnormal circulating cytokine level
|
J:200745
|
increased circulating interferon-gamma level
|
J:200745
|
increased circulating interleukin-1 beta level
|
J:200745
|
increased circulating interleukin-6 level
|
J:200745
|
increased circulating interleukin-12 level
|
J:200745
|
increased circulating interleukin-17 level
|
J:200745
|
increased circulating tumor necrosis factor level
|
J:200745
|
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd)
|
abnormal circulating complement protein level
|
J:161523
|
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
abnormal circulating chemokine level
|
J:200745
|
abnormal circulating cytokine level
|
J:200745
|
increased circulating interferon-gamma level
|
J:200745
|
increased circulating interleukin-6 level
|
J:200745
|
increased circulating interleukin-12 level
|
J:200745
|
increased circulating interleukin-17 level
|
J:200745
|
Lypd3tm1.1(KOMP)Vlcg/Lypd3+
(C57BL/6N-Lypd3tm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Lypd6btm1b(KOMP)Wtsi/Lypd6btm1b(KOMP)Wtsi
(C57BL/6N-Lypd6btm1b(KOMP)Wtsi/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Lypla1tm1b(EUCOMM)Hmgu/Lypla1tm1b(EUCOMM)Hmgu
(C57BL/6N-Lypla1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel)
|
decreased circulating alanine transaminase level
|
J:340413
|
decreased circulating aspartate transaminase level
|
J:340413
|
increased circulating triglyceride level
|
J:340413
|
Lyplal1tm1a(KOMP)Wtsi/Lyplal1tm1a(KOMP)Wtsi
(C57BL/6N-Lyplal1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Lystbg-J/Lystbg-J
(C57BL/6J-Lystbg-J/J)
|
increased bleeding time
|
J:7327
|
Lysttm1b(EUCOMM)Wtsi/Lysttm1b(EUCOMM)Wtsi
(C57BL/6N-Lysttm1b(EUCOMM)Wtsi/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Lyz2tm1(cre)Ifo/Lyz2+ Pdcd10tm1Wami/Pdcd10tm1Wami
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased circulating creatinine level
|
J:256076
|
Lyz2tm1(cre)Ifo/Lyz2+ Rnf217tm1.1Fudi/Rnf217tm1.1Fudi
(involves: 129P2/OlaHsd)
|
increased circulating iron level
|
J:315675
|
Lyz2tm1(cre)Ifo/Lyz2+ St18tm1c(KOMP)Wtsi/St18tm1c(KOMP)Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased circulating interleukin-1 beta level
|
J:298828
|
Lyz2tm1(HBEGF)Mtka/Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating lactate dehydrogenase level
|
J:145285
|
Lyz3tm1(KOMP)Vlcg/Lyz3tm1(KOMP)Vlcg
(C57BL/6N-Lyz3tm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)
|
increased circulating glucose level
|
J:287261
|
increased circulating leptin level
|
J:287261
|
m2Jrt/m2Jrt+
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating calcium level
|
J:163957
|
M3.8.6Djba/M3.8.6Djba+
(C3H/HeJ-M3.8.6Djba)
|
decreased circulating type I collagen C-terminal telopeptide level
|
J:163658
|
M4.8.4Djba/M4.8.4Djba+
(C3H/HeJ-M4.8.4Djba)
|
increased circulating alkaline phosphatase level
|
J:163658
|
m6.11.6Djba/m6.11.6Djba
(C3H/HeJ-m6.11.6Djba)
|
decreased circulating insulin-like growth factor I level
|
J:163658
|
Mab21l2em1(IMPC)Mbp/Mab21l2+
(C57BL/6N-Mab21l2em1(IMPC)Mbp/Ucd)
|
decreased circulating creatinine level
|
J:211773
|
Macf1tm2.1Liem/Macf1tm2.2Liem Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
cyanosis
|
J:164146
|
Macirtm1.1(KOMP)Vlcg/Macir+
(B6N(Cg)-Macirtm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Macrod2tm1.1(KOMP)Vlcg/Macrod2+
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Macrod2tm1.1(KOMP)Vlcg/Macrod2tm1.1(KOMP)Vlcg
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J)
|
increased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Macroh2a1tm1.1Oxbo/Macroh2a1tm1.1Oxbo
(B6.Cg-Macroh2a1tm1.1Oxbo)
|
decreased circulating alanine transaminase level
|
J:293382
|
decreased circulating aspartate transaminase level
|
J:293382
|
Macroh2a2em1(IMPC)Hmgu/Macroh2a2em1(IMPC)Hmgu
(C57BL/6NCrl-Macroh2a2em1(IMPC)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
hyperglycemia
|
J:234643
|
increased circulating insulin level
|
J:234643
|
increased circulating triglyceride level
|
J:234643
|
Maddtm1Bpra/Maddtm1Bpra Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:225256
|
hyperglycemia
|
J:225256
|
increased fasting circulating glucose level
|
J:225256
|
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6)
|
decreased circulating phospholipid level
|
J:222253
|
Mafem1(IMPC)Mbp/Maf+
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Mafatm1Staka/Mafa+
(involves: ICR)
|
decreased circulating insulin level
|
J:99126
|
Mafatm1Staka/Mafatm1Staka
(involves: ICR)
|
decreased circulating insulin level
|
J:99126
|
increased circulating glucose level
|
J:99126
|
Mafbtm1.2Good/Mafbtm1.2Good
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
cyanosis
|
J:207904
|
Mafbtm1Jeng/Mafbtm1Jeng
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating creatinine level
|
J:111415
|
Mafbtm1Mhs/Mafbtm1Mhs
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:85746
|
Magel2em2(IMPC)H/Magel2em2(IMPC)H
(C57BL/6NTac-Magel2em2(IMPC)H/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Magel2tm1.1Mus/Magel2+
(B6.129S2-Magel2tm1.1Mus)
|
decreased circulating glucose level
|
J:166548
|
Magel2tm1Stw/Magel2+
(C57BL/6-Magel2tm1Stw)
|
decreased circulating testosterone level
|
J:144836
|
Magi2tm1.1Knis/Magi2tm1.1Knis
(Not Specified)
|
increased circulating creatinine level
|
J:216062
|
Magi2tm1Key/Magi2tm1Key
(involves: 129S4/SvJae)
|
increased blood urea nitrogen level
|
J:213553
|
increased circulating creatinine level
|
J:213553
|
Magi2tm1Key/Magi2tm1Key
(involves: 129S4/SvJae * C57BL/6)
|
increased blood urea nitrogen level
|
J:213553
|
increased circulating creatinine level
|
J:213553
|
Magixem1(IMPC)Hmgu/Magixem1(IMPC)Hmgu
(C57BL/6NCrl-Magixem1(IMPC)Hmgu/Ieg)
|
increased circulating creatinine level
|
J:211773
|
Malrd1C57BL/6ByJ/Malrd1C57BL/6ByJ
(involves: A/J * C57BL/6J)
|
decreased circulating LDL cholesterol level
|
J:61563
|
decreased circulating VLDL cholesterol level
|
J:61563
|
Man1a2tm1.1Ahe/Man1a2tm1.1Ahe
(involves: 129S4/SvJae * C57BL/6)
|
cyanosis
|
J:119977
|
Man2a1em1(IMPC)Hmgu/Man2a1em1(IMPC)Hmgu
(C57BL/6N-Man2a1em1(IMPC)Hmgu/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp)
|
increased circulating glucose level
|
J:211773
|
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR)
|
decreased circulating insulin level
|
J:211812
|
hyperglycemia
|
J:211812
|
Manftm1c(KOMP)Wtsi/Manftm1c(KOMP)Wtsi
(involves: C57BL/6N * FVB/N)
|
decreased circulating insulin level
|
J:211812
|
hyperglycemia
|
J:211812
|
Mansc4tm1b(KOMP)Wtsi/Mansc4tm1b(KOMP)Wtsi
(C57BL/6N-Mansc4tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
MaoaTg(H2-K1-Ifnb1)8Seif/?
(involves: C3H/HeJ)
|
abnormal circulating hormone level
|
J:106365
|
Map2k1tm1Chrn/Map2k1tm1Chrn Map2k2tm1Chrn/Map2k2tm1Chrn Tg(Cyp17a1-icre)AJako/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
abnormal circulating androgen level
|
J:278979
|
increased circulating luteinizing hormone level
|
J:278979
|
Map3k1tm1a(KOMP)Wtsi/Map3k1+
(C57BL/6N-Map3k1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Map3k7tm1.1Gkl/Map3k7tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-10 level
|
J:211916
|
increased circulating interleukin-1 beta level
|
J:211916
|
increased circulating tumor necrosis factor level
|
J:211916
|
Map3k7tm1Aki/Map3k7tm1Aki Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased circulating bilirubin level
|
J:160521
|
Map3k7tm1Aki/Map3k7tm1Aki Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating alanine transaminase level
|
J:160521
|
increased circulating alkaline phosphatase level
|
J:160521
|
increased circulating aspartate transaminase level
|
J:160521
|
increased circulating bilirubin level
|
J:160521
|
increased circulating glutamate dehydrogenase level
|
J:160521
|
Map3k7tm1b(EUCOMM)Wtsi/Map3k7+
(C57BL/6N-Map3k7tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Map3k8tm1Pnt/Map3k8tm1Pnt Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S1/Sv * 129S4/SvJae)
|
decreased circulating interleukin-12b level
|
J:196528
|
Map3k10tm1b(EUCOMM)Hmgu/Map3k10tm1b(EUCOMM)Hmgu
(C57BL/6N-Map3k10tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Map3k10tm1Dsd/Map3k10tm1Dsd Map3k11tm1Rjd/Map3k11tm1Rjd
(involves: 129 * 129S6/SvEvTac * C57BL/6J)
|
abnormal circulating chemokine level
|
J:177426
|
abnormal circulating cytokine level
|
J:177426
|
Map3k10tm1Dsd/Map3k10tm1Dsd Map3k11tm2.1Rjd/Map3k11tm2.1Rjd
(involves: 129 * C57BL/6J)
|
abnormal circulating chemokine level
|
J:177426
|
abnormal circulating cytokine level
|
J:177426
|
Map3k12tm1b(EUCOMM)Hmgu/Map3k12+
(C57BL/6N-Map3k12tm1b(EUCOMM)Hmgu/Bay)
|
increased circulating creatinine level
|
J:211773
|
Map3k14aly/Map3k14+ RelbTg(H2-K1/GH1)106Bri/Relb+
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:120659
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
decreased circulating interferon-gamma level
|
J:120659
|
decreased circulating interleukin-4 level
|
J:120659
|
Mapk6tm1Melo/Mapk6tm1Melo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:153218
|
Mapk8tm1.1Jcbr/Mapk8tm1.1Jcbr
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating leptin level
|
J:195844
|
Mapk8tm1Jcbr/Mapk8tm1Jcbr Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:158650
|
decreased circulating growth hormone level
|
J:158650
|
decreased circulating insulin level
|
J:158650
|
decreased circulating insulin-like growth factor I level
|
J:158650
|
increased circulating triiodothyronine level
|
J:158650
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
abnormal circulating chemokine level
|
J:192551
|
abnormal circulating cytokine level
|
J:192551
|
decreased circulating glucose level
|
J:192551
|
decreased circulating insulin level
|
J:192551
|
Mapk8tm1Wag/Mapk8tm1Wag
(B6.129P2-Mapk8tm1Wag)
|
decreased circulating glucose level
|
J:80452
|
decreased circulating insulin level
|
J:80452
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
hypoglycemia
|
J:152617
|
Mapk8ip1tm3.1Rjd/Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd)
|
decreased circulating leptin level
|
J:163808
|
Mapk8ip3tm1Plhn/Mapk8ip3tm1Plhn
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:95744
|
Mapk8ip3tm1Plhn/Mapk8ip3tm1Plhn
(involves: 129S4/SvJae * C57BL/6)
|
cyanosis
|
J:136735
|
Mapk13em1(IMPC)Hmgu/Mapk13em1(IMPC)Hmgu
(C57BL/6N-Mapk13em1(IMPC)Hmgu/Ieg)
|
increased circulating creatinine level
|
J:211773
|
Mapk13tm2.1Lex/Mapk13tm2.1Lex
(B6.129S5-Mapk13tm2.1Lex)
|
decreased circulating glucose level
|
J:146185
|
increased circulating insulin level
|
J:146185
|
Mapk14tm1.1Dvb/Mapk14+
(B6(FVB)-Mapk14tm1.1Dvb)
|
decreased circulating glucose level
|
J:151980
|
Mapk15tm1b(EUCOMM)Hmgu/Mapk15tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapk15tm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Mapkapk2tm1.2Gkl/Mapkapk2tm1.2Gkl
(involves: BALB/cJ * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:262876
|
Mapkapk2tm1b(EUCOMM)Hmgu/Mapkapk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkapk2tm1b(EUCOMM)Hmgu/H)
|
increased circulating glucose level
|
J:211773
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating tumor necrosis factor level
|
J:59678
|
Mapkbp1tm1b(EUCOMM)Hmgu/Mapkbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkbp1tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Marchf2em1Cnu/Marchf2em1Cnu
(C57BL/6-Marchf2em1Cnu)
|
increased circulating interferon-beta level
|
J:297482
|
increased circulating interleukin-6 level
|
J:297482
|
increased circulating interleukin-12 level
|
J:297482
|
increased circulating tumor necrosis factor level
|
J:297482
|
Marchf3em1Hbsh/Marchf3em1Hbsh
(involves: C57BL/6J)
|
abnormal circulating cytokine level
|
J:267641
|
Marchf3tm1b(EUCOMM)Hmgu/Marchf3tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf3tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Marchf5tm1a(EUCOMM)Wtsi/Marchf5+
(C57BL/6-Marchf5tm1a(EUCOMM)Wtsi)
|
increased circulating interferon-beta level
|
J:225000
|
increased circulating interleukin-6 level
|
J:225000
|
Marchf6tm1b(EUCOMM)Hmgu/Marchf6tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf6tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Marchf8em2(IMPC)Ccpcz/Marchf8em2(IMPC)Ccpcz
(C57BL/6N-Marchf8em2(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Marchf9tm1a(EUCOMM)Wtsi/Marchf9tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:165965
|
Marckstm2b(KOMP)Wtsi/Marckstm2b(KOMP)Wtsi
(C57BL/6N-Marckstm2b(KOMP)Wtsi/BayMmucd)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Marcotm2b(EUCOMM)Hmgu/Marcotm2b(EUCOMM)Hmgu
(C57BL/6N-Marcotm2b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mark2Gt(pSABetageo)38Bss/Mark2Gt(pSABetageo)38Bss
(involves: 129S2/SvPas * MF1)
|
decreased circulating progesterone level
|
J:57958
|
decreased circulating prolactin level
|
J:57958
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:120128
|
decreased circulating insulin level
|
J:120128
|
decreased circulating insulin-like growth factor I level
|
J:120128
|
decreased circulating leptin level
|
J:120128
|
decreased circulating triglyceride level
|
J:120128
|
hypoglycemia
|
J:120128
|
Mark3tm1Hpw/Mark3tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:163905
|
hypoglycemia
|
J:163905
|
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:192469
|
decreased circulating glucose level
|
J:192469
|
decreased circulating insulin level
|
J:192469
|
decreased circulating triglyceride level
|
J:192469
|
Mars2tm1.1(KOMP)Vlcg/Mars2+
(C57BL/6N-Mars2tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Masp1tm1.1(KOMP)Vlcg/Masp1tm1.1(KOMP)Vlcg
(C57BL/6N-Masp1tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Mast3tm1.1(KOMP)Wtsi/Mast3tm1.1(KOMP)Wtsi
(C57BL/6N-Mast3tm1.1(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mat1atm1Jmm/Mat1atm1Jmm
(involves: 129/Sv * C57BL/6)
|
increased circulating methionine level
|
J:69408
|
Matr3em3Tcp/Matr3em3Tcp
(C57BL/6J-Matr3em3Tcp)
|
cyanosis
|
J:298091
|
Matr3em4Tcp/Matr3em4Tcp
(C57BL/6J-Matr3em4Tcp)
|
cyanosis
|
J:298091
|
Matr3em5Tcp/Matr3em5Tcp
(C57BL/6J-Matr3em5Tcp)
|
cyanosis
|
J:298091
|
Mavstm1Aki/Mavstm1Aki
(Not Specified)
|
decreased circulating interleukin-6 level
|
J:124405
|
Mavstm1Aki/Mavstm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-alpha level
|
J:130954
|
decreased circulating interferon-beta level
|
J:130954
|
decreased circulating interferon-gamma level
|
J:130954
|
decreased circulating interleukin-6 level
|
J:130954
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating interferon level
|
J:162888
|
increased circulating interferon-gamma level
|
J:162888
|
increased circulating interleukin-6 level
|
J:162888
|
increased circulating tumor necrosis factor level
|
J:162888
|
Mavstm1Aki/Mavstm1Aki Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-alpha level
|
J:130954
|
decreased circulating interferon-beta level
|
J:130954
|
decreased circulating interferon-gamma level
|
J:130954
|
decreased circulating interleukin-6 level
|
J:130954
|
decreased circulating interleukin-12b level
|
J:130954
|
Mavstm1Zjc/Mavstm1Zjc
(B6.Cg-Mavstm1Zjc)
|
abnormal circulating interferon level
|
J:243916
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
hyperglycemia
|
J:323838
|
Mbd5tm1.1Gxu/Mbd5tm1.1Gxu Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating growth hormone level
|
J:192212
|
decreased circulating insulin-like growth factor I level
|
J:192212
|
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating glucose level
|
J:192212
|
decreased circulating insulin level
|
J:192212
|
decreased circulating insulin-like growth factor I level
|
J:192212
|
hypoglycemia
|
J:192212
|
Mbd6tm1.1(KOMP)Vlcg/Mbd6+
(C57BL/6N-Mbd6tm1.1(KOMP)Vlcg/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Mbipem1(IMPC)J/Mbip+
(C57BL/6NJ-Mbipem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Mbl1tm1Kata/Mbl1tm1Kata
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating tumor necrosis factor level
|
J:90437
|
Mbl1tm1Kata/Mbl1tm1Kata Mbl2tm1Kata/Mbl2tm1Kata
(involves: 129 * C57BL/6)
|
abnormal circulating interleukin-6 level
|
J:98124
|
abnormal circulating tumor necrosis factor level
|
J:98124
|
Mboat4tm1Jagu/Mboat4tm1Jagu
(involves: C57BL/6)
|
abnormal circulating ghrelin level
|
J:151420
|
Mboat4tm1Vlcg/Mboat4tm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
decreased circulating ghrelin level
|
J:159327
|
decreased circulating glucose level
|
J:159327
|
decreased circulating growth hormone level
|
J:159327
|
Mboat4tm2Vlcg/Mboat4tm2Vlcg
(Not Specified)
|
abnormal blood homeostasis
|
J:180107
|
abnormal circulating hormone level
|
J:180107
|
increased circulating progesterone level
|
J:180107
|
MbsydC57BL/6J/MbsydPERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating triglyceride level
|
J:94548
|
Mbtps1tm1Jdh/Mbtps1tm1Jdh Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:72930
|
decreased circulating triglyceride level
|
J:72930
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
decreased circulating cholesterol level
|
J:94077,
J:123123
|
decreased circulating HDL cholesterol level
|
J:123123
|
increased circulating LDL cholesterol level
|
J:123123
|
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi)
|
decreased circulating adrenaline level
|
J:127445
|
decreased circulating aldosterone level
|
J:127445
|
decreased circulating corticosterone level
|
J:127445
|
hypoglycemia
|
J:127445
|
increased circulating adrenocorticotropin level
|
J:127445
|
increased circulating potassium level
|
J:127445
|
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl)
|
decreased circulating triglyceride level
|
J:178147
|
increased circulating insulin level
|
J:178147
|
increased circulating leptin level
|
J:178147
|
increased circulating resistin level
|
J:178147
|
Mc3rtm1Butl/Mc3rtm1Butl Tg(Nr5a1-cre)2Lowl/0
(involves: C57BL/6J * FVB/NJ)
|
abnormal circulating leptin level
|
J:178147
|
decreased circulating triglyceride level
|
J:178147
|
Mc3rtm1Lvp/Mc3rtm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating insulin level
|
J:64365
|
increased circulating leptin level
|
J:64365
|
Mc4rGlu3/Mc4r+
(involves: C57BL/6J)
|
hyperglycemia
|
J:85113
|
Mc4rGlu3/Mc4r+
(involves: 129S6/SvEvTac)
|
hyperglycemia
|
J:85113
|
Mc4rtm1Dhu/Mc4rtm1Dhu
(involves: 129S4/SvJae * C57BL/6J)
|
hyperglycemia
|
J:38224
|
increased circulating insulin level
|
J:38224
|
increased circulating leptin level
|
J:38224
|
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:177386
|
increased circulating free fatty acids level
|
J:177386
|
increased circulating insulin level
|
J:115192
|
increased circulating interleukin-6 level
|
J:177386
|
increased circulating leptin level
|
J:177386
|
Mc4rtm1Lowl/Mc4rtm1Lowl Chattm1(cre)Lowl/Chat+
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased circulating insulin level
|
J:193452
|
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu)
|
increased circulating alanine transaminase level
|
J:285412
|
increased circulating aspartate transaminase level
|
J:285412
|
increased circulating cholesterol level
|
J:285412
|
increased circulating insulin level
|
J:285412
|
Mcattm1.1Ssmi/Mcattm1.1Ssmi Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal circulating alanine transaminase level
|
J:192213
|
increased circulating glucose level
|
J:192213
|
increased circulating ketone body level
|
J:192213
|
increased circulating lactate level
|
J:192213
|
Mcf2ltm1a(EUCOMM)Hmgu/Mcf2ltm1a(EUCOMM)Hmgu
(C57BL/6N-Mcf2ltm1a(EUCOMM)Hmgu/Cnrm)
|
increased circulating phosphate level
|
J:165965
|
increased circulating serum albumin level
|
J:211773
|
Mcfd2tm1Dgi/Mcfd2tm1Dgi
(129S1/SvImJ-Mcfd2tm1Dgi)
|
abnormal circulating protein level
|
J:262681
|
decreased circulating aspartate transaminase level
|
J:262681
|
decreased circulating factor VIII level
|
J:262681
|
Mchr1tm1Ohl/Mchr1tm1Ohl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating type I collagen C-terminal telopeptide level
|
J:90102
|
Mchr1tm1Sqn/Mchr1tm1Sqn
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating leptin level
|
J:81787
|
increased circulating corticosterone level
|
J:81787
|
Mchr1tm1Yush/Mchr1tm1Yush
(involves: 129 * C57BL/6)
|
decreased circulating insulin level
|
J:106819
|
decreased circulating leptin level
|
J:106819
|
Mcidasem2(IMPC)Tcp/Mcidasem2(IMPC)Tcp
(C57BL/6NCrl-Mcidasem2(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Mcm10tm1(NCOM)Cmhd/Mcm10+
(C57BL/6N-Mcm10tm1(NCOM)Cmhd/Tcp)
|
decreased circulating alanine transaminase level
|
J:165965
|
Mcoln1tm1Asoy/Mcoln1tm1Asoy
(involves: 129 * C57BL/6)
|
increased circulating gastrin level
|
J:173516
|
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating gastrin level
|
J:135368
|
Mcpt1tm1Hrpm/Mcpt1tm1Hrpm
(involves: 129P2/OlaHsd * MF1)
|
decreased circulating tumor necrosis factor level
|
J:93616
|
Mcpt4tm1Mabr/Mcpt4tm1Mabr
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal blood coagulation
|
J:84839
|
Mcrip1tm1(KOMP)Vlcg/Mcrip1tm1(KOMP)Vlcg
(C57BL/6-Mcrip1tm1(KOMP)Vlcg)
|
cyanosis
|
J:278092
|
McuGt(IST11669F8)Tigm/McuGt(IST11669F8)Tigm
(involves: C57BL/6 * C57BL/6N * CD-1)
|
increased circulating lactate level
|
J:208297
|
Mcutm1b(EUCOMM)Hmgu/Mcu+
(C57BL/6N-Mcutm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Mdktm1.1(KOMP)Mbp/Mdk+
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J)
|
increased circulating sodium level
|
J:211773
|
Mdktm1.1(KOMP)Mbp/Mdktm1.1(KOMP)Mbp
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mdktm1Tmu/Mdktm1Tmu
(B6.129S2-Mdktm1Tmu)
|
abnormal circulating enzyme level
|
J:102069
|
Me1em1(IMPC)Tcp/Me1em1(IMPC)Tcp
(C57BL/6NCrl-Me1em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased circulating cholesterol level
|
J:198551
|
increased circulating LDL cholesterol level
|
J:198551
|
increased circulating triglyceride level
|
J:198551
|
Med1tm1Rgr/Med1+
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6J))
|
decreased circulating thyroxine level
|
J:61840
|
decreased circulating triiodothyronine level
|
J:61840
|
Med11tm1.1(KOMP)Vlcg/Med11+
(C57BL/6N-Med11tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Med12lem1(IMPC)J/Med12lem1(IMPC)J
(C57BL/6NJ-Med12lem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Med13tm1Eno/Med13tm1Eno Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:186193
|
increased circulating insulin level
|
J:186193
|
increased circulating leptin level
|
J:186193
|
increased circulating triglyceride level
|
J:186193
|
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ)
|
hyperglycemia
|
J:298822
|
increased circulating insulin level
|
J:298822
|
Med22tm1c(EUCOMM)Hmgu/Med22tm1c(EUCOMM)Hmgu Tg(Nphs1-cre)#Seq/0
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
increased blood urea nitrogen level
|
J:300239
|
Med23em1(IMPC)Wtsi/Med23+
(C57BL/6N-Med23em1(IMPC)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Med28tm1.1(KOMP)Vlcg/Med28+
(C57BL/6N-Med28tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
Mef2ctm1Eno/Mef2ctm1Jjs H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
cyanosis
|
J:122483
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae)
|
increased circulating interleukin-1 beta level
|
J:172117
|
increased circulating interleukin-6 level
|
J:172117
|
increased circulating tumor necrosis factor level
|
J:172117
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae Rag1tm1Mom/Rag1tm1Mom
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:172117
|
increased circulating interleukin-6 level
|
J:172117
|
increased circulating tumor necrosis factor level
|
J:172117
|
Mei4em1(IMPC)Mbp/Mei4em1(IMPC)Mbp
(C57BL/6NCrl-Mei4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Memo1tm1.1Neh/Memo1tm1.1Neh Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased circulating calcium level
|
J:206626
|
increased circulating parathyroid hormone level
|
J:206626
|
Men1tm1.2Ctre/Men1tm1.2Ctre Pax3tm1(cre)Joe/Pax3+
(involves: 129S6/SvEvTac)
|
cyanosis
|
J:127545
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:85042
|
increased circulating insulin level
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:85042
|
increased circulating insulin level
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased circulating glucose level
|
J:85042
|
increased circulating insulin level
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(PTH-cre)4167Slib/0
(Not Specified)
|
abnormal blood homeostasis
|
J:86642
|
increased circulating calcium level
|
J:86642
|
Men1tm1.2Zqw/Men1tm1.2Zqw Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
hypoglycemia
|
J:85133
|
increased circulating insulin level
|
J:85133
|
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
increased circulating insulin level
|
J:67128
|
Men1tm1Ctre/Men1+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
increased circulating insulin level
|
J:146440
|
Men1tm1Ctre/Men1tm1Ctre Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
decreased circulating glucose level
|
J:146440
|
increased circulating insulin level
|
J:146440
|
Men1tm1Mmey/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
hypoglycemia
|
J:102494
|
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6)
|
decreased circulating phosphate level
|
J:191261
|
increased circulating calcium level
|
J:191261
|
increased circulating corticosterone level
|
J:191261
|
Meox1tm1Bmk/Meox1tm1Bmk Meox2tm1Vpa/Meox2tm1Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:84754
|
Meox2tm1(cre)Sor/Meox2+ Procrtm2Cte/Procrtm2Cte
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * Black Swiss * C57BL/6)
|
decreased circulating fibrinogen level
|
J:119529
|
increased circulating C-reactive protein level
|
J:119529
|
Mep1atm1a(KOMP)Wtsi/Mep1atm1a(KOMP)Wtsi
(C57BL/6N-Mep1atm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Mep1atm1Bond/Mep1atm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:145037
|
abnormal blood urea nitrogen level
|
J:145037
|
abnormal circulating creatinine level
|
J:145037
|
abnormal circulating interleukin-1 beta level
|
J:145037
|
increased circulating interleukin-1 beta level
|
J:145685
|
increased circulating interleukin-6 level
|
J:145685
|
Mep1btm1Bond/Mep1btm1Bond
(B6.129-Mep1btm1Bond)
|
abnormal blood homeostasis
|
J:145037
|
Mep1btm1Bond/Mep1btm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased blood urea nitrogen level
|
J:132021
|
decreased circulating creatinine level
|
J:132021
|
Mertktm1Gkm/Mertktm1Gkm
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased circulating tumor necrosis factor level
|
J:53423
|
Mertktm1Lex/Mertktm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased platelet aggregation
|
J:102333
|
decreased susceptibility to induced thrombosis
|
J:102333
|
Mettm1Sst/Mettm1Sst Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:196854
|
increased circulating glucose level
|
J:196854
|
Metap1em1(IMPC)Tcp/Metap1+
(C57BL/6NCrl-Metap1em1(IMPC)Tcp/Cmmr)
|
decreased circulating glucose level
|
J:211773
|
Mettl5em1(IMPC)Hmgu/Mettl5+
(C57BL/6N-Mettl5em1(IMPC)Hmgu/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
Mettl6em1(IMPC)J/Mettl6em1(IMPC)J
(C57BL/6NJ-Mettl6em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Mettl15em1Pvs/Mettl15em1Pvs
(involves: C57BL/6 * CBA)
|
hypoglycemia
|
J:325995
|
Mettl16tm1b(KOMP)Mbp/Mettl16+
(C57BL/6N-Mettl16tm1b(KOMP)Mbp/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mettl18em1(IMPC)J/Mettl18em1(IMPC)J
(C57BL/6NJ-Mettl18em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Mettl22tm1.1(KOMP)Vlcg/Mettl22tm1.1(KOMP)Vlcg
(C57BL/6N-Mettl22tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mettl23em1(IMPC)Hmgu/Mettl23em1(IMPC)Hmgu
(C57BL/6NCrl-Mettl23em1(IMPC)Hmgu/Ieg)
|
increased circulating unsaturated transferrin level
|
J:211773
|
Mettl24tm1a(KOMP)Wtsi/Mettl24tm1a(KOMP)Wtsi
(C57BL/6N-Mettl24tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mex3cGt(DD0642)Wtsi/Mex3cGt(DD0642)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating growth hormone level
|
J:189503
|
Mex3cGt(DD0642)Wtsi/Mex3cGt(DD0642)Wtsi
(B6.129P2-Mex3cGt(DD0642)Wtsi)
|
cyanosis
|
J:189503
|
Mex3cGt(DD0642)Wtsi/Mex3cGt(DD0642)Wtsi
(FVB.129P2(B6)-Mex3cGt(DD0642)Wtsi)
|
decreased circulating insulin-like growth factor I level
|
J:189503
|
Mfap2tm1a(KOMP)Wtsi/Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
hyperglycemia
|
J:236092
|
increased fasting circulating glucose level
|
J:236092
|
Mfap2tm1Mech/Mfap2+
(B6.129X1-Mfap2tm1Mech)
|
decreased susceptibility to induced thrombosis
|
J:134343
|
Mfap2tm1Mech/Mfap2tm1Mech
(B6.129X1-Mfap2tm1Mech)
|
decreased susceptibility to induced thrombosis
|
J:134343
|
increased bleeding time
|
J:134343
|
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6)
|
abnormal circulating enzyme level
|
J:217719
|
decreased partial thromboplastin time
|
J:217719
|
decreased prothrombin time
|
J:217719
|
increased circulating factor IX level
|
J:217719
|
increased circulating factor XI level
|
J:217719
|
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Mfsd1tm1a(KOMP)Wtsi/Mfsd1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased circulating alanine transaminase level
|
J:280713
|
increased circulating aspartate transaminase level
|
J:280713
|
increased circulating glutamate dehydrogenase level
|
J:280713
|
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls)
|
decreased circulating triglyceride level
|
J:194781
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(B6JTyr;B6N-Mfsd2btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:175295
|
Mfsd4b4em1(IMPC)J/Mfsd4b4em1(IMPC)J
(C57BL/6NJ-Mfsd4b4em1(IMPC)J/Mmjax)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Mfsd8tm1b(EUCOMM)Hmgu/Mfsd8tm1b(EUCOMM)Hmgu
(C57BL/6N-Mfsd8tm1b(EUCOMM)Hmgu/H)
|
increased circulating aspartate transaminase level
|
J:211773
|
Mgamtm1Lex/Mgamtm1Lex
(129/Sv-Mgamtm1Lex)
|
decreased circulating insulin level
|
J:146501
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating calcium level
|
J:80661
|
decreased circulating total protein level
|
J:80661
|
hypoglycemia
|
J:80661
|
increased partial thromboplastin time
|
J:80661
|
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm)
|
abnormal blood homeostasis
|
J:117542
|
abnormal circulating insulin level
|
J:117542
|
decreased circulating insulin level
|
J:117542
|
hyperglycemia
|
J:117542
|
increased circulating free fatty acids level
|
J:117542
|
increased circulating glucose level
|
J:117542
|
increased circulating triglyceride level
|
J:117542
|
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:212313
|
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(B6.129-Mgat4btm1.1Jxm)
|
abnormal circulating protein level
|
J:212313
|
decreased circulating factor IX level
|
J:212313
|
decreased circulating factor VIII level
|
J:212313
|
decreased circulating prothrombin level
|
J:212313
|
decreased circulating VLDL cholesterol level
|
J:212313
|
decreased circulating von Willebrand factor level
|
J:212313
|
increased bleeding time
|
J:212313
|
increased partial thromboplastin time
|
J:212313
|
Mgat5btm1.1Cfg/Mgat5btm1.1Cfg
(involves: 129S6/SvEvTac)
|
increased circulating glucose level
|
J:217719
|
mgb/0
(involves: C57BL/6 * FVB/N)
|
increased circulating potassium level
|
J:130545
|
mgb/mgb
(involves: C57BL/6 * FVB/N)
|
abnormal circulating calcium level
|
J:130545
|
increased blood urea nitrogen level
|
J:130545
|
increased circulating creatinine level
|
J:130545
|
increased circulating potassium level
|
J:130545
|
Mglcq1M16/?
(involves: ICR * M16)
|
increased circulating glucose level
|
J:101200
|
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glycerol level
|
J:172679
|
decreased circulating insulin level
|
J:172679
|
decreased circulating ketone body level
|
J:172679
|
decreased circulating triglyceride level
|
J:172679
|
Mgme1em1(IMPC)J/Mgme1em1(IMPC)J
(C57BL/6NJ-Mgme1em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Mgmttm1b(EUCOMM)Wtsi/Mgmttm1b(EUCOMM)Wtsi
(C57BL/6N-Mgmttm1b(EUCOMM)Wtsi/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Mgmttm1Lds/Mgmttm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:118148
|
Mgptm1Kry/Mgptm1Kry
(involves: 129S7/SvEvBrd)
|
increased circulating osteocalcin level
|
J:203924
|
Mgrn1em1(IMPC)Tcp/Mgrn1em1(IMPC)Tcp
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Mgst1em1(IMPC)J/Mgst1em1(IMPC)J
(C57BL/6NJ-Mgst1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mhdabap001/Mhdabap001
(C3HeB/FeJ-Mhdabap001)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap003/Mhdabap003
(C3HeB/FeJ-Mhdabap003)
|
increased circulating alkaline phosphatase level
|
J:183993
|
increased circulating calcium level
|
J:183993
|
Mhdabap009/Mhdabap009
(C3HeB/FeJ-Mhdabap009)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap16/Mhdabap16
(C3HeB/FeJ-Mhdabap16)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap17/Mhdabap17
(C3HeB/FeJ-Mhdabap17)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap18/Mhdabap18
(C3HeB/FeJ-Mhdabap18)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap19/Mhdabap19
(C3HeB/FeJ-Mhdabap19)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Mhdabap21/Mhdabap21
(C3HeB/FeJ-Mhdabap21)
|
abnormal circulating aspartate transaminase level
|
J:183993
|
decreased circulating alkaline phosphatase level
|
J:183993
|
increased circulating alanine transaminase level
|
J:183993
|
Mhdabap22/Mhdabap22
(C3HeB/FeJ-Mhdabap22)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
Mhdabch6/Mhdabch6
(C3HeB/FeJ-Mhdabch6)
|
increased circulating calcium level
|
J:183993
|
Mhdabch8/Mhdabch8
(C3HeB/FeJ-Mhdabch8)
|
increased circulating calcium level
|
J:183993
|
Mhdabch9/Mhdabch9
(C3HeB/FeJ-Mhdabch9)
|
increased circulating calcium level
|
J:183993
|
Mhdabch10/Mhdabch10
(C3HeB/FeJ-Mhdabch10)
|
increased circulating calcium level
|
J:183993
|
Mhdasca1/Mhdasca1
(C3HeB/FeJ-Mhdasca1)
|
increased circulating calcium level
|
J:183993
|
Mia2cpto/Mia2cpto
(C57BL/6-Mia2cpto)
|
decreased circulating cholesterol level
|
J:176259
|
decreased circulating HDL cholesterol level
|
J:176259
|
decreased circulating triglyceride level
|
J:176259
|
decreased circulating VLDL triglyceride level
|
J:176259
|
Mia2tm1Zhxu/Mia2tm1Zhxu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:268333
|
decreased circulating triglyceride level
|
J:268333
|
Mib2tm1a(EUCOMM)Wtsi/Mib2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mib2tm1a(EUCOMM)Wtsi/Ics)
|
decreased blood urea nitrogen level
|
J:165965
|
decreased circulating amylase level
|
J:165965
|
Micos13tm1.1(KOMP)Vlcg/Micos13+
(C57BL/6N-Micos13tm1.1(KOMP)Vlcg/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Micu1em#Fink/Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
increased circulating lactate level
|
J:238984
|
Micu2tm1a(EUCOMM)Wtsi/Micu2tm1a(EUCOMM)Wtsi
(C57BL/6N-Micu2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Mier1tm1a(EUCOMM)Wtsi/Mier1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Mier1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating glucose level
|
J:165965
|
Miftm1Dvd/Miftm1Dvd
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:52300
|
Miga1tm1b(EUCOMM)Wtsi/Miga1tm1b(EUCOMM)Wtsi
(C57BL/6N-Miga1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Miga2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Miga2tm1c(KOMP)Wtsi/Miga2tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi/0
(B6.Cg-Miga2tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi)
|
abnormal blood homeostasis
|
J:339075
|
increased circulating hypoxanthine level
|
J:339075
|
increased circulating xanthine level
|
J:339075
|
Minar2tm1b(KOMP)Wtsi/Minar2tm1b(KOMP)Wtsi
(C57BL/6N-Minar2tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Mindy1tm1a(EUCOMM)Wtsi/Mindy1tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating glycerol level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Mink1tm1.2Lgrl/Mink1tm1.2Lgrl
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal platelet dense granule physiology
|
J:231551
|
abnormal platelet physiology
|
J:231551
|
decreased platelet aggregation
|
J:231551
|
decreased susceptibility to induced thrombosis
|
J:231551
|
increased bleeding time
|
J:231551
|
Mipepem1(IMPC)Mbp/Mipep+
(C57BL/6N-Mipepem1(IMPC)Mbp/MbpMmucd)
|
increased circulating serum albumin level
|
J:211773
|
Mipol1tm1b(EUCOMM)Hmgu/Mipol1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mipol1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Mir1a-2tm1Dsr/Mir1a-2tm1Dsr
(involves: 129/Sv * C57BL/6)
|
abnormal atrial thrombosis
|
J:211548
|
Mir10bem1Rosay/Mir10bem1Rosay
(C57BL/6J-Mir10bem1Rosay)
|
hyperglycemia
|
J:342486
|
Mir22tm1Boet/Mir22tm1Boet
(B6.129S2-Mir22tm1Boet)
|
decreased circulating free fatty acids level
|
J:266382
|
decreased circulating leptin level
|
J:266382
|
Mir26a-1em1Xfu/Mir26a-1em1Xfu Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6)
|
increased circulating glucose level
|
J:286108
|
increased circulating insulin level
|
J:286108
|
increased fasting circulating glucose level
|
J:286108
|
Mir32em1Gpt/Mir32em1Gpt Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt)
|
decreased circulating alanine transaminase level
|
J:344660
|
decreased circulating aspartate transaminase level
|
J:344660
|
decreased circulating cholesterol level
|
J:344660
|
decreased circulating LDL cholesterol level
|
J:344660
|
Mir33tm1.1Koho/Mir33tm1.1Koho
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:165420
|
increased circulating HDL cholesterol level
|
J:165420
|
Mir100em1Nju/Mir100em1Nju Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:281439
|
increased circulating aspartate transaminase level
|
J:281439
|
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:190066
|
decreased circulating HDL cholesterol level
|
J:190066
|
decreased circulating triglyceride level
|
J:190066
|
decreased circulating VLDL cholesterol level
|
J:190066
|
increased circulating alanine transaminase level
|
J:190066
|
increased circulating alkaline phosphatase level
|
J:190066
|
increased circulating interleukin-6 level
|
J:190066
|
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating enzyme level
|
J:190067
|
decreased circulating cholesterol level
|
J:190067
|
decreased circulating HDL cholesterol level
|
J:190067
|
increased circulating alanine transaminase level
|
J:190067
|
increased circulating alkaline phosphatase level
|
J:190067
|
increased circulating interleukin-6 level
|
J:190067
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal circulating enzyme level
|
J:190067
|
decreased circulating cholesterol level
|
J:190067
|
decreased circulating HDL cholesterol level
|
J:190067
|
decreased circulating LDL cholesterol level
|
J:190067
|
increased circulating alanine transaminase level
|
J:190067
|
increased circulating alkaline phosphatase level
|
J:190067
|
increased circulating interleukin-6 level
|
J:190067
|
Mir129-2em1(IMPC)Kmpc/Mir129-2em1(IMPC)Kmpc
(C57BL/6NTac-Mir129-2em1(IMPC)Kmpc/Kmpc)
|
decreased circulating total protein level
|
J:211773
|
Mir133a-1tm1Eno/Mir133a-1tm1Eno Mir133a-2tm1Eno/Mir133a-2tm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal atrial thrombosis
|
J:142220
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
increased circulating interleukin-1 beta level
|
J:173671
|
increased circulating interleukin-6 level
|
J:173671
|
increased circulating interleukin-10 level
|
J:173671
|
increased circulating tumor necrosis factor level
|
J:173671
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased circulating interleukin-1 beta level
|
J:173671
|
increased circulating interleukin-6 level
|
J:173671
|
increased circulating interleukin-10 level
|
J:173671
|
increased circulating tumor necrosis factor level
|
J:173671
|
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw)
|
increased circulating aspartate transaminase level
|
J:294318
|
Mir184tm1Ics/Mir184tm1Ics
(Not Specified)
|
decreased fasting circulating glucose level
|
J:210552
|
increased circulating insulin level
|
J:210552
|
Mir200btm1.1Osb/Mir200btm1.1Osb Mir429m1Osb/Mir429m1Osb
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:199159
|
decreased circulating progesterone level
|
J:199159
|
Mir205tm1.1Mtm/Mir205tm1.1Mtm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating prolactin level
|
J:278363
|
Mir205hgtm1.1Oers/Mir205hgtm1.1Oers
(B6(Cg)-Mir205hgtm1.1Oers)
|
decreased circulating prolactin level
|
J:278363
|
Mir375tm1Stf/Mir375tm1Stf
(B6.129-Mir375tm1Stf)
|
hyperglycemia
|
J:147572
|
increased circulating glucagon level
|
J:147572
|
increased circulating glucose level
|
J:147572
|
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating glucose level
|
J:190154
|
increased circulating triglyceride level
|
J:190154
|
Mir505em1Xhj/Mir505em1Xhj
(C57BL/6J-Mir505em1Xhj)
|
increased circulating follicle stimulating hormone level
|
J:289998
|
increased circulating luteinizing hormone level
|
J:289998
|
Mir802em3Gpt/Mir802em3Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
abnormal circulating insulin level
|
J:287584
|
increased circulating insulin level
|
J:287584
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
decreased blood urea nitrogen level
|
J:244067
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd1tm1.1Pcha/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
decreased circulating creatinine level
|
J:244067
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased circulating creatinine level
|
J:244067
|
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj Pkd2tm3Som/Pkd2tm3Som Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating creatinine level
|
J:244067
|
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified)
|
decreased fasting circulating glucose level
|
J:256444
|
Mirc13tm1Biat/Mirc13+ Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal circulating glucose level
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat
(involves: C57BL/6J * C57BL/6N)
|
abnormal circulating glucose level
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal circulating glucose level
|
J:314874
|
Mirc29tm1.1Wtsi/Mirc29tm1.1Wtsi Mirc33tm1.1Wtsi/Mirc33tm1.1Wtsi
(C57BL/6N-Mirc29tm1.1Wtsi Mirc33tm1.1Wtsi)
|
decreased circulating glucose level
|
J:267719
|
decreased circulating insulin level
|
J:267719
|
increased fasting circulating glucose level
|
J:267719
|
Mirc33em1Smoc/Mirc33em1Smoc
(Not Specified)
|
decreased circulating luteinizing hormone level
|
J:324059
|
decreased circulating progesterone level
|
J:324059
|
Mirc33tm1.1Wtsi/Mirc33tm1.1Wtsi
(C57BL/6N-Mirc33tm1.1Wtsi)
|
decreased circulating creatinine level
|
J:267719
|
Mirc36tm1.1Jcav/Mirc36+
(B6.129-Mirc36tm1.1Jcav)
|
decreased circulating glucose level
|
J:216177
|
decreased circulating ketone body level
|
J:216177
|
hypoglycemia
|
J:216177
|
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified)
|
decreased circulating cholesterol level
|
J:310890
|
decreased circulating glucose level
|
J:310890
|
decreased circulating triglyceride level
|
J:310890
|
MitfMi-wh/MitfMi-wh
(B6.Cg-MitfMi-wh)
|
decreased bleeding time
|
J:7327
|
MitfTg(Tff3-Tmem207)2Tamo/MitfTg(Tff3-Tmem207)2Tamo
(involves: C57BL/6)
|
increased circulating creatinine level
|
J:244533
|
Mkkstm1Vcs/Mkkstm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
increased circulating leptin level
|
J:99276
|
Mkrn2tm1b(KOMP)Wtsi/Mkrn2tm1b(KOMP)Wtsi
(C57BL/6N-Mkrn2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
Mkrn3em1(IMPC)Tcp/Mkrn3em1(IMPC)Tcp
(C57BL/6NCrl-Mkrn3em1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Mkrn3em1Rhu/Mkrn3+
(involves: C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:305000
|
increased circulating luteinizing hormone level
|
J:305000
|
Mks1tm1a(EUCOMM)Wtsi/Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
cyanosis
|
J:196290
|
Mldhrem1Zhgn/Mldhrem1Zhgn
(involves: C57BL/6)
|
increased circulating lactate level
|
J:303725
|
Mlectm1a(EUCOMM)Wtsi/Mlectm1a(EUCOMM)Wtsi
(C57BL/6N-Mlectm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating thyroxine level
|
J:211773
|
Mlepq1M16/?
(involves: ICR * M16)
|
decreased circulating leptin level
|
J:101200
|
Mlepq2M16/?
(involves: ICR * M16)
|
increased circulating leptin level
|
J:101200
|
Mlh1tm1b(EUCOMM)Hmgu/Mlh1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mlh1tm1b(EUCOMM)Hmgu/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Mllt3tm1b(EUCOMM)Hmgu/Mllt3+
(C57BL/6N-Mllt3tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating amylase level
|
J:211773
|
Mlphln/Mlphln Sgk3fz/Sgk3fz
(C57BL/6J-Sgk3fz Mlphln)
|
decreased bleeding time
|
J:7327
|
Mlxtm1.1(KOMP)Vlcg/Mlxtm1.1(KOMP)Vlcg
(C57BL/6N-Mlxtm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Mlxiptm1.2Lchan/Mlxiptm1.2Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating alanine level
|
J:217834
|
increased circulating lactate level
|
J:217834
|
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:89865
|
decreased circulating free fatty acids level
|
J:89865
|
increased circulating glucose level
|
J:89865
|
increased circulating insulin level
|
J:89865
|
Mlxipltm1Kuy/Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J)
|
decreased circulating cholesterol level
|
J:273754
|
decreased circulating glucose level
|
J:273754
|
decreased circulating triglyceride level
|
J:273754
|
increased circulating glucose level
|
J:273754
|
Mmaaem1(IMPC)J/Mmaaem1(IMPC)J
(C57BL/6NJ-Mmaaem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
MmachcGt(AZ0348)Wtsi/Mmachc+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
increased circulating homocysteine level
|
J:212387
|
Mmachctm1.1(NCOM)Mfgc/Mmachctm1.1(NCOM)Mfgc Tg(CAG-Mmachc,-GFP)1Poche/0
(C57BL/6-Mmachctm1.1(NCOM)Mfgc Tg(CAG-Mmachc,-GFP)1Poche)
|
increased circulating homocysteine level
|
J:297666
|
Mmdem1(IMPC)Hmgu/Mmdem1(IMPC)Hmgu
(C57BL/6N-Mmdem1(IMPC)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Mmeem1(IMPC)Mbp/Mmeem1(IMPC)Mbp
(C57BL/6N-Mmeem1(IMPC)Mbp/MbpMmucd)
|
increased circulating phosphate level
|
J:211773
|
Mmetm1Cge/Mmetm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating protein level
|
J:104962
|
Mmp8tm1.1(KOMP)Vlcg/Mmp8tm1.1(KOMP)Vlcg
(C57BL/6N-Mmp8tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
increased circulating interferon-beta level
|
J:148442
|
increased circulating interferon-gamma level
|
J:148442
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129/Sv * 129S6/SvEvTac)
|
decreased circulating interleukin-10 level
|
J:55723
|
Mmp11tm1b(EUCOMM)Hmgu/Mmp11tm1b(EUCOMM)Hmgu
(C57BL/6N-Mmp11tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating serum albumin level
|
J:211773
|
Mmp13em1(IMPC)Ccpcz/Mmp13em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp13em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mmp14tm1Noda/Mmp14tm1Noda Mmp2tm1Ito/Mmp2tm1Ito
(Not Specified)
|
cyanosis
|
J:91198
|
Mmp15tm1b(KOMP)Wtsi/Mmp15tm1b(KOMP)Wtsi
(C57BL/6N-Mmp15tm1b(KOMP)Wtsi/Bay)
|
decreased circulating calcium level
|
J:211773
|
Mmp25Gt(IST14198E10)Tigm/Mmp25Gt(IST14198E10)Tigm
(involves: C57BL/6N)
|
abnormal circulating cytokine level
|
J:347009
|
decreased circulating interleukin-1 alpha level
|
J:347009
|
Mmrn1tm1d(EUCOMM)Hmgu/Mmrn1+
(B6(Cg)-Mmrn1tm1d(EUCOMM)Hmgu)
|
abnormal platelet physiology
|
J:307643
|
decreased susceptibility to induced thrombosis
|
J:307643
|
Mmrn1tm1d(EUCOMM)Hmgu/Mmrn1tm1d(EUCOMM)Hmgu
(B6(Cg)-Mmrn1tm1d(EUCOMM)Hmgu)
|
abnormal platelet activation
|
J:307643
|
abnormal platelet physiology
|
J:307643
|
decreased susceptibility to induced thrombosis
|
J:307643
|
Mmuttm1.1Mrb/Mmuttm1.1Mrb
(involves: C57BL/6)
|
increased circulating ammonia level
|
J:237040
|
increased circulating carnitine level
|
J:237040
|
increased circulating glycine level
|
J:237040
|
Mmuttm1Cpv/Mmuttm1Cpv
(Not Specified)
|
abnormal blood homeostasis
|
J:147338
|
acidemia
|
J:147338
|
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal blood homeostasis
|
J:147313
|
abnormal circulating amino acid level
|
J:147313
|
Mmuttm1Cpv/Mmuttm1Cpv Tg(Alb-Mut)#Cpv/0
(involves: C57BL/6)
|
decreased circulating bicarbonate level
|
J:200689
|
increased circulating creatinine level
|
J:200689
|
increased circulating lipocalin 2 level
|
J:200689
|
Mmuttm1Pai/Mmuttm1.1Mrb
(involves: 129S1/Sv * C57BL/6)
|
increased blood urea nitrogen level
|
J:237040
|
increased circulating ammonia level
|
J:237040
|
increased circulating carnitine level
|
J:237040
|
increased circulating glycine level
|
J:237040
|
Mmuttm1Pai/Mmuttm1Pai
(involves: 129S1/Sv * C57BL/6)
|
increased circulating carnitine level
|
J:87081
|
Mmuttm1Pai/Mmuttm1Pai Tg(MUT)AHlps/0 Tg(MUT*R403X)#Hlps/0
(involves: 129S1/Sv * C57BL/6)
|
increased circulating carnitine level
|
J:191879
|
Mmuttm1Pai/Mmuttm1Pai Tg(MUT*R403X)#Hlps/0
(involves: 129S1/Sv * C57BL/6)
|
increased circulating carnitine level
|
J:191879
|
Mn1tm1Ecz/Mn1tm1Ecz
(FVB.129-Mn1tm1Ecz)
|
cyanosis
|
J:98889
|
Mob1atm1.1Asuz/Mob1atm1.1Asuz Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating bilirubin level
|
J:228499
|
Mobq1129P3/J/Mobq1129P3/J
(involves: 129P3/J * C57BL/10SnJ)
|
decreased circulating cholesterol level
|
J:24238
|
Mobq1BALB/cJ/Mobq1BALB/cJ
(involves: BALB/cJ * C57BL/10SnJ)
|
decreased circulating cholesterol level
|
J:24238
|
Mobq1C57BL/6J/Mobq1SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei)
|
increased circulating cholesterol level
|
J:88297
|
Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ)
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating free fatty acids level
|
J:116503
|
decreased circulating glucose level
|
J:116503
|
decreased circulating triglyceride level
|
J:116503
|
Mocosem2(IMPC)Ics/Mocos+
(C57BL/6N-Mocosem2(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N)
|
decreased blood uric acid level
|
J:336718
|
decreased circulating alanine transaminase level
|
J:336718
|
increased blood urea nitrogen level
|
J:336718
|
increased circulating alkaline phosphatase level
|
J:336718
|
increased circulating creatinine level
|
J:336718
|
increased circulating hypoxanthine level
|
J:336718
|
increased circulating xanthine level
|
J:336718
|
Mocs2tm1(KOMP)Vlcg/Mocs2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal blood homeostasis
|
J:242197
|
decreased blood uric acid level
|
J:242197
|
increased circulating creatinine level
|
J:242197
|
Mocs2tm1b(EUCOMM)Wtsi/Mocs2+
(C57BL/6N-Mocs2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Mogat2tm1.1Ryyo/Mogat2tm1.1Ryyo
(B6.Cg-Mogat2tm1.1Ryyo)
|
decreased circulating triglyceride level
|
J:155626
|
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far)
|
decreased circulating cholesterol level
|
J:149373
|
decreased circulating insulin level
|
J:149373
|
decreased circulating LDL cholesterol level
|
J:149373
|
decreased circulating triglyceride level
|
J:149373
|
decreased circulating VLDL cholesterol level
|
J:149373
|
Mon1aem1(IMPC)J/Mon1aem1(IMPC)J
(C57BL/6NJ-Mon1aem1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Morc2aem1(IMPC)Wtsi/Morc2a+
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Morc3tm1b(EUCOMM)Hmgu/Morc3+
(C57BL/6N-Morc3tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Morc4em1(IMPC)Mbp/Morc4em1(IMPC)Mbp
(C57BL/6N-Morc4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating creatinine level
|
J:211773
|
Moxd1tm2b(KOMP)Wtsi/Moxd1tm2b(KOMP)Wtsi
(C57BL/6N-Moxd1tm2b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)
|
decreased circulating cholesterol level
|
J:236662
|
decreased circulating glucose level
|
J:236662
|
decreased circulating triglyceride level
|
J:236662
|
increased circulating ketone body level
|
J:236662
|
increased circulating lactate level
|
J:236662
|
Mpc2em2Finc/Mpc2em2Finc
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:211781
|
decreased circulating triglyceride level
|
J:211781
|
increased circulating glucose level
|
J:211781
|
increased circulating ketone body level
|
J:211781
|
increased circulating lactate level
|
J:211781
|
mpc96H/mpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:234901
|
decreased circulating LDL cholesterol level
|
J:234901
|
mpc107H/mpc107H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased blood urea nitrogen level
|
J:234901
|
increased circulating creatinine level
|
J:234901
|
mpc131H/mpc131H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating phosphate level
|
J:234901
|
decreased circulating serum albumin level
|
J:234901
|
increased circulating alanine transaminase level
|
J:234901
|
increased circulating alkaline phosphatase level
|
J:234901
|
increased circulating aspartate transaminase level
|
J:234901
|
mpc134H/mpc134H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased circulating aspartate transaminase level
|
J:234901
|
mpc231H/mpc231H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased fasting circulating glucose level
|
J:234901
|
mpc234H/mpc234H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased fasting circulating glucose level
|
J:234901
|
mpc256H/mpc256H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased blood urea nitrogen level
|
J:234901
|
increased circulating creatinine level
|
J:234901
|
Mpdzem1(IMPC)J/Mpdzem1(IMPC)J
(C57BL/6NJ-Mpdzem1(IMPC)J/J)
|
increased circulating potassium level
|
J:211773
|
Mpgtm1a(EUCOMM)Wtsi/Mpgtm1a(EUCOMM)Wtsi
(C57BL/6N-Mpgtm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:118148
|
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating glucose level
|
J:70603
|
Mphosph9tm1e.1(EUCOMM)Hmgu/Mphosph9tm1e.1(EUCOMM)Hmgu
(C57BL/6N-Mphosph9tm1e.1(EUCOMM)Hmgu/Ieg)
|
increased circulating amylase level
|
J:211773
|
Mpig6btm1.1(KOMP)Vlcg/Mpig6btm1.1(KOMP)Vlcg
(C57BL/6N-Mpig6btm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mpig6btm1.1Arte/Mpig6btm1.1Arte
(involves: C57BL/6NTac)
|
abnormal platelet physiology
|
J:201266
|
decreased platelet aggregation
|
J:201266
|
increased bleeding time
|
J:201266
|
Mplhlb219/Mplhlb219
(C57BL/6J-Mplhlb219/J)
|
abnormal circulating cytokine level
|
J:146577
|
increased bleeding time
|
J:146577
|
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv)
|
abnormal circulating chemokine level
|
J:162629
|
Mpndem1(IMPC)J/Mpndem1(IMPC)J
(C57BL/6NJ-Mpndem1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
Mpp3tm1b(EUCOMM)Wtsi/Mpp3tm1b(EUCOMM)Wtsi
(C57BL/6N-Mpp3tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased circulating glucose level
|
J:211773
|
Mpripem1(IMPC)J/Mprip+
(C57BL/6NJ-Mpripem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mpv17/Mpv17
(CFW-Mpv17/J)
|
abnormal blood homeostasis
|
J:10661
|
decreased circulating serum albumin level
|
J:62419,
J:10661
|
increased blood urea nitrogen level
|
J:10661
|
increased circulating alanine transaminase level
|
J:143355
|
increased circulating aspartate transaminase level
|
J:143355
|
increased circulating cholesterol level
|
J:10661
|
increased circulating creatine kinase level
|
J:143355
|
increased circulating creatinine level
|
J:10661
|
increased circulating lactate level
|
J:143355
|
Mpv17em1(IMPC)J/Mpv17em1(IMPC)J
(C57BL/6NJ-Mpv17em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Mpzem1(IMPC)Tcp/Mpzem1(IMPC)Tcp
(C57BL/6NCrl-Mpzem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J)
|
increased circulating calcium level
|
J:93038
|
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz)
|
decreased circulating cholesterol level
|
J:199257
|
decreased circulating corticosterone level
|
J:199257
|
decreased circulating free fatty acids level
|
J:199257
|
decreased circulating leptin level
|
J:199257
|
decreased circulating phospholipid level
|
J:199257
|
decreased circulating triglyceride level
|
J:199257
|
Mr1em1(IMPC)H/Mr1em1(IMPC)H
(C57BL/6NTac-Mr1em1(IMPC)H/H)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Mrap2tm1.1Maj/Mrap2tm1.1Maj
(either: B6.129-Mrap2tm1.1Maj or (involves: 129 * 129S6/SvEvTac))
|
increased circulating leptin level
|
J:199365
|
Mrap2tm1a(EUCOMM)Wtsi/Mrap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mrap2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6)
|
decreased circulating corticosterone level
|
J:278935
|
Mrasem1(IMPC)H/Mrasem1(IMPC)H
(C57BL/6NTac-Mrasem1(IMPC)H/H)
|
increased circulating creatinine level
|
J:211773
|
Mrc1tm1Jub/Mrc1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating estrogen level
|
J:74332
|
increased circulating luteinizing hormone level
|
J:74332
|
Mrm3tm1.1(KOMP)Vlcg/Mrm3+
(B6N(Cg)-Mrm3tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Mrpl3em1(IMPC)J/Mrpl3+
(C57BL/6NJ-Mrpl3em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Mrpl22tm1b(KOMP)Mbp/Mrpl22+
(C57BL/6N-Mrpl22tm1b(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Mrpl39em1(IMPC)J/Mrpl39+
(C57BL/6NJ-Mrpl39em1(IMPC)J/J)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Mrpl51tm1.1(KOMP)Vlcg/Mrpl51+
(B6N(Cg)-Mrpl51tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Mrps18ctm1.1(KOMP)Vlcg/Mrps18c+
(B6N(Cg)-Mrps18ctm1.1(KOMP)Vlcg/J)
|
decreased circulating creatinine level
|
J:211773
|
Mrps22tm1.1(KOMP)Vlcg/Mrps22+
(B6N(Cg)-Mrps22tm1.1(KOMP)Vlcg/J)
|
decreased circulating creatinine level
|
J:211773
|
Mrps25tm1.1(KOMP)Vlcg/Mrps25+
(C57BL/6N-Mrps25tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Mrps34m1Anu/Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu)
|
increased circulating alanine transaminase level
|
J:222643
|
Mrps35tm1a(EUCOMM)Wtsi/Mrps35+
(C57BL/6N-Mrps35tm1a(EUCOMM)Wtsi/Ics)
|
increased circulating creatinine level
|
J:165965
|
Mrs2em1Muma/Mrs2em1Muma
(B6.Cg-Mrs2em1Muma)
|
abnormal blood homeostasis
|
J:298361
|
Ms4a4dem1(IMPC)J/Ms4a4dem1(IMPC)J
(C57BL/6NJ-Ms4a4dem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ms4a7em1.1Jddl/Ms4a7em1.1Jddl
(B6.Cg-Ms4a7em1.1Jddl)
|
decreased circulating alanine transaminase level
|
J:347975
|
decreased circulating aspartate transaminase level
|
J:347975
|
decreased circulating tumor necrosis factor level
|
J:347975
|
Ms4a7em1Jddl/Ms4a7em1Jddl Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Lyz2tm1(cre)Ifo Ms4a7em1Jddl)
|
decreased circulating alanine transaminase level
|
J:347975
|
decreased circulating aspartate transaminase level
|
J:347975
|
decreased circulating tumor necrosis factor level
|
J:347975
|
Ms4a12em1(IMPC)Mbp/Ms4a12em1(IMPC)Mbp
(C57BL/6N-Ms4a12em1(IMPC)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Msh5tm1b(EUCOMM)Wtsi/Msh5tm1b(EUCOMM)Wtsi
(C57BL/6N-Msh5tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating unsaturated transferrin level
|
J:211773
|
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Mskt2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating alkaline phosphatase level
|
J:111262
|
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx)
|
decreased circulating alanine transaminase level
|
J:311042
|
decreased circulating interleukin-6 level
|
J:311042
|
decreased circulating tumor necrosis factor level
|
J:311042
|
Mss51tm1(KOMP)Vlcg/Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased circulating insulin level
|
J:280597
|
increased fasting circulating glucose level
|
J:280597
|
Mst1rtm2(Mst1r*)Sew/Mst1rtm2(Mst1r*)Sew
(FVB.129P2(Cg)-Mst1rtm2(Mst1r*)Sew)
|
increased circulating alanine transaminase level
|
J:215969
|
increased circulating interferon-gamma level
|
J:215969
|
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean)
|
abnormal circulating tumor necrosis factor level
|
J:146513
|
decreased circulating cholesterol level
|
J:146513
|
decreased circulating glucose level
|
J:146513
|
decreased circulating insulin level
|
J:146513
|
decreased circulating leptin level
|
J:146513
|
decreased circulating triglyceride level
|
J:146513
|
decreased circulating tumor necrosis factor level
|
J:146513
|
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating leptin level
|
J:75178
|
Msto1em1(IMPC)Tcp/Msto1+
(C57BL/6N-Msto1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Msx1tm1b(KOMP)Wtsi/Msx1+
(C57BL/6N-Msx1tm1b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
Msx1tm1b(KOMP)Wtsi/Msx1tm1b(KOMP)Wtsi
(C57BL/6N-Msx1tm1b(KOMP)Wtsi/J)
|
cyanosis
|
J:211773
|
Msx1tm1Bero/Msx1tm1Bero
(B6.129P2-Msx1tm1Bero)
|
cyanosis
|
J:42035
|
Msx1tm1Rilm/Msx1tm1Rilm
(either: (involves: 129S4/SvJae-Msx1tm1Rilm) or (involves: 129S4/SvJae * BALB/c) or (involves: 129X1/SvJae * C57BL/6J))
|
cyanosis
|
J:17489
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri)
|
abnormal circulating enzyme level
|
J:16487
|
increased circulating alkaline phosphatase level
|
J:16487
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
increased circulating alanine transaminase level
|
J:120459
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
increased blood urea nitrogen level
|
J:126620
|
Mt1tm1Rch/Mt1tm1Rch Mt2tm1Rch/Mt2tm1Rch
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:120459
|
mt-Co1m1Jiha
(B6.Cg-mt-Co1m1Jiha)
|
increased circulating lactate level
|
J:132960
|
mt-Nd6m2Jiha
(involves: C3H/An * C57BL/6 * C57BL/6J * CBA)
|
abnormal circulating protein level
|
J:164405
|
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased blood urea nitrogen level
|
J:344247
|
increased circulating alanine transaminase level
|
J:344247
|
increased circulating glucose level
|
J:344247
|
increased circulating insulin level
|
J:344247
|
increased circulating lactate level
|
J:344247
|
increased circulating triglyceride level
|
J:344247
|
Mta1tm1a(EUCOMM)Wtsi/Mta1+
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH)
|
increased circulating triglyceride level
|
J:175295
|
Mta1tm1a(EUCOMM)Wtsi/Mta1tm1a(EUCOMM)Wtsi
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased circulating alanine transaminase level
|
J:137101
|
increased circulating interferon-gamma level
|
J:137101
|
increased circulating interleukin-2 level
|
J:137101
|
increased circulating interleukin-4 level
|
J:137101
|
Mta3tm3a(KOMP)Wtsi/Mta3tm3a(KOMP)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
Mtarc1em1(IMPC)H/Mtarc1em1(IMPC)H
(C57BL/6NTac-Mtarc1em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Mtarc1tm1.1Vlcg/Mtarc1tm1.1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
decreased circulating alanine transaminase level
|
J:346201
|
Mtf1tm1b(KOMP)Wtsi/Mtf1+
(C57BL/6N-Mtf1tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb)
|
decreased circulating alanine transaminase level
|
J:334467
|
decreased circulating interleukin-1 beta level
|
J:334467
|
decreased circulating triglyceride level
|
J:334467
|
Mthfd1tm2b(KOMP)Wtsi/Mthfd1+
(C57BL/6N-Mthfd1tm2b(KOMP)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Mthfd2tm1b(EUCOMM)Wtsi/Mthfd2+
(C57BL/6N-Mthfd2tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
Mthfrtm1Rzn/Mthfr+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
increased circulating homocysteine level
|
J:67779
|
Mthfrtm1Rzn/Mthfr+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cAnNCrl)
|
increased circulating homocysteine level
|
J:150548
|
Mthfrtm1Rzn/Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
increased circulating homocysteine level
|
J:67779
|
Mthfrtm1Rzn/Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ * BALB/cAnNCrl)
|
increased circulating homocysteine level
|
J:150548
|
Mthfrtm1Rzn/Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood homeostasis
|
J:165612
|
increased circulating homocysteine level
|
J:165612
|
Mtif3tm1b(EUCOMM)Wtsi/Mtif3+
(C57BL/6N-Mtif3tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
Mtmr2em1(IMPC)Hmgu/Mtmr2em1(IMPC)Hmgu
(C57BL/6NCrl-Mtmr2em1(IMPC)Hmgu/Ieg)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Mtmr3Gt(OST416539)Lex/Mtmr3Gt(OST416539)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating alkaline phosphatase level
|
J:103485
|
Mtmr3tm1b(EUCOMM)Hmgu/Mtmr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Mtmr3tm1b(EUCOMM)Hmgu/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Mtnr1btm1.1(KOMP)Vlcg/Mtnr1btm1.1(KOMP)Vlcg
(C57BL/6N-Mtnr1btm1.1(KOMP)Vlcg/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Mtortm1.1Clyn/Mtor+
(involves: BALB/c * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:162945
|
Mtortm1.2Koz/Mtortm1.2Koz Tg(ACTA1-cre)79Jme/?
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:162918
|
Mtortm1a(EUCOMM)Wtsi/Mtor+
(C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Mtpaptm1.1(KOMP)Vlcg/Mtpap+
(C57BL/6N-Mtpaptm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased circulating creatinine level
|
J:211773
|
Mtrtm1Lcb/Mtr+
(129S/SvEv-Mtrtm1Lcb)
|
increased circulating homocysteine level
|
J:67384
|
increased circulating methionine level
|
J:67384
|
Mtrtm1Lcb/Mtr+
(involves: 129S/SvEv * Black Swiss)
|
increased circulating homocysteine level
|
J:67384
|
increased circulating methionine level
|
J:67384
|
MtrrGt(XG334)Byg/MtrrGt(XG334)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating methionine level
|
J:121477
|
increased circulating homocysteine level
|
J:121477
|
MtrrGt(XG334)Byg/MtrrGt(XG334)Byg
(B6.129P2-MtrrGt(XG334)Byg)
|
abnormal circulating homocysteine level
|
J:121477
|
Mtss1tm1Pla/Mtss1tm1Pla
(Not Specified)
|
increased circulating alkaline phosphatase level
|
J:182970
|
Mtss2tm1a(KOMP)Wtsi/Mtss2tm1a(KOMP)Wtsi
(C57BL/6N-tss2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Mttptm1Chan/Mttptm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:53390
|
decreased circulating HDL cholesterol level
|
J:53390
|
decreased circulating LDL cholesterol level
|
J:53390
|
decreased circulating VLDL cholesterol level
|
J:53390
|
decreased circulating VLDL triglyceride level
|
J:53390
|
Mttptm1Sgy/Mttp+
(involves: 129S4/SvJae)
|
abnormal circulating cholesterol level
|
J:48934
|
abnormal circulating lipid level
|
J:48934
|
decreased circulating cholesterol level
|
J:48934
|
decreased circulating LDL cholesterol level
|
J:48934
|
decreased circulating VLDL cholesterol level
|
J:48934
|
Mttptm2Sgy/Mttptm2Sgy Tg(Mx1-cre)1Cgn/Tg(Mx1-cre)1Cgn
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal circulating protein level
|
J:83459
|
decreased circulating cholesterol level
|
J:83459
|
decreased circulating HDL cholesterol level
|
J:83459
|
decreased circulating LDL cholesterol level
|
J:83459
|
decreased circulating triglyceride level
|
J:83459
|
decreased circulating VLDL cholesterol level
|
J:83459
|
Mtx2em1(IMPC)J/Mtx2+
(C57BL/6NJ-Mtx2em1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
increased circulating triglyceride level
|
J:194148
|
Muc5actm1.1Evns/Muc5actm1.1Evns
(B6.129S1-Muc5actm1.1Evns)
|
increased circulating interferon-gamma level
|
J:177306
|
Muc5btm1.2Evns/Muc5btm1.2Evns
(B6.129S1-Muc5btm1.2Evns)
|
hypoxemia
|
J:207159
|
Mug1tm1Vln/Mug1tm1Vln
(B.129P2-Mug1tm1Vln)
|
increased circulating amylase level
|
J:57485
|
increased circulating lipase level
|
J:57485
|
Mug1tm2Vln/Mug1tm2Vln Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln)
|
increased circulating amylase level
|
J:57485
|
increased circulating lipase level
|
J:57485
|
Musktm1Gdy/Musktm1Gdy
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:33132
|
Mvwf2CASA/RkJ/Mvwf2CASA/RkJ
(involves: A/J * CASA/RkJ)
|
increased circulating von Willebrand factor level
|
J:135941
|
Mvwf2CASA/RkJ/Mvwf2CASA/RkJ Mvwf3CASA/RkJ/Mvwf3CASA/RkJ
(involves: A/J * CASA/RkJ)
|
increased circulating von Willebrand factor level
|
J:135941
|
Mvwf2CASA/RkJ/Mvwf2CASA/RkJ Mvwf4CASA/RkJ/Mvwf4CASA/RkJ
(involves: A/J * CASA/RkJ)
|
increased circulating von Willebrand factor level
|
J:135941
|
MvwfCASA/Rk/MvwfRIIIS/J
(involves: CASA/Rk * RIIIS/J)
|
decreased circulating von Willebrand factor level
|
J:37436
|
MvwfRIIIS/J/MvwfRIIIS/J
(involves: CASA/Rk * RIIIS/J)
|
decreased circulating von Willebrand factor level
|
J:37436
|
Mx2em1(IMPC)Ics/Mx2em1(IMPC)Ics
(C57BL/6N-Mx2em1(IMPC)Ics/Ics)
|
increased circulating bilirubin level
|
J:211773
|
Mxd4em1(IMPC)J/Mxd4em1(IMPC)J
(C57BL/6NJ-Mxd4em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Mxra7tm1b(EUCOMM)Wtsi/Mxra7tm1b(EUCOMM)Wtsi
(C57BL/6N-Mxra7tm1b(EUCOMM)Wtsi/H)
|
increased circulating creatine kinase level
|
J:211773
|
Mybbp1atm1b(EUCOMM)Hmgu/Mybbp1a+
(C57BL/6N-Mybbp1atm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Mybpc3tm1a(EUCOMM)Hmgu/Mybpc3tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased circulating amylase level
|
J:165965
|
Myctm1.1(Nmyc1)Fwa/Myctm1.1(Nmyc1)Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:62573
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
decreased circulating tumor necrosis factor level
|
J:139030
|
hyperglycemia
|
J:148283
|
Myd88tm1Aki/Myd88tm1Aki Traddtm1.1Mpa/Traddtm1.1Mpa
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:139030
|
Myd88tm1Defr/Myd88tm1Defr Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
decreased circulating interleukin-6 level
|
J:139001
|
decreased circulating interleukin-12b level
|
J:139001
|
Myd88tm1Hlz/Myd88tm1Hlz
(B6.129P2-Myd88tm1Hlz)
|
decreased circulating alanine transaminase level
|
J:188968
|
decreased circulating aspartate transaminase level
|
J:188968
|
decreased circulating interleukin-6 level
|
J:188968
|
decreased circulating interleukin-10 level
|
J:188968
|
decreased circulating interleukin-12b level
|
J:188968
|
Myd88tm1Hlz/Myd88tm1Hlz Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Myd88tm1Hlz Lyz2tm1(cre)Ifo)
|
abnormal circulating chemokine level
|
J:188968
|
increased circulating alanine transaminase level
|
J:188968
|
increased circulating aspartate transaminase level
|
J:188968
|
increased circulating tumor necrosis factor level
|
J:188968
|
Myd88tm1Jcbr/Myd88tm1Jcbr Tg(Nes-cre)1Kln/0
(B6.Cg-Myd88tm1Jcbr Tg(Nes-cre)1Kln)
|
decreased circulating insulin level
|
J:153664
|
Myf5tm3(cre)Sor/Myf5+ Sik1tm1.1Berd/Sik1tm1.1Berd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased circulating insulin level
|
J:236223
|
Myf5tm3(cre)Sor/Myf5+ Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:119237
|
Myf5tm3(cre)Sor/Myf5+ Stat5btm1Mam/Stat5btm1Mam
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
decreased circulating insulin-like growth factor I level
|
J:119237
|
increased circulating triglyceride level
|
J:119237
|
Myf5tm3(cre)Sor/Myf5+ Stat5btm1Mam/Stat5btm1Mam Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:119237
|
Myh6tm1Jse/Myh6+ Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal atrial thrombosis
|
J:153302
|
Myh6tm1Jse/Myh6tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
abnormal atrial thrombosis
|
J:51939
|
Myh7btm1a(KOMP)Wtsi/Myh7btm1a(KOMP)Wtsi
(C57BL/6N-Myh7btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Myh9tm1.1Gac/Myh9+ Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet physiology
|
J:148233
|
Myh9tm1.1Gac/Myh9tm1.1Gac Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal blood coagulation
|
J:148233
|
abnormal platelet physiology
|
J:148233
|
increased bleeding time
|
J:148233
|
Myh9tm1.1Mjk/Myh9+
(B6.129-Myh9tm1.1Mjk)
|
increased bleeding time
|
J:175367
|
Myh9tm1.1Mjk/Myh9tm1.1Mjk
(B6.129-Myh9tm1.1Mjk)
|
increased bleeding time
|
J:175367
|
Myh9tm6.1(EGFP/MYH9*)Rsad/Myh9+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
abnormal blood coagulation
|
J:175367
|
increased bleeding time
|
J:175367
|
Myh9tm7.1Rsad/Myh9+
(involves: BALB/cJ)
|
increased bleeding time
|
J:175367
|
Myh9tm7.1Rsad/Myh9tm7.1Rsad
(involves: BALB/cJ)
|
increased bleeding time
|
J:175367
|
Myh10em1(IMPC)J/Myh10+
(C57BL/6NJ-Myh10em1(IMPC)J/J)
|
increased fasting circulating glucose level
|
J:211773
|
Myh10tm7Rsad/Myh10tm7Rsad Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal atrial thrombosis
|
J:170148
|
Myh11tm1Bdr/Myh11tm1Bdr
(Not Specified)
|
increased circulating renin level
|
J:82859
|
Myl1tm1(cre)Sjb/0 Ndufab1tm1Xiwa/Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:293657
|
hypoglycemia
|
J:293657
|
Myl1tm1(cre)Sjb/Myl1+ Smarcd3tm1Jddl/Smarcd3tm1Jddl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating glucose level
|
J:256788
|
Myl2tm1(cre)Krc/Myl2+ Pip5k1ctm2Csab/Pip5k1ctm2Csab
(Not Specified)
|
abnormal platelet aggregation
|
J:196476
|
abnormal platelet physiology
|
J:196476
|
Myl2tm1(cre)Krc/Myl2+ Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae)
|
abnormal atrial thrombosis
|
J:96138
|
Myl2tm1b(EUCOMM)Hmgu/Myl2+
(C57BL/6N-Myl2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Myl4tm1a(EUCOMM)Wtsi/Myl4tm1a(EUCOMM)Wtsi
(C57BL/6N-Myl4tm1a(EUCOMM)Wtsi/Ieg)
|
increased circulating iron level
|
J:165965
|
Myl12btm1a(EUCOMM)Wtsi/Myl12btm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Myl12btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
increased blood urea nitrogen level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Myliptm1.1(KOMP)Vlcg/Myliptm1.1(KOMP)Vlcg
(C57BL/6N-Myliptm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Mymxem1Shcs/Mymxem1Shcs
(involves: C57BL/6J)
|
cyanosis
|
J:241564
|
Mynnem1(IMPC)J/Mynnem1(IMPC)J
(C57BL/6NJ-Mynnem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Myo1eGt(ROSA)74Sor/Myo1eGt(ROSA)74Sor Pdgfrbtm1Sor/Pdgfrb+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
increased blood urea nitrogen level
|
J:117491
|
Myo1etm1.1Flv/Myo1etm1.1Flv
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:159163
|
Myo1gem1(IMPC)Ccpcz/Myo1gem1(IMPC)Ccpcz
(C57BL/6NCrl-Myo1gem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating bilirubin level
|
J:211773
|
Myo5btm1a(KOMP)Wtsi/Myo5btm1a(KOMP)Wtsi
(C57BL/6N-Myo5btm1a(KOMP)Wtsi)
|
hypoglycemia
|
J:229427
|
Myo6em1(IMPC)Tcp/Myo6em1(IMPC)Tcp
(C57BL/6N-Myo6em1(IMPC)Tcp/Tcp)
|
decreased circulating potassium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Myo7atm1a(EUCOMM)Wtsi/Myo7atm1a(EUCOMM)Wtsi
(C57BL/6N-Myo7atm1a(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Myo7btm1b(EUCOMM)Hmgu/Myo7btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo7btm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Myo10tm2(KOMP)Wtsi/Myo10tm2(KOMP)Wtsi
(C57BL/6N-Myo10tm2(KOMP)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:211773
|
Myo18bem2(IMPC)Ics/Myo18b+
(C57BL/6N-Myo18bem2(IMPC)Ics/Ics)
|
increased circulating triglyceride level
|
J:211773
|
Myocdtm1Msp/Myocdtm1Msp H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129/Sv * C57BL/6 * CBA)
|
cyanosis
|
J:131288
|
Myocdtm1Msp/Myocdtm1Msp Tg(Myh6-cre)2182Mds/0
(involves: 129/Sv * FVB/N)
|
abnormal atrial thrombosis
|
J:154666
|
abnormal cardiac thrombosis
|
J:154666
|
Myoftm1b(EUCOMM)Hmgu/Myoftm1b(EUCOMM)Hmgu
(C57BL/6N-Myoftm1b(EUCOMM)Hmgu/BayMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
cyanosis
|
J:14208
|
Myogtm1Whk/Myogtm1Whk
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:110733
|
Myorgtm1b(KOMP)Wtsi/Myorgtm1b(KOMP)Wtsi
(B6N(Cg)-Myorgtm1b(KOMP)Wtsi/2J)
|
decreased circulating glucose level
|
J:211773
|
Myoz1tm1b(EUCOMM)Hmgu/Myoz1tm1b(EUCOMM)Hmgu
(C57BL/6N-Myoz1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Mysm1tm1a(KOMP)Wtsi/Mysm1+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating phosphate level
|
J:165965
|
Myt1ltm1a(EUCOMM)Wtsi/Myt1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Myt1ltm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating fructosamine level
|
J:211773
|
Myzapem1(IMPC)J/Myzapem1(IMPC)J
(C57BL/6NJ-Myzapem1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Mzb1em1(IMPC)Ccpcz/Mzb1em1(IMPC)Ccpcz
(C57BL/6N-Mzb1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating iron level
|
J:211773
|
decreased circulating sodium level
|
J:211773
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
increased circulating interleukin-6 level
|
J:297419
|
increased circulating tumor necrosis factor level
|
J:297419
|
Naa10em1(IMPC)Mbp/Naa10em1(IMPC)Mbp
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Naa11em1(IMPC)Kmpc/Naa11em1(IMPC)Kmpc
(C57BL/6NTac-Naa11em1(IMPC)Kmpc/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Naa35em1(IMPC)J/Naa35+
(C57BL/6NJ-Naa35em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Naa40tm1Qwzh/Naa40tm1Qwzh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh)
|
decreased circulating LDL cholesterol level
|
J:183119
|
decreased circulating VLDL triglyceride level
|
J:183119
|
increased circulating glucose level
|
J:183119
|
Naaatm1a(KOMP)Wtsi/Naaatm1a(KOMP)Wtsi
(C57BL/6N-Naaatm1a(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Naalad2em1(IMPC)J/Naalad2em1(IMPC)J
(C57BL/6NJ-Naalad2em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
Nab1em1(IMPC)H/Nab1em1(IMPC)H
(C57BL/6NTac-Nab1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu
(C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nacadtm1(KOMP)Wtsi/Nacadtm1(KOMP)Wtsi
(C57BL/6N-Nacadtm1(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Nacc2tm2b(EUCOMM)Wtsi/Nacc2tm2b(EUCOMM)Wtsi
(C57BL/6N-Nacc2tm2b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nadk2em1(IMPC)J/Nadk2+
(C57BL/6NJ-Nadk2em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Nadk2tm1a(EUCOMM)Wtsi/Nadk2tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
increased circulating carnitine level
|
J:255700
|
increased circulating free fatty acids level
|
J:255700
|
increased circulating lysine level
|
J:255700
|
increased circulating triglyceride level
|
J:255700
|
Nae1tm1b(EUCOMM)Wtsi/Nae1+
(C57BL/6N-Nae1tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating phosphate level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Nae1tm1c(EUCOMM)Wtsi/Nae1tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
cyanosis
|
J:261328
|
Nagatm1a(EUCOMM)Wtsi/Nagatm1a(EUCOMM)Wtsi
(C57BL/6N-Nagatm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nagktm1b(EUCOMM)Hmgu/Nagktm1b(EUCOMM)Hmgu
(C57BL/6N-Nagktm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Nagstm1(KOMP)Vlcg/Nagstm1(KOMP)Vlcg
(involves: C57BL/6N * Swiss Webster)
|
abnormal circulating amino acid level
|
J:184448
|
decreased circulating citrulline level
|
J:184448
|
increased circulating ammonia level
|
J:184448
|
NamptGt(RRT307)Byg/Nampt+
(B6.129P2-NamptGt(RRT307)Byg)
|
decreased circulating glucose level
|
J:130534
|
Nanos2em1(IMPC)Bay/Nanos2em1(IMPC)Bay
(C57BL/6N-Nanos2em1(IMPC)Bay/BayMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Nat8f2tm1.1(KOMP)Vlcg/Nat8f2tm1.1(KOMP)Vlcg
(C57BL/6N-Nat8f2tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Nav2em1(IMPC)Tcp/Nav2em1(IMPC)Tcp
(C57BL/6NCrl-Nav2em1(IMPC)Tcp/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
Naxetm1.1Lfan/Naxetm1.1Lfan Tg(APOA1)1Rub/0
(involves: C57BL/6 * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:261549
|
NbeaGt(RRK418)Byg/NbeaGt(RRK418)Byg
(involves: 129P2/OlaHsd * C57BL/6N)
|
cyanosis
|
J:159572
|
NbeaTg(GH1)240BNec/NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL)
|
cyanosis
|
J:128767
|
Nbeal2tm1Lex/Nbeal2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal platelet activation
|
J:201413
|
decreased platelet aggregation
|
J:201413
|
decreased susceptibility to induced thrombosis
|
J:201413
|
increased bleeding time
|
J:201413
|
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ncam2tm1b(EUCOMM)Hmgu/Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ncapd3em1(IMPC)J/Ncapd3+
(C57BL/6NJ-Ncapd3em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ncaph2tm1a(EUCOMM)Wtsi/Ncaph2+
(B6JTyr;B6N-Ncaph2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:175295
|
Ncf1em1(IMPC)Mbp/Ncf1em1(IMPC)Mbp
(C57BL/6N-Ncf1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
increased circulating renin level
|
J:111142
|
Ncf2tm1a(EUCOMM)Wtsi/Ncf2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ncf2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating thyroxine level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Ncf4tm1b(KOMP)Wtsi/Ncf4tm1b(KOMP)Wtsi
(C57BL/6N-Ncf4tm1b(KOMP)Wtsi/H)
|
increased circulating amylase level
|
J:211773
|
Nck1tm1b(EUCOMM)Wtsi/Nck1tm1b(EUCOMM)Wtsi
(C57BL/6N-Nck1tm1b(EUCOMM)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
increased circulating interleukin-6 level
|
J:141377
|
increased circulating interleukin-17 level
|
J:141377
|
Ncoa1tm1.1(KOMP)Vlcg/Ncoa1tm1.1(KOMP)Vlcg
(C57BL/6N-Ncoa1tm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ncoa1tm1.1Hkaw/Ncoa1tm1.1Hkaw
(B6.Cg-Ncoa1tm1.1Hkaw)
|
decreased circulating testosterone level
|
J:111490
|
increased circulating alkaline phosphatase level
|
J:111490
|
increased circulating estradiol level
|
J:111490
|
increased circulating leptin level
|
J:111490
|
Ncoa1tm1Bwo/Ncoa1tm1Bwo
(involves: 129/Sv * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:54182,
J:126521
|
increased circulating thyroxine level
|
J:126521
|
increased circulating triiodothyronine level
|
J:126521
|
Ncoa1tm1Bwo/Ncoa1tm1Bwo Thratm2Jas/Thratm2Jas
(B6.129-Thratm2Jas Ncoa1tm1Bwo)
|
decreased circulating thyroid-stimulating hormone level
|
J:126521
|
increased circulating thyroid-stimulating hormone level
|
J:126521
|
increased circulating thyroxine level
|
J:126521
|
increased circulating triiodothyronine level
|
J:126521
|
Ncoa1tm1Bwo/Ncoa1tm1Bwo Thrbtm1Olc/Thrbtm1Olc
(B6.129-Ncoa1tm1Bwo Thrbtm1Olc)
|
increased circulating thyroid-stimulating hormone level
|
J:126521
|
increased circulating thyroxine level
|
J:126521
|
increased circulating triiodothyronine level
|
J:126521
|
Ncoa2em1(IMPC)Mbp/Ncoa2+
(C57BL/6N-Ncoa2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating insulin level
|
J:211773
|
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating glucagon level
|
J:161276
|
hyperglycemia
|
J:161276
|
increased circulating insulin-like growth factor I level
|
J:161276
|
increased circulating leptin level
|
J:161276
|
Ncoa3tm1b(EUCOMM)Wtsi/Ncoa3+
(C57BL/6N-Ncoa3tm1b(EUCOMM)Wtsi/H)
|
increased circulating bilirubin level
|
J:211773
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac)
|
decreased circulating estradiol level
|
J:62724
|
decreased circulating insulin-like growth factor I level
|
J:62724
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:144060
|
decreased circulating free fatty acids level
|
J:144060
|
decreased circulating glucose level
|
J:144060
|
decreased circulating HDL cholesterol level
|
J:144060
|
decreased circulating insulin level
|
J:144060
|
decreased circulating triglyceride level
|
J:144060
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating glucose level
|
J:120086
|
increased circulating interleukin-1 beta level
|
J:120086
|
increased circulating interleukin-6 level
|
J:120086
|
increased circulating tumor necrosis factor level
|
J:120086
|
Ncoa3tm1Rsd/Ncoa3tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:66454
|
Ncoa3tm2.2Jxu/Ncoa3tm2.2Jxu
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:161101
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
abnormal circulating protein level
|
J:207622
|
increased circulating alanine transaminase level
|
J:207622
|
increased fasting circulating glucose level
|
J:207622
|
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia)
|
increased fasting circulating glucose level
|
J:207622
|
Ncoa6tm1Jkr/Ncoa6tm1Jkr Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal atrial thrombosis
|
J:269856
|
Ncoa6tm2Jxu/Ncoa6tm2Jxu
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal circulating triglyceride level
|
J:129067
|
increased circulating cholesterol level
|
J:129067
|
Ncor1tm1.1Anh/Ncor1tm1.1Anh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating thyroxine level
|
J:213990
|
decreased circulating triiodothyronine level
|
J:213990
|
Ncor1tm1.1Ics/Ncor1tm1.1Ics Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:178827
|
decreased circulating HDL cholesterol level
|
J:178827
|
decreased circulating LDL cholesterol level
|
J:178827
|
Ncor1tm1Anh/Ncor1tm1Anh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating LDL cholesterol level
|
J:142045
|
decreased circulating thyroxine level
|
J:142045
|
Ncor1tm1Laz/Ncor1tm1Laz
(C57BL/6-Ncor1tm1Laz)
|
increased circulating free fatty acids level
|
J:142342
|
increased circulating ketone body level
|
J:142342
|
Ncor2Gt(RRM275)Byg/Ncor2+
(B6.129P2-Ncor2Gt(RRM275)Byg)
|
decreased circulating insulin level
|
J:164558
|
decreased circulating leptin level
|
J:164558
|
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6)
|
abnormal circulating enzyme level
|
J:202976
|
abnormal circulating hormone level
|
J:202976
|
increased circulating glucose level
|
J:142665
|
Ncs1tm1b(EUCOMM)Hmgu/Ncs1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncs1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating phosphate level
|
J:211773
|
Ndfip2tm1a(EUCOMM)Hmgu/Ndfip2tm1a(EUCOMM)Hmgu
(C57BL/6N-Ndfip2tm1a(EUCOMM)Hmgu)
|
abnormal circulating iron level
|
J:235779
|
abnormal circulating unsaturated transferrin level
|
J:235779
|
Ndfip2tm1b(EUCOMM)Hmgu/Ndfip2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ndfip2tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ndntm1.1Mus/Ndntm1.1Mus
(involves: 129S2/SvPas * C57BL/6J)
|
cyanosis
|
J:66557
|
Ndntm1Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
cyanosis
|
J:57890
|
Ndntm2Stw/Ndn+
(involves: 129S1/Sv * C57BL/6J)
|
cyanosis
|
J:82266
|
Ndntm2Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
cyanosis
|
J:57890
|
Ndrg1tm2b(KOMP)Wtsi/Ndrg1tm2b(KOMP)Wtsi
(C57BL/6N-Ndrg1tm2b(KOMP)Wtsi/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ndrg3em1(IMPC)Mbp/Ndrg3+
(C57BL/6NCrl-Ndrg3em1(IMPC)Mbp/Mmucd)
|
decreased circulating calcium level
|
J:211773
|
Ndrg4tm1b(KOMP)Wtsi/Ndrg4tm1b(KOMP)Wtsi
(C57BL/6N-Ndrg4tm1b(KOMP)Wtsi/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Ndst1tm1Ekf/Ndst1tm1Ekf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:63996
|
Ndst1tm1Hgx/Ndst1tm1Hgx
(involves: 129S4/SvJae * C57BL/6)
|
cyanosis
|
J:60280
|
Ndst3tm1.1Grob/Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:138557
|
decreased circulating HDL cholesterol level
|
J:138557
|
Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac)
|
abnormal circulating amino acid level
|
J:257477
|
decreased circulating bilirubin level
|
J:257477
|
decreased circulating corticosterone level
|
J:257477
|
decreased circulating iron level
|
J:257477
|
Ndufa8tm1a(EUCOMM)Hmgu/Ndufa8+
(C57BL/6N-Ndufa8tm1a(EUCOMM)Hmgu/Ieg)
|
decreased circulating sodium level
|
J:165965
|
Ndufa13em1Nju/Ndufa13+
(C57BL/6-Ndufa13em1Nju)
|
decreased circulating testosterone level
|
J:326065
|
Ndufb9tm1b(EUCOMM)Hmgu/Ndufb9+
(C57BL/6N-Ndufb9tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Ndufs1tm1b(EUCOMM)Hmgu/Ndufs1+
(C57BL/6N-Ndufs1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Ndufs4fky/Ndufs4fky
(C57BL/6-Ndufs4fky)
|
increased circulating carnitine level
|
J:186512
|
increased circulating glycine level
|
J:186512
|
increased circulating homocitrulline level
|
J:186512
|
increased circulating phenylalanine level
|
J:186512
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
abnormal blood homeostasis
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
abnormal blood homeostasis
|
J:190475
|
Necap2em1(IMPC)J/Necap2em1(IMPC)J
(C57BL/6NJ-Necap2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Nedd1em1(IMPC)H/Nedd1+
(C57BL/6NTac-Nedd1em1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Nedd4tm2b(EUCOMM)Hmgu/Nedd4+
(C57BL/6N-Nedd4tm2b(EUCOMM)Hmgu/H)
|
decreased circulating creatinine level
|
J:211773
|
Nedd4ltm1.2Blyg/Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating aldosterone level
|
J:148641
|
increased circulating potassium level
|
J:148641
|
increased circulating sodium level
|
J:148641
|
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: C57BL/6 * C57BL/6J)
|
cyanosis
|
J:205657
|
Nefhtm1.1(KOMP)Vlcg/Nefhtm1.1(KOMP)Vlcg
(C57BL/6N-Nefhtm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6)
|
increased circulating insulin level
|
J:106077
|
increased circulating leptin level
|
J:106077
|
increased circulating triglyceride level
|
J:106077
|
Neil2em1(IMPC)J/Neil2em1(IMPC)J
(C57BL/6NJ-Neil2em1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
Nek1kat-2J/Nek1kat-2J
(C57BL/6J-Nek1kat-2J/J)
|
increased blood urea nitrogen level
|
J:59839
|
Nek2tm1b(KOMP)Wtsi/Nek2tm1b(KOMP)Wtsi
(C57BL/6N-Nek2tm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Nek8jck/Nek8jck
(involves: C57BL/6J)
|
increased circulating creatinine level
|
J:11885
|
Nek9tm1a(EUCOMM)Wtsi/Nek9+
(C57BL/6N-Nek9tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Nek11tm1b(KOMP)Wtsi/Nek11tm1b(KOMP)Wtsi
(C57BL/6N-Nek11tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Nelfcdem1(IMPC)J/Nelfcd+
(C57BL/6NJ-Nelfcdem1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Nemftm1b(EUCOMM)Hmgu/Nemf+
(B6N(Cg)-Nemftm1b(EUCOMM)Hmgu/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Nepntm1b(KOMP)Wtsi/Nepntm1b(KOMP)Wtsi
(C57BL/6N-Nepntm1b(KOMP)Wtsi/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Nestm1b(KOMP)Wtsi/Nestm1b(KOMP)Wtsi
(C57BL/6N-Nestm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
Neto2em1(IMPC)Hmgu/Neto2em1(IMPC)Hmgu
(C57BL/6N-Neto2em1(IMPC)Hmgu/Ieg)
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
decreased circulating total protein level
|
J:76937
|
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp)
|
increased blood urea nitrogen level
|
J:321653
|
increased circulating cholesterol level
|
J:321653
|
increased circulating free fatty acids level
|
J:321653
|
increased circulating triglyceride level
|
J:321653
|
Neurl2tm1.1(KOMP)Vlcg/Neurl2tm1.1(KOMP)Vlcg
(C57BL/6N-Neurl2tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Neurod1tm1Jle/Neurod1tm1Jle
(involves: 129S4/SvJaeSor * C57BL/6)
|
hyperglycemia
|
J:74715
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * C57BL/6)
|
hyperglycemia
|
J:43010
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
hyperglycemia
|
J:59932
|
Neurod2em1(IMPC)Hmgu/Neurod2em1(IMPC)Hmgu
(C57BL/6N-Neurod2em1(IMPC)Hmgu/Ieg)
|
decreased circulating calcium level
|
J:211773
|
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1(Neurog3,cre/ERT)Ggu Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating glucose level
|
J:150074
|
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1.1(cre/ERT)Ggu Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating glucose level
|
J:150074
|
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1.1(cre/ERT)Ggu Tg(Pdx1-cre/Esr1*)1Mga/0
(involves: 129S6/SvEvTac)
|
abnormal circulating insulin level
|
J:150074
|
hyperglycemia
|
J:150074
|
increased circulating glucose level
|
J:150074
|
Neurog3tm1Fgu/Neurog3tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased circulating glucose level
|
J:60642
|
Neurog3tm1Fgu/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
decreased circulating cholesterol level
|
J:161480
|
decreased circulating glucose level
|
J:161480
|
decreased circulating HDL cholesterol level
|
J:161480
|
decreased circulating serum albumin level
|
J:161480
|
decreased circulating triglyceride level
|
J:161480
|
increased blood urea nitrogen level
|
J:161480
|
increased circulating bicarbonate level
|
J:161480
|
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
decreased circulating cholesterol level
|
J:161480
|
decreased circulating glucose level
|
J:161480
|
decreased circulating HDL cholesterol level
|
J:161480
|
decreased circulating serum albumin level
|
J:161480
|
decreased circulating triglyceride level
|
J:161480
|
increased blood urea nitrogen level
|
J:161480
|
increased circulating bicarbonate level
|
J:161480
|
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nexntm1.1Chen/Nexntm1.1Chen
(Not Specified)
|
abnormal ventricular thrombosis
|
J:290931
|
Nexntm1Chen/Nexntm1Chen Tg(myl7.L-cre)1118Tmhn/0
(involves: MF1)
|
abnormal ventricular thrombosis
|
J:290931
|
Nf1tm1a(KOMP)Wtsi/Nf1+
(B6JTyr;B6N-Nf1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased circulating growth hormone level
|
J:138868
|
Nfasctm1a(EUCOMM)Hmgu/Nfasc+
(C57BL/6N-Nfasctm1a(EUCOMM)Hmgu/Ics)
|
increased circulating triglyceride level
|
J:165965
|
Nfat5tm1b(KOMP)Wtsi/Nfat5+
(C57BL/6N-Nfat5tm1b(KOMP)Wtsi/J)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Nfatc2ipem1(IMPC)Ics/Nfatc2ipem1(IMPC)Ics
(C57BL/6N-Nfatc2ipem1(IMPC)Ics/Ics)
|
increased circulating calcium level
|
J:211773
|
Nfatc2iptm1.1Glm/Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
decreased circulating interleukin-4 level
|
J:157559
|
Nfatc4tm1.1(KOMP)Vlcg/Nfatc4tm1.1(KOMP)Vlcg
(C57BL/6N-Nfatc4tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Nfe2l1tm1.1Mym/Nfe2l1+
(B6J.Cg-Nfe2l1tm1.1Mym)
|
decreased circulating glucose level
|
J:230118
|
decreased circulating insulin level
|
J:230118
|
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:97188
|
Nfe2l1tm1Mym/Nfe2l1tm1Mym Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:143468
|
increased circulating aspartate transaminase level
|
J:143468
|
Nfe2l2em1(IMPC)Ccpcz/Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
hypoglycemia
|
J:136120
|
increased circulating alanine transaminase level
|
J:136120
|
increased circulating interleukin-6 level
|
J:136120
|
increased circulating tumor necrosis factor level
|
J:136120
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym Tg(Alb1-cre)1Dlr/0 n-TUtca2tm2Mym/n-TUtca2tm2.1Mym
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
increased circulating alanine transaminase level
|
J:130723
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ)
|
decreased circulating interleukin-1 beta level
|
J:100106
|
increased circulating bilirubin level
|
J:130473
|
increased circulating interleukin-1 beta level
|
J:100106
|
Nfibtm1Hsch/Nfibtm1Hsch
(involves: 129S1/Sv * C57BL/6)
|
cyanosis
|
J:75698
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro)
|
abnormal circulating cytokine level
|
J:209365
|
increased circulating interferon-gamma level
|
J:209365
|
increased circulating interleukin-10 level
|
J:209365
|
increased circulating interleukin-12b level
|
J:209365
|
increased circulating interleukin-17 level
|
J:209365
|
increased circulating tumor necrosis factor level
|
J:209365
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nfkb1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:175295
|
decreased circulating sodium level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating free fatty acids level
|
J:175295
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased circulating alkaline phosphatase level
|
J:213427
|
Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased circulating interleukin-2 level
|
J:142340
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:163686
|
increased circulating interleukin-1 alpha level
|
J:163686
|
increased circulating interleukin-17 level
|
J:163686
|
increased circulating tumor necrosis factor level
|
J:163686
|
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal)
|
decreased circulating interleukin-1 beta level
|
J:163302
|
decreased circulating interleukin-6 level
|
J:163302
|
decreased circulating tumor necrosis factor level
|
J:163302
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbid+
(C57BL/6N-Nfkbidtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Nfkbil1tm1a(KOMP)Wtsi/Nfkbil1tm1a(KOMP)Wtsi
(C57BL/6N-Nfkbil1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Ngdntm1b(EUCOMM)Wtsi/Ngdn+
(C57BL/6N-Ngdntm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ngfrtm1a(EUCOMM)Wtsi/Ngfr+
(C57BL/6N-Ngfrtm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Ngfrtm1b(EUCOMM)Wtsi/Ngfrtm1b(EUCOMM)Wtsi
(C57BL/6N-Ngfrtm1b(EUCOMM)Wtsi/H)
|
increased circulating phosphate level
|
J:211773
|
Nhdlq1129S1/SvImJ/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq1CAST/Ei/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq2129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ Nhdlq5C57BL/6J/Nhdlq5C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ Nhdlq7C57BL/6J/Nhdlq7C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq9DBA/2J/?
(involves: DBA/2J * PERA/EiJ)
|
abnormal circulating cholesterol level
|
J:112668
|
Nhdlq10PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
abnormal circulating cholesterol level
|
J:112668
|
Nherf1em1(IMPC)H/Nherf1em1(IMPC)H
(C57BL/6NTac-Nherf1em1(IMPC)H/H)
|
decreased circulating iron level
|
J:211773
|
Nherf1tm1Geo/Nherf1tm1Geo
(involves: C57BL/6J)
|
decreased circulating phosphate level
|
J:95282
|
Nherf2tm2a(EUCOMM)Hmgu/Nherf2tm2a(EUCOMM)Hmgu
(C57BL/6N-Nherf2tm2a(EUCOMM)Hmgu/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nhlh2tm1b(KOMP)Mbp/Nhlh2tm1b(KOMP)Mbp
(C57BL/6N-Nhlh2tm1b(KOMP)Mbp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Nhlh2tm1Irk/Nhlh2tm1Irk
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:39356
|
decreased circulating testosterone level
|
J:39356
|
Nhlh2tm2Thbr/Nhlh2tm2Thbr Tg(CMV-cre)1Cgn/0
(involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6)
|
decreased circulating estradiol level
|
J:199640
|
Nhp2tm1a(KOMP)Wtsi/Nhp2+
(C57BL/6N-Nhp2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Nidd1kKK-A(y)/Jcl/Nidd1kKK-A(y)/Jcl
(involves: KK * PWK)
|
hyperglycemia
|
J:76775
|
Nidd2NON/LtHl/Nidd2NON/LtHl
(involves: NON/LtHl * NZO/Hl)
|
abnormal circulating glucose level
|
J:48957
|
Nidd2NON/LtHl/Nidd2NZO/Hl
(involves: NON/LtHl * NZO/Hl)
|
abnormal circulating glucose level
|
J:48957
|
Nidd2kKK/TaJcl/Nidd2kKK/TaJcl
(involves: KK * PWK)
|
hyperglycemia
|
J:76775
|
Nidd3kKK/TaJcl/Nidd3kKK/TaJcl
(involves: KK * PWK)
|
increased glycosylated hemoglobin level
|
J:76775
|
Nidd4TSOD/Nidd4TSOD
(involves: BALB/cA * TSOD)
|
hyperglycemia
|
J:55285
|
Nidd4kKK/TaJcl/Nidd4kKK/TaJcl
(involves: KK * PWK)
|
hyperglycemia
|
J:76775
|
Nidd5BALB/cA/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
decreased circulating insulin level
|
J:55285
|
Nidd5TSOD/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
decreased circulating insulin level
|
J:55285
|
Nidd5kKK/TaJcl/Nidd5kKK/TaJcl
(involves: KK * PWK)
|
hyperglycemia
|
J:76775
|
Nidd6kPWK/Nidd6kPWK
(involves: KK/Jcl-Ay * PWK)
|
hypoglycemia
|
J:76775
|
Nidd7kKK/TaJcl/Nidd7kKK/TaJcl
(involves: KK * PWK)
|
hyperglycemia
|
J:76775
|
NiddsNZO/HlBom/NiddsSJL/NBom
(involves: NZO/HlBom * SJL/NBom)
|
decreased circulating insulin level
|
J:64158
|
hyperglycemia
|
J:64158
|
NiddsSJL/NBom/?
(involves: NZO/HlBom * SJL/NBom)
|
hyperglycemia
|
J:78920
|
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu)
|
increased circulating glucose level
|
J:332575
|
increased circulating insulin level
|
J:332575
|
increased fasting circulating glucose level
|
J:332575
|
Ninj2tm1a(KOMP)Wtsi/Ninj2tm1a(KOMP)Wtsi
(C57BL/6N-Ninj2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:211773
|
Nipa1tm1a(KOMP)Wtsi/Nipa1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nipa1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:175295
|
Nipsnap3bem1(IMPC)J/Nipsnap3bem1(IMPC)J
(C57BL/6NJ-Nipsnap3bem1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Nischtm1b(EUCOMM)Hmgu/Nischtm1b(EUCOMM)Hmgu
(C57BL/6N-Nischtm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nkg7tm1.1(KOMP)Vlcg/Nkg7tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating interferon-gamma level
|
J:301637
|
decreased circulating tumor necrosis factor level
|
J:301637
|
Nkx2-1tm1Shk/Nkx2-1+
(involves: 129S4/SvJae)
|
increased circulating thyroid-stimulating hormone level
|
J:74696
|
Nkx2-1tm2Shk/Nkx2-1tm2Shk
(involves: 129S4/SvJae * 129X1/SvJ)
|
increased circulating thyroid-stimulating hormone level
|
J:111027
|
Nkx2-1tm2Shk/Nkx2-1tm2Shk Tg(TPO-cre)1Shk/0
(involves: 129X1/SvJ * FVB/NCr)
|
increased circulating thyroid-stimulating hormone level
|
J:111027
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr
(involves: 129X1/SvJ)
|
hyperglycemia
|
J:48576
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL)
|
hyperglycemia
|
J:177838
|
Nkx2-2tm5.1Suss/Nkx2-2tm5.1Suss Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL)
|
hyperglycemia
|
J:204869
|
increased circulating glucose level
|
J:204869
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating triglyceride level
|
J:64018
|
Nkx2-5tm1.1Hkas/Nkx2-5+
(129S2.Cg-Nkx2-5tm1.1Hkas)
|
cyanosis
|
J:273096
|
Nkx2-5tm1Krc/Nkx2-5tm1Krc Isl1tm1(cre)Tmj/Isl1+
(involves: 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:214093
|
Nkx2-6em1(IMPC)H/Nkx2-6em1(IMPC)H
(C57BL/6NTac-Nkx2-6em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL)
|
hyperglycemia
|
J:195153
|
Nkx6-3tm1Shiv/Nkx6-3tm1Shiv
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating gastrin level
|
J:136085
|
Nlgn2tm1.1Gchn/Nlgn2tm1.1Gchn
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating corticosterone level
|
J:272181
|
Nlgn3em1(IMPC)Rbrc/Y
(C57BL/6NJcl-Nlgn3em1(IMPC)Rbrc/Rbrc)
|
abnormal blood uric acid level
|
J:211773
|
Nlktm2b(KOMP)Wtsi/Nlk+
(C57BL/6N-Nlktm2b(KOMP)Wtsi/Orl)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nlrc3tm1Bhk/Nlrc3tm1Bhk
(B6.129S6-Nlrc3tm1Bhk)
|
increased circulating interleukin-6 level
|
J:187586
|
increased circulating tumor necrosis factor level
|
J:187586
|
Nlrp1am2Btlr/Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr)
|
hypoglycemia
|
J:265174
|
Nlrp2tm1b(KOMP)Wtsi/Nlrp2tm1b(KOMP)Wtsi
(C57BL/6N-Nlrp2tm1b(KOMP)Wtsi/BayMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:113333
|
decreased circulating interleukin-18 level
|
J:113333
|
Nlrp3tm1Hhf/Nlrp3+ Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal circulating chemokine level
|
J:150054
|
abnormal circulating cytokine level
|
J:150054
|
increased circulating interleukin-1 beta level
|
J:150054
|
increased circulating interleukin-6 level
|
J:150054
|
increased circulating interleukin-18 level
|
J:150054
|
increased circulating tumor necrosis factor level
|
J:150054
|
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(B6.B6N-Nlrp3tm1Vmd)
|
decreased circulating interleukin-1 beta level
|
J:193522
|
decreased circulating interleukin-18 level
|
J:193522
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
abnormal circulating chemokine level
|
J:202147
|
decreased circulating interleukin-5 level
|
J:202147
|
decreased circulating interleukin-12b level
|
J:202147
|
increased circulating interleukin-1 beta level
|
J:202147
|
increased circulating interleukin-3 level
|
J:202147
|
increased circulating interleukin-4 level
|
J:202147
|
increased circulating interleukin-6 level
|
J:202147
|
increased circulating interleukin-9 level
|
J:202147
|
increased circulating interleukin-13 level
|
J:202147
|
increased circulating interleukin-18 level
|
J:202147
|
increased circulating tumor necrosis factor level
|
J:202147
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
decreased circulating interleukin-18 level
|
J:173245
|
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:173995
|
nma/nma
(B6C3Fe a/a-nma/J)
|
decreased circulating glucose level
|
J:60439
|
Nme7tm2b(EUCOMM)Hmgu/Nme7+
(C57BL/6N-Nme7tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Nmiem1Hhl/Nmiem1Hhl
(C57BL/6-Nmiem1Hhl)
|
decreased circulating alanine transaminase level
|
J:298909
|
decreased circulating aspartate transaminase level
|
J:298909
|
decreased circulating interleukin-6 level
|
J:298909
|
decreased circulating tumor necrosis factor level
|
J:298909
|
Nmrk2tm1.1(KOMP)Vlcg/Nmrk2tm1.1(KOMP)Vlcg
(C57BL/6N-Nmrk2tm1.1(KOMP)Vlcg/J)
|
increased circulating phosphate level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru Nmt2tm1.1Poru/Nmt2tm1.1Poru Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased circulating interferon-gamma level
|
J:226234
|
decreased circulating interleukin-2 level
|
J:226234
|
decreased circulating tumor necrosis factor level
|
J:226234
|
Nmt2tm2b(EUCOMM)Hmgu/Nmt2+
(C57BL/6N-Nmt2tm2b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6)
|
decreased circulating corticosterone level
|
J:93213
|
hyperglycemia
|
J:93213
|
increased circulating cholesterol level
|
J:93213
|
increased circulating free fatty acids level
|
J:93213
|
increased circulating insulin level
|
J:93213
|
increased circulating leptin level
|
J:93213
|
Nmutm1Sjab/Nmutm1Sjab
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:142907
|
Nmur1tm1.1(KOMP)Vlcg/Nmur1tm1.1(KOMP)Vlcg
(C57BL/6N-Nmur1tm1.1(KOMP)Vlcg/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
Nmur2tm1Dgen/Nmur2tm1Dgen
(B6N.Cg-Nmur2tm1Dgen)
|
decreased circulating glucose level
|
J:152371
|
decreased circulating leptin level
|
J:152371
|
Nnattm1.1Geno/Nnat+ Ins1tm1.1(cre)Thor/Ins1+
(involves: 129S2/SvPas * C57BL/6J)
|
increased fasting circulating glucose level
|
J:265677
|
Nnattm1.2Geno/Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno)
|
increased circulating insulin level
|
J:265677
|
NntC57BL/6J/NntC57BL/6J
(C57BL/6J)
|
decreased circulating corticosterone level
|
J:185986
|
Nntem1(IMPC)H/Nntem1(IMPC)H
(C57BL/6N-Nntem1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Noboxtm1.1(KOMP)Vlcg/Nobox+
(C57BL/6N-Noboxtm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
Nobq2NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom)
|
increased circulating insulin level
|
J:66744
|
Noc4lem1(IMPC)J/Noc4l+
(C57BL/6NJ-Noc4lem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Nocttm1Bjc/Nocttm1Bjc
(B6.129S2-Nocttm1Bjc)
|
increased circulating glucose level
|
J:122301
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv)
|
increased circulating interferon-gamma level
|
J:147177
|
increased circulating interleukin-2 level
|
J:147177
|
increased circulating tumor necrosis factor level
|
J:147177
|
Nodaltm1b(EUCOMM)Wtsi/Nodal+
(C57BL/6N-Nodaltm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nogem1(IMPC)Mbp/Nog+
(C57BL/6N-Nogem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nol8tm1b(EUCOMM)Hmgu/Nol8+
(C57BL/6N-Nol8tm1b(EUCOMM)Hmgu/Ics)
|
increased fasting circulating glucose level
|
J:211773
|
Nol9em1(IMPC)J/Nol9+
(C57BL/6NJ-Nol9em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Nop10tm1.1(KOMP)Vlcg/Nop10+
(C57BL/6N-Nop10tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh)
|
increased circulating triglyceride level
|
J:155090
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased blood osmolality
|
J:100308
|
increased blood urea nitrogen level
|
J:100308
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal glomerular capillary thrombosis
|
J:100308
|
increased blood osmolality
|
J:100308
|
increased blood urea nitrogen level
|
J:100308
|
increased circulating alkaline phosphatase level
|
J:150159
|
increased circulating creatinine level
|
J:100308
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating glucose level
|
J:155090
|
increased circulating LDL cholesterol level
|
J:155090
|
increased circulating triglyceride level
|
J:155090
|
Nos1tm1Plh/Nos1tm1Plh Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
increased blood osmolality
|
J:100308
|
increased blood urea nitrogen level
|
J:100308
|
Nos1tm2Plh/Nos1tm2Plh
(Not Specified)
|
decreased circulating follicle stimulating hormone level
|
J:106816
|
increased circulating luteinizing hormone level
|
J:106816
|
Nos1aptm1b(KOMP)Wtsi/Nos1aptm1b(KOMP)Wtsi
(C57BL/6N-Nos1aptm1b(KOMP)Wtsi/Bay)
|
decreased circulating alanine transaminase level
|
J:211773
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:120673
|
decreased circulating leptin level
|
J:94571
|
increased circulating antidiuretic hormone level
|
J:106197
|
increased circulating creatinine level
|
J:120673
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
abnormal blood coagulation
|
J:117987
|
abnormal platelet physiology
|
J:117987
|
Nos2tm1Lau/Nos2tm1Lau
(B6;129P2-Nos2tm1Lau/J)
|
decreased circulating alanine transaminase level
|
J:148923
|
decreased circulating aspartate transaminase level
|
J:148923
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
abnormal platelet aggregation
|
J:120499
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal blood homeostasis
|
J:97522
|
abnormal circulating estradiol level
|
J:89542
|
abnormal circulating glucose level
|
J:65562
|
abnormal circulating serum albumin level
|
J:97522
|
increased circulating cholesterol level
|
J:97522
|
increased circulating creatinine level
|
J:97522
|
increased circulating triglyceride level
|
J:155090
|
Nos2tm1Mrl/Nos2tm1Mrl
(B6.129S7-Nos2tm1Mrl)
|
increased circulating prolactin level
|
J:162957
|
Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased blood osmolality
|
J:100308
|
increased blood urea nitrogen level
|
J:100308
|
Nos3em1(IMPC)Mbp/Nos3em1(IMPC)Mbp
(C57BL/6N-Nos3em1(IMPC)Mbp/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Nos3tm1.2Taka/Nos3tm1.2Taka
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
increased circulating glucose level
|
J:187860
|
increased circulating triglyceride level
|
J:187860
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating estradiol level
|
J:89542
|
increased circulating progesterone level
|
J:89542
|
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh)
|
abnormal circulating glucose level
|
J:155090
|
increased circulating triglyceride level
|
J:155090
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating glucose level
|
J:133437
|
decreased circulating insulin level
|
J:133437
|
increased circulating estradiol level
|
J:89702
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating renin level
|
J:36559
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
abnormal circulating protein level
|
J:129477
|
abnormal glomerular capillary thrombosis
|
J:148626
|
cyanosis
|
J:98913
|
increased blood urea nitrogen level
|
J:148626
|
increased circulating creatine kinase level
|
J:148626
|
increased circulating osteocalcin level
|
J:129477
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal blood homeostasis
|
J:103153
|
hyperlipidemia
|
J:103153
|
increased circulating cholesterol level
|
J:103153
|
increased circulating free fatty acids level
|
J:103153
|
increased circulating insulin level
|
J:103153
|
increased circulating triglyceride level
|
J:103153
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating renin level
|
J:36559
|
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating insulin level
|
J:198075
|
increased circulating free fatty acids level
|
J:198075
|
increased circulating LDL cholesterol level
|
J:198075
|
increased circulating leptin level
|
J:198075
|
Nos3tm3.1Plh/Nos3tm3.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating glucose level
|
J:198075
|
increased circulating insulin level
|
J:198075
|
NosipGt(OST138992)Lex/NosipGt(OST138992)Lex
(B6.129S5-NosipGt(OST138992)Lex)
|
cyanosis
|
J:245546
|
Notch2tm1.1Hhtg/Notch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:311038
|
increased circulating type I collagen C-terminal telopeptide level
|
J:311038
|
Notch2tm2Grid/Notch2tm3Grid Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:133171
|
increased circulating alkaline phosphatase level
|
J:133171
|
increased circulating bilirubin level
|
J:133171
|
Notch2tm3Grid/Notch2tm3.1Grid Pax3tm1(cre)Joe/Pax3+
(involves: 129 * C57BL/6)
|
cyanosis
|
J:132939
|
Notch2tm3Grid/Notch2tm3.1Grid Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:133171
|
increased circulating alkaline phosphatase level
|
J:133171
|
increased circulating bilirubin level
|
J:133171
|
Notch2tm3Grid/Notch2tm3.1Grid Tg(Tagln-cre)1Her/?
(involves: 129 * C57BL/6)
|
cyanosis
|
J:132939
|
Notch3tm1.1Dwr/Notch3+
(involves: 129S/SvEv * Swiss)
|
abnormal brain thrombosis
|
J:191454
|
Notch3tm1.1Dwr/Notch3tm1.1Dwr
(involves: 129S/SvEv * Swiss)
|
abnormal brain thrombosis
|
J:191454
|
Nox4em1(IMPC)Mbp/Nox4em1(IMPC)Mbp
(C57BL/6N-Nox4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating creatinine level
|
J:211773
|
Npas2tm1Slm/Npas2tm1Slm
(B6.129S6-Npas2tm1Slm)
|
decreased circulating adrenaline level
|
J:125921
|
decreased circulating noradrenaline level
|
J:125921
|
Npas2tm1Slm/Npas2tm1Slm
(involves: 129S6/SvEvTac)
|
abnormal circulating protein level
|
J:155089
|
Npas3tm1Mesu/Npas3tm1Mesu
(B6.129S6-Npas3tm1Mesu)
|
cyanosis
|
J:150793
|
Npbwr1tm1Rck/Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J)
|
hyperglycemia
|
J:94820
|
increased circulating insulin level
|
J:94820
|
increased circulating leptin level
|
J:94820
|
Npc1m1N/Npc1m1N
(involves: BALB/c)
|
decreased circulating prolactin level
|
J:91430
|
increased circulating cholesterol level
|
J:18511
|
increased circulating follicle stimulating hormone level
|
J:91430
|
increased circulating luteinizing hormone level
|
J:91430
|
Npc1l1tm1a(EUCOMM)Hmgu/Npc1l1tm1a(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:226578
|
Npc1l1tm1Yaio/Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio)
|
abnormal circulating LDL cholesterol level
|
J:98568
|
decreased circulating cholesterol level
|
J:98568
|
decreased circulating glucose level
|
J:98568
|
decreased circulating HDL cholesterol level
|
J:98568
|
Npc2tm1e.1(EUCOMM)Wtsi/Npc2+
(C57BL/6N-Npc2tm1e.1(EUCOMM)Wtsi/Tcp)
|
increased circulating potassium level
|
J:211773
|
Npcdem1(IMPC)J/Npcdem1(IMPC)J
(C57BL/6NJ-Npcdem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Npeppsgoku/Npeppsgoku
(involves: 129P2/OlaHsd * BALB/cA)
|
decreased circulating follicle stimulating hormone level
|
J:69615
|
decreased circulating luteinizing hormone level
|
J:69615
|
decreased circulating prolactin level
|
J:69615
|
decreased circulating testosterone level
|
J:69615
|
Npffr1tm1Lex/Npffr1tm1Lex
(involves: 129 * C57BL/6)
|
increased circulating luteinizing hormone level
|
J:214329
|
Npffr2tm1.1Hhzg/Npffr2tm1.1Hhzg
(involves: C57BL/6)
|
increased circulating insulin level
|
J:267918
|
increased circulating leptin level
|
J:267918
|
Nphp1em1Lisu/Nphp1em1Lisu
(C57BL/6J-Nphp1em1Lisu)
|
increased circulating creatinine level
|
J:324503
|
Nphp3pcy/Nphp3pcy
(KK-Nphp3pcy)
|
increased blood urea nitrogen level
|
J:8302
|
Nphp3pcy/Nphp3pcy
(involves: DBA/2Fg * KK)
|
abnormal circulating phospholipid level
|
J:2203
|
increased circulating cholesterol level
|
J:2203
|
Nphp3pcy/Nphp3pcy
(either: D2.KK-Nphp3pcy or (involves: DBA/2Fg * DBA/2J * KK))
|
increased blood urea nitrogen level
|
J:11399
|
Nphp3pol/Nphp3pol
(C57BL/6JSfdAnu-Nphp3pol/Anu)
|
increased blood urea nitrogen level
|
J:104190
|
Nphs2tm1Antc/Nphs2tm1Antc
(involves: 129 * C57BL/6J)
|
increased blood urea nitrogen level
|
J:87577
|
increased circulating creatinine level
|
J:87577
|
Nphs2tm1Antc/Nphs2tm1Antc
(129-Nphs2tm1Antc)
|
increased blood urea nitrogen level
|
J:87577
|
increased circulating creatinine level
|
J:87577
|
Nphs2tm1Antc/Nphs2tm3.1Antc Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129 * C57BL/6 * DBA)
|
increased blood urea nitrogen level
|
J:166320
|
increased circulating cholesterol level
|
J:166320
|
increased circulating creatinine level
|
J:166320
|
Nphs2tm2.1Antc/Nphs2tm2.1Antc
(involves: 129S2/SvPas * C57BL/6)
|
increased blood urea nitrogen level
|
J:152878
|
increased circulating creatinine level
|
J:152878
|
Nphs2tm2.1Antc/Nphs2tm3.1Antc Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129S2/SvPas * C57BL/6 * DBA)
|
decreased circulating serum albumin level
|
J:245693
|
increased circulating cholesterol level
|
J:245693
|
NplGt(OST15553)Lex/NplGt(OST15553)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:103485
|
Npm3tm1.1(KOMP)Vlcg/Npm3tm1.1(KOMP)Vlcg
(C57BL/6N-Npm3tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Nppatm1Unc/Nppatm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating adrenaline level
|
J:57623
|
Npr1tm1(Npr1)Unc/Npr1tm1(Npr1)Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating testosterone level
|
J:58344
|
Npr1tm1.1Rsha/Npr1+
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:201932
|
Npr1tm1.1Rsha/Npr1tm1.1Rsha
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:201932
|
Npr1tm1Gar/Npr1tm1Gar
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating atrial natriuretic factor
|
J:42893
|
Npr1tm1Kuhn/Npr1tm1Kuhn Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased circulating atrial natriuretic factor
|
J:83298
|
Npr1tm1Mae/Npr1tm1Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating renin level
|
J:74420
|
decreased circulating testosterone level
|
J:58344
|
Npr1tm1Mae/Npr1tm1Mae
(B6.129P2-Npr1tm1Mae)
|
increased circulating atrial natriuretic factor
|
J:78579
|
Npr2cn/Npr2cn
(AKR/J)
|
cyanosis
|
J:5109
|
Npr2em1(IMPC)H/Npr2em1(IMPC)H
(C57BL/6N-Npr2em1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Npr3kylb/Npr3kylb
(involves: BALB/c * C57BL/6J)
|
increased circulating alkaline phosphatase level
|
J:243806
|
Npr3tm1.1(KOMP)Vlcg/Npr3+
(C57BL/6N-Npr3tm1.1(KOMP)Vlcg/Tcp)
|
increased circulating phosphate level
|
J:211773
|
Npr3tm1Unc/Npr3tm1Unc
(involves: 129 * C57BL/6)
|
abnormal blood homeostasis
|
J:56058
|
increased circulating alkaline phosphatase level
|
J:56058
|
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL)
|
decreased circulating leptin level
|
J:180396
|
increased circulating corticosterone level
|
J:180396
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating interleukin-12 level
|
J:118850
|
decreased circulating tumor necrosis factor level
|
J:118850
|
Npy1rtm1Mnak/Npy1rtm1Mnak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:51684
|
Npy1rtm1Snby/Npy1rtm1Snby Npy5rtm1Snby/Npy5rtm1Snby
(involves: 129 * C57BL/6)
|
increased circulating glucose level
|
J:225097
|
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating free fatty acids level
|
J:47972
|
increased circulating insulin level
|
J:47972
|
increased circulating leptin level
|
J:47972
|
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped)
|
hyperglycemia
|
J:102554
|
increased circulating corticosterone level
|
J:87424
|
increased circulating insulin level
|
J:87424,
J:102554
|
increased circulating leptin level
|
J:87424
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:107169
|
decreased circulating insulin level
|
J:77345
|
increased circulating insulin-like growth factor I level
|
J:129609
|
increased circulating pancreatic peptide level
|
J:77345
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased circulating pancreatic peptide level
|
J:84570
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
decreased circulating insulin level
|
J:84570
|
decreased circulating leptin level
|
J:84570
|
increased circulating pancreatic peptide level
|
J:84570
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating insulin-like growth factor I level
|
J:129609
|
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating hormone level
|
J:77345
|
abnormal circulating insulin level
|
J:77345
|
increased circulating corticosterone level
|
J:77345,
J:97455
|
increased circulating pancreatic peptide level
|
J:77345
|
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating pancreatic peptide level
|
J:76479
|
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased circulating pancreatic peptide level
|
J:84570
|
Npy5rem1(IMPC)H/Npy5rem1(IMPC)H
(C57BL/6NTac-Npy5rem1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd)
|
increased circulating corticosterone level
|
J:87424
|
increased circulating insulin level
|
J:87424
|
increased circulating leptin level
|
J:87424
|
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal circulating corticosterone level
|
J:210546
|
abnormal circulating insulin-like growth factor I level
|
J:210546
|
decreased circulating insulin level
|
J:210546
|
decreased circulating insulin-like growth factor I level
|
J:210546
|
increased circulating glucose level
|
J:210546
|
increased circulating insulin level
|
J:210546
|
Nqo1tm1Akj/Nqo1tm1Akj
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:120478
|
increased circulating glucagon level
|
J:120478
|
increased circulating triglyceride level
|
J:120478
|
Nr0b1em2(IMPC)Wtsi/Y
(C57BL/6N-Nr0b1em2(IMPC)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Nr0b2tm1.1Auw/Nr0b2tm1.1Auw
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating testosterone level
|
J:118368
|
Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:149005
|
decreased circulating HDL cholesterol level
|
J:149005
|
decreased circulating LDL cholesterol level
|
J:149005
|
decreased circulating VLDL cholesterol level
|
J:149005
|
Nr0b2tm1Ddm/Nr0b2tm1Ddm
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:77065
|
Nr0b2tm1Mjev/Nr0b2tm1Mjev Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEvBrd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:149005
|
decreased circulating LDL cholesterol level
|
J:149005
|
Nr0b2tm1Rus/Nr0b2tm1Rus
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating alanine transaminase level
|
J:102129
|
increased circulating aspartate transaminase level
|
J:102129
|
Nr1d1tm1.1Rev/Nr1d1tm1.1Rev Nr1d2tm1.1Rev/Nr1d2tm1.1Rev Tg(CAG-cre/Esr1*)5Amc/0
(involves: BALB/cJ * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating glucose level
|
J:183855
|
decreased circulating triglyceride level
|
J:183855
|
increased circulating free fatty acids level
|
J:183855
|
Nr1d1tm1Schb/Nr1d1tm1Schb
(involves: 129S2/SvPas)
|
increased circulating HDL cholesterol level
|
J:153064
|
increased circulating LDL cholesterol level
|
J:153064
|
Nr1d2em1(IMPC)Mbp/Nr1d2em1(IMPC)Mbp
(C57BL/6N-Nr1d2em1(IMPC)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Nr1h2tm1Djm/Nr1h2tm1Djm Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:120913
|
decreased circulating testosterone level
|
J:120913
|
Nr1h3tm1.1(KOMP)Vlcg/Nr1h3tm1.1(KOMP)Vlcg
(C57BL/6N-Nr1h3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating alanine transaminase level
|
J:82096
|
increased circulating LDL cholesterol level
|
J:82096
|
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:120913
|
decreased circulating testosterone level
|
J:120913
|
increased circulating alanine transaminase level
|
J:47971
|
increased circulating aspartate transaminase level
|
J:47971
|
increased circulating cholesterol level
|
J:47971
|
increased circulating estradiol level
|
J:158168
|
increased circulating LDL cholesterol level
|
J:47971
|
increased erythrocyte sedimentation rate
|
J:158168
|
Nr1h4tm1.1Gonz/Nr1h4tm1.1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating cholesterol level
|
J:129978
|
increased circulating triglyceride level
|
J:129978
|
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj)
|
decreased circulating free fatty acids level
|
J:200842
|
decreased circulating glucose level
|
J:200842
|
decreased circulating insulin level
|
J:200842
|
increased circulating alanine transaminase level
|
J:200842
|
increased circulating bilirubin level
|
J:200842
|
increased circulating cholesterol level
|
J:200842
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
increased circulating cholesterol level
|
J:64792
|
increased circulating phospholipid level
|
J:64792
|
increased circulating triglyceride level
|
J:64792
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ)
|
increased circulating cholesterol level
|
J:129978
|
increased circulating triglyceride level
|
J:129978
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(STOCK Nr1h4tm1Gonz/J)
|
increased circulating alanine transaminase level
|
J:149005
|
increased circulating aspartate transaminase level
|
J:149005
|
increased circulating cholesterol level
|
J:149005
|
increased circulating triglyceride level
|
J:149005
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating aspartate transaminase level
|
J:118204
|
Nr1h4tm1Kok/Nr1h4tm1Kok
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal blood homeostasis
|
J:86154
|
Nr1i3tm1Ddm/Nr1i3tm1Ddm
(C3.129S7-Nr1i3tm1Ddm)
|
increased circulating glucose level
|
J:92777
|
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj)
|
abnormal blood homeostasis
|
J:169333
|
decreased circulating alanine transaminase level
|
J:169333
|
decreased circulating aspartate transaminase level
|
J:169333
|
decreased circulating cholesterol level
|
J:169333
|
decreased circulating glucose level
|
J:169333
|
decreased circulating insulin level
|
J:169333
|
decreased circulating LDL cholesterol level
|
J:169333
|
decreased circulating triglyceride level
|
J:169333
|
Nr2c2tm1Chc/Nr2c2tm1Chc
(Not Specified)
|
decreased circulating estradiol level
|
J:133000
|
decreased circulating progesterone level
|
J:133000
|
Nr2f2tm1Tsa/Nr2f2+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating progesterone level
|
J:100400
|
Nr2f2tm1Vco/Nr2f2+ Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating glucose level
|
J:98195
|
increased circulating insulin level
|
J:98195
|
increased circulating triglyceride level
|
J:98195
|
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs)
|
abnormal circulating corticosterone level
|
J:141205
|
increased circulating aldosterone level
|
J:141205
|
increased circulating angiotensinogen level
|
J:141205
|
increased circulating corticosterone level
|
J:141205
|
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
abnormal atrial thrombosis
|
J:201995
|
Nr3c1tm1.1Mvc/Nr3c1+ Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB)
|
increased circulating adrenocorticotropin level
|
J:179918
|
increased circulating corticosterone level
|
J:179918
|
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating adrenocorticotropin level
|
J:147914
|
decreased circulating corticosterone level
|
J:147914
|
decreased circulating testosterone level
|
J:147914
|
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating adrenocorticotropin level
|
J:147914
|
decreased circulating corticosterone level
|
J:147914
|
decreased circulating testosterone level
|
J:147914
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:27441
|
increased circulating adrenocorticotropin level
|
J:27441
|
increased circulating corticosterone level
|
J:27441
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd)
|
absent circulating adrenaline
|
J:54931
|
decreased circulating noradrenaline level
|
J:54931
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * 129/Sv)
|
increased circulating corticosterone level
|
J:98065
|
Nr3c1tm2.1Gsc/Nr3c1tm2.1Gsc
(involves: 129P2/OlaHsd)
|
absent circulating adrenaline
|
J:54931
|
decreased circulating noradrenaline level
|
J:54931
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Camk2a-cre/ERT2)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating corticosterone level
|
J:125230
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
decreased circulating adrenocorticotropin level
|
J:57315
|
increased circulating glucocorticoid level
|
J:57315
|
Nr3c1tm2Ljm/Nr3c1tm2Ljm Tg(Camk2a-cre)T50Stl/?
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
increased circulating corticosterone level
|
J:96260
|
Nr3c1tm3Gsc/Nr3c1tm3Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating corticosterone level
|
J:67720
|
Nr3c2tm1Gsc/Nr3c2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating aldosterone level
|
J:77285
|
increased circulating angiotensin II level
|
J:77285
|
increased circulating renin level
|
J:77285
|
Nr3c2tm1Gsc/Nr3c2tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating sodium level
|
J:77285
|
increased circulating aldosterone level
|
J:77285
|
increased circulating angiotensin II level
|
J:77285
|
increased circulating potassium level
|
J:77285
|
increased circulating renin level
|
J:77285
|
Nr3c2tm2Gsc/Nr3c2tm2Gsc Tg(Aqp2-cre/ERT2)4Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased circulating aldosterone level
|
J:169670
|
Nr5a1tm2Klp/Nr5a1tm2.1Klp Tg(Cga-cre)3Sac/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
decreased circulating follicle stimulating hormone level
|
J:66593
|
decreased circulating luteinizing hormone level
|
J:66593
|
Nr5a1tm2Klp/Nr5a1tm2Klp Tg(Cga-cre)3Sac/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
decreased circulating follicle stimulating hormone level
|
J:70412
|
decreased circulating luteinizing hormone level
|
J:70412
|
Nr5a2tm1Auw/Nr5a2+
(involves: C57BL/6J)
|
decreased circulating testosterone level
|
J:118368
|
Nr5a2tm1Bel/Nr5a2+
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:91695
|
decreased circulating progesterone level
|
J:124199
|
Nr5a2tm1Sakl/Nr5a2tm1Sakl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating aspartate transaminase level
|
J:135822
|
decreased circulating cholesterol level
|
J:135822
|
Nr5a2tm1Sakl/Nr5a2tm1Sakl Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)
|
decreased circulating aspartate transaminase level
|
J:135822
|
decreased circulating cholesterol level
|
J:135822
|
Nr6a1tm3Coo/Nr6a1tm3Coo Tg(Zp3-cre)93Knw/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating estradiol level
|
J:85054
|
decreased circulating follicle stimulating hormone level
|
J:85054
|
decreased circulating progesterone level
|
J:85054
|
decreased circulating testosterone level
|
J:85054
|
Nrastm1b(EUCOMM)Hmgu/Nras+
(C57BL/6N-Nrastm1b(EUCOMM)Hmgu/H)
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Nrcamtm2e.1(KOMP)Wtsi/Nrcam+
(C57BL/6N-Nrcamtm2e.1(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Nrde2tm2a(KOMP)Wtsi/Nrde2+
(C57BL/6N-Nrde2tm2a(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Nrg1tm1Lwr/Nrg1tm1Lwr
(129/Sv-Nrg1tm1Lwr)
|
cyanosis
|
J:60159
|
Nrgnem1(IMPC)H/Nrgnem1(IMPC)H
(C57BL/6NTac-Nrgnem1(IMPC)H/H)
|
decreased circulating amylase level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Nrn1ltm1.1(KOMP)Vlcg/Nrn1ltm1.1(KOMP)Vlcg
(C57BL/6N-Nrn1ltm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nrsn1tm1.1(KOMP)Vlcg/Nrsn1tm1.1(KOMP)Vlcg
(C57BL/6N-Nrsn1tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Nrsn2em1(IMPC)Kmpc/Nrsn2em1(IMPC)Kmpc
(C57BL/6NTac-Nrsn2em1(IMPC)Kmpc/Kmpc)
|
increased blood uric acid level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Nrxn1tm1b(KOMP)Wtsi/Nrxn1+
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H)
|
increased circulating amylase level
|
J:211773
|
Nrxn1tm1b(KOMP)Wtsi/Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Nrxn2em1(IMPC)H/Nrxn2em1(IMPC)H
(C57BL/6NTac-Nrxn2em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nsd3tm1b(EUCOMM)Hmgu/Nsd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Nsd3tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nsftm1b(KOMP)Mbp/Nsf+
(C57BL/6N-Nsftm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nsg2em1(IMPC)Kmpc/Nsg2em1(IMPC)Kmpc
(C57BL/6NTac-Nsg2em1(IMPC)Kmpc/Kmpc)
|
increased circulating serum albumin level
|
J:211773
|
Nsl1em1(IMPC)J/Nsl1+
(C57BL/6NJ-Nsl1em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Nsmce1em1(IMPC)Wtsi/Nsmce1+
(C57BL/6N-Nsmce1em1(IMPC)Wtsi/Wtsi)
|
increased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nsmftm1.2Mrkr/Nsmftm1.2Mrkr
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating estradiol level
|
J:232404
|
Nsrp1em1(IMPC)Mbp/Nsrp1+
(C57BL/6NCrl-Nsrp1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating phosphate level
|
J:211773
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2+
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:175295
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating amylase level
|
J:213427
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating free fatty acids level
|
J:213427
|
decreased circulating glucose level
|
J:213427
|
decreased circulating glycerol level
|
J:213427
|
decreased circulating HDL cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6N-Nsun5tm2b(EUCOMM)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6NJ-Nsun5tm2b(EUCOMM)Wtsi/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Nt5dc1em1(IMPC)J/Nt5dc1em1(IMPC)J
(C57BL/6NJ-Nt5dc1em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Nt5dc2em1(IMPC)J/Nt5dc2em1(IMPC)J
(C57BL/6NJ-Nt5dc2em1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Nt5dc3em1(IMPC)J/Nt5dc3em1(IMPC)J
(C57BL/6NJ-Nt5dc3em1(IMPC)J/Mmjax)
|
decreased fasting circulating glucose level
|
J:211773
|
Nt5etm1Jgsc/Nt5etm1Jgsc
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating alkaline phosphatase level
|
J:92598
|
Nt5etm1Jsc/Nt5etm1Jsc
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
abnormal platelet physiology
|
J:102299
|
decreased bleeding time
|
J:102299
|
increased susceptibility to induced thrombosis
|
J:102299
|
Ntaq1tm1.1(KOMP)Vlcg/Ntaq1tm1.1(KOMP)Vlcg
(C57BL/6N-Ntaq1tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Ntf5tm1b(EUCOMM)Hmgu/Ntf5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ntf5tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
(C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Ntrk2tm1Mini/Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:210229
|
increased circulating insulin level
|
J:210229
|
increased circulating leptin level
|
J:210229
|
Ntrk2tm1Rohr/Ntrk2+
(Not Specified)
|
abnormal circulating corticosterone level
|
J:179918
|
decreased circulating adrenocorticotropin level
|
J:179918
|
decreased circulating corticosterone level
|
J:179918
|
decreased circulating follicle stimulating hormone level
|
J:88782
|
Ntrk2tm1Rohr/Ntrk2tm1Rohr
(Not Specified)
|
decreased circulating follicle stimulating hormone level
|
J:88782
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal circulating corticosterone level
|
J:210229
|
increased circulating insulin level
|
J:210229
|
increased circulating leptin level
|
J:210229
|
Nuak1tm1Esu/Nuak1tm1Esu Tg(Ckmm-cre)5Khn/0
(B6.Cg-Nuak1tm1Esu Tg(Ckmm-cre)5Khn)
|
decreased circulating glucose level
|
J:185463
|
Nuak2tm1Esu/Nuak2+
(B6.129S4-Nuak2tm1Esu)
|
decreased circulating free fatty acids level
|
J:139603
|
increased circulating glucose level
|
J:139603
|
increased circulating triglyceride level
|
J:139603
|
Nub1tm1b(EUCOMM)Hmgu/Nub1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nub1tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased circulating iron level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Nubp2tm1b(EUCOMM)Hmgu/Nubp2+
(C57BL/6N-Nubp2tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating fructosamine level
|
J:211773
|
Nucb2Gt(OST287865)Lex/Nucb2Gt(OST287865)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating alkaline phosphatase level
|
J:103485
|
Nucb2tm1.2Vdix/Nucb2tm1.2Vdix
(involves: C57BL/6)
|
increased circulating free fatty acids level
|
J:270674
|
Nucks1tm1.2Vter/Nucks1tm1.2Vter
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL)
|
increased circulating glucose level
|
J:211777
|
increased circulating insulin level
|
J:211777
|
increased circulating leptin level
|
J:211777
|
Nucks1tm1b(EUCOMM)Hmgu/Nucks1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nucks1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Nudcd3em1(IMPC)Wtsi/Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Nudt13tm2b(EUCOMM)Hmgu/Nudt13tm2b(EUCOMM)Hmgu
(C57BL/6N-Nudt13tm2b(EUCOMM)Hmgu/BayMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Nudt16l1em1(IMPC)J/Nudt16l1em1(IMPC)J
(C57BL/6NJ-Nudt16l1em1(IMPC)J/Mmjax)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
Nufip2em1(IMPC)J/Nufip2+
(C57BL/6NJ-Nufip2em1(IMPC)J/Mmjax)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Numbtm1Zili/Numbtm1Zili Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:226578
|
Nup62clem1(IMPC)J/Y
(C57BL/6NJ-Nup62clem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Nup62clem1(IMPC)J/Nup62clem1(IMPC)J
(C57BL/6NJ-Nup62clem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Nup155em1(IMPC)Mbp/Nup155+
(C57BL/6NCrl-Nup155em1(IMPC)Mbp/Mmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Nup205em1(IMPC)J/Nup205+
(C57BL/6NJ-Nup205em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Nus1tm1.1Qrm/Nus1tm1.1Qrm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL)
|
abnormal circulating cholesterol level
|
J:243753
|
increased circulating free fatty acids level
|
J:243753
|
increased circulating triglyceride level
|
J:243753
|
Nutm1tm1b(KOMP)Wtsi/Nutm1tm1b(KOMP)Wtsi
(C57BL/6N-Nutm1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Nxnem1(IMPC)Bay/Nxn+
(C57BL/6N-Nxnem1(IMPC)Bay/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Nxnem1(IMPC)J/Nxn+
(C57BL/6NJ-Nxnem1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nxph4tm1Lex/Nxph4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating triglyceride level
|
J:171883
|
Oas1gtm1b(KOMP)Wtsi/Oas1g+
(C57BL/6N-Oas1gtm1b(KOMP)Wtsi/Ucd)
|
increased circulating glucose level
|
J:211773
|
Oasl1tm1Yjk/Oasl1tm1Yjk
(B6.129P2-Oasl1tm1Yjk)
|
abnormal circulating interferon level
|
J:194467
|
Oasl2tm1a(EUCOMM)Wtsi/Oasl2tm1a(EUCOMM)Wtsi
(C57BL/6N-Oasl2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Oatrhg/Oatrhg
(B6Ei;AKR-Oatrhg/J)
|
decreased circulating alkaline phosphatase level
|
J:147337
|
decreased circulating amylase level
|
J:147337
|
decreased circulating serum albumin level
|
J:147337
|
decreased circulating thyroxine level
|
J:147337
|
increased circulating ornithine level
|
J:213842
|
Oatrhg/Oattm1Dva
(involves: 129S7/SvEvBrd * AKR/J * C57BL/6J * C57BL/6JEi)
|
increased circulating ornithine level
|
J:213842
|
Oattm1Dva/Oattm1Dva
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal circulating amino acid level
|
J:29269
|
decreased circulating arginine level
|
J:29269
|
decreased circulating citrulline level
|
J:29269
|
decreased circulating ornithine level
|
J:29269
|
decreased circulating phenylalanine level
|
J:29269
|
increased circulating ammonia level
|
J:29269
|
increased circulating ornithine level
|
J:29269
|
Oattm1Dva/Oattm1Dva
(involves: 129S7/SvEvBrd)
|
abnormal circulating amino acid level
|
J:60200
|
Oaz2em1(IMPC)J/Oaz2em1(IMPC)J
(C57BL/6NJ-Oaz2em1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Obp2atm1b(EUCOMM)Wtsi/Obp2atm1b(EUCOMM)Wtsi
(C57BL/6N-Obp2atm1b(EUCOMM)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Obrq13A/J/Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
decreased circulating cholesterol level
|
J:145148
|
decreased circulating glucose level
|
J:145148
|
decreased circulating insulin level
|
J:145148
|
decreased circulating triglyceride level
|
J:145148
|
Obrq14A/J/Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
increased circulating cholesterol level
|
J:145148
|
Obrq15A/J/Obrq15A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
increased circulating free fatty acids level
|
J:145148
|
Obrq17A/J/Obrq17A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
decreased circulating triglyceride level
|
J:145148
|
Obsty5SM/J/?
(involves: LG/J * SM/J)
|
increased circulating cholesterol level
|
J:94605
|
increased circulating leptin level
|
J:94605
|
Oca2p-30PUb/Oca2p-x
(Not Specified)
|
abnormal circulating cholesterol level
|
J:89922
|
abnormal circulating HDL cholesterol level
|
J:89922
|
hyperglycemia
|
J:89922
|
increased circulating cholesterol level
|
J:89922
|
increased circulating insulin level
|
J:89922
|
increased circulating triglyceride level
|
J:89922
|
Ociad1em1(IMPC)J/Ociad1em1(IMPC)J
(C57BL/6NJ-Ociad1em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ociad2em1(IMPC)Tcp/Ociad2em1(IMPC)Tcp
(C57BL/6N-Ociad2em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ocstamptm2b(KOMP)Wtsi/Ocstamptm2b(KOMP)Wtsi
(C57BL/6N-Ocstamptm2b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Odaphem1(IMPC)Ccpcz/Odaphem1(IMPC)Ccpcz
(C57BL/6NCrl-Odaphem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Odf1tm1b(EUCOMM)Hmgu/Odf1tm1b(EUCOMM)Hmgu
(C57BL/6N-Odf1tm1b(EUCOMM)Hmgu/BayMmucd)
|
increased circulating iron level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
oed/oed
(STOCK pc-oed)
|
abnormal circulating cholesterol level
|
J:5609
|
abnormal circulating HDL cholesterol level
|
J:5609
|
decreased circulating cholesterol level
|
J:5609
|
decreased circulating LDL cholesterol level
|
J:5609
|
Ofcc1em1(IMPC)J/Ofcc1em1(IMPC)J
(C57BL/6NJ-Ofcc1em1(IMPC)J/J)
|
increased circulating phosphate level
|
J:211773
|
Ofcc1tm1.2Tohn/Ofcc1tm1.2Tohn
(involves: C57BL/6 * C57BL/6NSlc)
|
abnormal circulating enzyme level
|
J:223904
|
Ogfod1tm1a(KOMP)Wtsi/Ogfod1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Ogfod1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:175295
|
Ogntm1b(KOMP)Wtsi/Ogntm1b(KOMP)Wtsi
(C57BL/6N-Ogntm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Ogtem1Dvaa/Y
(C57BL/6J-Ogtem1Dvaa)
|
decreased circulating glucose level
|
J:353384
|
Oit3tm1Zgh/Oit3tm1Zgh
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased blood uric acid level
|
J:181913
|
Ola1Gt(OST312288)Lex/Ola1Gt(OST312288)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
cyanosis
|
J:236306
|
Olfm1tm1.1Lex/Olfm1tm1.1Lex
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
increased circulating follicle stimulating hormone level
|
J:226939
|
Olfm4tm1Gpro/Olfm4tm1Gpro
(involves: 129X1/SvJ * Black Swiss)
|
increased circulating interleukin-3 level
|
J:161279
|
increased circulating interleukin-12 level
|
J:161279
|
Olig1em2(IMPC)Ics/Olig1em2(IMPC)Ics
(C57BL/6N-Olig1em2(IMPC)Ics/Ics)
|
decreased circulating phosphate level
|
J:211773
|
Olig3tm1Qiu/Olig3tm1Qiu
(Not Specified)
|
cyanosis
|
J:143462
|
Olr1tm1Meht/Olr1tm1Meht
(B6.129X1-Olr1tm1Meht/Meht)
|
increased circulating interleukin-10 level
|
J:130794
|
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)
|
abnormal blood homeostasis
|
J:184716
|
decreased circulating insulin level
|
J:184716
|
increased circulating alanine transaminase level
|
J:184716
|
increased circulating aspartate transaminase level
|
J:184716
|
increased circulating leptin level
|
J:184716
|
increased circulating triglyceride level
|
J:184716
|
Onecut1tm1.1Mga/Onecut1tm1.1Mga Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
increased circulating glucose level
|
J:155058
|
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
decreased circulating glucagon level
|
J:62595
|
decreased circulating glucose level
|
J:62595
|
decreased circulating insulin level
|
J:62595
|
increased circulating glucose level
|
J:62595
|
Opa1tm1.1Hise/Opa1tm1.2Hise Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
|
decreased circulating insulin level
|
J:183074
|
increased circulating glucose level
|
J:183074
|
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl)
|
abnormal blood homeostasis
|
J:188346
|
decreased circulating insulin-like growth factor I level
|
J:188346
|
Oplahtm1b(KOMP)Wtsi/Oplahtm1b(KOMP)Wtsi
(C57BL/6N-Oplahtm1b(KOMP)Wtsi/Ieg)
|
decreased circulating unsaturated transferrin level
|
J:211773
|
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ)
|
abnormal circulating glycerol level
|
J:287419
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
increased circulating insulin level
|
J:147786
|
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal circulating glucose level
|
J:106857
|
Optntm1a(EUCOMM)Wtsi/Optntm1a(EUCOMM)Wtsi
(C57BL/6N-Optntm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
Or1e1cem1(IMPC)Mbp/Or1e1cem1(IMPC)Mbp
(C57BL/6NCrl-Or1e1cem1(IMPC)Mbp/Mmucd)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
Or2l13bem1Scjc/Or2l13bem1Scjc
(FVB/NTac-Or2l13bem1Scjc)
|
abnormal platelet activation
|
J:324598
|
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J)
|
abnormal circulating glucose level
|
J:314392
|
decreased circulating cholesterol level
|
J:279017
|
decreased circulating free fatty acids level
|
J:279017
|
decreased circulating glucose level
|
J:279017
|
decreased circulating insulin level
|
J:279017
|
decreased circulating leptin level
|
J:279017
|
decreased circulating triglyceride level
|
J:279017
|
decreased fasting circulating glucose level
|
J:279017
|
Or5b112em1(IMPC)Hmgu/Or5b112em1(IMPC)Hmgu
(C57BL/6NCrl-Or5b112em1(IMPC)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Or9g4em1(IMPC)Mbp/Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Or12d17em1Cya/Or12d17em1Cya
(C57BL/6N-Or12d17em1Cya)
|
decreased circulating glucose level
|
J:321591
|
decreased circulating insulin level
|
J:321591
|
decreased circulating leptin level
|
J:321591
|
decreased fasting circulating glucose level
|
J:321591
|
increased circulating insulin level
|
J:321591
|
Orai1tm1Fesk/Orai1tm1Fesk
(C57BL/6-Orai1tm1Fesk)
|
abnormal platelet activation
|
J:144861
|
Orc6em1(IMPC)J/Orc6+
(C57BL/6NJ-Orc6em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
Orm2em1Bcgen/Orm2+
(involves: C57BL/6J)
|
increased circulating alanine transaminase level
|
J:333118
|
increased circulating triglyceride level
|
J:333118
|
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J)
|
increased circulating alanine transaminase level
|
J:333118
|
increased circulating aspartate transaminase level
|
J:333118
|
increased circulating LDL cholesterol level
|
J:333118
|
increased circulating triglyceride level
|
J:333118
|
Os/Os+
(ROP/GnLeJ)
|
increased blood urea nitrogen level
|
J:3842
|
Osbpl8Gt(DD0748)Wtsi/Osbpl8Gt(DD0748)Wtsi
(B6.129P2-Osbpl8Gt(DD0748)Wtsi)
|
abnormal circulating apolipoprotein E level
|
J:199891
|
abnormal circulating apolipoprotein level
|
J:199891
|
increased circulating cholesterol level
|
J:199891
|
increased circulating phospholipid level
|
J:199891
|
increased circulating triglyceride level
|
J:199891
|
Osbpl11tm1b(EUCOMM)Hmgu/Osbpl11+
(C57BL/6N-Osbpl11tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Osmtm1b(KOMP)Wtsi/Osmtm1b(KOMP)Wtsi
(C57BL/6N-Osmtm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
increased circulating cholesterol level
|
J:214124
|
increased circulating free fatty acids level
|
J:214124
|
increased circulating glucose level
|
J:214124
|
increased circulating insulin level
|
J:214124
|
increased circulating interleukin-10 level
|
J:214124
|
increased circulating leptin level
|
J:214124
|
increased circulating triglyceride level
|
J:214124
|
increased circulating tumor necrosis factor level
|
J:214124
|
Ostm1om/Ostm1om
(C3HeB/FeJ-Ostm1om)
|
decreased circulating LDL cholesterol level
|
J:195249
|
decreased circulating triglyceride level
|
J:195249
|
increased circulating alkaline phosphatase level
|
J:195249
|
Otcem1(IMPC)Tcp/Otc+
(C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Otcspf-ash/Y
(Not Specified)
|
increased circulating ammonia level
|
J:26977
|
Otcspf-ash/Y
(B6EiC3Sn a/A-Otcspf-ash/J)
|
increased circulating ammonia level
|
J:108979
|
Otcspf-J/Y
(C57BL/6J-Otcspf-J/J)
|
abnormal blood homeostasis
|
J:226209
|
abnormal circulating amino acid level
|
J:226209
|
Otcspf/Y
(Not Specified)
|
abnormal circulating amino acid level
|
J:22268,
J:23017
|
increased circulating ammonia level
|
J:23017
|
Otcspf/Y
(involves: CD-1)
|
increased circulating ammonia level
|
J:23195,
J:2774,
J:784
|
increased circulating glutamine level
|
J:784
|
Otcspf/Y
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating arginine level
|
J:31237
|
decreased circulating citrulline level
|
J:31237
|
decreased circulating ornithine level
|
J:31237
|
increased circulating ammonia level
|
J:31237
|
increased circulating glutamine level
|
J:31237
|
Otcspf/Otc+
(Not Specified)
|
abnormal circulating amino acid level
|
J:23017
|
Otcspf/Otcspf
(involves: CD-1)
|
increased circulating ammonia level
|
J:784
|
Otogem1(IMPC)J/Otogem1(IMPC)J
(C57BL/6NJ-Otogem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Otop1em1(IMPC)Ccpcz/Otop1em1(IMPC)Ccpcz
(C57BL/6NCrl-Otop1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating aspartate transaminase level
|
J:211773
|
OtpM1H/Otp+
(C3H.Cg-OtpM1H)
|
increased circulating insulin level
|
J:251771
|
increased circulating leptin level
|
J:251771
|
Otptm1Asim/Otp+
(C3H.129P2(B6)-Otptm1Asim)
|
increased circulating leptin level
|
J:251771
|
Otptm1b(EUCOMM)Wtsi/Otp+
(C57BL/6N-Otptm1b(EUCOMM)Wtsi/H)
|
increased circulating iron level
|
J:211773
|
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased circulating interleukin-6 level
|
J:280549
|
Otud1em2Gpt/Otud1em2Gpt
(C57BL/6-Otud1em2Gpt)
|
increased circulating interferon-beta level
|
J:287309
|
Otud5tm1Vmd/Otud5tm1Vmd Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased circulating interleukin-17 level
|
J:219495
|
Otud6atm1(KOMP)Vlcg/Otud6atm1(KOMP)Vlcg
(C57BL/6N-Otud6atm1(KOMP)Vlcg/Nju)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Otud7btm1(NCOM)Cmhd/Otud7btm1(NCOM)Cmhd
(C57BL/6N-Otud7btm1(NCOM)Cmhd/Tcp)
|
decreased circulating cholesterol level
|
J:165965
|
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating testosterone level
|
J:47322
|
Otx2tm1Pas/Otx2+
(involves: C57BL/6 * FVB/N)
|
decreased circulating luteinizing hormone level
|
J:210118
|
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi)
|
decreased circulating lactate level
|
J:170537
|
hypoglycemia
|
J:170537
|
increased circulating ketone body level
|
J:170537
|
Oxgr1tm1(KOMP)Vlcg/Oxgr1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased circulating bicarbonate level
|
J:201611
|
Oxsr1tm1.1Ssy/Oxsr1tm1.1Ssy Tg(Cdh16-cre)91Igr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR)
|
decreased circulating potassium level
|
J:177443
|
Oxtrtm1.1(KOMP)Vlcg/Oxtrtm1.1(KOMP)Vlcg
(C57BL/6N-Oxtrtm1.1(KOMP)Vlcg/Rbrc)
|
increased circulating LDL cholesterol level
|
J:211773
|
P2rx2em1(IMPC)H/P2rx2em1(IMPC)H
(C57BL/6NTac-P2rx2em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
P2rx7tm1a(EUCOMM)Wtsi/P2rx7tm1a(EUCOMM)Wtsi
(C57BL/6N-P2rx7tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating glycerol level
|
J:165965
|
P2ry1tm1Bhk/P2ry1tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal thrombolysis
|
J:57960
|
decreased platelet aggregation
|
J:57960
|
increased bleeding time
|
J:57960
|
P2ry1tm1Gac/P2ry1+
(involves: 129S2/SvPas * C57BL/6)
|
decreased platelet aggregation
|
J:59055
|
P2ry1tm1Gac/P2ry1tm1Gac
(involves: 129S2/SvPas * C57BL/6)
|
decreased platelet aggregation
|
J:59055
|
decreased susceptibility to induced thrombosis
|
J:59055
|
increased bleeding time
|
J:59055
|
P2ry12tm1Cjf/P2ry12tm1Cjf
(involves: 129)
|
decreased platelet aggregation
|
J:70017
|
increased bleeding time
|
J:70017
|
P2ry12tm1Pcon/P2ry12tm1Pcon
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet physiology
|
J:84917
|
decreased platelet aggregation
|
J:84917
|
decreased susceptibility to induced thrombosis
|
J:84917
|
increased bleeding time
|
J:84917
|
P2ry13tm1Dgen/P2ry13tm1Dgen
(B6N.Cg-P2ry13tm1Dgen)
|
decreased circulating cholesterol level
|
J:170217
|
decreased circulating glycerol level
|
J:170217
|
decreased circulating HDL cholesterol level
|
J:170217
|
decreased circulating LDL cholesterol level
|
J:170217
|
increased circulating glucose level
|
J:170217
|
P2ry14em1(IMPC)H/P2ry14em1(IMPC)H
(C57BL/6NTac-P2ry14em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
P2ry14tm1.1Shbg/P2ry14tm1.1Shbg
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating insulin level
|
J:223427
|
P3h2em1(IMPC)H/P3h2em1(IMPC)H
(C57BL/6N-P3h2em1(IMPC)H/H)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
P3h2tm1Hpb/P3h2tm1Hpb
(involves: 129 * C57BL/6J)
|
abnormal thrombosis
|
J:206377
|
P3h3tm1.1(KOMP)Vlcg/P3h3tm1.1(KOMP)Vlcg
(C57BL/6N-P3h3tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating phosphate level
|
J:211773
|
P4hbtm1.1Geno/P4hbtm1.1Geno Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA/J)
|
decreased platelet aggregation
|
J:229395
|
decreased susceptibility to induced thrombosis
|
J:229395
|
P4hbtm1.1Geno/P4hbtm1.1Geno Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet dense granule physiology
|
J:229395
|
decreased platelet aggregation
|
J:229395
|
decreased susceptibility to induced thrombosis
|
J:229395
|
increased bleeding time
|
J:229395
|
Pabpc4tm1a(KOMP)Wtsi/Pabpc4tm1a(KOMP)Wtsi
(C57BL/6N-Pabpc4tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Pabr1129X1/SvJ/Pabr1129X1/SvJ
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating protein level
|
J:69759
|
Pabr1C57BL/6J/Pabr1C57BL/6J
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating protein level
|
J:69759
|
Pabr2129X1/SvJ/Pabr2129X1/SvJ
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating protein level
|
J:69759
|
Pabr2C57BL/6J/Pabr2C57BL/6J
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating protein level
|
J:69759
|
Pacrgem1(IMPC)J/Pacrgem1(IMPC)J
(C57BL/6NJ-Pacrgem1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Pacsin1em1(IMPC)H/Pacsin1em1(IMPC)H
(C57BL/6NTac-Pacsin1em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Pacsin1Gt(OST287788)Lex/Pacsin1Gt(OST287788)Lex
(B6.129S5-Pacsin1Gt(OST287788)Lex)
|
decreased circulating interferon-alpha level
|
J:187784
|
Pacsin2tm1b(EUCOMM)Hmgu/Pacsin2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pacsin2tm1b(EUCOMM)Hmgu/J)
|
increased fasting circulating glucose level
|
J:211773
|
Padi1em1(IMPC)J/Padi1em1(IMPC)J
(C57BL/6NJ-Padi1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Padi2tm1b(KOMP)Wtsi/Padi2+
(C57BL/6N-Padi2tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Padi3tm1b(KOMP)Wtsi/Padi3tm1b(KOMP)Wtsi
(C57BL/6N-Padi3tm1b(KOMP)Wtsi/Orl)
|
increased circulating HDL cholesterol level
|
J:211773
|
Padi4em1(IMPC)Mbp/Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pafah2tm1Arai/Pafah2tm1Arai
(B6.129P2-Pafah2tm1Arai)
|
increased circulating alanine transaminase level
|
J:130728
|
Pahem1Skym/Pahem1Skym
(C57BL/6J-Pahem1Skym)
|
decreased circulating cholesterol level
|
J:305392
|
decreased circulating HDL cholesterol level
|
J:305392
|
decreased circulating LDL cholesterol level
|
J:305392
|
decreased circulating tyrosine level
|
J:305392
|
increased circulating phenylalanine level
|
J:305392
|
Pahenu1/Pahenu1
(involves: 101 * C3H)
|
abnormal circulating amino acid level
|
J:62365,
J:10355
|
Pahenu1/Pahenu2
(involves: 101 * C3H * BTBR)
|
abnormal circulating amino acid level
|
J:62365
|
Pahenu2/Pahenu2
(involves: BTBR)
|
increased circulating phenylalanine level
|
J:13320
|
Pahenu3/Pahenu3
(involves: BTBR)
|
increased circulating phenylalanine level
|
J:13320
|
Paip1em1(IMPC)Tcp/Paip1em1(IMPC)Tcp
(C57BL/6NCrl-Paip1em1(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
Pak1tm1b(EUCOMM)Hmgu/Pak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Pak1tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pak2em1(IMPC)H/Pak2+
(C57BL/6NTac-Pak2em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Pak6em1(IMPC)Bay/Pak6em1(IMPC)Bay
(C57BL/6N-Pak6em1(IMPC)Bay/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Palb2tm1.1(KOMP)Vlcg/Palb2+
(C57BL/6N-Palb2tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Palmem1(IMPC)Wtsi/Palmem1(IMPC)Wtsi
(C57BL/6N-Palmem1(IMPC)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J)
|
abnormal blood homeostasis
|
J:161798
|
decreased circulating glucose level
|
J:161798
|
decreased circulating triglyceride level
|
J:161798
|
Pank1tm1.1Suja/Pank1tm1.1Suja Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
hypoglycemia
|
J:189609
|
increased circulating ketone body level
|
J:189609
|
Pank2em1(IMPC)Ccpcz/Pank2em1(IMPC)Ccpcz
(C57BL/6NCrl-Pank2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Pank3tm1b(KOMP)Mbp/Pank3tm1b(KOMP)Mbp
(C57BL/6N-Pank3tm1b(KOMP)Mbp/Bay)
|
decreased circulating fructosamine level
|
J:211773
|
Panx1tm1b(KOMP)Wtsi/Panx1tm1b(KOMP)Wtsi
(C57BL/6N-Panx1tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
Paoxtm1.1(KOMP)Wtsi/Paoxtm1.1(KOMP)Wtsi
(C57BL/6N-Paoxtm1.1(KOMP)Wtsi/Ieg)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Papolaem1(IMPC)J/Papola+
(C57BL/6NJ-Papolaem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Pappatm1Cac/Pappatm1Cac
(involves: 129 * C57BL/6)
|
decreased circulating estradiol level
|
J:161983
|
decreased circulating progesterone level
|
J:161983
|
increased circulating estradiol level
|
J:161983
|
Papss2bm/Papss2bm
(B6C3Fe a/a-Papss2bm/J)
|
increased bleeding time
|
J:31800
|
Paqr5em1(IMPC)Ccpcz/Paqr5em1(IMPC)Ccpcz
(C57BL/6NCrl-Paqr5em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating calcium level
|
J:211773
|
Paqr6tm1b(KOMP)Wtsi/Paqr6tm1b(KOMP)Wtsi
(C57BL/6N-Paqr6tm1b(KOMP)Wtsi/Bay)
|
increased circulating calcium level
|
J:211773
|
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating glucose level
|
J:92244
|
increased circulating tumor necrosis factor level
|
J:92244
|
Park7em1(IMPC)H/Park7em1(IMPC)H
(C57BL/6NTac-Park7em1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Parp1em1(IMPC)Ccpcz/Parp1em1(IMPC)Ccpcz
(C57BL/6NCrl-Parp1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J)
|
decreased circulating creatinine level
|
J:95418
|
Parp1tm2Zqw/Parp1tm2Zqw
(either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased circulating interleukin-1 beta level
|
J:93479
|
decreased circulating tumor necrosis factor level
|
J:93479
|
Parp4em1(IMPC)Mbp/Parp4em1(IMPC)Mbp
(C57BL/6N-Parp4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Parp6em1Msco/Parp6em1Msco
(C57BL/6N-Parp6em1Msco)
|
cyanosis
|
J:319836
|
Parp9tm1.2Arte/Parp9tm1.2Arte
(involves: C57BL/6N * FVB/N)
|
abnormal circulating interferon level
|
J:306337
|
Parp11tm1.1(KOMP)Vlcg/Parp11tm1.1(KOMP)Vlcg
(C57BL/6N-Parp11tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
Parvbtm1a(EUCOMM)Wtsi/Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating glucose level
|
J:165965
|
decreased circulating iron level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
decreased circulating insulin level
|
J:125307
|
Pate4tm1.1(KOMP)Mbp/Pate4tm1.1(KOMP)Mbp
(C57BL/6N-Pate4tm1.1(KOMP)Mbp/J)
|
increased fasting circulating glucose level
|
J:211773
|
Patjem1(IMPC)J/Patjem1(IMPC)J
(C57BL/6NJ-Patjem1(IMPC)J/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
Patl1tm1b(EUCOMM)Wtsi/Patl1+
(C57BL/6N-Patl1tm1b(EUCOMM)Wtsi/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Pawrtm1b(EUCOMM)Wtsi/Pawr+
(C57BL/6N-Pawrtm1b(EUCOMM)Wtsi/H)
|
decreased circulating creatinine level
|
J:211773
|
Pax3tm1(FOXO1A)Gcg/Pax3+
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))
|
cyanosis
|
J:79365
|
Pax3tm2Joe/Pax3tm2Joe H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
cyanosis
|
J:159124
|
Pax4tm1b(EUCOMM)Hmgu/Pax4+
(C57BL/6N-Pax4tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Pax5tm1b(EUCOMM)Wtsi/Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pax6Sey-Neu/Pax6Sey-Neu
(involves: 102 * C3H)
|
decreased circulating growth hormone level
|
J:56185
|
Pax6tm1Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI)
|
decreased circulating insulin level
|
J:90642
|
hyperglycemia
|
J:90642
|
increased circulating ketone body level
|
J:90642
|
Pax6tm2Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI)
|
decreased circulating insulin level
|
J:90642
|
hyperglycemia
|
J:90642
|
increased circulating ketone body level
|
J:90642
|
Pax7tm1(cre)Mrc/Pax7+ Styxl2tm1Nju/Styxl2tm1Nju
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:351096
|
Pax7tm1.1(KOMP)Vlcg/Pax7+
(C57BL/6N-Pax7tm1.1(KOMP)Vlcg/J)
|
decreased circulating triglyceride level
|
J:211773
|
Pax8tm1Pgr/Pax8+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased circulating thyroid-stimulating hormone level
|
J:47310
|
Pax8tm1Pgr/Pax8tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased circulating thyroxine level
|
J:47310,
J:116236
|
decreased circulating triiodothyronine level
|
J:116236
|
Pax8tm1Rdl/Pax8tm1.1(cre)Mbu
(B6.129(Cg)-Pax8tm1Rdl Pax8tm1.1(cre)Mbu)
|
decreased circulating thyroxine level
|
J:220108
|
increased circulating thyroid-stimulating hormone level
|
J:220108
|
Pbld1em1(IMPC)Bay/Pbld1em1(IMPC)Bay
(C57BL/6N-Pbld1em1(IMPC)Bay/Bay)
|
decreased circulating calcium level
|
J:211773
|
Pbrm1tm1b(EUCOMM)Wtsi/Pbrm1+
(C57BL/6N-Pbrm1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Pbx3tm1.1Og/Pbx3tm1.1Og
(involves: 129S4/SvJae * C57BL/6)
|
cyanosis
|
J:130927
|
Pbx3tm1a(EUCOMM)Wtsi/Pbx3tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
increased circulating cholesterol level
|
J:165965
|
Pbx3tm1b(EUCOMM)Wtsi/Pbx3+
(C57BL/6N-Pbx3tm1b(EUCOMM)Wtsi/H)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Pbx3tm1Mlc/Pbx3tm1Mlc
(involves: C57BL/6)
|
cyanosis
|
J:93761
|
Pbx4em2Hncs/Pbx4em2Hncs
(involves: C57BL/6J * DBA * ICR)
|
decreased circulating erythropoietin level
|
J:349843
|
Pcbd1tm1Grc/Pcbd1tm1Grc
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
increased circulating insulin level
|
J:78257
|
increased circulating phenylalanine level
|
J:78257
|
Pccatm1Tmiy/Pccatm1Tmiy Tg(CAG-PCCA*A138T,-EGFP)#Miab/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating alanine level
|
J:286218
|
increased circulating ammonia level
|
J:286218
|
increased circulating glycine level
|
J:286218
|
Pcdh9tm1.1(KOMP)Vlcg/Pcdh9+
(C57BL/6N-Pcdh9tm1.1(KOMP)Vlcg/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Pcdh15av-3J/Pcdh15av-3J
(C57BL/6J-Pcdh15av-3J/J)
|
abnormal circulating lipid level
|
J:320724
|
decreased circulating cholesterol level
|
J:320724
|
decreased circulating triglyceride level
|
J:320724
|
Pcdhb13em1(IMPC)Tcp/Pcdhb13em1(IMPC)Tcp
(C57BL/6N-Pcdhb13em1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pcdhgb2em1(IMPC)Hmgu/Pcdhgb2em1(IMPC)Hmgu
(C57BL/6N-Pcdhgb2em1(IMPC)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Pcgf1tm1.1(KOMP)Vlcg/Pcgf1+
(C57BL/6N-Pcgf1tm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased circulating ketone body level
|
J:73977
|
decreased circulating triglyceride level
|
J:73977
|
hyperglycemia
|
J:73977
|
Pck1tm1.1Mgn/Pck1tm1.1Mgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac)
|
increased circulating free fatty acids level
|
J:63929
|
increased circulating triglyceride level
|
J:63929
|
Pck1tm1.2Mgn/Pck1tm1.2Mgn
(involves: 129S6/SvEvTac)
|
hypoglycemia
|
J:63929
|
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating amino acid level
|
J:145210
|
abnormal circulating lipid level
|
J:145210
|
decreased circulating glucose level
|
J:145210
|
increased blood urea nitrogen level
|
J:145210
|
increased circulating ammonia level
|
J:145210
|
increased circulating ketone body level
|
J:145210
|
increased circulating lactate level
|
J:145210
|
increased circulating triglyceride level
|
J:145210
|
Pck2em1(IMPC)Tcp/Pck2em1(IMPC)Tcp
(C57BL/6N-Pck2em1(IMPC)Tcp/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:46228
|
decreased circulating creatine kinase level
|
J:46228
|
decreased circulating ferritin level
|
J:46228
|
decreased circulating lactate dehydrogenase level
|
J:46228
|
decreased circulating phosphate level
|
J:46228
|
increased blood urea nitrogen level
|
J:46228
|
increased circulating aldosterone level
|
J:46228
|
increased circulating corticosterone level
|
J:46228
|
increased circulating triglyceride level
|
J:46228
|
Pcnx2em1(IMPC)J/Pcnx2+
(C57BL/6NJ-Pcnx2em1(IMPC)J/J)
|
increased circulating total protein level
|
J:211773
|
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli)
|
decreased circulating glucose level
|
J:324309
|
increased circulating insulin level
|
J:324309
|
Pcsk1N222D/Pcsk1N222D
(C57BL/6-Pcsk1N222D)
|
increased circulating leptin level
|
J:109531
|
Pcsk1tm1Dfs/Pcsk1+
(involves: 129 * C57BL/6J)
|
decreased circulating insulin level
|
J:78369
|
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
decreased circulating glucagon level
|
J:78369
|
decreased circulating growth hormone level
|
J:78369
|
decreased circulating insulin level
|
J:78369
|
hypoglycemia
|
J:78369
|
increased circulating interferon-gamma level
|
J:184882
|
increased circulating interleukin-1 beta level
|
J:184882
|
increased circulating interleukin-6 level
|
J:184882
|
increased circulating interleukin-10 level
|
J:184882
|
increased circulating interleukin-12 level
|
J:184882
|
increased circulating tumor necrosis factor level
|
J:184882
|
Pcsk2em1(IMPC)H/Pcsk2+
(C57BL/6NTac-Pcsk2em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Pcsk2em1(IMPC)H/Pcsk2em1(IMPC)H
(C57BL/6NTac-Pcsk2em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:41505
|
decreased circulating insulin level
|
J:41505
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J)
|
decreased circulating glucagon level
|
J:236905
|
increased circulating insulin level
|
J:236905
|
Pcsk4tm1b(KOMP)Wtsi/Pcsk4tm1b(KOMP)Wtsi
(C57BL/6N-Pcsk4tm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Pcsk5tm1b(KOMP)Mbp/Pcsk5+
(C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Pcsk9m1Bms/Pcsk9+
(B6.Cg-Pcsk9m1Bms)
|
decreased circulating LDL cholesterol level
|
J:200728
|
Pcsk9m1Bms/Pcsk9m1Bms
(B6.Cg-Pcsk9m1Bms)
|
decreased circulating LDL cholesterol level
|
J:200728
|
Pcsk9tm1.1Prat/Pcsk9tm1.1Prat Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:169834
|
decreased circulating HDL cholesterol level
|
J:169834
|
decreased circulating LDL cholesterol level
|
J:169834
|
Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating cholesterol level
|
J:169834
|
decreased circulating HDL cholesterol level
|
J:169834
|
decreased circulating LDL cholesterol level
|
J:169834
|
Pcsk9tm1Jdh/Pcsk9tm1Jdh
(involves: 129S6/SvEvTac)
|
decreased circulating cholesterol level
|
J:97836
|
decreased circulating HDL cholesterol level
|
J:97836
|
decreased circulating LDL cholesterol level
|
J:97836
|
Pcsk9tm2b(EUCOMM)Hmgu/Pcsk9tm2b(EUCOMM)Hmgu
(C57BL/6N-Pcsk9tm2b(EUCOMM)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL)
|
decreased circulating glucose level
|
J:332296
|
decreased fasting circulating glucose level
|
J:332296
|
hypoglycemia
|
J:332296
|
increased circulating free fatty acids level
|
J:332296
|
increased circulating ketone body level
|
J:332296
|
increased circulating lactate level
|
J:332296
|
increased circulating triglyceride level
|
J:332296
|
Pcyt1atm1Irt/Pcyt1atm1Irt Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/Tg(tetO-cre)1Jaw
(involves: C57BL/6J * FVB/N)
|
cyanosis
|
J:118292
|
Pcyt1btm1Mkar/Pcyt1btm1Mkar
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:90150
|
increased circulating luteinizing hormone level
|
J:90150
|
Pcyt2tm1.1Suja/Pcyt2tm1.1Suja Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:155630
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
increased circulating noradrenaline level
|
J:155373
|
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
hyperglycemia
|
J:123785
|
Pdcd6ipem1(IMPC)Hmgu/Pdcd6ipem1(IMPC)Hmgu
(C57BL/6N-Pdcd6ipem1(IMPC)Hmgu/Ieg)
|
increased blood urea nitrogen level
|
J:211773
|
Pdcd6ipem1(IMPC)Mbp/Pdcd6ipem1(IMPC)Mbp
(C57BL/6NCrl-Pdcd6ipem1(IMPC)Mbp/Mmucd)
|
decreased circulating bilirubin level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pdcd7em1(IMPC)Mbp/Pdcd7+
(C57BL/6NCrl-Pdcd7em1(IMPC)Mbp/Mmucd)
|
decreased circulating serum albumin level
|
J:211773
|
Pde1aem1(IMPC)H/Pde1aem1(IMPC)H
(C57BL/6N-Pde1aem1(IMPC)H/H)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Pde2aem1(IMPC)H/Pde2a+
(C57BL/6NTac-Pde2aem1(IMPC)H/H)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc)
|
abnormal circulating hormone level
|
J:117353
|
increased circulating free fatty acids level
|
J:117353
|
increased circulating glycerol level
|
J:117353
|
increased circulating insulin level
|
J:117353
|
Pde6aem1(IMPC)Mbp/Pde6aem1(IMPC)Mbp
(C57BL/6NCrl-Pde6aem1(IMPC)Mbp/Mmucd)
|
increased circulating phosphate level
|
J:211773
|
Pde7bem1(IMPC)Mbp/Pde7bem1(IMPC)Mbp
(C57BL/6NCrl-Pde7bem1(IMPC)Mbp/Mmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Pde8btm1Dgen/Pde8btm1Dgen
(B6.129P2-Pde8btm1Dgen)
|
decreased circulating adrenocorticotropin level
|
J:203335
|
Pde10aem1(IMPC)H/Pde10aem1(IMPC)H
(C57BL/6NTac-Pde10aem1(IMPC)H/H)
|
increased circulating iron level
|
J:211773
|
Pde10atm1Smsh/Pde10atm1Smsh
(B6NTac.Cg-Pde10atm1Smsh)
|
abnormal circulating glucose level
|
J:209032
|
abnormal circulating insulin level
|
J:209032
|
decreased circulating alanine transaminase level
|
J:209032
|
decreased circulating cholesterol level
|
J:209032
|
decreased circulating insulin level
|
J:209032
|
decreased circulating leptin level
|
J:209032
|
Pdgfctm1b(EUCOMM)Hmgu/Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating creatinine level
|
J:211773
|
Pdgfdem1(IMPC)Ccpcz/Pdgfdem1(IMPC)Ccpcz
(C57BL/6N-Pdgfdem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating potassium level
|
J:211773
|
Pdgfdtm1Ueks/Pdgfdtm1Ueks
(B6.Cg-Pdgfdtm1Ueks)
|
increased circulating calcium level
|
J:249014
|
Pdgfraem1(IMPC)Ccpcz/Pdgfra+
(C57BL/6NCrl-Pdgfraem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pdgfratm1Sor/Pdgfra+ Plekha1Gt(ROSA)82Sor/Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
Pdgfratm1Sor/Pdgfra+ Schip1Gt(ROSA)77Sor/Schip1Gt(ROSA)77Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
Pdgfratm8Sor/Pdgfratm8Sor Pdgfrbtm1Mdt/Pdgfrbtm1Mdt H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6 * CBA)
|
cyanosis
|
J:122584
|
Pdgfratm8Sor/Pdgfratm8Sor Tg(Nr5a1-cre)2Klp/0
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
Pdgfrbtm1b(EUCOMM)Hmgu/Pdgfrb+
(C57BL/6N-Pdgfrbtm1b(EUCOMM)Hmgu/H)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pdgfrbtm1Sor/Pdgfrb+ Schip1Gt(ROSA)77Sor/Schip1Gt(ROSA)77Sor
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd)
|
increased blood urea nitrogen level
|
J:117491
|
Pdgfrbtm5Sor/Pdgfrbtm5Sor
(either: 129S4/SvJaeSor-Pdgfratm5Sor or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal glomerular capillary thrombosis
|
J:67735
|
Pdgfrlem1(IMPC)J/Pdgfrlem1(IMPC)J
(C57BL/6NJ-Pdgfrlem1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
Pdha1tm1Ptl/Y Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased circulating insulin level
|
J:141289
|
Pdha1tm1Ptl/Pdha1+ Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased circulating insulin level
|
J:141289
|
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdia4tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6N)
|
decreased platelet aggregation
|
J:244748
|
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6N)
|
decreased platelet aggregation
|
J:244748
|
increased bleeding time
|
J:244748
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
abnormal circulating cytokine level
|
J:288824
|
decreased circulating insulin level
|
J:288824
|
decreased circulating insulin-like growth factor I level
|
J:288824
|
decreased circulating triglyceride level
|
J:288824
|
increased fasting circulating glucose level
|
J:288824
|
Pdk1tm1a(EUCOMM)Hmgu/Pdk1tm1a(EUCOMM)Hmgu Pdk2tm1Rhar/Pdk2tm1Rhar Pdk3em1Eze/Pdk3em1Eze Pdk4tm1Rhar/Pdk4tm1Rhar
(involves: 129 * C57BL/6J * C57BL/6N)
|
abnormal circulating protein level
|
J:303714
|
decreased circulating glucose level
|
J:303714
|
decreased circulating lactate level
|
J:303714
|
increased circulating ketone body level
|
J:303714
|
Pdk4tm1Rhar/Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar)
|
abnormal blood homeostasis
|
J:115895
|
abnormal circulating amino acid level
|
J:115895
|
decreased circulating alanine level
|
J:115895
|
decreased circulating glucose level
|
J:115895
|
decreased circulating lactate level
|
J:115895
|
increased circulating free fatty acids level
|
J:115895
|
increased circulating insulin level
|
J:115895
|
increased circulating ketone body level
|
J:115895
|
Pdlim1Gt(IST12013D3)Tigm/Pdlim1Gt(IST12013D3)Tigm
(involves: C57BL/6N)
|
abnormal platelet physiology
|
J:212221
|
abnormal thrombosis
|
J:212221
|
increased platelet aggregation
|
J:212221
|
Pdlim1Gt(XC262)Byg/Pdlim1Gt(XC262)Byg
(involves: 129P2/OlaHsd)
|
abnormal platelet dense granule physiology
|
J:212221
|
abnormal platelet physiology
|
J:212221
|
abnormal thrombosis
|
J:212221
|
increased platelet aggregation
|
J:212221
|
Pdlim4em1(IMPC)Ics/Pdlim4em1(IMPC)Ics
(C57BL/6N-Pdlim4em2(IMPC)Ics/Ics)
|
decreased circulating glucose level
|
J:211773
|
Pdlim7Gt(OST445990)Lex/Pdlim7+
(B6.129S5-Pdlim7Gt(OST445990)Lex)
|
abnormal cardiac thrombosis
|
J:209780
|
decreased bleeding time
|
J:209780
|
Pdlim7Gt(OST445990)Lex/Pdlim7Gt(OST445990)Lex
(B6.129S5-Pdlim7Gt(OST445990)Lex)
|
abnormal cardiac thrombosis
|
J:209780
|
abnormal thrombosis
|
J:209780
|
decreased bleeding time
|
J:209780
|
Pdpk1tm1Dral/Pdpk1tm1Dral
(B6.129P2-Pdpk1tm1Dral)
|
increased circulating insulin level
|
J:136089
|
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
abnormal circulating leptin level
|
J:134336
|
decreased circulating corticosterone level
|
J:134336
|
decreased circulating glucose level
|
J:134336
|
increased circulating glucose level
|
J:134336
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N)
|
increased circulating glucose level
|
J:109359
|
increased circulating insulin level
|
J:109359
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
decreased circulating corticosterone level
|
J:162892
|
hypoglycemia
|
J:162892
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:109010
|
hyperglycemia
|
J:109010
|
increased circulating glucose level
|
J:109010
|
Pdpntm1b(EUCOMM)Wtsi/Pdpn+
(C57BL/6N-Pdpntm1b(EUCOMM)Wtsi/H)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Pdpntm1Mcws/Pdpntm1Mcws
(involves: 129S6/SvEvTac)
|
cyanosis
|
J:82687
|
Pdprtm1b(EUCOMM)Wtsi/Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating creatinine level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Pds5btm1Jmi/Pds5btm1Jmi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:124279
|
Pdss2tm1b(EUCOMM)Hmgu/Pdss2+
(C57BL/6N-Pdss2tm1b(EUCOMM)Hmgu/H)
|
increased circulating bilirubin level
|
J:211773
|
Pdss2tm1Dalg/Pdss2tm1Dalg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating cholesterol level
|
J:136670
|
Pdss2tm1Dalg/Pdss2tm1Dalg Tg(NPHS2-cre)295Lbh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating cholesterol level
|
J:136670
|
Pdx1tm1.1Stof/Pdx1+
(involves: 129/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:152582
|
Pdx1tm1.1Stof/Pdx1tm1.1Stof
(involves: 129/Sv * C57BL/6)
|
decreased circulating insulin level
|
J:152582
|
hyperglycemia
|
J:152582
|
Pdx1tm1Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating glucose level
|
J:165268
|
Pdx1tm1Cvw/Pdx1+ Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
hyperglycemia
|
J:75811
|
Pdx1tm1Cvw/Pdx1+ SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating glucose level
|
J:165268
|
Pdx1tm1Cvw/Pdx1tm1.1Stof
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:152582
|
Pdx1tm1Cvw/Pdx1tm4Cvw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:130389
|
increased circulating glucose level
|
J:130389
|
Pdx1tm1Heed/Pdx1tm1Heed Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:48516
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:101742
|
increased circulating glucose level
|
J:79206
|
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd)
|
increased circulating glucose level
|
J:82969
|
Pdx1tm1Ted/Pdx1tm1Ted
(involves: 129P2/OlaHsd)
|
increased circulating glucose level
|
J:20779
|
Pdx1tm2Cvw/Pdx1+ Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
decreased circulating insulin level
|
J:97234
|
increased circulating glucose level
|
J:97234
|
Pdx1tm3Cvw/Pdx1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
decreased circulating insulin level
|
J:104617
|
increased circulating glucose level
|
J:104617
|
Pdynem1(IMPC)Rbrc/Pdynem1(IMPC)Rbrc
(C57BL/6NJcl-Pdynem1(IMPC)Rbrc/Rbrc)
|
abnormal circulating iron level
|
J:211773
|
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating glucagon level
|
J:122399
|
decreased circulating glucose level
|
J:122399
|
decreased circulating insulin-like growth factor I level
|
J:122399
|
decreased circulating thyroxine level
|
J:122399
|
increased circulating corticosterone level
|
J:122399
|
Pdzd2Gt(S3-7A1)Sor/Pdzd2Gt(S3-7A1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
decreased circulating glucose level
|
J:307008
|
increased circulating insulin level
|
J:307008
|
Pdzd2Gt(S7-9G1)Sor/Pdzd2Gt(S7-9G1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
decreased circulating glucose level
|
J:307008
|
increased circulating insulin level
|
J:307008
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8+
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pdzk1tm1Dls/Pdzk1tm1Dls
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal circulating protein level
|
J:107125
|
Pdzk1tm1Oko/Pdzk1tm1Oko
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased circulating cholesterol level
|
J:81814
|
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1+
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Peak1em1(IMPC)J/Peak1em1(IMPC)J
(C57BL/6NJ-Peak1em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pear1tm1a(KOMP)Wtsi/Pear1tm1a(KOMP)Wtsi
(C57BL/6N-Pear1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pear1tm1a(KOMP)Wtsi/Pear1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased platelet aggregation
|
J:237835
|
Pedm14/Pedm14+
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Pedm35/Pedm35+
(involves: C3H/HeH * C57BL/6J)
|
hyperglycemia
|
J:169366
|
Pedm105/Pedm105+
(Not Specified)
|
increased circulating phosphate level
|
J:169366
|
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Peds1tm1a(KOMP)Wtsi Tyrc-Brd/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6)
|
decreased circulating interferon-beta level
|
J:152781
|
decreased circulating interleukin-6 level
|
J:152781
|
decreased circulating interleukin-12b level
|
J:152781
|
decreased circulating tumor necrosis factor level
|
J:152781
|
Peli2tm1.1Arte/Peli2tm1.1Arte
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:265431
|
decreased circulating interleukin-1 beta level
|
J:265431
|
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:83870
|
decreased circulating cholesterol level
|
J:83870
|
decreased circulating HDL cholesterol level
|
J:83870
|
decreased circulating homocysteine level
|
J:81995
|
Pepddal/Pepddal
(involves: C3H/HeJ * CBA/J)
|
decreased circulating testosterone level
|
J:143333
|
Pepdtm1a(KOMP)Wtsi/Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd)
|
increased circulating insulin level
|
J:211773
|
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Per1tm1Brd/Per1tm1Brd Per2tm1Brd/Per2tm1Brd
(involves: 129S7/SvEvBrd)
|
increased circulating leptin level
|
J:115188
|
Per2tm1a(EUCOMM)Hmgu/Per2tm1a(EUCOMM)Hmgu
(C57BL/6N-Per2tm1a(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:165965
|
Pes1tm1b(EUCOMM)Wtsi/Pes1+
(C57BL/6N-Pes1tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
|
abnormal venous thrombosis
|
J:278655
|
hyperglycemia
|
J:278655
|
Pex1tm1.1Sjms/Pex1tm1.1Sjms
(involves: 129 * C57BL/6N)
|
abnormal circulating phospholipid level
|
J:210296
|
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
decreased circulating cholesterol level
|
J:87591
|
decreased circulating HDL cholesterol level
|
J:87591
|
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating free fatty acids level
|
J:44975
|
decreased circulating cholesterol level
|
J:87591
|
Pex3tm1a(EUCOMM)Wtsi/Pex3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pex3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
increased circulating fructosamine level
|
J:175295
|
Pex5tm1Pec/Pex5tm1Pec Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal blood homeostasis
|
J:112503
|
increased circulating lactate level
|
J:112503
|
Pex10m1Nisw/Pex10m1Nisw
(129S1.B6-Pex10m1Nisw)
|
cyanosis
|
J:216140
|
Pex11atm1Itl/Pex11atm1Itl
(C57BL/6-Pex11atm1Itl)
|
abnormal circulating triglyceride level
|
J:195940
|
increased circulating free fatty acids level
|
J:195940
|
increased circulating ketone body level
|
J:195940
|
Pf4tm1Mako/Pf4+
(B6.129X1-Pf4tm1Mako)
|
decreased susceptibility to induced thrombosis
|
J:94900
|
Pf4tm1Mako/Pf4tm1Mako
(B6.129X1-Pf4tm1Mako)
|
decreased susceptibility to induced thrombosis
|
J:94900
|
Pfasem1(IMPC)J/Pfas+
(C57BL/6NJ-Pfasem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Pfdn6tm1.1(KOMP)Vlcg/Pfdn6+
(C57BL/6N-Pfdn6tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Pfkfb2tm1.2Dap/Pfkfb2tm1.2Dap
(involves: C57BL/6)
|
decreased blood urea nitrogen level
|
J:296139
|
Pfkfb2tm1b(KOMP)Wtsi/Pfkfb2tm1b(KOMP)Wtsi
(C57BL/6N-Pfkfb2tm1b(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Pfkfb3tm1.1Pec/Pfkfb3tm1.1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
decreased circulating lactate level
|
J:296552
|
PfkmGT(OST56064)Lex/PfkmGT(OST56064)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:125530
|
increased circulating glucose level
|
J:125530
|
Pfkmtm1Fbos/Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating lactate level
|
J:152153
|
increased circulating bilirubin level
|
J:152153
|
Pfn1tm1a(EUCOMM)Wtsi/Pfn1+
(B6Brd;B6Dnk;B6N-Tyrc-Brd Pfn1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:175295
|
increased circulating amylase level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Pgam5tm1b(EUCOMM)Wtsi/Pgam5tm1b(EUCOMM)Wtsi
(C57BL/6N-Pgam5tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Pgap4em1Osbir/Pgap4em1Osbir
(involves: C57BL/6NSlc)
|
increased circulating alkaline phosphatase level
|
J:333707
|
increased circulating calcium level
|
J:333707
|
Pgbd5em1(IMPC)Tcp/Pgbd5em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd5em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Pgcem1Hcz/Pgcem1Hcz
(Not Specified)
|
decreased circulating alkaline phosphatase level
|
J:338079
|
Pgcka1em1(IMPC)Ccpcz/Pgcka1em1(IMPC)Ccpcz
(C57BL/6NCrl-Pgcka1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Pgdtm1.1Pse/Pgdtm1.1Pse Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating interferon-gamma level
|
J:313817
|
increased circulating interleukin-4 level
|
J:313817
|
increased circulating interleukin-5 level
|
J:313817
|
increased circulating interleukin-17 level
|
J:313817
|
Pglyrp2tm1Lky/Pglyrp2tm1Lky
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:159600
|
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz)
|
abnormal circulating chemokine level
|
J:178054
|
Pgpep1em1(IMPC)J/Pgpep1em1(IMPC)J
(C57BL/6NJ-Pgpep1em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
increased circulating prolactin level
|
J:85196
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:56917
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating glucose level
|
J:125584
|
increased circulating insulin level
|
J:125584
|
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N)
|
decreased circulating triglyceride level
|
J:268130
|
increased circulating alanine transaminase level
|
J:268130
|
increased circulating free fatty acids level
|
J:268130
|
Pgrmc2tm1.1Jjp/Pgrmc2tm1.1Jjp Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating progesterone level
|
J:247103
|
Pgs1tm1b(EUCOMM)Hmgu/Pgs1+
(C57BL/6N-Pgs1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating phosphate level
|
J:211773
|
Phactr1em1(IMPC)Mbp/Phactr1em1(IMPC)Mbp
(C57BL/6NCrl-Phactr1em1(IMPC)Mbp/Mmucd)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
Phb1em1(IMPC)H/Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Phc3tm2b(KOMP)Wtsi/Phc3tm2b(KOMP)Wtsi
(C57BL/6N-Phc3tm2b(KOMP)Wtsi/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Phdlc1C57BL/6J/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
Phdlc1CASA/RkJ/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
Phdlc2C57BL/6J/Phdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
PhexHpr/Y
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating phosphate level
|
J:187142
|
increased circulating alkaline phosphatase level
|
J:187142
|
PhexHpr/Phex+
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating phosphate level
|
J:187142
|
increased circulating alkaline phosphatase level
|
J:187142
|
PhexHyp-2J/Y
(C57BL/6-PhexHyp-2J/J)
|
decreased circulating calcium level
|
J:88352
|
decreased circulating potassium level
|
J:88352
|
PhexHyp-Duk/Y
(involves: BALB/cAnBomUrd)
|
decreased circulating calcium level
|
J:88352
|
decreased circulating potassium level
|
J:88352
|
PhexHyp/Y
(Not Specified)
|
decreased circulating phosphate level
|
J:110579,
J:131043
|
PhexHyp/Y
(B6.Cg-PhexHyp/J)
|
decreased circulating calcium level
|
J:88352
|
decreased circulating phosphate level
|
J:87808
|
decreased circulating potassium level
|
J:88352
|
PhexHyp/?
(involves: C57BL/6J)
|
decreased circulating phosphate level
|
J:99866
|
PhexHyp/Y
(involves: C57BL/6)
|
decreased circulating phosphate level
|
J:8335
|
increased circulating alkaline phosphatase level
|
J:8335
|
PhexHyp/Y
(involves: C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
PhexHyp/Y
(involves: C3H/HeSnJ * C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
PhexHyp/Phex+
(B6.Cg-PhexHyp/J)
|
decreased circulating phosphate level
|
J:87808
|
PhexHyp/Phex+
(involves: C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
PhexHyp/Phex+ Tg(Bglap2-Phex)1Ldq/?
(involves: C57BL/6J)
|
decreased circulating phosphate level
|
J:74324
|
PhexHyp/PhexHyp
(B6.Cg-PhexHyp/J)
|
decreased circulating phosphate level
|
J:87808
|
PhexHyp/PhexHyp
(involves: C3H/HeSnJ * C57BL/6J)
|
decreased circulating phosphate level
|
J:17152
|
Phexm1Jrt/Y
(B6.129S1-PhexM1Jrt)
|
decreased circulating calcium level
|
J:196537
|
decreased circulating phosphate level
|
J:196537
|
increased circulating alkaline phosphatase level
|
J:196537
|
Phexm1Jrt/Phex+
(B6.129S1-PhexM1Jrt)
|
decreased circulating calcium level
|
J:196537
|
decreased circulating phosphate level
|
J:196537
|
increased circulating alkaline phosphatase level
|
J:196537
|
PhexMhdabap012/PhexMhdabap012
(C3HeB/FeJ-PhexMhdabap012)
|
decreased circulating phosphate level
|
J:183993
|
increased circulating alkaline phosphatase level
|
J:183993
|
PhexMhdabap024/Y
(C3HeB/FeJ-PhexMhdabap024)
|
abnormal blood homeostasis
|
J:264682
|
decreased circulating C-reactive protein level
|
J:264682
|
decreased circulating phosphate level
|
J:264682
|
increased circulating parathyroid hormone level
|
J:264682
|
PhexMhdabap024/Phex+
(C3HeB/FeJ-PhexMhdabap024)
|
abnormal blood homeostasis
|
J:264682
|
decreased circulating phosphate level
|
J:264682
|
increased circulating parathyroid hormone level
|
J:264682
|
PhexMhdabap024/PhexMhdabap024
(C3HeB/FeJ-PhexMhdabap024)
|
decreased circulating alkaline phosphatase level
|
J:183993
|
decreased circulating phosphate level
|
J:183993
|
PhexPug/Y
(involves: C57BL/6J)
|
decreased circulating calcium level
|
J:136463
|
decreased circulating phosphate level
|
J:136463
|
PhexSka1/Y
(C57BL/6-PhexSka1)
|
decreased circulating phosphate level
|
J:79953
|
increased circulating alkaline phosphatase level
|
J:79953
|
PhexSka1/Phex+
(C57BL/6-PhexSka1)
|
decreased circulating phosphate level
|
J:79953
|
increased circulating alkaline phosphatase level
|
J:79953
|
PhexSka1/PhexSka1
(C57BL/6-PhexSka1)
|
decreased circulating calcium level
|
J:79953
|
decreased circulating phosphate level
|
J:79953
|
increased circulating alkaline phosphatase level
|
J:79953
|
Phextm1.1Mkd/Y Tg(BGLAP-cre)1Clem/0
(B6.Cg-Phextm1.1Mkd Tg(BGLAP-cre)1Clem)
|
decreased circulating phosphate level
|
J:131043
|
Phextm1.2Mkd/Y
(B6.129-Phextm1.2Mkd)
|
decreased circulating phosphate level
|
J:131043
|
Phf6tm1.1Avo/Y Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
increased circulating interferon-alpha level
|
J:276228
|
Phf6tm1.2Avo/Y
(involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N)
|
decreased circulating growth hormone level
|
J:299742
|
decreased circulating insulin-like growth factor I level
|
J:299742
|
Phf7tm1b(EUCOMM)Hmgu/Phf7tm1b(EUCOMM)Hmgu
(C57BL/6N-Phf7tm1b(EUCOMM)Hmgu/Kmpc)
|
decreased circulating lactate dehydrogenase level
|
J:211773
|
Phf8em2(IMPC)Wtsi/Phf8em2(IMPC)Wtsi
(C57BL/6N-Phf8em2(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Phf8tm1dIcs/Y
(C57BL/6N-Phf8tm1dIcs/Ics)
|
increased circulating HDL cholesterol level
|
J:211773
|
Phf8tm1dIcs/Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Phf14em1(IMPC)Hmgu/Phf14+
(C57BL/6N-Phf14em1(IMPC)Hmgu/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Phf14tm1Take/Phf14tm1Take
(B6.Cg-Phf14tm1Take)
|
cyanosis
|
J:184822
|
Phgdhtm1.2Shfu/Phgdhtm1.2Shfu Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating glycine level
|
J:167572
|
Phipem1(IMPC)Tcp/Phip+
(C57BL/6NCrl-Phipem1(IMPC)Tcp/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
PhipGt(RRJ571)Byg/PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
hypoglycemia
|
J:164354
|
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:330539
|
decreased fasting circulating glucose level
|
J:330539
|
increased blood uric acid level
|
J:330539
|
increased circulating ketone body level
|
J:330539
|
increased circulating triglyceride level
|
J:330539
|
Phkbem1(IMPC)J/Phkbem1(IMPC)J
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Phospho1m1Jlm/Phospho1m1Jlm
(involves: C3HeB/FeJ * C57BL/6)
|
increased circulating phosphate level
|
J:173678
|
Phox2a/Inppl1tm1Ssch/Phox2a/Inppl1tm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:96443
|
decreased circulating insulin level
|
J:96443
|
hypoglycemia
|
J:96443
|
Phox2a/Inppl1tm1Ssch/Phox2a/Inppl1tm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:96443
|
decreased circulating insulin level
|
J:96443
|
hypoglycemia
|
J:96443
|
Phox2btm1.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
cyanosis
|
J:190742
|
Phox2btm1Rth/Phox2b+ Hprt1tm1(CAG-cre)Mnn/?
(involves: 129 * 129S1/Sv * C57BL/6)
|
cyanosis
|
J:331513
|
Phox2btm2.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
cyanosis
|
J:190742
|
Phox2btm2Jbr/Phox2b+
(involves: 129S2/SvPas * C57BL/6)
|
cyanosis
|
J:131365
|
Phpt1tm1.1Eys/Phpt1tm1.1Eys
(involves: C57BL/6J * FVB/N)
|
decreased circulating glucose level
|
J:262099
|
decreased circulating insulin level
|
J:262099
|
increased circulating insulin level
|
J:262099
|
Phrf1em1(IMPC)Tcp/Phrf1em1(IMPC)Tcp
(C57BL/6N-Phrf1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)
|
abnormal blood homeostasis
|
J:142512
|
abnormal circulating lipid level
|
J:142512
|
decreased circulating cholesterol level
|
J:142512
|
decreased circulating free fatty acids level
|
J:142512
|
decreased circulating triglyceride level
|
J:142512
|
increased circulating alanine transaminase level
|
J:142512
|
increased circulating amylase level
|
J:142512
|
Phykpltm1a(EUCOMM)Wtsi/Phykpltm1a(EUCOMM)Wtsi
(C57BL/6N-Phykpltm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
decreased circulating creatinine level
|
J:165965
|
Pi4k2aGt(AK0094)Wtsi/Pi4k2aGt(AK0094)Wtsi
(involves: 129P2/OlaHsd * BALB/c)
|
increased circulating aspartate transaminase level
|
J:150794
|
Pi16em1(IMPC)Mbp/Pi16em1(IMPC)Mbp
(C57BL/6NCrl-Pi16em1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Pias2tm1a(KOMP)Wtsi/Pias2tm1a(KOMP)Wtsi
(C57BL/6N-Pias2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Pibf1tm1.1(KOMP)Vlcg/Pibf1+
(B6N(Cg)-Pibf1tm1.1(KOMP)Vlcg/J)
|
increased circulating bilirubin level
|
J:211773
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
increased circulating erythropoietin level
|
J:220728
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
increased circulating erythropoietin level
|
J:220728
|
increased circulating iron level
|
J:220728
|
Pierce2em1(IMPC)H/Pierce2em1(IMPC)H
(C57BL/6N-Pierce2em1(IMPC)H/H)
|
increased circulating calcium level
|
J:211773
|
Piezo1tm1b(KOMP)Wtsi/Piezo1+
(C57BL/6N-Piezo1tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Piezo1tm2.1Apat/Piezo1tm2.1Apat Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA)
|
decreased blood osmolality
|
J:229436
|
decreased circulating haptoglobin level
|
J:229436
|
Piezo2em2(IMPC)J/Piezo2+
(C57BL/6NJ-Piezo2em2(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Pigcem1(IMPC)J/Pigc+
(C57BL/6NJ-Pigcem1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Pightm1.1(KOMP)Vlcg/Pigh+
(C57BL/6N-Pightm1.1(KOMP)Vlcg/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Pigzem1(IMPC)J/Pigzem1(IMPC)J
(C57BL/6NJ-Pigzem1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal blood homeostasis
|
J:169710
|
decreased circulating bilirubin level
|
J:169710
|
increased blood urea nitrogen level
|
J:169710
|
increased circulating alkaline phosphatase level
|
J:169710
|
increased circulating cholesterol level
|
J:169710
|
increased circulating creatinine level
|
J:169710
|
increased circulating phosphate level
|
J:169710
|
increased circulating potassium level
|
J:169710
|
Pik3c2atm1Bvan/Pik3c2a+
(involves: C57BL/6)
|
abnormal platelet physiology
|
J:226344
|
decreased platelet aggregation
|
J:226344
|
decreased susceptibility to induced thrombosis
|
J:226344
|
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6)
|
increased circulating cholesterol level
|
J:223018
|
increased circulating glucose level
|
J:223018
|
increased circulating insulin level
|
J:223018
|
increased circulating triglyceride level
|
J:223018
|
Pik3c3tm1a(EUCOMM)Wtsi/Pik3c3+
(C57BL/6N-Pik3c3tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating aspartate transaminase level
|
J:165965
|
Pik3catm1.1Rzl/Pik3catm1.1Rzl Tg(Fabp4-cre)1Blw/0
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal circulating androgen level
|
J:315599
|
decreased circulating luteinizing hormone level
|
J:315599
|
increased circulating leptin level
|
J:315599
|
increased circulating testosterone level
|
J:315599
|
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating insulin level
|
J:109024
|
increased circulating leptin level
|
J:109024
|
Pik3catm1Nbm/Pik3ca+ Pik3cbtm1Nbm/Pik3cb+
(involves: 129S6/SvEvTac)
|
increased circulating insulin level
|
J:96761
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased circulating cholesterol level
|
J:152332
|
decreased circulating triglyceride level
|
J:152332
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi)
|
increased circulating glucose level
|
J:152332
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129P2/OlaHsd)
|
abnormal platelet physiology
|
J:152267
|
decreased platelet aggregation
|
J:152267
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:165087
|
Pik3cbtm1a(EUCOMM)Wtsi/Pik3cb+
(B6JTyr;B6N-Pik3cbtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:175295
|
Pik3cbtm1Bvan/Pik3cbtm1Bvan Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd)
|
decreased platelet aggregation
|
J:158839
|
Pik3cbtm1Jjz/Pik3cbtm1Jjz
(involves: 129 * C57BL/6)
|
increased circulating leptin level
|
J:138565
|
Pik3cdm2Btlr/Pik3cdm2Btlr
(C57BL/6J-Pik3cdm2Btlr)
|
increased circulating interferon-alpha level
|
J:236693
|
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(B6.129P2-Pik3cdtm1.1Bvan)
|
abnormal platelet aggregation
|
J:114310
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal platelet aggregation
|
J:114310
|
Pik3cgtm1a(EUCOMM)Wtsi/Pik3cgtm1a(EUCOMM)Wtsi
(B6NTac;B6N-Atm1Brd Pik3cgtm1a(EUCOMM)Wtsi/WtsiOulu)
|
decreased circulating alanine transaminase level
|
J:175295
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
abnormal platelet physiology
|
J:107460
|
decreased platelet aggregation
|
J:107460
|
decreased susceptibility to induced thrombosis
|
J:107460
|
Pik3cgtm1Ehi/Pik3cgtm1Ehi
(Not Specified)
|
decreased platelet aggregation
|
J:152267
|
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J)
|
hyperglycemia
|
J:234657
|
increased circulating insulin level
|
J:234657
|
increased circulating insulin-like growth factor I level
|
J:234657
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating insulin level
|
J:65523
|
hypoglycemia
|
J:65523
|
Pik3r1tm1Khn/Pik3r1tm1Khn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating insulin level
|
J:87598
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:52576
|
decreased circulating insulin level
|
J:52576
|
hypoglycemia
|
J:52576
|
Pik3r1tm2Dfr/Pik3r1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
hypoglycemia
|
J:94077
|
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
hypoglycemia
|
J:94077
|
Pik3r2tm1e(KOMP)Wtsi/Pik3r2tm1e(KOMP)Wtsi
(C57BL/6N-Pik3r2tm1e(KOMP)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:175295
|
Pik3r2tm1Lca/Pik3r2tm1Lca
(involves: 129S6/SvEvTac)
|
decreased circulating glucose level
|
J:73703
|
decreased circulating insulin level
|
J:73703
|
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)
|
increased circulating creatine kinase level
|
J:198770
|
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi Tg(Ckm-cre)28Arte/0
(involves: C57BL/6)
|
increased circulating insulin level
|
J:199213
|
increased circulating triglyceride level
|
J:199213
|
Pikfyvetm2.1Tssk/Pikfyvetm2.1Tssk Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal circulating enzyme level
|
J:193689
|
decreased circulating free fatty acids level
|
J:193689
|
decreased circulating serum albumin level
|
J:193689
|
decreased circulating total protein level
|
J:193689
|
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb)
|
increased blood urea nitrogen level
|
J:191085
|
increased circulating alanine transaminase level
|
J:191085
|
increased circulating lactate dehydrogenase level
|
J:191085
|
Pilrb1tm1Pgh/Pilrb1tm1Pgh
(involves: C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:157763
|
decreased circulating interleukin-6 level
|
J:157763
|
decreased circulating tumor necrosis factor level
|
J:157763
|
increased circulating interferon-gamma level
|
J:157763
|
increased circulating interleukin-12 level
|
J:157763
|
Pip4k2bGt(Betageo)1Lca/Pip4k2bGt(Betageo)1Lca
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating insulin level
|
J:91023
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal circulating chemokine level
|
J:234283
|
abnormal circulating protein level
|
J:234283
|
decreased blood urea nitrogen level
|
J:234283
|
increased circulating aspartate transaminase level
|
J:234283
|
increased circulating interferon-gamma level
|
J:234283
|
increased circulating interleukin-2 level
|
J:234283
|
increased circulating interleukin-4 level
|
J:234283
|
increased circulating interleukin-10 level
|
J:234283
|
increased circulating interleukin-12 level
|
J:234283
|
increased circulating interleukin-12b level
|
J:234283
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(C57BL/6N-Pip4k2ctm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Pip5k1ctm1b(KOMP)Wtsi/Pip5k1c+
(C57BL/6N-Pip5k1ctm1b(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pip5k1ctm1Csab/Pip5k1ctm1Csab Tg(Pf4-icre)Q3Rsko/0
(Not Specified)
|
abnormal platelet physiology
|
J:196476
|
Pipem1(IMPC)Mbp/Pipem1(IMPC)Mbp
(C57BL/6NCrl-Pipem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd)
|
decreased circulating glucagon level
|
J:85204
|
decreased circulating insulin level
|
J:85204
|
decreased circulating triglyceride level
|
J:85204
|
hypoglycemia
|
J:85204
|
increased circulating alkaline phosphatase level
|
J:85204
|
increased circulating aspartate transaminase level
|
J:85204
|
increased circulating bilirubin level
|
J:85204
|
increased circulating corticosterone level
|
J:85204
|
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd)
|
decreased circulating glucagon level
|
J:85204
|
decreased circulating insulin level
|
J:85204
|
decreased circulating triglyceride level
|
J:85204
|
hypoglycemia
|
J:85204
|
increased circulating alkaline phosphatase level
|
J:85204
|
increased circulating aspartate transaminase level
|
J:85204
|
increased circulating bilirubin level
|
J:85204
|
increased circulating corticosterone level
|
J:85204
|
Pitpnc1em1(IMPC)Kmpc/Pitpnc1em1(IMPC)Kmpc
(C57BL/6NTac-Pitpnc1em1(IMPC)Kmpc/Kmpc)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Pitpnm1tm1a(EUCOMM)Wtsi/Pitpnm1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating calcium level
|
J:207051
|
decreased circulating cholesterol level
|
J:207051
|
Pitpnm1tm1a(EUCOMM)Wtsi/Pitpnm1tm1a(EUCOMM)Wtsi
(C57BL/6N-Pitpnm1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
Pitx2tm1.1Sac/Pitx2tm2Sac Tg(Tshb-cre)4Sac/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating thyroid-stimulating hormone level
|
J:197591
|
Pitx2tm2Sac/Pitx2+ Tbx1tm1Bem/Tbx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
cyanosis
|
J:107397
|
Pitx2tm3.1Jfm/Pitx2tm3.1Jfm
(involves: 129S4/SvJaeSor * C57BL/6J)
|
cyanosis
|
J:79853
|
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6)
|
decreased blood uric acid level
|
J:156878
|
decreased circulating amylase level
|
J:156878
|
decreased circulating cholesterol level
|
J:156878
|
decreased circulating iron level
|
J:156878
|
decreased circulating triglyceride level
|
J:156878
|
increased blood uric acid level
|
J:156878
|
increased circulating alkaline phosphatase level
|
J:156878
|
increased circulating phosphate level
|
J:156878
|
Pitx3tm1.1(KOMP)Vlcg/Pitx3tm1.1(KOMP)Vlcg
(C57BL/6N-Pitx3tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Pkd1tm1.1Fqi/Pkd1tm1.1Fqi
(B6.129S6-Pkd1tm1.1Fqi)
|
increased blood urea nitrogen level
|
J:127628
|
Pkd1tm1.1Fqi/Pkd1tm1.1Fqi
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:193175
|
increased circulating creatinine level
|
J:193175
|
Pkd1tm1.1Pcha/Pkd1+ Pkd2tm1Som/Pkd2tm2Som
(involves: 129 * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:220561
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha
(involves: 129S1/Sv * C57BL/6)
|
increased blood urea nitrogen level
|
J:193544
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Pkd2tm1Som/Pkd2+
(involves: 129 * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:220561
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Pkd2tm1Som/Pkd2tm2Som
(involves: 129 * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:220561
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Pkd2tm2Som/Pkd2+
(involves: 129 * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:220561
|
Pkd1tm1.1Pcha/Pkd1tm1.1Pcha Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
increased blood urea nitrogen level
|
J:244067
|
Pkd1tm1.1Pcha/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR)
|
increased circulating creatinine level
|
J:244067
|
Pkd1tm1b(EUCOMM)Hmgu/Pkd1+
(C57BL/6N-Pkd1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pkd1tm1Hung/Pkd1tm1Hung
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
increased blood urea nitrogen level
|
J:104361
|
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
abnormal circulating creatinine level
|
J:52573
|
Pkd1tm1Shh/Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased blood urea nitrogen level
|
J:193544
|
uremia
|
J:193544
|
Pkd1tm1Som/Pkd1+ Prkcshtm1Som/Prkcshtm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased blood urea nitrogen level
|
J:188763
|
Pkd1tm1Som/Pkd1+ Sec63tm1Som/Sec63tm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased blood urea nitrogen level
|
J:188763
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1)
|
abnormal circulating mineral level
|
J:191967
|
increased blood urea nitrogen level
|
J:191967
|
increased circulating parathyroid hormone level
|
J:191967
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Hoxb7-cre)13Amc/0
(involves: 129S4/SvJae * C57BL/6)
|
increased blood urea nitrogen level
|
J:171619
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Nes-cre)Wme/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased blood urea nitrogen level
|
J:185855
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Pax8-rtTA2S*M2)1Koes/0 Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA * SJL)
|
increased blood urea nitrogen level
|
J:284006
|
Pkd1tm2Som/Pkd1tm2.1Som Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL)
|
decreased circulating glucose level
|
J:135301
|
increased blood urea nitrogen level
|
J:135301
|
increased circulating cholesterol level
|
J:135301
|
increased circulating phosphate level
|
J:135301
|
Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL)
|
decreased circulating glucose level
|
J:135301
|
increased blood urea nitrogen level
|
J:135301
|
increased circulating cholesterol level
|
J:135301
|
increased circulating phosphate level
|
J:135301
|
Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
increased circulating creatinine level
|
J:244067
|
Pkd2tm1.1Gwu/Pkd2tm1.1Gwu Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:265516
|
increased circulating creatinine level
|
J:265516
|
Pkd2tm1Som/Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL)
|
increased blood urea nitrogen level
|
J:59314,
J:220561
|
Pkd2tm2Som/Pkd2+ Prkcshtm1Som/Prkcshtm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased blood urea nitrogen level
|
J:188763
|
Pkd2tm2Som/Pkd2+ Sec63tm1Som/Sec63tm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)
|
increased blood urea nitrogen level
|
J:188763
|
Pkd2tm3Som/Pkd2tm3Som Tg(Pkhd1-cre)1Igr/0
(involves: 129S4/SvJae * C57BL/6)
|
increased blood urea nitrogen level
|
J:244067
|
increased circulating creatinine level
|
J:244067
|
Pkd2l2tm1b(EUCOMM)Wtsi/Pkd2l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Pkd2l2tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Pkdcctm1.1Mask/Pkdcctm1.1Mask
(involves: C57BL/6 * CBA * FVB/N)
|
cyanosis
|
J:158147
|
Pkdcctm1Hssk/Pkdcctm1Hssk
(involves: C57BL/6 * CBA)
|
cyanosis
|
J:140470
|
Pkigtm1b(EUCOMM)Hmgu/Pkigtm1b(EUCOMM)Hmgu
(C57BL/6N-Pkigtm1b(EUCOMM)Hmgu/Ieg)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Pklrslc/Pklrslc
(CBA/NSlc-Pklrslc)
|
increased circulating bilirubin level
|
J:30035
|
Pkn1tm1b(KOMP)Wtsi/Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Pkn2tm1b(KOMP)Wtsi/Pkn2+
(C57BL/6N-Pkn2tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating unsaturated transferrin level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Pkn3tm1.1(KOMP)Vlcg/Pkn3tm1.1(KOMP)Vlcg
(C57BL/6N-Pkn3tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Pkp4tm1b(EUCOMM)Wtsi/Pkp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Pkp4tm1b(EUCOMM)Wtsi/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pla2g1btm1Dyh/Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)
|
abnormal circulating glucose level
|
J:80216
|
decreased circulating insulin level
|
J:80216
|
decreased circulating leptin level
|
J:80216
|
Pla2g2etm1b(EUCOMM)Wtsi/Pla2g2etm1b(EUCOMM)Wtsi
(C57BL/6N-Pla2g2etm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae * C57BL/6)
|
increased blood osmolality
|
J:114240
|
Pla2g4etm2b(EUCOMM)Hmgu/Pla2g4etm2b(EUCOMM)Hmgu
(C57BL/6N-Pla2g4etm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pla2g4ftm1a(EUCOMM)Hmgu/Pla2g4ftm1a(EUCOMM)Hmgu
(C57BL/6N-Pla2g4ftm1a(EUCOMM)Hmgu/Ics)
|
increased circulating sodium level
|
J:165965
|
Pla2g5em1(IMPC)Ccpcz/Pla2g5em1(IMPC)Ccpcz
(C57BL/6NCrl-Pla2g5em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pla2g7em1(IMPC)J/Pla2g7em1(IMPC)J
(C57BL/6NJ-Pla2g7em1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Pla2g10tm1Itl/Pla2g10tm1Itl
(involves: C57BL/6NTac)
|
increased circulating corticosterone level
|
J:164545
|
Pla2g12bhlb218/Pla2g12bhlb218
(C57BL/6J-Pla2g12bhlb218/J)
|
decreased circulating cholesterol level
|
J:187708,
J:82961
|
decreased circulating HDL cholesterol level
|
J:187708,
J:82961
|
decreased circulating triglyceride level
|
J:187708
|
Pla2g12bmpc96H/Pla2g12bmpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:234901
|
decreased circulating LDL cholesterol level
|
J:234901
|
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv)
|
abnormal circulating cholesterol level
|
J:97471
|
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul)
|
decreased circulating free fatty acids level
|
J:239202
|
decreased circulating leptin level
|
J:239202
|
decreased circulating triglyceride level
|
J:239202
|
increased circulating alanine transaminase level
|
J:239202
|
increased circulating glucose level
|
J:239202
|
increased circulating insulin level
|
J:239202
|
increased fasting circulating glucose level
|
J:239202
|
Plac9tm1b(EUCOMM)Hmgu/Plac9tm1b(EUCOMM)Hmgu
(C57BL/6N-Plac9tm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Plag1em1(IMPC)Hmgu/Plag1em1(IMPC)Hmgu
(C57BL/6N-Plag1em1(IMPC)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Plagl2tm1Wjmv/Plagl2tm1Wjmv
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased circulating cholesterol level
|
J:130260
|
increased circulating triglyceride level
|
J:130260
|
Plast1C57BL/6J/Plast1C57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1C57BL/6J Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1CASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1CASA/Rk Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1aCASA/Rk/Plast1aCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:116492
|
Plast1bCASA/Rk/Plast1bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:116492
|
Plast2aC57BL/6J/Plast2aC57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast2aC57BL/6J/Plast2aCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast2bC57BL/6J/Plast2bC57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to induced thrombosis
|
J:17427
|
reduced thrombolysis
|
J:17427
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
increased circulating corticosterone level
|
J:81694,
J:94733
|
reduced thrombolysis
|
J:64220
|
Plattm1Mlg/Plattm1Mlg Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thrombosis
|
J:17427
|
reduced thrombolysis
|
J:17427
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating protein level
|
J:104962
|
abnormal thrombosis
|
J:17427
|
increased susceptibility to induced thrombosis
|
J:17427
|
Plautm1Mlg/Plautm1Mlg
(either: B6.Cg-Plautm1Mlg or (involves: Black Swiss * C57BL/6))
|
reduced thrombolysis
|
J:64220
|
Plcb2tm1Dwu/Plcb2tm1Dwu Plcb3tm1Dwu/Plcb3tm1Dwu
(involves: 129S1/Sv * CD-1)
|
abnormal platelet physiology
|
J:60348
|
decreased platelet aggregation
|
J:60348
|
decreased susceptibility to induced thrombosis
|
J:60348
|
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
increased circulating interleukin-17 level
|
J:205633
|
Plcd1tm1Tta/Plcd1tm1Tta
(involves: 129P2/OlaHsd)
|
increased circulating interleukin-17 level
|
J:205633
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
decreased platelet aggregation
|
J:114266
|
Plcz1em1(IMPC)H/Plcz1em1(IMPC)H
(C57BL/6N-Plcz1em1(IMPC)H/H)
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Pld1tm1.1Mafr/Pld1tm1.1Mafr
(B6.Cg-Pld1tm1.1Mafr)
|
abnormal platelet physiology
|
J:193451
|
Pld1tm3Mafr/Pld1tm3Mafr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased platelet aggregation
|
J:211547
|
Pld1tm3Mafr/Pld1tm3Mafr
(B6.129-Pld1tm3Mafr)
|
abnormal platelet activation
|
J:216114
|
Pld1tm3Mafr/Pld1tm3Mafr Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal platelet activation
|
J:216114
|
decreased susceptibility to induced thrombosis
|
J:216114
|
Pld3em1Nemz/Pld3em1Nemz Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz)
|
abnormal circulating chemokine level
|
J:281205
|
increased circulating CXCL10 level
|
J:281205
|
increased circulating ferritin level
|
J:281205
|
increased circulating interferon-gamma level
|
J:281205
|
increased circulating tumor necrosis factor level
|
J:281205
|
Pld4em1(IMPC)Mbp/Pld4em1(IMPC)Mbp
(C57BL/6N-Pld4em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.129(Cg)-Pld4tm1.1Nemz)
|
increased circulating CXCL10 level
|
J:281205
|
increased circulating interferon-gamma level
|
J:281205
|
Pld5tm1b(KOMP)Wtsi/Pld5tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Pld5tm1b(KOMP)Wtsi Tyrc-Brd/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Plektm1Csab/Plektm1Csab
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal platelet activation
|
J:148429
|
decreased platelet aggregation
|
J:148429
|
Plekha1Gt(ROSA)82Sor/Plekha1Gt(ROSA)82Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating testosterone level
|
J:142042
|
Plekha1tm1b(EUCOMM)Hmgu/Plekha1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plekha1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Plekhf1tm1.1Caox/Plekhf1tm1.1Caox Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Plekhf1tm1.1Caox Lyz2tm1(cre)Ifo)
|
decreased circulating interferon-beta level
|
J:277440
|
decreased circulating interleukin-6 level
|
J:277440
|
decreased circulating tumor necrosis factor level
|
J:277440
|
Plekhf2em1(IMPC)Wtsi/Plekhf2em1(IMPC)Wtsi
(C57BL/6NCrl-Plekhf2em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating unsaturated transferrin level
|
J:211773
|
Plekhg1tm1a(EUCOMM)Wtsi/Plekhg1tm1a(EUCOMM)Wtsi
(C57BL/6N-Plekhg1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating fructosamine level
|
J:175295
|
Plekhg2em1(IMPC)J/Plekhg2em1(IMPC)J
(C57BL/6NJ-Plekhg2em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Plekhh1tm1.1(KOMP)Mbp/Plekhh1tm1.1(KOMP)Mbp
(C57BL/6N-Plekhh1tm1.1(KOMP)Mbp/Ieg)
|
increased circulating lipase level
|
J:211773
|
Plekhm1tm1b(EUCOMM)Hmgu/Plekhm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plekhm1tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Plekhm2tm1a(EUCOMM)Wtsi/Plekhm2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
increased circulating alkaline phosphatase level
|
J:233985
|
Plekhn1tm1.1Hkon/Plekhn1tm1.1Hkon
(B6.Cg-Plekhn1tm1.1Hkon)
|
increased circulating leptin level
|
J:251603
|
Plet1em1(IMPC)Wtsi/Plet1em1(IMPC)Wtsi
(C57BL/6N-Plet1em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating sodium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Plgtm1.1Fjc/Plgtm1.1Fjc
(involves: C57BL/6 * C57BL/6JJcl)
|
increased circulating fibrinogen level
|
J:210802
|
Plgtm1Dco/Plg+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Plgtm1Dco/Plg+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:30174
|
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal blood coagulation
|
J:80114
|
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:30174
|
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas)
|
increased circulating fibrinogen level
|
J:210802
|
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
abnormal thrombosis
|
J:39419
|
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal kidney thrombosis
|
J:36591
|
abnormal thrombosis
|
J:36591
|
Plin1tm1Asg/Plin1tm1Asg
(B6.129S6-Plin1tm1Asg)
|
abnormal circulating free fatty acids level
|
J:113735
|
Plin1tm1Cdl/Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating insulin level
|
J:69629
|
increased circulating leptin level
|
J:69629
|
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:66267
|
abnormal circulating free fatty acids level
|
J:66267
|
abnormal circulating ketone body level
|
J:66267
|
decreased circulating leptin level
|
J:66267
|
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg)
|
decreased circulating free fatty acids level
|
J:196302
|
decreased circulating leptin level
|
J:196302
|
decreased circulating triglyceride level
|
J:196302
|
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl)
|
increased circulating free fatty acids level
|
J:188390
|
Plk4m1Lja/Plk4+
(C57BL/6J-Plk4m1Lja)
|
increased circulating follicle stimulating hormone level
|
J:177071
|
Pllptm1(KOMP)Vlcg/Pllptm1(KOMP)Vlcg
(C57BL/6NCrl-Pllptm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Plpp1Gt(RRD231)Byg/Plpp1Gt(RRD231)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:149782
|
Plpp3tm1b(EUCOMM)Hmgu/Plpp3+
(C57BL/6N-Plpp3tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating creatinine level
|
J:211773
|
Plpp4em1(IMPC)Hmgu/Plpp4em1(IMPC)Hmgu
(C57BL/6NCrl-Plpp4em1(IMPC)Hmgu/Ieg)
|
decreased circulating glucose level
|
J:211773
|
Plpp7em1Eno/Plpp7em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
hypoglycemia
|
J:302139
|
Pls3tm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Pls3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pls3tm1a(EUCOMM)Wtsi/Pls3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pls3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:92404
|
hyperglycemia
|
J:92404
|
increased circulating free fatty acids level
|
J:92404
|
increased circulating leptin level
|
J:92404
|
increased circulating triglyceride level
|
J:92404
|
Pltptm1Jia/Pltptm1Jia
(involves: C57BL/6)
|
abnormal circulating cholesterol level
|
J:53521
|
decreased circulating HDL cholesterol level
|
J:53521
|
increased circulating LDL cholesterol level
|
J:53521
|
increased circulating VLDL cholesterol level
|
J:53521
|
Pltptm2.1Jia/Pltptm2.1Jia
(involves: C57BL/6J)
|
abnormal circulating non-HDL cholesterol level
|
J:239143
|
decreased circulating cholesterol level
|
J:239143
|
decreased circulating HDL cholesterol level
|
J:239143
|
decreased circulating HDL phospholipid level
|
J:239143
|
decreased circulating non-HDL phospholipid level
|
J:239143
|
decreased circulating phospholipid level
|
J:239143
|
decreased circulating triglyceride level
|
J:239143
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J)
|
abnormal circulating lipid level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
decreased circulating total protein level
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
abnormal circulating lipid level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
decreased circulating total protein level
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL)
|
abnormal circulating protein level
|
J:191046
|
decreased circulating calcium level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
decreased circulating serum albumin level
|
J:191046
|
decreased circulating total protein level
|
J:191046
|
hyperchylomicronemia
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plxnc1em1(IMPC)Mbp/Plxnc1em1(IMPC)Mbp
(C57BL/6N-Plxnc1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Plxnd1tm1.1Tmj/Plxnd1tm1.1Tmj Tg(Tek-cre)1Ywa/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
cyanosis
|
J:143763
|
Plxnd1tm1Joe/Plxnd1tm1Joe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:91658
|
Pm20d1em1(IMPC)H/Pm20d1em1(IMPC)H
(C57BL/6NTac-Pm20d1em1(IMPC)H/H)
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating leptin level
|
J:51659
|
Pmeltm1b(EUCOMM)Wtsi/Pmeltm1b(EUCOMM)Wtsi
(C57BL/6N-Pmeltm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
Pmepa1tm2b(EUCOMM)Hmgu/Pmepa1tm2b(EUCOMM)Hmgu
(C57BL/6N-Pmepa1tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Pmm2tm1.1Jins/Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal blood homeostasis
|
J:236704
|
decreased circulating antithrombin level
|
J:236704
|
decreased circulating insulin-like growth factor I level
|
J:236704
|
Pmm2tm1b(EUCOMM)Hmgu/Pmm2+
(C57BL/6N-Pmm2tm1b(EUCOMM)Hmgu/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Pmp22Mhdatre002/Pmp22Mhdatre002
(C3HeB/FeJ-Pmp22Mhdatre002)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Pmpcaem1(IMPC)J/Pmpca+
(C57BL/6NJ-Pmpcaem1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
pnc/pnc
(involves: PERU-COPPOCK)
|
increased circulating insulin level
|
J:13889
|
Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc2C57BL/6J/Pnhdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc3C57BL/6J/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc3CASA/RkJ/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:124658
|
decreased circulating insulin level
|
J:124658
|
Pnma3em1(IMPC)Rbrc/Pnma3em1(IMPC)Rbrc
(C57BL/6NJcl-Pnma3em1(IMPC)Rbrc/Rbrc)
|
abnormal blood uric acid level
|
J:211773
|
Pnmttm1.1(KOMP)Vlcg/Pnmttm1.1(KOMP)Vlcg
(C57BL/6N-Pnmttm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Pnpla2tm1.1Hsul/Pnpla2tm1.1Hsul Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:176083
|
decreased circulating insulin level
|
J:176083
|
Pnpla2tm1Gam/Pnpla2tm1Gam Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA)
|
increased circulating alanine transaminase level
|
J:185116
|
increased circulating free fatty acids level
|
J:185116
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating glucose level
|
J:108546
|
abnormal circulating hormone level
|
J:108546
|
abnormal circulating insulin level
|
J:108546
|
decreased circulating free fatty acids level
|
J:108546
|
decreased circulating glucose level
|
J:108546
|
decreased circulating HDL cholesterol level
|
J:108546
|
decreased circulating insulin level
|
J:108546
|
decreased circulating triglyceride level
|
J:108546
|
decreased circulating VLDL triglyceride level
|
J:108546
|
increased circulating leptin level
|
J:108546
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd)
|
decreased circulating free fatty acids level
|
J:176252
|
decreased circulating triglyceride level
|
J:176252
|
Pnpla2tm1Rze/Pnpla2tm1Rze Tg(Myh6-Pnpla2)94Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating free fatty acids level
|
J:176252
|
decreased circulating triglyceride level
|
J:176252
|
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm)
|
abnormal circulating triglyceride level
|
J:333442
|
decreased circulating glucose level
|
J:333442
|
decreased circulating insulin level
|
J:333442
|
decreased circulating insulin-like growth factor I level
|
J:333442
|
decreased circulating leptin level
|
J:333442
|
decreased circulating thyroxine level
|
J:333442
|
increased circulating ketone body level
|
J:333442
|
Pnpla8tm1Rigr/Pnpla8tm1Rigr
(involves: 129X1/SvJ)
|
decreased circulating glucose level
|
J:333442
|
decreased circulating triglyceride level
|
J:333442
|
Pnrc2tm1Shch/Pnrc2tm1Shch
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating leptin level
|
J:130294
|
Poc1atm1.1(KOMP)Mbp/Poc1a+
(C57BL/6N-Poc1atm1.1(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Pof1bem1(IMPC)Mbp/Pof1bem1(IMPC)Mbp
(C57BL/6N-Pof1bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
Polbtm1Koy/Polbtm1Koy
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:61143
|
Pold3tm1b(EUCOMM)Wtsi/Pold3+
(C57BL/6N-Pold3tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Pold4em1(IMPC)J/Pold4em1(IMPC)J
(C57BL/6NJ-Pold4em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Polgtm1Jiha/Polgtm1Jiha
(involves: C57BL/6JJcl)
|
decreased circulating glucose level
|
J:199416
|
increased circulating lactate level
|
J:199416
|
Polr1dem1(IMPC)J/Polr1d+
(C57BL/6NJ-Polr1dem1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Polr2htm1.1(KOMP)Wtsi/Polr2h+
(B6N(Cg)-Polr2htm1.1(KOMP)Wtsi/J)
|
decreased circulating iron level
|
J:211773
|
decreased circulating sodium level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:291184
|
increased circulating alkaline phosphatase level
|
J:291184
|
Polr3dem1(IMPC)Tcp/Polr3d+
(C57BL/6N-Polr3dem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Pom121l2em1(IMPC)J/Pom121l2em1(IMPC)J
(C57BL/6NJ-Pom121l2em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low)
|
increased circulating insulin level
|
J:115712
|
increased circulating leptin level
|
J:115712
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating adrenocorticotropin level
|
J:102955
|
decreased circulating corticosterone level
|
J:102955
|
increased circulating interleukin-6 level
|
J:102955
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low/J)
|
increased circulating corticosterone level
|
J:84463
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased circulating adrenocorticotropin level
|
J:119240
|
decreased circulating corticosterone level
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
decreased circulating adrenocorticotropin level
|
J:119240
|
increased circulating adrenocorticotropin level
|
J:119240
|
increased circulating corticosterone level
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/Tg(Pomc)#Low
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
increased circulating corticosterone level
|
J:119240
|
Pomctm1Sora/Pomc+
(involves: 129S2/SvHsd * 129S6/SvEvTac)
|
decreased circulating corticosterone level
|
J:89244
|
Pomctm1Sora/Pomctm1Sora
(involves: 129S2/SvHsd * 129S6/SvEvTac)
|
decreased circulating corticosterone level
|
J:89244
|
decreased circulating thyroxine level
|
J:89244
|
Pomctm2Ute/Pomc+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating leptin level
|
J:57503
|
Pomctm2Ute/Pomctm2Ute
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating adrenaline level
|
J:57503
|
decreased circulating adrenocorticotropin level
|
J:57503
|
decreased circulating aldosterone level
|
J:57503
|
decreased circulating corticosterone level
|
J:57503
|
increased circulating leptin level
|
J:57503
|
Pomgnt1tm1Lex/Pomgnt1tm1Lex
(B6;129S5-Pomgnt1tm1Lex/Mmucd)
|
decreased circulating glucose level
|
J:171883
|
Pon1tm1Lus/Pon1tm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:63392
|
increased circulating VLDL cholesterol level
|
J:63392
|
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg)
|
abnormal circulating protein level
|
J:116935
|
decreased circulating cholesterol level
|
J:116935
|
decreased circulating LDL cholesterol level
|
J:116935
|
decreased circulating VLDL cholesterol level
|
J:116935
|
Pon2tm1b(EUCOMM)Hmgu/Pon2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pon2tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
Pon3tm1b(KOMP)Wtsi/Pon3tm1b(KOMP)Wtsi
(C57BL/6N-Pon3tm1b(KOMP)Wtsi/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh)
|
decreased circulating free fatty acids level
|
J:234615
|
decreased circulating HDL cholesterol level
|
J:234615
|
decreased circulating triglyceride level
|
J:234615
|
increased circulating alanine transaminase level
|
J:234615
|
increased circulating aspartate transaminase level
|
J:234615
|
increased circulating bilirubin level
|
J:234615
|
increased circulating cholesterol level
|
J:234615
|
increased circulating LDL cholesterol level
|
J:234615
|
increased circulating triglyceride level
|
J:234615
|
Portm1Ding/Portm1Ding Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:84422
|
Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating cholesterol level
|
J:82951
|
decreased circulating triglyceride level
|
J:82951
|
increased circulating alanine transaminase level
|
J:82951
|
Portm2Ding/Portm2Ding
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:119630
|
decreased circulating progesterone level
|
J:119630
|
increased circulating testosterone level
|
J:119630
|
Portm2Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating cholesterol level
|
J:82951
|
decreased circulating triglyceride level
|
J:82951
|
increased circulating alanine transaminase level
|
J:82951
|
Portm3Ding/Portm3Ding
(C57BL/6-Portm3Ding)
|
decreased circulating cholesterol level
|
J:159168
|
Portm3Ding/Portm3Ding Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating progesterone level
|
J:159168
|
increased circulating testosterone level
|
J:159168
|
Postntm1.1(KOMP)Vlcg/Postntm1.1(KOMP)Vlcg
(C57BL/6N-Postntm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pou1f1dw/Pou1f1dw
(Not Specified)
|
decreased circulating prolactin level
|
J:6754
|
Pou2af3tm1b(NCOM)Mfgc/Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas)
|
cyanosis
|
J:4555
|
Pou3f1tm1Rsd/Pou3f1tm1Rsd
(either: (involves: 129S4/SvJae * 129/Sv * C57BL/6J) or (involves: 129S4/SvJae * C57BL/6 * C57BL/6J))
|
cyanosis
|
J:34460
|
Pou3f3tm1Tno/Pou3f3tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
increased blood urea nitrogen level
|
J:84756
|
increased circulating potassium level
|
J:84756
|
Pou3f3urehr2/Pou3f3urehr2
(C3HeB/FeJ-Pou3f3urehr2)
|
decreased circulating glucose level
|
J:121470
|
increased blood urea nitrogen level
|
J:121470
|
increased circulating creatinine level
|
J:121470
|
Pou3f4sdl/Y
(C3HeB/FeJ-Pou3f4sdl)
|
increased circulating potassium level
|
J:220419
|
Pou3f4sdl/Pou3f4sdl
(C3HeB/FeJ-Pou3f4sdl)
|
increased circulating potassium level
|
J:220419
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
hypoglycemia
|
J:50024
|
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz)
|
abnormal circulating glucose level
|
J:72932
|
abnormal circulating HDL cholesterol level
|
J:72185
|
abnormal circulating insulin level
|
J:72932
|
abnormal circulating ketone body level
|
J:56056
|
increased circulating cholesterol level
|
J:72185
|
increased circulating free fatty acids level
|
J:56056
|
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz)
|
abnormal circulating glucose level
|
J:72932
|
abnormal circulating insulin level
|
J:72932
|
increased circulating triglyceride level
|
J:72185
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae)
|
decreased circulating glucose level
|
J:127793
|
increased circulating cholesterol level
|
J:127793
|
increased circulating free fatty acids level
|
J:127793
|
increased circulating insulin level
|
J:127793
|
Ppardtm1(PPARD)Bsls/Ppardtm1(PPARD)Bsls
(B6.Cg-Ppardtm1(PPARD)Bsls)
|
decreased circulating cholesterol level
|
J:211453
|
decreased circulating HDL cholesterol level
|
J:211453
|
hypoglycemia
|
J:211453
|
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating protein level
|
J:219677
|
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N)
|
increased circulating triglyceride level
|
J:89827
|
increased circulating VLDL cholesterol level
|
J:89827
|
Ppargtm1.1Auw/Ppargtm1.1Auw
(B6.Cg-Ppargtm1.1Auw)
|
decreased circulating cholesterol level
|
J:144344
|
decreased circulating triglyceride level
|
J:144344
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Tg(Aqp2-cre)1Dek/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal circulating aldosterone level
|
J:99873
|
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J))
|
abnormal circulating alanine transaminase level
|
J:86705
|
hyperlipidemia
|
J:86705
|
increased circulating aspartate transaminase level
|
J:86705
|
increased circulating free fatty acids level
|
J:86705
|
increased circulating triglyceride level
|
J:86705
|
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating triglyceride level
|
J:116568
|
Ppargtm1b(KOMP)Wtsi/Pparg+
(C57BL/6N-Ppargtm1b(KOMP)Wtsi/H)
|
increased fasting circulating glucose level
|
J:211773
|
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating free fatty acids level
|
J:135904
|
decreased circulating leptin level
|
J:135904
|
decreased circulating triglyceride level
|
J:135904
|
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating free fatty acids level
|
J:98786
|
increased circulating insulin level
|
J:98786
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:58222
|
increased circulating leptin level
|
J:58222
|
Ppargtm1Yec/Ppargtm1Yec
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating leptin level
|
J:91479
|
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
hyperglycemia
|
J:125992
|
increased circulating cholesterol level
|
J:125992
|
increased circulating free fatty acids level
|
J:125992
|
increased circulating insulin level
|
J:125992
|
increased circulating triglyceride level
|
J:125992
|
Ppargtm2Avp/Ppargtm2Avp
(Not Specified)
|
increased circulating glucose level
|
J:121693
|
increased circulating leptin level
|
J:121693
|
Ppargtm2Rev/Ppargtm2Rev Tg(Fabp4-cre)1Rev/0
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating insulin level
|
J:88210
|
Ppargtm2Rev/Ppargtm2Rev Tg(Lhb-cre)1Sac/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating follicle stimulating hormone level
|
J:170272
|
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
increased circulating insulin level
|
J:125992
|
increased circulating triglyceride level
|
J:125992
|
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc)
|
decreased circulating cholesterol level
|
J:82809
|
increased circulating alkaline phosphatase level
|
J:82809
|
Ppargc1atm1Aztc/Ppargc1atm1Aztc
(C57BL/6-Ppargc1atm1Aztc)
|
decreased circulating glucose level
|
J:82809
|
decreased circulating insulin level
|
J:82809
|
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased circulating insulin level
|
J:93896
|
hypoglycemia
|
J:93896
|
Ppargc1atm1Brsp/Ppargc1atm2Brsp Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N)
|
decreased circulating insulin level
|
J:127403
|
hyperglycemia
|
J:127403
|
increased circulating glucose level
|
J:127403
|
increased circulating interleukin-6 level
|
J:127403
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
decreased circulating glucose level
|
J:137598
|
Ppargc1atm2.1Brsp/Ppargc1atm2.1Brsp Tg(Myog-cre)1Eno/0
(involves: 129 * BALB/c * C57BL/6J * C57BL/6N)
|
decreased circulating glucose level
|
J:208380
|
decreased circulating insulin level
|
J:208380
|
Ppargc1atm2Brsp/Ppargc1a+ Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6)
|
increased circulating glucose level
|
J:127403
|
increased circulating interleukin-6 level
|
J:127403
|
Ppargc1atm2Brsp/Ppargc1atm2Brsp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
abnormal blood homeostasis
|
J:115197
|
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:116167
|
decreased circulating triglyceride level
|
J:116167
|
Ppargc1btm1.1Rev/Ppargc1btm1.1Rev
(involves: 129 * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:120079
|
decreased circulating triglyceride level
|
J:120079
|
increased circulating free fatty acids level
|
J:120079
|
increased circulating triglyceride level
|
J:120079
|
Ppbptm1.1(KOMP)Vlcg/Ppbptm1.1(KOMP)Vlcg
(C57BL/6N-Ppbptm1.1(KOMP)Vlcg/Ucd)
|
increased circulating total protein level
|
J:211773
|
Ppdpftm1Nju/Ppdpftm1Nju Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:307283
|
increased circulating triglyceride level
|
J:307283
|
Ppiaem1(IMPC)Mbp/Ppiaem1(IMPC)Mbp
(C57BL/6NCrl-Ppiaem1(IMPC)Mbp/MbpMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn)
|
increased circulating interleukin-4 level
|
J:93591
|
Ppieem1(IMPC)Tcp/Ppie+
(C57BL/6N-Ppieem1(IMPC)Tcp/Tcp)
|
decreased circulating total protein level
|
J:211773
|
Ppil1em1(IMPC)Mbp/Ppil1+
(C57BL/6N-Ppil1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating creatinine level
|
J:211773
|
Ppil3tm1b(EUCOMM)Wtsi/Ppil3tm1b(EUCOMM)Wtsi
(C57BL/6N-Ppil3tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ppm1atm1b(EUCOMM)Hmgu/Ppm1atm1b(EUCOMM)Hmgu
(C57BL/6N-Ppm1atm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Ppm1ktm1Yiwa/Ppm1ktm1Yiwa
(involves: 129/Sv * C57BL/6)
|
abnormal circulating amino acid level
|
J:150451
|
Ppm1ltm1Dgen/Ppm1ltm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:134171
|
increased circulating glucose level
|
J:134171
|
Ppme1em1(IMPC)Rbrc/Ppme1+
(C57BL/6NJcl-Ppme1em1(IMPC)Rbrc/Rbrc)
|
increased circulating triglyceride level
|
J:211773
|
Ppoxem1(IMPC)J/Ppox+
(C57BL/6NJ-Ppoxem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ppp1r3btm1.1Arte/Ppp1r3b+
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating triglyceride level
|
J:157291
|
Ppp1r3btm1.1Arte/Ppp1r3btm1.1Arte
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating glucose level
|
J:157291
|
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars)
|
increased circulating insulin level
|
J:83297
|
increased circulating leptin level
|
J:83297
|
increased circulating triglyceride level
|
J:83297
|
Ppp1r9btm1.1(KOMP)Vlcg/Ppp1r9btm1.1(KOMP)Vlcg
(C57BL/6N-Ppp1r9btm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ppp1r13ltm1.1Xlu/Ppp1r13ltm1.1Xlu
(involves: 129 * C57BL/6J)
|
abnormal cardiac thrombosis
|
J:220162
|
Ppp1r13lwa3/Ppp1r13lwa3
(either: C57BL/6-Ppp1r13lwa3 or (involves: C57BL/6 * DBA/2J))
|
abnormal arterial thrombosis
|
J:96392
|
Ppp1r15aem2(IMPC)H/Ppp1r15aem2(IMPC)H
(C57BL/6NTac-Ppp1r15aem2(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Ppp1r26tm1.1(KOMP)Vlcg/Ppp1r26tm1.1(KOMP)Vlcg
(C57BL/6N-Ppp1r26tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Ppp1r35tm1.1(KOMP)Vlcg/Ppp1r35+
(B6N(Cg)-Ppp1r35tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Ppp2r1btm1b(EUCOMM)Wtsi/Ppp2r1btm1b(EUCOMM)Wtsi
(C57BL/6N-Ppp2r1btm1b(EUCOMM)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Ppp2r2aigt10/Ppp2r2a+
(involves: C3H/HeH * C57BL/6J)
|
increased circulating insulin level
|
J:246319
|
Ppp2r2btm1a(KOMP)Wtsi/Ppp2r2btm1a(KOMP)Wtsi
(C57BL/6N-Ppp2r2btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:175295
|
Ppp2r2btm1b(KOMP)Wtsi/Ppp2r2btm1b(KOMP)Wtsi
(C57BL/6N-Ppp2r2btm1b(KOMP)Wtsi/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Ppp2r3atm1(KOMP)Mbp/Ppp2r3atm1(KOMP)Mbp
(C57BL/6N-Ppp2r3atm1(KOMP)Mbp/Nju)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ppp3catm1Jse/Ppp3catm1Jse
(involves: 129S4/SvJae)
|
decreased circulating calcium level
|
J:110350
|
decreased circulating glucose level
|
J:110350
|
increased blood urea nitrogen level
|
J:110350
|
increased circulating creatinine level
|
J:110350
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:89217
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:89217
|
Ppp4cem1(IMPC)Ics/Ppp4c+
(C57BL/6N-Ppp4cem1(IMPC)Ics/Ics)
|
increased circulating bilirubin level
|
J:211773
|
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(B6Dnk;B6Brd;B6N-Ppp5ctm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating glucose level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating triglyceride level
|
J:175295
|
Ppp6ctm1b(EUCOMM)Hmgu/Ppp6c+
(C57BL/6N-Ppp6ctm1b(EUCOMM)Hmgu/Ics)
|
decreased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ppt2tm2b(KOMP)Wtsi/Ppt2tm2b(KOMP)Wtsi
(C57BL/6N-Ppt2tm2b(KOMP)Wtsi/H)
|
increased blood urea nitrogen level
|
J:211773
|
Pptc7em1Pagd/Pptc7em1Pagd
(C57BL/6J-Pptc7em1Pagd)
|
decreased circulating ketone body level
|
J:277086
|
hypoglycemia
|
J:277086
|
increased circulating lactate level
|
J:277086
|
Pptc7em2Pagd/Pptc7em2Pagd
(C57BL/6J-Pptc7em2Pagd)
|
decreased circulating ketone body level
|
J:277086
|
hypoglycemia
|
J:277086
|
increased circulating lactate level
|
J:277086
|
Ppytm1b(KOMP)Wtsi/Ppytm1b(KOMP)Wtsi
(C57BL/6N-Ppytm1b(KOMP)Wtsi/Ieg)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Pradc1Gt(OST419896)Lex/Pradc1Gt(OST419896)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating glucose level
|
J:171883
|
Prag1em2(IMPC)Tcp/Prag1em2(IMPC)Tcp
(C57BL/6NCrl-Prag1em2(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
Pramel1em1(IMPC)Tcp/Pramel1em1(IMPC)Tcp
(C57BL/6NCrl-Pramel1em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Pramel31tm2b(KOMP)Wtsi/Pramel31tm2b(KOMP)Wtsi
(C57BL/6N-Pramel31tm2b(KOMP)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
Prap1tm1Lex/Prap1tm1Lex
(B6.129S5-Prap1tm1Lex)
|
increased circulating interleukin-2 level
|
J:304152
|
increased circulating interleukin-4 level
|
J:304152
|
increased circulating interleukin-12 level
|
J:304152
|
Prdm4tm1b(EUCOMM)Hmgu/Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H)
|
increased circulating amylase level
|
J:211773
|
Prdm5em1(IMPC)Tcp/Prdm5em1(IMPC)Tcp
(C57BL/6NCrl-Prdm5em1(IMPC)Tcp/Tcp)
|
increased circulating sodium level
|
J:211773
|
Prdm8em1(IMPC)Wtsi/Prdm8em1(IMPC)Wtsi
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi)
|
increased circulating sodium level
|
J:211773
|
Prdm12tm2b(EUCOMM)Hmgu/Prdm12+
(C57BL/6N-Prdm12tm2b(EUCOMM)Hmgu/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Prdm13em1(IMPC)Tcp/Prdm13em1(IMPC)Tcp
(C57BL/6NCrl-Prdm13em1(IMPC)Tcp/Tcp)
|
increased circulating bilirubin level
|
J:211773
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N)
|
increased circulating insulin level
|
J:208683
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating haptoglobin level
|
J:84677
|
increased circulating lactate dehydrogenase level
|
J:84677
|
Prdx3tm1Hjha/Prdx3tm1Hjha
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating protein level
|
J:228860
|
decreased circulating triglyceride level
|
J:228860
|
increased circulating cholesterol level
|
J:228860
|
increased circulating insulin level
|
J:228860
|
increased fasting circulating glucose level
|
J:228860
|
Prdx5tm1.1(KOMP)Vlcg/Prdx5tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased circulating interleukin-12b level
|
J:271141
|
increased circulating tumor necrosis factor level
|
J:271141
|
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6)
|
increased circulating insulin level
|
J:294801
|
increased circulating leptin level
|
J:294801
|
Prdx6tm1Pgn/Prdx6tm1Pgn
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
|
abnormal blood coagulation
|
J:84376
|
abnormal kidney venous thrombosis
|
J:84376
|
abnormal venous thrombosis
|
J:84376
|
Prelptm1.1(KOMP)Vlcg/Prelptm1.1(KOMP)Vlcg
(C57BL/6N-Prelptm1.1(KOMP)Vlcg/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
PrepGt(RRM213)Byg/PrepGt(RRM213)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating leptin level
|
J:151643
|
Preptm1b(KOMP)Wtsi/Prep+
(C57BL/6N-Preptm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Prex2Gt(AH0440)Wtsi/Prex2Gt(AH0440)Wtsi
(B6.129P2-Prex2Gt(AH0440)Wtsi)
|
increased circulating glucose level
|
J:206382
|
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
|
abnormal circulating glucose level
|
J:43468
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
abnormal circulating cytokine level
|
J:92260
|
decreased circulating fibrinogen level
|
J:92260
|
increased circulating aspartate transaminase level
|
J:193137
|
increased circulating interferon-alpha level
|
J:92260
|
increased circulating interferon-gamma level
|
J:92260,
J:193137
|
increased circulating interleukin-1 beta level
|
J:193137
|
increased circulating interleukin-6 level
|
J:92260,
J:193137
|
increased circulating interleukin-10 level
|
J:92260
|
increased circulating interleukin-18 level
|
J:92260
|
increased circulating lactate dehydrogenase level
|
J:193137
|
increased circulating triglyceride level
|
J:92260
|
increased circulating tumor necrosis factor level
|
J:92260,
J:193137
|
Prf1tm1Sdz/Prf1tm1Sdz Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/SzJ)
|
increased circulating glucose level
|
J:91764
|
Prf1tm1Tsc/Prf1tm1Tsc
(involves: 129S2/SvPas)
|
decreased circulating alanine transaminase level
|
J:50903
|
Prg4em1(IMPC)Ccpcz/Prg4em1(IMPC)Ccpcz
(C57BL/6N-Prg4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating potassium level
|
J:211773
|
Prkaa1tm1Sbj/Prkaa1tm1Sbj
(involves: 129)
|
abnormal circulating hormone level
|
J:147215
|
Prkaa1tm1Sbj/Prkaa1tm1Sbj
(involves: 129S2/SvPas)
|
increased circulating anti-Mullerian hormone level
|
J:324163
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating insulin level
|
J:81120
|
decreased circulating leptin level
|
J:81120
|
hyperglycemia
|
J:81120
|
increased circulating free fatty acids level
|
J:81120
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas)
|
decreased circulating insulin level
|
J:87719
|
Prkaa2tm1b(EUCOMM)Hmgu/Prkaa2tm1b(EUCOMM)Hmgu
(C57BL/6N-Prkaa2tm1b(EUCOMM)Hmgu/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Prkaa2tm1Vio/Prkaa2tm1Vio Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N)
|
increased circulating glucose level
|
J:108399
|
increased circulating insulin level
|
J:108399
|
increased circulating leptin level
|
J:108399
|
Prkab1em1(IMPC)J/Prkab1em1(IMPC)J
(C57BL/6NJ-Prkab1em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Prkab1tm1a(KOMP)Wtsi/Prkab1tm1a(KOMP)Wtsi
(C57BL/6N-Prkab1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:175295
|
increased circulating bilirubin level
|
J:175295
|
Prkab1tm1b(KOMP)Wtsi/Prkab1+
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Rbrc)
|
decreased circulating amylase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased glycosylated hemoglobin level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(B6N(Cg)-Prkab1tm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased circulating iron level
|
J:236972
|
increased circulating erythropoietin level
|
J:236972
|
increased circulating ferritin level
|
J:236972
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:158295
|
decreased circulating interleukin-6 level
|
J:158295
|
decreased circulating leptin level
|
J:158295
|
Prkab1tm1Grst/Prkab1tm1Grst Prkab2tm1Grst/Prkab2tm1Grst Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
increased circulating glucose level
|
J:176578
|
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi)
|
decreased circulating glucose level
|
J:186658
|
increased circulating insulin level
|
J:186658
|
increased circulating triglyceride level
|
J:186658
|
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6)
|
increased circulating insulin level
|
J:167339
|
Prkacatm3Gsm/Prkacatm3Gsm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating insulin level
|
J:103418
|
increased circulating glucose level
|
J:103418
|
increased circulating triglyceride level
|
J:103418
|
Prkacbem1(IMPC)H/Prkacb+
(C57BL/6NTac-Prkacbem1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Prkag1tm1.2Mfor/Prkag1tm1.2Mfor
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)
|
increased circulating bilirubin level
|
J:167779
|
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
decreased circulating insulin level
|
J:235379
|
Prkar1atm1.1Geno/Prkar1a+
(involves: C57BL/6J)
|
increased circulating parathyroid hormone level
|
J:303060
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Ptentm1.1Mwst/Ptentm1.1Mwst Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
increased circulating thyroxine level
|
J:225245
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased circulating growth hormone level
|
J:130264
|
Prkar1atm1Lsk/Prkar1atm1Lsk Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased circulating corticosterone level
|
J:161521
|
Prkar2btm1Gsm/Prkar2btm1Gsm
(Not Specified)
|
decreased circulating leptin level
|
J:34751
|
Prkar2btm1Gsm/Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm)
|
decreased circulating cholesterol level
|
J:72414
|
decreased circulating insulin level
|
J:72414
|
decreased circulating LDL cholesterol level
|
J:72414
|
decreased circulating leptin level
|
J:72414
|
decreased circulating VLDL cholesterol level
|
J:72414
|
Prkar2btm2Gsm/Prkar2b+
(involves: C57BL/6)
|
decreased circulating leptin level
|
J:131039
|
Prkar2btm3Gsm/Prkar2btm2Gsm Tg(Drd2-cre)ER44Gsat/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating leptin level
|
J:196157
|
Prkar2btm3Gsm/Prkar2btm2Gsm Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
decreased circulating leptin level
|
J:196157
|
Prkar2btm3Gsm/Prkar2btm2Gsm Tg(Ppp1r1b-cre)1Meeh/0
(involves: C57BL/6)
|
decreased circulating leptin level
|
J:196157
|
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm)
|
decreased circulating cholesterol level
|
J:196157
|
decreased circulating insulin level
|
J:196157
|
decreased circulating LDL cholesterol level
|
J:196157
|
decreased circulating leptin level
|
J:196157
|
decreased circulating VLDL cholesterol level
|
J:196157
|
Prkcetm1Bsca/Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:103337
|
decreased circulating tumor necrosis factor level
|
J:103337
|
Prkcitm1Kido/Prkcitm1.1Kido Tg(Nphs1-cre)33Mska/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
increased blood urea nitrogen level
|
J:144995
|
increased circulating creatinine level
|
J:144995
|
Prkcitm1Kido/Prkcitm1Kido Tg(Ins2-cre)25Mgn/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
decreased circulating glucose level
|
J:95378
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal circulating lipid level
|
J:123964
|
decreased circulating HDL cholesterol level
|
J:123964
|
increased circulating cholesterol level
|
J:123964
|
increased circulating free fatty acids level
|
J:123964
|
increased circulating glucose level
|
J:123964
|
increased circulating insulin level
|
J:123964
|
increased circulating LDL cholesterol level
|
J:123964
|
increased circulating leptin level
|
J:123964
|
increased circulating triglyceride level
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal circulating lipid level
|
J:123964
|
decreased circulating HDL cholesterol level
|
J:123964
|
increased circulating cholesterol level
|
J:123964
|
increased circulating free fatty acids level
|
J:123964
|
increased circulating glucose level
|
J:123964
|
increased circulating insulin level
|
J:123964
|
increased circulating LDL cholesterol level
|
J:123964
|
increased circulating leptin level
|
J:123964
|
increased circulating triglyceride level
|
J:123964
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal platelet activation
|
J:144254
|
abnormal platelet dense granule physiology
|
J:144254
|
abnormal platelet physiology
|
J:144254
|
increased platelet aggregation
|
J:144254
|
Prkcztm1a(EUCOMM)Wtsi/Prkcz+
(B6JTyr;B6N-Prkcztm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating iron level
|
J:175295
|
Prkcztm1a(EUCOMM)Wtsi/Prkcztm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prkcztm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:175295
|
increased circulating alkaline phosphatase level
|
J:175295
|
increased circulating aspartate transaminase level
|
J:175295
|
Prkcztm1a(EUCOMM)Wtsi/Prkcztm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased circulating alkaline phosphatase level
|
J:213427
|
Prkd1em2(IMPC)Wtsi/Prkd1+
(C57BL/6N-Prkd1em2(IMPC)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Prkd2em1(IMPC)Hmgu/Prkd2em1(IMPC)Hmgu
(C57BL/6N-Prkd2em1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
Prkd3tm1b(EUCOMM)Wtsi/Prkd3+
(C57BL/6N-Prkd3tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Prkdcem2(IMPC)Ics/Prkdcem2(IMPC)Ics
(C57BL/6N-Prkdcem2(IMPC)Ics/Ics)
|
increased circulating phosphate level
|
J:211773
|
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid/J)
|
increased circulating glucose level
|
J:91764
|
Prkdcscid/Prkdcscid Gnrh1hpg/Gnrh1hpg
(STOCK Prkdcscid Gnrh1hpg/Bm)
|
abnormal circulating protein level
|
J:138840
|
decreased circulating testosterone level
|
J:138840
|
Prkdcscid/Prkdcscid Tg(B2M)55Hpl/0 Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(NOD.Cg-Mcph1Tg(HLA-A2.1)1Enge Prkdcscid Tg(B2M)55Hpl/Sz)
|
increased circulating glucose level
|
J:91764
|
Prkdcscid/Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin/0
(C.BKa-Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin)
|
decreased circulating insulin level
|
J:204420
|
hyperglycemia
|
J:204420
|
Prkdcscid/Prkdcscid Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129 * C3H * CF-1)
|
decreased circulating follicle stimulating hormone level
|
J:129629
|
decreased circulating luteinizing hormone level
|
J:129629
|
decreased circulating testosterone level
|
J:129629
|
Prkg1tm2.1Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating hormone level
|
J:134639
|
Prkraem1(IMPC)H/Prkraem1(IMPC)H
(C57BL/6N-Prkraem1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Prl3c1tm1(KOMP)Vlcg/Prl3c1tm1(KOMP)Vlcg
(involves: C57BL/6NTac * CD-1)
|
increased circulating luteinizing hormone level
|
J:256588
|
increased circulating testosterone level
|
J:256588
|
Prl7b1tm1.1(KOMP)Vlcg/Prl7b1tm1.1(KOMP)Vlcg
(C57BL/6N-Prl7b1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas)
|
decreased circulating estradiol level
|
J:79661
|
decreased circulating estrogen level
|
J:79661
|
decreased circulating luteinizing hormone level
|
J:83246
|
decreased circulating prolactin level
|
J:45243
|
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon)
|
increased circulating insulin level
|
J:144729
|
increased circulating leptin level
|
J:144729
|
increased circulating triglyceride level
|
J:144729
|
Prlhtm2Smln/Prlhtm2Smln
(involves: C57BL/6J)
|
hyperglycemia
|
J:215557
|
increased circulating insulin level
|
J:215557
|
increased circulating leptin level
|
J:215557
|
Prlhrtm1Askr/Prlhrtm1Askr
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating insulin level
|
J:90533
|
Prlhrtm1Dgen/Prlhrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating corticosterone level
|
J:127335
|
increased circulating glucose level
|
J:127335
|
increased circulating HDL cholesterol level
|
J:127335
|
increased circulating LDL cholesterol level
|
J:127335
|
increased circulating leptin level
|
J:127335
|
Prlhrtm1Map/Prlhrtm1Map
(involves: 129S6/SvEvTac * CD-1)
|
decreased circulating corticosterone level
|
J:103932
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal circulating calcium level
|
J:52026
|
decreased circulating estradiol level
|
J:52026
|
decreased circulating progesterone level
|
J:52026
|
increased circulating parathyroid hormone level
|
J:52026
|
increased circulating prolactin level
|
J:52026
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased circulating leptin level
|
J:67354
|
Prmt1tm1a(EUCOMM)Wtsi/Prmt1+
(B6JTyr;B6N-Prmt1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:175295
|
Prmt9em1Cya/Prmt9em1Cya Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased circulating interferon-beta level
|
J:328263
|
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal blood coagulation
|
J:50527
|
abnormal brain thrombosis
|
J:50527
|
abnormal cardiac thrombosis
|
J:50527
|
abnormal lung thrombosis
|
J:50527
|
Procrtm1.1Pcl/Procr+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating protein level
|
J:225914
|
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating protein level
|
J:225914
|
increased circulating interleukin-6 level
|
J:225914
|
increased susceptibility to induced thrombosis
|
J:225914
|
Procrtm1Cte/Procr+
(B6.129S7-Procrtm1Cte)
|
abnormal blood coagulation
|
J:144388
|
Procrtm1Cte/Procrtm1Cte
(either: 129S/SvEv-Procrtm1Cte or (involves: 129S7/SvEvBrd * Black Swiss))
|
abnormal blood coagulation
|
J:80043
|
abnormal placental thrombosis
|
J:80043
|
Prodh2em1Jkni/Prodh2em1Jkni
(involves: C57BL/6J)
|
increased circulating hydroxyproline level
|
J:283585
|
Prodhm1Kara/Prodhm1Kara
(involves: C57BL/6J * PRO/Re)
|
increased circulating proline level
|
J:54012
|
Prokr2tm1Api/Prokr2tm1Api
(involves: C57BL/6 * CBA)
|
decreased circulating testosterone level
|
J:107587
|
Prom2tm1.1(KOMP)Vlcg/Prom2+
(C57BL/6N-Prom2tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Prop1df/Prop1df
(STOCK Prop1df)
|
decreased circulating follicle stimulating hormone level
|
J:5900
|
decreased circulating growth hormone level
|
J:6340
|
decreased circulating prolactin level
|
J:5900
|
decreased circulating thyroid-stimulating hormone level
|
J:6340
|
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
cyanosis
|
J:94409
|
increased circulating corticosterone level
|
J:94409
|
Pros1tm1.1Ansc/Pros1+
(involves: 129/Sv * C57BL/6J * FVB/N)
|
increased susceptibility to induced thrombosis
|
J:152423
|
Pros1tm1.1Ansc/Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N)
|
abnormal thrombosis
|
J:152423
|
Pros1tm1.2Grl/Pros1+
(involves: 129S1/SvImJ * FVB/N)
|
decreased bleeding time
|
J:198769
|
Pros1tm1.2Grl/Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N)
|
abnormal blood coagulation
|
J:198769
|
abnormal thrombosis
|
J:198769
|
Pros1tm1Grl/Pros1tm1Grl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/SvImJ * C57BL/6 * DBA)
|
abnormal thrombosis
|
J:198769
|
Pros1tm1Grl/Pros1tm1Grl Tg(Tek-cre)1Ywa/0
(involves: 129S1/SvImJ * C57BL/6 * SJL)
|
abnormal thrombosis
|
J:198769
|
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
cyanosis
|
J:102652
|
increased circulating alanine transaminase level
|
J:102652
|
increased circulating glucagon level
|
J:102652
|
increased circulating insulin level
|
J:102652
|
increased circulating leptin level
|
J:102652
|
Prox1tm2Gco/Prox1tm2Gco Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
abnormal atrial thrombosis
|
J:212185
|
abnormal cardiac thrombosis
|
J:212185
|
abnormal ventricular thrombosis
|
J:212185
|
Proztm1Gjb/Proztm1Gjb
(involves: 129X1/SvJ)
|
increased susceptibility to induced thrombosis
|
J:136102
|
Prpf6tm1.1(KOMP)Vlcg/Prpf6+
(C57BL/6N-Prpf6tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Prps1tm1b(EUCOMM)Wtsi/Prps1+
(C57BL/6N-Prps1tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating total protein level
|
J:211773
|
Prr5em1(IMPC)J/Prr5em1(IMPC)J
(C57BL/6NJ-Prr5em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Prrg2tm1b(EUCOMM)Wtsi/Prrg2tm1b(EUCOMM)Wtsi
(C57BL/6N-Prrg2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Prrt2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
Prrt2tm1b(KOMP)Wtsi/Prrt2tm1b(KOMP)Wtsi
(C57BL/6N-Prrt2tm1b(KOMP)Wtsi/Ics)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Prrx1tm1Jfm/Prrx1tm1Jfm
(involves: 129S4/SvJaeSor)
|
cyanosis
|
J:99153
|
Prrx1tm1Jfm/Prrx1tm1Jfm Prrx2tm1Mjk/Prrx2tm1Mjk
(involves: 129S4/SvJaeSor)
|
cyanosis
|
J:51596
|
Prrx1tm1Tex/Prrx1tm1Tex
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:25649
|
Prrx1tm1Tex/Prrx1tm1Tex Prrx2tm1Hubr/Prrx2tm1Hubr
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB)
|
cyanosis
|
J:50488
|
Prrx1tm1Tex/Prrx1tm1Tex Prrx2tm1Mjk/Prrx2tm1Mjk
(involves: 129S7/SvEvBrd * C57BL/6)
|
cyanosis
|
J:51596
|
Prss2tm1.1(KOMP)Vlcg/Prss2tm1.1(KOMP)Vlcg
(C57BL/6N-Prss2tm1.1(KOMP)Vlcg/J)
|
decreased circulating phosphate level
|
J:211773
|
Prss3btm1.1Satom/Prss3b+
(B6(FVB)-Prss3btm1.1Satom)
|
decreased circulating amylase level
|
J:267764
|
Prss3btm1b(KOMP)Wtsi/Prss3btm1b(KOMP)Wtsi
(C57BL/6N-Prss3btm1b(KOMP)Wtsi/Bay)
|
decreased circulating alanine transaminase level
|
J:211773
|
Prss8tm1b(EUCOMM)Hmgu/Prss8+
(C57BL/6N-Prss8tm1b(EUCOMM)Hmgu/J)
|
increased fasting circulating glucose level
|
J:211773
|
Prss12em1(IMPC)Ccpcz/Prss12em1(IMPC)Ccpcz
(C57BL/6N-Prss12em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Prss53em3(IMPC)Wtsi/Prss53em3(IMPC)Wtsi
(C57BL/6N-Prss53em3(IMPC)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Prss54em1(IMPC)Ccpcz/Prss54em1(IMPC)Ccpcz
(C57BL/6N-Prss54em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Prxl2atm1(KOMP)Vlcg/Prxl2atm1(KOMP)Vlcg
(C57BL/6N-Prxl2atm1(KOMP)Vlcg)
|
increased circulating insulin level
|
J:234040
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
abnormal circulating testosterone level
|
J:106511
|
Psat1tm1a(KOMP)Wtsi/Psat1+
(B6JTyr;B6N-Psat1tm1a(KOMP)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:175295
|
Psd3em1(IMPC)H/Psd3em1(IMPC)H
(C57BL/6N-Psd3em1(IMPC)H/H)
|
decreased circulating total protein level
|
J:211773
|
Psen1tm1.1(KOMP)Vlcg/Psen1tm1.1(KOMP)Vlcg
(C57BL/6N-Psen1tm1.1(KOMP)Vlcg/J)
|
cyanosis
|
J:211773
|
Psen1tm1.1Ruvi/Psen1tm1.1Ruvi
(C57BL/6J-Psen1tm1.1Ruvi)
|
increased circulating follicle stimulating hormone level
|
J:187475
|
Psen1tm1Lpr/Psen1tm1Lpr
(involves: 129 * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:128243
|
Psen1tm1Lpr/Psen1tm1Lpr Tg(Thy1-APPSL)28Lpr/0
(involves: 129 * C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:128243
|
increased circulating cholesterol level
|
J:128243
|
Psg20em1(IMPC)Wtsi/Psg20em1(IMPC)Wtsi
(C57BL/6N-Psg20em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Psg22em1(IMPC)Wtsi/Psg22em1(IMPC)Wtsi
(C57BL/6N-Psg22em1(IMPC)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Psg25em1(IMPC)Wtsi/Psg25em1(IMPC)Wtsi
(C57BL/6N-Psg25em1(IMPC)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Psg27em1(IMPC)Wtsi/Psg27em1(IMPC)Wtsi
(C57BL/6N-Psg27em1(IMPC)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Psip1em1(IMPC)J/Psip1+
(C57BL/6NJ-Psip1em1(IMPC)J/Mmjax)
|
decreased circulating creatinine level
|
J:211773
|
Pskh1tm1b(EUCOMM)Wtsi/Pskh1+
(C57BL/6N-Pskh1tm1b(EUCOMM)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
increased circulating interleukin-1 level
|
J:261081
|
increased circulating interleukin-6 level
|
J:261081
|
increased circulating tumor necrosis factor level
|
J:261081
|
Psmc2tm1b(EUCOMM)Hmgu/Psmc2+
(C57BL/6N-Psmc2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating total protein level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Psmd5tm1b(EUCOMM)Wtsi/Psmd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Psmd5tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Psphtm1.1(KOMP)Vlcg/Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Pstpip1em1(IMPC)Ccpcz/Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Pstpip2em1(IMPC)Tcp/Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ptbp2tm1.1Dblk/Ptbp2tm1.1Dblk Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
cyanosis
|
J:207976
|
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg)
|
increased circulating leptin level
|
J:256004
|
increased circulating triglyceride level
|
J:256004
|
Ptcd3tm1.1(KOMP)Vlcg/Ptcd3+
(C57BL/6N-Ptcd3tm1.1(KOMP)Vlcg/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(KRT14-cre)8Brn/0
(involves: 129T2/SvEms * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:231264
|
Ptch2tm3b(EUCOMM)Hmgu/Ptch2tm3b(EUCOMM)Hmgu
(C57BL/6N-Ptch2tm3b(EUCOMM)Hmgu/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Ptchd1tm1b(KOMP)IcsOrl/Ptchd1tm1b(KOMP)IcsOrl
(C57BL/6N-Ptchd1tm1b(KOMP)IcsOrl/Ics)
|
increased circulating creatinine level
|
J:211773
|
Ptdss1tm1b(EUCOMM)Hmgu/Ptdss1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ptdss1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating calcium level
|
J:211773
|
Ptdss2Gt(KST314)Byg/Ptdss2Gt(KST314)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating follicle stimulating hormone level
|
J:80673
|
Ptentm1Hwu/Ptentm1Hwu Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
decreased circulating insulin level
|
J:170129
|
hypoglycemia
|
J:170129
|
Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating free fatty acids level
|
J:88441
|
decreased circulating glucose level
|
J:88441
|
decreased circulating insulin level
|
J:88441
|
decreased circulating leptin level
|
J:88441
|
increased circulating alanine transaminase level
|
J:218587
|
Ptentm1Hwu/Ptentm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr * FVB/NJ)
|
increased circulating thyroxine level
|
J:177181
|
increased circulating triiodothyronine level
|
J:177181
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ckmm-cre)5Khn/?
(involves: 129S4/SvJae * FVB)
|
decreased circulating glucose level
|
J:169364
|
decreased circulating insulin level
|
J:169364
|
Ptentm1Hwu/Ptentm1Hwu Tg(Fabp4-cre)1Abel/0
(involves: 129S4/SvJae)
|
decreased circulating insulin level
|
J:97588
|
decreased circulating resistin level
|
J:97588
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
hypoglycemia
|
J:106937
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
abnormal platelet activation
|
J:165893
|
decreased bleeding time
|
J:165893
|
increased platelet aggregation
|
J:165893
|
Ptentm1Hwu/Ptentm1Hwu Twist2tm1.1(cre)Dor/Twist2+
(B6.129-Twist2tm1.1(cre)Dor Ptentm1Hwu)
|
cyanosis
|
J:192736
|
decreased blood oxygen capacity
|
J:192736
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:138099
|
increased circulating alkaline phosphatase level
|
J:138099
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
|
decreased circulating insulin level
|
J:90905
|
decreased fasting circulating glucose level
|
J:90905
|
increased circulating alanine transaminase level
|
J:90905
|
increased circulating alkaline phosphatase level
|
J:90905
|
increased circulating aspartate transaminase level
|
J:90905
|
Ptentm2Mak/Ptentm2Mak Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
cyanosis
|
J:127405
|
Ptf1atm1Pkwe/Ptf1atm1Pkwe
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:51571
|
hypoglycemia
|
J:51571
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
decreased circulating adrenocorticotropin level
|
J:82750
|
Ptger2tm1Brey/Ptger2tm1Brey
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal circulating calcium level
|
J:77679
|
Ptger3tm1Cof/Ptger3tm1Cof
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to induced thrombosis
|
J:125376
|
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna)
|
decreased circulating adrenocorticotropin level
|
J:82750
|
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal circulating interleukin-6 level
|
J:78964
|
abnormal circulating serum amyloid protein level
|
J:78964
|
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:42275
|
abnormal platelet activation
|
J:79049
|
increased susceptibility to induced thrombosis
|
J:42275,
J:108957
|
Ptgistm1Tada/Ptgistm1Tada
(B6.129-Ptgistm1Tada)
|
increased blood urea nitrogen level
|
J:103380
|
increased circulating creatinine level
|
J:103380
|
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased platelet aggregation
|
J:97351
|
decreased susceptibility to induced thrombosis
|
J:97351
|
increased bleeding time
|
J:97351
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood coagulation
|
J:29511
|
decreased platelet aggregation
|
J:29511
|
increased circulating progesterone level
|
J:50148
|
Ptgs1tm1Unc/Ptgs1tm1Unc Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:67208
|
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
(involves: 129S6/SvEvTac)
|
increased blood urea nitrogen level
|
J:148699
|
Ptgs2tm1Fun/Ptgs2tm1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal blood coagulation
|
J:108957
|
abnormal platelet physiology
|
J:108957
|
abnormal thrombolysis
|
J:108957
|
decreased susceptibility to induced thrombosis
|
J:108957
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd)
|
increased blood urea nitrogen level
|
J:29974
|
increased circulating creatinine level
|
J:29974
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased blood urea nitrogen level
|
J:104002,
J:118171
|
increased circulating creatinine level
|
J:104002
|
Ptgs2tm1Unc/Ptgs2+
(D1.129P2-Ptgs2tm1Unc)
|
increased circulating insulin level
|
J:102779
|
increased circulating leptin level
|
J:102779
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thrombosis
|
J:109021
|
increased circulating follicle stimulating hormone level
|
J:55145
|
increased circulating luteinizing hormone level
|
J:55145
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(D1.129P2(B6J)-Ptgs2tm1Unc)
|
increased blood urea nitrogen level
|
J:102777
|
increased circulating creatinine level
|
J:102777
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased blood urea nitrogen level
|
J:104002
|
increased circulating creatinine level
|
J:104002
|
Ptgs2tm2.1(Ptgs1)Fun/Ptgs2tm2.1(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
increased blood urea nitrogen level
|
J:118171
|
Ptgs2tm3Fun/Ptgs2tm3Fun
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased blood urea nitrogen level
|
J:148699
|
increased platelet aggregation
|
J:148699
|
increased susceptibility to induced thrombosis
|
J:148699
|
Ptgs2ostm1Scrp/Ptgs2ostm1Scrp
(Not Specified)
|
decreased circulating CCL3 level
|
J:325487
|
decreased circulating interleukin-6 level
|
J:325487
|
Pth1rtm1Abas/Pth1rtm1Abas
(B6.Cg-Pth1rtm1Abas)
|
abnormal blood homeostasis
|
J:113660
|
abnormal circulating phosphate level
|
J:113660
|
decreased circulating parathyroid hormone level
|
J:113660
|
increased circulating calcium level
|
J:113660
|
Pthtm1a(EUCOMM)Wtsi/Pthtm1a(EUCOMM)Wtsi
(C57BL/6N-Pthtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
Pthlhtm1a(KOMP)Wtsi/Pthlh+
(C57BL/6N-Pthlhtm1a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Pthlhtm1Ack/Pthlhtm1Hmk Tg(LGB-cre)74Acl/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal circulating hormone level
|
J:86536
|
Pthlhtm1Fbe/Pthlhtm1Fbe
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating calcium level
|
J:79622
|
Pthlhtm1Hmk/Pthlhtm1Hmk
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))
|
cyanosis
|
J:16911
|
Pthlhtm2Ack/Pthlhtm2Ack
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating glucose level
|
J:142669
|
Ptmstm1.1(KOMP)Wtsi/Ptms+
(C57BL/6N-Ptmstm1.1(KOMP)Wtsi/J)
|
increased circulating phosphate level
|
J:211773
|
Ptntm1Tmu/Ptntm1Tmu
(B6.Cg-Ptntm1Tmu)
|
abnormal circulating enzyme level
|
J:102069
|
Ptp4a1em2(IMPC)Tcp/Ptp4a1em2(IMPC)Tcp
(C57BL/6NCrl-Ptp4a1em2(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ptp4a3tm1.2Xhan/Ptp4a3tm1.2Xhan
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased circulating glucose level
|
J:197019
|
Ptpdc1tm1.1(KOMP)Vlcg/Ptpdc1tm1.1(KOMP)Vlcg
(C57BL/6N-Ptpdc1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating phosphate level
|
J:211773
|
Ptpn1tm1Bbk/Ptpn1+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating insulin level
|
J:63236
|
decreased circulating leptin level
|
J:63236
|
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating glucose level
|
J:63236
|
decreased circulating insulin level
|
J:63236
|
decreased circulating leptin level
|
J:63236
|
Ptpn1tm1Bpk/Ptpn1+
(involves: 129S4/SvJae * BALB/c)
|
decreased circulating glucose level
|
J:53437
|
Ptpn1tm1Bpk/Ptpn1tm1Bpk
(involves: 129S4/SvJae * BALB/c)
|
decreased circulating glucose level
|
J:53437
|
decreased circulating insulin level
|
J:53437
|
Ptpn1tm2Bbk/Ptpn1+ Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:111969
|
decreased circulating insulin level
|
J:111969
|
Ptpn1tm2Bbk/Ptpn1tm2Bbk Ptpn2tm1.1Ttig/Ptpn2tm1.1Ttig Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:179621
|
decreased circulating leptin level
|
J:179621
|
Ptpn1tm2Bbk/Ptpn1tm2Bbk Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:111969
|
decreased circulating insulin level
|
J:111969
|
decreased circulating leptin level
|
J:179621
|
increased circulating leptin level
|
J:111969
|
Ptpn2tm1.1Kry/Ptpn2tm1.1Kry Tg(Col1a1-cre)1Kry/0
(involves: 129 * C57BL/6J * FVB)
|
increased circulating osteocalcin level
|
J:183709
|
Ptpn2tm1.1Ttig/Ptpn2tm1.1Ttig Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:179621
|
decreased circulating growth hormone level
|
J:179621
|
decreased circulating insulin level
|
J:179621
|
decreased circulating insulin-like growth factor I level
|
J:179621
|
decreased circulating leptin level
|
J:179621
|
Ptpn6m1Amgn/Ptpn6m1Amgn
(involves: C3H/HeSnJ * C57BL/6J * Swiss)
|
increased circulating interleukin-17 level
|
J:168664
|
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c)
|
abnormal circulating chemokine level
|
J:169850
|
increased circulating interferon-gamma level
|
J:169850
|
increased circulating interleukin-1 beta level
|
J:169850
|
increased circulating interleukin-6 level
|
J:169850
|
increased circulating interleukin-10 level
|
J:169850
|
increased circulating serum amyloid protein level
|
J:169850
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
abnormal platelet physiology
|
J:118880
|
decreased platelet aggregation
|
J:118880
|
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased circulating alanine transaminase level
|
J:216593
|
decreased circulating glucose level
|
J:216593
|
decreased circulating insulin level
|
J:216593
|
decreased circulating leptin level
|
J:216593
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:172422
|
increased circulating aspartate transaminase level
|
J:172422
|
increased circulating interleukin-6 level
|
J:172422
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Stat3tm1Vpo/Stat3tm1Vpo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:172422
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal circulating hormone level
|
J:94738
|
decreased circulating thyroxine level
|
J:94738
|
decreased circulating triiodothyronine level
|
J:94738
|
hyperglycemia
|
J:94738
|
hypoglycemia
|
J:94738
|
increased circulating corticosterone level
|
J:94738
|
increased circulating growth hormone level
|
J:94738
|
increased circulating insulin level
|
J:94738
|
increased circulating leptin level
|
J:94738
|
increased circulating thyroid-stimulating hormone level
|
J:94738
|
increased circulating triglyceride level
|
J:94738
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
increased circulating insulin level
|
J:144767
|
increased circulating triglyceride level
|
J:144767
|
Ptpn11tm3Bgn/Ptpn11tm3Bgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA)
|
decreased circulating glucose level
|
J:167406
|
decreased circulating insulin level
|
J:167406
|
decreased circulating triglyceride level
|
J:167406
|
Ptpn18em1(IMPC)J/Ptpn18+
(C57BL/6NJ-Ptpn18em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Ptpn23tm1b(EUCOMM)Hmgu/Ptpn23+
(C57BL/6N-Ptpn23tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ptprdtm2a(KOMP)Wtsi/Ptprdtm2a(KOMP)Wtsi
(C57BL/6N-Ptprdtm2a(KOMP)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Ptpretm1Ael/Ptpretm1Ael
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating type I collagen C-terminal telopeptide level
|
J:90031
|
Ptprmem1(IMPC)Rbrc/Ptprmem1(IMPC)Rbrc
(C57BL/6NJcl-Ptprmem1(IMPC)Rbrc/Rbrc)
|
abnormal circulating glucose level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Ptprntm1Aln/Ptprntm1Aln Ptprn2tm1Aln/Ptprn2tm1Aln
(involves: 129S4/SvJae * C57BL/6N)
|
decreased circulating luteinizing hormone level
|
J:129445
|
Ptprstm1Mtr/Ptprstm1Mtr
(involves: 129/Sv * BALB/c)
|
decreased circulating insulin-like growth factor I level
|
J:53434
|
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd)
|
decreased circulating glucose level
|
J:126780
|
increased circulating testosterone level
|
J:170888
|
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating glucose level
|
J:152695
|
increased circulating insulin level
|
J:152695
|
Ptprvtm1b(NCOM)Mfgc/Ptprvtm1b(NCOM)Mfgc
(C57BL/6N-Ptprvtm1b(NCOM)Mfgc/Tcp)
|
decreased circulating potassium level
|
J:211773
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
decreased circulating free fatty acids level
|
J:126780
|
decreased circulating glucose level
|
J:126780
|
decreased circulating triglyceride level
|
J:126780
|
hypoglycemia
|
J:126780
|
increased circulating insulin level
|
J:126780
|
increased circulating testosterone level
|
J:170888
|
Ptstm1Ich/Ptstm1Ich Tg(DBH-PTS)6Csic/0
(B6.Cg-Ptstm1Ich Tg(DBH-PTS)6Csic)
|
decreased circulating phenylalanine level
|
J:102278
|
Ptstm1Thny/Ptstm1Thny
(involves: 129/Sv * C57BL/6)
|
abnormal circulating amino acid level
|
J:84533
|
Pttg1tm1b(EUCOMM)Wtsi/Pttg1tm1b(EUCOMM)Wtsi
(C57BL/6N-Pttg1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating creatinine level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating insulin level
|
J:82724
|
hyperglycemia
|
J:82724
|
increased bleeding time
|
J:72267
|
Pttg1ipem1(IMPC)H/Pttg1ipem1(IMPC)H
(C57BL/6NTac-Pttg1ipem1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pudptm1.1(KOMP)Vlcg/Pudptm1.1(KOMP)Vlcg
(C57BL/6N-Pudptm1.1(KOMP)Vlcg/J)
|
increased fasting circulating glucose level
|
J:211773
|
Pus1em1(IMPC)J/Pus1em1(IMPC)J
(C57BL/6NJ-Pus1em1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Pus7em1(IMPC)J/Pus7+
(C57BL/6NJ-Pus7em1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
Pus10tm1b(EUCOMM)Hmgu/Pus10tm1b(EUCOMM)Hmgu
(C57BL/6N-Pus10tm1b(EUCOMM)Hmgu/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pvrem1(IMPC)Wtsi/Pvrem1(IMPC)Wtsi
(C57BL/6N-Pvrem1(IMPC)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Pwwp3aem1(IMPC)Tcp/Pwwp3aem1(IMPC)Tcp
(C57BL/6NCrl-Pwwp3aem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Pxkem1(IMPC)Tcp/Pxkem1(IMPC)Tcp
(C57BL/6N-Pxkem1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Pxmp2tm1Jkh/Pxmp2tm1Jkh
(B6.129X1-Pxmp2tm1Jkh)
|
increased blood uric acid level
|
J:148171
|
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:113333
|
decreased circulating interleukin-18 level
|
J:113333,
J:158969
|
Pycardtm1Vmd/Pycardtm1Vmd
(B6.129-Pycardtm1Vmd)
|
decreased circulating interleukin-1 beta level
|
J:193522
|
decreased circulating interleukin-18 level
|
J:193522
|
Pycr1tm1(KOMP)Vlcg/Pycr1tm1(KOMP)Vlcg
(C57BL/6NTac-Pycr1tm1(KOMP)Vlcg)
|
decreased circulating triglyceride level
|
J:308336
|
Pycr1tm1.1(KOMP)Vlcg/Pycr1tm1.1(KOMP)Vlcg
(B6N(Cg)-Pycr1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:308336
|
decreased circulating glutamic acid level
|
J:308336
|
decreased circulating HDL cholesterol level
|
J:308336
|
decreased circulating potassium level
|
J:308336
|
decreased circulating triglyceride level
|
J:308336
|
increased blood urea nitrogen level
|
J:308336
|
Pycr2tm1a(EUCOMM)Wtsi/Pycr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Pycr2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi)
|
decreased circulating cholesterol level
|
J:284765
|
decreased circulating triglyceride level
|
J:284765
|
decreased fasting circulating glucose level
|
J:284765
|
hypoglycemia
|
J:284765
|
increased circulating alanine transaminase level
|
J:330539,
J:284765
|
increased circulating aspartate transaminase level
|
J:330539,
J:284765
|
increased circulating ketone body level
|
J:284765
|
Pygmem1(IMPC)J/Pygmem1(IMPC)J
(C57BL/6NJ-Pygmem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Pyytm1(cre)Hhzg/Pyytm1(cre)Hhzg
(involves: 129)
|
increased circulating insulin level
|
J:111480
|
increased circulating insulin-like growth factor I level
|
J:111480
|
increased circulating testosterone level
|
J:111480
|
Pyytm1.1Batt/Pyytm1.1Batt
(involves: C57BL/6 * FVB/N * SJL)
|
increased circulating leptin level
|
J:129742
|
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln)
|
increased circulating amylase level
|
J:57485
|
increased circulating lipase level
|
J:57485
|
Qdprtm1Lex/Qdprtm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
increased circulating homocysteine level
|
J:216352
|
Qrfptm1Stak/Qrfptm1Stak
(B6J.129-Qrfptm1Stak)
|
decreased circulating leptin level
|
J:250913
|
Qsox1em1(IMPC)Kmpc/Qsox1em1(IMPC)Kmpc
(C57BL/6NTac-Qsox1em1(IMPC)Kmpc/Kmpc)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Qsox2em1(IMPC)Kmpc/Qsox2em1(IMPC)Kmpc
(C57BL/6NTac-Qsox2em1(IMPC)Kmpc/Kmpc)
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Qtrt1Gt(S12-11A1)Sor/Qtrt1+
(involves: 129S4/SvJaeSor)
|
decreased circulating tyrosine level
|
J:173496
|
Qtrt1Gt(S12-11A1)Sor/Qtrt1Gt(S12-11A1)Sor
(involves: 129S4/SvJaeSor)
|
decreased circulating tyrosine level
|
J:173496
|
Rab3atm1Sud/Rab3atm1Sud Rab3btm1Sud/Rab3btm1Sud Rab3ctm1Sud/Rab3ctm1Sud Rab3dtm1Rja/Rab3dtm1Rja
(involves: 129 * 129P2/OlaHsd)
|
cyanosis
|
J:105478
|
Rab3gap1em1(IMPC)J/Rab3gap1em1(IMPC)J
(C57BL/6NJ-Rab3gap1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rab3gap2tm1b(KOMP)Wtsi/Rab3gap2tm1b(KOMP)Wtsi
(C57BL/6N-Rab3gap2tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Rab3iptm1.1(KOMP)Vlcg/Rab3iptm1.1(KOMP)Vlcg
(C57BL/6N-Rab3iptm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rab4atm1b(EUCOMM)Hmgu/Rab4atm1b(EUCOMM)Hmgu
(C57BL/6N-Rab4atm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating creatinine level
|
J:211773
|
Rab4bem1(IMPC)J/Rab4bem1(IMPC)J
(C57BL/6NJ-Rab4bem1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Rab5atm1b(KOMP)Wtsi/Rab5atm1b(KOMP)Wtsi
(C57BL/6N-Rab5atm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Rab5ctm1a(EUCOMM)Wtsi/Rab5c+
(C57BL/6N-Rab5ctm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Rab10tm1c(KOMP)Wtsi/Rab10tm1c(KOMP)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ)
|
increased circulating insulin level
|
J:249843
|
Rab11fip1em1(IMPC)Bay/Rab11fip1em1(IMPC)Bay
(C57BL/6N-Rab11fip1em1(IMPC)Bay/BayMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Rab11fip5tm1.1(KOMP)Vlcg/Rab11fip5tm1.1(KOMP)Vlcg
(C57BL/6N-Rab11fip5tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Rab15tm1a(KOMP)Wtsi/Rab15tm1a(KOMP)Wtsi
(C57BL/6N-Rab15tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating insulin level
|
J:211773
|
Rab19tm1b(EUCOMM)Hmgu/Rab19tm1b(EUCOMM)Hmgu
(C57BL/6N-Rab19tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating calcium level
|
J:211773
|
Rab20tm1b(EUCOMM)Hmgu/Rab20tm1b(EUCOMM)Hmgu
(C57BL/6N-Rab20tm1b(EUCOMM)Hmgu/J)
|
increased circulating sodium level
|
J:211773
|
Rab23tm1b(EUCOMM)Wtsi/Rab23+
(C57BL/6N-Rab23tm1b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Rab27aash/Rab27aash
(involves: C3H/HeDiSn)
|
increased bleeding time
|
J:63231
|
Rab27aash/Rab27aash
(B6.C3Sn-Rab27aash)
|
increased circulating aspartate transaminase level
|
J:193137
|
increased circulating interferon-gamma level
|
J:193137
|
increased circulating interleukin-1 beta level
|
J:193137
|
increased circulating interleukin-6 level
|
J:193137
|
increased circulating lactate dehydrogenase level
|
J:193137
|
increased circulating tumor necrosis factor level
|
J:193137
|
Rab27aash/Rab27aash
(C3H/HeSn-Rab27aash/J)
|
abnormal platelet dense granule physiology
|
J:77395
|
decreased platelet aggregation
|
J:77395
|
increased bleeding time
|
J:77395
|
Rab27aash/Rab27aash Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C3H/HeSn * C57BL/6J)
|
abnormal blood coagulation
|
J:120307
|
abnormal platelet dense granule physiology
|
J:120307
|
decreased platelet aggregation
|
J:120307
|
Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal blood coagulation
|
J:120307
|
abnormal platelet dense granule physiology
|
J:120307
|
decreased platelet aggregation
|
J:120307
|
Rab28em1(IMPC)J/Rab28em1(IMPC)J
(C57BL/6NJ-Rab28em1(IMPC)J/Mmjax)
|
decreased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rab32tm1b(KOMP)Wtsi/Rab32tm1b(KOMP)Wtsi Rab38tm1.1Ics/Rab38tm1.1Ics
(involves: C57BL/6N * C57BL/6NTac)
|
decreased platelet aggregation
|
J:293385
|
decreased susceptibility to induced thrombosis
|
J:293385
|
increased bleeding time
|
J:293385
|
Rab33aem1(IMPC)H/Y
(C57BL/6N-Rab33aem1(IMPC)H/H)
|
increased circulating serum albumin level
|
J:211773
|
Rab33bem1(IMPC)J/Rab33bem1(IMPC)J
(C57BL/6NJ-Rab33bem1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Rab36tm1b(KOMP)Wtsi/Rab36tm1b(KOMP)Wtsi
(C57BL/6N-Rab36tm1b(KOMP)Wtsi/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Rab37tm1Hsliu/Rab37tm1Hsliu
(involves: C57BL/6J * C57BL/6N)
|
hyperglycemia
|
J:334080
|
Rab39bem1(IMPC)Tcp/Rab39bem1(IMPC)Tcp
(C57BL/6NCrl-Rab39bem1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Rab40ctm1b(KOMP)Wtsi/Rab40c+
(C57BL/6N-Rab40ctm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Rab43tm1.1(KOMP)Vlcg/Rab43tm1.1(KOMP)Vlcg
(C57BL/6N-Rab43tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rab44em1Rbrc/Rab44em1Rbrc
(Not Specified)
|
decreased circulating histamine level
|
J:304506
|
Rabgap1tm1b(EUCOMM)Hmgu/Rabgap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rabgap1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating total protein level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Rabgef1tm1Glli/Rabgef1tm1Glli
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased circulating histamine level
|
J:91790
|
Rabggtagm/Rabggtagm
(C57BL/6J-Rabggtagm)
|
increased bleeding time
|
J:12434
|
increased circulating von Willebrand factor level
|
J:12434
|
Rabl2tm1.1(KOMP)Wtsi/Rabl2tm1.1(KOMP)Wtsi
(C57BL/6N-Rabl2tm1.1(KOMP)Wtsi/Ucd)
|
increased circulating insulin level
|
J:211773
|
Rac1em1(IMPC)Mbp/Rac1+
(C57BL/6N-Rac1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rac1tm1Djk/Rac1tm1Djk Tg(Pf4-icre)Q3Rsko/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal platelet activation
|
J:214607
|
decreased platelet aggregation
|
J:214607
|
Rac2tm1Mddw/Rac2tm1Mddw Tg(TcrAND)53Hed/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
decreased circulating interleukin-2 level
|
J:119437
|
Rad1tm1b(KOMP)Wtsi/Rad1+
(C57BL/6N-Rad1tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Rad21ltm1b(KOMP)Wtsi/Rad21ltm1b(KOMP)Wtsi
(C57BL/6N-Rad21ltm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Rad51ap1tm1.1(KOMP)Vlcg/Rad51ap1tm1.1(KOMP)Vlcg
(C57BL/6N-Rad51ap1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Rag1tm1Mom/Rag1tm1Mom Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:117880
|
Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased circulating glucose level
|
J:111874
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraTcrbNY8.3)1Pesa/0
(NOD.Cg-Rag2tm1Fwa Tg(TcraTcrbNY8.3)1Pesa)
|
increased circulating glucose level
|
J:94192
|
Rai1tm1Jrl/Rai1+
(B6.129S7-Rai1tm1Jrl/J)
|
increased circulating corticosterone level
|
J:164451
|
increased circulating leptin level
|
J:164451
|
Rai1tm2.1Luo/Rai1tm2.1Luo Tg(Sim1-cre)1Lowl/?
(either: (involves: 129S1/Sv * C57BL/6 * FVB) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB))
|
increased circulating HDL cholesterol level
|
J:237687
|
increased circulating LDL cholesterol level
|
J:237687
|
increased circulating VLDL cholesterol level
|
J:237687
|
Rai14em1(IMPC)J/Rai14em1(IMPC)J
(C57BL/6NJ-Rai14em1(IMPC)J/J)
|
cyanosis
|
J:211773
|
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:287672
|
increased circulating free fatty acids level
|
J:287672
|
increased circulating insulin level
|
J:287672
|
increased circulating triglyceride level
|
J:287672
|
increased fasting circulating glucose level
|
J:287672
|
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
increased circulating cholesterol level
|
J:287672
|
increased circulating free fatty acids level
|
J:287672
|
increased circulating insulin level
|
J:287672
|
increased circulating triglyceride level
|
J:287672
|
Ralgapbtm1a(KOMP)Wtsi/Ralgapb+
(C57BL/6N-Ralgapbtm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:211773
|
Ralgps1em1(IMPC)J/Ralgps1em1(IMPC)J
(C57BL/6NJ-Ralgps1em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Ralyem2(IMPC)Tcp/Ralyem2(IMPC)Tcp
(C57BL/6NCrl-Ralyem2(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Ramp1tm1.1Tsuj/Ramp1tm1.1Tsuj
(C.129S2-Ramp1tm1.1Tsuj)
|
increased circulating interferon-gamma level
|
J:125974
|
increased circulating interleukin-6 level
|
J:125974
|
increased circulating tumor necrosis factor level
|
J:125974
|
Ranbp10Gt(RRZ226)Byg/Ranbp10Gt(RRZ226)Byg
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal platelet dense granule physiology
|
J:193236
|
decreased platelet aggregation
|
J:193236
|
increased bleeding time
|
J:193236
|
Ranbp10tm1.1(KOMP)Vlcg/Ranbp10tm1.1(KOMP)Vlcg
(C57BL/6N-Ranbp10tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating glucose level
|
J:211773
|
Rap1btm1Gwht/Rap1btm1Gwht
(involves: 129S/SvEv * C57BL/6)
|
decreased platelet aggregation
|
J:96758
|
decreased susceptibility to induced thrombosis
|
J:96758
|
increased bleeding time
|
J:96758
|
Rap1gap2tm1b(EUCOMM)Hmgu/Rap1gap2tm1b(EUCOMM)Hmgu
(C57BL/6N-Rap1gap2tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating phosphate level
|
J:211773
|
Rap1gapem1(IMPC)H/Rap1gapem1(IMPC)H
(C57BL/6NTac-Rap1gapem1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
cyanosis
|
J:62244
|
Rap2btm1.1(KOMP)Vlcg/Rap2btm1.1(KOMP)Vlcg
(C57BL/6N-Rap2btm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Rapgef2em1(IMPC)H/Rapgef2+
(C57BL/6N-Rapgef2em1(IMPC)H/H)
|
increased circulating bilirubin level
|
J:211773
|
Rapgef3tm1.1Chen/Rapgef3tm1.1Chen
(B6.129(Cg)-Rapgef3tm1.1Chen)
|
decreased circulating glucose level
|
J:207599
|
decreased circulating insulin level
|
J:207599
|
decreased circulating leptin level
|
J:207599
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
decreased blood urea nitrogen level
|
J:201171
|
decreased circulating cholesterol level
|
J:201171
|
decreased circulating HDL cholesterol level
|
J:201171
|
decreased circulating insulin level
|
J:201171
|
hyperglycemia
|
J:201171
|
increased circulating triglyceride level
|
J:201171
|
Rapgef4em1(IMPC)H/Rapgef4+
(C57BL/6NTac-Rapgef4em1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
Rapgef4em1(IMPC)H/Rapgef4em1(IMPC)H
(C57BL/6NTac-Rapgef4em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Rapsnem1Gan/Rapsnem1Gan
(C57BL/6J-Rapsnem1Gan)
|
cyanosis
|
J:282816
|
Rapsntm1b(EUCOMM)Wtsi/Rapsn+
(C57BL/6N-Rapsntm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
decreased circulating free fatty acids level
|
J:206120
|
increased circulating glucose level
|
J:206120
|
Rars2tm1a(EUCOMM)Wtsi/Rars2+
(B6JTyr;B6N-Rars2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
Rasa1tm1b(EUCOMM)Hmgu/Rasa1+
(C57BL/6N-Rasa1tm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Rasa3hlb381/Rasa3hlb381
(C57BL/6J-Rasa3hlb381/J)
|
abnormal platelet physiology
|
J:221899
|
Rasa3hlb381/Rasa3hlb381 Rasgrp2tm1Amg/Rasgrp2tm1Amg
(involves: C57BL/6J)
|
abnormal hemostasis
|
J:221899
|
Rasa3scat/Rasa3scat
(involves: BALB/cBy)
|
hyperlipidemia
|
J:186485
|
increased circulating bilirubin level
|
J:186485
|
Rasa3tm1.1Llp/Rasa3tm1.1Llp Tg(Mx1-cre)1Cgn/?
(involves: 129S1/SvImJ * C57BL/6J * CBA/J)
|
increased circulating bilirubin level
|
J:301035
|
increased circulating lactate dehydrogenase level
|
J:301035
|
Rasa3tm1b(KOMP)J/Rasa3+
(C57BL/6N-Rasa3tm1b(KOMP)J/J)
|
decreased circulating glucose level
|
J:211773
|
Rasal3tm1.1Fuj/Rasal3tm1.1Fuj
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased circulating alanine transaminase level
|
J:229641
|
decreased circulating aspartate transaminase level
|
J:229641
|
decreased circulating interferon-gamma level
|
J:229641
|
decreased circulating interleukin-4 level
|
J:229641
|
Rasal3tm1b(EUCOMM)Hmgu/Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rasgrf1tm1Esn/Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N)
|
decreased circulating insulin level
|
J:83950
|
Rasgrf1tm1Toc/Rasgrf1+
(involves: 129)
|
decreased circulating insulin-like growth factor I level
|
J:47681
|
Rasgrp2tm1Amg/Rasgrp2tm1Amg
(Not Specified)
|
abnormal platelet physiology
|
J:92864
|
decreased platelet aggregation
|
J:122618,
J:92864
|
increased bleeding time
|
J:92864
|
Raver2em1(IMPC)J/Raver2em1(IMPC)J
(C57BL/6NJ-Raver2em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd)
|
increased circulating glucagon level
|
J:216559
|
Rb1tm3Tyj/Rb1tm3Tyj Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
increased circulating alkaline phosphatase level
|
J:199542
|
Rb1cc1tm1.1Guan/Rb1cc1tm1.1Guan Tg(SFTPC-cre)11Yo/0
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:300057
|
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Rbl2tm1b(EUCOMM)Hmgu/Rbl2+
(C57BL/6N-Rbl2tm1b(EUCOMM)Hmgu/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rbm4tm1Wtarn/Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:192831
|
hyperglycemia
|
J:192831
|
Rbm4btm1.1(KOMP)Vlcg/Rbm4btm1.1(KOMP)Vlcg
(C57BL/6N-Rbm4btm1.1(KOMP)Vlcg/J)
|
increased circulating bilirubin level
|
J:211773
|
Rbm4btm1Wtarn/Rbm4btm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:192831
|
Rbm6em1(IMPC)J/Rbm6em1(IMPC)J
(C57BL/6NJ-Rbm6em1(IMPC)J/Mmjax)
|
decreased fasting circulating glucose level
|
J:211773
|
Rbm14tm1a(KOMP)Wtsi/Rbm14tm1a(KOMP)Wtsi
(C57BL/6N-Rbm14tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rbm20em1(IMPC)Mbp/Rbm20em1(IMPC)Mbp
(C57BL/6N-Rbm20em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Rbm39em1(IMPC)Hmgu/Rbm39+
(C57BL/6NCrl-Rbm39em1(IMPC)Hmgu/Ieg)
|
decreased fasting circulating glucose level
|
J:211773
|
Rbms1tm1b(EUCOMM)Wtsi/Rbms1+
(C57BL/6N-Rbms1tm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rbms1tm1Hiro/Rbms1tm1Hiro
(involves: C57BL/6 * CBA)
|
decreased circulating progesterone level
|
J:77893
|
Rbmxtm2a(KOMP)Wtsi/Rbmxtm2a(KOMP)Wtsi
(C57BL/6N-Rbmxtm2a(KOMP)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Rbmxtm2b(KOMP)Wtsi/Y
(C57BL/6N-Rbmxtm2b(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
Rbmxtm2b(KOMP)Wtsi/Rbmxtm2b(KOMP)Wtsi
(C57BL/6N-Rbmxtm2b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rbp1tm2b(EUCOMM)Hmgu/Rbp1tm2b(EUCOMM)Hmgu
(C57BL/6N-Rbp1tm2b(EUCOMM)Hmgu/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Rbpjtm1b(EUCOMM)Hmgu/Rbpj+
(C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Rbpjltm1b(KOMP)Wtsi/Rbpjltm1b(KOMP)Wtsi
(C57BL/6N-Rbpjltm1b(KOMP)Wtsi/H)
|
increased circulating amylase level
|
J:211773
|
Rbpmsem1(IMPC)H/Rbpms+
(C57BL/6NTac-Rbpmsem1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rbpmsem1Eno/Rbpmsem1Eno
(involves: C3H * C57BL/6)
|
cyanosis
|
J:324468
|
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu)
|
increased circulating tumor necrosis factor level
|
J:196137
|
Rc3h1san/Rc3h1san Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased circulating tumor necrosis factor level
|
J:196137
|
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae)
|
abnormal circulating protein level
|
J:152536
|
Rcc2tm1b(EUCOMM)Wtsi/Rcc2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rcc2tm1b(EUCOMM)Wtsi/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Rce1tm2Kim/Rce1tm2.1Kim Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6)
|
abnormal atrial thrombosis
|
J:87958
|
Rcn1tm1b(EUCOMM)Hmgu/Rcn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rcn1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rcn3tm1Rzm/Rcn3tm1Rzm
(involves: 129S6/SvEvTac * C57BL/6J)
|
cyanosis
|
J:265611
|
Rdh16tm1a(KOMP)Wtsi/Rdh16tm1a(KOMP)Wtsi
(C57BL/6N-Rdh16tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating potassium level
|
J:175295
|
Rdurem1Jiche/Rdurem1Jiche
(Not Specified)
|
increased circulating interleukin-1 level
|
J:340209
|
increased circulating interleukin-6 level
|
J:340209
|
Rdxtm1Sts/Rdxtm1Sts
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood homeostasis
|
J:77485
|
increased circulating alkaline phosphatase level
|
J:77485
|
increased circulating aspartate transaminase level
|
J:77485
|
increased circulating bilirubin level
|
J:77485
|
Rec8tm1b(KOMP)Wtsi/Rec8tm1b(KOMP)Wtsi
(C57BL/6N-Rec8tm1b(KOMP)Wtsi/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Reep1Gt(OST398247)Lex/Reep1Gt(OST398247)Lex
(B6.129S5-Reep1Gt(OST398247)Lex)
|
decreased circulating cholesterol level
|
J:239250
|
decreased circulating insulin level
|
J:239250
|
decreased circulating triglyceride level
|
J:239250
|
Reg3bem1(IMPC)Mbp/Reg3bem1(IMPC)Mbp
(C57BL/6NCrl-Reg3bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Reg3gtm1a(KOMP)Wtsi/Reg3gtm1a(KOMP)Wtsi
(C57BL/6N-Reg3gtm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Relbshep/Relbshep
(A;C-Relbshep/GrsrJ)
|
abnormal circulating protein level
|
J:171971
|
decreased circulating amylase level
|
J:171971
|
decreased circulating serum albumin level
|
J:171971
|
decreased circulating total protein level
|
J:171971
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(involves: C57BL/6)
|
decreased circulating interleukin-4 level
|
J:120659
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
increased circulating aldosterone level
|
J:169129
|
Ren1tm1Afu/Ren1tm1Afu
(involves: C57BL/6 * CBA)
|
abnormal blood homeostasis
|
J:59299
|
decreased circulating renin level
|
J:59299
|
Ren1tm1Bjm/Ren1tm1Bjm
(B6.Cg-Ren1tm1Bjm)
|
increased circulating creatinine level
|
J:117294
|
Ren1tm1Gom/Ren1tm1Gom
(involves: 129S6/SvEvTac)
|
decreased circulating renin level
|
J:72077
|
Ren1tm1Mgfs/Ren1tm1Mgfs
(involves: 129P2/OlaHsd)
|
abnormal blood homeostasis
|
J:41714
|
decreased circulating renin level
|
J:41714
|
Ren1tm1Tkh/Ren1tm1Tkh
(C57BL/6-Ren1tm1Tkh)
|
decreased circulating angiotensin II level
|
J:110082
|
decreased circulating renin level
|
J:110082
|
increased blood urea nitrogen level
|
J:110082
|
increased circulating creatinine level
|
J:110082
|
Ren1tm3Gom/Ren1+
(129S6/SvEvTac-Ren1tm3Gom)
|
decreased circulating renin level
|
J:95786
|
Ren1tm3Gom/Ren1tm3Gom
(129S6/SvEvTac-Ren1tm3Gom)
|
decreased circulating renin level
|
J:95786
|
increased blood urea nitrogen level
|
J:95786
|
increased circulating potassium level
|
J:95786
|
repro19/repro19
(B6;C3Fe-repro19/J)
|
increased circulating luteinizing hormone level
|
J:92463
|
increased circulating testosterone level
|
J:92463
|
Reps2em1(IMPC)J/Reps2em1(IMPC)J
(C57BL/6NJ-Reps2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Resp18tm1.1(KOMP)Vlcg/Resp18+
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Resp18tm1.1(KOMP)Vlcg/Resp18tm1.1(KOMP)Vlcg
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating glucose level
|
J:90033
|
Retntm1Laz/Retntm1Laz Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating free fatty acids level
|
J:171262
|
increased circulating glycerol level
|
J:171262
|
increased circulating insulin level
|
J:171262
|
Retnlatm1Mer/Retnlatm1Mer
(C57BL/6-Retnlatm1Mer)
|
decreased circulating leptin level
|
J:144784
|
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex)
|
decreased circulating interleukin-6 level
|
J:235058
|
increased circulating interleukin-13 level
|
J:235058
|
Retnlgem1(IMPC)J/Retnlgem1(IMPC)J
(C57BL/6NJ-Retnlgem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Retreg3tm2b(EUCOMM)Wtsi/Retreg3tm2b(EUCOMM)Wtsi
(C57BL/6N-Fam134ctm2b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rev3ltm1b(EUCOMM)Hmgu/Rev3l+
(C57BL/6N-Rev3ltm1b(EUCOMM)Hmgu/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Rfc1tm1b(KOMP)Mbp/Rfc1+
(B6N(Cg)-Rfc1tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rfc5em1(IMPC)J/Rfc5+
(C57BL/6NJ-Rfc5em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Rfx7tm2b(EUCOMM)Hmgu/Rfx7+
(C57BL/6N-Rfx7tm2b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Rfxanktm1b(EUCOMM)Hmgu/Rfxanktm1b(EUCOMM)Hmgu
(C57BL/6N-Rfxanktm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rfxapem1(IMPC)J/Rfxapem1(IMPC)J
(C57BL/6NJ-Rfxapem1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
Rgl3em1(IMPC)H/Rgl3em1(IMPC)H
(C57BL/6NTac-Rgl3em1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
Rgntm1Aish/Y
(involves: 129P2/OlaHsd)
|
abnormal circulating amino acid level
|
J:108295
|
Rgp1tm1.1(KOMP)Vlcg/Rgp1+
(C57BL/6N-Rgp1tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Rgs2em1(IMPC)H/Rgs2em1(IMPC)H
(C57BL/6NTac-Rgs2em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Rgs4tm1Dgen/Rgs4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
Rgs4tm1Sdlk/Rgs4tm1Sdlk Tg(Myh11-icre/ERT2)1Soff/?
(involves: FVB/N)
|
increased circulating creatinine level
|
J:215588
|
Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh)
|
hypoglycemia
|
J:136259
|
Rgs9em1(IMPC)Ccpcz/Rgs9em1(IMPC)Ccpcz
(C57BL/6NCrl-Rgs9em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rgs10Gt(OST24334)Lex/Rgs10Gt(OST24334)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating glucose level
|
J:103485
|
Rgs16tm1Tmw/Rgs16tm1Tmw
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased circulating ketone body level
|
J:172091
|
Rgs18m1H/Rgs18m1H
(BALB/cAnN-Rgs18m1H/H)
|
abnormal hemostasis
|
J:228457
|
decreased bleeding time
|
J:228457
|
increased platelet aggregation
|
J:228457
|
increased susceptibility to induced thrombosis
|
J:228457
|
Rgs18tm1.1Ics/Rgs18tm1.1Ics
(involves: 129S2/SvPas * C57BL/6J)
|
increased platelet aggregation
|
J:225296
|
Rgsc25/Rgsc25+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
Rgsc160/Rgsc160+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
Rgsc172/Rgsc172+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased blood urea nitrogen level
|
J:133634
|
increased circulating amylase level
|
J:133634
|
Rgsc197/Rgsc197+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc263/Rgsc263+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc264/Rgsc264+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating alkaline phosphatase level
|
J:133634
|
Rgsc273/Rgsc273+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc333/Rgsc333+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
decreased circulating total protein level
|
J:133634
|
Rgsc370/Rgsc370+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating amylase level
|
J:133634
|
Rgsc391/Rgsc391+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc453/Rgsc453+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc466/Rgsc466+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased blood uric acid level
|
J:133634
|
Rgsc477/Rgsc477+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating copper level
|
J:133634
|
Rgsc484/Rgsc484+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc522/Rgsc522+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating amylase level
|
J:133634
|
Rgsc528/Rgsc528+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc545/Rgsc545+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc627/Rgsc627+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating alkaline phosphatase level
|
J:133634
|
increased circulating bilirubin level
|
J:133634
|
increased circulating copper level
|
J:133634
|
Rgsc629/Rgsc629+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating amylase level
|
J:133634
|
Rgsc663/Rgsc663+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc668/Rgsc668+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc679/Rgsc679+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating cholesterol level
|
J:133634
|
increased circulating HDL cholesterol level
|
J:133634
|
Rgsc733/Rgsc733+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc832/Rgsc832+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating alkaline phosphatase level
|
J:133634
|
Rgsc833/Rgsc833+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc846/Rgsc846+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc855/Rgsc855+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc916/Rgsc916+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased blood uric acid level
|
J:133634
|
Rgsc1196/Rgsc1196+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc1361/Rgsc1361+
(involves: KJR * MSM)
|
increased circulating glucose level
|
J:133634
|
Rgsc1472/Rgsc1472+
(involves: C3H * C57BL/6JJcl)
|
decreased circulating amylase level
|
J:133634
|
Rgsc1566/Rgsc1566+
(involves: C3H * C57BL/6JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc1662/Rgsc1662+
(involves: C3H * C57BL/6JJcl)
|
decreased blood uric acid level
|
J:133634
|
Rgsc1663/Rgsc1663+
(involves: C3H * C57BL/6JJcl)
|
increased blood urea nitrogen level
|
J:133634
|
Rgsc1666/Rgsc1666+
(involves: C3H * C57BL/6JJcl)
|
decreased blood uric acid level
|
J:133634
|
Rgsc1688/Rgsc1688+
(involves: C3H * C57BL/6JJcl)
|
decreased circulating alkaline phosphatase level
|
J:133634
|
Rgsc1740/Rgsc1740+
(involves: C3H * C57BL/6JJcl)
|
decreased circulating copper level
|
J:133634
|
Rgsc1851/Rgsc1851
(C57BL/6JJcl-Rgsc1851)
|
increased circulating triglyceride level
|
J:133634
|
Rhagem1(IMPC)Ccpcz/Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Rhagtm1Goo/Rhagtm1Goo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:182122
|
increased circulating iron level
|
J:182122
|
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
increased circulating alanine transaminase level
|
J:197348
|
increased circulating aspartate transaminase level
|
J:197348
|
increased circulating interferon-gamma level
|
J:197348
|
increased circulating interleukin-6 level
|
J:197348
|
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)
|
abnormal cardiac thrombosis
|
J:203951
|
Rhbdf2em1(IMPC)Wtsi/Rhbdf2em1(IMPC)Wtsi
(C57BL/6N-Rhbdf2em1(IMPC)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:211773
|
Rhbdf2tm1.1Mfm/Rhbdf2tm1.1Mfm
(B6.129S-Rhbdf2tm1.1Mfm)
|
decreased circulating tumor necrosis factor level
|
J:179654
|
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(B6.129P2-Rhbdf2tm1Mak)
|
decreased circulating tumor necrosis factor level
|
J:179653
|
Rhbdl1tm1.1(KOMP)Vlcg/Rhbdl1+
(C57BL/6N-Rhbdl1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Rhbgem1(IMPC)Hmgu/Rhbgem1(IMPC)Hmgu
(C57BL/6N-Rhbgem1(IMPC)Hmgu/Ieg)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Rhcgtm1Ibmm/Rhcgtm1Ibmm
(involves: 129P2/OlaHsd * CD-1)
|
decreased circulating potassium level
|
J:141372
|
Rhdtm1a(EUCOMM)Wtsi/Rhdtm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Rhdtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Rhdtm1Goo/Rhdtm1Goo
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating iron level
|
J:182122
|
Rhoatm1Jrel/Rhoatm1Jrel Rhpn1tm1Ktry/Rhpn1tm1Ktry Tg(NPHS2-cre)295Lbh/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating creatinine level
|
J:276466
|
Rhobtb1em2(IMPC)Ccpcz/Rhobtb1em2(IMPC)Ccpcz
(C57BL/6N-Rhobtb1em2(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Rhot1tm1.2Jmsu/Rhot1tm1.2Jmsu
(involves: 129 * 129S1/Sv * C57BL/6 * SJL)
|
cyanosis
|
J:216408
|
Rhot1tm1d(EUCOMM)Wtsi/Rhot1tm1d(EUCOMM)Wtsi
(involves: C57BL/6Dnk * C57BL/6N)
|
cyanosis
|
J:240500
|
Rhot2tm1(KOMP)Wtsi/Rhot2tm1(KOMP)Wtsi
(C57BL/6N-Rhot2tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:175295
|
Rhoutm1a(KOMP)Wtsi/Rhoutm1a(KOMP)Wtsi
(C57BL/6N-Rhoutm1a(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:175295
|
Rhpn1tm1b(KOMP)Wtsi/Rhpn1tm1b(KOMP)Wtsi
(C57BL/6N-Rhpn1tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rhpn1tm1Ktry/Rhpn1tm1Ktry Rhpn2tm1Ssch/Rhpn2tm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased circulating creatinine level
|
J:276466
|
Ric1tm1a(EUCOMM)Hmgu/Ric1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ric1tm1a(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:165965
|
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
hyperglycemia
|
J:170129
|
Rictortm1.1Mnh/Rictortm1.1Mnh Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev)
|
increased circulating cholesterol level
|
J:150064
|
increased circulating insulin level
|
J:150064
|
increased circulating insulin-like growth factor I level
|
J:150064
|
Ridatm1a(KOMP)Wtsi/Ridatm1a(KOMP)Wtsi
(C57BL/6N-Ridatm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating iron level
|
J:211773
|
Rilpl1tm1b(EUCOMM)Hmgu/Rilpl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rilpl1tm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Rilpl2tm1b(KOMP)Wtsi/Rilpl2tm1b(KOMP)Wtsi
(C57BL/6N-Rilpl2tm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Rims2tm1Sse/Rims2tm1Sse
(B6.Cg-Rims2tm1Sse)
|
decreased circulating adrenaline level
|
J:163080
|
decreased circulating glucose level
|
J:163080
|
decreased circulating growth hormone level
|
J:163080
|
decreased circulating insulin level
|
J:163080
|
decreased circulating insulin-like growth factor I level
|
J:163080
|
increased circulating glucagon level
|
J:163080
|
increased circulating glucose level
|
J:163080
|
Rin3tm1.1(KOMP)Vlcg/Rin3tm1.1(KOMP)Vlcg
(C57BL/6N-Rin3tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Rint1tm1b(KOMP)Wtsi/Rint1+
(C57BL/6N-Rint1tm1b(KOMP)Wtsi/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Riok2tm1b(KOMP)Wtsi/Riok2+
(C57BL/6N-Riok2tm1b(KOMP)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Riok2tm1c(KOMP)Wtsi/Riok2+ Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal circulating interleukin level
|
J:305794
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
abnormal circulating interferon-gamma level
|
J:201871
|
abnormal circulating interleukin-4 level
|
J:201871
|
Ripply3tm1Sjt/Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
cyanosis
|
J:167713
|
Rit1em1(IMPC)Mbp/Rit1em1(IMPC)Mbp
(C57BL/6N-Rit1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Rit1tm1.1Tumg/Rit1+
(B6.Cg-Rit1tm1.1Tumg)
|
increased circulating aspartate transaminase level
|
J:277548
|
Rln1tm1Wint/Rln1tm1Wint
(involves: 129S1/Sv * C57BL/6J)
|
increased blood osmolality
|
J:52024
|
Rln3tm1(KOMP)Mbp/Rln3tm1(KOMP)Mbp
(C57BL/6N-Rln3tm1(KOMP)Mbp/Ucd)
|
increased circulating iron level
|
J:211773
|
Rln3tm1Lex/Rln3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:181242
|
decreased circulating leptin level
|
J:181242
|
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:168271
|
Rmrpem1(IMPC)Ccpcz/Rmrp+
(C57BL/6NCrl-Rmrpem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnase1tm1.2Rtrs/Rnase1tm1.2Rtrs
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
abnormal blood coagulation
|
J:288762
|
abnormal blood homeostasis
|
J:288762
|
Rnasektm1b(EUCOMM)Wtsi/Rnasek+
(C57BL/6N-Rnasektm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Rnf4em1(IMPC)Ccpcz/Rnf4+
(C57BL/6N-Rnf4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rnf7tm1a(EUCOMM)Wtsi/Rnf7+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Rnf10em1(IMPC)Mbp/Rnf10em1(IMPC)Mbp
(C57BL/6N-Rnf10em1(IMPC)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Rnf10tm1a(KOMP)Wtsi/Rnf10tm1a(KOMP)Wtsi
(C57BL/6N-Rnf10tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
increased circulating cholesterol level
|
J:175295
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating triglyceride level
|
J:175295
|
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/MbpMmucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rnf14em1(IMPC)Ccpcz/Rnf14em1(IMPC)Ccpcz
(C57BL/6N-Rnf14em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf25tm1.1(KOMP)Vlcg/Rnf25tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf25tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Rnf43em1(IMPC)Tcp/Rnf43em1(IMPC)Tcp
(C57BL/6NCrl-Rnf43em1(IMPC)Tcp/Tcp)
|
increased circulating potassium level
|
J:211773
|
Rnf115em1(IMPC)H/Rnf115em1(IMPC)H
(C57BL/6N-Rnf115em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
Rnf115em1Gpt/Rnf115em1Gpt
(C57BL/6JGpt-Rnf115em1Gpt/Gpt)
|
increased circulating interferon-beta level
|
J:297834
|
Rnf122em1Caox/Rnf122em1Caox
(involves: C57BL/6J)
|
increased circulating interferon-alpha level
|
J:344769
|
increased circulating interferon-beta level
|
J:344769
|
increased circulating interleukin-6 level
|
J:344769
|
Rnf123em1(IMPC)J/Rnf123em1(IMPC)J
(C57BL/6NJ-Rnf123em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Rnf125tm1a(EUCOMM)Hmgu/Rnf125tm1a(EUCOMM)Hmgu
(C57BL/6N-Rnf125tm1a(EUCOMM)Hmgu/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Rnf126em1(IMPC)J/Rnf126+
(C57BL/6NJ-Rnf126em1(IMPC)J/J)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Rnf128tm1.1Flv/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating interleukin-2 level
|
J:153216
|
Rnf128tm1.1Flv/Y Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
increased circulating interleukin-2 level
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating interleukin-2 level
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
increased circulating interleukin-2 level
|
J:153216
|
Rnf130tm1a(EUCOMM)Wtsi/Rnf130tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating cholesterol level
|
J:338210
|
decreased circulating LDL cholesterol level
|
J:338210
|
Rnf144btm1b(EUCOMM)Hmgu/Rnf144btm1b(EUCOMM)Hmgu
(C57BL/6N-Rnf144btm1b(EUCOMM)Hmgu/Ics)
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Rnf145em1(IMPC)Wtsi/Rnf145+
(C57BL/6N-Rnf145em1(IMPC)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:243612
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased circulating insulin level
|
J:244583
|
decreased circulating osteocalcin level
|
J:244583
|
increased circulating glucose level
|
J:244583
|
increased circulating triglyceride level
|
J:244583
|
Rnf148em1(IMPC)Ccpcz/Rnf148em1(IMPC)Ccpcz
(C57BL/6N-Rnf148em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating serum albumin level
|
J:211773
|
Rnf157tm1b(EUCOMM)Wtsi/Rnf157tm1b(EUCOMM)Wtsi
(C57BL/6N-Rnf157tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
Rnf166em1(IMPC)J/Rnf166em1(IMPC)J
(C57BL/6NJ-Rnf166em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Rnf168em1(IMPC)H/Rnf168em1(IMPC)H
(C57BL/6NTac-Rnf168em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Rnf168tm2b(EUCOMM)Hmgu/Rnf168tm2b(EUCOMM)Hmgu
(C57BL/6N-Rnf168tm2b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Rnf169tm1a(EUCOMM)Hmgu/Rnf169tm1a(EUCOMM)Hmgu
(B6NTac;B6N-Rnf169tm1a(EUCOMM)Hmgu/H)
|
decreased circulating free fatty acids level
|
J:165965
|
Rnf180em1(IMPC)J/Rnf180em1(IMPC)J
(C57BL/6NJ-Rnf180em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Rnf187em1(IMPC)J/Rnf187em1(IMPC)J
(C57BL/6NJ-Rnf187em1(IMPC)J/Mmjax)
|
increased blood urea nitrogen level
|
J:211773
|
Rnf208em1(IMPC)Ccpcz/Rnf208em1(IMPC)Ccpcz
(C57BL/6N-Rnf208em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N)
|
decreased circulating glucose level
|
J:200802
|
Rnf214em1(IMPC)J/Rnf214em1(IMPC)J
(C57BL/6NJ-Rnf214em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Rnf216tm1b(EUCOMM)Wtsi/Rnf216tm1b(EUCOMM)Wtsi
(C57BL/6N-Rnf216tm1b(EUCOMM)Wtsi/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Rnl23/?
(C57BL/6J-Rnl23)
|
increased blood urea nitrogen level
|
J:82961
|
Rnl25/?
(C57BL/6J-Rnl25)
|
increased blood urea nitrogen level
|
J:82961
|
Rnl27/?
(C57BL/6J-Rnl27/J)
|
increased blood urea nitrogen level
|
J:82961
|
Rnl29/?
(C57BL/6J-Rnl29)
|
increased blood urea nitrogen level
|
J:82961
|
Rnl32/?
(C57BL/6J-Rnl32)
|
increased blood urea nitrogen level
|
J:82961
|
Rnl43/?
(C57BL/6J-Rnl43)
|
increased blood urea nitrogen level
|
J:82961
|
Rnlstm1Gvd/Rnlstm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
increased circulating adrenaline level
|
J:186878
|
increased circulating noradrenaline level
|
J:186878
|
Rnps1em1(IMPC)Hmgu/Rnps1+
(C57BL/6NCrl-Rnps1em1(IMPC)Hmgu/Ieg)
|
increased circulating alanine transaminase level
|
J:211773
|
Robo1tm1Matl/Robo1tm1Matl Robo2tm1Mrt/Robo2tm1Mrt
(involves: 129P2/OlaHsd)
|
cyanosis
|
J:193400
|
Robo3em1(IMPC)H/Robo3+
(C57BL/6NTac-Robo3em1(IMPC)H/H)
|
increased circulating bilirubin level
|
J:211773
|
Robo3tm1Matl/Robo3tm1Matl
(involves: C57BL/6)
|
cyanosis
|
J:165285
|
Robo4tm1Kzh/Robo4tm1Kzh
(Not Specified)
|
decreased circulating glucose level
|
J:294754
|
decreased fasting circulating glucose level
|
J:294754
|
Rock1tm1.1Itl/Rock1tm1.1Itl Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased circulating insulin level
|
J:204885
|
increased circulating leptin level
|
J:204885
|
Rock2tm1Zpj/Rock2+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal circulating cholesterol level
|
J:224630
|
decreased circulating free fatty acids level
|
J:224630
|
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N)
|
decreased circulating calcium level
|
J:344072
|
increased circulating alkaline phosphatase level
|
J:344072
|
Romo1em1(IMPC)Kmpc/Romo1+
(C57BL/6NTac-Romo1em1(IMPC)Kmpc/Kmpc)
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Ror1tm1Ymi/Ror1tm1Ymi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:72948
|
cyanosis
|
J:72948
|
Ror2tm1Ymi/Ror2tm1Ymi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood homeostasis
|
J:60125
|
cyanosis
|
J:60125
|
Rorasg/Rorasg
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:52105
|
decreased circulating HDL cholesterol level
|
J:52105
|
Roratm1b(EUCOMM)Wtsi/Rora+
(C57BL/6N-Roratm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Rp9tm1b(EUCOMM)Wtsi/Rp9tm1b(EUCOMM)Wtsi
(C57BL/6N-Rp9tm1b(EUCOMM)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Rpa1tm1b(KOMP)Wtsi/Rpa1+
(C57BL/6N-Rpa1tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Rpap3em1(IMPC)Mbp/Rpap3+
(C57BL/6N-Rpap3em1(IMPC)Mbp/Ucd)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Rph3altm1Sse/Rph3altm1Sse
(B6.129-Rph3altm1Sse)
|
increased circulating glucose level
|
J:90669
|
Rpiatm1a(KOMP)Wtsi/Rpia+
(C57BL/6N-Rpiatm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(FVB.129S5(Cg)-Rpl13atm1.1Jesc)
|
abnormal circulating glucose level
|
J:237822
|
Rpl13atm1.1Mazu/Rpl13atm1.1Mazu Lyz2tm1(cre)Ifo/Lyz2+
(involves: C57BL/6)
|
increased blood urea nitrogen level
|
J:194920
|
increased circulating aspartate transaminase level
|
J:194920
|
increased circulating tumor necrosis factor level
|
J:194920
|
Rpl38Ts/Rpl38+
(TSJ/Le)
|
increased circulating phosphate level
|
J:168509
|
RplagFVB/NJ/?
(involves: C57BL/6J * FVB/NJ)
|
abnormal platelet physiology
|
J:90287
|
Rpn2tm1a(EUCOMM)Wtsi/Rpn2+
(B6JTyr;B6N-Rpn2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Rps2tm1.1Geno/Rps2+
(B6.129(Cg)-Rps2tm1.1Geno)
|
increased circulating creatine kinase level
|
J:321029
|
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating insulin level
|
J:100952
|
Rps6ka3tm1Ljg/Y
(involves: 129 * C57BL/6)
|
decreased circulating leptin level
|
J:83536
|
increased circulating glucose level
|
J:83536
|
increased circulating insulin level
|
J:83536
|
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(B6.Cg-Rps6ka5tm1Jsca Rps6ka4tm1Jsca)
|
decreased circulating interleukin-10 level
|
J:139576
|
increased circulating interleukin-6 level
|
J:139576
|
increased circulating interleukin-12a level
|
J:139576
|
increased circulating interleukin-12b level
|
J:139576
|
increased circulating tumor necrosis factor level
|
J:139576
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating insulin level
|
J:66406
|
hyperglycemia
|
J:66406
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho)
|
decreased circulating insulin level
|
J:144599
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:89696
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb)
|
decreased circulating glucose level
|
J:144599
|
decreased circulating insulin level
|
J:144599
|
Rps6kc1tm1b(EUCOMM)Wtsi/Rps6kc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Rps6kc1tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Rps6kl1tm1.1(KOMP)Vlcg/Rps6kl1tm1.1(KOMP)Vlcg
(C57BL/6N-Rps6kl1tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Rps26tm2b(EUCOMM)Hmgu/Rps26tm2b(EUCOMM)Hmgu
(C57BL/6N-Rps26tm2b(EUCOMM)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Rptortm1.1Dmsa/Rptortm1.1Dmsa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA)
|
increased circulating ketone body level
|
J:167208
|
Rptortm1Rueg/Rptortm1Rueg Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:143749
|
decreased circulating glucose level
|
J:143749
|
decreased circulating insulin level
|
J:143749
|
decreased circulating leptin level
|
J:143749
|
Rr2tm1Hgc/Rr2tm1Hgc
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased blood urea nitrogen level
|
J:128347
|
Rr28tm1Tilg/Rr28+ Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal circulating hormone level
|
J:77413
|
Rr29Hx/Rr29+
(B10.D2/nSn-Rr29Hx/J)
|
increased bleeding time
|
J:31800
|
Rr266em1Hino/Rr266em1Hino Rr268em1Hino/Rr268em1Hino
(C57BL/6J-Rr266em1Hino Rr268em1Hino)
|
hyperglycemia
|
J:312429
|
Rr344em1Jfer/Rr344em1Jfer
(B6.Cg-Rr344em1Jfer)
|
decreased circulating insulin level
|
J:328047
|
hyperglycemia
|
J:328047
|
Rr401em1Yushi/Rr401em1Yushi
(Not Specified)
|
decreased circulating follicle stimulating hormone level
|
J:334319
|
Rr594em2Mrub/Rr594em2Mrub Rr596tm1.1Low/Rr596tm1.1Low
(C57BL/6J-Rr594em2Mrub Rr596tm1.1Low)
|
increased circulating cholesterol level
|
J:357475
|
increased circulating triglyceride level
|
J:357475
|
increased fasting circulating glucose level
|
J:357475
|
Rr596tm1.1Low/Rr596tm1.1Low
(C57BL/6J-Rr596tm1.1Low)
|
increased circulating cholesterol level
|
J:357475
|
increased circulating triglyceride level
|
J:357475
|
increased fasting circulating glucose level
|
J:357475
|
Rr609m1H/Rr609+
(involves: C3H/HeH * C57BL/6J)
|
abnormal blood homeostasis
|
J:208708
|
decreased circulating osteocalcin level
|
J:208708
|
decreased circulating parathyroid hormone level
|
J:208708
|
hyperglycemia
|
J:208708
|
increased blood uric acid level
|
J:208708
|
increased circulating alanine transaminase level
|
J:208708
|
increased circulating alkaline phosphatase level
|
J:208708
|
increased circulating aspartate transaminase level
|
J:208708
|
increased circulating calcium level
|
J:208708
|
increased circulating cholesterol level
|
J:208708
|
increased circulating corticosterone level
|
J:208708
|
increased circulating creatinine level
|
J:208708
|
increased circulating glucagon level
|
J:208708
|
increased circulating insulin level
|
J:208708
|
increased circulating leptin level
|
J:208708
|
increased circulating total protein level
|
J:208708
|
increased circulating triglyceride level
|
J:208708
|
Rr124128tm1.1Jfer/Rr124128tm1.1Jfer Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating insulin level
|
J:332319
|
hyperglycemia
|
J:332319
|
Rr124128tm1.2Jfer/Rr124128tm1.2Jfer
(involves: C57BL/6 * FVB/N)
|
decreased circulating insulin level
|
J:332319
|
Rradtm1.1(KOMP)Vlcg/Rradtm1.1(KOMP)Vlcg
(C57BL/6N-Rradtm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Rragatm1.1Dmsa/Rragatm1.1Dmsa
(involves: 129 * C57BL/6 * C57BL/6J)
|
abnormal circulating amino acid level
|
J:194401
|
hypoglycemia
|
J:194401
|
Rragatm2Dmsa/Rragatm2Dmsa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating glucose level
|
J:213516
|
Rrasem1(IMPC)H/Rrasem1(IMPC)H
(C57BL/6N-Rrasem1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rrbp1em1(IMPC)J/Rrbp1em1(IMPC)J
(C57BL/6NJ-Rrbp1em1(IMPC)J/Mmjax)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Rreb1tm1b(EUCOMM)Wtsi/Rreb1+
(C57BL/6N-Rreb1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Rrm2tm1b(KOMP)Wtsi/Rrm2+
(C57BL/6N-Rrm2tm1b(KOMP)Wtsi/Bay)
|
increased circulating phosphate level
|
J:211773
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal blood homeostasis
|
J:186071
|
decreased circulating alkaline phosphatase level
|
J:186071
|
decreased circulating glucose level
|
J:186071
|
decreased circulating serum albumin level
|
J:186071
|
hyperlipidemia
|
J:186071
|
increased blood urea nitrogen level
|
J:186071
|
increased circulating cholesterol level
|
J:186071
|
increased circulating creatinine level
|
J:186071
|
increased circulating phosphate level
|
J:186071
|
increased circulating triglyceride level
|
J:186071
|
Rrm2btm1Ynak/Rrm2btm1Ynak
(involves: 129 * C57BL/6J)
|
decreased circulating serum albumin level
|
J:84841
|
increased blood urea nitrogen level
|
J:84841
|
increased circulating creatinine level
|
J:84841
|
Rrp8tm1.1(KOMP)Vlcg/Rrp8+
(C57BL/6N-Rrp8tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Rsad1tm1.1(KOMP)Vlcg/Rsad1+
(C57BL/6N-Rsad1tm1.1(KOMP)Vlcg/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
Rsad2em1(IMPC)H/Rsad2em1(IMPC)H
(C57BL/6NTac-Rsad2em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Rsad2tm1Aki/Rsad2tm1Aki
(involves: 129/Sv * C57BL/6)
|
decreased circulating interferon-alpha level
|
J:169840
|
Rsbn1tm1b(EUCOMM)Wtsi/Rsbn1+
(C57BL/6N-Rsbn1tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Rsc1a1tm1Koep/Rsc1a1tm1Koep
(B6.129-Rsc1a1tm1Koep)
|
increased circulating cholesterol level
|
J:95148
|
increased circulating leptin level
|
J:95148
|
Rspo1tm2b(KOMP)Wtsi/Rspo1tm2b(KOMP)Wtsi
(C57BL/6N-Rspo1tm2b(KOMP)Wtsi/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Rspo2tm1Suda/Rspo2tm1Suda
(B6.Cg-Rspo2tm1Suda)
|
cyanosis
|
J:146829
|
Rspo4tm1a(KOMP)Wtsi/Rspo4tm1a(KOMP)Wtsi
(C57BL/6N-Rspo4tm1a(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Rtn2tm1Lex/Rtn2tm1Lex
(involves: 129S/SvEvBrd)
|
abnormal circulating glucose level
|
J:158249
|
Rtn3tm1Yanr/Rtn3tm1Yanr
(involves: 129S6/SvEvTac * C57BL/6)
|
increased blood urea nitrogen level
|
J:326034
|
increased circulating creatinine level
|
J:326034
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased blood urea nitrogen level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Rubcnem1Dgre/Rubcnem1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
Rubcnlem1Qsun/Rubcnlem1Qsun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun)
|
decreased circulating ketone body level
|
J:272052
|
Rufy3tm1.1Migar/Rufy3tm1.1Migar
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
cyanosis
|
J:253649
|
Rundc1tm1a(EUCOMM)Wtsi/Rundc1+
(C57BL/6N-Rundc1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rundc3atm1b(EUCOMM)Wtsi/Rundc3atm1b(EUCOMM)Wtsi
(C57BL/6N-Rundc3atm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Runx1t1tm1b(EUCOMM)Hmgu/Runx1t1+
(C57BL/6N-Runx1t1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Runx2tm1Kish/Runx2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating thyroxine level
|
J:162258
|
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:40783
|
Runx3tm1Yito/Runx3tm1Yito
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucose level
|
J:75869
|
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rwdd2aem1(IMPC)J/Rwdd2aem1(IMPC)J
(C57BL/6NJ-Rwdd2aem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Rxfp2tm1b(EUCOMM)Wtsi/Rxfp2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Rybpem1(IMPC)Bay/Rybp+
(C57BL/6N-Rybpem1(IMPC)Bay/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Ryktm1Stac/Ryktm1Stac
(involves: 129S1/Sv * C57BL/6J)
|
cyanosis
|
J:84392
|
Ryr1m1Nisw/Ryr1+
(129S1.B6-Ryr1m1Nisw)
|
increased circulating potassium level
|
J:219285
|
Ryr1tm1.1Dhm/Ryr1+
(involves: 129S2/SvPasCrl * 129S6/SvEvTac)
|
cyanosis
|
J:155825
|
Ryr1tm1.1Dhm/Ryr1tm1.1Dhm
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
cyanosis
|
J:127629
|
Ryr1tm1.1Inp/Ryr1tm1.1Inp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
acidemia
|
J:181523
|
Ryr1tm1Slh/Ryr1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating potassium level
|
J:105738
|
Ryr1tm1Tno/Ryr1tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:18895
|
Ryr1tm2.1Alle/Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
acidemia
|
J:168222
|
Ryr2tm1Krbr/Ryr2tm1Krbr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal atrial thrombosis
|
J:210083
|
S2bpcox16em1(IMPC)J/S2bpcox16em1(IMPC)J
(C57BL/6NJ-S2bpcox16em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
S100a9tm1Nck/S100a9tm1Nck
(B6.129P2-S100a9tm1Nck)
|
decreased circulating tumor necrosis factor level
|
J:125179
|
S100a14tm1b(EUCOMM)Hmgu/S100a14+
(C57BL/6N-S100a14tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
S100a16em1(IMPC)J/S100a16+
(C57BL/6NJ-S100a16em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
S100a16em1.1Gpt/S100a16+
(involves: C57BL/6JGpt * FVB/N)
|
decreased circulating alanine transaminase level
|
J:330793
|
decreased circulating aspartate transaminase level
|
J:330793
|
S100btm1a(EUCOMM)Wtsi/S100btm1a(EUCOMM)Wtsi
(B6JTyr;B6N-S100btm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:175295
|
S100gtm1Ebje/S100gtm1Ebje Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased circulating parathyroid hormone level
|
J:136038
|
Saa3tm1(KOMP)Vlcg/Saa3+
(involves: C57BL/6NTac)
|
decreased circulating LDL cholesterol level
|
J:220630
|
Saa3tm1(KOMP)Vlcg/Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating cholesterol level
|
J:220630
|
decreased circulating LDL cholesterol level
|
J:220630
|
decreased circulating serum amyloid protein level
|
J:220630
|
decreased circulating triglyceride level
|
J:220630
|
Saa3tm1.1(KOMP)Vlcg/Saa3tm1.1(KOMP)Vlcg
(C57BL/6N-Saa3tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Safbtm1So/Safb+
(involves: 129 * C57BL/6J)
|
decreased circulating testosterone level
|
J:97633
|
Safbtm1So/Safbtm1So
(involves: 129 * C57BL/6J)
|
cyanosis
|
J:97633
|
decreased circulating estradiol level
|
J:97633
|
decreased circulating insulin-like growth factor I level
|
J:97633
|
decreased circulating testosterone level
|
J:97633
|
Sagtm1a(EUCOMM)Wtsi/Sagtm1a(EUCOMM)Wtsi
(C57BL/6N-Sagtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Samd1tm1Pfi/Samd1+
(involves: C57BL/6J * C57BL/6N)
|
abnormal circulating insulin level
|
J:333561
|
decreased circulating HDL cholesterol level
|
J:333561
|
decreased circulating VLDL cholesterol level
|
J:333561
|
increased circulating aldosterone level
|
J:333561
|
increased circulating angiotensin II level
|
J:333561
|
increased circulating corticosterone level
|
J:333561
|
Samd3em1(IMPC)H/Samd3em1(IMPC)H
(C57BL/6N-Samd3em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
decreased circulating cholesterol level
|
J:208616
|
decreased circulating glucose level
|
J:208616
|
decreased circulating HDL cholesterol level
|
J:208616
|
decreased circulating insulin level
|
J:208616
|
increased circulating LDL cholesterol level
|
J:208616
|
Samd9ltm1.1(KOMP)Wtsi/Samd9ltm1.1(KOMP)Wtsi
(C57BL/6N-Samd9ltm1.1(KOMP)Wtsi/Ucd)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Samsn1tm1Xyw/Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw)
|
increased circulating interferon-gamma level
|
J:158032
|
SAP003/SAP003
(C3HeB/FeJ-SAP003)
|
increased circulating alkaline phosphatase level
|
J:183993
|
SAP004/SAP004
(C3HeB/FeJ-SAP004)
|
decreased circulating calcium level
|
J:183993
|
decreased circulating phosphate level
|
J:183993
|
SAP006/SAP006
(C3HeB/FeJ-SAP006)
|
increased circulating alkaline phosphatase level
|
J:183993
|
SAP008/SAP008
(C3HeB/FeJ-SAP008)
|
increased circulating alkaline phosphatase level
|
J:183993
|
Sap30em1(IMPC)J/Sap30em1(IMPC)J
(C57BL/6NJ-Sap30em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
sar/sar
(BTBR-sar)
|
abnormal blood homeostasis
|
J:37
|
increased circulating glycine level
|
J:37
|
increased circulating methionine level
|
J:37
|
Sar1bem1Emle/Sar1b+
(C57BL/6N-Sar1bem1Emle)
|
abnormal circulating non-HDL cholesterol level
|
J:319817
|
decreased circulating cholesterol level
|
J:319817
|
decreased circulating HDL cholesterol level
|
J:319817
|
decreased circulating triglyceride level
|
J:319817
|
Sar1bem2Emle/Sar1b+
(C57BL/6N-Sar1bem2Emle)
|
abnormal circulating non-HDL cholesterol level
|
J:319817
|
decreased circulating cholesterol level
|
J:319817
|
decreased circulating HDL cholesterol level
|
J:319817
|
decreased circulating triglyceride level
|
J:319817
|
Sar1btm1a(EUCOMM)Wtsi/Sar1b+
(C57BL/6N-Sar1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating free fatty acids level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)
|
increased circulating corticosterone level
|
J:337869
|
increased circulating thyroid-stimulating hormone level
|
J:337869
|
Sarm1tm1.1Diam/Sarm1tm1.1Diam
(involves: 129X1/SvJ * C57BL/6)
|
abnormal circulating tumor necrosis factor level
|
J:200140
|
Sat1tm1Alh/Sat1tm1Alh
(B6.129X1-Sat1tm1Alh)
|
increased circulating leptin level
|
J:120870
|
Satb1tm1b(EUCOMM)Hmgu/Satb1+
(C57BL/6N-Satb1tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating aspartate transaminase level
|
J:211773
|
Satb2em3(IMPC)Tcp/Satb2+
(C57BL/6NCrl-Satb2em3(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Satb2Mhdabap002/Satb2Mhdabap002
(C3HeB/FeJ-Satb2Mhdabap002)
|
increased circulating alkaline phosphatase level
|
J:183993
|
increased circulating calcium level
|
J:183993
|
Sbdstm1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating amylase level
|
J:189357
|
Sbdstm2.1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating amylase level
|
J:189357
|
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Sbk1tm1b(EUCOMM)Wtsi/Sbk1+
(C57BL/6N-Sbk1tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Sbk2em1(IMPC)Bay/Sbk2em1(IMPC)Bay
(C57BL/6N-Sbk2em1(IMPC)Bay/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Sbno1tm1b(EUCOMM)Hmgu/Sbno1+
(C57BL/6N-Sbno1tm1b(EUCOMM)Hmgu/H)
|
increased circulating fructosamine level
|
J:211773
|
Sbsnem1(IMPC)Ccpcz/Sbsnem1(IMPC)Ccpcz
(C57BL/6N-Sbsnem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham)
|
abnormal blood homeostasis
|
J:296400
|
Scamp2em1(IMPC)J/Scamp2em1(IMPC)J
(C57BL/6NJ-Scamp2em1(IMPC)J/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Scamp5tm1.1(KOMP)Vlcg/Scamp5+
(C57BL/6N-Scamp5tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Scand1em1(IMPC)H/Scand1em1(IMPC)H
(C57BL/6NTac-Scand1em1(IMPC)H/H)
|
increased circulating creatinine level
|
J:211773
|
Scaptm1Mbjg/Scaptm1Mbjg Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased circulating free fatty acids level
|
J:69592
|
Scapertm1b(EUCOMM)Hmgu/Scapertm1b(EUCOMM)Hmgu
(C57BL/6N-Scapertm1b(EUCOMM)Hmgu/Ics)
|
decreased blood urea nitrogen level
|
J:211773
|
Scarb1Chohd1/Scarb1+
(C3HeB/FeJ-Scarb1Chohd1/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Scarb1Hdlq1-129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Scarb1Hdlq1-129S1/SvImJ/Scarb1Hdlq1-129S1/SvImJ Hdlq16129S1/SvImJ/Hdlq16129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:144089
|
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Scarb1Hlb398/?
(C57BL/6J-Scarb1Hlb398)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Scarb1Hlb398/Scarb1+
(C57BL/6J-Scarb1Hlb398)
|
increased circulating HDL cholesterol level
|
J:152482
|
Scarb1Hlb398/Scarb1Hlb398
(C57BL/6J-Scarb1Hlb398)
|
increased circulating cholesterol level
|
J:152482
|
increased circulating HDL cholesterol level
|
J:152482
|
increased circulating phospholipid level
|
J:152482
|
increased circulating triglyceride level
|
J:152482
|
Scarb1tm1.1Thh/Scarb1tm1.1Thh
(B6.129X1-Scarb1tm1.1Thh)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
increased circulating interleukin-6 level
|
J:114663
|
Scarb1tm1b(EUCOMM)Wtsi/Scarb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Scarb1tm1b(EUCOMM)Wtsi/Bay)
|
increased circulating cholesterol level
|
J:211773
|
Scarb1tm1Dhu/Scarb1tm1Dhu
(involves: 129S4/SvJae * BALB/cByJ)
|
abnormal circulating HDL cholesterol level
|
J:47439
|
increased circulating cholesterol level
|
J:47439
|
increased circulating HDL cholesterol level
|
J:47439
|
Scarb1tm1Kri/Scarb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating cholesterol level
|
J:44187
|
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating cholesterol level
|
J:73138
|
increased circulating cholesterol level
|
J:44187
|
Scarb1tm1Thh/Scarb1tm1Thh
(B6.129X1-Scarb1tm1Thh)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
Scarb1tm1Thh/Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
increased circulating interleukin-6 level
|
J:114663
|
Scarb2em2(IMPC)Tcp/Scarb2em2(IMPC)Tcp
(C57BL/6NCrl-Scarb2em2(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
|
increased blood urea nitrogen level
|
J:208237
|
Scd1tm1Ntam/Scd1tm1Ntam
(involves: 129S6/SvEvTac)
|
decreased circulating insulin level
|
J:78607
|
increased circulating ketone body level
|
J:78607
|
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:130441
|
decreased circulating triglyceride level
|
J:130441
|
Scd1tm2Ntam/Scd1tm2Ntam Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam)
|
decreased circulating glucose level
|
J:130441
|
decreased circulating triglyceride level
|
J:130441
|
decreased circulating VLDL triglyceride level
|
J:130441
|
increased circulating cholesterol level
|
J:130441
|
Scd2tm1Myz/Scd2tm1Myz
(129S6.129-Scd2tm1Myz)
|
decreased circulating triglyceride level
|
J:101158
|
Scelem1(IMPC)Ccpcz/Scelem1(IMPC)Ccpcz
(C57BL/6NCrl-Scelem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating sodium level
|
J:211773
|
Scfd2em1(IMPC)J/Scfd2em1(IMPC)J
(C57BL/6NJ-Scfd2em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Scg3Gt(VICTR20)13Lex/Scg3Gt(VICTR20)13Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating insulin level
|
J:256077
|
Scg5em1(IMPC)Mbp/Scg5em1(IMPC)Mbp
(C57BL/6NCrl-Scg5em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal circulating insulin level
|
J:53349
|
decreased circulating glucagon level
|
J:53349
|
decreased circulating magnesium level
|
J:77510
|
hypoglycemia
|
J:53349
|
increased circulating corticosterone level
|
J:53349
|
increased circulating lactate level
|
J:77510
|
Scgb1a1tm1Abm/Scgb1a1tm1Abm
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood homeostasis
|
J:57504
|
decreased circulating calcium level
|
J:40748
|
Scimptm1Lex/Scimptm1Lex
(B6;129S5-Scimptm1Lex/Mmucd)
|
increased circulating cholesterol level
|
J:171883
|
Sclt1em1(IMPC)Tcp/Sclt1+
(C57BL/6NCrl-Sclt1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Sclt1Tg(CAG-sb10)1Dla/Sclt1Tg(CAG-sb10)1Dla
(FVB/N-Sclt1Tg(CAG-sb10)1Dla)
|
increased blood urea nitrogen level
|
J:243427
|
Scml4em1(IMPC)J/Scml4em1(IMPC)J
(C57BL/6NJ-Scml4em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Scn2atm1Mml/Scn2atm1Mml
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cyanosis
|
J:76457
|
Scn4am1Aaa/Scn4a+
(involves: BALB/c * C57BL/6J)
|
decreased circulating leptin level
|
J:217522
|
Scn4atm2b(KOMP)Wtsi/Scn4a+
(C57BL/6N-Scn4atm2b(KOMP)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Scnn1atm1Rss/Scnn1atm1Rss
(involves: 129P2/OlaHsd * C57BL/6J)
|
cyanosis
|
J:31762
|
Scnn1atm1Rss/Scnn1atm1Rss Tg(CMV-Scnn1a)1352Rss/0
(involves: 129P2/OlaHsd * NMRI)
|
increased circulating aldosterone level
|
J:43583
|
Scnn1btm1.1Ipt/Scnn1b+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased circulating aldosterone level
|
J:59840
|
hypokalemia
|
J:59840
|
Scnn1btm1.1Ipt/Scnn1btm1.1Ipt
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased circulating aldosterone level
|
J:59840
|
hypokalemia
|
J:59840
|
Scnn1btm1b(EUCOMM)Hmgu/Scnn1b+
(C57BL/6N-Scnn1btm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating fructosamine level
|
J:211773
|
Scnn1btm1Wsh/Scnn1btm1Wsh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating sodium level
|
J:53058
|
increased circulating aldosterone level
|
J:53058
|
increased circulating potassium level
|
J:53058
|
Scnn1gtm1Bhk/Scnn1gtm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating sodium level
|
J:50528
|
increased circulating potassium level
|
J:50528
|
Scocem1(IMPC)J/Scoc+
(C57BL/6NJ-Scocem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr)
|
decreased circulating triglyceride level
|
J:124895
|
increased circulating cholesterol level
|
J:124895
|
Scp2tm1Usee/Scp2tm1Usee
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:73460
|
decreased circulating free fatty acids level
|
J:47280
|
increased circulating HDL cholesterol level
|
J:73460
|
increased circulating LDL cholesterol level
|
J:73460
|
increased circulating triglyceride level
|
J:47280
|
increased circulating VLDL cholesterol level
|
J:73460
|
Scribtm1b(NCOM)Mfgc/Scrib+
(C57BL/6N-Scribtm1a(NCOM)Mfgc/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Scrn1em1(IMPC)J/Scrn1em1(IMPC)J
(C57BL/6NJ-Scrn1em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Scttm1.1Bkcc/Scttm1.1Bkcc
(B6.Cg-Scttm1.1Bkcc)
|
abnormal circulating antidiuretic hormone level
|
J:166370
|
Sctrtm1Bkcc/Sctrtm1Bkcc
(B6.129S7-Sctrtm1Bkcc)
|
abnormal circulating antidiuretic hormone level
|
J:166370
|
increased circulating glucose level
|
J:121376
|
Scube1tm2.1Rbya/Scube1tm2.1Rbya
(Not Specified)
|
decreased platelet aggregation
|
J:223899
|
decreased susceptibility to induced thrombosis
|
J:223899
|
increased bleeding time
|
J:223899
|
Scube3m1Mhda/Scube3m1Mhda
(C3HeB/FeJ-Scube3m1Mhda)
|
decreased circulating cholesterol level
|
J:237904
|
decreased circulating free fatty acids level
|
J:237904
|
decreased circulating glucose level
|
J:237904
|
decreased circulating glycerol level
|
J:237904
|
decreased circulating phosphate level
|
J:237904
|
decreased circulating serum albumin level
|
J:237904
|
decreased circulating total protein level
|
J:237904
|
decreased circulating triglyceride level
|
J:237904
|
increased blood urea nitrogen level
|
J:237904
|
increased blood uric acid level
|
J:237904
|
increased circulating calcium level
|
J:237904
|
increased circulating creatinine level
|
J:237904
|
increased circulating potassium level
|
J:237904
|
Sdc1em1(IMPC)H/Sdc1em1(IMPC)H
(C57BL/6NTac-Sdc1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Sdc2tm1b(KOMP)Wtsi/Sdc2tm1b(KOMP)Wtsi
(C57BL/6N-Sdc2tm1b(KOMP)Wtsi/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Sdc3tm1Rau/Sdc3tm1Rau
(B6.129S-Sdc3tm1Rau)
|
decreased circulating insulin level
|
J:94417
|
Sdc4tm1Tmu/Sdc4tm1Tmu
(B6.129S2-Sdc4tm1Tmu)
|
increased blood urea nitrogen level
|
J:68843
|
Sdc4tm2b(KOMP)Wtsi/Sdc4tm2b(KOMP)Wtsi
(C57BL/6N-Sdc4tm2b(KOMP)Wtsi/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Sdhatm2b(KOMP)Wtsi/Sdha+
(C57BL/6N-Sdhatm2b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sdhbtm1b(EUCOMM)Hmgu/Sdhb+
(C57BL/6N-Sdhbtm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased circulating insulin level
|
J:326592
|
hyperglycemia
|
J:326592
|
increased fasting circulating glucose level
|
J:326592
|
Sdhctm1c(EUCOMM)Wtsi/Sdhctm1c(EUCOMM)Wtsi Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal blood homeostasis
|
J:284745
|
decreased circulating glucose level
|
J:284745
|
decreased circulating insulin level
|
J:284745
|
increased circulating creatine kinase level
|
J:284745
|
Sdsltm1b(EUCOMM)Hmgu/Sdsltm1b(EUCOMM)Hmgu
(C57BL/6N-Sdsltm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
Seboxem1(IMPC)J/Seboxem1(IMPC)J
(C57BL/6NJ-Seboxem1(IMPC)J/J)
|
increased fasting circulating glucose level
|
J:211773
|
Sec14l1em1(IMPC)J/Sec14l1em1(IMPC)J
(C57BL/6NJ-Sec14l1em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sec14l2tm1Arai/Sec14l2tm1Arai
(involves: 129S7/SvEvBrd)
|
decreased circulating cholesterol level
|
J:129749
|
decreased circulating VLDL cholesterol level
|
J:129749
|
Sec16btm1a(KOMP)Wtsi/Sec16btm1a(KOMP)Wtsi
(C57BL/6N-Sec16btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi)
|
decreased circulating glucose level
|
J:186391
|
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(B6JTyr;B6N-Sec24atm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating free fatty acids level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased blood urea nitrogen level
|
J:175295
|
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Sec31aem3(IMPC)H/Sec31a+
(C57BL/6N-Sec31aem3(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Sec31bem1(IMPC)J/Sec31bem1(IMPC)J
(C57BL/6NJ-Sec31bem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Sec61a1m1Gek/Sec61a1+
(C57BL/6J-Sec61a1m1Gek)
|
decreased circulating insulin level
|
J:164159
|
hyperglycemia
|
J:164159
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
decreased circulating insulin level
|
J:164159
|
hyperglycemia
|
J:164159
|
increased circulating cholesterol level
|
J:164159
|
increased circulating glucagon level
|
J:164159
|
increased circulating triglyceride level
|
J:164159
|
Sec61a2em1(IMPC)J/Sec61a2em1(IMPC)J
(C57BL/6NJ-Sec61a2em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Sec61bem1(IMPC)Mbp/Sec61bem1(IMPC)Mbp
(C57BL/6NCrl-Sec61bem1(IMPC)Mbp/Mmucd)
|
increased circulating insulin level
|
J:211773
|
Sec63tm1b(EUCOMM)Hmgu/Sec63+
(C57BL/6N-Sec63tm1b(EUCOMM)Hmgu/Bay)
|
increased circulating alanine transaminase level
|
J:211773
|
Sec63tm1Som/Sec63tm1Som Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * ICR)
|
increased blood urea nitrogen level
|
J:188763
|
Secisbp2lem1(IMPC)J/Secisbp2lem1(IMPC)J
(C57BL/6NJ-Secisbp2lem1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
increased circulating interleukin-1 beta level
|
J:317204
|
increased circulating interleukin-6 level
|
J:317204
|
increased circulating tumor necrosis factor level
|
J:317204
|
Sel1l3em1(IMPC)J/Sel1l3em1(IMPC)J
(C57BL/6NJ-Sel1l3em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Seletm1Hyn/Seletm1Hyn Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
increased circulating interleukin-3 level
|
J:31626
|
Seletm2Alb/Seletm2Alb Selltm2Alb/Selltm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:106550
|
Selenbp1tm1b(KOMP)Wtsi/Selenbp1+
(C57BL/6N-Selenbp1tm1b(KOMP)Wtsi/Mbp)
|
abnormal blood homeostasis
|
J:255748
|
Selenbp1tm1b(KOMP)Wtsi/Selenbp1tm1b(KOMP)Wtsi
(C57BL/6N-Selenbp1tm1b(KOMP)Wtsi/Mbp)
|
abnormal blood homeostasis
|
J:255748
|
Selenbp1tm1b(KOMP)Wtsi/Selenbp1tm1b(KOMP)Wtsi
(C57BL/6N-Selenbp1tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Selenbp1tm1Hyama/Selenbp1tm1Hyama
(C57BL/6-Selenbp1tm1Hyama)
|
increased circulating serum albumin level
|
J:202420
|
Selenoktm1.2Itl/Selenoktm1.2Itl
(involves: BALB/cJ * C57BL/6)
|
abnormal circulating chemokine level
|
J:169169
|
Selenoktm1a(EUCOMM)Wtsi/Selenoktm1a(EUCOMM)Wtsi
(C57BL/6N-Selenoktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
Selenomtm1(KOMP)Vlcg/Selenomtm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating corticosterone level
|
J:203545
|
increased circulating leptin level
|
J:203545
|
Selenottm1.1Ics/Selenottm1.1Ics Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA)
|
decreased circulating insulin level
|
J:203279
|
increased circulating glucose level
|
J:203279
|
Selltm1.1Rpmc/Selltm1.1Rpmc
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
increased susceptibility to induced thrombosis
|
J:249558
|
Selltm2.1Tft/Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating protein level
|
J:142184
|
Selltm2Tft/Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating protein level
|
J:142184
|
Selltm3Tft/Selltm3Tft
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating protein level
|
J:142184
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
increased bleeding time
|
J:31431
|
Selptm2Hyn/Selptm2Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:125020
|
abnormal blood homeostasis
|
J:125020,
J:51068
|
Selplgtm1Rpmc/Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
increased bleeding time
|
J:138731
|
Selplgtm2Rpmc/Selplgtm2Rpmc
(B6.Cg-Selplgtm2Rpmc)
|
increased bleeding time
|
J:138731
|
Sema3atm1Mcf/Sema3atm1Mcf
(involves: 129S4/SvJae)
|
abnormal atrial thrombosis
|
J:35824
|
Sema3eem1(IMPC)H/Sema3eem1(IMPC)H
(C57BL/6NTac-Sema3eem1(IMPC)H/H)
|
decreased circulating phosphate level
|
J:211773
|
Sema3ftm1b(EUCOMM)Hmgu/Sema3ftm1b(EUCOMM)Hmgu
(C57BL/6N-Sema3ftm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Sema4dtm1b(EUCOMM)Wtsi/Sema4dtm1b(EUCOMM)Wtsi
(C57BL/6N-Sema4dtm1b(EUCOMM)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Senp1em1(IMPC)H/Senp1+
(C57BL/6NTac-Senp1em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:226392
|
Senp1tm1Wami/Senp1tm1Wami Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr)
|
hyperglycemia
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
abnormal circulating cytokine level
|
J:228009
|
decreased circulating cholesterol level
|
J:228009
|
decreased circulating insulin level
|
J:228009
|
decreased circulating triglyceride level
|
J:228009
|
hyperglycemia
|
J:228009
|
increased circulating C-reactive protein level
|
J:228009
|
increased circulating interleukin-1 beta level
|
J:228009
|
increased circulating interleukin-6 level
|
J:228009
|
increased circulating ketone body level
|
J:228009
|
increased circulating tumor necrosis factor level
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc)
|
hyperglycemia
|
J:228009
|
Senp2Gt(OST66117)Lex/Senp2+
(B6;129S5-Senp2Gt(OST66117)Lex/Orl)
|
decreased circulating glucose level
|
J:82809
|
Senp3tm1(NCOM)Cmhd/Senp3+
(C57BL/6N-Senp3tm1(NCOM)Cmhd/Tcp)
|
increased circulating serum albumin level
|
J:165965
|
Sepsecsem1(IMPC)Tcp/Sepsecs+
(C57BL/6NCrl-Sepsecsem1(IMPC)Tcp/Cmmr)
|
increased circulating calcium level
|
J:211773
|
Sepsecstm1.1Usch/Sepsecstm1.1Usch
(B6.Cg-Sepsecstm1.1Usch)
|
cyanosis
|
J:315052
|
Septin3tm1b(KOMP)Wtsi/Septin3+
(C57BL/6N-Septin3tm1b(KOMP)Wtsi/Orl)
|
decreased circulating phosphate level
|
J:211773
|
Septin5tm1Wtr/Septin5tm1Wtr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet physiology
|
J:109519
|
increased platelet aggregation
|
J:109519
|
Septin6tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Septin6tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Septin14em1(IMPC)Tcp/Septin14em1(IMPC)Tcp
(C57BL/6NCrl-Septin14em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
decreased circulating cholesterol level
|
J:326672
|
Serf1tm1a(EUCOMM)Hmgu/Serf1tm1a(EUCOMM)Hmgu
(C57BL/6N-Serf1tm1a(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:165965
|
increased circulating HDL cholesterol level
|
J:165965
|
Serinc3tm1a(KOMP)Wtsi/Serinc3tm1a(KOMP)Wtsi
(C57BL/6N-Serinc3tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
Serp1tm1Hori/Serp1tm1Hori
(B6.Cg-Serp1tm1Hori)
|
decreased circulating insulin level
|
J:109619
|
Serp1tm1Hori/Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating growth hormone level
|
J:109619
|
decreased circulating insulin level
|
J:109619
|
Serpina1fem1(IMPC)J/Serpina1fem1(IMPC)J
(C57BL/6NJ-Serpina1fem1(IMPC)J/J)
|
increased circulating total protein level
|
J:211773
|
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc)
|
increased circulating triglyceride level
|
J:343846
|
Serpina3kem1(IMPC)J/Serpina3kem1(IMPC)J
(C57BL/6NJ-Serpina3kem1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:345330
|
decreased circulating creatinine level
|
J:345330
|
Serpina6tm1.1Mmp/Serpina6+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal circulating corticosterone level
|
J:164345
|
Serpina6tm1.1Mmp/Serpina6tm1.1Mmp
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal circulating corticosterone level
|
J:164345
|
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N)
|
abnormal circulating corticosterone level
|
J:112974
|
abnormal circulating cytokine level
|
J:112974
|
Serpina10tm1Gjb/Serpina10tm1Gjb
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced thrombosis
|
J:136102
|
Serpina12tm1Jwada/Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada)
|
increased circulating leptin level
|
J:208508
|
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada)
|
increased circulating cholesterol level
|
J:208508
|
increased circulating LDL cholesterol level
|
J:208508
|
increased circulating leptin level
|
J:208508
|
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben)
|
abnormal circulating cytokine level
|
J:125918
|
Serpinb2tm1b(EUCOMM)Wtsi/Serpinb2tm1b(EUCOMM)Wtsi
(C57BL/6N-Serpinb2tm1b(EUCOMM)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Serpinb5tm1b(KOMP)Wtsi/Serpinb5tm1b(KOMP)Wtsi
(C57BL/6N-Serpinb5tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
Serpinb10em1(IMPC)Mbp/Serpinb10em1(IMPC)Mbp
(C57BL/6NCrl-Serpinb10em1(IMPC)Mbp/Mmucd)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Serpinc1tm1Dwr/Serpinc1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cardiac thrombosis
|
J:115658
|
Serpinc1tm1Dwr/Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal atrial thrombosis
|
J:115658
|
abnormal blood coagulation
|
J:115658
|
abnormal cardiac thrombosis
|
J:115658
|
abnormal placental thrombosis
|
J:115658
|
abnormal thrombosis
|
J:115658
|
Serpinc1tm1Sai/Serpinc1+
(involves: 129S2/SvPas * C57BL/6J)
|
increased susceptibility to induced thrombosis
|
J:75955
|
Serpinc1tm1Sai/Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thrombosis
|
J:65092
|
Serpind1tm1Moto/Serpind1+
(B6.Cg-Serpind1tm1Moto)
|
abnormal platelet aggregation
|
J:122173
|
increased susceptibility to induced thrombosis
|
J:122173
|
Serpind1tm1Toll/Serpind1tm1Toll
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to induced thrombosis
|
J:74337
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:133227
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J)
|
decreased circulating cholesterol level
|
J:127478
|
hyperglycemia
|
J:127478
|
increased blood urea nitrogen level
|
J:127478
|
Serpinf2tm1Hrl/Serpinf2tm1Hrl
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal blood coagulation
|
J:54047
|
abnormal thrombolysis
|
J:54047
|
Serping1em1(IMPC)Mbp/Serping1em1(IMPC)Mbp
(C57BL/6N-Serping1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Sertad2Gt(OST98734)Lex/Sertad2+
(B6.129S5-Sertad2Gt(OST98734)Lex)
|
decreased circulating cholesterol level
|
J:194928
|
decreased circulating leptin level
|
J:194928
|
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex)
|
abnormal circulating hormone level
|
J:194928
|
decreased circulating cholesterol level
|
J:194928
|
decreased circulating glucose level
|
J:194928
|
decreased circulating insulin level
|
J:194928
|
decreased circulating leptin level
|
J:194928
|
Sertad4btm1b(EUCOMM)Wtsi/Sertad4btm1b(EUCOMM)Wtsi
(C57BL/6N-Sertad4btm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi
(C57BL/6N-Sesn3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating sodium level
|
J:175295
|
Setbp1tm1b(EUCOMM)Wtsi/Setbp1+
(C57BL/6N-Setbp1tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
Setd1atm1a(EUCOMM)Wtsi/Setd1a+
(C57BL/6N-Setd1atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Setd4tm1a(KOMP)Wtsi/Setd4tm1a(KOMP)Wtsi
(C57BL/6N-Setd4tm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Setd6tm1.1(KOMP)Mbp/Setd6tm1.1(KOMP)Mbp
(C57BL/6N-Setd6tm1.1(KOMP)Mbp/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Setmartm1a(EUCOMM)Wtsi/Setmartm1a(EUCOMM)Wtsi
(C57BL/6N-Setmartm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:165965
|
Sez6ltm1b(EUCOMM)Hmgu/Sez6ltm1b(EUCOMM)Hmgu
(C57BL/6N-Sez6ltm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sf3b1tm1.1Mdf/Sf3b1+ Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
increased circulating erythropoietin level
|
J:234976
|
Sfpqtm1a(EUCOMM)Wtsi/Sfpq+
(C57BL/6N-Sfpqtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
Sfr1em1(IMPC)Mbp/Sfr1+
(C57BL/6NCrl-Sfr1em1(IMPC)Mbp/Mmucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Sfrp1tm1Bsk/Sfrp1tm1Bsk
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating phosphate level
|
J:89547
|
Sfswapem1(IMPC)J/Sfswap+
(C57BL/6NJ-Sfswapem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Sftpbtm1Jaw/Sftpbtm1Jaw
(involves: 129S2/SvPas * Black Swiss)
|
cyanosis
|
J:28289
|
Sfxn1tm1b(EUCOMM)Wtsi/Sfxn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sfxn1tm1b(EUCOMM)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Sfxn3tm1b(KOMP)Wtsi/Sfxn3tm1b(KOMP)Wtsi
(C57BL/6N-Sfxn3tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
Sfxn5tm1b(EUCOMM)Hmgu/Sfxn5+
(C57BL/6N-Sfxn5tm1b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Sgcatm1Kcam/Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating pyruvate kinase level
|
J:49992
|
increased circulating creatine kinase level
|
J:49992,
J:130252
|
Sgcatm2Kcam/Sgcatm2Kcam
(either: (129S6/SvEvTac-Sgcatm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J))
|
increased circulating creatine kinase level
|
J:130252
|
Sgcatm2Kcam/Sgcatm2Kcam
(B6.129S6-Sgcatm2Kcam/J)
|
increased circulating creatine kinase level
|
J:250485
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
increased circulating creatine kinase level
|
J:76730
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(B6.129-Sgcdtm1Mcn/J)
|
increased circulating creatine kinase level
|
J:250485
|
Sgcgtm1Mcn/Sgcgtm1Mcn
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating creatine kinase level
|
J:49871,
J:57664
|
Sgcgtm1Oza/Sgcgtm1Oza
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating creatine kinase level
|
J:102780
|
Sgf29tm1a(EUCOMM)Hmgu/Sgf29+
(C57BL/6N-Sgf29tm1a(EUCOMM)Hmgu/Cnrm)
|
decreased circulating glucose level
|
J:165965
|
Sgip1tm1b(EUCOMM)Hmgu/Sgip1+
(C57BL/6N-Sgip1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Sgk1tm1.2Palm/Sgk1tm1.2Palm
(129/Sv-Sgk1tm1.2Palm)
|
increased circulating aldosterone level
|
J:148648
|
Sgk1tm1Kuhl/Sgk1tm1Kuhl
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * 129X1/SvJ))
|
increased circulating aldosterone level
|
J:80115
|
Sgk3tm1Dpea/Sgk3tm1Dpea
(involves: 129X1/SvJ * C57BL/6)
|
decreased fasting circulating glucose level
|
J:279604
|
Sgms1tm1a(EUCOMM)Wtsi/Sgms1tm1a(EUCOMM)Wtsi
(C57BL/6N-Sgms1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Sgms1tm1Jia/Sgms1tm1Jia
(involves: C57BL/6)
|
decreased circulating interleukin-6 level
|
J:201497
|
decreased circulating tumor necrosis factor level
|
J:201497
|
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating insulin level
|
J:168726
|
hyperglycemia
|
J:168726
|
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6)
|
abnormal circulating protein level
|
J:162192
|
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw)
|
abnormal circulating glucose level
|
J:175924
|
decreased circulating triglyceride level
|
J:175924
|
increased circulating free fatty acids level
|
J:175924
|
Sgo1tm1a(EUCOMM)Wtsi/Sgo1+
(B6JTyr;B6N-Sgo1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
Sgp1DBA/2/Sgp1DBA/2
(B10.D2-H2d)
|
abnormal circulating protein level
|
J:7046
|
Sgp2129/Sgp2129
(involves: 129 * C57BL/6)
|
abnormal circulating protein level
|
J:7218
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor)
|
decreased circulating serum albumin level
|
J:242932
|
increased blood urea nitrogen level
|
J:117491
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
decreased circulating testosterone level
|
J:142042
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
decreased circulating insulin level
|
J:235035
|
Sgshem3(IMPC)Tcp/Sgshem3(IMPC)Tcp
(C57BL/6NCrl-Sgshem3(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sgsm1tm1b(EUCOMM)Wtsi/Sgsm1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sgsm1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Sgtatm1.1Drmcr/Sgta+
(involves: C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:234007
|
Sgtatm1.1Drmcr/Sgtatm1.1Drmcr
(involves: C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:234007
|
Sgtatm1b(KOMP)Mbp/Sgtatm1b(KOMP)Mbp
(C57BL/6N-Sgtatm1b(KOMP)Mbp/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Sh2b1tm1Lr/Sh2b1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:92794
|
Sh2b1tm1Lr/Sh2b1tm1Lr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hyperglycemia
|
J:92794
|
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased circulating insulin level
|
J:209019
|
increased circulating glucose level
|
J:209019
|
Sh2b2tm1Yeb/Sh2b2tm1Yeb
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:86301
|
Sh2d1atm1.1Knic/Y Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
decreased circulating interleukin-4 level
|
J:196692
|
Sh2d1atm1.1Knic/Sh2d1atm1.1Knic Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
decreased circulating interleukin-4 level
|
J:196692
|
Sh2d5tm1a(EUCOMM)Wtsi/Sh2d5tm1a(EUCOMM)Wtsi
(C57BL/6N-Sh2d5tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating creatinine level
|
J:211773
|
Sh3bp2tm1.1Ics/Sh3bp2+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating cytokine level
|
J:221901
|
Sh3bp2tm1.1Ics/Sh3bp2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating cytokine level
|
J:221901
|
increased circulating interleukin-6 level
|
J:221901
|
increased circulating interleukin-12 level
|
J:221901
|
increased circulating tumor necrosis factor level
|
J:221901
|
Sh3bp2tm1b(KOMP)Wtsi/Sh3bp2tm1b(KOMP)Wtsi
(C57BL/6N-Sh3bp2tm1b(KOMP)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:117880
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cytokine level
|
J:221901
|
Sh3bp4tm1a(EUCOMM)Wtsi/Sh3bp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Sh3bp4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Sh3gl2tm1b(EUCOMM)Wtsi/Sh3gl2tm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3gl2tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2a+
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sh3rf3em1(IMPC)J/Sh3rf3em1(IMPC)J
(C57BL/6NJ-Sh3rf3em1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Sh3tc2tm1b(KOMP)Wtsi/Sh3tc2tm1b(KOMP)Wtsi
(C57BL/6N-Sh3tc2tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Shank3em1(IMPC)H/Shank3em1(IMPC)H
(C57BL/6NTac-Shank3em1(IMPC)H/H)
|
decreased circulating calcium level
|
J:211773
|
Shfltm1.1(KOMP)Mbp/Shfltm1.1(KOMP)Mbp
(C57BL/6N-Shfltm1.1(KOMP)Mbp/Ucd)
|
increased circulating bilirubin level
|
J:211773
|
Shhtm1b(EUCOMM)Wtsi/Shh+
(C57BL/6N-Shhtm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Shhtm2Amc/Shhtm2.1Amc Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:168522
|
increased circulating adrenocorticotropin level
|
J:168522
|
Shisal1em1(IMPC)Ccpcz/Shisal1em1(IMPC)Ccpcz
(C57BL/6N-Shisal1em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Shkbp1em1(IMPC)J/Shkbp1em1(IMPC)J
(C57BL/6NJ-Shkbp1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Shld1em1(IMPC)Wtsi/Shld1em1(IMPC)Wtsi
(C57BL/6N-Shld1em1(IMPC)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Shmt1tm1b(KOMP)Wtsi/Shmt1tm1b(KOMP)Wtsi
(C57BL/6N-Shmt1tm1b(KOMP)Wtsi/H)
|
increased circulating amylase level
|
J:211773
|
Shmt1tm1Stov/Shmt1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cystathionine level
|
J:141998
|
Shmt1tm1Stov/Shmt1tm1Stov
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cystathionine level
|
J:141998
|
increased circulating cysteine level
|
J:141998
|
sho/sho
(Not Specified)
|
cyanosis
|
J:255
|
Shroom2em1(IMPC)Mbp/Y
(C57BL/6NCrl-Shroom2em1(IMPC)Mbp/Mmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sidt2em1(IMPC)Wtsi/Sidt2em1(IMPC)Wtsi
(C57BL/6N-Sidt2em1(IMPC)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating insulin level
|
J:204228
|
increased circulating alanine transaminase level
|
J:236042
|
increased circulating aspartate transaminase level
|
J:236042
|
increased circulating glucose level
|
J:204228
|
increased circulating triglyceride level
|
J:236042
|
Siglec1tm1Croc/Siglec1tm1Croc
(B6.129-Siglec1tm1Croc)
|
decreased circulating interleukin-6 level
|
J:189854
|
decreased circulating tumor necrosis factor level
|
J:189854
|
Siglec1tm2.1Croc/Siglec1tm2.1Croc
(B6.129P2(C)-Siglec1tm2.1Croc)
|
decreased circulating interleukin-6 level
|
J:189854
|
decreased circulating tumor necrosis factor level
|
J:189854
|
Siglec15tm1Yohi/Siglec15tm1Yohi
(B6.129S6-Siglec15tm1Yohi)
|
increased circulating osteocalcin level
|
J:193852
|
Siglecetm1.1(SIGLEC16)Avrk/Siglecetm1.1(SIGLEC16)Avrk
(involves: C57BL/6)
|
increased circulating interleukin-6 level
|
J:264224
|
increased circulating interleukin-12 level
|
J:264224
|
Siglechtm1.1Cfg/Siglechtm1.1Cfg
(involves: C57BL/6)
|
increased blood urea nitrogen level
|
J:217719
|
Siglechtm1.1Ksat/Siglechtm1.1Ksat
(B6.Cg-Siglechtm1.1Ksat)
|
abnormal circulating cytokine level
|
J:179283
|
decreased circulating interferon-alpha level
|
J:179283
|
decreased circulating interleukin-12b level
|
J:179283
|
increased circulating interferon-alpha level
|
J:179283
|
increased circulating interleukin-12b level
|
J:179283
|
Sik1tm1.1(KOMP)Vlcg/Sik1tm1.1(KOMP)Vlcg
(C57BL/6N-Sik1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sik1tm1.2Berd/Sik1tm1.2Berd
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating glucose level
|
J:236223
|
increased circulating insulin level
|
J:236223
|
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
increased circulating glucose level
|
J:229999
|
increased circulating insulin level
|
J:229999
|
increased circulating triglyceride level
|
J:229999
|
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating potassium level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N)
|
abnormal circulating hormone level
|
J:183827
|
abnormal circulating protein level
|
J:183827
|
decreased circulating alanine transaminase level
|
J:183827
|
decreased circulating cholesterol level
|
J:183827
|
decreased circulating glucose level
|
J:183827
|
decreased circulating HDL cholesterol level
|
J:183827
|
decreased circulating insulin level
|
J:183827
|
decreased circulating leptin level
|
J:183827
|
decreased circulating triglyceride level
|
J:183827
|
decreased circulating VLDL triglyceride level
|
J:183827
|
increased circulating alanine transaminase level
|
J:183827
|
increased circulating alkaline phosphatase level
|
J:183827
|
increased circulating bilirubin level
|
J:183827
|
increased circulating triglyceride level
|
J:183827
|
Sim1Rgsc646/Sim1+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
hyperglycemia
|
J:133634
|
increased circulating insulin level
|
J:133634
|
increased glycosylated hemoglobin level
|
J:133634
|
Sim1tm1.1Az/Sim1+
(involves: 129X1/SvJ * C57BL/6 * FVB)
|
increased circulating glucose level
|
J:95410
|
increased circulating insulin level
|
J:95410
|
increased circulating leptin level
|
J:95410
|
Sim1tm1Fan/Sim1+
(involves: 129/Sv * C57BL/6)
|
increased circulating insulin level
|
J:70586
|
Sinhcafem1(IMPC)Ccpcz/Sinhcaf+
(C57BL/6N-Sinhcafem1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
Sirpatm1b(EUCOMM)Hmgu/Sirpatm1b(EUCOMM)Hmgu
(C57BL/6N-Sirpatm1b(EUCOMM)Hmgu/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
Sirpb1aem1(IMPC)Wtsi/Sirpb1aem1(IMPC)Wtsi
(C57BL/6N-Sirpb1aem1(IMPC)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Sirt1tm1.2Cxd/Sirt1tm1.2Cxd Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating free fatty acids level
|
J:179193
|
increased circulating triglyceride level
|
J:179193
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased circulating thyroxine level
|
J:133127
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(129/Sv-Sirt1tm1Mcby)
|
decreased circulating follicle stimulating hormone level
|
J:146009
|
decreased circulating luteinizing hormone level
|
J:146009
|
Sirt1tm2.1Mcby/Sirt1tm2.1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased circulating insulin level
|
J:180628
|
Sirt1tm3Fwa/Sirt1tm3Fwa Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal circulating hormone level
|
J:155802
|
decreased circulating glucose level
|
J:155802
|
decreased circulating growth hormone level
|
J:155802
|
decreased circulating insulin level
|
J:155802
|
decreased circulating insulin-like growth factor I level
|
J:155802
|
increased circulating prolactin level
|
J:155802
|
Sirt2tm1a(EUCOMM)Wtsi/Sirt2tm1a(EUCOMM)Wtsi
(C57BL/6N-Sirt2tm1a(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:165965
|
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac)
|
hyperglycemia
|
J:178653
|
increased circulating cholesterol level
|
J:178653
|
increased circulating insulin level
|
J:178653
|
increased circulating interferon-gamma level
|
J:178653
|
increased circulating interleukin-6 level
|
J:178653
|
increased circulating interleukin-10 level
|
J:178653
|
increased circulating interleukin-12 level
|
J:178653
|
increased circulating LDL cholesterol level
|
J:178653
|
increased circulating triglyceride level
|
J:178653
|
increased circulating tumor necrosis factor level
|
J:178653
|
increased circulating VLDL cholesterol level
|
J:178653
|
Sirt3tm1b(EUCOMM)Wtsi/Sirt3tm1b(EUCOMM)Wtsi
(C57BL/6N-Sirt3tm1b(EUCOMM)Wtsi/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Sirt4tm1b(EUCOMM)Hmgu/Sirt4tm1b(EUCOMM)Hmgu
(C57BL/6N-Sirt4tm1b(EUCOMM)Hmgu/H)
|
increased circulating fructosamine level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Sirt6tm1.1Cxd/Sirt6tm1.1Cxd Tg(Alb1-cre)1Dlr/0
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating glucose level
|
J:166368
|
Sirt6tm1a(EUCOMM)Wtsi/Sirt6+
(C57BL/6N-Sirt6tm1a(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:165965
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased circulating glucose level
|
J:112817
|
decreased circulating insulin-like growth factor I level
|
J:112817
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * BALB/cJ)
|
decreased circulating insulin level
|
J:247143
|
Sirt6tm2.1Cxd/Sirt6tm2.1Cxd
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
decreased circulating glucose level
|
J:167023
|
decreased circulating insulin level
|
J:167023
|
hypoglycemia
|
J:167023
|
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
decreased circulating glucose level
|
J:167023
|
decreased circulating insulin level
|
J:167023
|
hypoglycemia
|
J:167023
|
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N * NIH Black Swiss)
|
decreased circulating glucose level
|
J:167023
|
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv)
|
decreased circulating triglyceride level
|
J:205529
|
decreased circulating VLDL triglyceride level
|
J:205529
|
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J)
|
decreased circulating glucose level
|
J:344683
|
Siva1tm1b(EUCOMM)Hmgu/Siva1tm1b(EUCOMM)Hmgu
(C57BL/6N-Siva1tm1b(EUCOMM)Hmgu/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Six1em1(IMPC)Mbp/Six1+
(C57BL/6N-Six1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
Six5tm1Rdd/Six5+
(129S4/SvJae-Six5tm1Rdd)
|
increased circulating follicle stimulating hormone level
|
J:91207
|
Six5tm1Rdd/Six5tm1Rdd
(129S4/SvJae-Six5tm1Rdd)
|
increased circulating follicle stimulating hormone level
|
J:91207
|
Six6tm1Rsd/Six6tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating follicle stimulating hormone level
|
J:168233
|
Ska2tm1b(KOMP)Wtsi/Ska2+
(B6N(Cg)-Ska2tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Skic2tm2b(EUCOMM)Wtsi/Skic2+
(C57BL/6N-Skic2tm2b(EUCOMM)Wtsi/Bay)
|
increased circulating total protein level
|
J:211773
|
Skic3em1(IMPC)Tcp/Skic3+
(C57BL/6NCrl-Skic3em1(IMPC)Tcp/Cmmr)
|
increased circulating potassium level
|
J:211773
|
Skida1tm1(KOMP)Wtsi/Skida1+
(C57BL/6N-Skida1tm1(KOMP)Wtsi/Wtsi)
|
increased circulating thyroxine level
|
J:211773
|
skimp/skimp
(involves: C3H/HeH)
|
decreased circulating glucose level
|
J:77535
|
decreased circulating ketone body level
|
J:77535
|
Skor1em1(IMPC)J/Skor1+
(C57BL/6NJ-Skor1em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Sla2em1(IMPC)Ccpcz/Sla2em1(IMPC)Ccpcz
(C57BL/6N-Sla2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Slain2em1(IMPC)J/Slain2+
(C57BL/6NJ-Slain2em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Slamf6tm1Dhow/Slamf6tm1Dhow
(involves: 129/Sv * C57BL/6)
|
increased circulating interleukin-12b level
|
J:98995
|
increased circulating interleukin-16 level
|
J:98995
|
increased circulating tumor necrosis factor level
|
J:98995
|
Slbptm1.1(KOMP)Vlcg/Slbp+
(C57BL/6N-Slbptm1.1(KOMP)Vlcg/J)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Slc1a1tm1b(KOMP)Wtsi/Slc1a1tm1b(KOMP)Wtsi
(C57BL/6N-Slc1a1tm1b(KOMP)Wtsi/J)
|
increased circulating iron level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Slc1a4tm1e(KOMP)Wtsi/Slc1a4tm1e(KOMP)Wtsi
(C57BL/6N-Slc1a4tm1e(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Slc2a2tm1b(KOMP)Wtsi/Slc2a2+
(C57BL/6N-Slc2a2tm1b(KOMP)Wtsi/Rbrc)
|
increased fasting circulating glucose level
|
J:211773
|
increased glycosylated hemoglobin level
|
J:211773
|
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating insulin level
|
J:43839
|
hyperglycemia
|
J:43839
|
increased blood osmolality
|
J:43839
|
increased circulating glucagon level
|
J:43839
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6)
|
abnormal circulating glucose level
|
J:75418
|
hyperglycemia
|
J:75418
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
increased circulating glucose level
|
J:110773
|
increased circulating insulin level
|
J:110773
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6)
|
increased circulating glucose level
|
J:123335
|
increased circulating insulin level
|
J:123335
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased circulating glucose level
|
J:123335
|
increased circulating insulin level
|
J:123335
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL)
|
hyperglycemia
|
J:43650
|
increased circulating insulin level
|
J:43935,
J:43650
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)
|
abnormal circulating glucose level
|
J:49328
|
decreased circulating free fatty acids level
|
J:49328
|
decreased circulating ketone body level
|
J:49328
|
increased circulating insulin level
|
J:49328
|
Slc2a6em1Kusu/Slc2a6em1Kusu
(involves: C57BL/6JCrlj)
|
increased circulating tumor necrosis factor level
|
J:270487
|
Slc2a8tm1Khm/Slc2a8tm1Khm
(involves: 129X1/SvJ)
|
abnormal blood homeostasis
|
J:189148
|
increased circulating cholesterol level
|
J:189148
|
increased circulating insulin level
|
J:189148
|
increased circulating LDL cholesterol level
|
J:189148
|
Slc2a9tm1.1Thor/Slc2a9tm1.1Thor Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
increased blood uric acid level
|
J:153089
|
Slc2a9tm1.2Thor/Slc2a9+
(involves: C57BL/6 * C57BL/6N)
|
increased circulating magnesium level
|
J:153089
|
Slc2a9tm1.2Thor/Slc2a9tm1.2Thor
(involves: C57BL/6 * C57BL/6N)
|
increased blood uric acid level
|
J:153089
|
increased circulating creatinine level
|
J:153089
|
increased circulating magnesium level
|
J:153089
|
Slc2a9tm1Khm/Slc2a9tm1Khm Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
abnormal circulating lipid level
|
J:221544
|
increased blood uric acid level
|
J:221544
|
increased circulating cholesterol level
|
J:221544
|
increased circulating free fatty acids level
|
J:221544
|
increased circulating insulin level
|
J:221544
|
increased circulating triglyceride level
|
J:221544
|
Slc2a12em2(IMPC)Bay/Slc2a12em2(IMPC)Bay
(C57BL/6N-Slc2a12em2(IMPC)Bay/BayMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Slc3a1m1Crl/Slc3a1m1Crl
(129S2/SvPasCrl)
|
increased circulating creatinine level
|
J:219017
|
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl)
|
increased circulating cholesterol level
|
J:85461
|
increased circulating creatinine level
|
J:85461
|
increased circulating LDL cholesterol level
|
J:85461
|
uremia
|
J:85461
|
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ)
|
increased circulating cholesterol level
|
J:85461
|
increased circulating LDL cholesterol level
|
J:85461
|
Slc3a1tm1.1(KOMP)Vlcg/Slc3a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc3a1tm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal blood homeostasis
|
J:148154
|
acidemia
|
J:148154
|
decreased circulating bicarbonate level
|
J:148154
|
increased blood osmolality
|
J:148154
|
increased blood urea nitrogen level
|
J:148154
|
increased circulating phosphate level
|
J:148154
|
Slc4a4tm1.1Slin/Slc4a4+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
acidemia
|
J:186877
|
Slc4a4tm1.1Slin/Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:186877
|
acidemia
|
J:186877
|
increased circulating aldosterone level
|
J:186877
|
increased circulating calcium level
|
J:186877
|
increased circulating renin level
|
J:186877
|
uremia
|
J:186877
|
Slc4a4tm1Ges/Slc4a4+
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating bicarbonate level
|
J:279694,
J:120867
|
Slc4a4tm1Ges/Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating bicarbonate level
|
J:279694,
J:120867
|
decreased circulating sodium level
|
J:120867
|
increased circulating aldosterone level
|
J:120867
|
Slc4a5tm1.1Boet/Slc4a5tm1.1Boet
(involves: 129 * C57BL/6)
|
abnormal blood homeostasis
|
J:180608
|
decreased circulating aldosterone level
|
J:180608
|
decreased circulating bicarbonate level
|
J:180608
|
decreased circulating creatinine level
|
J:180608
|
decreased circulating renin level
|
J:180608
|
increased circulating atrial natriuretic factor
|
J:180608
|
Slc5a1Gt(OST315271)Lex/Slc5a1Gt(OST315271)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal circulating glucose level
|
J:195941
|
decreased circulating insulin level
|
J:195941
|
Slc5a1Gt(OST315271)Lex/Slc5a1Gt(OST315271)Lex Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating glucose level
|
J:195941
|
decreased circulating insulin level
|
J:195941
|
Slc5a1tm1.1Koep/Slc5a1tm1.1Koep
(B6.129P2-Slc5a1tm1.1Koep)
|
abnormal circulating hormone level
|
J:186790
|
decreased circulating glucose level
|
J:186790
|
decreased circulating insulin level
|
J:186790
|
Slc5a2tm1Lex/Slc5a2tm1Lex
(B6.129S5-Slc5a2tm1Lex)
|
decreased circulating aldosterone level
|
J:169917
|
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal blood homeostasis
|
J:195941
|
abnormal circulating glucose level
|
J:195941
|
decreased circulating glucose level
|
J:195941
|
decreased circulating insulin level
|
J:195941
|
decreased circulating phosphate level
|
J:195941
|
increased circulating sodium level
|
J:195941
|
Slc5a3tm1Gtb/Slc5a3tm1Gtb
(involves: 129X1/SvJ)
|
cyanosis
|
J:83591
|
Slc5a3tm1Skc/Slc5a3tm1Skc
(involves: 129S7/SvEvBrd)
|
cyanosis
|
J:102665
|
Slc5a5tm1b(KOMP)Wtsi/Slc5a5tm1b(KOMP)Wtsi
(C57BL/6N-Slc5a5tm1b(KOMP)Wtsi/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc5a5tm1d(KOMP)Wtsi/Slc5a5tm1d(KOMP)Wtsi
(involves: C57BL/6 * FVB/N * SJL)
|
decreased circulating thyroxine level
|
J:250121
|
decreased circulating triiodothyronine level
|
J:250121
|
increased circulating thyroid-stimulating hormone level
|
J:250121
|
Slc5a7tm1a(KOMP)Wtsi/Slc5a7+
(C57BL/6N-Slc5a7tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Slc5a7tm1Rbl/Slc5a7tm1Rbl
(involves: 129S6/SvEvTac * C57BL/6)
|
cyanosis
|
J:90846
|
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk)
|
decreased circulating triglyceride level
|
J:199406
|
increased circulating alanine transaminase level
|
J:199406
|
increased circulating aspartate transaminase level
|
J:199406
|
increased circulating insulin level
|
J:199406
|
increased circulating lactate dehydrogenase level
|
J:199406
|
increased circulating serum albumin level
|
J:199406
|
Slc5a11em1(IMPC)Tcp/Slc5a11em1(IMPC)Tcp
(C57BL/6NCrl-Slc5a11em1(IMPC)Tcp/Cmmr)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slc6a2tm1.1Mkh/Slc6a2+
(B6.129S6-Slc6a2tm1.1Mkh)
|
increased circulating noradrenaline level
|
J:200046
|
Slc6a2tm1.1Mkh/Slc6a2tm1.1Mkh
(B6.129S6-Slc6a2tm1.1Mkh)
|
increased circulating adrenaline level
|
J:200046
|
Slc6a3tm1b(KOMP)Wtsi/Slc6a3+
(C57BL/6N-Slc6a3tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Slc6a6em1(IMPC)Mbp/Slc6a6em1(IMPC)Mbp
(C57BL/6N-Slc6a6em1(IMPC)Mbp/MbpMmucd)
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Slc6a6tm1Dhau/Slc6a6tm1Dhau
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating taurine level
|
J:74276
|
Slc6a8tm1e(KOMP)Wtsi/Y
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating glucose level
|
J:264220
|
decreased fasting circulating glucose level
|
J:264220
|
Slc6a14tm1Gana/Slc6a14tm1Gana
(Not Specified)
|
abnormal circulating chemokine level
|
J:226105
|
abnormal circulating cytokine level
|
J:226105
|
decreased circulating interleukin-1 alpha level
|
J:226105
|
decreased circulating interleukin-4 level
|
J:226105
|
Slc6a15em1(IMPC)Hmgu/Slc6a15em1(IMPC)Hmgu
(C57BL/6N-Slc6a15em1(IMPC)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Slc6a19tm1Dgen/Slc6a19tm1Dgen
(involves: 129 * C57BL/6J)
|
decreased circulating insulin level
|
J:175382
|
Slc6a20bem1(IMPC)J/Slc6a20bem1(IMPC)J
(C57BL/6NJ-Slc6a20bem1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Slc7a2tm1b(EUCOMM)Hmgu/Slc7a2tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc7a2tm1b(EUCOMM)Hmgu/BayMmucd)
|
decreased circulating fructosamine level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Slc7a5em1(IMPC)H/Slc7a5+
(C57BL/6NTac-Slc7a5em1(IMPC)H/H)
|
increased circulating potassium level
|
J:211773
|
Slc7a7Gt(OST41878)Lex/Slc7a7Gt(OST41878)Lex
(B6.129S-Slc7a7Gt(OST41878)Lex)
|
increased circulating ammonia level
|
J:125847
|
Slc7a8tm2b(EUCOMM)Hmgu/Slc7a8+
(C57BL/6N-Slc7a8tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating fructosamine level
|
J:211773
|
Slc7a9tm1Nune/Slc7a9tm1Nune
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating amino acid level
|
J:85462
|
Slc7a11sut/Slc7a11sut
(C3H/HeSnJ-Slc7a11sut/J)
|
increased bleeding time
|
J:31616
|
Slc7a11tm1b(EUCOMM)Wtsi/Slc7a11tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc7a11tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating glucose level
|
J:211773
|
Slc7a11tm1Hsat/Slc7a11tm1Hsat
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating amino acid level
|
J:102902
|
increased circulating cysteine level
|
J:102902
|
Slc8a3tm1.1(KOMP)Vlcg/Slc8a3tm1.1(KOMP)Vlcg
(C57BL/6N-Slc8a3tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Slc9a3tm1Ges/Slc9a3tm1Ges
(Not Specified)
|
abnormal blood pH regulation
|
J:70885
|
increased circulating aldosterone level
|
J:70885
|
Slc9a4tm1b(EUCOMM)Wtsi/Slc9a4tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc9a4tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Slc9a8Gt(YHB273)Byg/Slc9a8Gt(YHB273)Byg
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal blood coagulation
|
J:191151
|
decreased circulating bicarbonate level
|
J:191151
|
Slc9a9em1(IMPC)J/Slc9a9em1(IMPC)J
(C57BL/6NJ-Slc9a9em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc9b2Gt(D174F03)Wrst/Slc9b2Gt(D174F03)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glucose level
|
J:197386
|
Slc9b2tm1.1(KOMP)Vlcg/Slc9b2tm1.1(KOMP)Vlcg
(C57BL/6N-Slc9b2tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating phosphate level
|
J:211773
|
Slc9b2tm1.1Dgfu/Slc9b2+
(involves: 129 * C57BL/6)
|
increased circulating glucose level
|
J:197386
|
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(involves: 129 * C57BL/6)
|
decreased circulating insulin level
|
J:197386
|
increased circulating glucose level
|
J:197386
|
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(B6.129-Slc9b2tm1.1Dgfu)
|
increased circulating glucose level
|
J:197386
|
Slc10a1tm1Tac/Slc10a1tm1Tac
(either: B6.Cg-Slc10a1tm1Tac or (involves: 129S/SvEv * C57BL/6J))
|
increased circulating alkaline phosphatase level
|
J:274149
|
increased circulating bilirubin level
|
J:274149
|
Slc10a2tm1Pda/Slc10a2tm1Pda
(either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased circulating cholesterol level
|
J:85312
|
Slc10a3em1(IMPC)J/Y
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc10a3em1(IMPC)J/Slc10a3em1(IMPC)J
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Slc10a6tm1Jmge/Slc10a6tm1Jmge
(B6N.129S5-Slc10a6tm1Jmge)
|
increased circulating cholesterol level
|
J:301761
|
Slc12a1tm1Haca/Slc12a1tm1Haca
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased circulating renin level
|
J:135710
|
Slc12a1tm1Tkh/Slc12a1tm1Tkh
(involves: 129S6/SvEvTac)
|
abnormal blood homeostasis
|
J:62224
|
decreased circulating glucose level
|
J:62224
|
increased circulating creatinine level
|
J:62224
|
increased circulating sodium level
|
J:62224
|
increased circulating total protein level
|
J:62224
|
Slc12a1tm2Haca/Slc12a1tm2Haca
(involves: 129S/SvEv * FVB/N)
|
abnormal circulating magnesium level
|
J:148062
|
increased circulating renin level
|
J:148062
|
Slc12a1urehr3/Slc12a1urehr3
(C3HeB/FeJ-Slc12a1urehr3)
|
decreased circulating glucose level
|
J:121470
|
increased blood urea nitrogen level
|
J:121470
|
increased circulating creatinine level
|
J:121470
|
Slc12a1urehr3/Slc12a1urehr3
(involves: C3HeB/FeJ)
|
abnormal blood homeostasis
|
J:159994
|
decreased circulating creatinine level
|
J:159994
|
decreased circulating renin level
|
J:159994
|
increased blood urea nitrogen level
|
J:159994
|
increased circulating alkaline phosphatase level
|
J:159994
|
increased circulating atrial natriuretic factor
|
J:159994
|
increased circulating calcium level
|
J:159994
|
increased circulating magnesium level
|
J:159994
|
Slc12a3em3Gpt/Slc12a3em3Gpt
(involves: C57BL/6)
|
decreased circulating magnesium level
|
J:336073
|
hypokalemia
|
J:336073
|
Slc12a3em3Gpt/Slc12a3em4Gpt
(involves: C57BL/6)
|
decreased circulating magnesium level
|
J:336073
|
hypokalemia
|
J:336073
|
Slc12a3em4Gpt/Slc12a3em4Gpt
(involves: C57BL/6)
|
decreased circulating magnesium level
|
J:336073
|
hypokalemia
|
J:336073
|
Slc12a3tm1Ges/Slc12a3tm1Ges
(Not Specified)
|
decreased circulating magnesium level
|
J:50596
|
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J)
|
hyposulfatemia
|
J:86561
|
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J)
|
decreased circulating insulin-like growth factor I level
|
J:86561
|
hyposulfatemia
|
J:86561
|
Slc13a3tm1b(KOMP)Wtsi/Slc13a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc13a3tm1b(KOMP)Wtsi/Ucd)
|
increased circulating creatinine level
|
J:211773
|
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf)
|
decreased circulating glucose level
|
J:176732
|
decreased circulating insulin level
|
J:176732
|
decreased circulating lactate level
|
J:176732
|
Slc14a1tm1Ask/Slc14a1tm1Ask
(involves: C57BL/6J)
|
abnormal blood homeostasis
|
J:75466
|
increased blood urea nitrogen level
|
J:179936
|
Slc14a1tm1Ask/Slc14a1tm1Ask
(involves: C57BL/6J * CD-1)
|
abnormal blood homeostasis
|
J:125840
|
Slc14a1tm1Ask/Slc14a1tm1Ask Slc14a2tm1Bxy/Slc14a2tm1Bxy
(involves: C57BL/6J)
|
increased blood urea nitrogen level
|
J:179936
|
Slc14a2tm1Raf/Slc14a2tm1Raf
(B6.129S6-Slc14a2tm1Raf)
|
decreased blood urea nitrogen level
|
J:110070
|
Slc15a3tm1b(KOMP)Wtsi/Slc15a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc15a3tm1b(KOMP)Wtsi/H)
|
increased circulating serum albumin level
|
J:211773
|
Slc15a4tm1Tkyo/Slc15a4tm1Tkyo
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:270965
|
decreased circulating interleukin-1 beta level
|
J:270965
|
decreased circulating interleukin-6 level
|
J:270965
|
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel)
|
abnormal circulating hormone level
|
J:205481
|
decreased circulating alanine transaminase level
|
J:205481
|
decreased circulating insulin level
|
J:205481
|
decreased circulating leptin level
|
J:205481
|
decreased circulating triglyceride level
|
J:205481
|
Slc16a2tm1.1Sref/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating hormone level
|
J:113732
|
abnormal circulating triiodothyronine level
|
J:113732
|
decreased circulating cholesterol level
|
J:113732
|
decreased circulating thyroxine level
|
J:113732
|
increased circulating alkaline phosphatase level
|
J:113732
|
Slc16a2tm1.1Sref/Y
(involves: 129/Sv * 129P2/OlaHsd)
|
abnormal circulating hormone level
|
J:113732
|
decreased circulating thyroxine level
|
J:113732
|
Slc16a2tm1.1Sref/Slc16a2tm1.1Sref
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating hormone level
|
J:113732
|
decreased circulating thyroxine level
|
J:113732
|
Slc16a2tm1a(KOMP)Wtsi/Y
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Slc16a2tm1a(KOMP)Wtsi/Slc16a2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating creatinine level
|
J:175295
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating alkaline phosphatase level
|
J:175295
|
increased circulating amylase level
|
J:175295
|
Slc16a2tm1Dgen/Y
(either: (involves: C57BL/6N) or (involves: NMRI))
|
decreased circulating thyroxine level
|
J:120737
|
increased circulating triiodothyronine level
|
J:120737
|
Slc16a2tm1Dgen/Slc16a2tm1Dgen
(either: (involves: C57BL/6N) or (involves: NMRI))
|
decreased circulating thyroxine level
|
J:120737
|
increased circulating triiodothyronine level
|
J:120737
|
Slc16a4tm2e(EUCOMM)Wtsi/Slc16a4tm2e(EUCOMM)Wtsi
(C57BL/6N-Slc16a4tm2e(EUCOMM)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Slc16a10m1Ingm/Slc16a10m1Ingm
(B6.C3Fe-Slc16a10m1Ingm)
|
abnormal circulating amino acid level
|
J:205101
|
Slc17a3em1Araka/Slc17a3em1Araka
(C57BL/6J-Slc17a3em1Araka)
|
abnormal blood homeostasis
|
J:351593
|
increased blood uric acid level
|
J:351593
|
increased circulating hypoxanthine level
|
J:351593
|
Slc17a6tm1.1Kldr/Slc17a6tm1.1Kldr
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
cyanosis
|
J:116180
|
Slc17a6tm1Lowl/Slc17a6tm1Lowl Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Nr5a1-cre)2Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB)
|
decreased circulating adrenaline level
|
J:129860
|
decreased circulating glucagon level
|
J:129860
|
hypoglycemia
|
J:129860
|
Slc17a9tm1Nomu/Slc17a9tm1Nomu
(involves: 129 * C57BL/6J)
|
decreased circulating insulin level
|
J:256580
|
hypoglycemia
|
J:256580
|
Slc19a2tm1Gelb/Slc19a2tm1Gelb
(involves: 129X1/SvJ)
|
decreased circulating insulin level
|
J:79974
|
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6NTac-Slc20a2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating phosphate level
|
J:234034
|
Slc22a1tm1Kmgi/Slc22a1tm1Kmgi
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
abnormal fasting circulating glucose level
|
J:122106
|
Slc22a5jvs/Slc22a5jvs
(C3.OH-H2o2 Slc22a5jvs)
|
decreased circulating carnitine level
|
J:18523
|
hypoglycemia
|
J:31000
|
increased circulating ammonia level
|
J:31000
|
Slc22a8tm1b(KOMP)Wtsi/Slc22a8tm1b(KOMP)Wtsi
(C57BL/6N-Slc22a8tm1b(KOMP)Wtsi/H)
|
increased circulating creatinine level
|
J:211773
|
Slc22a12tm1Dgen/Slc22a12tm1Dgen
(B6.129P2-Slc22a12tm1Dgen)
|
abnormal blood homeostasis
|
J:136005
|
Slc23a1tm1Mlev/Slc23a1+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal blood homeostasis
|
J:159697
|
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm)
|
decreased circulating corticosterone level
|
J:85988
|
Slc24a3em#Ebje/Slc24a3em#Ebje
(C57BL/6J-Slc24a3em#Ebje)
|
increased circulating parathyroid hormone level
|
J:254307
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4tm1b(KOMP)Wtsi
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slc24a5tm1b(KOMP)Mbp/Slc24a5tm1b(KOMP)Mbp
(C57BL/6N-Slc24a5tm1b(KOMP)Mbp/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Slc25a4tm1a(EUCOMM)Wtsi/Slc25a4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Slc25a4tm1a(EUCOMM)Wtsi/WtsiH)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Slc25a4tm2Dwa/Slc25a4tm2Dwa
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal blood homeostasis
|
J:41256
|
increased circulating alanine level
|
J:41256
|
increased circulating lactate level
|
J:41256
|
Slc25a10tm1b(EUCOMM)Wtsi/Slc25a10tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc25a10tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating amylase level
|
J:211773
|
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct)
|
decreased circulating insulin level
|
J:124766
|
hypoglycemia
|
J:124766
|
Slc25a18tm1b(KOMP)Wtsi/Slc25a18tm1b(KOMP)Wtsi
(C57BL/6N-Slc25a18tm1b(KOMP)Wtsi/Kmpc)
|
increased circulating alanine transaminase level
|
J:211773
|
Slc25a21tm1a(KOMP)Wtsi/Slc25a21tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc25a21tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
Slc25a21tm1d(KOMP)Wtsi/Slc25a21tm1d(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Slc25a21tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:211773
|
Slc25a30tm1a(EUCOMM)Wtsi/Slc25a30tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a30tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Slc25a32em1Liliu/Slc25a32em2Liliu
(C57BL/6-Slc25a32em1Liliu/Slc25a32em2Liliu)
|
decreased circulating carnitine level
|
J:338257
|
increased circulating carnitine level
|
J:338257
|
Slc25a32em2Liliu/Slc25a32em2Liliu
(C57BL/6-Slc25a32em2Liliu)
|
decreased circulating carnitine level
|
J:338257
|
increased circulating carnitine level
|
J:338257
|
Slc25a32em3Liliu/Slc25a32em3Liliu
(C57BL/6-Slc25a32em3Liliu)
|
decreased circulating carnitine level
|
J:338257
|
increased circulating carnitine level
|
J:338257
|
Slc25a34em1Duna/Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna)
|
decreased circulating glucose level
|
J:344152
|
decreased fasting circulating glucose level
|
J:344152
|
Slc25a46em1(IMPC)J/Slc25a46+
(C57BL/6NJ-Slc25a46em1(IMPC)J/J)
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Slc25a47tm1b(EUCOMM)Hmgu/Slc25a47tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc25a47tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating sodium level
|
J:211773
|
Slc26a1tm1Mark/Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1)
|
hyposulfatemia
|
J:158567
|
increased circulating alanine transaminase level
|
J:158567
|
increased circulating calcium level
|
J:158567
|
Slc26a3tm1Sole/Slc26a3tm1Sole
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating potassium level
|
J:117587
|
decreased circulating sodium level
|
J:117587
|
increased blood urea nitrogen level
|
J:117587
|
increased circulating aldosterone level
|
J:117587
|
Slc26a4tm1Sole/Slc26a4tm1Sole
(involves: 129S/SvEv * C57BL/6)
|
increased circulating bicarbonate level
|
J:162257
|
Slc26a6tm1Psar/Slc26a6tm1Psar
(involves: 129S6/SvEvTac)
|
abnormal blood homeostasis
|
J:107558
|
Slc26a7tm1Sole/Slc26a7tm1Sole
(involves: 129)
|
acidemia
|
J:156969
|
decreased circulating bicarbonate level
|
J:156969
|
decreased circulating thyroxine level
|
J:325346
|
decreased circulating triiodothyronine level
|
J:325346
|
increased circulating thyroid-stimulating hormone level
|
J:325346
|
Slc27a4tm1.1Wsr/Slc27a4tm1.1Wsr
(involves: 129P2/OlaHsd * BALB/cJ)
|
cyanosis
|
J:84096
|
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:124917
|
decreased circulating free fatty acids level
|
J:124917
|
decreased circulating ketone body level
|
J:124917
|
decreased circulating triglyceride level
|
J:124917
|
increased circulating glucose level
|
J:124917
|
increased circulating insulin level
|
J:124917
|
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129)
|
decreased circulating leptin level
|
J:124916
|
Slc28a1em1Govr/Slc28a1em1Govr
(C57BL/6NTac-Slc28a1em1Govr)
|
increased circulating calcium level
|
J:336148
|
increased circulating cholesterol level
|
J:336148
|
increased circulating creatinine level
|
J:336148
|
Slc28a3em1(IMPC)H/Slc28a3em1(IMPC)H
(C57BL/6N-Slc28a3em1(IMPC)H/H)
|
increased circulating creatine kinase level
|
J:211773
|
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Slc30a2em1(IMPC)Tcp/Slc30a2+
(C57BL/6N-Slc30a2em1(IMPC)Tcp/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Slc30a8tm1.1Geno/Slc30a8tm1.1Geno
(involves: 129/Sv * C57BL/6JRj)
|
increased circulating glucose level
|
J:153253
|
Slc30a8tm1a(KOMP)Wtsi/Slc30a8tm1a(KOMP)Wtsi
(C57BL/6N-Slc30a8tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:175295
|
Slc30a8tm1Lex/Slc30a8tm1Lex
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating insulin level
|
J:152629
|
Slc30a10tm1.1Sommu/Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating prolactin level
|
J:243657
|
decreased circulating thyroxine level
|
J:243657
|
increased circulating copper level
|
J:243657
|
increased circulating iron level
|
J:243657
|
increased circulating manganese level
|
J:243657
|
increased circulating thyroid-stimulating hormone level
|
J:243657
|
Slc31a1tm2Djt/Slc31a1tm2Djt Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
decreased circulating copper level
|
J:129741
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating cytokine level
|
J:211266
|
increased circulating interleukin-17 level
|
J:211266
|
increased circulating interleukin-18 level
|
J:211266
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating parathyroid hormone level
|
J:47637
|
decreased circulating phosphate level
|
J:47637
|
increased circulating alkaline phosphatase level
|
J:47637
|
increased circulating calcium level
|
J:47637
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(B6.129S2-Slc34a1tm1Hten/J)
|
decreased circulating phosphate level
|
J:152195
|
increased circulating calcium level
|
J:152195
|
Slc34a1tm1Hten/Slc34a1tm1Hten Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi Slc34a1tm1Hten)
|
abnormal circulating protein level
|
J:152195
|
decreased circulating parathyroid hormone level
|
J:152195
|
decreased circulating phosphate level
|
J:152195
|
increased circulating calcium level
|
J:152195
|
Slc34a2tm1Sega/Slc34a2+
(involves: 129S6/SvEvTac * C57BL/6JJcl)
|
decreased circulating calcium level
|
J:179947
|
decreased circulating creatinine level
|
J:179947
|
decreased circulating phosphate level
|
J:179947
|
Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi)
|
abnormal circulating protein level
|
J:152521
|
increased circulating calcium level
|
J:152521
|
Slc35d1tm2b(EUCOMM)Hmgu/Slc35d1+
(C57BL/6N-Slc35d1tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Slc35f5em1(IMPC)Hmgu/Slc35f5em1(IMPC)Hmgu
(C57BL/6NCrl-Slc35f5em1(IMPC)Hmgu/Ieg)
|
decreased circulating sodium level
|
J:211773
|
Slc35f6tm1a(EUCOMM)Wtsi/Slc35f6tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Slc37a1tm1b(EUCOMM)Hmgu/Slc37a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc37a1tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating bilirubin level
|
J:211773
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
hyperlipidemia
|
J:86005
|
hypoglycemia
|
J:86005
|
increased circulating cholesterol level
|
J:86005
|
increased circulating triglyceride level
|
J:86005
|
Slc38a2tm1a(KOMP)Wtsi/Slc38a2+
(C57BL/6N-Slc38a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Slc38a2tm1a(KOMP)Wtsi/Slc38a2tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
cyanosis
|
J:304644
|
Slc38a3m1Ingm/Slc38a3m1Ingm
(B6.C3Fe-Slc38a3m1Ingm)
|
abnormal circulating amino acid level
|
J:234835
|
decreased circulating alanine level
|
J:234835
|
decreased circulating glucose level
|
J:234835
|
decreased circulating insulin level
|
J:234835
|
decreased circulating tyrosine level
|
J:234835
|
increased blood urea nitrogen level
|
J:234835
|
increased circulating cysteine level
|
J:234835
|
increased circulating histidine level
|
J:234835
|
increased circulating homocysteine level
|
J:234835
|
increased circulating leucine level
|
J:234835
|
increased circulating threonine level
|
J:234835
|
Slc38a4em#Smtb/Slc38a4+
(C57BL/6NSlc-Slc38a4em#Ogu)
|
decreased circulating glutamine level
|
J:280426
|
decreased circulating glycine level
|
J:280426
|
decreased circulating histidine level
|
J:280426
|
decreased circulating isoleucine level
|
J:280426
|
decreased circulating serine level
|
J:280426
|
decreased circulating valine level
|
J:280426
|
Slc38a4em#Smtb/Slc38a4em#Smtb
(C57BL/6NSlc-Slc38a4em#Ogu)
|
abnormal circulating amino acid level
|
J:280426
|
decreased circulating glutamine level
|
J:280426
|
decreased circulating histidine level
|
J:280426
|
decreased circulating isoleucine level
|
J:280426
|
decreased circulating lysine level
|
J:280426
|
Slc38a8em1Cya/Slc38a8em1Cya
(C57BL/6J-Slc38a8em1Cya)
|
decreased circulating aspartate transaminase level
|
J:336781
|
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc38a10tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Slc38a10tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:175295
|
decreased circulating calcium level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating amylase level
|
J:213427
|
decreased circulating serum albumin level
|
J:213427
|
increased circulating creatinine level
|
J:213427
|
Slc38a10tm2a(EUCOMM)Wtsi/Slc38a10tm2a(EUCOMM)Wtsi
(C57BL/6N-Slc38a10tm2a(EUCOMM)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
decreased circulating amylase level
|
J:165965
|
decreased circulating calcium level
|
J:165965
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating sodium level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
increased circulating potassium level
|
J:165965
|
increased circulating triglyceride level
|
J:165965
|
Slc38a11tm2b(KOMP)Mbp/Slc38a11tm2b(KOMP)Mbp
(C57BL/6N-Slc38a11tm2b(KOMP)Mbp/Tcp)
|
increased circulating phosphate level
|
J:211773
|
Slc39a4tm1.1(KOMP)Wtsi/Slc39a4+
(C57BL/6N-Slc39a4tm1.1(KOMP)Wtsi/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Slc39a5tm1b(KOMP)Wtsi/Slc39a5tm1b(KOMP)Wtsi
(C57BL/6N-Slc39a5tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slc39a8tm1.1Brvo/Slc39a8tm1.1Brvo
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:341571
|
increased circulating glucose level
|
J:341571
|
increased circulating insulin level
|
J:341571
|
increased circulating phosphate level
|
J:341571
|
Slc39a8tm1b(EUCOMM)Wtsi/Slc39a8+
(C57BL/6N-Slc39a8tm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating triglyceride level
|
J:211773
|
Slc39a14tm1Lex/Slc39a14tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:236296
|
Slc39a14tm1Thir/Slc39a14tm1Thir
(involves: 129 * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:171670
|
Slc40a1ffe/Slc40a1+
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))
|
increased circulating ferritin level
|
J:118592
|
increased circulating unsaturated transferrin level
|
J:118592
|
Slc40a1Pcm/Slc40a1Pcm
(A.Cg-Slc40a1Pcm)
|
decreased circulating iron level
|
J:89185
|
Slc40a1tm1.1Mmfe/Slc40a1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating unsaturated transferrin level
|
J:215585
|
increased circulating ferritin level
|
J:215585
|
increased circulating iron level
|
J:215585
|
increased circulating lipase level
|
J:215585
|
Slc40a1tm1.1Mmfe/Slc40a1tm1.1Mmfe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating unsaturated transferrin level
|
J:215585
|
increased circulating ferritin level
|
J:215585
|
increased circulating iron level
|
J:215585
|
increased circulating lipase level
|
J:215585
|
Slc40a1tm1b(EUCOMM)Hmgu/Slc40a1+
(C57BL/6N-Slc40a1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Slc41a1tm1.1Geno/Slc41a1tm1.1Geno Slc41a3tm1a(KOMP)Wtsi/Slc41a3tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating magnesium level
|
J:344881
|
Slc41a3tm1a(KOMP)Wtsi/Slc41a3tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating magnesium level
|
J:236099
|
Slc41a3tm1a(KOMP)Wtsi/Slc41a3tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating magnesium level
|
J:344881
|
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal circulating amino acid level
|
J:237439
|
abnormal circulating glucose level
|
J:237439
|
decreased circulating alanine level
|
J:237439
|
decreased circulating histidine level
|
J:237439
|
decreased circulating proline level
|
J:237439
|
decreased circulating serine level
|
J:237439
|
decreased fasting circulating glucose level
|
J:237439
|
increased circulating carnitine level
|
J:237439
|
Slc44a3tm1b(EUCOMM)Wtsi/Slc44a3tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc44a3tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slc44a4tm1b(EUCOMM)Hmgu/Slc44a4tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc44a4tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Slc46a1tm1b(KOMP)Mbp/Slc46a1+
(C57BL/6N-Slc46a1tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Slc46a1tm1Hija/Slc46a1tm1Hija
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating homocysteine level
|
J:150548
|
Slc46a3tm1.1(KOMP)Vlcg/Slc46a3tm1.1(KOMP)Vlcg
(C57BL/6N-Slc46a3tm1.1(KOMP)Vlcg/J)
|
decreased circulating iron level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc47a1tm1b(EUCOMM)Wtsi/Slc47a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc47a1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Slc47a1tm1Kinu/Slc47a1tm1Kinu
(C57BL/6-Slc47a1tm1Kinu)
|
increased blood urea nitrogen level
|
J:163959
|
increased circulating creatinine level
|
J:163959
|
Slc47a2tm1.1(KOMP)Vlcg/Slc47a2tm1.1(KOMP)Vlcg
(C57BL/6N-Slc47a2tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * C57BL/6J)
|
increased circulating ferritin level
|
J:282829
|
Slc50a1tm1.1(KOMP)Vlcg/Slc50a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc50a1tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Slc51atm1Pda/Slc51atm1Pda
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:132778
|
decreased circulating triglyceride level
|
J:132778
|
Slc51bem1(IMPC)Mbp/Slc51bem1(IMPC)Mbp
(C57BL/6NCrl-Slc51bem1(IMPC)Mbp/Mmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slc52a3tm2a(KOMP)Wtsi/Slc52a3tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
hyperlipidemia
|
J:236029
|
hypoglycemia
|
J:236029
|
increased circulating carnitine level
|
J:236029
|
Slco1a1tm1Dgen/Slco1a1tm1Dgen
(B6N.129P2-Slco1a1tm1Dgen)
|
abnormal blood homeostasis
|
J:174999
|
Slco1a4tm1Dgen/Slco1a4tm1Dgen
(B6N.129P2-Slco1a4tm1Dgen)
|
abnormal blood homeostasis
|
J:174999
|
Slco1b2em1(IMPC)Mbp/Slco1b2em1(IMPC)Mbp
(C57BL/6NCrl-Slco1b2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(B6.129S1-Slco1b2tm1Cdk)
|
abnormal circulating mineral level
|
J:133919
|
abnormal circulating protein level
|
J:133919
|
abnormal circulating serum albumin level
|
J:133919
|
decreased circulating amylase level
|
J:133919
|
increased circulating alanine transaminase level
|
J:133919
|
increased circulating bilirubin level
|
J:133919
|
increased circulating cholesterol level
|
J:133919
|
increased circulating sodium level
|
J:133919
|
increased circulating total protein level
|
J:133919
|
Slco2b1tm1d(KOMP)Wtsi/Slco2b1tm1d(KOMP)Wtsi
(involves: C57BL/6N)
|
increased blood urea nitrogen level
|
J:287311
|
Slco3a1em1Smoc/Slco3a1em1Smoc
(C57BL/6JSmoc-Slco3a1em1Smoc/Smoc)
|
increased circulating alanine transaminase level
|
J:279167
|
increased circulating aspartate transaminase level
|
J:279167
|
Slfn14em1Nvm/Slfn14+
(C57BL/6J-Slfn14em1Nvm)
|
abnormal thrombosis
|
J:325381
|
Slitrk1tm1.1(KOMP)Vlcg/Slitrk1tm1.1(KOMP)Vlcg
(C57BL/6N-Slitrk1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Slitrk4tm1b(KOMP)Wtsi/Y
(C57BL/6N-Slitrk4tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:211773
|
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:193427
|
increased circulating glucose level
|
J:193427
|
increased circulating triglyceride level
|
J:193427
|
Slpitm1Smw/Slpitm1Smw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal platelet physiology
|
J:95293
|
Slu7tm1a(KOMP)Wtsi/Slu7+
(C57BL/6NTac-Slu7tm1a(KOMP)Wtsi/WtsiPh)
|
abnormal blood homeostasis
|
J:345496
|
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified)
|
decreased circulating cholesterol level
|
J:210836
|
decreased circulating insulin level
|
J:210836
|
decreased circulating leptin level
|
J:210836
|
decreased circulating triglyceride level
|
J:210836
|
Slurp2tm1Lex/Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:231067
|
Slx1bem1(IMPC)Ics/Slx1b+
(C57BL/6N-Slx1bem1(IMPC)Ics/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
increased circulating glucose level
|
J:168567
|
SMA010/SMA010
(C3HeB/FeJ-SMA010)
|
increased circulating alkaline phosphatase level
|
J:183993
|
increased circulating calcium level
|
J:183993
|
Smad3em1(IMPC)H/Smad3+
(C57BL/6NTac-Smad3em1(IMPC)H/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating creatinine level
|
J:137529
|
Smad3tm1Par/Smad3tm1Par
(129-Smad3tm1Par/J)
|
abnormal circulating interleukin-6 level
|
J:175290
|
decreased blood urea nitrogen level
|
J:175290
|
decreased circulating creatinine level
|
J:175290
|
Smad3tm1Sche/Smad3tm1Sche
(B6.129P2-Smad3tm1Sche)
|
decreased blood urea nitrogen level
|
J:145114
|
decreased circulating creatinine level
|
J:145114
|
Smad6tm1Glvn/Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ)
|
abnormal thrombosis
|
J:60214
|
Smagptm1b(KOMP)Mbp/Smagptm1b(KOMP)Mbp
(C57BL/6N-Smagptm1b(KOMP)Mbp/Bay)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Smarca2em1(IMPC)J/Smarca2em1(IMPC)J
(C57BL/6NJ-Smarca2em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Smarca4tm1.1Pcn/Smarca4+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
cyanosis
|
J:172661
|
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
cyanosis
|
J:172661
|
Smarcal1tm1a(EUCOMM)Wtsi/Smarcal1tm1a(EUCOMM)Wtsi
(C57BL/6N-Smarcal1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:175295
|
Smarcb1tm1b(EUCOMM)Hmgu/Smarcb1+
(C57BL/6N-Smarcb1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Smarcb1tm1Mya/Smarcb1tm2Mya Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N)
|
hypoglycemia
|
J:103919
|
Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating alanine transaminase level
|
J:228944
|
decreased circulating aspartate transaminase level
|
J:228944
|
decreased circulating cholesterol level
|
J:228944
|
decreased circulating HDL cholesterol level
|
J:228944
|
decreased circulating LDL cholesterol level
|
J:228944
|
decreased circulating VLDL cholesterol level
|
J:228944
|
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating HDL cholesterol level
|
J:220422
|
increased circulating calcium level
|
J:220422
|
increased circulating glucose level
|
J:220422
|
Smc6tm1b(EUCOMM)Hmgu/Smc6+
(C57BL/6N-Smc6tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating serum albumin level
|
J:211773
|
Smcr8em1Btlr/Smcr8em1Btlr
(C57BL/6J-Smcr8em1Btlr)
|
increased circulating interleukin-12b level
|
J:268243
|
Smcr8em2Btlr/Smcr8em2Btlr
(C57BL/6J-Smcr8em2Btlr)
|
increased circulating interleukin-12b level
|
J:268243
|
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-1 beta level
|
J:193626
|
increased circulating interleukin-6 level
|
J:193626
|
Smg1tm1b(EUCOMM)Hmgu/Smg1+
(C57BL/6N-Smg1tm1b(EUCOMM)Hmgu/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Smg9em1(IMPC)J/Smg9+
(C57BL/6NJ-Smg9em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Smim8tm1.1(KOMP)Vlcg/Smim8tm1.1(KOMP)Vlcg
(C57BL/6N-Smim8tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Smn1tm1Jme/Smn1tm1.1Jme Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
increased circulating creatine kinase level
|
J:67884
|
Smoc1tm1b(EUCOMM)Wtsi/Smoc1+
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased circulating iron level
|
J:211773
|
Smoc2tm1.1(KOMP)Vlcg/Smoc2tm1.1(KOMP)Vlcg
(C57BL/6N-Smoc2tm1.1(KOMP)Vlcg/J)
|
increased circulating phosphate level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:26732
|
Smpd3fro/Smpd3fro
(Not Specified)
|
cyanosis
|
J:3906
|
increased circulating parathyroid hormone level
|
J:7673,
J:100158
|
Smpd3tm1Wst/Smpd3tm1Wst
(involves: 129S1/Sv)
|
decreased circulating cortisol level
|
J:97284
|
decreased circulating insulin-like growth factor I level
|
J:97284
|
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi)
|
abnormal circulating chemokine level
|
J:224870
|
increased circulating interleukin-6 level
|
J:224870
|
increased circulating interleukin-12b level
|
J:224870
|
increased circulating tumor necrosis factor level
|
J:224870
|
Smstm1a(EUCOMM)Wtsi/Y
(B6JTyr;B6N-Smstm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
increased blood urea nitrogen level
|
J:175295
|
Smyd2tm1a(KOMP)Wtsi/Smyd2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Smyd2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified)
|
decreased circulating ghrelin level
|
J:226064
|
hyperglycemia
|
J:226064
|
increased circulating cholesterol level
|
J:226064
|
increased circulating insulin level
|
J:226064
|
increased circulating leptin level
|
J:226064
|
increased circulating triglyceride level
|
J:226064
|
Snapc1tm1b(KOMP)Mbp/Snapc1+
(C57BL/6N-Snapc1tm1b(KOMP)Mbp/H)
|
increased circulating potassium level
|
J:211773
|
Snapintm1.1(KOMP)Vlcg/Snapin+
(C57BL/6N-Snapintm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sncaem1(IMPC)H/Sncaem1(IMPC)H
(C57BL/6NTac-Sncaem1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Snd1em1(IMPC)Tcp/Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Snf8tm1a(EUCOMM)Wtsi/Snf8+
(C57BL/6N-Snf8tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:165965
|
Snip1tm1a(EUCOMM)Wtsi/Snip1+
(B6JTyr;B6N-Snip1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:175295
|
Snorctm1Lex/Snorctm1Lex
(B6;129S5-Snorctm1Lex/Mmucd)
|
decreased circulating triglyceride level
|
J:171883
|
Snord116tm1.1Uta/Snord116+
(involves: C57BL/6J)
|
decreased circulating glucose level
|
J:131662
|
decreased circulating insulin-like growth factor I level
|
J:131662
|
increased circulating ghrelin level
|
J:131662
|
Snord116tm1Uta/Snord116+ Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J)
|
decreased circulating glucose level
|
J:131427
|
decreased circulating insulin-like growth factor I level
|
J:131427
|
increased circulating ghrelin level
|
J:131427
|
Snrktm1.1Hxu/Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr)
|
abnormal circulating chemokine level
|
J:257980
|
increased circulating free fatty acids level
|
J:257980
|
increased circulating interleukin-6 level
|
J:257980
|
increased circulating triglyceride level
|
J:257980
|
increased circulating tumor necrosis factor level
|
J:257980
|
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu)
|
increased circulating glucose level
|
J:257980
|
Snrktm1Hxu/Snrktm1Hxu
(C57BL/6-Snrktm1Hxu)
|
decreased circulating glucose level
|
J:257980
|
Snrktm1Rra/Snrktm1Rra
(involves: C57BL/6J)
|
decreased circulating free fatty acids level
|
J:218247
|
decreased circulating triglyceride level
|
J:218247
|
increased circulating cholesterol level
|
J:218247
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
increased circulating interferon-beta level
|
J:282417
|
increased circulating interferon-gamma level
|
J:282417
|
increased circulating interleukin-6 level
|
J:282417
|
increased circulating interleukin-12 level
|
J:282417
|
increased circulating interleukin-17 level
|
J:282417
|
increased circulating tumor necrosis factor level
|
J:282417
|
Snrpntm2Cbr/Snrpn+
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating glucose level
|
J:47318
|
Snx3tm1.1(KOMP)Vlcg/Snx3+
(C57BL/6N-Snx3tm1.1(KOMP)Vlcg/J)
|
increased blood urea nitrogen level
|
J:211773
|
Snx5Gt(XA155)Byg/Snx5Gt(XA155)Byg
(B6.129P2-Snx5Gt(XA155)Byg)
|
cyanosis
|
J:199909
|
Snx5tm1a(KOMP)Wtsi/Snx5tm1a(KOMP)Wtsi
(B6JTyr;B6N-Snx5tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating potassium level
|
J:175295
|
Snx6em1(IMPC)J/Snx6em1(IMPC)J
(C57BL/6NJ-Snx6em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Snx8tm1Hbsh/Snx8tm1Hbsh
(Not Specified)
|
abnormal circulating chemokine level
|
J:254306
|
decreased circulating CXCL10 level
|
J:254306
|
decreased circulating tumor necrosis factor level
|
J:254306
|
Snx8tm2a(EUCOMM)Hmgu/Snx8tm2a(EUCOMM)Hmgu
(C57BL/6N-Snx8tm2a(EUCOMM)Hmgu/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal blood homeostasis
|
J:289051
|
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal blood homeostasis
|
J:289051
|
Snx10tm1a(EUCOMM)Raba/Snx10tm1a(EUCOMM)Raba
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
decreased circulating calcium level
|
J:224711
|
increased circulating parathyroid hormone level
|
J:224711
|
Snx12em1(IMPC)J/Y
(C57BL/6NJ-Snx12em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Snx13tm1b(EUCOMM)Hmgu/Snx13+
(C57BL/6N-Snx13tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Snx15tm1.1(KOMP)Vlcg/Snx15tm1.1(KOMP)Vlcg
(C57BL/6N-Snx15tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:37049
|
increased circulating HDL cholesterol level
|
J:37049
|
Soat1tm1Ishi/Soat1tm1Ishi Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:63468
|
Soat1tm1Ishi/Soat1tm1Ishi Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:63468
|
Soat2tm1.1Llr/Soat2tm1.1Llr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:184908
|
decreased circulating LDL cholesterol level
|
J:184908
|
decreased circulating VLDL cholesterol level
|
J:184908
|
increased circulating triglyceride level
|
J:184908
|
Soat2tm1.1Llr/Soat2tm1.1Llr Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:184908
|
decreased circulating VLDL cholesterol level
|
J:184908
|
increased circulating triglyceride level
|
J:184908
|
Soat2tm1Far/Soat2tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:82032
|
decreased circulating LDL cholesterol level
|
J:82032
|
decreased circulating VLDL cholesterol level
|
J:82032
|
increased circulating HDL cholesterol level
|
J:82032
|
increased circulating triglyceride level
|
J:82032
|
Socs1tm3.1Wehi/Socs1tm3.1Wehi
(C57BL/6-Socs1tm3.1Wehi)
|
increased circulating interferon-gamma level
|
J:83009
|
Socs2em1(IMPC)H/Socs2em1(IMPC)H
(C57BL/6NTac-Socs2em1(IMPC)H/H)
|
increased circulating creatinine level
|
J:211773
|
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
abnormal circulating cytokine level
|
J:186227
|
abnormal circulating hormone level
|
J:186227
|
decreased circulating growth hormone level
|
J:186227
|
decreased circulating insulin-like growth factor I level
|
J:186227
|
increased circulating glucose level
|
J:186227
|
increased circulating insulin level
|
J:186227
|
increased circulating interferon-gamma level
|
J:186227
|
increased circulating interleukin-1 beta level
|
J:186227
|
Socs3tm1Ayos/Socs3tm1Ayos Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6)
|
decreased circulating free fatty acids level
|
J:91796
|
decreased circulating triglyceride level
|
J:91796
|
Socs3tm1Ayos/Socs3tm1Ayos Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6)
|
decreased circulating free fatty acids level
|
J:91796
|
decreased circulating triglyceride level
|
J:91796
|
Socs3tm1Jni/Socs3+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating leptin level
|
J:91797
|
Socs7tm1Pbro/Socs7tm1Pbro
(B6.129S1-Socs7tm1Pbro)
|
hypoglycemia
|
J:100915
|
Sod1tm1Leb/Sod1tm1Leb
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating luteinizing hormone level
|
J:64299
|
increased circulating interleukin-6 level
|
J:219024
|
increased circulating tumor necrosis factor level
|
J:219024
|
suppressed circulating follicle stimulating hormone level
|
J:64299
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1)
|
decreased circulating lactate level
|
J:29899
|
increased circulating ketone body level
|
J:29899
|
Sod2tm1Cje/Sod2tm1Cje
(D2.Cg-Sod2tm1Cje)
|
abnormal blood gas level
|
J:73998
|
abnormal blood homeostasis
|
J:73998
|
decreased circulating glucose level
|
J:73998
|
increased blood urea nitrogen level
|
J:73998
|
increased circulating alkaline phosphatase level
|
J:73998
|
increased circulating aspartate transaminase level
|
J:73998
|
increased circulating ketone body level
|
J:73998
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J)
|
abnormal blood homeostasis
|
J:73998
|
abnormal blood pH regulation
|
J:73998
|
decreased circulating glucose level
|
J:73998
|
increased blood urea nitrogen level
|
J:73998
|
increased circulating ketone body level
|
J:73998
|
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc)
|
abnormal circulating insulin level
|
J:121762
|
Sorbs2tm1.1(KOMP)Mbp/Sorbs2tm1.1(KOMP)Mbp
(C57BL/6N-Sorbs2tm1.1(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sordem1(IMPC)Ccpcz/Sordem1(IMPC)Ccpcz
(C57BL/6NCrl-Sordem1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
Sox4em1(IMPC)Mbp/Sox4+
(C57BL/6NCrl-Sox4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sox4Igt4/Sox4+
(involves: C3H/HeH * C57BL/6)
|
decreased circulating insulin level
|
J:141688
|
Sox4M91Ark/Sox4+
(involves: C3H/HeH)
|
decreased circulating insulin level
|
J:141688
|
Sox5Tn(sb-lacZ,GFP)IF2.OR123Jtak/Sox5Tn(sb-lacZ,GFP)IF2.OR123Jtak
(involves: C3H * C57BL/6 * DBA/2 * ICR)
|
cyanosis
|
J:104043
|
Sox9em1(cre/ERT2)Smoc/Sox9+ Tnfsf18em1Pwan/Tnfsf18em1Pwan
(involves: C57BL/6J)
|
decreased circulating alanine transaminase level
|
J:346395
|
decreased circulating aspartate transaminase level
|
J:346395
|
Sox10tm1Weg/Sox10tm1Weg
(involves: 129S1/Sv * 129X1/SvJ * C3HeB/FeJ * C57BL/6J)
|
cyanosis
|
J:67383
|
Sox11tm1Weg/Sox11tm1Weg
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:92251
|
Sox17SHIVA/Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN))
|
decreased circulating HDL cholesterol level
|
J:219119
|
decreased circulating ketone body level
|
J:219119
|
decreased fasting circulating glucose level
|
J:219119
|
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk)
|
increased circulating alanine transaminase level
|
J:194071
|
increased circulating alkaline phosphatase level
|
J:194071
|
Sox18Ra-Op/Sox18+
(involves: C57BL/6J * DBA/2J)
|
cyanosis
|
J:260
|
Sox18tm1.1(KOMP)Vlcg/Sox18tm1.1(KOMP)Vlcg
(C57BL/6N-Sox18tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Sox30tm1b(KOMP)Wtsi/Sox30tm1b(KOMP)Wtsi
(C57BL/6N-Sox30tm1b(KOMP)Wtsi/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Sp5tm1b(KOMP)Wtsi/Sp5tm1b(KOMP)Wtsi
(C57BL/6N-Sp5tm1b(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
Sp7em1(IMPC)Ccpcz/Sp7+
(C57BL/6NCrl-Sp7em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sp7tm1Crm/Sp7tm1Crm
(involves: 129S7/SvEvBrd * C57BL/6)
|
cyanosis
|
J:74344
|
Spag4tm1.1(KOMP)Mbp/Spag4tm1.1(KOMP)Mbp
(C57BL/6N-Spag4tm1.1(KOMP)Mbp/Ucd)
|
increased fasting circulating glucose level
|
J:211773
|
Spag17tm1d(KOMP)Wtsi/Spag17tm1d(KOMP)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
cyanosis
|
J:211752
|
Sparttm1.1Xen/Sparttm1.1Xen
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:185987
|
increased blood uric acid level
|
J:185987
|
Sparttm2b(EUCOMM)Hmgu/Sparttm2b(EUCOMM)Hmgu
(C57BL/6N-Sparttm2b(EUCOMM)Hmgu/Cnrm)
|
increased fasting circulating glucose level
|
J:211773
|
Spata3em1(IMPC)J/Spata3em1(IMPC)J
(C57BL/6NJ-Spata3em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Spata7tm1.1(KOMP)Vlcg/Spata7tm1.1(KOMP)Vlcg
(C57BL/6N-Spata7tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Spatc1em1(IMPC)J/Spatc1em1(IMPC)J
(C57BL/6NJ-Spatc1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Spatc1lem1(IMPC)H/Spatc1lem1(IMPC)H
(C57BL/6N-Spatc1lem1(IMPC)H/H)
|
decreased circulating creatinine level
|
J:211773
|
Specc1lem1(IMPC)J/Specc1lem1(IMPC)J
(C57BL/6NJ-Specc1lem1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA)
|
abnormal circulating enzyme level
|
J:263073
|
decreased circulating alanine transaminase level
|
J:263073
|
decreased circulating alkaline phosphatase level
|
J:263073
|
decreased circulating aspartate transaminase level
|
J:263073
|
decreased circulating glucose level
|
J:263073
|
decreased circulating insulin level
|
J:263073
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:279111
|
increased circulating aspartate transaminase level
|
J:279111
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Trmutm1Tomik/Trmutm1Tomik
(involves: C57BL/6 * DBA)
|
decreased circulating amylase level
|
J:235644
|
decreased circulating calcium level
|
J:235644
|
decreased circulating cholesterol level
|
J:235644
|
decreased circulating creatinine level
|
J:235644
|
decreased circulating HDL cholesterol level
|
J:235644
|
decreased circulating serum albumin level
|
J:235644
|
increased circulating alanine transaminase level
|
J:235644
|
increased circulating aspartate transaminase level
|
J:235644
|
increased circulating lactate dehydrogenase level
|
J:235644
|
increased circulating lactate level
|
J:235644
|
Spg11em1(IMPC)J/Spg11em1(IMPC)J
(C57BL/6NJ-Spg11em1(IMPC)J/Mmjax)
|
decreased circulating total protein level
|
J:211773
|
Sphkaptm1.1Nina/Sphkaptm1.1Nina
(Not Specified)
|
decreased circulating glucose level
|
J:272327
|
decreased circulating insulin level
|
J:272327
|
increased circulating insulin level
|
J:272327
|
Spice1tm1b(EUCOMM)Hmgu/Spice1tm1b(EUCOMM)Hmgu
(C57BL/6N-Spice1tm1b(EUCOMM)Hmgu/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Spin1tm1.1(KOMP)Vlcg/Spin1+
(C57BL/6N-Spin1tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Spink12em1(IMPC)J/Spink12em1(IMPC)J
(C57BL/6NJ-Spink12em1(IMPC)J/J)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Spmip9tm1.1(KOMP)Vlcg/Spmip9tm1.1(KOMP)Vlcg
(C57BL/6N-Spmip9tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating glucose level
|
J:213427
|
increased circulating bilirubin level
|
J:213427
|
Spo11tm2b(KOMP)Wtsi/Spo11tm2b(KOMP)Wtsi
(C57BL/6N-Spo11tm2b(KOMP)Wtsi/Bay)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Spock1em1(IMPC)H/Spock1em1(IMPC)H
(C57BL/6N-Spock1em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Spoptm1b(KOMP)Wtsi/Spop+
(C57BL/6N-Spoptm1b(KOMP)Wtsi/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating glucose level
|
J:127389
|
decreased circulating insulin level
|
J:127389
|
decreased circulating interleukin-6 level
|
J:127389
|
decreased circulating triglyceride level
|
J:127389
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased blood urea nitrogen level
|
J:56204
|
increased circulating creatinine level
|
J:56204
|
Sprtm1Spo/Sprtm1Spo
(involves: 129 * C57BL/6)
|
decreased circulating insulin-like growth factor I level
|
J:124817
|
increased circulating phenylalanine level
|
J:124817
|
Spred1em1(IMPC)Ccpcz/Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Spred2em1(IMPC)Mbp/Spred2em1(IMPC)Mbp
(C57BL/6N-Spred2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Spred3em1(IMPC)Tcp/Spred3+
(C57BL/6NCrl-Spred3em1(IMPC)Tcp/Tcp)
|
increased circulating creatinine level
|
J:211773
|
Spry4tm1b(KOMP)Mbp/Spry4tm1b(KOMP)Mbp
(C57BL/6N-Spry4tm1b(KOMP)Mbp/Kmpc)
|
decreased fasting circulating glucose level
|
J:211773
|
Spryd3tm1a(EUCOMM)Hmgu/Spryd3tm1a(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1a(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:165965
|
Spryd3tm1b(EUCOMM)Hmgu/Spryd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Spsb2tm1Nch/Spsb2+
(involves: C57BL/6)
|
decreased blood urea nitrogen level
|
J:99226
|
Spsb2tm1Nch/Spsb2tm1Nch
(involves: C57BL/6)
|
decreased blood urea nitrogen level
|
J:99226
|
Spta1ihj/Spta1ihj
(involves: HRS/J * LAH)
|
increased circulating bilirubin level
|
J:105409
|
Spta1sph-2Bc/Spta1sph-2Bc
(involves: SELH)
|
increased circulating bilirubin level
|
J:7048
|
Spta1sph-2Bc/Spta1sph-2Bc
((WB.Cg-Spta1sph-2Bc/Brk x B6.Cg-Spta1sph-2Bc/Brk)F1)
|
abnormal cardiac thrombosis
|
J:62355
|
Spta1sph-3J/Spta1sph-3J
(NOD.Cg-H2b Spta1sph-3J)
|
increased circulating bilirubin level
|
J:157766
|
increased circulating iron level
|
J:157766
|
Spta1sph-4J/Spta1sph-4J
(C57BL/6J-Spta1sph-4J/Llp)
|
increased circulating bilirubin level
|
J:157766
|
increased circulating iron level
|
J:157766
|
Spta1sph-Dem/Spta1sph-Dem
(CcS3/Dem-Spta1sph-Dem)
|
abnormal cardiac thrombosis
|
J:62355
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
abnormal thrombosis
|
J:12830
|
increased circulating bilirubin level
|
J:12830
|
Spta1sph-ha/Spta1sph-ha
((WB.D1-Spta1sph-ha/Brk x B6.D1-Spta1sph-ha/Brk)F1)
|
abnormal cardiac thrombosis
|
J:62355
|
increased circulating bilirubin level
|
J:162532
|
Spta1sph/Spta1sph
(involves: C3H)
|
increased circulating bilirubin level
|
J:12276
|
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
abnormal cardiac thrombosis
|
J:62355,
J:44313
|
increased circulating bilirubin level
|
J:162532
|
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1)
|
abnormal cardiac thrombosis
|
J:62355,
J:44313
|
decreased circulating glucose level
|
J:44313
|
increased blood urea nitrogen level
|
J:44313
|
increased circulating bilirubin level
|
J:162532,
J:44313
|
increased circulating iron level
|
J:44313
|
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1+
(B6JTyr;B6N-Sptbn1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
decreased circulating total protein level
|
J:175295
|
Sptbn2tm1b(EUCOMM)Hmgu/Sptbn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Sptbn2tm1b(EUCOMM)Hmgu/H)
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Sptlc1tm1Jia/Sptlc1+
(B6.Cg-Sptlc1tm1Jia)
|
abnormal circulating lipid level
|
J:140627
|
Sptlc2tm1Jia/Sptlc2+
(B6.Cg-Sptlc2tm1Jia)
|
abnormal circulating lipid level
|
J:140627
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal circulating protein level
|
J:202954
|
increased blood urea nitrogen level
|
J:202954
|
increased circulating alanine transaminase level
|
J:202954
|
increased circulating serum albumin level
|
J:202954
|
Sptlc2tm2.1Jia/Sptlc2tm2.1Jia
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased circulating cholesterol level
|
J:155507
|
increased circulating HDL cholesterol level
|
J:155507
|
increased circulating phospholipid level
|
J:155507
|
Sptlc3em1(IMPC)Hmgu/Sptlc3em1(IMPC)Hmgu
(C57BL/6NCrl-Sptlc3em1(IMPC)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
Sptlc3em1Cowl/Sptlc3em1Cowl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased fasting circulating glucose level
|
J:361357
|
Sptssatm1b(KOMP)Wtsi/Sptssa+
(B6N(Cg)-Sptssatm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Sptssbtm1b(KOMP)Mbp/Sptssbtm1b(KOMP)Mbp
(C57BL/6N-Sptssbtm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Sqstm1em1Kmts/Sqstm1+
(involves: C57BL/6N)
|
hypoglycemia
|
J:342766
|
increased blood urea nitrogen level
|
J:342766
|
increased circulating aspartate transaminase level
|
J:342766
|
increased circulating cholesterol level
|
J:342766
|
increased circulating creatinine level
|
J:342766
|
Sqstm1tm1a(KOMP)Wtsi/Sqstm1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Sqstm1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:175295
|
Sqstm1tm1Keta/Sqstm1tm1Keta
(involves: 129)
|
hyperglycemia
|
J:130839
|
Sqstm1tm1Keta/Sqstm1tm1Keta
(B6.129-Sqstm1tm1Keta)
|
increased circulating leptin level
|
J:201732
|
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating insulin level
|
J:214131
|
decreased circulating tumor necrosis factor level
|
J:214131
|
Srebf1Gt(XC354)Byg/Srebf1Gt(XC354)Byg
(either: B6.129P2-Srebf1Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6))
|
increased circulating ketone body level
|
J:152612
|
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac)
|
decreased circulating cholesterol level
|
J:75320
|
decreased circulating triglyceride level
|
J:75320
|
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:101307
|
decreased circulating triglyceride level
|
J:101307
|
Srebf1tm2Jdh/Srebf1tm2Jdh
(involves: 129S/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:43570
|
decreased circulating triglyceride level
|
J:43570
|
Srebf2tm1Jdh/Srebf2tm1Jdh Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:241873
|
decreased circulating triglyceride level
|
J:241873
|
Srek1em1(IMPC)J/Srek1+
(C57BL/6NJ-Srek1em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Srftm2.1Nor/Srftm2.1Nor Tg(Myog-cre)1Eno/0
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:96122
|
Srgap3tm1.1Zi/Srgap3tm1.1Zi
(B6.129(SJL)-Srgap3tm1.1Zi)
|
decreased circulating testosterone level
|
J:192388
|
Sritm1.1Hhv/Sritm1.1Hhv
(involves: 129S1/SvImJ)
|
decreased circulating insulin level
|
J:246708
|
Sros1em1Caox/Sros1em1Caox
(involves: C57BL/6J)
|
abnormal circulating chemokine level
|
J:306407
|
increased circulating CXCL10 level
|
J:306407
|
Srp9tm1.1(KOMP)Vlcg/Srp9+
(C57BL/6N-Srp9tm1.1(KOMP)Vlcg/J)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Srprbtm2b(EUCOMM)Hmgu/Srprb+
(C57BL/6N-Srprbtm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating creatinine level
|
J:211773
|
Srpx2em1(IMPC)Hmgu/Srpx2em1(IMPC)Hmgu
(C57BL/6NCrl-Srpx2em1(IMPC)Hmgu/Ieg)
|
decreased circulating phosphate level
|
J:211773
|
Srrm4tm1b(EUCOMM)Wtsi/Srrm4tm1b(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cyanosis
|
J:221584
|
Srsf3tm1Pjln/Srsf3tm1Pjln Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:205756
|
decreased circulating HDL cholesterol level
|
J:205756
|
decreased circulating insulin-like growth factor I level
|
J:205756
|
decreased circulating serum albumin level
|
J:205756
|
decreased circulating triglyceride level
|
J:205756
|
hypoglycemia
|
J:205756
|
increased circulating alanine transaminase level
|
J:205756
|
increased circulating alkaline phosphatase level
|
J:205756
|
increased circulating aspartate transaminase level
|
J:205756
|
increased circulating bilirubin level
|
J:205756
|
increased circulating growth hormone level
|
J:205756
|
Srsf4tm1a(EUCOMM)Wtsi/Srsf4+
(C57BL/6N-Srsf4tm1a(EUCOMM)Wtsi/Ics)
|
increased circulating creatinine level
|
J:165965
|
Srxn1tm1Mtol/Srxn1tm1Mtol
(either: B6.129S2-Srxn1tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6))
|
increased circulating alanine transaminase level
|
J:199277
|
increased circulating aspartate transaminase level
|
J:199277
|
Srxn1tm1Sgrh/Srxn1tm1Sgrh Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J)
|
abnormal circulating corticosterone level
|
J:222986
|
increased circulating adrenocorticotropin level
|
J:222986
|
X/Sryem1Takas
(involves: C57BL/6 * DBA/2)
|
abnormal circulating testosterone level
|
J:207780
|
Ss18em1(IMPC)J/Ss18+
(C57BL/6NJ-Ss18em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Ssh2em1(IMPC)J/Ssh2em1(IMPC)J
(C57BL/6NJ-Ssh2em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Ssttm1b(KOMP)Wtsi/Ssttm1b(KOMP)Wtsi
(C57BL/6N-Ssttm1b(KOMP)Wtsi/Rbrc)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Ssttm1Low/Ssttm1Low
(B6.129P2-Ssttm1Low)
|
abnormal circulating pituitary hormone level
|
J:70016
|
increased circulating gastrin level
|
J:126384
|
Ssttm1Ute/Ssttm1Ute
(129-Ssttm1Ute/J)
|
increased circulating corticosterone level
|
J:70426
|
increased circulating growth hormone level
|
J:70426
|
Ssttm1Ute/Ssttm1Ute
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating prolactin level
|
J:179095
|
increased circulating ghrelin level
|
J:179095
|
increased circulating insulin level
|
J:179095
|
Sstr1tm1Dgen/Sstr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
Sstr2tm1Rgs/Sstr2tm1Rgs
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:89420
|
Sstr5tm1Fcb/Sstr5tm2Fcb Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:99786
|
increased circulating insulin level
|
J:99786
|
Sstr5tm1Hawi/Sstr5tm1Hawi
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating glucose level
|
J:101259
|
decreased circulating insulin level
|
J:101259
|
increased circulating glucagon level
|
J:101259
|
increased circulating leptin level
|
J:101259
|
Ssu72tm1Cwl/Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating alanine transaminase level
|
J:309624
|
increased circulating aspartate transaminase level
|
J:309624
|
St3gal2tm1Jxm/St3gal2tm1Jxm
(Not Specified)
|
increased bleeding time
|
J:217719
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm)
|
abnormal platelet physiology
|
J:136946
|
increased bleeding time
|
J:136946
|
St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S/SvEv * C57BL/6)
|
hypoglycemia
|
J:82723
|
St6galnac2tm1.1Cfg/St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating creatinine level
|
J:217719
|
increased circulating alanine transaminase level
|
J:217719
|
St18tm1a(KOMP)Wtsi/St18tm1a(KOMP)Wtsi
(C57BL/6N-St18tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
Stab1tm1.1Cger/Stab1tm1.1Cger Stab2tm1.1Cger/Stab2tm1.1Cger
(B6.129S2-Stab2tm1.1Cger Stab1tm1.1Cger)
|
increased circulating glutamate dehydrogenase level
|
J:171818
|
Stab2tm1Ami/Stab2tm1Ami
(B6.Cg-Stab2tm1Ami)
|
increased circulating hyaluronic acid level
|
J:182239
|
Stag1em1(IMPC)Mbp/Stag1+
(C57BL/6N-Stag1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Stag3tm1e.1(KOMP)Wtsi/Stag3tm1e.1(KOMP)Wtsi
(C57BL/6N-Stag3tm1e.1(KOMP)Wtsi/J)
|
increased circulating total protein level
|
J:211773
|
Startm1Klp/Startm1Klp
(involves: 129P2/OlaHsd)
|
cyanosis
|
J:43589
|
decreased circulating aldosterone level
|
J:43589
|
decreased circulating corticosterone level
|
J:43589
|
increased circulating corticotropin-releasing hormone level
|
J:43589
|
Stard4tm1.2Bres/Stard4tm1.2Bres
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:160807
|
decreased circulating LDL cholesterol level
|
J:160807
|
Stard7tm1b(EUCOMM)Wtsi/Stard7+
(C57BL/6N-Stard7tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Stard9em1(IMPC)J/Stard9em1(IMPC)J
(C57BL/6NJ-Stard9em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Stard10tm1Saaa/Stard10tm1Saaa
(B6.Cg-Stard10tm1Saaa)
|
decreased circulating cholesterol level
|
J:198860
|
decreased circulating free fatty acids level
|
J:198860
|
decreased circulating triglyceride level
|
J:198860
|
Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv)
|
increased circulating interferon-gamma level
|
J:130622
|
Stat1tm1Dlv/Stat1tm1Dlv
(B6.129S-Stat1tm1Dlv)
|
increased circulating interferon-gamma level
|
J:79552
|
increased circulating interleukin-12b level
|
J:79552
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
decreased circulating interferon-gamma level
|
J:122801
|
Stat1tm2b(EUCOMM)Wtsi/Stat1tm2b(EUCOMM)Wtsi
(C57BL/6N-Stat1tm2b(EUCOMM)Wtsi/Orl)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Stat3tm1Dnl/Stat3tm1Dlv
(involves: C57BL/6)
|
abnormal circulating insulin-like growth factor I level
|
J:87599
|
Stat3tm1Flv/Stat3tm1Flv Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
hyperglycemia
|
J:89242
|
increased circulating corticosterone level
|
J:89242
|
increased circulating insulin level
|
J:89242
|
increased circulating leptin level
|
J:89242
|
increased circulating triglyceride level
|
J:89242
|
Stat3tm1Flv/Stat3tm1Flv Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
increased circulating interferon-gamma level
|
J:81973
|
increased circulating tumor necrosis factor level
|
J:81973
|
Stat3tm1Vpo/Stat3tm1Vpo Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal atrial thrombosis
|
J:141591
|
Stat3tm2Aki/Stat3tm2Aki
(involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating glucose level
|
J:131301
|
increased circulating insulin level
|
J:131301
|
Stat4ity14/Stat4ity14
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating interferon-gamma level
|
J:207092
|
increased circulating interleukin-12 level
|
J:207092
|
Stat4tm1Gru/Stat4+
(NOD.129S2-Stat4tm1Gru)
|
abnormal circulating glucose level
|
J:90600
|
Stat4tm1Gru/Stat4tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
decreased circulating interferon-gamma level
|
J:163843
|
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru)
|
decreased circulating interferon-gamma level
|
J:90600
|
decreased circulating interleukin-2 level
|
J:90600
|
Stat4tm1Gru/Stat4tm1Gru
(C.129S2-Stat4tm1Gru)
|
decreased circulating interferon-gamma level
|
J:90600
|
decreased circulating interleukin-2 level
|
J:90600
|
Stat4tm1Jni/Stat4tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:79552
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
decreased circulating insulin-like growth factor I level
|
J:119237
|
increased circulating triglyceride level
|
J:119237
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
increased circulating interleukin-17 level
|
J:120176
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:127051
|
increased circulating glucose level
|
J:127051
|
increased circulating leptin level
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating free fatty acids level
|
J:132806
|
increased circulating insulin level
|
J:132806
|
increased circulating leptin level
|
J:132806
|
increased circulating triglyceride level
|
J:132806
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating iron level
|
J:138904
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: 129 * BALB/c)
|
decreased circulating insulin-like growth factor I level
|
J:41784
|
increased circulating growth hormone level
|
J:41784
|
Stat5btm1Mam/Stat5btm1Mam Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
increased circulating interleukin-17 level
|
J:120176
|
Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:127051
|
increased circulating glucose level
|
J:127051
|
increased circulating leptin level
|
J:127051
|
Stat5btm1Mam/Stat5btm1Mam Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating free fatty acids level
|
J:132806
|
increased circulating insulin level
|
J:132806
|
increased circulating leptin level
|
J:132806
|
increased circulating triglyceride level
|
J:132806
|
Stat5btm1Mam/Stat5btm1Mam Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating iron level
|
J:138904
|
Stat6tm1Aki/Stat6tm1Aki Tg(KRT14-CASP1)1Miz/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating histamine level
|
J:78602
|
increased circulating interleukin-18 level
|
J:78602
|
Stat6tm1Gru/Stat6tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
abnormal circulating alanine transaminase level
|
J:85386
|
increased circulating tumor necrosis factor level
|
J:85386
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru)
|
abnormal circulating interleukin level
|
J:66222
|
abnormal circulating interleukin-4 level
|
J:66222
|
abnormal circulating interleukin-5 level
|
J:66222
|
Stc2tm1Rred/Stc2tm1Rred
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating alkaline phosphatase level
|
J:136007
|
Steap3fred/Steap3fred
(C57BL/6-Steap3fred)
|
decreased circulating copper level
|
J:145194
|
Steap3tm1.1Atel/Steap3tm1.1Atel
(involves: C57BL/6)
|
abnormal blood osmolality
|
J:154356
|
increased circulating glucose level
|
J:154356
|
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:187736
|
decreased circulating insulin level
|
J:187736
|
increased circulating glucose level
|
J:187736
|
increased circulating leptin level
|
J:187736
|
increased circulating triglyceride level
|
J:187736
|
Stim1Gt(RRS558)Byg/Stim1Gt(RRS558)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet activation
|
J:137364
|
abnormal thrombosis
|
J:137364
|
cyanosis
|
J:137364
|
decreased platelet aggregation
|
J:137364
|
Stim1Sax/Stim1+
(involves: C3HeB/FeJ * C57BL/6)
|
abnormal platelet activation
|
J:127381
|
abnormal thrombosis
|
J:127381
|
increased bleeding time
|
J:127381
|
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6)
|
abnormal circulating creatine kinase level
|
J:285187
|
increased bleeding time
|
J:285187
|
Stim1tm3Ics/Stim1+
(involves: C57BL/6N)
|
decreased circulating calcium level
|
J:277842
|
decreased circulating glucose level
|
J:277842
|
increased bleeding time
|
J:277842
|
increased circulating alanine transaminase level
|
J:277842
|
increased circulating aspartate transaminase level
|
J:277842
|
increased circulating creatine kinase level
|
J:277842
|
increased circulating insulin level
|
J:277842
|
increased circulating phosphate level
|
J:277842
|
Stimatetm2b(KOMP)Wtsi/Stimatetm2b(KOMP)Wtsi
(C57BL/6N-Stimatetm2b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Sting1em1Jmin/Sting1+
(involves: C57BL/6N)
|
abnormal lung thrombosis
|
J:251372
|
increased circulating interleukin-10 level
|
J:251372
|
increased circulating interleukin-13 level
|
J:251372
|
increased circulating tumor necrosis factor level
|
J:251372
|
Sting1gt/Sting1gt
(C57BL/6-Sting1gt)
|
decreased circulating interferon-alpha level
|
J:201167
|
decreased circulating interferon-beta level
|
J:201167,
J:168746
|
Sting1tm1Camb/Sting1tm1Camb
(involves: C57BL/6N)
|
decreased circulating interferon-beta level
|
J:179270
|
decreased circulating interleukin-6 level
|
J:179270
|
Stk3em1(IMPC)H/Stk3em1(IMPC)H
(C57BL/6NTac-Stk3em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Stk3tm1.1Yy/Stk3+ Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA)
|
decreased circulating alanine transaminase level
|
J:156541
|
decreased circulating aspartate transaminase level
|
J:156541
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA)
|
decreased circulating alanine transaminase level
|
J:156541
|
decreased circulating aspartate transaminase level
|
J:156541
|
Stk3tm1.1Yy/Stk3tm1Yy Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA)
|
increased circulating alanine transaminase level
|
J:156541
|
increased circulating aspartate transaminase level
|
J:156541
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S6/SvEvTac)
|
abnormal circulating glucose level
|
J:174020
|
increased circulating glucose level
|
J:174020
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)
|
increased circulating glucose level
|
J:134078
|
Stk11tm1Keis/Stk11tm1Keis Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased circulating interleukin-10 level
|
J:191723
|
Stk24Gt(AM0826)Wtsi/Stk24Gt(AM0826)Wtsi
(B6.129P2-Stk24Gt(AM0826)Wtsi)
|
increased circulating creatinine level
|
J:256076
|
Stk26tm1b(EUCOMM)Hmgu/Stk26tm1b(EUCOMM)Hmgu
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased circulating creatinine level
|
J:211773
|
Stk32ctm2b(KOMP)Wtsi/Stk32ctm2b(KOMP)Wtsi
(C57BL/6N-Stk32ctm2b(KOMP)Wtsi/J)
|
decreased blood urea nitrogen level
|
J:211773
|
Stk33em1(IMPC)J/Stk33em1(IMPC)J
(C57BL/6NJ-Stk33em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Stk35em1(IMPC)J/Stk35em1(IMPC)J
(C57BL/6N-Stk35em1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Stk38tm1b(KOMP)Wtsi/Stk38+
(C57BL/6N-Stk38tm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Stk38tm1Xen/Stk38tm1Xen
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating interleukin-6 level
|
J:224932
|
increased circulating tumor necrosis factor level
|
J:224932
|
Stk39tm1.1Arte/Stk39tm1.1Arte
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased circulating magnesium level
|
J:191566
|
hypokalemia
|
J:191566
|
Stk39tm1.2Slin/Stk39tm1.2Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood homeostasis
|
J:165706
|
decreased circulating magnesium level
|
J:165706
|
decreased circulating potassium level
|
J:165706
|
increased circulating aldosterone level
|
J:165706
|
Stk39tm1Pawe/Stk39tm1Pawe
(involves: 129S6/SvEvTac * C57BL/6J)
|
hypokalemia
|
J:287773
|
increased blood urea nitrogen level
|
J:287773
|
Stk39tm1Pawe/Stk39tm1Pawe Pvalbtm1(cre)Arbr/Pvalb+
(B6.129-Stk39tm1Pawe Pvalbtm1(cre)Arbr)
|
decreased blood urea nitrogen level
|
J:287773
|
hyperkalemia
|
J:287773
|
Stk39tm2.1Arte/Stk39tm2.1Arte
(involves: C57BL/6J)
|
decreased circulating magnesium level
|
J:224087
|
decreased circulating potassium level
|
J:224087
|
Stk40tm1Nju/Stk40tm1Nju
(B6.129-Stk40tm1Nju)
|
cyanosis
|
J:196001
|
Stoml2tm1(KOMP)Vlcg/Stoml2tm1(KOMP)Vlcg
(C57BL/6N-Stoml2tm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Stox2tm2b(EUCOMM)Hmgu/Stox2+
(C57BL/6N-Stox2tm2b(EUCOMM)Hmgu/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Strbpem1(IMPC)Hmgu/Strbpem1(IMPC)Hmgu
(C57BL/6N-Strbpem1(IMPC)Hmgu/Ieg)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Strn3tm1b(KOMP)Wtsi/Strn3+
(B6N(Cg)-Strn3tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Strntm1a(KOMP)Wtsi/Strn+
(C57BL/6N-Strntm1a(KOMP)Wtsi)
|
increased circulating aldosterone level
|
J:232621
|
Stt3bem1(IMPC)J/Stt3b+
(C57BL/6NJ-Stt3bem1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Stx2tm1b(EUCOMM)Wtsi/Stx2tm1b(EUCOMM)Wtsi
(C57BL/6N-Stx2tm1b(EUCOMM)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Stx4atm1Jpes/Stx4a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating insulin level
|
J:69598
|
Stx6em1(IMPC)H/Stx6em1(IMPC)H
(C57BL/6NTac-Stx6em1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Stx7em1(IMPC)Rbrc/Stx7em1(IMPC)Rbrc
(C57BL/6NJcl-Stx7em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating phosphate level
|
J:211773
|
Stx8tm2a(EUCOMM)Wtsi/Stx8tm2a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal platelet dense granule physiology
|
J:218388
|
abnormal platelet physiology
|
J:218388
|
abnormal thrombosis
|
J:218388
|
decreased platelet aggregation
|
J:218388
|
Stx11em1(IMPC)Mbp/Stx11em1(IMPC)Mbp
(C57BL/6N-Stx11em1(IMPC)Mbp/MbpMmucd)
|
increased blood urea nitrogen level
|
J:211773
|
Stx11tm1.2Ics/Stx11tm1.2Ics
(involves: C57BL/6NTac)
|
increased circulating aspartate transaminase level
|
J:193137
|
increased circulating interferon-gamma level
|
J:193137
|
increased circulating interleukin-1 beta level
|
J:193137
|
increased circulating interleukin-6 level
|
J:193137
|
increased circulating lactate dehydrogenase level
|
J:193137
|
increased circulating tumor necrosis factor level
|
J:193137
|
Stx16tm1b(KOMP)Wtsi/Stx16tm1b(KOMP)Wtsi
(C57BL/6N-Stx16tm1b(KOMP)Wtsi/J)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Stx18tm2b(KOMP)Wtsi/Stx18+
(C57BL/6N-Stx18tm2b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
Stx19tm1.1(KOMP)Vlcg/Stx19tm1.1(KOMP)Vlcg
(C57BL/6N-Stx19tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Stxbp3tm1Jpes/Stxbp3+
(B6.129-Stxbp3tm1Jpes)
|
hyperglycemia
|
J:96731
|
Stxbp4tm1a(EUCOMM)Wtsi/Stxbp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Stxbp4tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
Stxbp5ltm1.1(KOMP)Vlcg/Stxbp5ltm1.1(KOMP)Vlcg
(C57BL/6N-Stxbp5ltm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Stxbp5ltm1.1Aljg/Stxbp5ltm1.1Aljg
(involves: C57BL/6J)
|
increased partial thromboplastin time
|
J:263474
|
Stzid3NSY/Stzid3NSY
(C3H/He-Chr 11NSY)
|
hyperglycemia
|
J:95507
|
Sucla2Gt(IST10208H1)Tigm/Sucla2+
(involves: 129S/SvEv * C57BL/6N)
|
increased circulating carnitine level
|
J:241325
|
Sucla2Gt(IST10208H1)Tigm/Sucla2+ Suclg2Gt(Ayu21-KBW131)Imeg/Suclg2+
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
increased circulating carnitine level
|
J:241325
|
Sucnr1tm1Lex/Sucnr1tm1Lex
(involves: 129S/SvEvBrd)
|
decreased circulating renin level
|
J:137706
|
SucoGt(KST050)Byg/SucoGt(KST050)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased circulating insulin-like growth factor I level
|
J:159823
|
decreased circulating osteocalcin level
|
J:159823
|
hypoglycemia
|
J:159823
|
increased circulating alkaline phosphatase level
|
J:159823
|
Sult1a1tm1Glatt/Sult1a1tm1Glatt
(FVB.Cg-Sult1a1tm1Glatt)
|
abnormal blood homeostasis
|
J:217578
|
Sult1c1tm1b(KOMP)Wtsi/Sult1c1tm1b(KOMP)Wtsi
(C57BL/6N-Sult1c1tm1b(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
Sult1d1tm1Glatt/Sult1d1tm1Glatt
(FVB.Cg-Sult1d1tm1Glatt)
|
abnormal blood homeostasis
|
J:217578
|
Sult1e1tm1Song/Sult1e1tm1Song
(B6.129S6-Sult1e1tm1Song)
|
abnormal placental thrombosis
|
J:96050
|
abnormal platelet physiology
|
J:96050
|
increased circulating estradiol level
|
J:96050
|
Sun1tm1b(EUCOMM)Wtsi/Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Sun1tm1Mhan/Sun1tm1Mhan Sun2tm1Mhan/Sun2tm1Mhan
(involves: 129S6/SvEvTac)
|
cyanosis
|
J:150047
|
Sun3em1(IMPC)J/Sun3em1(IMPC)J
(C57BL/6NJ-Sun3em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Sun5em1(IMPC)Mbp/Sun5em1(IMPC)Mbp
(C57BL/6N-Sun5em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating calcium level
|
J:211773
|
Supt7ltm1a(EUCOMM)Wtsi/Supt7l+
(C57BL/6N-Supt7ltm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:175295
|
Surf4em1(IMPC)J/Surf4+
(C57BL/6NJ-Surf4em1(IMPC)J/Mmjax)
|
decreased circulating phosphate level
|
J:211773
|
Surf4em1Bcgen/Surf4+
(C57BL/6J-Surf4em1Bcgen)
|
decreased circulating cholesterol level
|
J:302969
|
decreased circulating triglyceride level
|
J:302969
|
Surf4em1Bcgen/Surf4em1Bcgen
(C57BL/6J-Surf4em1Bcgen)
|
decreased circulating cholesterol level
|
J:302969
|
decreased circulating triglyceride level
|
J:302969
|
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating iron level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Svep1tm1b(EUCOMM)Hmgu/Svep1+
(C57BL/6N-Svep1tm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
decreased circulating sodium level
|
J:211773
|
SvilGt(RRF043)Byg/SvilGt(RRF043)Byg
(B6.129P2-SvilGt(RRF043)Byg)
|
abnormal platelet physiology
|
J:198612
|
increased platelet aggregation
|
J:198612
|
Syce1tm1b(KOMP)Wtsi/Syce1tm1b(KOMP)Wtsi
(C57BL/6N-Syce1tm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Syce1ltm1.1(KOMP)Vlcg/Syce1ltm1.1(KOMP)Vlcg
(C57BL/6N-Syce1ltm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Syktm1.1Nns/Syktm1.1Nns Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
abnormal platelet physiology
|
J:181715
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
decreased blood urea nitrogen level
|
J:188422
|
decreased circulating creatinine level
|
J:188422
|
increased circulating glucose level
|
J:188422
|
Syn3tm1.1(KOMP)Vlcg/Syn3tm1.1(KOMP)Vlcg
(C57BL/6N-Syn3tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Synctm1.1Ked/Synctm1.1Ked
(involves: 129/Sv * C57BL/6)
|
increased circulating creatine kinase level
|
J:138552
|
Syncriptm1b(EUCOMM)Hmgu/Syncrip+
(C57BL/6N-Syncriptm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Syne1tm1.1Mcn/Syne1tm1.1Mcn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)
|
cyanosis
|
J:144757
|
Syne3tm1b(KOMP)Wtsi/Syne3tm1b(KOMP)Wtsi
(C57BL/6N-Syne3tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating glucose level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Syngr2em1(IMPC)J/Syngr2em1(IMPC)J
(C57BL/6NJ-Syngr2em1(IMPC)J/Mmjax)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Synrgtm1b(EUCOMM)Wtsi/Synrg+
(C57BL/6N-Synrgtm1b(EUCOMM)Wtsi/Bay)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Syt4em2(IMPC)H/Syt4em2(IMPC)H
(C57BL/6N-Syt4em2(IMPC)H/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Syt7em2(IMPC)H/Syt7em2(IMPC)H
(C57BL/6N-Syt7em2(IMPC)H/H)
|
decreased circulating phosphate level
|
J:211773
|
Syt17tm1b(KOMP)Wtsi/Syt17tm1b(KOMP)Wtsi
(C57BL/6N-Syt17tm1b(KOMP)Wtsi/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating amylase level
|
J:213427
|
Sytl3em1(IMPC)Wtsi/Sytl3em1(IMPC)Wtsi
(C57BL/6N-Sytl3em1(IMPC)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:211773
|
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He)
|
decreased circulating glucose level
|
J:102610
|
T2dm1saSM/JNshm/?
(involves: A/J * SM/J)
|
hyperglycemia
|
J:80998
|
T2dm2C57BL/6J/T2dm2C57BL/6J
(BTBR.B6-T2dm2C57BL/6J)
|
decreased circulating insulin level
|
J:109581
|
T2dm2saA/JNshm/T2dm2saA/JNshm
(involves: SM/J * SMXA5)
|
increased circulating glucose level
|
J:107889
|
increased circulating insulin level
|
J:107889
|
T2dm2saA/JNshm/T2dm2saA/JNshm
(involves: SM.A-(D2Mit295-D2Mit281))
|
increased circulating glucose level
|
J:107889
|
increased circulating insulin level
|
J:107889
|
Tab2tm2.1Aki/Tab2tm2.1Aki Tab3tm1Aki/Tab3tm1Aki Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:195289
|
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng)
|
increased circulating glucose level
|
J:100831
|
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng
(B6.TLHO-Tabw2TALLYHO/Jng)
|
increased circulating leptin level
|
J:100831
|
Tabw2TALLYHO/Jng/Tabw2TALLYHO/Jng Tanidd1TALLYHO/Jng/Tanidd1TALLYHO/Jng
(involves: C57BL/6J * TALLYHO/Jng)
|
increased circulating glucose level
|
J:100831
|
Tac2tm1Tigm/Tac2tm1Tigm
(involves: 129 * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:223528
|
Taco1em1(IMPC)J/Taco1em1(IMPC)J
(C57BL/6NJ-Taco1em1(IMPC)J/Mmjax)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn)
|
decreased circulating corticosterone level
|
J:77640
|
Tacr2tm1(KOMP)Wtsi/Tacr2tm1(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased circulating luteinizing hormone level
|
J:302970
|
increased circulating glucose level
|
J:302970
|
Tacr3tm1Jasi/Tacr3tm1Jasi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:182547
|
Taf2tm1b(EUCOMM)Hmgu/Taf2+
(C57BL/6N-Taf2tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Taf4btm1Rtj/Taf4btm1Rtj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:156655
|
Taf4btm1Rtj/Taf4btm1Rtj
(B6.129-Taf4btm1Rtj)
|
increased circulating follicle stimulating hormone level
|
J:97245
|
Taf6tm1b(EUCOMM)Hmgu/Taf6+
(C57BL/6N-Taf6tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Taf15em1(IMPC)Mbp/Taf15em1(IMPC)Mbp
(C57BL/6NCrl-Taf15em1(IMPC)Mbp/MbpMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Tafa2em1(IMPC)H/Tafa2em1(IMPC)H
(C57BL/6NTac-Tafa2em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
Tafa4em1(IMPC)Mbp/Tafa4em1(IMPC)Mbp
(C57BL/6N-Tafa4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tagap1em1(IMPC)Tcp/Tagap1em1(IMPC)Tcp
(C57BL/6N-Tagap1em1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Tamm41tm1(NCOM)Cmhd/Tamm41tm1(NCOM)Cmhd
(C57BL/6N-Tamm41tm1(NCOM)Cmhd/Tcp)
|
increased circulating iron level
|
J:165965
|
Tanc1em1(IMPC)Tcp/Tanc1em1(IMPC)Tcp
(C57BL/6NCrl-Tanc1em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Tanc2em1(IMPC)Hmgu/Tanc2em1(IMPC)Hmgu
(C57BL/6NCrl-Tanc2em1(IMPC)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Tanidd1TALLYHO/Jng/Tanidd1TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))
|
hyperglycemia
|
J:70227
|
Tanidd2TALLYHO/Jng/Tanidd2TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))
|
hyperglycemia
|
J:70227
|
Tanidd3TALLYHO/Jng/Tanidd3TALLYHO/Jng
(either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))
|
hyperglycemia
|
J:70227
|
Taok2tm1.2Dkap/Taok2tm1.2Dkap
(B6(Cg)-Taok2tm1.2Dkap)
|
abnormal blood homeostasis
|
J:206781
|
Taok2tm1b(EUCOMM)Hmgu/Taok2+
(C57BL/6N-Taok2tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tarbp1tm1b(EUCOMM)Hmgu/Tarbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tarbp1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Tardbptm1b(EUCOMM)Wtsi/Tardbp+
(C57BL/6N-Tardbptm1b(EUCOMM)Wtsi/H)
|
decreased blood urea nitrogen level
|
J:211773
|
Tars3em1(IMPC)J/Tars3em1(IMPC)J
(C57BL/6NJ-Tars3em1(IMPC)J/Mmjax)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Tars3em1Smoc/Tars3em1Smoc
(C57BL/6-Tars3em1Smoc)
|
decreased circulating cholesterol level
|
J:341137
|
decreased circulating glucose level
|
J:341137
|
decreased circulating HDL cholesterol level
|
J:341137
|
decreased circulating LDL cholesterol level
|
J:341137
|
decreased circulating triglyceride level
|
J:341137
|
decreased fasting circulating glucose level
|
J:341137
|
Tatdn3tm1a(EUCOMM)Wtsi/Tatdn3tm1a(EUCOMM)Wtsi
(C57BL/6N-Tatdn3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
Tax1bp3tm1b(EUCOMM)Hmgu/Tax1bp3+
(C57BL/6N-Tax1bp3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating bilirubin level
|
J:211773
|
Tbc1d1Nobq1-NZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom)
|
increased circulating insulin level
|
J:66744
|
Tbc1d1Nobq1-SJL/NBom/Tbc1d1Nobq1-SJL/NBom
(B6.SJL-(D5Mit302-D5Mit307))
|
decreased circulating glucose level
|
J:143559
|
Tbc1d2tm1(NCOM)Cmhd/Tbc1d2tm1(NCOM)Cmhd
(C57BL/6N-Tbc1d2tm1(NCOM)Cmhd/Tcp)
|
increased circulating phosphate level
|
J:165965
|
Tbc1d2btm1a(EUCOMM)Hmgu/Tbc1d2btm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA)
|
decreased circulating glucose level
|
J:194026
|
decreased circulating insulin level
|
J:194026
|
increased circulating free fatty acids level
|
J:194026
|
Tbc1d4tm1b(EUCOMM)Hmgu/Tbc1d4tm1b(EUCOMM)Hmgu
(C57BL/6N-Tbc1d4tm1b(EUCOMM)Hmgu/J)
|
increased circulating sodium level
|
J:211773
|
Tbc1d4tm1Lex/Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased circulating glucose level
|
J:191749
|
decreased circulating insulin level
|
J:191749
|
Tbc1d5em1(IMPC)J/Tbc1d5em1(IMPC)J
(C57BL/6NJ-Tbc1d5em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Tbc1d9bem1(IMPC)J/Tbc1d9bem1(IMPC)J
(C57BL/6NJ-Tbc1d9bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Tbc1d10atm2a(EUCOMM)Wtsi/Tbc1d10atm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating alanine transaminase level
|
J:213427
|
decreased circulating alkaline phosphatase level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Tbc1d12em1(IMPC)J/Tbc1d12em1(IMPC)J
(C57BL/6NJ-Tbc1d12em1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
Tbc1d16em1(IMPC)J/Tbc1d16em1(IMPC)J
(C57BL/6NJ-Tbc1d16em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tbc1d22atm1b(KOMP)Wtsi/Tbc1d22atm1b(KOMP)Wtsi
(C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Tbc1d23Gt(BA0556)Wtsi/Tbc1d23Gt(BA0556)Wtsi
(B6.129P2-Tbc1d23Gt(BA0556)Wtsi)
|
increased circulating interleukin-6 level
|
J:181861
|
increased circulating tumor necrosis factor level
|
J:181861
|
Tbc1d30em1(IMPC)J/Tbc1d30em1(IMPC)J
(C57BL/6NJ-Tbc1d30em1(IMPC)J/J)
|
increased circulating calcium level
|
J:211773
|
Tbc1d31em1(IMPC)J/Tbc1d31em1(IMPC)J
(C57BL/6NJ-Tbc1d31em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
increased circulating interleukin-1 beta level
|
J:166476
|
increased circulating interleukin-6 level
|
J:166476
|
increased circulating interleukin-10 level
|
J:166476
|
increased circulating tumor necrosis factor level
|
J:166476
|
Tbk1tm1Arte/Tbk1tm1Arte Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
increased blood urea nitrogen level
|
J:188560
|
increased circulating creatinine level
|
J:188560
|
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased circulating leptin level
|
J:198124
|
Tbl1xr1tm1b(EUCOMM)Hmgu/Tbl1xr1+
(C57BL/6N-Tbl1xr1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Tbptm1.1Ees/Tbptm1.1Ees
(B6.129X1(Cg)-Tbptm1.1Ees)
|
abnormal blood coagulation
|
J:77714
|
Tbr1tm1.1(KOMP)Mbp/Tbr1+
(C57BL/6N-Tbr1tm1.1(KOMP)Mbp/Ucd)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Tbx3em1(IMPC)Mbp/Tbx3+
(C57BL/6NCrl-Tbx3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c))
|
decreased circulating adrenocorticotropin level
|
J:82562
|
decreased circulating corticosterone level
|
J:82562
|
hypoglycemia
|
J:82562
|
increased circulating glucose level
|
J:82562
|
Tbx22tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Tbx22tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * 129S/SvEv))
|
abnormal platelet aggregation
|
J:52125
|
increased bleeding time
|
J:52125
|
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(C.129P2(B6)-Tbxa2rtm1Cof)
|
abnormal platelet physiology
|
J:79049
|
Tbxas1tm1Swl/Tbxas1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased platelet aggregation
|
J:90922
|
increased bleeding time
|
J:90922
|
Tbxas1tm1Swl/Tbxas1tm1Swl
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased platelet aggregation
|
J:90922
|
increased bleeding time
|
J:90922
|
Tcaimtm1b(EUCOMM)Wtsi/Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Tcea2em1(IMPC)J/Tcea2em1(IMPC)J
(C57BL/6NJ-Tcea2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Tcerg1ltm1a(KOMP)Wtsi/Tcerg1ltm1a(KOMP)Wtsi
(C57BL/6N-Tcerg1ltm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Tcf3tm1(TCF3/HLF)Homy/Tcf3+ Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal thrombosis
|
J:160392
|
Tcf7tm1a(EUCOMM)Wtsi/Tcf7tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7tm1a(EUCOMM)Wtsi/Ics)
|
increased circulating alkaline phosphatase level
|
J:165965
|
Tcf7l2em1Nobr/Tcf7l2+
(involves: CD-1)
|
decreased circulating glucose level
|
J:175874
|
decreased circulating insulin level
|
J:175874
|
hypoglycemia
|
J:175874
|
Tcf7l2em1Nobr/Tcf7l2em1Nobr
(involves: CD-1)
|
hypoglycemia
|
J:175874
|
Tcf7l2em2Nobr/Tcf7l2+
(involves: CD-1)
|
decreased circulating glucose level
|
J:175874
|
decreased circulating insulin level
|
J:175874
|
hypoglycemia
|
J:175874
|
Tcf7l2em2Nobr/Tcf7l2em2Nobr
(involves: CD-1)
|
hypoglycemia
|
J:175874
|
Tcf7l2em3Nobr/Tcf7l2em3Nobr
(involves: CD-1)
|
hypoglycemia
|
J:175874
|
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
(C57BL/6-Tcf7l2tm1a(EUCOMM)Wtsi)
|
increased circulating glucose level
|
J:190447
|
Tcf7l2tm1Geno/Tcf7l2tm1Geno Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
increased circulating insulin level
|
J:189204
|
Tcf20em1(IMPC)Wtsi/Tcf20em1(IMPC)Wtsi
(C57BL/6N-Tcf20em1(IMPC)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Tcf21em1(IMPC)Mbp/Tcf21+
(C57BL/6NCrl-Tcf21em1(IMPC)Mbp/MbpMmucd)
|
increased circulating calcium level
|
J:211773
|
Tcf21tm1Eno/Tcf21tm1Eno
(involves: 129 * Black Swiss)
|
cyanosis
|
J:64068
|
Tcf21tm2Eno/Tcf21tm2Eno
(involves: 129 * Black Swiss)
|
cyanosis
|
J:64068
|
Tchol1BALB/c/Tchol1KK/Ta
(involves: BALB/c * KK/Ta)
|
increased circulating cholesterol level
|
J:88209
|
Tchol1KK/Ta/Tchol1KK/Ta
(involves: BALB/c * KK/Ta)
|
increased circulating cholesterol level
|
J:88209
|
Tchptm1a(EUCOMM)Wtsi/Tchptm1a(EUCOMM)Wtsi
(C57BL/6N-Tchptm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Tchptm1Inag/Tchptm1Inag
(B6.129P2-Tchptm1Inag)
|
decreased circulating cholesterol level
|
J:304307
|
decreased circulating triglyceride level
|
J:304307
|
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J)
|
decreased circulating insulin level
|
J:116082
|
Tcirg1tm1Ypl/Tcirg1tm1Ypl
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating calcium level
|
J:224711
|
Tcnq1C3H/HeJJcl/Tcnq1C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating insulin level
|
J:130968
|
Tcnq1C3H/HeJJcl/Tcnq1NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating insulin level
|
J:130968
|
Tcnq2C3H/HeJJcl/Tcnq2C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating glucose level
|
J:130968
|
Tcnq2C3H/HeJJcl/Tcnq2NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating glucose level
|
J:130968
|
Tcnq4NOD/Tcnq4NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating glucose level
|
J:130968
|
Tcnq5C3H/HeJJcl/Tcnq5C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak
(involves: C3H/HeJJcl * NOD)
|
increased circulating insulin level
|
J:130968
|
Tcq1CAST/EiJ/Tcq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
|
decreased circulating cholesterol level
|
J:117545
|
Tcq2CAST/EiJ/Tcq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
|
decreased circulating cholesterol level
|
J:117545
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased circulating alanine transaminase level
|
J:135830
|
decreased circulating interleukin-5 level
|
J:121037
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating interferon-gamma level
|
J:155199
|
Tctn3em1(IMPC)J/Tctn3+
(C57BL/6NJ-Tctn3em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Tdmq1DBA/2/Tdmq1DBA/2
(involves: BKS.Cg M +/+ Leprdb * DBA/2)
|
increased circulating glucose level
|
J:97535
|
Tdo2tm1Tnak/Tdo2tm1Tnak
(B6.129-Tdo2tm1Tnak)
|
abnormal circulating amino acid level
|
J:177903
|
increased circulating methionine level
|
J:177903
|
increased circulating threonine level
|
J:177903
|
Tdp1Gt(XD105)Byg/Tdp1Gt(XD105)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating serum albumin level
|
J:127605
|
Tead3tm1a(EUCOMM)Wtsi/Tead3tm1a(EUCOMM)Wtsi
(C57BL/6N-Tead3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating magnesium level
|
J:211773
|
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased platelet aggregation
|
J:86448
|
Tecrem1(IMPC)Rbrc/Tecr+
(C57BL/6NJcl-Tecrem1(IMPC)Rbrc/Rbrc)
|
increased circulating LDL cholesterol level
|
J:211773
|
Tedc1em1(IMPC)Tcp/Tedc1+
(C57BL/6NCrl-Tedc1em1(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Teddm1aem1(IMPC)Tcp/Teddm1aem1(IMPC)Tcp
(C57BL/6N-Teddm1aem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Tektm1b(EUCOMM)Hmgu/Tek+
(C57BL/6N-Tektm1b(EUCOMM)Hmgu/BayMmucd)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Tenm1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Tenm1em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Tenm4em1(IMPC)Tcp/Tenm4em1(IMPC)Tcp
(C57BL/6NCrl-Tenm4em1(IMPC)Tcp/Tcp)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Tent4atm1b(EUCOMM)Hmgu/Tent4atm1b(EUCOMM)Hmgu
(C57BL/6N-Tent4atm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tent5aem1(IMPC)Ccpcz/Tent5aem1(IMPC)Ccpcz
(C57BL/6N-Tent5aem1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Tent5dem1Adki/Y
(involves: C57BL/6JTar * CBA/WTar)
|
decreased circulating testosterone level
|
J:360869
|
Terb1tm1b(KOMP)Mbp/Terb1+
(C57BL/6N-Terb1tm1b(KOMP)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Terctm1Rdp/Terctm1Rdp Wrntm1Lgu/Wrntm1Lgu
(involves: 129/Sv * BALB/c * C57BL/6 * SLJ)
|
hyperglycemia
|
J:91715
|
increased circulating insulin level
|
J:91715
|
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N)
|
increased circulating glucose level
|
J:199372
|
increased circulating insulin level
|
J:199372
|
Tesk1em1(IMPC)J/Tesk1em1(IMPC)J
(C57BL/6NJ-Tesk1em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
Tet1tm1.1Gxu/Tet1tm1.1Gxu
(involves: 129 * 129P2/OlaHsd * C57BL/6J)
|
increased circulating iron level
|
J:315675
|
Tex2em1(IMPC)J/Tex2em1(IMPC)J
(C57BL/6NJ-Tex2em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
Tex2tm1.1(KOMP)Vlcg/Tex2+
(C57BL/6N-Tex2tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Tex2tm1.1(KOMP)Vlcg/Tex2tm1.1(KOMP)Vlcg
(C57BL/6N-Tex2tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Tex101tm1b(KOMP)Wtsi/Tex101tm1b(KOMP)Wtsi
(C57BL/6N-Tex101tm1b(KOMP)Wtsi/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Tex261tm1b(EUCOMM)Wtsi/Tex261tm1b(EUCOMM)Wtsi
(C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal circulating insulin level
|
J:65522
|
Tfap2btm1Rbu/Tfap2btm1Rbu
(129P2.129-Tfap2btm1Rbu)
|
decreased circulating calcium level
|
J:83000
|
increased blood urea nitrogen level
|
J:83000
|
increased circulating creatinine level
|
J:83000
|
increased circulating parathyroid hormone level
|
J:83000
|
increased circulating phosphate level
|
J:83000
|
Tfap4tm1.1(KOMP)Vlcg/Tfap4tm1.1(KOMP)Vlcg
(C57BL/6N-Tfap4tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2m+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased circulating insulin level
|
J:256448
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2mtm1a(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased circulating insulin level
|
J:256448
|
hyperglycemia
|
J:256448
|
increased circulating glucose level
|
J:256448
|
Tfebtm1a(EUCOMM)Wtsi/Tfeb+
(C57BL/6N-Tfebtm1a(EUCOMM)Wtsi/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Tfectm1b(KOMP)Wtsi/Tfectm1b(KOMP)Wtsi
(C57BL/6N-Tfectm1b(KOMP)Wtsi/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
Tff1tm1a(EUCOMM)Wtsi/Tff1tm1a(EUCOMM)Wtsi
(C57BL/6N-Tff1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Tfpi2tm1Dgen/Tfpi2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating interleukin-6 level
|
J:301794
|
increased circulating interleukin-10 level
|
J:301794
|
Tfpitm1.1Rdsi/Tfpitm1.1Rdsi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S6/SvEvTac * BALB/cJ * C57BL/6)
|
abnormal circulating protein level
|
J:164530
|
Tfpitm1.1Rdsi/Tfpitm1.1Rdsi Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * BALB/cJ * C3H * C57BL/6)
|
abnormal circulating protein level
|
J:164530
|
increased susceptibility to induced thrombosis
|
J:164530
|
Tfpitm1.1Rdsi/Tfpitm1.1Rdsi Tg(Tek-cre)12Flv/0
(B6.Cg-Tfpitm1.1Rdsi Tg(Tek-cre)12Flv)
|
abnormal circulating protein level
|
J:164530
|
Tfpitm1Gjb/Tfpitm1Gjb
(involves: 129)
|
abnormal blood coagulation
|
J:51137
|
abnormal thrombosis
|
J:51137
|
Tfr2em1(IMPC)Rbrc/Tfr2em1(IMPC)Rbrc
(C57BL/6N-Tfr2em1(IMPC)Rbrc/Rbrc)
|
increased circulating iron level
|
J:211773
|
Tfr2m1Btlr/Tfr2m1Btlr
(C57BL/6J-Tfr2m1Btlr)
|
increased circulating ferritin level
|
J:148982
|
increased circulating iron level
|
J:148982
|
Tfr2tm1.1Nsub/Tfr2tm1.1Nsub
(involves: 129T2/SvEms * C57BL/6)
|
increased circulating iron level
|
J:114330
|
Tfr2tm1.1Nsub/Tfr2tm1.1Nsub
(involves: 129T2/SvEms)
|
increased circulating iron level
|
J:160785
|
Tfr2tm1Slu/Tfr2tm1Slu
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating iron level
|
J:78360
|
Tfrctm2Nca/Tfrctm2Nca
(involves: 129S4/SvJae * FVB/N)
|
decreased circulating iron level
|
J:133221
|
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:78963
|
decreased circulating HDL cholesterol level
|
J:78963
|
decreased circulating phytosterol level
|
J:78963,
J:100491
|
Tg(ACTA1-Il15*)11650Lsq/0
(involves: C3H * C57BL/6)
|
decreased circulating leptin level
|
J:145611
|
increased circulating interleukin-15 level
|
J:145611
|
Tg(Actb-Ptma)T12Clwu/Tg(Actb-Ptma)T12Clwu
(involves: FVB/N)
|
increased blood urea nitrogen level
|
J:128557
|
Tg(ACTB-SLC2A1)224Cwh/0
(B6.Cg-Tg(ACTB-SLC2A1)224Cwh)
|
increased circulating creatinine level
|
J:160943
|
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased fasting circulating glucose level
|
J:249843
|
Tg(Adipoq-cre)1Evdr/0 Tg(CAG-Jmjd8)#Kaso/0
(involves: C57BL/6 * FVB/NJ)
|
increased circulating insulin level
|
J:319518
|
Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln)
|
decreased circulating cholesterol level
|
J:226970
|
decreased circulating HDL cholesterol level
|
J:226970
|
decreased circulating LDL cholesterol level
|
J:226970
|
decreased fasting circulating glucose level
|
J:226970
|
Tg(Alb1-cre)7Gsc/0 Tfr2tm1.1Anro/Tfr2tm1.1Anro
(involves: 129/Sv * C57BL/6 * FVB/N)
|
increased circulating iron level
|
J:160785
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0
(B6.Cg-Tg(Alb1-GP33/H2-Kb)1Hpi)
|
increased circulating alanine transaminase level
|
J:162605
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0 Tg(Alb1-HBV)66Bri/0
(involves: C57BL/6 * C57BL/10 * DBA/2)
|
increased circulating alanine transaminase level
|
J:162605
|
Tg(Alb1-Ren)1Unc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating creatinine level
|
J:89252
|
Tg(Alb1-Ren)2Unc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating creatinine level
|
J:89252
|
Tg(ALB-cre,CMV-rtTA)#Wcyy/0 Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0
(involves: ICR)
|
decreased circulating cholesterol level
|
J:93624
|
Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6)
|
increased circulating alanine transaminase level
|
J:104728
|
Tg(Alb-MYLIP*)1Pton/?
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:228420
|
increased circulating cholesterol level
|
J:228420
|
increased circulating LDL cholesterol level
|
J:228420
|
increased circulating triglyceride level
|
J:228420
|
Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan)
|
hyperglycemia
|
J:177591
|
increased circulating triglyceride level
|
J:177591
|
increased circulating VLDL triglyceride level
|
J:177591
|
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6)
|
abnormal circulating enzyme level
|
J:96979
|
abnormal circulating protein level
|
J:211984
|
increased circulating alanine transaminase level
|
J:211984
|
increased circulating alkaline phosphatase level
|
J:96979,
J:211984
|
increased circulating aspartate transaminase level
|
J:211984
|
increased circulating interleukin-6 level
|
J:211984
|
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6)
|
increased circulating alanine transaminase level
|
J:185313
|
increased circulating aspartate transaminase level
|
J:185313
|
increased circulating free fatty acids level
|
J:185313
|
increased circulating glucose level
|
J:185313
|
increased circulating insulin level
|
J:185313
|
increased circulating leptin level
|
J:185313
|
Tg(AlbLCAT)1Jdm/0
(involves: FVB/N)
|
decreased circulating triglyceride level
|
J:121992
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0
(involves: C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
increased circulating LDL cholesterol level
|
J:121992
|
increased circulating VLDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
Tg(AMH-Fshr*D580H)14Hht/0
(involves: FVB/N)
|
decreased circulating follicle stimulating hormone level
|
J:160015
|
decreased circulating luteinizing hormone level
|
J:160015
|
increased circulating estradiol level
|
J:160015
|
increased circulating prolactin level
|
J:160015
|
Tg(Amh-Smad4)1Tkw/0
(involves: CD-1)
|
increased circulating testosterone level
|
J:79698
|
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
abnormal atrial thrombosis
|
J:92579
|
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
hyperglycemia
|
J:50770
|
increased circulating cholesterol level
|
J:50770
|
increased circulating insulin level
|
J:50770,
J:249664
|
increased circulating triglyceride level
|
J:50770
|
increased fasting circulating glucose level
|
J:249664
|
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2)
|
abnormal circulating enzyme level
|
J:16979
|
increased circulating alanine transaminase level
|
J:135124
|
increased circulating interleukin-12 level
|
J:135124
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2)
|
decreased circulating insulin level
|
J:57075
|
decreased circulating triglyceride level
|
J:57075
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N)
|
decreased circulating free fatty acids level
|
J:69591
|
decreased circulating glucose level
|
J:69591
|
decreased circulating insulin level
|
J:69591
|
decreased circulating triglyceride level
|
J:69591
|
Tg(APCS-Tnfsf11*)#aKhs/0
(C57BL/6J-Tg(APCS-Tnfsf11*)#aKhs)
|
increased circulating alkaline phosphatase level
|
J:264357
|
Tg(APOA1)1Rub/0
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:121992
|
Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
increased circulating cholesterol level
|
J:129136
|
increased circulating HDL cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Tg(APOA1)1Rub/Tg(APOA1)1Rub
(C57BL/6-Tg(APOA1)1Rub/J)
|
abnormal circulating HDL cholesterol level
|
J:190966
|
abnormal circulating interleukin-17 level
|
J:190966
|
increased circulating cholesterol level
|
J:42425
|
increased circulating HDL cholesterol level
|
J:42425
|
Tg(APOA1)427Bres/?
(involves: C57BL/6J * CBA/J)
|
abnormal circulating protein level
|
J:104719
|
Tg(Apoa2)1Lus/?
(involves: C57BL/6J * DBA/2)
|
increased circulating cholesterol level
|
J:92454,
J:127063
|
increased circulating HDL cholesterol level
|
J:92454,
J:127063
|
increased circulating LDL cholesterol level
|
J:92454
|
increased circulating triglyceride level
|
J:92454
|
increased circulating VLDL cholesterol level
|
J:92454
|
Tg(APOA2)3Rub/0
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
decreased circulating triglyceride level
|
J:121992
|
Tg(APOA5)1Hgc/0
(FVB/N-Tg(APOA5)1Hgc)
|
decreased circulating triglyceride level
|
J:72092
|
decreased circulating VLDL cholesterol level
|
J:72092
|
Tg(APOB)11Rub/?
(involves: FVB)
|
increased circulating cholesterol level
|
J:78212
|
increased circulating LDL cholesterol level
|
J:78212
|
Tg(APOB)11Rub/0 Tg(UcpDta)1Kz/0
(involves: C57BL/6J * FVB/N)
|
decreased circulating HDL cholesterol level
|
J:73122
|
increased circulating cholesterol level
|
J:73122
|
increased circulating insulin level
|
J:73122
|
increased circulating LDL cholesterol level
|
J:73122
|
increased circulating triglyceride level
|
J:73122
|
Tg(APOC1)1Bres/Tg(APOC1)1Bres
(involves: C57BL/6J * CBA/J)
|
hyperlipidemia
|
J:80950
|
increased circulating cholesterol level
|
J:80950
|
increased circulating LDL cholesterol level
|
J:80950
|
increased circulating triglyceride level
|
J:80950
|
increased circulating VLDL cholesterol level
|
J:80950
|
increased circulating VLDL triglyceride level
|
J:80950
|
Tg(APOC1)1Lmh/0
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/?
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65146
|
increased circulating triglyceride level
|
J:65146
|
increased circulating VLDL cholesterol level
|
J:65146
|
increased circulating VLDL triglyceride level
|
J:65146
|
Tg(APOC1)1Lmh/0 Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)1Lmh Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6J)
|
decreased circulating factor VIII level
|
J:117317
|
increased circulating cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Tg(APOC1)3Lmh/Y
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
Tg(APOC1)3Lmh/?
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65146
|
Tg(APOC2)2Bres/0
(involves: C57BL/6J * CBA/J)
|
increased circulating triglyceride level
|
J:81186
|
increased circulating VLDL triglyceride level
|
J:81186
|
Tg(APOC3)2674Bres/0
(involves: C57BL/6J * CBA/J)
|
increased circulating triglyceride level
|
J:81184
|
increased circulating VLDL triglyceride level
|
J:81184
|
Tg(APOC3)2674Bres/Tg(APOC3)2674Bres
(involves: C57BL/6J * CBA/J)
|
increased circulating triglyceride level
|
J:81184
|
Tg(APOC3)2721Bres/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:81184
|
increased circulating triglyceride level
|
J:81184
|
increased circulating VLDL triglyceride level
|
J:81184
|
Tg(APOC3)3707Bres/0
(involves: C57BL/6J * CBA/J)
|
increased circulating cholesterol level
|
J:119638
|
increased circulating triglyceride level
|
J:119638
|
Tg(APOE-ABCA1)30Ssf/?
(C57BL/6N-Tg(APOE-ABCA1)30Ssf)
|
abnormal circulating apolipoprotein E level
|
J:70494
|
increased circulating cholesterol level
|
J:70494
|
increased circulating HDL cholesterol level
|
J:70494
|
increased circulating phospholipid level
|
J:70494
|
Tg(APOE-ABCG1)1Ssf/?
(C57BL/6-Tg(APOE-ABCG1)1Ssf)
|
decreased circulating HDL cholesterol level
|
J:94077
|
Tg(APOE-Adipoq)#Kry/0
(involves: 129 * C57BL/6J)
|
decreased circulating osteocalcin level
|
J:199264
|
Tg(APOE-ANGPTL4)1Akos/0
(involves: C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:103363
|
increased circulating triglyceride level
|
J:103363
|
increased circulating VLDL cholesterol level
|
J:103363
|
Tg(APOE-Cyp7a1)1Road/?
(B6.Cg-Tg(APOE-Cyp7a1)1Road)
|
decreased circulating HDL cholesterol level
|
J:70134
|
decreased circulating LDL cholesterol level
|
J:70134
|
decreased circulating VLDL cholesterol level
|
J:70134
|
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd)
|
decreased circulating free fatty acids level
|
J:124005
|
decreased circulating triglyceride level
|
J:124005
|
increased circulating alanine transaminase level
|
J:124005
|
increased circulating aspartate transaminase level
|
J:124005
|
Tg(APOE-DGAT2)24Far/0
(involves: C57BL/6NHsd)
|
decreased circulating free fatty acids level
|
J:124005
|
decreased circulating triglyceride level
|
J:124005
|
increased circulating alanine transaminase level
|
J:124005
|
increased circulating aspartate transaminase level
|
J:124005
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
decreased circulating calcium level
|
J:93981
|
decreased circulating phosphate level
|
J:93981
|
increased circulating parathyroid hormone level
|
J:93981
|
Tg(APOE-GHRL)1Jagu/0 Tg(APOE-MBOAT4)1Jagu/0
(Not Specified)
|
abnormal circulating hormone level
|
J:151420
|
Tg(APOE-NPC1L1)20Lqyu/0
(involves: C57BL/6 * DBA/2)
|
increased circulating cholesterol level
|
J:124193
|
Tg(APOE-PCSK9)1Jdh/0
(Not Specified)
|
increased circulating LDL cholesterol level
|
J:114949
|
Tg(Apoe-Pcsk9)#Prat/?
(involves: C3H * C57BL/6)
|
increased circulating cholesterol level
|
J:169834
|
increased circulating HDL cholesterol level
|
J:169834
|
increased circulating LDL cholesterol level
|
J:169834
|
Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:172091
|
decreased circulating glucose level
|
J:172091
|
decreased circulating ketone body level
|
J:172091
|
increased circulating triglyceride level
|
J:172091
|
Tg(APOE-SGMS2)#Jia/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal circulating protein level
|
J:162192
|
Tg(APOE_i3*,APOC1)2Lmh/?
(involves: C57BL/6J * CBA)
|
increased circulating cholesterol level
|
J:228420
|
increased circulating LDL cholesterol level
|
J:228420
|
increased circulating triglyceride level
|
J:228420
|
increased circulating VLDL cholesterol level
|
J:228420
|
Tg(APOM)HCchr/0
(B6.Cg-Tg(APOM)HCchr)
|
increased circulating cholesterol level
|
J:130647
|
increased circulating phospholipid level
|
J:130647
|
increased circulating triglyceride level
|
J:130647
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax)
|
increased circulating cholesterol level
|
J:129021
|
increased circulating insulin level
|
J:129021
|
increased circulating triglyceride level
|
J:113199
|
Tg(ATN1*)Q129Stsu/0
(involves: 129S/SvEv * C57BL/6J)
|
decreased blood osmolality
|
J:144379
|
decreased circulating antidiuretic hormone level
|
J:144379
|
Tg(AZIP/F)1Vsn/0
(involves: FVB/N)
|
decreased circulating leptin level
|
J:50807
|
hyperglycemia
|
J:50807
|
increased circulating free fatty acids level
|
J:50807
|
increased circulating insulin level
|
J:50807
|
increased circulating triglyceride level
|
J:50807
|
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J)
|
decreased circulating glucose level
|
J:145998
|
increased circulating insulin level
|
J:145998
|
Tg(BAC144D14)5A2Masu/0
(B6J.Cg-Tg(BAC144D14)5A2Masu)
|
hypoglycemia
|
J:232408
|
Tg(BAC144D14)5D3Masu/0
(B6J.Cg-Tg(BAC144D14)5D3Masu)
|
hypoglycemia
|
J:232408
|
Tg(CAG-ANGPT1*)5Yo/0 Tg(SFTPC-cre)11Yo/0
(involves: C57BL/6 * CBA)
|
cyanosis
|
J:147388
|
Tg(CAG-Angptl6)8.1Yo/0
(involves: C57BL/6 * CBA)
|
abnormal circulating hormone level
|
J:97552
|
decreased circulating leptin level
|
J:97552
|
Tg(CAG-APP)0304Shoj/0
(involves: C3H * C57BL/6N)
|
abnormal circulating serum amyloid protein level
|
J:100977
|
Tg(CAG-Bgeo/ALPP)1Lbe/0 Tg(Ins2-cre/ERT)1Dam/0 Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
hyperglycemia
|
J:127412
|
Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo)
|
cyanosis
|
J:103364
|
Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo)
|
cyanosis
|
J:103364
|
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh)
|
abnormal circulating cytokine level
|
J:286175
|
increased circulating interferon-gamma level
|
J:286175
|
increased circulating interleukin-17 level
|
J:286175
|
Tg(CAG-Map3k7*K63W)1232Mds/0 Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:117108
|
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:80609
|
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:80609
|
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:80609
|
Tg(CAG-Ndufab1)#Xiwa/0
(involves: C57BL/6J)
|
decreased circulating glucose level
|
J:293657
|
decreased fasting circulating glucose level
|
J:293657
|
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:175885
|
Tg(CAG-rtTA)72Wiek/0 Tg(tetO-Rnf5)1Zron/0
(involves: C3H * C57BL/6 * DBA/2)
|
increased circulating creatine kinase level
|
J:132185
|
Tg(CAG-VCP*A232E)93Jpat/0
(involves: C57BL/6 * SJL)
|
increased circulating alkaline phosphatase level
|
J:158713
|
increased circulating creatine kinase level
|
J:158713
|
Tg(CAG-VCP*R155H)55Jpat/0
(involves: C57BL/6 * SJL)
|
increased circulating alkaline phosphatase level
|
J:158713
|
increased circulating creatine kinase level
|
J:158713
|
Tg(CAMalpha1b)7Wjk/?
(Not Specified)
|
abnormal atrial thrombosis
|
J:134704
|
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD/MrkTac-Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
hyperglycemia
|
J:87013,
J:86540
|
Tg(CD4-CIITA)357Ccum/?
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased circulating type I collagen C-terminal telopeptide level
|
J:233241
|
Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N)
|
increased circulating interleukin-1 beta level
|
J:219652
|
increased circulating interleukin-17 level
|
J:219652
|
Tg(Cdh16-Wnk1*)#Cihu/0
(involves: C57BL/6)
|
decreased circulating potassium level
|
J:168700
|
increased circulating aldosterone level
|
J:168700
|
increased circulating angiotensinogen level
|
J:168700
|
Tg(CETP)5203Tall/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:48202
|
Tg(CETP)UCTP20Pnu/0
(C57BL/6-Tg(CETP)UCTP20Pnu)
|
abnormal circulating cholesterol level
|
J:118358,
J:92448
|
abnormal circulating protein level
|
J:92448
|
decreased circulating HDL cholesterol level
|
J:118358
|
increased circulating LDL cholesterol level
|
J:118358
|
increased circulating VLDL cholesterol level
|
J:118358
|
Tg(Cga-LHB/CGB)94Jhn/?
(involves: C57BL/6 * SJL)
|
increased circulating luteinizing hormone level
|
J:55157
|
increased circulating progesterone level
|
J:55157
|
Tg(Ckm-Cd36)1Naa/0
(involves: FVB)
|
decreased circulating cholesterol level
|
J:57650
|
decreased circulating free fatty acids level
|
J:57650
|
decreased circulating triglyceride level
|
J:57650
|
decreased circulating VLDL triglyceride level
|
J:57650
|
increased circulating glucose level
|
J:57650
|
increased circulating insulin level
|
J:57650
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
hyperglycemia
|
J:210518
|
increased circulating cholesterol level
|
J:210518
|
increased circulating creatinine level
|
J:210518
|
increased circulating free fatty acids level
|
J:71205
|
increased circulating glucose level
|
J:71205
|
increased circulating insulin level
|
J:71205
|
increased circulating triglyceride level
|
J:71205
|
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
Tg(Ckm-LPL)LRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
|
increased circulating glucose level
|
J:129848
|
increased circulating insulin level
|
J:129848
|
Tg(Ckm-Prkaa2*K45R)1Mbb/0
(involves: C57BL/6J * SJL/J)
|
abnormal circulating glucose level
|
J:110092
|
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)
|
abnormal circulating enzyme level
|
J:205907
|
increased circulating creatine kinase level
|
J:205907
|
Tg(Ckmm-Ucp1)1Boud/0
(involves: C57BL/6J * DBA/2J)
|
abnormal blood homeostasis
|
J:80053
|
decreased circulating creatinine level
|
J:80053
|
Tg(Ckmm-Ucp1)1Boud/Tg(Ckmm-Ucp1)1Boud
(involves: C57BL/6J * DBA/2J)
|
abnormal blood homeostasis
|
J:80053
|
decreased circulating creatinine level
|
J:80053
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
increased circulating corticosterone level
|
J:95465
|
Tg(Col1a1-Atf4)1Kry/0
(involves: FVB)
|
abnormal circulating glucose level
|
J:152695
|
decreased circulating insulin level
|
J:152695
|
increased circulating glucose level
|
J:152695
|
Tg(Col1a1-FGF2*,-Sapphire)203Mmh/Tg(Col1a1-FGF2*,-Sapphire)203Mmh
(involves: FVB/N)
|
abnormal circulating protein level
|
J:159949
|
decreased circulating phosphate level
|
J:159949
|
increased circulating parathyroid hormone level
|
J:159949
|
increased circulating type I collagen C-terminal telopeptide level
|
J:159949
|
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified)
|
decreased circulating insulin level
|
J:126780
|
hyperglycemia
|
J:126780
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
increased circulating adrenocorticotropin level
|
J:92996
|
increased circulating corticosterone level
|
J:92996
|
increased circulating corticotropin-releasing hormone level
|
J:92996
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ)
|
decreased circulating insulin level
|
J:97926
|
hyperglycemia
|
J:97926
|
increased circulating glucagon level
|
J:97926
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove)
|
decreased circulating serum albumin level
|
J:94602
|
hyperglycemia
|
J:106851,
J:94602
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0 Tg(Myh6-SOD2,Tyr)3Pne/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove Tg(Myh6-SOD2,Tyr)3Pne)
|
hyperglycemia
|
J:106815
|
Tg(Cyp17a1-NGF)2456Oje/Tg(Cyp17a1-NGF)2456Oje
(involves: C57BL/6J * DBA/2J)
|
decreased circulating progesterone level
|
J:158186
|
increased circulating estradiol level
|
J:218686
|
increased circulating insulin level
|
J:218686
|
increased circulating testosterone level
|
J:218686
|
Tg(Cyp19)C2-3Rrte/0
(involves: BALB/c * C57BL/6)
|
increased circulating estradiol level
|
J:60034
|
Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:130658
|
Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:130658
|
Tg(DMWD,DMPK*,SIX5)328Ggo/Tg(DMWD,DMPK*,SIX5)328Ggo
(involves: C57BL/6 * DBA/2)
|
decreased blood oxygen saturation level
|
J:196337
|
Tg(Dyrk1a)189N3Yah/0
(B6.129P2-Tg(Dyrk1a)189N3Yah/Yah)
|
abnormal circulating androgen level
|
J:324151
|
decreased circulating follicle stimulating hormone level
|
J:324151
|
decreased circulating gonadotropin level
|
J:324151
|
decreased circulating luteinizing hormone level
|
J:324151
|
decreased circulating testosterone level
|
J:324151
|
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)
|
increased circulating interleukin-6 level
|
J:180282
|
Tg(Edn1-NOS3)22Yky/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood homeostasis
|
J:81132
|
Tg(EEF1A1-Socs6)1Pwg/?
(B6.129P2-Tg(EEF1A1-Socs6)1Pwg)
|
decreased circulating glucose level
|
J:181312
|
decreased circulating insulin level
|
J:181312
|
Tg(EEF1A1-Socs6)2Pwg/?
(B6.129P2-Tg(EEF1A1-Socs6)2Pwg)
|
decreased circulating glucose level
|
J:181312
|
decreased circulating insulin level
|
J:181312
|
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
increased circulating interferon-alpha level
|
J:117018
|
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
decreased circulating arginine level
|
J:80204
|
increased circulating glycine level
|
J:80556
|
Tg(Fabp4-Aebp1)1Hsro/?
(involves: FVB)
|
increased circulating insulin level
|
J:125334
|
increased circulating leptin level
|
J:125334
|
Tg(Fabp4-Agt)2Mte/0
(involves: C57BL/6 * CD-1 * DBA/2 * ICR)
|
abnormal blood homeostasis
|
J:73163
|
decreased circulating renin level
|
J:73163
|
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul)
|
abnormal circulating glycerol level
|
J:344362
|
decreased circulating free fatty acids level
|
J:344362
|
increased circulating cholesterol level
|
J:344362
|
increased circulating HDL cholesterol level
|
J:344362
|
increased circulating LDL cholesterol level
|
J:344362
|
increased circulating triglyceride level
|
J:344362
|
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:110277
|
increased circulating glucose level
|
J:110277
|
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J)
|
decreased circulating leptin level
|
J:182179
|
increased circulating free fatty acids level
|
J:182179
|
increased circulating insulin level
|
J:182179
|
increased circulating triglyceride level
|
J:182179
|
Tg(Fabp4-Fabp5)1Hota/0
(involves: C57BL/6)
|
increased circulating glucose level
|
J:81609
|
Tg(Fabp4-Fam13a)1Iked/0
(C57BL/6J-Tg(Fabp4-Fam13a)1Iked)
|
decreased circulating free fatty acids level
|
J:258290
|
Tg(Fabp4-FOXC2)ASven/0
(involves: C57BL/6J * CBA)
|
decreased circulating free fatty acids level
|
J:94144
|
decreased circulating glucose level
|
J:94144
|
decreased circulating insulin level
|
J:94144
|
decreased circulating triglyceride level
|
J:94144
|
Tg(Fabp4-Hsd11b1)7Jesf/0
(FVB-Tg(Fabp4-Hsd11b1)7Jesf)
|
hyperglycemia
|
J:107046
|
increased circulating free fatty acids level
|
J:107046
|
increased circulating insulin level
|
J:107046
|
increased circulating leptin level
|
J:107046
|
increased circulating triglyceride level
|
J:107046
|
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J)
|
decreased circulating cholesterol level
|
J:67311
|
decreased circulating glucose level
|
J:67311
|
decreased circulating insulin level
|
J:67311
|
decreased circulating triglyceride level
|
J:67311
|
increased circulating leptin level
|
J:67311
|
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc)
|
decreased circulating glucose level
|
J:84349
|
decreased circulating triglyceride level
|
J:84349
|
increased circulating leptin level
|
J:84349
|
Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl)
|
increased circulating glucose level
|
J:149858
|
increased circulating insulin level
|
J:149858
|
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1)
|
decreased circulating cholesterol level
|
J:230172
|
decreased circulating ghrelin level
|
J:230172
|
decreased circulating glycerol level
|
J:230172
|
decreased circulating triglyceride level
|
J:230172
|
increased circulating estradiol level
|
J:242981
|
increased circulating free fatty acids level
|
J:230172
|
increased circulating insulin level
|
J:230172
|
increased circulating leptin level
|
J:230172
|
Tg(Fabp4-Phb*Y114F)#Smis/0
(Not Specified)
|
abnormal circulating chemokine level
|
J:227976
|
abnormal circulating cytokine level
|
J:227976
|
decreased circulating ghrelin level
|
J:227976
|
increased circulating ghrelin level
|
J:227976
|
increased circulating insulin level
|
J:227976
|
increased circulating insulin-like growth factor I level
|
J:227976
|
increased circulating leptin level
|
J:227976
|
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl)
|
decreased circulating insulin level
|
J:208508
|
decreased circulating LDL cholesterol level
|
J:208508
|
decreased circulating leptin level
|
J:208508
|
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB)
|
hyperglycemia
|
J:189510
|
increased circulating insulin level
|
J:189510
|
Tg(Fabp4-TLE3)#aPton/0
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:172245
|
decreased circulating insulin level
|
J:172245
|
increased circulating resistin level
|
J:172245
|
Tg(Fabp4-Wdct1*)1Jmgr/?
(involves: ICR)
|
increased circulating glucose level
|
J:129966
|
Tg(Fabp4-Wdtc1)1Jmgr/?
(involves: ICR)
|
decreased circulating glucose level
|
J:129966
|
decreased circulating insulin level
|
J:129966
|
decreased circulating leptin level
|
J:129966
|
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL)
|
increased susceptibility to induced thrombosis
|
J:72220
|
Tg(Fga,Fgb,Fgg)1Unc/?
(C57BL/6-Tg(Fga,Fgb,Fgg)1Unc)
|
increased circulating fibrinogen level
|
J:118353
|
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
abnormal lung thrombosis
|
J:288386
|
increased circulating aspartate transaminase level
|
J:288386
|
Tg(Fst)4Zuk/0
(involves: C3H * C57BL/6 * ICR)
|
decreased circulating follicle stimulating hormone level
|
J:45065
|
Tg(GAS7)63.2Lus/0
(involves: FVB/N)
|
decreased circulating glucose level
|
J:148831
|
Tg(GAS)2Tcw/0
(involves: FVB/N)
|
abnormal blood homeostasis
|
J:63579
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
increased blood urea nitrogen level
|
J:104241
|
Tg(Ggt1-tTA)#Agoc/0 Tg(tetO/CMV-PTHLH)#Agoc/0
(involves: CD-1)
|
decreased circulating phosphate level
|
J:130310
|
Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL)
|
increased circulating growth hormone level
|
J:86486
|
increased circulating prolactin level
|
J:86486
|
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron)
|
increased circulating insulin level
|
J:210298
|
Tg(GHRL-TAg)3-1Hiwa/0
(C57BL/6-Tg(GHRL-TAg)3-1Hiwa)
|
decreased circulating insulin level
|
J:152492
|
decreased circulating leptin level
|
J:152492
|
increased circulating glucose level
|
J:152492
|
increased circulating insulin-like growth factor I level
|
J:152492
|
Tg(Gpbar1)1Auw/0
(involves: C57BL/6J)
|
increased circulating insulin level
|
J:152388
|
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
abnormal circulating cytokine level
|
J:209872
|
increased circulating interleukin-6 level
|
J:209872
|
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal circulating cytokine level
|
J:209872
|
decreased circulating interleukin-6 level
|
J:209872
|
increased circulating interleukin-17 level
|
J:209872
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
decreased circulating alkaline phosphatase level
|
J:128016
|
decreased circulating glucose level
|
J:128016
|
decreased circulating serum albumin level
|
J:128016
|
decreased circulating triglyceride level
|
J:128016
|
increased circulating total protein level
|
J:128016
|
Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J)
|
increased blood urea nitrogen level
|
J:276641
|
increased circulating creatinine level
|
J:276641
|
Tg(HBx-HCV)C5Tto/0
(B6.Cg-Tg(HBx-HCV)C5Tto)
|
increased circulating alanine transaminase level
|
J:243110
|
Tg(HCRT-MJD)1Stak/?
(involves: C57BL/6 * DBA/1)
|
increased circulating leptin level
|
J:128233
|
Tg(HCRT-tTA)1Ahky/0 Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
increased circulating insulin level
|
J:211045
|
increased circulating leptin level
|
J:211045
|
Tg(HDexon1)61Gpb/?
(involves: C57BL/6 * CBA)
|
increased circulating noradrenaline level
|
J:203027
|
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:96353
|
Tg(HIV)26Aln/0
(involves: FVB/N)
|
abnormal blood urea nitrogen level
|
J:90297
|
increased circulating creatinine level
|
J:90297
|
Tg(Hmgcr-PSEN1*M146L)#Lpr/0 Tg(Thy1-APPSL)28Lpr/0
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:128243
|
Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA)
|
increased circulating glucose level
|
J:128964
|
increased circulating insulin level
|
J:84652,
J:128964
|
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel)
|
abnormal circulating insulin level
|
J:121961
|
decreased circulating glucose level
|
J:121961
|
decreased circulating leptin level
|
J:121961
|
decreased circulating triglyceride level
|
J:121961
|
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
increased circulating glucose level
|
J:91865
|
Tg(Igh-HMGA2)#Cro/0
(FVB/N-Tg(Igh-HMGA2)#Cro)
|
increased circulating interleukin-6 level
|
J:233225
|
increased circulating tumor necrosis factor level
|
J:233225
|
Tg(Igh-TCL1A)1Ypek/0
(FVB/N-Tg(Igh-TCL1A)1Ypek)
|
abnormal circulating chemokine level
|
J:160184
|
increased circulating tumor necrosis factor level
|
J:160184
|
Tg(Il1rn)1Dih/0
(involves: C57BL/6 * CBA)
|
decreased circulating interleukin-6 level
|
J:88605
|
decreased circulating serum amyloid protein level
|
J:61600
|
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: C57BL/6 * CBA)
|
increased circulating interleukin-1 level
|
J:36387
|
Tg(Ins1-Cat,Tyr)25Pne/0
(involves: FVB)
|
decreased circulating glucose level
|
J:59275
|
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6 * FVB/N)
|
hyperglycemia
|
J:209714
|
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
hyperglycemia
|
J:209714
|
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
decreased circulating insulin level
|
J:127015
|
Tg(Ins1-GAS)1Sbr/0
(involves: FVB/NTac)
|
increased circulating gastrin level
|
J:59575,
J:63579
|
Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:72216
|
increased circulating insulin level
|
J:72216
|
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb)
|
hypoglycemia
|
J:144599
|
increased circulating insulin level
|
J:144599
|
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj)
|
increased circulating glucose level
|
J:26618
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca)
|
increased circulating glucose level
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
increased circulating glucose level
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca)
|
increased circulating glucose level
|
J:93555
|
Tg(Ins2-CDKN1B)1Maka/0
(involves: C57BL/6J)
|
decreased circulating insulin level
|
J:96047
|
hyperglycemia
|
J:96047
|
Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:156725
|
increased circulating glucose level
|
J:156725
|
Tg(Ins2-Chrm3*)1Jwe/0
(involves: C57BL/6)
|
hypoglycemia
|
J:129643
|
increased circulating insulin level
|
J:129643
|
Tg(Ins2-cre)23Herr/0 Tsc2tm1Kido/Tsc2tm1Kido
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:135811
|
hypoglycemia
|
J:135811
|
increased circulating glucose level
|
J:135811
|
increased circulating insulin level
|
J:135811
|
Tg(Ins2-cre)25Mgn/0
(either: (B6.Cg-Tg(Ins2-cre)25Mgn/J) or (involves: 129 * C57BL/6 * DBA/2))
|
abnormal circulating insulin level
|
J:108244
|
Tg(Ins2-GLUD1*H454Y)1Csta/0
(involves: C57BL/6 * SJL)
|
hypoglycemia
|
J:113458
|
Tg(Ins2-GLUD1*H454Y)2Csta/0
(involves: C57BL/6 * SJL)
|
hypoglycemia
|
J:113458
|
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6)
|
decreased circulating insulin level
|
J:81287
|
increased circulating glucose level
|
J:81287
|
Tg(Ins2-GP)#Psoh/0
(involves: C57BL/6)
|
hyperglycemia
|
J:81285
|
Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
hyperglycemia
|
J:81285
|
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL)
|
hyperglycemia
|
J:127706
|
increased circulating glucose level
|
J:93555,
J:127706
|
increased circulating triglyceride level
|
J:127706
|
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)
|
hyperglycemia
|
J:99756
|
Tg(Ins2-HA)165Bri/? Tg(TcraCl4,TcrbCl4)1Shrm/?
(involves: BALB/c * C57BL/6 * C57BL/10)
|
hyperglycemia
|
J:99756
|
Tg(Ins2-HBEGF)5Rin/?
(C57BL/6-Tg(Ins2-HBEGF)5Rin)
|
decreased circulating insulin level
|
J:204420
|
hyperglycemia
|
J:204420
|
Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J)
|
decreased circulating insulin level
|
J:134757
|
increased circulating glucose level
|
J:134757
|
Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc)
|
decreased circulating insulin level
|
J:142009
|
hyperglycemia
|
J:142009
|
increased circulating glucagon level
|
J:142009
|
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N)
|
decreased circulating insulin level
|
J:130022
|
hyperglycemia
|
J:130022
|
Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6)
|
increased circulating insulin level
|
J:94000
|
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified)
|
decreased circulating insulin level
|
J:210552
|
hyperglycemia
|
J:210552
|
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat)
|
decreased circulating insulin level
|
J:314874
|
hyperglycemia
|
J:314874
|
Tg(Ins2-Nos2)31Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
decreased circulating insulin level
|
J:45520
|
hyperglycemia
|
J:45520
|
Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
decreased circulating insulin level
|
J:45520
|
hyperglycemia
|
J:45520
|
increased circulating ketone body level
|
J:45520
|
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)
|
hyperglycemia
|
J:116040
|
increased circulating creatinine level
|
J:116040
|
Tg(Ins2-Nos2)40Okam/0 Tg(Kdr-AGER)102Hyam/0
(involves: C57BL/6J * CBA/J * CD-1 * DBA/2)
|
hyperglycemia
|
J:70495
|
increased circulating creatinine level
|
J:70495
|
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6)
|
decreased circulating insulin level
|
J:81287
|
increased circulating glucose level
|
J:81284,
J:81287
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA)
|
increased circulating glucose level
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
hyperglycemia
|
J:127412
|
increased circulating glucose level
|
J:127412
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased circulating insulin level
|
J:210552
|
increased circulating glucose level
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)1Hhv/0
(involves: C57BL/6 * CBA)
|
increased circulating insulin level
|
J:246708
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)10Hhv/0
(involves: C57BL/6 * CBA)
|
decreased fasting circulating glucose level
|
J:246708
|
increased circulating insulin level
|
J:246708
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-TAg)1Efr/0
(involves: C3HeB/FeJ * C57BL/6 * CBA)
|
hypoglycemia
|
J:130049
|
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL)
|
hyperglycemia
|
J:73760
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL)
|
hyperglycemia
|
J:141527
|
increased circulating free fatty acids level
|
J:141527
|
increased circulating glucose level
|
J:141527
|
increased circulating insulin level
|
J:141527
|
increased circulating triglyceride level
|
J:141527
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL)
|
hyperglycemia
|
J:141527
|
increased circulating free fatty acids level
|
J:141527
|
increased circulating insulin level
|
J:141527
|
increased circulating triglyceride level
|
J:141527
|
Tg(INS-Il10)#Sar/0 Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD)
|
increased circulating glucose level
|
J:64051
|
Tg(INS-Il10)#Sar/0 Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD)
|
increased circulating glucose level
|
J:64051
|
Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne)
|
hyperglycemia
|
J:90564
|
Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA)
|
abnormal circulating cytokine level
|
J:210758
|
Tg(JAK2*V617F)FF1Rsko/0 Tg(Tek-cre)1Arnd/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal blood coagulation
|
J:206659
|
abnormal blood homeostasis
|
J:206659
|
decreased platelet aggregation
|
J:206659
|
decreased susceptibility to induced thrombosis
|
J:206659
|
increased bleeding time
|
J:206659
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
abnormal brain thrombosis
|
J:294084
|
abnormal circulating chemokine level
|
J:294084
|
abnormal circulating cytokine level
|
J:302313
|
increased circulating CXCL10 level
|
J:302313
|
increased circulating interferon-gamma level
|
J:302313
|
increased circulating interleukin-6 level
|
J:294084
|
increased circulating interleukin-10 level
|
J:294084,
J:302313
|
increased circulating tumor necrosis factor level
|
J:294084
|
Tg(KRT5-IKBKB)2Armz/0
(involves: C57BL/6 * DBA/2)
|
increased circulating interferon-gamma level
|
J:160072
|
increased circulating interleukin-1 alpha level
|
J:160072
|
increased circulating interleukin-2 level
|
J:160072
|
increased circulating interleukin-4 level
|
J:160072
|
increased circulating interleukin-5 level
|
J:160072
|
increased circulating interleukin-6 level
|
J:160072
|
increased circulating interleukin-10 level
|
J:160072
|
increased circulating tumor necrosis factor level
|
J:160072
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)
|
increased circulating interleukin-4 level
|
J:182756
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
increased circulating histamine level
|
J:78602
|
increased circulating interleukin-18 level
|
J:78602,
J:79706
|
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
increased circulating histamine level
|
J:78602
|
increased circulating interleukin-18 level
|
J:78602
|
Tg(Krt14-Rac1*G12V)#Mrnk/0
(involves: CBA/CaJ)
|
abnormal circulating interleukin level
|
J:237134
|
Tg(KRT18*R89C)22Rgo/0
(involves: FVB/N)
|
increased circulating alanine transaminase level
|
J:241700
|
increased circulating aspartate transaminase level
|
J:241700
|
Tg(KRT18*R89C)30Rgo/0
(involves: FVB/N)
|
increased circulating alanine transaminase level
|
J:241700
|
increased circulating aspartate transaminase level
|
J:241700
|
Tg(KRT18*R89C)50Rgo/0
(involves: FVB/N)
|
increased circulating alanine transaminase level
|
J:241700
|
increased circulating aspartate transaminase level
|
J:241700
|
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N)
|
increased blood urea nitrogen level
|
J:64395
|
Tg(Lcat)1Ssf/Tg(Lcat)1Ssf
(C57BL/6-Tg(Lcat)1Ssf)
|
increased circulating cholesterol level
|
J:94077
|
increased circulating HDL cholesterol level
|
J:94077
|
increased circulating phospholipid level
|
J:94077
|
Tg(LCAT)A31Ssf/0
(C57BL/6N-Tg(LCAT)A31Ssf)
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
increased circulating phospholipid level
|
J:118356
|
Tg(LCAT)A31Ssf/Tg(LCAT)A31Ssf
(C57BL/6N-Tg(LCAT)A31Ssf)
|
abnormal circulating apolipoprotein E level
|
J:118356
|
abnormal circulating apolipoprotein level
|
J:118356
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
increased circulating phospholipid level
|
J:118356
|
Tg(LCAT)T59Ssf/0
(C57BL/6N-Tg(LCAT)T59Ssf)
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
increased circulating cholesterol level
|
J:120962
|
increased circulating triglyceride level
|
J:120962
|
Tg(Lck-Tnfsf14)24Yxf/? Tnfrsf14tm1Kpf/Tnfrsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:120962
|
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea)
|
abnormal glomerular capillary thrombosis
|
J:72982
|
increased blood urea nitrogen level
|
J:72982
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
increased circulating phosphate level
|
J:107359
|
Tg(LIPC)6784His/0
(C57BL/6-Tg(LIPC)6784His)
|
decreased circulating HDL cholesterol level
|
J:48486
|
decreased circulating phospholipid level
|
J:48486
|
decreased circulating triglyceride level
|
J:48486
|
Tg(LIPG)1Tq/0
(involves: C57BL/6)
|
abnormal circulating phospholipid level
|
J:81821
|
decreased circulating cholesterol level
|
J:81821
|
decreased circulating HDL cholesterol level
|
J:81821
|
Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2)
|
abnormal blood homeostasis
|
J:230118
|
decreased circulating ammonia level
|
J:230118
|
hyperglycemia
|
J:230118
|
increased circulating insulin level
|
J:230118
|
Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2)
|
hyperglycemia
|
J:230118
|
increased circulating insulin level
|
J:230118
|
Tg(Mc2r-Arntl)1Kyki/0
(C57BL/6J-Tg(Mc2r-Arntl)1Kyki)
|
abnormal circulating corticosterone level
|
J:146305
|
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(ML5sHEL)5Ccg)
|
abnormal circulating protein level
|
J:78308
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased circulating insulin-like growth factor I level
|
J:93548
|
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
abnormal circulating cytokine level
|
J:147923
|
increased circulating tumor necrosis factor level
|
J:147923
|
Tg(Mt1-GH1)#Jjk/0
(C57BL/6J-Tg(Mt1-GH1)#Jjk)
|
decreased circulating leptin level
|
J:132437
|
Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2)
|
increased blood urea nitrogen level
|
J:177825,
J:18424
|
increased circulating interleukin-6 level
|
J:177825
|
increased circulating serum amyloid protein level
|
J:177825
|
Tg(Mt1-LDLR)93-4Reh/0
(involves: C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:127519
|
decreased circulating LDL cholesterol level
|
J:127519
|
Tg(Mt1a-GPHB5)1Sok/0
(involves: C57BL/6)
|
increased circulating thyroxine level
|
J:105176
|
Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6)
|
increased circulating alanine transaminase level
|
J:66132
|
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps)
|
abnormal circulating alanine transaminase level
|
J:233146
|
Tg(Myh6*)1Lnwd/0
(involves: C57BL/6 * FVB/N)
|
abnormal cardiac thrombosis
|
J:55938
|
Tg(Myh6*)1Lnwd/Tg(Myh6*)1Lnwd
(involves: C57BL/6 * FVB/N)
|
abnormal cardiac thrombosis
|
J:55938
|
Tg(Myh6-1810058I24Rik)#Eno/0
(involves: C57BL/6)
|
abnormal atrial thrombosis
|
J:325962
|
Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc)
|
cyanosis
|
J:68639
|
Tg(Myh6-ANKRD1)#Camm/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:302922
|
Tg(Myh6-Bclaf1)#Cya/0
(Not Specified)
|
increased circulating lactate dehydrogenase level
|
J:301260
|
Tg(Myh6-BRUNOL4*)10Coop/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:99369
|
Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:134761
|
Tg(Myh6-Camk2d_ic)LJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
abnormal atrial thrombosis
|
J:130644
|
Tg(Myh6-Camk2d_ic)MJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
abnormal atrial thrombosis
|
J:130644
|
Tg(Myh6-cre)TG9Pjay/0
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:198043
|
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1)
|
abnormal atrial thrombosis
|
J:133881
|
abnormal thrombosis
|
J:133881
|
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns)
|
abnormal atrial thrombosis
|
J:133093
|
Tg(Myh6-CRYAB*R120G)7302Ijb/0
(involves: C57BL/6)
|
abnormal atrial thrombosis
|
J:126781
|
Tg(Myh6-EGFR*)9-12Iko/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood homeostasis
|
J:182337
|
Tg(Myh6-Gnaq*Q209L)44Ejne/Tg(Myh6-Gnaq*Q209L)44Ejne
(involves: FVB)
|
abnormal atrial thrombosis
|
J:127756
|
Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB)
|
abnormal atrial thrombosis
|
J:204274
|
Tg(Myh6-HBEGF)#Iko/0
(involves: C57BL/6 * DBA/2)
|
abnormal atrial thrombosis
|
J:93335
|
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno)
|
abnormal circulating cholesterol level
|
J:186193
|
Tg(Myh6-Mef2d)2Eno/0
(Not Specified)
|
abnormal thrombosis
|
J:130825
|
Tg(Myh6-MT2A)15Pne/?
(involves: FVB)
|
increased circulating insulin level
|
J:126583
|
Tg(Myh6-Murc)#Tue/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:136004
|
Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N)
|
cyanosis
|
J:82353
|
Tg(Myh6-Prkaca)2Eno/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:263774
|
Tg(Myh6-Prkaca)33Eno/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:263774
|
Tg(Myh6-Rxra)41Pcn/0
(Not Specified)
|
abnormal cardiac thrombosis
|
J:60351
|
Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6)
|
abnormal atrial thrombosis
|
J:139414
|
Tg(Myh6-TEAD4)3Afrs/0
(involves: FVB)
|
abnormal atrial thrombosis
|
J:112740
|
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:107823
|
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL)
|
abnormal atrial thrombosis
|
J:100006
|
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL)
|
abnormal atrial thrombosis
|
J:100006
|
Tg(Myh6-TNNT2*R141W)#Lian/0
(involves: C57BL/6J)
|
abnormal thrombosis
|
J:211769
|
Tg(Myh6-Tpm1*D175N)#Dfw/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:57365
|
Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: FVB/N)
|
abnormal atrial thrombosis
|
J:127507
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
abnormal atrial thrombosis
|
J:128617
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-TPR/MET,-EGFP)12Tcre/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetO-TPR/MET,-EGFP)12Tcre)
|
cyanosis
|
J:241276
|
Tg(Myh7-Phc1)#Yota/0
(involves: C57BL/6)
|
abnormal atrial thrombosis
|
J:75968
|
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
(FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns)
|
abnormal atrial thrombosis
|
J:123963
|
Tg(Myh7-RARA/lacZ)30Mcco/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:146424
|
Tg(Myh7-RARA/lacZ)32Mcco/0
(Not Specified)
|
abnormal atrial thrombosis
|
J:146424
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
decreased circulating glucagon level
|
J:76323
|
decreased circulating glucose level
|
J:76323
|
decreased circulating insulin level
|
J:76323
|
decreased circulating insulin-like growth factor I level
|
J:76323
|
decreased circulating leptin level
|
J:76323
|
Tg(Myl2SLC2A1)2Mue/0
(involves: C57BL/6 * SJL)
|
decreased circulating glucose level
|
J:93868
|
Tg(Neurog3-cre)C1Able/0 Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0
(involves: 129 * C57BL/6 * CD-1)
|
hyperglycemia
|
J:158215
|
increased circulating glucose level
|
J:158215
|
increased circulating insulin level
|
J:158215
|
Tg(Nphs1-ACE2)#Kdbu/0
(FVB//N-Tg(Nphs1-ACE2)#Kdbu)
|
decreased circulating triglyceride level
|
J:198181
|
Tg(Nphs1-IL2RA)18Mska/0
(B6N.Cg-Tg(Nphs1-IL2RA)18Mska)
|
decreased circulating total protein level
|
J:127013
|
Tg(Nphs1-rtTA*3G)8Jhm/0 Tg(tetO-GFP,-APOL1*)#Susz/0
(involves: C57BL/6J * CBA/J * FVB/N)
|
increased blood urea nitrogen level
|
J:251848
|
increased circulating creatinine level
|
J:251848
|
uremia
|
J:251848
|
Tg(NPHS2-rtTA2*M2)1Jbk/0 Tg(tetO-RNAi:Vegfa)#Atuf/0
(involves: FVB)
|
increased circulating creatinine level
|
J:189626
|
Tg(PAH-INSR)1Rjv/0
(involves: C57BL/6 * CBA)
|
hypoglycemia
|
J:80773
|
Tg(PDGFB-LRRK2*R1441C)574Djmo/0
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating noradrenaline level
|
J:171645
|
Tg(PF4-tTA/VP16)42Kra/0 Tg(tetO-Aurkb,lacZ)41Kra/0
(FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)
|
abnormal platelet physiology
|
J:104239
|
Tg(PGK1-FTL*)#Sle/0
(B6J.FVB-Tg(PGK1-FTL*)#Sle)
|
decreased circulating ferritin level
|
J:227451
|
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased blood osmolality
|
J:157952
|
increased circulating sodium level
|
J:157952
|
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased blood osmolality
|
J:157952
|
increased circulating phosphate level
|
J:157952
|
increased circulating sodium level
|
J:157952
|
Tg(Pkd1*)39Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased blood urea nitrogen level
|
J:198147
|
increased circulating creatinine level
|
J:198147
|
Tg(PLTP)1Pgn/0
(C57BL/6J-Tg(PLTP)1Pgn/J)
|
abnormal circulating cholesterol level
|
J:92804
|
decreased circulating cholesterol level
|
J:92804
|
decreased circulating LDL phospholipid level
|
J:92804
|
decreased circulating VLDL phospholipid level
|
J:92804
|
increased circulating HDL phospholipid level
|
J:92804
|
Tg(Pmch-ATXN3*)3Rck/0
(involves: FVB/NJ)
|
decreased circulating glucose level
|
J:104264
|
decreased circulating insulin level
|
J:104264
|
decreased circulating leptin level
|
J:104264
|
Tg(PML-RARA)556Kog/?
(involves: FVB/N)
|
abnormal blood coagulation
|
J:39327
|
abnormal lung thrombosis
|
J:39327
|
Tg(Prl-EGFR)#Sme/0
(Not Specified)
|
increased circulating prolactin level
|
J:219654
|
Tg(PRNP-APPSweInd)8Dwst/?
(involves: 129S6/SvEvTac)
|
increased circulating triglyceride level
|
J:113199
|
increased circulating VLDL triglyceride level
|
J:113199
|
Tg(Prnp-ATXN3)BVcg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:121039
|
Tg(Prnp-ATXN3)BVcg/Tg(Prnp-ATXN3)BVcg
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:121039
|
decreased circulating luteinizing hormone level
|
J:121039
|
decreased circulating prolactin level
|
J:121039
|
decreased circulating thyroid-stimulating hormone level
|
J:121039
|
Tg(Prnp-ATXN3)CVcg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:121039
|
Tg(Prnp-ATXN3)CVcg/Tg(Prnp-ATXN3)CVcg
(involves: C3H/HeJ * C57BL/6)
|
decreased circulating follicle stimulating hormone level
|
J:121039
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:182671
|
decreased circulating insulin level
|
J:182671
|
decreased circulating insulin-like growth factor I level
|
J:182671
|
decreased circulating leptin level
|
J:182671
|
decreased fasting circulating glucose level
|
J:182671
|
Tg(PTH-CCND1)PC2Anar/0
(FVB/N-Tg(PTH-CCND1)PC2Anar)
|
abnormal circulating mineral level
|
J:69423
|
increased circulating calcium level
|
J:69423
|
increased circulating parathyroid hormone level
|
J:69423
|
Tg(PyLT)1Vb/0
(Not Specified)
|
increased circulating adrenocorticotropin level
|
J:55528
|
Tg(Rgs4-EGFP)#Surm/?
(involves: C57BL/6J * DBA)
|
abnormal blood urea nitrogen level
|
J:215588
|
abnormal circulating creatinine level
|
J:215588
|
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J)
|
hypoglycemia
|
J:50695,
J:205389
|
Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh)
|
hypoglycemia
|
J:136259
|
Tg(RIR-Tag)87Dh/0
(involves: C57BL/6J * DBA/2J)
|
hypoglycemia
|
J:50695
|
Tg(RNU6-RNAi:Cldn16)551Dago/0
(involves: C57BL/6 * DBA/2)
|
decreased circulating magnesium level
|
J:122766
|
hypokalemia
|
J:122766
|
increased circulating aldosterone level
|
J:122766
|
Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca)
|
hyperglycemia
|
J:91709
|
Tg(RP11-578M14)5Mkru/0
(involves: FVB/N)
|
abnormal circulating hormone level
|
J:256501
|
decreased circulating follicle stimulating hormone level
|
J:256501
|
decreased circulating free fatty acids level
|
J:256501
|
decreased circulating ghrelin level
|
J:256501
|
decreased circulating luteinizing hormone level
|
J:256501
|
decreased circulating thyroid-stimulating hormone level
|
J:256501
|
increased circulating C-peptide level
|
J:256501
|
increased circulating insulin level
|
J:256501
|
increased circulating leptin level
|
J:256501
|
increased circulating peptide YY level
|
J:256501
|
increased circulating phospholipid level
|
J:256501
|
increased circulating resistin level
|
J:256501
|
increased fasting circulating glucose level
|
J:256501
|
Tg(RP23-352G18)1Coppa/0
(C57BL/6-Tg(RP23-352G18)1Coppa)
|
decreased circulating glucose level
|
J:229077
|
Tg(rPEPCKSREBF2)788Reh/0
(Not Specified)
|
increased circulating cholesterol level
|
J:86518
|
Tg(SFTPC-Tnf)2Pva/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood coagulation
|
J:28120
|
cyanosis
|
J:28120
|
Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * CBA)
|
increased circulating testosterone level
|
J:239368
|
Tg(SLC2A4-OGT)15Jaha/0
(involves: C57BL/6)
|
increased circulating insulin level
|
J:93113
|
increased circulating leptin level
|
J:93113
|
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N)
|
abnormal circulating hormone level
|
J:91800
|
decreased circulating insulin level
|
J:91800
|
decreased circulating leptin level
|
J:91800
|
decreased circulating triiodothyronine level
|
J:91800
|
increased circulating corticosterone level
|
J:91800
|
increased circulating glucose level
|
J:91800
|
increased circulating ketone body level
|
J:91800
|
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal circulating hormone level
|
J:91800
|
decreased circulating insulin level
|
J:91800
|
decreased circulating leptin level
|
J:91800
|
increased circulating corticosterone level
|
J:91800
|
Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J)
|
decreased circulating triglyceride level
|
J:35770
|
increased circulating aspartate transaminase level
|
J:35770
|
increased circulating serum albumin level
|
J:35770
|
increased circulating total protein level
|
J:35770
|
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh)
|
decreased circulating leptin level
|
J:100328
|
increased circulating glucose level
|
J:100328
|
increased circulating insulin level
|
J:100328
|
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:93775
|
decreased circulating HDL cholesterol level
|
J:93775
|
Tg(SULT1A1,SULT1A2)1Glatt/0
(FVB/N-Tg(SULT1A1,SULT1A2)1Glatt)
|
abnormal blood homeostasis
|
J:217578
|
Tg(TcraTcrbNY8.3)1Pesa/?
(involves: C57BL/6 * NOD * SJL)
|
increased circulating glucose level
|
J:44202
|
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcrbAI4)1Dvs)
|
abnormal circulating glucose level
|
J:93553
|
Tg(Tek-cre)1Ywa/0 Thbdtm2Rdr/Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal blood coagulation
|
J:71269
|
abnormal placental thrombosis
|
J:71269
|
abnormal thrombosis
|
J:71269
|
increased circulating D-dimer level
|
J:71269
|
increased circulating interleukin-6 level
|
J:71269
|
Tg(Tek-Procr)1Cte/0
(B6.FVB-Tg(Tek-Procr)1Cte)
|
abnormal blood coagulation
|
J:119637
|
abnormal platelet physiology
|
J:119637
|
Tg(Tek-tTA)1Rwng/0 Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N)
|
abnormal thrombosis
|
J:139943
|
Tg(tetO-BRAF*V600E)26Jaf/0 Tg(TG-rtTA)30Jaf/0
(involves: FVB/N)
|
decreased circulating thyroid-stimulating hormone level
|
J:184420
|
decreased circulating thyroxine level
|
J:184420
|
Tg(TG-BRAF*V600E)2Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)2Jaf)
|
decreased circulating triiodothyronine level
|
J:98550
|
increased circulating thyroid-stimulating hormone level
|
J:98550
|
Tg(TG-BRAF*V600E)3Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)3Jaf)
|
increased circulating thyroid-stimulating hormone level
|
J:98550
|
Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N)
|
decreased circulating thyroxine level
|
J:93679
|
decreased circulating triiodothyronine level
|
J:93679
|
increased circulating thyroid-stimulating hormone level
|
J:93679
|
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J)
|
decreased circulating thyroxine level
|
J:209788
|
Tg(Tlr7)1Boll/0
(involves: C57BL/6)
|
abnormal circulating chemokine level
|
J:127600
|
increased circulating interleukin-6 level
|
J:127600
|
increased circulating tumor necrosis factor level
|
J:127600
|
Tg(TNFSF11)5519Edou/0
(involves: C57BL/6J * CBA/J)
|
increased circulating alkaline phosphatase level
|
J:233240
|
Tg(Ttr-Cdkn1a)36Tvd/?
(B6.Cg-Tg(Ttr-Cdkn1a)36Tvd)
|
hyperglycemia
|
J:94077
|
Tg(Ttr-Foxo1)305Dac/0
(involves: FVB * C57BL/6)
|
decreased circulating insulin level
|
J:79560
|
hyperglycemia
|
J:79560
|
Tg(Ttr-Foxo1)307Dac/0
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:94423
|
increased circulating HDL cholesterol level
|
J:94423
|
increased circulating triglyceride level
|
J:94423
|
Tg(Ttr-Foxo1)307Dac/0
(involves: FVB * C57BL/6)
|
hyperglycemia
|
J:79560
|
increased circulating insulin level
|
J:79560
|
Tg(Ttr-IGF1)1Sykr/0
(FVB/N-Tg(Ttr-IGF1)1Sykr)
|
decreased circulating insulin level
|
J:157350
|
increased circulating insulin-like growth factor I level
|
J:157350
|
Tg(Ttr-KLF6)1Fdmn/?
(Not Specified)
|
decreased circulating serum albumin level
|
J:122903
|
Tg(TTR-p19Cdkn2a)2Tvd/0
(involves: C57BL/6J * DBA/2J)
|
increased circulating glucose level
|
J:94077
|
Tg(Ttr-Retn)1Laz/?
(involves: C57BL/6 * SJL)
|
hyperglycemia
|
J:91890
|
increased circulating glucose level
|
J:91890
|
Tg(UcpDta)1Kz/?
(involves: FVB/N)
|
hyperglycemia
|
J:78211
|
hyperlipidemia
|
J:78211
|
increased circulating cholesterol level
|
J:78211
|
increased circulating insulin level
|
J:78211
|
increased circulating triglyceride level
|
J:147417,
J:78211
|
Tg(Umod*C147W)958Lura/0
(involves: FVB)
|
increased blood osmolality
|
J:161532
|
increased blood urea nitrogen level
|
J:161532
|
increased circulating antidiuretic hormone level
|
J:161532
|
increased circulating creatinine level
|
J:161532
|
Tg(Vav1-JAK2*V617F)AZjz/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood homeostasis
|
J:135993
|
decreased circulating erythropoietin level
|
J:135993
|
Tg(VDR*L233S,luc)T807Pike/0 Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating calcium level
|
J:218709
|
decreased circulating phosphate level
|
J:218709
|
increased circulating parathyroid hormone level
|
J:218709
|
Tg(Vil1-cre)997Gum/? Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J)
|
increased circulating cholesterol level
|
J:229155
|
increased circulating triglyceride level
|
J:229155
|
increased fasting circulating glucose level
|
J:229155
|
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N)
|
increased circulating tumor necrosis factor level
|
J:173946
|
Tg(Wnk4)#Rpl/Tg(Wnk4)#Rpl
(involves: C3H * C57BL/6)
|
decreased circulating magnesium level
|
J:113094
|
decreased circulating potassium level
|
J:113094
|
Tg(Wnk4*Q562E)#Rpl/Tg(Wnk4*Q562E)#Rpl
(involves: C3H * C57BL/6)
|
decreased circulating bicarbonate level
|
J:113094
|
hyperkalemia
|
J:113094
|
increased circulating magnesium level
|
J:113094
|
Tg(WTbeta2)4Wjk/?
(Not Specified)
|
abnormal atrial thrombosis
|
J:128583
|
Tg(WTbeta2)4Wjk/0
(B6.Cg-Tg(WTbeta2)4Wjk)
|
cyanosis
|
J:125581
|
Tg(Zp3-cre)93Knw/0 Yy1tm1Yshi/Yy1tm2.1Yshi
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal circulating hormone level
|
J:170240
|
increased circulating follicle stimulating hormone level
|
J:170240
|
Tgcog/Tgcog
(AKR/J-Tgcog)
|
decreased circulating thyroxine level
|
J:13923
|
Tgcog/Tgcog
(involves: AKR/J * C57BL/6By)
|
decreased circulating thyroxine level
|
J:8567
|
decreased circulating triiodothyronine level
|
J:8567
|
increased circulating thyroid-stimulating hormone level
|
J:8567
|
Tgem1(IMPC)J/Tgem1(IMPC)J
(C57BL/6NJ-Tgem1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Tgm4Btlr/Tgm4Btlr
(C57BL/6J-Tgm4Btlr)
|
increased fasting circulating glucose level
|
J:272522
|
Tgdsem1(IMPC)Mbp/Tgds+
(C57BL/6N-Tgdsem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tgfb1tm1(Tgfb3)Kul/Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:204892
|
decreased circulating leptin level
|
J:204892
|
Tgfb1tm1.1Mki/Tgfb1tm1.1Mki
(C57BL/6-Tgfb1tm1.1Mki)
|
decreased circulating aldosterone level
|
J:194237
|
increased circulating angiotensinogen level
|
J:194237
|
increased circulating renin level
|
J:194237
|
Tgfb1tm1Doe/Tgfb1+
(involves: 129S2/SvPas * CF-1)
|
increased circulating creatinine level
|
J:137529
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1)
|
increased circulating alanine transaminase level
|
J:69346
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe)
|
increased circulating alanine transaminase level
|
J:69346
|
Tgfb1tm1Mki/Tgfb1tm1Mki
(C57BL/6-Tgfb1tm1Mki)
|
decreased circulating angiotensinogen level
|
J:194237
|
decreased circulating potassium level
|
J:194237
|
decreased circulating renin level
|
J:194237
|
increased circulating aldosterone level
|
J:194237
|
increased circulating corticosterone level
|
J:194237
|
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv)
|
abnormal atrial thrombosis
|
J:50848
|
Tgfb1i1tm1b(KOMP)Wtsi/Tgfb1i1tm1b(KOMP)Wtsi
(C57BL/6N-Tgfb1i1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Tgfb2tm1Doe/Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
cyanosis
|
J:41682
|
Tgfb3tm1Doe/Tgfb3tm1Doe
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CF-1))
|
cyanosis
|
J:29901
|
Tgfb3tm1Jhg/Tgfb3tm1Jhg
(either: (involves: 129S1/Sv * 129X1/SvJ * Black Swiss) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
cyanosis
|
J:29902
|
Tgfbr3lem2Djb/Tgfbr3lem2Djb
(C57BL/6N-Tgfbr3lem2Djb)
|
increased circulating follicle stimulating hormone level
|
J:316383
|
Tgif2tm1b(EUCOMM)Wtsi/Tgif2+
(C57BL/6N-Tgif2tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating calcium level
|
J:211773
|
Tglq1MRL/MpJ/Tglq1MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033
|
Tglq1MRL/MpJ/Tglq1SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033
|
Tglq2MRL/MpJ/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033,
J:123776
|
Tglq2SJL/J/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033,
J:123776
|
Tglq3RF/J/Tglq3RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating triglyceride level
|
J:123776
|
Tglq4NZB/BlNJ/Tglq4NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating triglyceride level
|
J:123776
|
Tglq4NZB/BlNJ/Tglq4RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating triglyceride level
|
J:123776
|
Tgls1KK/Ta/Tgls1KK/Ta
(involves: BALB/c * KK/Ta)
|
decreased circulating triglyceride level
|
J:88209
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating insulin level
|
J:78633
|
hyperglycemia
|
J:78633
|
Tgm6tm1a(KOMP)Wtsi/Tgm6tm1a(KOMP)Wtsi
(C57BL/6N-Tgm6tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Tgq9DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq10DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq11DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq13DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq14DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq15DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq17DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq18DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq19DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq20DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq21DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq22DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq23DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq24DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq25DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq26DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq27DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq28DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq29DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Thap11em1Poche/Thap11em1Poche
(C57BL/6J-Thap11em1Poche)
|
cyanosis
|
J:317822
|
Thap12em1(IMPC)J/Thap12+
(C57BL/6NJ-Thap12em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Thbdtm1.1Hlwu/Thbdtm1.1Hlwu Lyz2tm1(cre)Ifo/Lyz2+
(B6.129-Thbdtm1.1Hlwu Lyz2tm1(cre)Ifo)
|
decreased circulating interleukin-6 level
|
J:188879
|
decreased circulating tumor necrosis factor level
|
J:188879
|
Thbdtm1Emc/Thbdtm1Emc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating protein level
|
J:54997
|
Thbdtm1Wlr/Thbdtm1Wlr
(B6.129S2-Thbdtm1Wlr)
|
abnormal blood coagulation
|
J:111502
|
decreased circulating tumor necrosis factor level
|
J:111502
|
increased circulating D-dimer level
|
J:111502
|
increased circulating interleukin-1 beta level
|
J:111502
|
increased circulating interleukin-6 level
|
J:111502
|
increased susceptibility to induced thrombosis
|
J:111502
|
Thbdtm1Wlr/Thbdtm2Rdr
(involves: 129S2/SvPas * C57BL/6)
|
abnormal blood coagulation
|
J:111502
|
abnormal lung thrombosis
|
J:47676
|
increased circulating D-dimer level
|
J:111502
|
increased susceptibility to induced thrombosis
|
J:111502
|
Thbdtm2.1Emc/Thbdtm2.1Emc
(involves: 129/Sv * BALB/c * C57BL/6)
|
increased circulating interleukin-1 beta level
|
J:118000
|
increased circulating tumor necrosis factor level
|
J:118000
|
Thbs1tm1.1(KOMP)Vlcg/Thbs1tm1.1(KOMP)Vlcg
(C57BL/6N-Thbs1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Thbs1tm1Hyn/Thbs1tm1Hyn Thbs2tm1Bst/Thbs2tm1Bst
(involves: 129T2/SvEms * 129X1/SvJ)
|
increased bleeding time
|
J:78876
|
Thbs2tm1Bst/Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))
|
increased bleeding time
|
J:45509
|
Them5tm1Hem/Them5tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating free fatty acids level
|
J:186657
|
Themis2tm1a(KOMP)Wtsi/Themis2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Themis2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:175295
|
increased circulating potassium level
|
J:175295
|
Thoc7em1(IMPC)J/Thoc7+
(C57BL/6NJ-Thoc7em1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
increased bleeding time
|
J:290567
|
Thratm1.1Fcas/Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas)
|
increased circulating glucagon level
|
J:179839
|
increased circulating glucose level
|
J:179839
|
increased circulating insulin level
|
J:179839
|
increased circulating thyroxine level
|
J:179839
|
increased circulating triiodothyronine level
|
J:179839
|
Thratm1b(EUCOMM)Wtsi/Thra+
(C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Thratm1Brnt/Thra+
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating glucose level
|
J:85803
|
increased circulating insulin level
|
J:85803
|
increased circulating leptin level
|
J:85803
|
increased circulating thyroid-stimulating hormone level
|
J:85803
|
increased circulating thyroxine level
|
J:85803
|
increased circulating triiodothyronine level
|
J:85803
|
Thratm1Jas/Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating thyroxine level
|
J:68577
|
Thratm1Jas/Thratm1Jas Thrbtm1Olc/Thrbtm1Olc
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ)
|
increased circulating thyroid-stimulating hormone level
|
J:52829
|
increased circulating thyroxine level
|
J:52829
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased circulating thyroid-stimulating hormone level
|
J:73446
|
increased circulating triiodothyronine level
|
J:73446
|
Thratm1Ven/Thratm1Ven Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:95391
|
increased circulating thyroxine level
|
J:95391
|
increased circulating triiodothyronine level
|
J:95391
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
decreased circulating insulin-like growth factor I level
|
J:120899
|
decreased circulating thyroxine level
|
J:68577,
J:120899
|
Thratm2Jas/Thratm2Jas
(involves: 129/Sv * C57BL/6)
|
decreased circulating thyroxine level
|
J:126521
|
Thratm2Ven/Thra+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased circulating insulin-like growth factor I level
|
J:72959
|
decreased circulating thyroxine level
|
J:72959
|
decreased circulating triiodothyronine level
|
J:72959
|
Thratm2Ven/Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c)
|
decreased circulating insulin-like growth factor I level
|
J:72959
|
decreased circulating thyroxine level
|
J:72959
|
decreased circulating triiodothyronine level
|
J:72959
|
Thratm2Ven/Thratm2Ven Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased circulating thyroxine level
|
J:118402
|
decreased circulating triiodothyronine level
|
J:118402
|
Thratm4.1Ven/Thra+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N)
|
increased circulating triiodothyronine level
|
J:166513
|
Thrap3tm1c(KOMP)Wtsi/Thrap3tm1c(KOMP)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)
|
decreased circulating alanine transaminase level
|
J:339439
|
decreased circulating aspartate transaminase level
|
J:339439
|
decreased circulating cholesterol level
|
J:339439
|
decreased circulating free fatty acids level
|
J:339439
|
decreased circulating glucose level
|
J:339439
|
decreased circulating insulin level
|
J:339439
|
decreased circulating triglyceride level
|
J:339439
|
Thrbtm1.1Syc/Thrb+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
increased circulating thyroid-stimulating hormone level
|
J:65885
|
increased circulating thyroxine level
|
J:65885
|
increased circulating triiodothyronine level
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal circulating hormone level
|
J:65885
|
increased circulating thyroid-stimulating hormone level
|
J:65885
|
increased circulating thyroxine level
|
J:84310,
J:65885
|
increased circulating triiodothyronine level
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:95391
|
increased circulating thyroxine level
|
J:95391
|
increased circulating triiodothyronine level
|
J:95391
|
Thrbtm1Df/Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J)
|
decreased circulating thyroxine level
|
J:34421
|
increased circulating thyroxine level
|
J:34421
|
increased circulating triiodothyronine level
|
J:34421
|
Thrbtm1Df/Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J))
|
increased circulating thyroxine level
|
J:103702
|
increased circulating triiodothyronine level
|
J:103702
|
Thrbtm1Few/Thrbtm1Few
(involves: 129S4/SvJae)
|
increased circulating thyroid-stimulating hormone level
|
J:56668
|
Thrbtm1Mkni/Thrbtm1Mkni Hprt1tm1(TG-cre)1Sasr/Y
(involves: 129/Sv * C57BL/6)
|
decreased circulating thyroid-stimulating hormone level
|
J:208718
|
increased circulating levels of thyroid hormone
|
J:208718
|
increased circulating thyroxine level
|
J:208718
|
Thrbtm1Olc/Thrbtm1Olc
(involves: 129)
|
decreased circulating insulin-like growth factor I level
|
J:120899
|
increased circulating thyroid-stimulating hormone level
|
J:126521,
J:52829,
J:120899
|
increased circulating thyroxine level
|
J:126521,
J:52829,
J:68577,
J:120899
|
increased circulating triiodothyronine level
|
J:126521,
J:52829
|
Thrbtm2a(EUCOMM)Wtsi/Thrbtm2a(EUCOMM)Wtsi
(C57BL/6N-Thrbtm2a(EUCOMM)Wtsi/H)
|
decreased circulating glycerol level
|
J:165965
|
Thrbtm2Df/Thrbtm2Df
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating thyroid-stimulating hormone level
|
J:66737
|
increased circulating triiodothyronine level
|
J:66737
|
Thrbtm2Few/Thrb+
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:77623
|
Thrbtm2Few/Thrbtm2Few
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:77623
|
Thrbtm3Few/Thrbtm3Few
(involves: 129 * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:85158
|
increased circulating thyroxine level
|
J:85158
|
increased circulating triiodothyronine level
|
J:85158
|
Thrbtm4Few/Thrbtm4Few
(involves: 129 * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:85158
|
Thrbtm5Few/Thrb+
(involves: 129 * C57BL/6)
|
increased circulating thyroxine level
|
J:100929
|
Thrbtm5Few/Thrbtm5Few
(involves: 129 * C57BL/6)
|
increased circulating thyroid-stimulating hormone level
|
J:100929
|
increased circulating thyroxine level
|
J:100929
|
increased circulating triiodothyronine level
|
J:100929
|
Thrbtm6.1Few/Thrb+
(involves: 129 * C57BL/6)
|
increased circulating thyroxine level
|
J:150008
|
increased circulating triiodothyronine level
|
J:150008
|
Thrbtm6.1Few/Thrbtm6.1Few
(involves: 129 * C57BL/6)
|
increased circulating thyroxine level
|
J:150008
|
increased circulating triiodothyronine level
|
J:150008
|
Thsd7bem1(IMPC)Kmpc/Thsd7bem1(IMPC)Kmpc
(C57BL/6NTac-Thsd7bem1(IMPC)Kmpc/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Tial1tm1b(EUCOMM)Wtsi/Tial1+
(C57BL/6N-Tial1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Ticam1Lps2/Ticam1Lps2
(involves: C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:86521
|
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2)
|
abnormal circulating tumor necrosis factor level
|
J:138963
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-6 level
|
J:145306
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:130954
|
decreased circulating interleukin-6 level
|
J:130954
|
decreased circulating interleukin-12b level
|
J:130954
|
Ticam1tm1Aki/Ticam1tm1Aki
(B6.129P2-Ticam1tm1Aki)
|
decreased circulating tumor necrosis factor level
|
J:144301
|
Tigd3em1(IMPC)J/Tigd3em1(IMPC)J
(C57BL/6NJ-Tigd3em1(IMPC)J/Mmjax)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Tigittm1.1(IMPC)Wtsi/Tigittm1.1(IMPC)Wtsi
(C57BL/6N-Tigittm1.1(IMPC)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Timd4tm1Kuch/Timd4tm1Kuch
(involves: C57BL/6)
|
abnormal circulating chemokine level
|
J:235399
|
decreased circulating interleukin-10 level
|
J:235399
|
increased circulating creatinine level
|
J:235399
|
increased circulating interleukin-1 beta level
|
J:235399
|
increased circulating interleukin-6 level
|
J:235399
|
increased circulating interleukin-12b level
|
J:235399
|
Timm8a1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Timm8a1em1(IMPC)Tcp/Tcp)
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Timm8a1em1(IMPC)Tcp/Timm8a1em1(IMPC)Tcp
(C57BL/6NCrl-Timm8a1em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Timm10btm1.1(KOMP)Vlcg/Timm10b+
(C57BL/6N-Timm10btm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Timm17bem1(IMPC)J/Y
(C57BL/6NJ-Timm17bem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Timm17bem1(IMPC)J/Timm17bem1(IMPC)J
(C57BL/6NJ-Timm17bem1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
Timm22tm1b(KOMP)Wtsi/Timm22+
(B6N(Cg)-Timm22tm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Timm44em1(IMPC)Mbp/Timm44+
(C57BL/6NCrl-Timm44em1(IMPC)Mbp/MbpMmucd)
|
increased fasting circulating glucose level
|
J:211773
|
Timm50tm1b(EUCOMM)Wtsi/Timm50+
(C57BL/6N-Timm50tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating alanine transaminase level
|
J:211773
|
Timmdc1tm1b(EUCOMM)Wtsi/Timmdc1+
(C57BL/6N-Timmdc1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))
|
increased circulating cholesterol level
|
J:127183
|
increased circulating glucose level
|
J:127183
|
increased circulating insulin level
|
J:127183
|
increased circulating LDL cholesterol level
|
J:127183
|
increased circulating leptin level
|
J:127183
|
Timo/Timo+
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))
|
increased circulating LDL cholesterol level
|
J:127183
|
Timp1tm1Pds/Y
(involves: 129S4/SvJae)
|
increased circulating testosterone level
|
J:49303
|
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae)
|
decreased circulating progesterone level
|
J:64154
|
increased circulating estradiol level
|
J:64154
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor)
|
increased blood urea nitrogen level
|
J:117491
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
decreased circulating estradiol level
|
J:142042
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)
|
decreased fasting circulating glucose level
|
J:250417
|
increased circulating alanine transaminase level
|
J:250417
|
Tjp1tm1.1Whun/Tjp1tm1.1Whun Tjp2tm2Whun/Tjp2tm2Whun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2)
|
increased circulating alanine transaminase level
|
J:306936
|
increased circulating alkaline phosphatase level
|
J:306936
|
increased circulating aspartate transaminase level
|
J:306936
|
increased circulating bilirubin level
|
J:306936
|
increased circulating LDL cholesterol level
|
J:306936
|
Tjp2tm2Whun/Tjp2tm2Whun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)
|
increased circulating alanine transaminase level
|
J:306936
|
increased circulating aspartate transaminase level
|
J:306936
|
increased circulating LDL cholesterol level
|
J:306936
|
Tldc2em1(IMPC)J/Tldc2em1(IMPC)J
(C57BL/6NJ-Tldc2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Tle3tm1.1Pton/Tle3tm1.1Pton Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
hyperglycemia
|
J:307817
|
Tle3tm1.1Pton/Tle3tm1.1Pton Tle4tm1.1Dasw/Tle4tm1.1Dasw Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
hyperglycemia
|
J:307817
|
Tlk1tm1b(EUCOMM)Hmgu/Tlk1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tlk1tm1b(EUCOMM)Hmgu/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Tln1tm1.1Bpet/Tln1tm4.1Crit Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet physiology
|
J:177971
|
reduced thrombolysis
|
J:177971
|
Tln1tm4.1Crit/Tln1tm4.1Crit Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal platelet activation
|
J:129708
|
abnormal thrombosis
|
J:129708
|
increased bleeding time
|
J:129708
|
Tln1tm4.1Crit/Tln1tm4.1Crit Tg(Pf4-icre)Q3Rsko/?
(involves: 129P2/OlaHsd)
|
abnormal platelet activation
|
J:129707
|
abnormal thrombosis
|
J:129707
|
increased bleeding time
|
J:129707
|
Tln1tm4.1Crit/Tln1tm4.1Crit Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced thrombolysis
|
J:177971
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
abnormal circulating cholesterol level
|
J:158035
|
abnormal circulating glucose level
|
J:158035
|
abnormal circulating insulin level
|
J:158035
|
abnormal circulating LDL cholesterol level
|
J:158035
|
abnormal circulating lipid level
|
J:158035
|
decreased circulating VLDL cholesterol level
|
J:158035
|
increased circulating free fatty acids level
|
J:158035
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
decreased circulating alanine transaminase level
|
J:135830
|
decreased circulating interleukin-1 beta level
|
J:119941
|
decreased circulating tumor necrosis factor level
|
J:119941
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
decreased circulating insulin level
|
J:162168
|
decreased circulating leptin level
|
J:162168
|
decreased circulating tumor necrosis factor level
|
J:162168
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129)
|
abnormal circulating corticosterone level
|
J:94463
|
abnormal circulating pituitary hormone level
|
J:94463
|
decreased circulating corticosterone level
|
J:94463
|
increased circulating adrenocorticotropin level
|
J:94463
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
hyperglycemia
|
J:135353
|
increased circulating troponin I level
|
J:119967
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
abnormal circulating enzyme level
|
J:114368
|
decreased circulating alanine transaminase level
|
J:114368
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal circulating glucose level
|
J:126488
|
abnormal circulating leptin level
|
J:126488
|
decreased circulating insulin level
|
J:126488
|
increased circulating interleukin-6 level
|
J:37271
|
Tlr4lps-del/Tlr4lps-del
(involves: C57BL/10ScN)
|
abnormal circulating enzyme level
|
J:114368
|
decreased circulating alanine transaminase level
|
J:114368
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-6 level
|
J:145306
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased circulating cholesterol level
|
J:158055
|
increased circulating insulin level
|
J:158055
|
increased circulating lipocalin 2 level
|
J:158055
|
increased circulating triglyceride level
|
J:158055
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
increased circulating interferon-gamma level
|
J:324448
|
increased circulating interleukin-6 level
|
J:324448
|
increased circulating interleukin-10 level
|
J:324448
|
increased circulating tumor necrosis factor level
|
J:324448
|
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Tlr7em2Anu)
|
increased circulating interferon-gamma level
|
J:324448
|
increased circulating interleukin-6 level
|
J:324448
|
increased circulating interleukin-10 level
|
J:324448
|
increased circulating tumor necrosis factor level
|
J:324448
|
Tlr7tm1Flv/Tlr7tm1Flv
(involves: 129S1/Sv)
|
decreased circulating interferon-alpha level
|
J:89257
|
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg)
|
increased circulating interleukin-12 level
|
J:165267
|
Tlx3tm1Sjk/Tlx3tm1Sjk
(involves: 129X1/SvJ)
|
cyanosis
|
J:60751
|
tm/tm
(Not Specified)
|
abnormal circulating protein level
|
J:315
|
increased circulating serum albumin level
|
J:315
|
Tm6sf2em1Yech/Tm6sf2em1Yech
(C57BL/6-Tm6sf2em1Yech)
|
decreased circulating cholesterol level
|
J:235704
|
decreased circulating HDL cholesterol level
|
J:235704
|
decreased circulating LDL cholesterol level
|
J:235704
|
increased circulating triglyceride level
|
J:235704
|
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2tm1a(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi)
|
abnormal circulating apolipoprotein level
|
J:234195
|
decreased circulating cholesterol level
|
J:234195
|
decreased circulating HDL cholesterol level
|
J:234195
|
decreased circulating LDL cholesterol level
|
J:234195
|
decreased circulating VLDL triglyceride level
|
J:234195
|
increased circulating alanine transaminase level
|
J:234195
|
increased circulating triglyceride level
|
J:234195
|
Tm6sf2tm1b(KOMP)Wtsi/Tm6sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1b(KOMP)Wtsi/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Tm7sf2tm1b(KOMP)Wtsi/Tm7sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm7sf2tm1b(KOMP)Wtsi/Orl)
|
decreased circulating serum albumin level
|
J:211773
|
Tm9sf3em1(IMPC)Mbp/Tm9sf3+
(C57BL/6NCrl-Tm9sf3em1(IMPC)Mbp/Mmucd)
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Tm9sf4tm1a(KOMP)Wtsi/Tm9sf4tm1a(KOMP)Wtsi
(C57BL/6N-Tm9sf4tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Tm59/?
(involves: C3H/HeH * C57BL/6J)
|
increased circulating insulin level
|
J:169366
|
Tm60/?
(involves: C3H/HeH * C57BL/6J)
|
increased circulating insulin level
|
J:169366
|
Tmbim1tm1Noj/Tmbim1tm1Noj
(B6.129S2-Tmbim1tm1Noj)
|
abnormal circulating enzyme level
|
J:210916
|
Tmc6tm1a(EUCOMM)Wtsi/Tmc6tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmc6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating aspartate transaminase level
|
J:175295
|
Tmc7em1(IMPC)Mbp/Tmc7em1(IMPC)Mbp
(C57BL/6NCrl-Tmc7em1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Tmco1tm1Tsta/Tmco1tm1Tsta
(B6.Cg-Tmco1tm1Tsta)
|
decreased circulating estradiol level
|
J:268917
|
increased circulating follicle stimulating hormone level
|
J:268917
|
increased circulating luteinizing hormone level
|
J:268917
|
Tmco2tm1a(KOMP)Wtsi/Tmco2tm1a(KOMP)Wtsi
(C57BL/6N-Tmco2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Tmco6tm1.1(KOMP)Vlcg/Tmco6tm1.1(KOMP)Vlcg
(C57BL/6N-Tmco6tm1.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
Tmed3tm2b(EUCOMM)Hmgu/Tmed3tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmed3tm2b(EUCOMM)Hmgu/BayMmucd)
|
increased circulating iron level
|
J:211773
|
Tmeff2em1(IMPC)Hmgu/Tmeff2+
(C57BL/6NCrl-Tmeff2em1(IMPC)Hmgu/Ieg)
|
decreased circulating creatinine level
|
J:211773
|
Tmem9bem1(IMPC)J/Tmem9bem1(IMPC)J
(C57BL/6NJ-Tmem9bem1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem11em1(IMPC)Tcp/Tmem11em1(IMPC)Tcp
(C57BL/6N-Tmem11em1(IMPC)Tcp/Tcp)
|
increased circulating aspartate transaminase level
|
J:211773
|
Tmem18tm1b(EUCOMM)Wtsi/Tmem18tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem18tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glucose level
|
J:211773
|
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA)
|
increased circulating alanine transaminase level
|
J:249038
|
increased circulating aspartate transaminase level
|
J:249038
|
increased circulating bilirubin level
|
J:249038
|
Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg)
|
increased circulating corticosterone level
|
J:244268
|
Tmem37tm1a(EUCOMM)Wtsi/Tmem37tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem37tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Tmem38btm1Hta/Tmem38btm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
cyanosis
|
J:150355
|
Tmem41bem1Cya/Tmem41b+
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:316472
|
decreased circulating LDL cholesterol level
|
J:316472
|
decreased circulating triglyceride level
|
J:316472
|
Tmem41btm1b(KOMP)Wtsi/Tmem41b+
(C57BL/6N-Tmem41btm1b(KOMP)Wtsi/Kmpc)
|
increased circulating creatine kinase level
|
J:211773
|
Tmem42tm1b(KOMP)Wtsi/Tmem42tm1b(KOMP)Wtsi
(C57BL/6N-Tmem42tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tmem51tm1b(EUCOMM)Hmgu/Tmem51tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem51tm1b(EUCOMM)Hmgu/H)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem60em1(IMPC)Ccpcz/Tmem60em1(IMPC)Ccpcz
(C57BL/6N-Tmem60em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Tmem63btm1b(EUCOMM)Wtsi/Tmem63b+
(C57BL/6N-Tmem63btm1b(EUCOMM)Wtsi/Ics)
|
increased circulating bilirubin level
|
J:211773
|
Tmem64Gt(SYA242)Byg/Tmem64Gt(SYA242)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating osteocalcin level
|
J:198051
|
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating potassium level
|
J:165965
|
increased circulating calcium level
|
J:165965
|
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi)
|
decreased circulating triglyceride level
|
J:339870
|
Tmem72tm1b(KOMP)Wtsi/Tmem72tm1b(KOMP)Wtsi
(C57BL/6N-Tmem72tm1b(KOMP)Wtsi/Kmpc)
|
decreased blood urea nitrogen level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Tmem79tm1.1(KOMP)Wtsi/Tmem79tm1.1(KOMP)Wtsi
(C57BL/6N-Tmem79tm1.1(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Tmem86atm1b(KOMP)Mbp/Tmem86atm1b(KOMP)Mbp
(C57BL/6N-Tmem86atm1b(KOMP)Mbp/Kmpc)
|
increased blood urea nitrogen level
|
J:211773
|
Tmem86btm2b(EUCOMM)Hmgu/Tmem86btm2b(EUCOMM)Hmgu
(C57BL/6N-Tmem86btm2b(EUCOMM)Hmgu/Bay)
|
increased circulating phosphate level
|
J:211773
|
Tmem87aem1(IMPC)Kmpc/Tmem87aem1(IMPC)Kmpc
(C57BL/6NTac-Tmem87aem1(IMPC)Kmpc/Kmpc)
|
increased circulating serum albumin level
|
J:211773
|
Tmem87bem1(IMPC)J/Tmem87bem1(IMPC)J
(C57BL/6NJ-Tmem87bem1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem100tm1e.1(KOMP)Wtsi/Tmem100+
(C57BL/6N-Tmem100tm1e.1(KOMP)Wtsi/Tcp)
|
decreased circulating calcium level
|
J:211773
|
Tmem104tm1.1(KOMP)Vlcg/Tmem104tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem104tm1.1(KOMP)Vlcg/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Tmem106aem1Cheyy/Tmem106aem1Cheyy
(B6.Cg-Tmem106aem1Cheyy)
|
increased circulating interferon-beta level
|
J:345342
|
increased circulating interleukin-6 level
|
J:345342
|
increased circulating tumor necrosis factor level
|
J:345342
|
Tmem106btm2b(KOMP)Wtsi/Tmem106btm2b(KOMP)Wtsi
(C57BL/6N-Tmem106btm2b(KOMP)Wtsi/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tmem108tm1b(EUCOMM)Wtsi/Tmem108tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem108tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating aspartate transaminase level
|
J:211773
|
Tmem115tm1(KOMP)Vlcg/Tmem115+
(C57BL/6N-Tmem115tm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating bilirubin level
|
J:211773
|
Tmem116tm1b(EUCOMM)Hmgu/Tmem116tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem116tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Tmem117tm1.1Thor/Tmem117tm1.1Thor
(involves: C57BL/6N)
|
increased circulating antidiuretic hormone level
|
J:339175
|
Tmem121bem1(IMPC)Tcp/Tmem121bem1(IMPC)Tcp
(C57BL/6NCrl-Tmem121bem1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Tmem127tm1(KOMP)Wtsi/Tmem127tm1(KOMP)Wtsi
(C57BL/6N-Tmem127tm1(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Tmem129tm1.1(KOMP)Vlcg/Tmem129tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem129tm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem131em1(IMPC)J/Tmem131+
(C57BL/6NJ-Tmem131em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tmem145em1(IMPC)Mbp/Tmem145em1(IMPC)Mbp
(C57BL/6N-Tmem145em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Tmem151btm1b(KOMP)Wtsi/Tmem151btm1b(KOMP)Wtsi
(C57BL/6N-Tmem151btm1b(KOMP)Wtsi/J)
|
increased circulating sodium level
|
J:211773
|
Tmem161btm2b(EUCOMM)Hmgu/Tmem161b+
(C57BL/6N-Tmem161btm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Tmem163em1(IMPC)Kmpc/Tmem163em1(IMPC)Kmpc
(C57BL/6NTac-Tmem163em1(IMPC)Kmpc/Kmpc)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Tmem163em1(IMPC)Mbp/Tmem163em1(IMPC)Mbp
(C57BL/6N-Tmem163em1(IMPC)Mbp/MbpMmucd)
|
increased circulating insulin level
|
J:211773
|
Tmem163em1Lwbch/Tmem163em1Lwbch
(C57BL/6J-Tmem163em1Lwbch)
|
abnormal platelet physiology
|
J:323340
|
decreased platelet aggregation
|
J:323340
|
increased bleeding time
|
J:323340
|
Tmem167tm1a(EUCOMM)Hmgu/Tmem167+
(C57BL/6N-Tmem167tm1a(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:165965
|
decreased circulating total protein level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating serum albumin level
|
J:165965
|
Tmem174tm1Myz/Tmem174tm1Myz
(either: B6.Cg-Tmem174tm1Myz or D2.Cg-Tmem174tm1Myz)
|
abnormal circulating hormone level
|
J:328157
|
increased circulating parathyroid hormone level
|
J:328157
|
increased circulating phosphate level
|
J:328157
|
Tmem175tm1b(KOMP)Wtsi/Tmem175tm1b(KOMP)Wtsi
(C57BL/6N-Tmem175tm1b(KOMP)Wtsi/Kmpc)
|
increased circulating aspartate transaminase level
|
J:211773
|
Tmem176aem1(IMPC)Kmpc/Tmem176aem1(IMPC)Kmpc
(C57BL/6NTac-Tmem176aem1(IMPC)Kmpc/Kmpc)
|
decreased circulating alanine transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Tmem178btm1a(KOMP)Wtsi/Tmem178btm1a(KOMP)Wtsi
(C57BL/6N-Tmem178btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
Tmem203em1(IMPC)H/Tmem203em1(IMPC)H
(C57BL/6N-Tmem203em1(IMPC)H/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
Tmem212em1(IMPC)J/Tmem212em1(IMPC)J
(C57BL/6NJ-Tmem212em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
Tmem218Gt(OST40451)Lex/Tmem218Gt(OST40451)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased blood urea nitrogen level
|
J:227399
|
increased circulating alkaline phosphatase level
|
J:227399
|
increased circulating calcium level
|
J:227399
|
increased circulating creatinine level
|
J:227399
|
Tmem237tm1b(EUCOMM)Hmgu/Tmem237+
(C57BL/6N-Tmem237tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Tmem240em1(IMPC)Ccpcz/Tmem240em1(IMPC)Ccpcz
(C57BL/6N-Tmem240em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Tmem241tm1b(EUCOMM)Wtsi/Tmem241tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem241tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tmem254tm2a(KOMP)Wtsi/Tmem254tm2a(KOMP)Wtsi
(C57BL/6N-Tmem254tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating calcium level
|
J:211773
|
Tmem260tm1a(KOMP)Wtsi/Tmem260tm1a(KOMP)Wtsi
(C57BL/6N-Tmem260tm1a(KOMP)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Tmem263em1Gww/Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww)
|
abnormal blood homeostasis
|
J:345905
|
decreased circulating calcium level
|
J:345905
|
decreased circulating glucose level
|
J:345905
|
decreased circulating insulin level
|
J:345905
|
decreased circulating insulin-like growth factor I level
|
J:345905
|
Tmem268em1Cheyy/Tmem268em1Cheyy
(involves: C57BL/6)
|
increased circulating interferon-beta level
|
J:350812
|
increased circulating tumor necrosis factor level
|
J:350812
|
Tmlheem1Plaa/Tmlheem1Plaa
(C57BL/6N-Tmlheem1Plaa)
|
decreased circulating carnitine level
|
J:341247
|
decreased circulating lactate level
|
J:341247
|
Tmod1tm1a(KOMP)Wtsi/Tmod1+
(C57BL/6N-Tmod1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:175295
|
Tmprss2em1(IMPC)Ccpcz/Tmprss2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tmprss2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating alanine transaminase level
|
J:211773
|
Tmprss2tm2b(EUCOMM)Hmgu/Tmprss2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmprss2tm2b(EUCOMM)Hmgu/Orl)
|
increased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Tmprss6hem8/Tmprss6hem8
(C57BL/6J-Tmprss6hem8)
|
decreased circulating iron level
|
J:237155
|
increased circulating unsaturated transferrin level
|
J:237155
|
Tmprss6hem8/Tmprss6tm1Dgen
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating iron level
|
J:237155
|
increased circulating unsaturated transferrin level
|
J:237155
|
Tmprss6m2Btlr/Tmprss6m2Btlr
(C57BL/6J-Tmprss6m2Btlr)
|
decreased circulating iron level
|
J:140084
|
Tmprss6m3Btlr/Tmprss6m3Btlr
(C57BL/6J-Tmprss6m3Btlr)
|
decreased circulating iron level
|
J:143779
|
Tmprss6msk/Tmprss6msk
(C57BL/6J-Tmprss6msk)
|
decreased circulating iron level
|
J:134446
|
Tmprss6tm1b(EUCOMM)Wtsi/Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating calcium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Tmprss6tm1Dgen/Tmprss6+
(B6.129P2-Tmprss6tm1Dgen/Crl)
|
decreased circulating iron level
|
J:160248
|
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(B6.129P2-Tmprss6tm1Dgen/Crl)
|
decreased circulating iron level
|
J:237155,
J:160248
|
increased circulating unsaturated transferrin level
|
J:237155
|
Tmprss6tm1Otin/Tmprss6tm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating iron level
|
J:138734
|
Tmprss15tm1a(KOMP)Wtsi/Tmprss15tm1a(KOMP)Wtsi
(C57BL/6N-Tmprss15tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
increased blood urea nitrogen level
|
J:175295
|
increased circulating amylase level
|
J:175295
|
increased circulating sodium level
|
J:175295
|
Tmt1btm1.1(KOMP)Vlcg/Tmt1btm1.1(KOMP)Vlcg
(C57BL/6N-Timt1btm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
Tmtc2em2(IMPC)Kmpc/Tmtc2em2(IMPC)Kmpc
(C57BL/6NTac-Tmtc2em2(IMPC)Kmpc/Kmpc)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tmtc3Gt(JST185)Byg/Tmtc3Gt(JST185)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:178869
|
Tmtc3Gt(JST185)Byg/Tmtc3Gt(JST185)Byg
(involves: 129P2/OlaHsd * A/J)
|
cyanosis
|
J:178869
|
Tmtc4tm1.1(KOMP)Vlcg/Tmtc4tm1.1(KOMP)Vlcg
(C57BL/6N-Tmtc4tm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
TnfBpsm1/Tnf+
(involves: C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:226052
|
TnfBpsm1/Tnf+ Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:226052
|
TnfBpsm1/TnfBpsm1
(involves: C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:226052
|
TnfBpsm1/TnfBpsm1 Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:226052
|
Tnftm1.1Sned/Tnftm1.1Sned Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:95684
|
Tnftm1.1Sned/Tnftm1.1Sned Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased circulating tumor necrosis factor level
|
J:95684
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating glucose level
|
J:42579
|
decreased circulating insulin level
|
J:42579
|
decreased circulating leptin level
|
J:42579
|
decreased circulating triglyceride level
|
J:42579
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv)
|
decreased circulating tumor necrosis factor level
|
J:95684
|
Tnftm1Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:54056
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv)
|
decreased circulating tumor necrosis factor level
|
J:95684
|
Tnftm1Sek/Tnftm1Sek
(B6.Cg-Tnftm1Sek)
|
decreased circulating interferon-gamma level
|
J:44841
|
decreased circulating interleukin-1 alpha level
|
J:44841
|
decreased circulating interleukin-1 beta level
|
J:44841
|
decreased circulating interleukin-6 level
|
J:44841
|
Tnftm2.1Gkl/Tnftm2.1Gkl Tg(Fabp1-cre)1Jig/0
(involves: 129S/SvEv * FVB/N)
|
increased circulating tumor necrosis factor level
|
J:204557
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
abnormal circulating chemokine level
|
J:204922
|
abnormal circulating leptin level
|
J:204922
|
increased circulating tumor necrosis factor level
|
J:54056,
J:204922
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:264147
|
Tnftm2Gkl/Tnf+ Tnfrsf1btm1.1Gkl/Tnfrsf1btm1.1Gkl Tg(Col6a1-cre)1Gkl/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)
|
increased circulating tumor necrosis factor level
|
J:264147
|
Tnftm2Gkl/Tnf+ Tnfrsf1btm1.2Gkl/Tnfrsf1btm1.2Gkl
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
increased circulating tumor necrosis factor level
|
J:264147
|
Tnftm2Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:54056
|
Tnftm2Gkl/Tnftm2Gkl Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:54056
|
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:114740
|
Tnfaip1tm1a(EUCOMM)Wtsi/Tnfaip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfaip1tm1a(EUCOMM)Wtsi/H)
|
increased blood urea nitrogen level
|
J:165965
|
increased circulating alkaline phosphatase level
|
J:165965
|
increased circulating glucose level
|
J:165965
|
increased circulating triglyceride level
|
J:165965
|
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
decreased circulating luteinizing hormone level
|
J:324062
|
decreased fasting circulating glucose level
|
J:324062
|
increased circulating insulin level
|
J:324062
|
increased circulating progesterone level
|
J:324062
|
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum)
|
increased circulating alanine transaminase level
|
J:163410
|
increased circulating aspartate transaminase level
|
J:163410
|
increased circulating interleukin-6 level
|
J:163410
|
Tnfaip3tm1Homy/Tnfaip3tm1Homy Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal circulating cytokine level
|
J:212681
|
abnormal circulating interleukin level
|
J:212681
|
increased circulating interferon-gamma level
|
J:212681
|
increased circulating interleukin-1 beta level
|
J:212681
|
increased circulating interleukin-6 level
|
J:212681
|
increased circulating tumor necrosis factor level
|
J:212681
|
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
(involves: C57BL/6N)
|
increased circulating interleukin-6 level
|
J:223320
|
increased circulating interleukin-17 level
|
J:223320
|
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn)
|
increased circulating interleukin-1 beta level
|
J:139785
|
increased circulating interleukin-6 level
|
J:139785
|
increased circulating interleukin-10 level
|
J:139785
|
increased circulating interleukin-12 level
|
J:139785
|
increased circulating tumor necrosis factor level
|
J:139785
|
Tnfrsf1aem1(IMPC)Ccpcz/Tnfrsf1aem1(IMPC)Ccpcz
(C57BL/6NCrl-Tnfrsf1aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating aspartate transaminase level
|
J:211773
|
Tnfrsf1atm1Blt/Tnfrsf1a+
(involves: 129P2/OlaHsd)
|
decreased circulating interleukin-6 level
|
J:210950
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased circulating alanine transaminase level
|
J:50903
|
Tnfrsf1atm1Imx/Tnfrsf1a+
(involves: C57BL/6)
|
decreased circulating interleukin-6 level
|
J:210950
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
increased circulating tumor necrosis factor level
|
J:45147
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx/J)
|
decreased circulating interleukin-6 level
|
J:160543
|
increased circulating tumor necrosis factor level
|
J:160543
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal thrombosis
|
J:117987
|
increased circulating tumor necrosis factor level
|
J:45147
|
Tnfrsf1atm1Mak/Tnfrsf1a+
(involves: 129S2/SvPas)
|
decreased circulating interleukin-6 level
|
J:210950
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas)
|
decreased circulating interleukin-6 level
|
J:138824
|
increased circulating tumor necrosis factor level
|
J:139030
|
Tnfrsf1atm1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm1Rsie)
|
increased circulating tumor necrosis factor level
|
J:160543
|
Tnfrsf1atm1Rsie/Tnfrsf1atm1Rsie
(B6.Cg-Tnfrsf1atm1Rsie)
|
decreased circulating interleukin-1 beta level
|
J:160543
|
decreased circulating interleukin-6 level
|
J:160543
|
increased circulating tumor necrosis factor level
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
decreased circulating interleukin-1 beta level
|
J:160543
|
decreased circulating interleukin-6 level
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1atm2.1Rsie
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
decreased circulating interleukin-6 level
|
J:160543
|
increased circulating tumor necrosis factor level
|
J:160543
|
Tnfrsf1atm2b(EUCOMM)Wtsi/Tnfrsf1atm2b(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1atm2b(EUCOMM)Wtsi/H)
|
decreased circulating calcium level
|
J:211773
|
Tnfrsf1btm1a(EUCOMM)Wtsi/Tnfrsf1btm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1btm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating creatinine level
|
J:165965
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating tumor necrosis factor level
|
J:45147
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(B6.129S7-Tnfrsf1btm1Imx)
|
abnormal blood gas level
|
J:143836
|
Tnfrsf10btm1Wnt/Tnfrsf10btm1Wnt
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating interferon-gamma level
|
J:94681
|
increased circulating interleukin-12b level
|
J:94681
|
Tnfrsf11bem1(IMPC)Mbp/Tnfrsf11bem1(IMPC)Mbp
(C57BL/6N-Tnfrsf11bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Tnfsf4Ath1-A/J/Tnfsf4Ath1-A/J Ath2A/J/Ath2A/J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:9832
|
Tnfsf4Ath1-BALB/cJ/?
(involves: BALB/cJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:8735
|
Tnfsf4Ath1-C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:9135
|
Tnfsf4Ath1-C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:8735,
J:9135
|
Tnfsf4Ath1-C57BL/6J/Tnfsf4Ath1-C57BL/6J Ath2C57BL/6J/Ath2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:9832
|
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-C57BL/6J
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn)
|
increased circulating HDL cholesterol level
|
J:79722
|
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-PERA/EiJ
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn)
|
increased circulating HDL cholesterol level
|
J:79722
|
Tnfsf10tm1b(KOMP)Wtsi/Tnfsf10tm1b(KOMP)Wtsi
(C57BL/6N-Tnfsf10tm1b(KOMP)Wtsi/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Tnfsf11tm1Ywc/Tnfsf11tm1Ywc
(involves: 129P2/OlaHsd)
|
decreased circulating calcium level
|
J:233265
|
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J)
|
decreased circulating cholesterol level
|
J:241611
|
decreased circulating glucose level
|
J:241611
|
decreased circulating HDL cholesterol level
|
J:241611
|
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Tnk2tm1.2Npma/Tnk2tm1.2Npma
(B6(Cg)-Tnk2tm1.2Npma)
|
increased circulating interferon-gamma level
|
J:341740
|
increased circulating interleukin-2 level
|
J:341740
|
Tnks1bp1em1(IMPC)J/Tnks1bp1em1(IMPC)J
(C57BL/6NJ-Tnks1bp1em1(IMPC)J/J)
|
decreased circulating serum albumin level
|
J:211773
|
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating leptin level
|
J:154388
|
hypoglycemia
|
J:154388
|
increased circulating insulin level
|
J:154388
|
increased circulating ketone body level
|
J:154388
|
Tnni2tm1.1(KOMP)Vlcg/Tnni2+
(C57BL/6N-Tnni2tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J)
|
decreased circulating insulin level
|
J:339644
|
hyperglycemia
|
J:339644
|
Tnrem1(IMPC)Rbrc/Tnrem1(IMPC)Rbrc
(C57BL/6NJcl-Tnrem1(IMPC)Rbrc/Rbrc)
|
abnormal circulating phosphate level
|
J:211773
|
Tnrc6cGt(IST11346C2)Tigm/Tnrc6cGt(IST11346C2)Tigm
(involves: C57BL/6N)
|
cyanosis
|
J:248980
|
Tns2nph/Tns2nph
(involves: ICR)
|
decreased circulating total protein level
|
J:24698
|
increased blood urea nitrogen level
|
J:24698
|
increased circulating cholesterol level
|
J:24698
|
Tns3em1(IMPC)Bay/Tns3+
(C57BL/6N-Tns3em1(IMPC)Bay/Bay)
|
increased fasting circulating glucose level
|
J:211773
|
Tnxbtm1b(EUCOMM)Hmgu/Tnxbtm1b(EUCOMM)Hmgu
(C57BL/6N-Tnxbtm1b(EUCOMM)Hmgu/H)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Tolliptm1Kbns/Tolliptm1Kbns
(involves: C57BL/6)
|
decreased circulating interleukin-6 level
|
J:105514
|
Tomm6tm1a(KOMP)Wtsi/Tomm6+
(C57BL/6N-Tomm6tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Tomtem1(IMPC)Tcp/Tomtem1(IMPC)Tcp
(C57BL/6NCrl-Tomtem1(IMPC)Tcp/Cmmr)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating potassium level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Top1mttm1.1Hlzh/Top1mttm1.1Hlzh
(Not Specified)
|
abnormal blood homeostasis
|
J:189886
|
Top2aem2(IMPC)Tcp/Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Toporsem1(IMPC)J/Toporsem1(IMPC)J
(C57BL/6NJ-Toporsem1(IMPC)J/Mmjax)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Tox4tm1b(KOMP)Mbp/Tox4+
(C57BL/6N-Tox4tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Toxtm1b(KOMP)Wtsi/Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tpcn2tm1b(EUCOMM)Hmgu/Tpcn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Tpcn2tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Tpd52l1em1(IMPC)J/Tpd52l1em1(IMPC)J
(C57BL/6NJ-Tpd52l1em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tpgs2tm1.1(KOMP)Vlcg/Tpgs2tm1.1(KOMP)Vlcg
(C57BL/6N-Tpgs2tm1.1(KOMP)Vlcg/J)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
Tph2tm1Bdr/Tph2tm1Bdr
(B6.129P2-Tph2tm1Bdr)
|
decreased circulating insulin-like growth factor I level
|
J:150042
|
Tph2tm1Bdr/Tph2tm1Bdr
(FVB.129P2-Tph2tm1Bdr)
|
decreased circulating insulin-like growth factor I level
|
J:150042
|
Tph2tm1Bdr/Tph2tm1Bdr
(involves: 129P2/OlaHsd * FVB/N)
|
decreased circulating insulin-like growth factor I level
|
J:150042
|
Tpi1rbc19/Tpi1rbc19
(SJL-Tpi1rbc19)
|
increased circulating bilirubin level
|
J:263104
|
Tpoem1(IMPC)H/Tpo+
(C57BL/6NTac-Tpoem1(IMPC)H/H)
|
decreased circulating glucose level
|
J:211773
|
TpoR479C/TpoR479C
(involves: ICR)
|
increased circulating thyroid-stimulating hormone level
|
J:112930
|
Tppptm1.1(KOMP)Vlcg/Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Tpst2grt/Tpst2grt
(involves: DW/JMuaf)
|
decreased circulating thyroxine level
|
J:20343
|
Tra2bGt(P142D08)Wrst/Tra2b+
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating triglyceride level
|
J:176730
|
increased circulating VLDL triglyceride level
|
J:176730
|
Trabd2bem2(IMPC)Ccpcz/Trabd2bem2(IMPC)Ccpcz
(C57BL/6N-Trabd2bem2(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Traddtm1.1Mak/Traddtm1.1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased circulating interleukin-6 level
|
J:138824
|
Traddtm1.1Mpa/Traddtm1.1Mpa
(involves: BALB/cJ * C57BL/6)
|
decreased circulating tumor necrosis factor level
|
J:139030
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
increased circulating tumor necrosis factor level
|
J:44360
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
hypoglycemia
|
J:37065
|
increased circulating corticosterone level
|
J:37065
|
Traf6tm1.1Mpa/Traf6tm1.1Mpa Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating interleukin-6 level
|
J:145306
|
Traf6tm1Mak/Traf6tm1Mak
(involves: 129P3/J)
|
decreased circulating phosphate level
|
J:54467
|
Trafd1tm1Ayos/Trafd1tm1Ayos
(involves: 129 * C57BL/6J)
|
increased circulating alanine transaminase level
|
J:144594
|
increased circulating interleukin-6 level
|
J:144594
|
Traj18em1Hwata/Traj18em1Hwata
(C57BL/6-Traj18em1Hwata)
|
decreased fasting circulating glucose level
|
J:256533
|
Traj18tm1.1Kro/Traj18tm1.1Kro
(involves: C57BL/6NTac)
|
abnormal circulating interleukin-4 level
|
J:232957
|
Trak1em1(IMPC)Ccpcz/Trak1+
(C57BL/6NCrl-Trak1em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
Tram1em1(IMPC)J/Tram1em1(IMPC)J
(C57BL/6NJ-Tram1em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
Tram2tm1a(KOMP)Wtsi/Tram2tm1a(KOMP)Wtsi
(C57BL/6N-Tram2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
Trank1em1(IMPC)J/Trank1em1(IMPC)J
(C57BL/6NJ-Trank1em1(IMPC)J/Mmjax)
|
decreased circulating creatinine level
|
J:211773
|
Trap1em1(IMPC)Mbp/Trap1em1(IMPC)Mbp
(C57BL/6N-Trap1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating phosphate level
|
J:211773
|
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating creatinine level
|
J:226880
|
decreased circulating glucose level
|
J:226880
|
Trappc8em1(IMPC)Tcp/Trappc8+
(C57BL/6NCrl-Trappc8em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased circulating cholesterol level
|
J:294716
|
increased circulating glycerol level
|
J:294716
|
increased circulating HDL cholesterol level
|
J:294716
|
increased circulating insulin level
|
J:294716
|
increased circulating LDL cholesterol level
|
J:294716
|
increased circulating triglyceride level
|
J:294716
|
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Trarg1tm1a(KOMP)Wtsi/Trarg1tm1a(KOMP)Wtsi
(C57BL/6N-Trarg1tm1a(KOMP)Wtsi)
|
abnormal circulating insulin level
|
J:234039
|
abnormal fasting circulating glucose level
|
J:234039
|
hyperglycemia
|
J:234039
|
increased circulating insulin level
|
J:234039
|
Trbv19em1(IMPC)Wtsi/Trbv19em1(IMPC)Wtsi
(C57BL/6N-Trbv19em1(IMPC)Wtsi/Wtsi)
|
decreased circulating serum albumin level
|
J:211773
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
increased circulating interleukin-6 level
|
J:242126
|
increased circulating tumor necrosis factor level
|
J:242126
|
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic)
|
decreased platelet aggregation
|
J:150578
|
increased bleeding time
|
J:150578
|
increased circulating D-dimer level
|
J:150578
|
Trex1em3Gpt/Trex1em3Gpt
(C57BL/6JGpt-Trex1em3Gpt)
|
increased circulating tumor necrosis factor level
|
J:330879
|
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
abnormal atrial thrombosis
|
J:220965
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
abnormal atrial thrombosis
|
J:92264
|
Trfem1(IMPC)Rbrc/Trf+
(C57BL/6NJcl-Trfem1(IMPC)Rbrc/Rbrc)
|
abnormal circulating phosphate level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
Trfhpx/Trf+
(BALB/cJ-Trfhpx)
|
increased circulating iron level
|
J:8936
|
Trfhpx/Trfhpx
(BALB/cJ-Trfhpx)
|
increased circulating iron level
|
J:8936
|
Trhem1(IMPC)Tcp/Trhem1(IMPC)Tcp
(C57BL/6NCrl-Trhem1(IMPC)Tcp/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA)
|
decreased circulating thyroid-stimulating hormone level
|
J:59141
|
decreased circulating thyroxine level
|
J:59141
|
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR)
|
decreased circulating insulin level
|
J:43657
|
hyperglycemia
|
J:43657
|
Trhrtm1Bau/Trhrtm1Bau
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating prolactin level
|
J:90365
|
Trhrtm1Bau/Trhrtm1Bau
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating ghrelin level
|
J:220755
|
decreased circulating ghrelin level
|
J:220755
|
decreased circulating levels of thyroid hormone
|
J:220755
|
decreased circulating thyroxine level
|
J:220755
|
decreased circulating triiodothyronine level
|
J:220755
|
increased circulating ghrelin level
|
J:220755
|
Trhrtm1Hzg/Trhrtm1Hzg
(involves: 129/Sv * 129S1/SvImJ)
|
decreased circulating thyroxine level
|
J:125915
|
increased circulating glucose level
|
J:125915
|
Trib1tm1b(KOMP)Wtsi/Trib1+
(C57BL/6N-Trib1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating serum albumin level
|
J:211773
|
Trib2tm1b(KOMP)Wtsi/Trib2+
(C57BL/6N-Trib2tm1b(KOMP)Wtsi/Bay)
|
decreased circulating cholesterol level
|
J:211773
|
Triglq1SM/J/?
(involves: A/J * SM/J)
|
increased circulating triglyceride level
|
J:64138
|
Triglq2SM/J/?
(involves: A/J * SM/J)
|
increased circulating triglyceride level
|
J:64138
|
Trim8em1(IMPC)Wtsi/Trim8em1(IMPC)Wtsi
(C57BL/6N-Trim8em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac)
|
abnormal circulating chemokine level
|
J:251270
|
increased circulating interleukin-6 level
|
J:251270
|
increased circulating tumor necrosis factor level
|
J:251270
|
Trim9em1(IMPC)Ccpcz/Trim9em1(IMPC)Ccpcz
(C57BL/6N-Trim9em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating sodium level
|
J:211773
|
Trim13em1(IMPC)Tcp/Trim13em1(IMPC)Tcp
(C57BL/6N-Trim13em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Trim13tm1.1Jskg/Trim13tm1.1Jskg
(B6.129S7(Cg)-Trim13tm1.1Jskg)
|
abnormal circulating interferon level
|
J:243916
|
decreased circulating interferon-beta level
|
J:243916
|
Trim16em1(IMPC)Tcp/Trim16em1(IMPC)Tcp
(C57BL/6NCrl-Trim16em1(IMPC)Tcp/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Trim24mpc232H/Trim24mpc232H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
abnormal circulating alanine transaminase level
|
J:234901
|
Trim27tm1Sis/Trim27tm1Sis
(B6.Cg-Trim27tm1Sis)
|
decreased circulating alanine transaminase level
|
J:206755
|
decreased circulating aspartate transaminase level
|
J:206755
|
Trim29tm1a(EUCOMM)Wtsi/Trim29tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased circulating creatine kinase level
|
J:349246
|
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased circulating creatine kinase level
|
J:349246
|
Trim31em1Cya/Trim31em1Cya
(involves: C57BL/6)
|
abnormal circulating cytokine level
|
J:243237
|
increased circulating interleukin-1 beta level
|
J:243237
|
Trim35em1Smoc/Trim35em1Smoc
(C57BL/6J-Trim35em1Smoc)
|
decreased circulating interferon-beta level
|
J:303214
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
decreased circulating insulin level
|
J:232482
|
increased circulating follicle stimulating hormone level
|
J:232482
|
increased circulating luteinizing hormone level
|
J:232482
|
increased fasting circulating glucose level
|
J:232482
|
Trim38tm1(KOMP)Vlcg/Trim38tm1(KOMP)Vlcg
(involves: C57BL/6N)
|
increased circulating interferon-alpha level
|
J:239773
|
increased circulating interferon-beta level
|
J:239773
|
increased circulating interleukin-6 level
|
J:239773
|
increased circulating tumor necrosis factor level
|
J:239773
|
Trim39tm1b(EUCOMM)Hmgu/Trim39tm1b(EUCOMM)Hmgu
(C57BL/6N-Trim39tm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Trim41tm1Caox/Trim41tm1Caox
(B6.Cg-Trim41tm1Caox)
|
decreased circulating interferon-beta level
|
J:340065
|
decreased circulating interleukin-6 level
|
J:340065
|
Trim55tm1Slbt/Trim55tm1Slbt Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
abnormal cardiac thrombosis
|
J:130921
|
Trim55tm2b(EUCOMM)Hmgu/Trim55tm2b(EUCOMM)Hmgu
(C57BL/6N-Trim55tm2b(EUCOMM)Hmgu/Bay)
|
decreased fasting circulating glucose level
|
J:211773
|
Trim56tm1a(EUCOMM)Wtsi/Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Trim65em1Cya/Trim65em1Cya
(involves: C57BL/6)
|
decreased circulating interferon-alpha level
|
J:240099
|
decreased circulating interferon-beta level
|
J:240099
|
Triobpem1(IMPC)J/Triobpem1(IMPC)J
(C57BL/6NJ-Triobpem1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Trip10tm1Sejc/Trip10tm1Sejc
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased circulating glucose level
|
J:159952
|
Trip11Gt(AJ0490)Wtsi/Trip11Gt(AJ0490)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:142875
|
Trip13tm1.1(KOMP)Vlcg/Trip13+
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Trmotm1a(EUCOMM)Wtsi/Trmotm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Trmotm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:175295
|
Trmt1tm1b(EUCOMM)Hmgu/Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
Trmt2atm1.1(KOMP)Vlcg/Trmt2atm1.1(KOMP)Vlcg
(C57BL/6NTac-Trmt2atm1.1(KOMP)Vlcg/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Trmt10atm1a(EUCOMM)Wtsi/Trmt10atm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased circulating magnesium level
|
J:200082
|
Trmt10atm1a(EUCOMM)Wtsi/Trmt10atm1a(EUCOMM)Wtsi
(C57BL/6N-Trmt10atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Trmt10bem1(IMPC)J/Trmt10bem1(IMPC)J
(C57BL/6NJ-Trmt10bem1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Trnt1tm1a(EUCOMM)Hmgu/Trnt1+
(Not Specified)
|
increased circulating serum albumin level
|
J:165965
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
increased circulating interferon-gamma level
|
J:173271
|
increased circulating interleukin-3 level
|
J:173271
|
increased circulating interleukin-5 level
|
J:173271
|
increased circulating interleukin-6 level
|
J:173271
|
increased circulating tumor necrosis factor level
|
J:173271
|
Trp53tm1b(EUCOMM)Hmgu/Trp53+
(C57BL/6N-Trp53tm1b(EUCOMM)Hmgu/H)
|
decreased circulating creatine kinase level
|
J:211773
|
Trp53tm1Ldo/Trp53+
(B6.129S7-Trp53tm1Ldo)
|
decreased circulating insulin-like growth factor I level
|
J:130123
|
Trp53bp2tm1b(EUCOMM)Hmgu/Trp53bp2+
(C57BL/6N-Trp53bp2tm1b(EUCOMM)Hmgu/H)
|
increased circulating aspartate transaminase level
|
J:211773
|
Trp53i11em1(IMPC)J/Trp53i11em1(IMPC)J
(C57BL/6NJ-Trp53i11em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6)
|
hyperglycemia
|
J:233434
|
increased circulating insulin level
|
J:233434
|
Trp73em1(IMPC)H/Trp73+
(C57BL/6NTac-Trp73em1(IMPC)H/H)
|
increased blood urea nitrogen level
|
J:211773
|
Trpc1em1(IMPC)H/Trpc1em1(IMPC)H
(C57BL/6N-Trpc1em1(IMPC)H/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Trpc2Gt(OST448844)Lex/Trpc2Gt(OST448844)Lex
(involves: 129S5/SvEvBrd)
|
increased circulating cholesterol level
|
J:103485
|
increased circulating triglyceride level
|
J:103485
|
Trpc4apem1Cya/Trpc4apem1Cya
(C57BL/6J-Trpc4apem1Cya/Cya)
|
increased circulating insulin level
|
J:300649
|
increased fasting circulating glucose level
|
J:300649
|
Trpc5tm1.1Clph/Trpc5tm1.1Clph
(involves: 129S1/SvImJ)
|
decreased circulating prolactin level
|
J:277600
|
Trpc5tm1.2Mfre/Trpc5tm1.2Mfre
(B6N.129-Trpc5tm1.2Mfre)
|
decreased circulating prolactin level
|
J:277600
|
Trpm1tm1b(KOMP)Wtsi/Trpm1tm1b(KOMP)Wtsi
(C57BL/6N-Trpm1tm1b(KOMP)Wtsi/H)
|
increased circulating creatine kinase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Trpm2em1(IMPC)H/Trpm2em1(IMPC)H
(C57BL/6N-Trpm2em1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Trpm2tm1.1Alp/Trpm2tm1.1Alp
(B6.129P2-Trpm2tm1.1Alp)
|
decreased circulating interferon-gamma level
|
J:174397
|
decreased circulating interleukin-12 level
|
J:174397
|
decreased circulating interleukin-12b level
|
J:174397
|
Trpm6tm1.1Rws/Trpm6+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating magnesium level
|
J:153718
|
Trpm6tm1b(KOMP)Wtsi/Trpm6+
(C57BL/6N-Trpm6tm1b(KOMP)Wtsi/Orl)
|
decreased circulating phosphate level
|
J:211773
|
Trpm7tm1Agry/Trpm7+
(involves: 129)
|
decreased circulating magnesium level
|
J:205665
|
decreased erythrocyte magnesium level
|
J:205665
|
Trpm7tm1b(KOMP)Wtsi/Trpm7+
(C57BL/6N-Trpm7tm1b(KOMP)Wtsi/H)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Trps1em1(IMPC)Wtsi/Trps1+
(C57BL/6N-Trps1em1(IMPC)Wtsi/Wtsi)
|
decreased fasting circulating glucose level
|
J:211773
|
Trps1tm1Ymur/Trps1tm1Ymur
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:130140
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J)
|
increased blood osmolality
|
J:105254
|
Trpv4tm1Rck/Trpv4tm1Rck
(Not Specified)
|
decreased blood osmolality
|
J:86560
|
decreased circulating antidiuretic hormone level
|
J:86560
|
increased blood osmolality
|
J:86560
|
Trpv5Hcalc1/Trpv5Hcalc1
(involves: C3H/HeH * C57BL/6J)
|
decreased circulating calcium level
|
J:196612
|
decreased circulating phosphate level
|
J:196612
|
Trraptm1a(EUCOMM)Wtsi/Trrap+
(B6JTyr;B6N-Trraptm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating magnesium level
|
J:175295
|
Trub1tm1b(EUCOMM)Hmgu/Trub1tm1b(EUCOMM)Hmgu
(C57BL/6N-Trub1tm1b(EUCOMM)Hmgu/Bay)
|
decreased circulating creatinine level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Trub2tm2a(EUCOMM)Wtsi/Trub2+
(C57BL/6N-Trub2tm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Try10em1(IMPC)J/Try10em1(IMPC)J
(C57BL/6NJ-Try10em1(IMPC)J/Mmjax)
|
increased circulating creatinine level
|
J:211773
|
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating ketone body level
|
J:167208
|
Tsc1tm1Djk/Tsc1tm1Djk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:171445
|
Tsc1tm1Djk/Tsc1tm1Djk Tg(Gdf9-icre)5092Coo/?
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:155357
|
increased circulating luteinizing hormone level
|
J:155357
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
abnormal circulating hormone level
|
J:223992
|
abnormal circulating sodium level
|
J:223992
|
decreased circulating corticosterone level
|
J:223992
|
increased circulating follicle stimulating hormone level
|
J:223992
|
increased circulating insulin level
|
J:223992
|
increased circulating potassium level
|
J:223992
|
increased circulating testosterone level
|
J:223992
|
Tsga13em1(IMPC)J/Tsga13em1(IMPC)J
(C57BL/6NJ-Tsga13em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Tshrhyt-2J/Tshrhyt-2J
(B6;129P3-Tshrhyt-2J/GrsrJ)
|
decreased circulating thyroxine level
|
J:213054
|
Tshrhyt/Tshrhyt
(CBy.RF-Tshrhyt/J)
|
decreased circulating progesterone level
|
J:72929
|
Tshrhyt/Tshrhyt
(involves: BALB/cByJ * RF/J)
|
decreased circulating thyroxine level
|
J:6479
|
increased circulating cholesterol level
|
J:6479
|
increased circulating thyroid-stimulating hormone level
|
J:6479
|
Tshrtm1Rmar/Tshrtm1Rmar
(involves: 129S1/Sv * C57BL/6J)
|
decreased circulating levels of thyroid hormone
|
J:80513
|
decreased circulating thyroxine level
|
J:80513
|
decreased circulating triiodothyronine level
|
J:80513
|
increased circulating thyroid-stimulating hormone level
|
J:80513
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
decreased circulating interleukin-4 level
|
J:187770
|
Tspan7em1(IMPC)J/Y
(C57BL/6NJ-Tspan7em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Tspan13em1(IMPC)Kmpc/Tspan13em1(IMPC)Kmpc
(C57BL/6NTac-Tspan13em1(IMPC)Kmpc/Kmpc)
|
decreased fasting circulating glucose level
|
J:211773
|
Tspan17em1(IMPC)H/Tspan17em1(IMPC)H
(C57BL/6N-Tspan17em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Tspan18tm1.1(KOMP)Vlcg/Tspan18tm1.1(KOMP)Vlcg
(C57BL/6N-Tspan18tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Tspan18tm1Lex/Tspan18tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal hemostasis
|
J:295079
|
decreased circulating von Willebrand factor level
|
J:295079
|
decreased susceptibility to induced thrombosis
|
J:295079
|
Tspoap1em1(IMPC)H/Tspoap1em1(IMPC)H
(C57BL/6N-Tspoap1em1(IMPC)H/H)
|
decreased circulating total protein level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ttbk1em1(IMPC)J/Ttbk1em1(IMPC)J
(C57BL/6NJ-Ttbk1em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Ttc7fsn/Ttc7fsn
(CByJ.A-Ttc7fsn)
|
abnormal circulating iron level
|
J:92699
|
Ttc7hea/Ttc7hea
(WBB6F1)
|
increased circulating iron level
|
J:92699
|
Ttc17em1(IMPC)J/Ttc17em1(IMPC)J
(C57BL/6NJ-Ttc17em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Ttc21btm2c(KOMP)Wtsi/Ttc21baln Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * A/J * C57BL/6N)
|
increased blood urea nitrogen level
|
J:213263
|
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ttc32em1(IMPC)J/Ttc32em1(IMPC)J
(C57BL/6NJ-Ttc32em1(IMPC)J/J)
|
increased circulating bilirubin level
|
J:211773
|
Ttc39atm1b(KOMP)Mbp/Ttc39atm1b(KOMP)Mbp
(C57BL/6N-Ttc39atm1b(KOMP)Mbp/Orl)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ttc39btm1e(EUCOMM)Wtsi/Ttc39b+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Ttc39btm1e(EUCOMM)Wtsi/Ttc39btm1e(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating creatinine level
|
J:165965
|
Tti1em1(IMPC)J/Tti1+
(C57BL/6NJ-Tti1em1(IMPC)J/Mmjax)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ttll3tm1a(EUCOMM)Wtsi/Ttll3tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ttll3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating potassium level
|
J:165965
|
Ttll6tm1.1(KOMP)Vlcg/Ttll6tm1.1(KOMP)Vlcg
(C57BL/6N-Ttll6tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Ttll10em1(IMPC)J/Ttll10em1(IMPC)J
(C57BL/6NJ-Ttll10em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Ttrtm1Kymm/Ttrtm1Kymm
(B6.Cg-Ttrtm1Kymm)
|
abnormal circulating protein level
|
J:146510
|
decreased circulating thyroxine level
|
J:146510
|
decreased circulating triiodothyronine level
|
J:146510
|
Ttrtm1Wsb/Ttr+
(involves: 129S/SvEv * MF1)
|
decreased circulating thyroxine level
|
J:4183
|
decreased circulating triiodothyronine level
|
J:4183
|
Ttrtm1Wsb/Ttrtm1Wsb
(involves: 129S/SvEv)
|
abnormal blood homeostasis
|
J:22576
|
decreased circulating thyroxine level
|
J:22576
|
Ttrtm1Wsb/Ttrtm1Wsb
(involves: 129S/SvEv * MF1)
|
abnormal circulating protein level
|
J:4183
|
decreased circulating levels of thyroid hormone
|
J:4183
|
decreased circulating thyroxine level
|
J:4183
|
decreased circulating triiodothyronine level
|
J:4183
|
Ttrtm2(TTR)Kymm/Ttr+
(B6.Cg-Ttrtm2(TTR)Kymm)
|
abnormal circulating protein level
|
J:146510
|
decreased circulating thyroxine level
|
J:146510
|
decreased circulating triiodothyronine level
|
J:146510
|
Ttrtm2(TTR)Kymm/Ttrtm2(TTR)Kymm
(B6.Cg-Ttrtm2(TTR)Kymm)
|
abnormal circulating protein level
|
J:146510
|
decreased circulating thyroxine level
|
J:146510
|
decreased circulating triiodothyronine level
|
J:146510
|
Ttrtm2(TTR)Kymm/Ttrtm3(TTR*)Kymm
(B6.Cg-Ttrtm2(TTR)Kymm/Ttrtm3(TTR*)Kymm)
|
abnormal circulating protein level
|
J:146510
|
Ttrtm3(TTR*)Kymm/Ttrtm3(TTR*)Kymm
(B6.Cg-Ttrtm3(TTR*)Kymm)
|
abnormal circulating protein level
|
J:146510
|
Tubtub/Tubtub
(B6(AU)-Tubtub/J)
|
increased circulating cholesterol level
|
J:18161
|
increased circulating insulin level
|
J:32415
|
increased circulating triglyceride level
|
J:18161
|
Tubtub/Tubtub
(C57BL/6J-Tubtub)
|
increased circulating insulin level
|
J:13772
|
Tuba1cem1(IMPC)J/Tuba1cem1(IMPC)J
(C57BL/6NJ-Tuba1cem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Tubal3em1(IMPC)J/Tubal3em1(IMPC)J
(C57BL/6NJ-Tubal3em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Tubb1tm1Shiv/Tubb1tm1Shiv
(involves: 129/Sv * BALB/c)
|
increased bleeding time
|
J:94498
|
Tubb1tm1Shiv/Tubb1tm1Shiv
(Not Specified)
|
abnormal platelet physiology
|
J:95293
|
Tubb4atm1.1(KOMP)Wtsi/Tubb4atm1.1(KOMP)Wtsi
(C57BL/6N-Tubb4atm1.1(KOMP)Wtsi/J)
|
decreased fasting circulating glucose level
|
J:211773
|
Tuft1tm1a(KOMP)Wtsi/Tuft1tm1a(KOMP)Wtsi
(C57BL/6N-Tuft1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tulp3m1Kflj/Tulp3m1Kflj
(involves: C57BL/6J * FVB/NJ)
|
increased blood urea nitrogen level
|
J:284006
|
increased circulating creatinine level
|
J:284006
|
Tulp3tm1b(EUCOMM)Hmgu/Tulp3+
(C57BL/6N-Tulp3tm1b(EUCOMM)Hmgu/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Tulp3tm1c(EUCOMM)Hmgu/Tulp3+ Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Pax8-rtTA2S*M2)1Koes/0 Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA * SJL)
|
increased blood urea nitrogen level
|
J:284006
|
Tulp3tm1c(EUCOMM)Hmgu/Tulp3tm1c(EUCOMM)Hmgu Pkd1tm2Ggg/Pkd1+ Tg(Pax8-rtTA2S*M2)1Koes/0 Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA * SJL)
|
increased blood urea nitrogen level
|
J:284006
|
Tulp3tm1c(EUCOMM)Hmgu/Tulp3tm1c(EUCOMM)Hmgu Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Pax8-rtTA2S*M2)1Koes/0 Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA * SJL)
|
increased blood urea nitrogen level
|
J:284006
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
abnormal glomerular capillary thrombosis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
abnormal glomerular capillary thrombosis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
abnormal glomerular capillary thrombosis
|
J:309768
|
Tut4Gt(RRR277)Byg/Tut4Gt(RRR277)Byg
(B6.129P2-Tut4Gt(RRR277)Byg)
|
decreased circulating insulin-like growth factor I level
|
J:194669
|
Twf1tm1a(EUCOMM)Wtsi/Twf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Twf1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Twist1em1(IMPC)Rbrc/Twist1+
(C57BL/6NJcl-Twist1em1(IMPC)Rbrc/Rbrc)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
|
hypoglycemia
|
J:81485
|
Twsg1tm1Ecan/Twsg1tm1Ecan
(involves: 129 * C57BL/6)
|
decreased circulating osteocalcin level
|
J:137597
|
Txlnatm1b(EUCOMM)Hmgu/Txlnatm1b(EUCOMM)Hmgu
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
increased circulating potassium level
|
J:211773
|
Txndc2tm1Lex/Txndc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal circulating phosphate level
|
J:103485
|
decreased circulating interleukin-6 level
|
J:103485
|
Txndc5tm1.1(KOMP)Vlcg/Txndc5+
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Txndc5tm1.1(KOMP)Vlcg/Txndc5tm1.1(KOMP)Vlcg
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating insulin level
|
J:211773
|
Txndc11em1(IMPC)J/Txndc11em1(IMPC)J
(C57BL/6NJ-Txndc11em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1)
|
increased circulating cholesterol level
|
J:47109
|
increased circulating triglyceride level
|
J:47109
|
increased circulating VLDL cholesterol level
|
J:47109
|
Txniptm1.1Rlee/Txniptm1.1Rlee
(involves: 129S4/SvJae)
|
decreased circulating glucose level
|
J:141487
|
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
hypoglycemia
|
J:132756
|
increased circulating ketone body level
|
J:132756
|
increased circulating lactate level
|
J:132756
|
increased circulating triglyceride level
|
J:132756
|
Txniptm1b(EUCOMM)Hmgu/Txniptm1b(EUCOMM)Hmgu
(C57BL/6N-Txniptm1b(EUCOMM)Hmgu/H)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA)
|
abnormal blood homeostasis
|
J:104563
|
abnormal circulating insulin level
|
J:104563
|
abnormal circulating phospholipid level
|
J:104563
|
decreased circulating antithrombin level
|
J:104563
|
decreased circulating glucose level
|
J:104563
|
decreased circulating sodium level
|
J:104563
|
increased bleeding time
|
J:104563
|
increased blood urea nitrogen level
|
J:104563
|
increased circulating cholesterol level
|
J:104563
|
increased circulating free fatty acids level
|
J:104563
|
increased circulating ketone body level
|
J:104563
|
increased circulating potassium level
|
J:104563
|
increased circulating triglyceride level
|
J:104563
|
increased partial thromboplastin time
|
J:104563
|
increased prothrombin time
|
J:104563
|
Txniptm1Road/Txniptm1Road Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
hypoglycemia
|
J:132756
|
increased circulating ketone body level
|
J:132756
|
increased circulating triglyceride level
|
J:132756
|
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ)
|
increased circulating interleukin-12 level
|
J:120304
|
Tyk2tm1Shmd/Tyk2tm1Shmd
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased circulating free fatty acids level
|
J:195099
|
increased circulating insulin level
|
J:195099
|
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Tyro3em1(IMPC)Ccpcz/Tyro3em1(IMPC)Ccpcz
(C57BL/6NCrl-Tyro3em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating creatine kinase level
|
J:211773
|
Tyrp1b-J/Tyrp1b-J
(C57BL/6J-Tyrp1b-J/J)
|
decreased bleeding time
|
J:7327
|
Tyrp1B-lt/Tyrp1B-lt
(involves: C57BL/6J)
|
increased bleeding time
|
J:7327
|
Tysnd1tm1.1Arte/Tysnd1tm1.1Arte
(involves: C57BL/6J * C57BL/6N)
|
increased circulating alanine transaminase level
|
J:223054
|
increased circulating aspartate transaminase level
|
J:223054
|
increased circulating lactate dehydrogenase level
|
J:223054
|
Tyw1tm1b(KOMP)Wtsi/Tyw1tm1b(KOMP)Wtsi
(C57BL/6N-Tyw1tm1b(KOMP)Wtsi/J)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
U2af2em1(IMPC)J/U2af2+
(C57BL/6NJ-U2af2em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
U2surpem1(IMPC)J/U2surp+
(C57BL/6NJ-U2surpem1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
U90926em1Dnkv/U90926em1Dnkv
(C57BL6/J-U90926em1Dnkv)
|
increased circulating interleukin-6 level
|
J:340649
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
increased circulating alanine transaminase level
|
J:157049
|
increased circulating alkaline phosphatase level
|
J:157049
|
increased circulating aspartate transaminase level
|
J:157049
|
increased circulating cholesterol level
|
J:157049
|
increased circulating lactate dehydrogenase level
|
J:157049
|
Ubac1em1(IMPC)J/Ubac1em1(IMPC)J
(C57BL/6NJ-Ubac1em1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
Ubap2em1(IMPC)J/Ubap2em1(IMPC)J
(C57BL/6NJ-Ubap2em1(IMPC)J/Mmjax)
|
decreased blood urea nitrogen level
|
J:211773
|
Ubash3atm1b(KOMP)Wtsi/Ubash3atm1b(KOMP)Wtsi
(C57BL/6N-Ubash3atm1b(KOMP)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Ubbtm1Rrk/Ubbtm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating leptin level
|
J:132767
|
Ube2atm1.1(KOMP)Vlcg/Ube2atm1.1(KOMP)Vlcg
(C57BL/6N-Ube2atm1.1(KOMP)Vlcg/J)
|
decreased circulating serum albumin level
|
J:211773
|
Ube2btm1a(EUCOMM)Wtsi/Ube2b+
(C57BL/6N-Ube2btm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating triglyceride level
|
J:165965
|
Ube2d1tm3e(EUCOMM)Wtsi/Ube2d1tm3e(EUCOMM)Wtsi
(C57BL/6N-Ube2d1tm3e(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Ube2iem1(IMPC)J/Ube2i+
(C57BL/6NJ-Ube2iem1(IMPC)J/Mmjax)
|
increased circulating calcium level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Ube2j1tm1.1(NCOM)Mfgc/Ube2j1tm1.1(NCOM)Mfgc
(C57BL/6N-Ube2j1tm1.1(NCOM)Mfgc/Rbrc)
|
increased circulating amylase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Ube2j2em1(IMPC)Rbrc/Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc)
|
abnormal blood urea nitrogen level
|
J:211773
|
Ube2mtm1.1(KOMP)Wtsi/Ube2m+
(B6N(Cg)-Ube2mtm1.1(KOMP)Wtsi/2J)
|
increased circulating sodium level
|
J:211773
|
Ube2otm1.1(KOMP)Mbp/Ube2o+
(B6N(Cg)-Ube2otm1.1(KOMP)Mbp/J)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Ube2q1tm1Grz/Ube2q1tm1Grz
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating prolactin level
|
J:195898
|
Ube2stm1.1Smoc/Ube2stm1.1Smoc
(involves: C57BL/6)
|
increased circulating interferon-alpha level
|
J:306461
|
increased circulating interferon-beta level
|
J:306461
|
increased circulating interleukin-6 level
|
J:306461
|
increased circulating tumor necrosis factor level
|
J:306461
|
Ube2wtm1b(EUCOMM)Wtsi/Ube2wtm1b(EUCOMM)Wtsi
(C57BL/6N-Ube2wtm1b(EUCOMM)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca)
|
decreased circulating cholesterol level
|
J:203652
|
decreased circulating LDL cholesterol level
|
J:203652
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6N-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating lactate dehydrogenase level
|
J:211773
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
decreased circulating iron level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Ubiad1tm1.1Thka/Ubiad1+
(C57BL/6-Ubiad1tm1.1Thka)
|
increased circulating cholesterol level
|
J:221005
|
increased circulating HDL cholesterol level
|
J:221005
|
Ubl4atm1.2Arte/Y
(involves: C57BL/6)
|
cyanosis
|
J:226059
|
Ubl4atm1.2Arte/Ubl4atm1.2Arte
(involves: C57BL/6)
|
cyanosis
|
J:226059
|
Ubl4bem1(IMPC)Ccpcz/Ubl4bem1(IMPC)Ccpcz
(C57BL/6N-Ubl4bem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating serum albumin level
|
J:211773
|
Ubl7em1(IMPC)Tcp/Ubl7em1(IMPC)Tcp
(C57BL/6N-Ubl7em1(IMPC)Tcp/Tcp)
|
increased blood urea nitrogen level
|
J:211773
|
Ubn1em1(IMPC)J/Ubn1em1(IMPC)J
(C57BL/6NJ-Ubn1em1(IMPC)J/J)
|
increased circulating alanine transaminase level
|
J:211773
|
Ubp1tm1b(KOMP)Mbp/Ubp1+
(C57BL/6N-Ubp1tm1b(KOMP)Mbp/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Ubqln4em1(IMPC)Mbp/Ubqln4em1(IMPC)Mbp
(C57BL/6NCrl-Ubqln4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
decreased blood urea nitrogen level
|
J:72859
|
decreased circulating serum albumin level
|
J:72859
|
decreased circulating total protein level
|
J:72859
|
decreased circulating triglyceride level
|
J:72859
|
hypoglycemia
|
J:72859
|
Ubr7em1(IMPC)Tcp/Ubr7em1(IMPC)Tcp
(C57BL/6NCrl-Ubr7em1(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
Ubtfem1(IMPC)Mbp/Ubtf+
(C57BL/6NCrl-Ubtfem1(IMPC)Mbp/Mmucd)
|
decreased circulating serum albumin level
|
J:211773
|
Ubxn1em1(IMPC)J/Ubxn1em1(IMPC)J
(C57BL/6N-Ubxn1em1(IMPC)J/J)
|
decreased circulating total protein level
|
J:211773
|
Ubxn10tm1b(EUCOMM)Wtsi/Ubxn10tm1b(EUCOMM)Wtsi
(C57BL/6N-Ubxn10tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating creatine kinase level
|
J:211773
|
Uchl1tm1b(EUCOMM)Hmgu/Uchl1+
(C57BL/6N-Uchl1tm1b(EUCOMM)Hmgu/H)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Uchl1tm1Dgen/Uchl1tm1Dgen
(B6.129P2-Uchl1tm1Dgen/Mmnc)
|
decreased circulating estradiol level
|
J:361266
|
Uchl4em1(IMPC)Ccpcz/Uchl4em1(IMPC)Ccpcz
(C57BL/6N-Uchl4em1(IMPC)Ccpcz/Ccpcz)
|
increased fasting circulating glucose level
|
J:211773
|
Uckl1em1(IMPC)J/Uckl1em1(IMPC)J
(C57BL/6NJ-Uckl1em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ucn2tm1Pbl/Ucn2tm1Pbl
(involves: 129 * C57BL/6)
|
increased circulating adrenocorticotropin level
|
J:108744
|
increased circulating corticosterone level
|
J:108744
|
Ucn3tm1.1(KOMP)Vlcg/Ucn3tm1.1(KOMP)Vlcg
(C57BL/6N-Ucn3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating creatinine level
|
J:211773
|
Ucn3tm1Pbl/Ucn3tm1Pbl
(Not Specified)
|
decreased circulating insulin level
|
J:119417
|
Ucntm1Abas/Ucntm1Abas
(B6.129S4-Ucntm1Abas)
|
abnormal circulating corticosterone level
|
J:122730
|
increased circulating corticosterone level
|
J:122730
|
Ucp1tm1b(EUCOMM)Hmgu/Ucp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ucp1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Ucp1tm1Kz/Ucp1tm1Kz
(B6.Cg-Ucptm1Kz)
|
decreased circulating free fatty acids level
|
J:81820
|
decreased circulating thyroxine level
|
J:81820
|
decreased circulating triglyceride level
|
J:81820
|
increased circulating triiodothyronine level
|
J:81820
|
Ucp2tm1Rcq/Ucp2tm1Rcq
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:122094
|
decreased circulating lactate level
|
J:122094
|
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Pmch-cre)1Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ)
|
decreased circulating glucose level
|
J:167906
|
decreased circulating insulin level
|
J:167906
|
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating free fatty acids level
|
J:62312
|
decreased circulating glucose level
|
J:62312
|
Ufl1tm1a(EUCOMM)Wtsi/Ufl1+
(C57BL/6N-Ufl1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
Ugcgem1(IMPC)H/Ugcg+
(C57BL/6NTac-Ugcgem1(IMPC)H/H)
|
increased circulating alanine transaminase level
|
J:211773
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL)
|
increased circulating bilirubin level
|
J:182805
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(B6.Cg-Ugt1tm1.1Afmu)
|
increased circulating bilirubin level
|
J:216224
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu)
|
increased circulating bilirubin level
|
J:216224
|
Ugt1tm1Rhtu/Ugt1tm1Rhtu
(involves: 129 * C57BL/6)
|
increased circulating bilirubin level
|
J:133790
|
Uhmk1tm1Enbl/Uhmk1tm1Enbl
(involves: 129/Sv * C57BL/6)
|
increased circulating cholesterol level
|
J:144737
|
Uhrf2tm1b(EUCOMM)Wtsi/Uhrf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Uhrf2tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ulk3em2(IMPC)Tcp/Ulk3em2(IMPC)Tcp
(C57BL/6NCrl-Ulk3em2(IMPC)Tcp/Tcp)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Umodem1Duf/Umod+
(C57BL/6J-Umodem1Duf)
|
increased blood urea nitrogen level
|
J:252597
|
increased circulating creatinine level
|
J:252597
|
Umodtm1.1Rvt/Umod+
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))
|
increased blood osmolality
|
J:242593
|
increased blood urea nitrogen level
|
J:242593
|
increased circulating creatinine level
|
J:242593
|
Umodtm1.1Rvt/Umodtm1.1Rvt
(either: B6J.129-Umodtm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))
|
increased blood osmolality
|
J:242593
|
increased blood urea nitrogen level
|
J:242593
|
increased circulating calcium level
|
J:242593
|
increased circulating creatinine level
|
J:242593
|
UmodUrehd1/Umod+
(C3HeB/FeJ-UmodUrehd1)
|
decreased circulating glucose level
|
J:121470
|
increased blood urea nitrogen level
|
J:121470
|
increased circulating creatinine level
|
J:121470
|
UmodUrehd1/Umod+
(involves: C3HeB/FeJ)
|
decreased circulating cholesterol level
|
J:201084
|
decreased circulating ferritin level
|
J:201084
|
decreased circulating iron level
|
J:201084
|
decreased circulating phosphate level
|
J:201084
|
decreased circulating transferrin level
|
J:201084
|
decreased circulating triglyceride level
|
J:201084
|
increased blood urea nitrogen level
|
J:201084
|
increased circulating alkaline phosphatase level
|
J:201084
|
increased circulating calcium level
|
J:201084
|
increased circulating creatinine level
|
J:201084
|
increased circulating potassium level
|
J:201084
|
UmodUrehd1/UmodUrehd1
(involves: C3HeB/FeJ)
|
increased blood urea nitrogen level
|
J:201084
|
Umodurehr4/Umod+
(C3HeB/FeJ-Umodurehr4)
|
abnormal blood homeostasis
|
J:153895
|
abnormal circulating lipid level
|
J:153895
|
decreased circulating cholesterol level
|
J:153895
|
decreased circulating triglyceride level
|
J:153895
|
increased blood urea nitrogen level
|
J:201084
|
increased circulating creatinine level
|
J:153895
|
Umodurehr4/Umodurehr4
(C3HeB/FeJ-Umodurehr4)
|
abnormal blood homeostasis
|
J:153895
|
abnormal circulating lipid level
|
J:153895
|
decreased circulating cholesterol level
|
J:153895
|
decreased circulating triglyceride level
|
J:153895
|
increased blood urea nitrogen level
|
J:121470
|
increased blood uric acid level
|
J:153895
|
increased circulating calcium level
|
J:153895
|
increased circulating creatinine level
|
J:153895,
J:121470
|
uremia
|
J:153895
|
Unc5clem1(IMPC)Mbp/Unc5clem1(IMPC)Mbp
(C57BL/6NCrl-Unc5clem1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Unc13cem1(IMPC)H/Unc13cem1(IMPC)H
(C57BL/6N-Unc13cem1(IMPC)H/H)
|
increased circulating creatinine level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Unc13dtm1(KOMP)Vlcg/Unc13dtm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal platelet dense granule physiology
|
J:231217
|
decreased platelet aggregation
|
J:231217
|
impaired blood coagulation
|
J:231217
|
increased bleeding time
|
J:231217
|
Unc80em1(IMPC)Tcp/Unc80+
(C57BL/6N-Unc80em1(IMPC)Tcp/Tcp)
|
decreased circulating sodium level
|
J:211773
|
Unc93b13d/Unc93b13d
(C57BL/6J-Unc93b13d)
|
abnormal circulating interferon level
|
J:105484
|
increased circulating tumor necrosis factor level
|
J:105484
|
Unc93b1tm1(KOMP)Vlcg/Unc93b1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating interleukin-6 level
|
J:211069
|
decreased circulating interleukin-12b level
|
J:211069
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating alanine transaminase level
|
J:174308
|
increased circulating aspartate transaminase level
|
J:174308
|
increased circulating bilirubin level
|
J:174308
|
increased circulating creatinine level
|
J:174308
|
increased circulating lactate dehydrogenase level
|
J:174308
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
decreased circulating triglyceride level
|
J:271949
|
increased blood urea nitrogen level
|
J:271949
|
increased blood uric acid level
|
J:271949
|
increased circulating cholesterol level
|
J:271949
|
increased circulating creatinine level
|
J:271949
|
increased circulating LDL cholesterol level
|
J:271949
|
increased circulating triglyceride level
|
J:271949
|
Uoxin/Uoxin
(involves: C57BL/6J * DBA/2J)
|
increased blood urea nitrogen level
|
J:70677
|
increased circulating creatinine level
|
J:70677
|
Uoxtm1Bay/Uoxtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased blood urea nitrogen level
|
J:103187
|
increased blood uric acid level
|
J:16490
|
uremia
|
J:103187
|
Upf3bem1(IMPC)Tcp/Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Upk2tm1Tsun/Upk2tm1Tsun
(involves: 129S/SvEv * Black Swiss)
|
increased blood urea nitrogen level
|
J:95622
|
Upk3atm1Tsun/Upk3atm1Tsun
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * Swiss Webster))
|
increased blood urea nitrogen level
|
J:77653
|
increased circulating creatinine level
|
J:77653
|
Upp1tm1Gp/Upp1tm1Gp
(involves: 129)
|
abnormal blood homeostasis
|
J:99912
|
Uqcc6em1Lenh/Uqcc6em1Lenh
(C57BL/6J-Uqcc6em1Lenh)
|
increased circulating lactate level
|
J:330815
|
Uqcrhtm1b(EUCOMM)Wtsi/Uqcrh+
(C57BL/6NCrl-Uqcrhtm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
increased blood uric acid level
|
J:267227
|
urehr1/urehr1
(C3HeB/FeJ-urehr1)
|
abnormal glomerular capillary thrombosis
|
J:121470
|
decreased circulating glucose level
|
J:121470
|
increased blood urea nitrogen level
|
J:121470
|
increased circulating cholesterol level
|
J:121470
|
increased circulating creatinine level
|
J:121470
|
Uri1tm1.1Ndj/Uri1tm1.1Ndj Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj)
|
increased circulating alanine transaminase level
|
J:217463
|
Uri1tm1a(EUCOMM)Wtsi/Uri1tm1a(EUCOMM)Wtsi
(C57BL/6N-Uri1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Urm1em1(IMPC)J/Urm1+
(C57BL/6NJ-Urm1em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Urostm2Rjde/Urostm3Rjde
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating haptoglobin level
|
J:132542
|
Ush1ctm1a(KOMP)Wtsi/Ush1ctm1a(KOMP)Wtsi
(C57BL/6N-Ush1ctm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Usp1tm1.1Ada/Usp1tm1.1Ada
(C57BL/6-Usp1tm1.1Ada)
|
cyanosis
|
J:146616
|
Usp1tm1b(KOMP)Wtsi/Usp1tm1b(KOMP)Wtsi
(C57BL/6N-Usp1tm1b(KOMP)Wtsi/Wtsi)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Usp1tm1d(KOMP)Wtsi/Usp1tm1d(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased circulating alkaline phosphatase level
|
J:207363
|
Usp8tm1.1Kpk/Usp8tm1.1Kpk Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)
|
increased circulating bilirubin level
|
J:122732
|
Usp11tm1(KOMP)Wtsi/Y
(C57BL/6N-Usp11tm1(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Usp12tm1a(EUCOMM)Hmgu/Usp12tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased circulating alanine transaminase level
|
J:165965
|
Usp12tm1b(EUCOMM)Hmgu/Usp12tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp12tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Usp15tm1b(EUCOMM)Wtsi/Usp15tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp15tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
decreased circulating interferon-gamma level
|
J:163843
|
increased circulating interleukin-6 level
|
J:163843
|
Usp18tm1Dez/Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating enzyme level
|
J:214425
|
decreased circulating interferon-alpha level
|
J:214425
|
decreased circulating interferon-beta level
|
J:214425
|
decreased circulating interferon-gamma level
|
J:214425
|
Usp20em1Cya/Usp20em1Cya
(Not Specified)
|
decreased circulating cholesterol level
|
J:299971
|
decreased circulating triglyceride level
|
J:299971
|
Usp20em1Dalin/Usp20em1Dalin
(involves: C57BL/6)
|
abnormal circulating chemokine level
|
J:274572
|
decreased circulating interferon-beta level
|
J:274572
|
decreased circulating interleukin-6 level
|
J:274572
|
Usp20em1Gpt/Usp20em1Gpt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA)
|
abnormal circulating enzyme level
|
J:299971
|
decreased circulating cholesterol level
|
J:299971
|
decreased circulating free fatty acids level
|
J:299971
|
decreased circulating glucose level
|
J:299971
|
decreased circulating HDL cholesterol level
|
J:299971
|
decreased circulating insulin level
|
J:299971
|
decreased circulating LDL cholesterol level
|
J:299971
|
decreased circulating triglyceride level
|
J:299971
|
decreased circulating VLDL triglyceride level
|
J:299971
|
decreased fasting circulating glucose level
|
J:299971
|
Usp20tm1a(EUCOMM)Hmgu/Usp20tm1a(EUCOMM)Hmgu
(C57BL/6N-Usp20tm1a(EUCOMM)Hmgu/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Usp21tm1.1Jhy/Usp21tm1.1Jhy
(B6.129S7(Cg)-Usp21tm1.1Jhy)
|
increased circulating interferon-alpha level
|
J:208320
|
increased circulating interferon-beta level
|
J:208320
|
Usp21tm1a(EUCOMM)Wtsi/Usp21tm1a(EUCOMM)Wtsi
(C57BL/6N-Usp21tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
Usp24tm1a(KOMP)Wtsi/Usp24tm1a(KOMP)Wtsi
(C57BL/6N-Usp24tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Usp26tm1Smoc/Y
(B6.129S6-Usp26tm1Smoc)
|
decreased circulating follicle stimulating hormone level
|
J:277424
|
decreased circulating testosterone level
|
J:277424
|
increased circulating luteinizing hormone level
|
J:277424
|
Usp30tm2b(EUCOMM)Hmgu/Usp30tm2b(EUCOMM)Hmgu
(C57BL/6N-Usp30tm2b(EUCOMM)Hmgu/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Usp31em1(IMPC)H/Usp31em1(IMPC)H
(C57BL/6NTac-Usp31em1(IMPC)H/H)
|
increased circulating potassium level
|
J:211773
|
Usp32em1(IMPC)Mhzh/Usp32+
(C57BL/6N-Usp32em1(IMPC)Mhzh/Mhzh)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
Usp33tm1a(EUCOMM)Wtsi/Usp33tm1a(EUCOMM)Wtsi
(C57BL/6N-Usp33tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:175295
|
Usp36tm1b(EUCOMM)Hmgu/Usp36+
(C57BL/6N-Usp36tm1b(EUCOMM)Hmgu/Nju)
|
increased circulating glucose level
|
J:211773
|
Usp38tm1b(EUCOMM)Hmgu/Usp38tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp38tm1b(EUCOMM)Hmgu/H)
|
decreased circulating creatinine level
|
J:211773
|
Usp47tm1b(EUCOMM)Wtsi/Usp47tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp47tm1b(EUCOMM)Wtsi/Nju)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Usp49em1Gpt/Usp49em1Gpt
(involves: C57BL/6NGpt)
|
increased circulating interferon-beta level
|
J:285681
|
increased circulating interleukin-6 level
|
J:285681
|
Usp53em1(IMPC)Tcp/Usp53em1(IMPC)Tcp
(C57BL/6N-Usp53em1(IMPC)Tcp/Tcp)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Usp54tm1b(KOMP)Wtsi/Usp54tm1b(KOMP)Wtsi
(C57BL/6N-Usp54tm1b(KOMP)Wtsi/H)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Utp4em1(IMPC)J/Utp4+
(C57BL/6NJ-Utp4em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Utp14bjsd/Utp14bjsd
(involves: C57BL/6J)
|
increased circulating follicle stimulating hormone level
|
J:9278
|
Uts2tm1Ags/Uts2tm1Ags
(B6.129P2-Uts2tm1Ags)
|
decreased circulating LDL cholesterol level
|
J:214289
|
increased circulating HDL cholesterol level
|
J:214289
|
Vamp3tm1Jpes/Vamp3tm1Jpes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal platelet physiology
|
J:121010
|
Vamp7tm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glycerol level
|
J:181320
|
Vamp8tm1.1Hong/Vamp8tm1.1Hong
(129-Vamp8tm1.1Hong)
|
increased blood osmolality
|
J:156248
|
increased circulating renin level
|
J:156248
|
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating amylase level
|
J:137704
|
abnormal circulating lipase level
|
J:137704
|
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal platelet activation
|
J:121010
|
abnormal platelet physiology
|
J:121010
|
Vangl2em1(IMPC)Mbp/Vangl2+
(C57BL/6N-Vangl2em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating phosphate level
|
J:211773
|
Vasptm1Mzim/Vasptm1Mzim
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal platelet activation
|
J:56356
|
Vasptm1Ref/Vasptm1Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal platelet physiology
|
J:51905
|
increased platelet aggregation
|
J:51905
|
Vav1tm4Tyb/Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
increased circulating interferon-gamma level
|
J:190087
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
increased circulating adrenaline level
|
J:124056
|
increased circulating aldosterone level
|
J:124056
|
increased circulating antidiuretic hormone level
|
J:124056
|
increased circulating noradrenaline level
|
J:124056
|
increased circulating renin level
|
J:124056
|
Vav2tm1Tnr/Vav2tm1Tnr Vav3tm1Xrb/Vav3tm1Xrb
(involves: 129P2/OlaHsd)
|
increased circulating adrenaline level
|
J:124056
|
increased circulating noradrenaline level
|
J:124056
|
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified)
|
abnormal blood homeostasis
|
J:111973
|
increased circulating adrenaline level
|
J:111973,
J:124056
|
increased circulating aldosterone level
|
J:111973
|
increased circulating angiotensin II level
|
J:111973
|
increased circulating antidiuretic hormone level
|
J:111973
|
increased circulating noradrenaline level
|
J:111973,
J:124056
|
increased circulating renin level
|
J:111973
|
Vax1tm1b(KOMP)Mbp/Vax1+
(C57BL/6N-Vax1tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Vcantm2Hwat/Vcantm2Hwat
(involves: 129 * BALB/c * C57BL/6)
|
cyanosis
|
J:225115
|
Vcf1tm2a(EUCOMM)Wtsi/Vcf1tm2a(EUCOMM)Wtsi
(B6JTyr;B6N-Vcf1tm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating aspartate transaminase level
|
J:175295
|
Vcpem1Kene/Vcp+
(C57BL/6J-Vcpem1Kene)
|
increased circulating triglyceride level
|
J:325062
|
Vcpkmttm1.1(KOMP)Vlcg/Vcpkmttm1.1(KOMP)Vlcg
(C57BL/6N-Vcpkmttm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating calcium level
|
J:111515
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129 * BALB/c * C57BL/6 * Swiss)
|
decreased circulating calcium level
|
J:72578
|
increased circulating parathyroid hormone level
|
J:72578
|
Vdrtm1.1Sgcg/Vdrtm1.2Sgcg Myl2tm1(cre)Krc/Myl2+
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased circulating atrial natriuretic factor
|
J:189471
|
Vdrtm1.2Sgcg/Vdrtm1.2Sgcg
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased circulating calcium level
|
J:189471
|
increased circulating atrial natriuretic factor
|
J:189471
|
Vdrtm1Gcm/Vdrtm1Gcm Tg(Col2a1-cre)1Bhr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating phosphate level
|
J:117377
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae)
|
decreased circulating calcium level
|
J:42815,
J:78067
|
increased circulating angiotensin II level
|
J:78067
|
increased circulating angiotensinogen level
|
J:78067
|
increased circulating parathyroid hormone level
|
J:42815,
J:78067,
J:63291
|
increased circulating renin level
|
J:78067
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating phosphate level
|
J:99866
|
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating calcium level
|
J:77748
|
increased circulating parathyroid hormone level
|
J:77748
|
Vdrtm1Rge/Vdrtm1Rge
(B6.129-Vdrtm1Rge)
|
decreased circulating phosphate level
|
J:121006
|
increased circulating alkaline phosphatase level
|
J:121006
|
increased circulating parathyroid hormone level
|
J:121006
|
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal blood homeostasis
|
J:112519
|
decreased circulating calcium level
|
J:83237,
J:71459,
J:42054,
J:69822,
J:112519,
J:72578
|
decreased circulating phosphate level
|
J:42054
|
increased circulating alkaline phosphatase level
|
J:42054
|
increased circulating follicle stimulating hormone level
|
J:83237
|
increased circulating luteinizing hormone level
|
J:83237
|
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
decreased circulating calcium level
|
J:127787
|
Vdrtm1Tyam/Vdrtm1Tyam
(involves: C57BL/6 * CBA)
|
decreased circulating calcium level
|
J:101456
|
decreased circulating phosphate level
|
J:101456
|
increased circulating parathyroid hormone level
|
J:101456
|
Vdrtm2.1Ska/Vdrtm2.1Ska
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
decreased circulating calcium level
|
J:196471
|
decreased circulating phosphate level
|
J:196471
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
cyanosis
|
J:81698
|
increased blood urea nitrogen level
|
J:111504
|
increased circulating creatinine level
|
J:111504
|
Vegfatm2Gne/Vegfa+ Tg(Nphs1-cre)1Seq/0
(involves: 129)
|
increased blood urea nitrogen level
|
J:82440
|
increased circulating creatinine level
|
J:82440
|
Vegfbtm1b(EUCOMM)Hmgu/Vegfbtm1b(EUCOMM)Hmgu
(C57BL/6N-Vegfbtm1b(EUCOMM)Hmgu/J)
|
decreased circulating phosphate level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Vezttm1b(EUCOMM)Hmgu/Vezt+
(C57BL/6N-Vezttm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
Vgfem1(IMPC)H/Vgfem1(IMPC)H
(C57BL/6NTac-Vgfem1(IMPC)H/H)
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Vgftm1Srjs/Vgftm1Srjs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating glucose level
|
J:56499
|
decreased circulating insulin level
|
J:56499
|
decreased circulating thyroid-stimulating hormone level
|
J:56499
|
decreased circulating thyroxine level
|
J:56499
|
increased circulating corticosterone level
|
J:56499
|
Vgftm1Vlcg/Vgftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
increased circulating adrenaline level
|
J:212045
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4+
(C57BL/6N-Vgll4tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Vhltm1Jae/Vhltm1Jae Tg(NPHS2-cre)295Lbh/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased blood urea nitrogen level
|
J:162099
|
Vhltm1Jae/Vhltm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * CD-1)
|
increased circulating erythropoietin level
|
J:186085
|
Vhltm1Lss/Vhltm1.1Lss Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased blood urea nitrogen level
|
J:155367
|
decreased circulating creatinine level
|
J:155367
|
Vil1em1(IMPC)Wtsi/Vil1em1(IMPC)Wtsi
(C57BL/6N-Vil1em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Vimtm1Cba/Vimtm1Cba
(involves: 129S2/SvPas)
|
increased circulating creatinine level
|
J:43049
|
Viptm1Clw/Viptm1Clw
(B6.129S-Viptm1Clw)
|
decreased circulating follicle stimulating hormone level
|
J:122403
|
decreased circulating testosterone level
|
J:122403
|
Vipr1tm1Msod/Vipr1tm1Msod
(B6.129-Vipr1tm1Msod)
|
hypoglycemia
|
J:177616
|
Vipr2tm1Hmh/Vipr2tm1Hmh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating triiodothyronine level
|
J:106803
|
Vkorc1L128S/Vkorc1L128S
(involves: wild)
|
abnormal blood coagulation
|
J:101681
|
Vkorc1tm1.1Jobg/Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
abnormal blood coagulation
|
J:207884
|
Vkorc1tm1.1Kry/Vkorc1tm1.1Kry Tg(BGLAP-cre)1Clem/0
(involves: FVB/NJ)
|
abnormal circulating osteocalcin level
|
J:264734
|
Vkorc1tm1.1Kry/Vkorc1tm1.1Kry Vkorc1l1tm1.1Kry/Vkorc1l1tm1.1Kry Tg(BGLAP-cre)1Clem/0
(involves: FVB/NJ)
|
abnormal circulating osteocalcin level
|
J:264734
|
Vkorc1Y139C/Vkorc1Y139C
(involves: Swiss outbred * wild)
|
abnormal blood coagulation
|
J:101681
|
Vkorc1l1em1(IMPC)J/Vkorc1l1em1(IMPC)J
(C57BL/6NJ-Vkorc1l1em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Vpreb3em1(IMPC)Wtsi/Vpreb3em1(IMPC)Wtsi
(C57BL/6N-Vpreb3em1(IMPC)Wtsi/Wtsi)
|
decreased circulating total protein level
|
J:211773
|
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
Vps13ctm1.1Geno/Vps13ctm1.1Geno
(involves: C57BL/6)
|
decreased circulating insulin level
|
J:241413
|
decreased circulating insulin level
|
J:241413
|
Vps13ctm1b(EUCOMM)Hmgu/Vps13ctm1b(EUCOMM)Hmgu
(C57BL/6N-Vps13ctm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Vps13ctm1b(EUCOMM)Hmgu/Vps13ctm1b(EUCOMM)Hmgu
(C57BL/6NTac-Vps13ctm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Vps33abf/Vps33abf
(C57BL/6J-Vps33abf)
|
abnormal blood coagulation
|
J:88018
|
abnormal platelet physiology
|
J:88018
|
decreased platelet aggregation
|
J:88018
|
increased bleeding time
|
J:7327
|
Vps33btm1.1Arte/Vps33btm1.1Arte Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
decreased platelet aggregation
|
J:222766
|
increased bleeding time
|
J:222766
|
Vps33btm1a(EUCOMM)Wtsi/Vps33b+
(C57BL/6N-Vps33btm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Vps37bem1(IMPC)H/Vps37bem1(IMPC)H
(C57BL/6NTac-Vps37bem1(IMPC)H/H)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Vps51tm1a(KOMP)Wtsi/Vps51+
(C57BL/6N-Vps51tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating bilirubin level
|
J:211773
|
Vps54wr/Vps54wr
(multiple strains)
|
decreased circulating estrogen level
|
J:6029
|
Vrk1em1(IMPC)Mbp/Vrk1+
(C57BL/6N-Vrk1em1(IMPC)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Vsig4tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Vsig4tm1b(EUCOMM)Hmgu/Vsig4tm1b(EUCOMM)Hmgu
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J)
|
decreased circulating glucose level
|
J:211773
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
increased circulating interleukin-1 beta level
|
J:281762
|
Vsig8tm1.1(KOMP)Mbp/Vsig8tm1.1(KOMP)Mbp
(C57BL/6N-Vsig8tm1.1(KOMP)Mbp/J)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Vtcn1tm1Xxz/Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased circulating glucose level
|
J:177612
|
Vti1atm1.1(KOMP)Vlcg/Vti1atm1.1(KOMP)Vlcg
(C57BL/6N-Vti1atm1.1(KOMP)Vlcg/Ucd)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Vtntm1Dgi/Vtntm1Dgi
(B6.129S2-Vtntm1Dgi)
|
abnormal blood coagulation
|
J:134443
|
abnormal platelet aggregation
|
J:134443
|
Vwa8tm1b(EUCOMM)Wtsi/Vwa8tm1b(EUCOMM)Wtsi
(C57BL/6N-Vwa8tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating potassium level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Vwftm1.1Diac/Vwftm1.1Diac
(Not Specified)
|
abnormal platelet activation
|
J:181672
|
impaired blood coagulation
|
J:220792
|
increased bleeding time
|
J:220792,
J:181672
|
Vwftm1.1Geno/Vwf+
(involves: C57BL/6)
|
abnormal platelet aggregation
|
J:250145
|
abnormal platelet physiology
|
J:250145
|
decreased platelet aggregation
|
J:250145
|
increased bleeding time
|
J:250145
|
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6)
|
abnormal platelet aggregation
|
J:250145
|
abnormal platelet physiology
|
J:250145
|
decreased platelet aggregation
|
J:250145
|
decreased susceptibility to induced thrombosis
|
J:250145
|
increased bleeding time
|
J:250145
|
Vwftm1.1Vhf/Vwf+
(involves: C57BL/6J * C57BL/6N)
|
abnormal blood coagulation
|
J:295694
|
abnormal platelet physiology
|
J:295694
|
decreased susceptibility to induced thrombosis
|
J:295694
|
increased bleeding time
|
J:295694
|
Vwftm1.1Vhf/Vwftm1.1Vhf
(involves: C57BL/6J * C57BL/6N)
|
abnormal blood coagulation
|
J:295694
|
abnormal platelet physiology
|
J:295694
|
decreased susceptibility to induced thrombosis
|
J:295694
|
increased bleeding time
|
J:295694
|
Vwftm1Wgr/Vwf+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:49083
|
Vwftm1Wgr/Vwftm1Wgr
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal blood coagulation
|
J:49083
|
abnormal platelet physiology
|
J:49083
|
decreased susceptibility to induced thrombosis
|
J:63750
|
increased bleeding time
|
J:49083
|
increased partial thromboplastin time
|
J:49083
|
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr)
|
decreased susceptibility to induced thrombosis
|
J:133469
|
Vwftm2.1Diac/Vwftm2.1Diac
(Not Specified)
|
impaired blood coagulation
|
J:220792
|
increased bleeding time
|
J:220792
|
Vwftm3.1(VWF)Diac/Vwftm3.1(VWF)Diac
(Not Specified)
|
impaired blood coagulation
|
J:220792
|
increased bleeding time
|
J:220792
|
Wactm2b(EUCOMM)Wtsi/Wac+
(C57BL/6N-Wactm2b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating amylase level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Wars1tm1b(EUCOMM)Hmgu/Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating unsaturated transferrin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Washc4em1(IMPC)J/Washc4+
(C57BL/6NJ-Washc4em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal circulating chemokine level
|
J:271857
|
increased circulating interleukin-1 alpha level
|
J:271857
|
increased circulating interleukin-6 level
|
J:271857
|
increased circulating interleukin-17 level
|
J:271857
|
increased circulating tumor necrosis factor level
|
J:271857
|
Wbp1ltm2b(EUCOMM)Hmgu/Wbp1ltm2b(EUCOMM)Hmgu
(C57BL/6N-Wbp1ltm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating alkaline phosphatase level
|
J:211773
|
decreased circulating calcium level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Wbp2tm2a(EUCOMM)Wtsi/Wbp2tm2a(EUCOMM)Wtsi
(C57BL/6N-Wbp2tm2a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
Wbp2tm2a(EUCOMM)Wtsi/Wbp2tm2a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased circulating amylase level
|
J:229594
|
Wdfy2tm1.1Wgz/Wdfy2tm1.1Wgz
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:296933
|
increased circulating insulin level
|
J:296933
|
increased circulating triglyceride level
|
J:296933
|
Wdfy3Tn(pb-Act-RFP)1.1Zhu/Wdfy3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6 * FVB/NJ)
|
cyanosis
|
J:285853
|
Wdhd1em1(IMPC)Rbrc/Wdhd1+
(C57BL/6NJcl-Wdhd1em1(IMPC)Rbrc/Rbrc)
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede)
|
increased bleeding time
|
J:134092
|
Wdr6em1(IMPC)J/Wdr6em1(IMPC)J
(C57BL/6NJ-Wdr6em1(IMPC)J/Mmjax)
|
increased fasting circulating glucose level
|
J:211773
|
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased circulating glucose level
|
J:225111
|
increased circulating insulin level
|
J:225111
|
Wdr27em1(IMPC)Ccpcz/Wdr27em1(IMPC)Ccpcz
(C57BL/6NCrl-Wdr27em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating iron level
|
J:211773
|
Wdr36tm1.1(KOMP)Vlcg/Wdr36+
(C57BL/6N-Wdr36tm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Wdr37tm1a(KOMP)Wtsi/Wdr37tm1a(KOMP)Wtsi
(C57BL/6N-Wdr37tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
Wdr38em1(IMPC)J/Wdr38em1(IMPC)J
(C57BL/6NJ-Wdr38em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Wdr41em1(IMPC)J/Wdr41em1(IMPC)J
(C57BL/6NJ-Wdr41em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Wdr41m1Btlr/Wdr41m1Btlr
(C57BL/6J-Wdr41m1Btlr)
|
increased circulating interleukin-12b level
|
J:268243
|
Wdr45em1(IMPC)J/Y
(C57BL/6NJ-Wdr45em1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Wdr45em1(IMPC)J/Wdr45em1(IMPC)J
(C57BL/6NJ-Wdr45em1(IMPC)J/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Wdr45em1Wrst/Y
(involves: C57BL/6N * FVB)
|
decreased circulating amylase level
|
J:307284
|
decreased circulating lactate level
|
J:307284
|
decreased circulating serum albumin level
|
J:307284
|
decreased circulating total protein level
|
J:307284
|
decreased circulating triglyceride level
|
J:307284
|
decreased circulating unsaturated transferrin level
|
J:307284
|
increased circulating aspartate transaminase level
|
J:307284
|
increased circulating glucose level
|
J:307284
|
increased circulating iron level
|
J:307284
|
increased circulating lactate dehydrogenase level
|
J:307284
|
Wdr45em1Wrst/Wdr45em1Wrst
(involves: C57BL/6N * FVB)
|
decreased circulating lactate level
|
J:307284
|
increased circulating aspartate transaminase level
|
J:307284
|
increased circulating glucose level
|
J:307284
|
increased circulating iron level
|
J:307284
|
increased circulating lactate dehydrogenase level
|
J:307284
|
Wdr47tm1a(EUCOMM)Wtsi/Wdr47tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Wdr47tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating alkaline phosphatase level
|
J:175295
|
Wdr53em1(IMPC)J/Wdr53em1(IMPC)J
(C57BL/6NJ-Wdr53em1(IMPC)J/Mmjax)
|
decreased circulating glucose level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Wdr62em1(IMPC)Tcp/Wdr62em1(IMPC)Tcp
(C57BL/6NCrl-Wdr62em1(IMPC)Tcp/Tcp)
|
increased circulating sodium level
|
J:211773
|
Wdr73em1(IMPC)J/Wdr73+
(C57BL/6NJ-Wdr73em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
Wdr81em1(IMPC)J/Wdr81+
(C57BL/6NJ-Wdr81em1(IMPC)J/J)
|
increased blood urea nitrogen level
|
J:211773
|
Wdr83tm1Guwo/Wdr83+
(involves: C57BL/6)
|
decreased blood urea nitrogen level
|
J:153983
|
decreased circulating creatinine level
|
J:153983
|
Wdr89tm1a(KOMP)Wtsi/Wdr89tm1a(KOMP)Wtsi
(C57BL/6N-Wdr89tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:211773
|
Wdsub1tm1b(EUCOMM)Wtsi/Wdsub1+
(C57BL/6N-Wdsub1tm1b(EUCOMM)Wtsi/Ccpcz)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Wdtc1Gt(RRF015)Byg/Wdtc1+
(involves: 129P2/OlaHsd * ICR)
|
increased circulating glucose level
|
J:129966
|
increased circulating insulin level
|
J:129966
|
increased circulating leptin level
|
J:129966
|
Wdtc1tm1a(KOMP)Wtsi/Wdtc1tm1a(KOMP)Wtsi
(C57BL/6N-Wdtc1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased fasting circulating glucose level
|
J:211773
|
Wee1tm1b(EUCOMM)Wtsi/Wee1+
(C57BL/6N-Wee1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating alanine transaminase level
|
J:211773
|
Wee2em1(IMPC)J/Wee2em1(IMPC)J
(C57BL/6NJ-Wee2em1(IMPC)J/J)
|
decreased circulating iron level
|
J:211773
|
Wfdc2em1(IMPC)H/Wfdc2+
(C57BL/6NTac-Wfdc2em1(IMPC)H/H)
|
increased circulating amylase level
|
J:211773
|
Wfdc2em1Fcw/Wfdc2em1Fcw
(involves: C57)
|
cyanosis
|
J:293623
|
decreased blood oxygen saturation level
|
J:293623
|
Wfdc2tm1.1Ohbo/Wfdc2tm1.1Ohbo
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
cyanosis
|
J:282576
|
Wfs1tm1Koks/Wfs1tm1Koks
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating corticosterone level
|
J:145548
|
Wfs1tm1Koks/Wfs1tm1Koks
(129S6/SvEvTac-Wfs1tm1Koks)
|
abnormal blood homeostasis
|
J:221943
|
decreased circulating glucose level
|
J:221943
|
decreased circulating insulin level
|
J:221943
|
decreased circulating leptin level
|
J:221941
|
hyperglycemia
|
J:221943
|
increased circulating insulin-like growth factor I level
|
J:157967
|
Wfs1tm1Perm/Wfs1tm1Perm Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
decreased circulating insulin level
|
J:104712
|
hyperglycemia
|
J:104712
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6)
|
increased circulating glucose level
|
J:90420
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka)
|
decreased circulating insulin level
|
J:90420
|
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs)
|
decreased circulating glucose level
|
J:5538
|
increased circulating corticosterone level
|
J:5538
|
Wizem1(IMPC)Ccpcz/Wiz+
(C57BL/6N-Wizem1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
Wnk1tm2.1Juha/Wnk1+ Tg(Pgk1-cre)1Lni/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
hyperkalemia
|
J:200742
|
Wnk1tm2Cihu/Wnk1tm2Cihu
(129-Wnk1tm2Cihu)
|
increased circulating sodium level
|
J:168700
|
Wnk4em1Cjc/Wnk4em1Cjc
(Not Specified)
|
decreased circulating bicarbonate level
|
J:274218
|
hyperkalemia
|
J:274218
|
increased circulating potassium level
|
J:274218
|
Wnk4tm1Pfi/Wnk4tm1Pfi
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal blood homeostasis
|
J:184790
|
decreased circulating aldosterone level
|
J:184790
|
decreased circulating magnesium level
|
J:184790
|
hypokalemia
|
J:184790
|
increased circulating renin level
|
J:184790
|
Wnk4tm1Suc/Wnk4+
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating bicarbonate level
|
J:129716
|
increased circulating potassium level
|
J:129716
|
Wnk4tm3.1Suc/Wnk4tm3.1Suc
(involves: 129S4/SvJae * C57BL/6J)
|
alkalemia
|
J:241978
|
decreased circulating sodium level
|
J:241978
|
Wnt1tm1b(EUCOMM)Wtsi/Wnt1+
(C57BL/6N-Wnt1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Wnt2tm1.1(rtTA)Eem/Wnt2tm1.1(rtTA)Eem
(involves: 129X1/SvJ * C57BL/6)
|
cyanosis
|
J:153098
|
Wnt3aem1(IMPC)Ccpcz/Wnt3a+
(C57BL/6NCrl-Wnt3aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Wnt4em1(IMPC)Hmgu/Wnt4+
(C57BL/6NCrl-Wnt4em1(IMPC)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Wnt7btm2Amc/Wnt7btm2.1Amc Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
cyanosis
|
J:134483
|
Wnt11tm1.1(KOMP)Vlcg/Wnt11tm1.1(KOMP)Vlcg
(C57BL/6N-Wnt11tm1.1(KOMP)Vlcg/Ucd)
|
increased blood urea nitrogen level
|
J:211773
|
Wrap53tm1b(EUCOMM)Wtsi/Wrap53+
(C57BL/6N-Wrap53tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating fructosamine level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Wrntm1Led/Wrntm1Led
(B6.129S6(BKSW)-Wrntm1Led)
|
hyperglycemia
|
J:106446
|
hyperlipidemia
|
J:106446
|
increased circulating cholesterol level
|
J:106446
|
increased circulating hyaluronic acid level
|
J:106446
|
increased circulating insulin level
|
J:106446
|
increased circulating triglyceride level
|
J:106446
|
Wrntm1Led/Wrntm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal thrombosis
|
J:106446
|
Wrnip1tm1a(EUCOMM)Wtsi/Wrnip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating triglyceride level
|
J:165965
|
Wsb2tm1b(EUCOMM)Hmgu/Wsb2tm1b(EUCOMM)Hmgu
(C57BL/6N-Wsb2tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Wscd2em1(IMPC)J/Wscd2em1(IMPC)J
(C57BL/6NJ-Wscd2em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
ww1/ww1
(Not Specified)
|
decreased circulating testosterone level
|
J:85113
|
Wwoxtm1.1Mald/Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N)
|
decreased circulating bicarbonate level
|
J:155406
|
decreased circulating calcium level
|
J:155406
|
decreased circulating glucose level
|
J:155406
|
increased blood urea nitrogen level
|
J:155406
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal circulating enzyme level
|
J:138140
|
decreased circulating alkaline phosphatase level
|
J:138140
|
decreased circulating aspartate transaminase level
|
J:138140
|
decreased circulating calcium level
|
J:138140
|
decreased circulating cholesterol level
|
J:138140
|
decreased circulating serum albumin level
|
J:138140
|
decreased circulating sodium level
|
J:138140
|
decreased circulating testosterone level
|
J:146986
|
decreased circulating total protein level
|
J:138140
|
decreased circulating triglyceride level
|
J:138140
|
hypoglycemia
|
J:138140
|
increased blood uric acid level
|
J:138140
|
increased circulating bilirubin level
|
J:138140
|
increased circulating phosphate level
|
J:138140
|
increased circulating potassium level
|
J:138140
|
Wwoxtm2.1Ria/Wwoxtm2.1Ria
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
hypoglycemia
|
J:198845
|
Wwp1em1(IMPC)H/Wwp1em1(IMPC)H
(C57BL/6N-Wwp1em1(IMPC)H/H)
|
decreased fasting circulating glucose level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Wwp2tm1.1Yyiw/Wwp2tm1.1Yyiw
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased circulating interferon-beta level
|
J:228707
|
increased circulating interleukin-6 level
|
J:228707
|
increased circulating tumor necrosis factor level
|
J:228707
|
Wwtr1tm1.1Eno/Wwtr1tm1.1Eno Yap1tm1.1Eno/Yap1+ Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
abnormal atrial thrombosis
|
J:200670
|
Wwtr1tm1Whun/Wwtr1tm1Whun
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
increased blood urea nitrogen level
|
J:119488
|
Xaf1em1Gaod/Xaf1em1Gaod
(involves: C57BL/6)
|
decreased circulating glucose level
|
J:338549
|
decreased circulating insulin level
|
J:338549
|
Xaf1em2.1Cya/Xaf1em2.1Cya
(C57BL/6J-Xaf1em2.1Cya)
|
abnormal circulating protein level
|
J:344340
|
decreased circulating CXCL10 level
|
J:344340
|
decreased circulating interferon-beta level
|
J:344340
|
Xbp1tm1a(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased circulating triglyceride level
|
J:137188
|
Xdhrenf/Xdhrenf
(involves: C3H * C57BL/6J)
|
decreased blood uric acid level
|
J:187066
|
increased blood urea nitrogen level
|
J:187066
|
increased circulating alkaline phosphatase level
|
J:187066
|
increased circulating calcium level
|
J:187066
|
increased circulating creatinine level
|
J:187066
|
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J)
|
decreased blood uric acid level
|
J:103558
|
increased blood urea nitrogen level
|
J:103558
|
increased circulating amylase level
|
J:103558
|
increased circulating hypoxanthine level
|
J:166326
|
increased circulating xanthine level
|
J:166326
|
Xktm1Ariv/Y
(B6.Cg-Xktm1Ariv)
|
increased erythrocyte magnesium level
|
J:212528
|
Xktm1b(KOMP)Mbp/Xktm1b(KOMP)Mbp
(C57BL/6N-Xktm1b(KOMP)Mbp/Ucd)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Xkr5tm1b(KOMP)Mbp/Xkr5tm1b(KOMP)Mbp
(C57BL/6N-Xkr5tm1b(KOMP)Mbp/Ieg)
|
increased fasting circulating glucose level
|
J:211773
|
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
increased circulating follicle stimulating hormone level
|
J:141237
|
Xrcc2tm1Jtk/Xrcc2tm1Jtk
(involves: 129S/SvEv * C57BL/6)
|
cyanosis
|
J:66529
|
Xrcc5em1(IMPC)Ccpcz/Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Xrn1em1Tya/Xrn1em1Tya Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N)
|
increased circulating glucose level
|
J:342928
|
increased circulating insulin level
|
J:342928
|
increased circulating leptin level
|
J:342928
|
Xylbtm1a(EUCOMM)Hmgu/Xylbtm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased circulating alkaline phosphatase level
|
J:165965
|
Xylt2tm1Meh/Xylt2tm1Meh
(involves: 129P2/OlaHsd)
|
increased blood urea nitrogen level
|
J:122291
|
X/Yaa
(BXSB/MpJ)
|
increased circulating interleukin-21 level
|
J:93740
|
Yae1d1tm1b(EUCOMM)Hmgu/Yae1d1+
(C57BL/6N-Yae1d1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating lipase level
|
J:211773
|
Yap1tm1.1Dupa/Yap1tm1.1Dupa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased circulating alanine transaminase level
|
J:162628
|
increased circulating bilirubin level
|
J:162628
|
Yap1tm1.1Eno/Yap1tm1.1Eno Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
abnormal atrial thrombosis
|
J:200670
|
Ybx1tm1Ley/Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6))
|
cyanosis
|
J:99099
|
Ydjctm1.1(KOMP)Vlcg/Ydjctm1.1(KOMP)Vlcg
(C57BL/6N-Ydjctm1.1(KOMP)Vlcg/J)
|
decreased circulating glucose level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Yif1aem1(IMPC)J/Yif1aem1(IMPC)J
(C57BL/6NJ-Yif1aem1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ylpm1tm1b(KOMP)Wtsi/Ylpm1+
(B6N(Cg)-Ylpm1tm1b(KOMP)Wtsi/J)
|
increased fasting circulating glucose level
|
J:211773
|
Yme1l1tm1Tlan/Yme1l1tm1Tlan Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6NCrl * FVB)
|
decreased circulating insulin level
|
J:229455
|
Yme1l1tm1Tlan/Yme1l1tm1Tlan Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6NCrl * FVB/N)
|
increased circulating troponin T level
|
J:229455
|
Yod1em1Smoc/Yod1em1Smoc
(C57BL/6JSmoc-Yod1em1Smoc/Smoc)
|
abnormal blood coagulation
|
J:350806
|
decreased circulating fibrinogen level
|
J:350806
|
increased circulating D-dimer level
|
J:350806
|
increased circulating interleukin-1 beta level
|
J:350806
|
increased partial thromboplastin time
|
J:350806
|
increased susceptibility to induced thrombosis
|
J:350806
|
Yod1tm1bNarl/Yod1tm1bNarl
(C57BL/6N-Yod1tm1bNarl/Narl)
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Ypel3tm1.1(KOMP)Vlcg/Ypel3tm1.1(KOMP)Vlcg
(C57BL/6N-Ypel3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Ypel4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Ythdf3em1(IMPC)Mbp/Ythdf3em1(IMPC)Mbp
(C57BL/6N-Ythdf3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Ywhabem1Gpt/Ywhabem1Gpt Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Ywhabem1Gpt Albem1(icre)Gpt)
|
increased circulating glucose level
|
J:323777
|
Ywhabtm1b(EUCOMM)Hmgu/Ywhabtm1b(EUCOMM)Hmgu
(C57BL/6N-Ywhabtm1b(EUCOMM)Hmgu/Ieg)
|
decreased blood urea nitrogen level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Ywhaetm1Awb/Ywhaetm1Awb
(involves: 129S6/SvEvTac)
|
cyanosis
|
J:192860
|
Yy1tm1Yshi/Yy1tm2Yshi
(involves: 129S4/SvJae)
|
cyanosis
|
J:108369
|
Zbtb4tm1.1(KOMP)Vlcg/Zbtb4tm1.1(KOMP)Vlcg
(B6N(Cg)-Zbtb4tm1.1(KOMP)Vlcg/J)
|
increased circulating sodium level
|
J:211773
|
Zbtb16tm1Ppp/Zbtb16tm1Ppp
(involves: 129S1/Sv)
|
increased circulating testosterone level
|
J:91129
|
Zbtb20tm1.1Wpjz/Zbtb20tm1.1Wpjz
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating insulin level
|
J:148992
|
decreased circulating leptin level
|
J:148992
|
hypoglycemia
|
J:148992
|
increased blood urea nitrogen level
|
J:148992
|
increased circulating alkaline phosphatase level
|
J:148992
|
increased circulating aspartate transaminase level
|
J:148992
|
increased circulating bilirubin level
|
J:148992
|
increased circulating glucagon level
|
J:148992
|
increased circulating ketone body level
|
J:148992
|
increased circulating potassium level
|
J:148992
|
increased circulating resistin level
|
J:148992
|
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified)
|
decreased circulating triglyceride level
|
J:344976
|
decreased fasting circulating glucose level
|
J:344976
|
Zbtb24tm1b(EUCOMM)Hmgu/Zbtb24+
(C57BL/6N-Zbtb24tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating HDL cholesterol level
|
J:211773
|
Zbtb32tm1b(KOMP)Mbp/Zbtb32tm1b(KOMP)Mbp
(C57BL/6N-Zbtb32tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating insulin level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Zbtb43tm1b(KOMP)Mbp/Zbtb43+
(C57BL/6N-Zbtb43tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
Zbtb43tm1b(KOMP)Mbp/Zbtb43tm1b(KOMP)Mbp
(C57BL/6N-Zbtb43tm1b(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
increased circulating alanine transaminase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating phosphate level
|
J:211773
|
Zbtb44em1(IMPC)J/Zbtb44em1(IMPC)J
(C57BL/6NJ-Zbtb44em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Zc3h4em1(IMPC)Mbp/Zc3h4+
(C57BL/6NCrl-Zc3h4em1(IMPC)Mbp/Mmucd)
|
increased circulating serum albumin level
|
J:211773
|
Zc3h7aitem1Caox/Zc3h7aitem1Caox
(C57BL/6J-Zc3h7aitem1Caox)
|
decreased circulating interferon-alpha level
|
J:282488
|
decreased circulating interferon-beta level
|
J:282488
|
decreased circulating interleukin-6 level
|
J:282488
|
Zc3h8em1(IMPC)Ccpcz/Zc3h8+
(C57BL/6N-Zc3h8em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating total protein level
|
J:211773
|
Zc3h11aem1(IMPC)Mbp/Zc3h11a+
(C57BL/6NCrl-Zc3h11aem1(IMPC)Mbp/Mmucd)
|
increased circulating alanine transaminase level
|
J:211773
|
Zc3h12atm1b(EUCOMM)Hmgu/Zc3h12a+
(C57BL/6N-Zc3h12atm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating lipase level
|
J:211773
|
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA)
|
increased circulating alkaline phosphatase level
|
J:304105
|
Zc3h12atm1Fum/Zc3h12atm1Fum
(C57BL/6-Zc3h12atm1Fum)
|
abnormal circulating chemokine level
|
J:176866
|
increased circulating tumor necrosis factor level
|
J:176866
|
Zc3h12bem1(IMPC)Tcp/Zc3h12bem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12bem1(IMPC)Tcp/Tcp)
|
increased circulating total protein level
|
J:211773
|
Zc3h12cem1(IMPC)Tcp/Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Zc3h12ctm2d(EUCOMM)Hmgu/Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
increased circulating interferon-gamma level
|
J:277714
|
Zc3h12dtm1b(EUCOMM)Hmgu/Zc3h12dtm1b(EUCOMM)Hmgu
(C57BL/6N-Zc3h12dtm1b(EUCOMM)Hmgu/Orl)
|
increased circulating alanine transaminase level
|
J:211773
|
Zc3h13em1(IMPC)J/Zc3h13+
(C57BL/6NJ-Zc3h13em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zcchc3em1(IMPC)J/Zcchc3em1(IMPC)J
(C57BL/6NJ-Zcchc3em1(IMPC)J/Mmjax)
|
increased circulating bilirubin level
|
J:211773
|
increased circulating serum albumin level
|
J:211773
|
Zcchc3em1Hbsh/Zcchc3em1Hbsh
(involves: C57BL/6)
|
decreased circulating CXCL10 level
|
J:271802
|
decreased circulating interferon-beta level
|
J:271802
|
decreased circulating interleukin-6 level
|
J:271802
|
Zdhhc1tm1Yyiw/Zdhhc1tm1Yyiw
(involves: 129S6/SvEvTac)
|
abnormal circulating cytokine level
|
J:284987
|
decreased circulating interferon-alpha level
|
J:284987
|
decreased circulating interferon-beta level
|
J:284987
|
decreased circulating interleukin-6 level
|
J:284987
|
decreased circulating tumor necrosis factor level
|
J:284987
|
Zdhhc2tm1b(KOMP)Wtsi/Zdhhc2tm1b(KOMP)Wtsi
(C57BL/6N-Zdhhc2tm1b(KOMP)Wtsi/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Zdhhc4em1Smoc/Zdhhc4em1Smoc
(C57BL/6JSmoc-Zdhhc4em1Smoc)
|
decreased circulating glucose level
|
J:270120
|
increased circulating free fatty acids level
|
J:270120
|
increased circulating triglyceride level
|
J:270120
|
Zdhhc5tm1.1Smoc/Zdhhc5tm1.1Smoc Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ)
|
decreased circulating glucose level
|
J:270120
|
increased circulating free fatty acids level
|
J:270120
|
increased circulating triglyceride level
|
J:270120
|
Zdhhc11tm1.1(KOMP)Vlcg/Zdhhc11tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating interleukin-6 level
|
J:310891
|
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
increased blood urea nitrogen level
|
J:161519
|
increased circulating alanine transaminase level
|
J:161519
|
increased circulating aspartate transaminase level
|
J:161519
|
increased circulating bilirubin level
|
J:161519
|
increased circulating creatine kinase level
|
J:161519
|
Zdhhc20em1(IMPC)Hmgu/Zdhhc20em1(IMPC)Hmgu
(C57BL/6N-Zdhhc20em1(IMPC)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
Zeb1tm1.1Ajg/Zeb1tm2.1Ajg
(C57BL/6-Zeb1tm1.1Ajg/Zeb1tm2.1Ajg)
|
abnormal circulating hormone level
|
J:177274
|
abnormal circulating lipid level
|
J:177274
|
increased circulating corticosterone level
|
J:177274
|
increased circulating free fatty acids level
|
J:177274
|
increased circulating insulin level
|
J:177274
|
increased circulating leptin level
|
J:177274
|
increased circulating triglyceride level
|
J:177274
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(B6.129-Zeb1tm2Yhi)
|
cyanosis
|
J:45575
|
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw)
|
abnormal circulating hormone level
|
J:177274
|
abnormal circulating lipid level
|
J:177274
|
increased circulating corticosterone level
|
J:177274
|
increased circulating free fatty acids level
|
J:177274
|
increased circulating insulin level
|
J:177274
|
increased circulating leptin level
|
J:177274
|
increased circulating triglyceride level
|
J:177274
|
Zfand3em1(IMPC)J/Zfand3em1(IMPC)J
(C57BL/6NJ-Zfand3em1(IMPC)J/Mmjax)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Zfand6em1(IMPC)Mbp/Zfand6em1(IMPC)Mbp
(C57BL/6N-Zfand6em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
increased circulating bilirubin level
|
J:211773
|
Zfhx4tm1.1Rnis/Zfhx4tm1.1Rnis
(involves: C57BL * C57BL/6NCrlj * CBA/JNCrlj * DBA)
|
cyanosis
|
J:316165
|
Zfp13tm1a(EUCOMM)Hmgu/Zfp13tm1a(EUCOMM)Hmgu
(C57BL/6N-Zfp13tm1a(EUCOMM)Hmgu/Ics)
|
decreased circulating creatinine level
|
J:165965
|
Zfp35tm1Naka/Zfp35tm1Naka
(either: B6.Cg-Zfp35tm1Naka or C.Cg-Zfp35tm1Naka)
|
increased circulating interleukin-4 level
|
J:153828
|
increased circulating interleukin-5 level
|
J:153828
|
increased circulating interleukin-13 level
|
J:153828
|
Zfp36tm1(KOMP)Vlcg/Zfp36+
(C57BL/6N-Zfp36tm1(KOMP)Vlcg/Nju)
|
increased fasting circulating glucose level
|
J:211773
|
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased blood urea nitrogen level
|
J:188677
|
increased circulating alanine transaminase level
|
J:188677
|
increased circulating lactate dehydrogenase level
|
J:188677
|
increased circulating tumor necrosis factor level
|
J:188677
|
Zfp42tm1b(KOMP)Mbp/Zfp42+
(C57BL/6N-Zfp42tm1b(KOMP)Mbp/J)
|
decreased circulating serum albumin level
|
J:211773
|
Zfp54em1(IMPC)Wtsi/Zfp54em1(IMPC)Wtsi
(C57BL/6N-Zfp54em1(IMPC)Wtsi/Wtsi)
|
increased circulating serum albumin level
|
J:211773
|
Zfp60tm1b(KOMP)Mbp/Zfp60tm1b(KOMP)Mbp
(C57BL/6N-Zfp60tm1b(KOMP)Mbp/J)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp61tm1b(EUCOMM)Hmgu/Zfp61tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp61tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
increased circulating creatinine level
|
J:211773
|
Zfp69tm1b(EUCOMM)Hmgu/Zfp69tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp69tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating iron level
|
J:211773
|
Zfp84tm1b(KOMP)Wtsi/Zfp84tm1b(KOMP)Wtsi
(C57BL/6N-Zfp84tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zfp106tm1a(KOMP)Wtsi/Zfp106+
(B6JTyr;B6N-Zfp106tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating calcium level
|
J:175295
|
Zfp148Gt(XB878)Byg/Zfp148Gt(XB878)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
cyanosis
|
J:198319
|
Zfp175tm1b(EUCOMM)Wtsi/Zfp175tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp175tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp182tm1b(KOMP)Wtsi/Zfp182tm1b(KOMP)Wtsi
(C57BL/6N-Zfp182tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zfp202em1(IMPC)J/Zfp202em1(IMPC)J
(C57BL/6NJ-Zfp202em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Zfp207tm1b(EUCOMM)Hmgu/Zfp207+
(C57BL/6N-Zfp207tm1b(EUCOMM)Hmgu/H)
|
decreased circulating serum albumin level
|
J:211773
|
Zfp219em1(IMPC)J/Zfp219em1(IMPC)J
(C57BL/6NJ-Zfp219em1(IMPC)J/J)
|
decreased circulating glucose level
|
J:211773
|
Zfp251em1Hgseo/Zfp251em1Hgseo
(C57BL/6J-Zfp251em1Hgseo)
|
increased fasting circulating glucose level
|
J:334395
|
Zfp266tm1b(EUCOMM)Wtsi/Zfp266tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp266tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp280dem1(IMPC)Hmgu/Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
Zfp281em1(IMPC)Mbp/Zfp281+
(C57BL/6N-Zfp281em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp334tm1.1(KOMP)Vlcg/Zfp334tm1.1(KOMP)Vlcg
(C57BL/6N-Zfp334tm1.1(KOMP)Vlcg/J)
|
increased circulating bilirubin level
|
J:211773
|
Zfp341tm1a(KOMP)Wtsi/Zfp341tm1a(KOMP)Wtsi
(C57BL/6N-Zfp341tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating amylase level
|
J:211773
|
increased circulating sodium level
|
J:211773
|
Zfp346tm1.1(KOMP)Vlcg/Zfp346+
(C57BL/6N-Zfp346tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Zfp354aem1(IMPC)Mbp/Zfp354aem1(IMPC)Mbp
(C57BL/6NCrl-Zfp354aem1(IMPC)Mbp/MbpMmucd)
|
increased circulating creatinine level
|
J:211773
|
Zfp367tm1a(KOMP)Wtsi/Zfp367tm1a(KOMP)Wtsi
(B6JTyr;B6N-Zfp367tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating creatinine level
|
J:175295
|
Zfp383em1(IMPC)Wtsi/Zfp383em1(IMPC)Wtsi
(C57BL/6N-Zfp383em1(IMPC)Wtsi/Wtsi)
|
increased circulating alanine transaminase level
|
J:211773
|
Zfp385atm1Ber/Zfp385atm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal blood coagulation
|
J:93829
|
Zfp423em1(IMPC)J/Zfp423+
(C57BL/6NJ-Zfp423em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp445tm1b(EUCOMM)Hmgu/Zfp445tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp445tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating calcium level
|
J:211773
|
Zfp469em1(IMPC)Mbp/Zfp469em1(IMPC)Mbp
(C57BL/6N-Zfp469em1(IMPC)Mbp/MbpMmucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp503em1(IMPC)Mbp/Zfp503+
(C57BL/6N-Zfp503em1(IMPC)Mbp/Ucd)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
Zfp513em1(IMPC)J/Zfp513em1(IMPC)J
(C57BL/6NJ-Zfp513em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Zfp532em1(IMPC)J/Zfp532+
(C57BL/6NJ-Zfp532em1(IMPC)J/J)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp536tm1.1(KOMP)Wtsi/Zfp536tm1.1(KOMP)Wtsi
(C57BL/6N-Zfp536tm1.1(KOMP)Wtsi/Ucd)
|
cyanosis
|
J:211773
|
Zfp551em1(IMPC)J/Zfp551em1(IMPC)J
(C57BL/6NJ-Zfp551em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
decreased circulating creatinine level
|
J:211773
|
Zfp558em1(IMPC)Mbp/Zfp558em1(IMPC)Mbp
(C57BL/6NCrl-Zfp558em1(IMPC)Mbp/Mmucd)
|
decreased circulating creatinine level
|
J:211773
|
decreased circulating glucose level
|
J:211773
|
decreased circulating serum albumin level
|
J:211773
|
decreased circulating total protein level
|
J:211773
|
Zfp579em1(IMPC)J/Zfp579em1(IMPC)J
(C57BL/6NJ-Zfp579em1(IMPC)J/J)
|
increased circulating serum albumin level
|
J:211773
|
increased circulating total protein level
|
J:211773
|
Zfp593em1(IMPC)J/Zfp593em1(IMPC)J
(C57BL/6NJ-Zfp593em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Zfp595tm1b(KOMP)Wtsi/Zfp595tm1b(KOMP)Wtsi
(C57BL/6N-Zfp595tm1b(KOMP)Wtsi/Bay)
|
decreased circulating glucose level
|
J:211773
|
Zfp612em1(IMPC)J/Zfp612em1(IMPC)J
(C57BL/6NJ-Zfp612em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
Zfp616tm1b(KOMP)Wtsi/Zfp616tm1b(KOMP)Wtsi
(C57BL/6N-Zfp616tm1b(KOMP)Wtsi/Wtsi)
|
increased fasting circulating glucose level
|
J:211773
|
Zfp637em1(IMPC)Wtsi/Zfp637em1(IMPC)Wtsi
(C57BL/6N-Zfp637em1(IMPC)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Zfp644em1(IMPC)Ccpcz/Zfp644em1(IMPC)Ccpcz
(C57BL/6N-Zfp644em1(IMPC)Ccpcz/Ccpcz)
|
increased blood urea nitrogen level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Zfp664tm1b(EUCOMM)Wtsi/Zfp664tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp664tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfp691em1(IMPC)J/Zfp691em1(IMPC)J
(C57BL/6NJ-Zfp691em1(IMPC)J/Mmjax)
|
increased circulating serum albumin level
|
J:211773
|
Zfp692em1(IMPC)J/Zfp692em1(IMPC)J
(C57BL/6NJ-Zfp692em1(IMPC)J/J)
|
decreased circulating creatinine level
|
J:211773
|
Zfp697em1(IMPC)J/Zfp697em1(IMPC)J
(C57BL/6NJ-Zfp697em1(IMPC)J/Mmjax)
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Zfp704tm1a(EUCOMM)Wtsi/Zfp704tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Zfp715tm1a(EUCOMM)Hmgu/Zfp715tm1a(EUCOMM)Hmgu
(C57BL/6N-Zfp715tm1a(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:165965
|
increased circulating cholesterol level
|
J:165965
|
Zfp760tm1a(EUCOMM)Hmgu/Zfp760+
(C57BL/6N-Zfp760tm1a(EUCOMM)Hmgu/Ieg)
|
increased circulating serum albumin level
|
J:165965
|
Zfp763em1(IMPC)Wtsi/Zfp763em1(IMPC)Wtsi
(C57BL/6N-Zfp763em1(IMPC)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased fasting circulating glucose level
|
J:211773
|
Zfp831tm1b(KOMP)Wtsi/Zfp831tm1b(KOMP)Wtsi
(C57BL/6N-Zfp831tm1b(KOMP)Wtsi/Bay)
|
increased circulating phosphate level
|
J:211773
|
Zfp950Gt(ROSA)76Sor/Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
|
increased blood urea nitrogen level
|
J:117491
|
Zfp961tm1.1(KOMP)Mbp/Zfp961tm1.1(KOMP)Mbp
(C57BL/6N-Zfp961tm1.1(KOMP)Mbp/J)
|
decreased circulating glucose level
|
J:211773
|
decreased circulating iron level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zfpm1tm1.1Geab/Zfpm1tm1.1Geab
(Not Specified)
|
abnormal circulating chemokine level
|
J:162629
|
Zfyve19em1(IMPC)J/Zfyve19em1(IMPC)J
(C57BL/6NJ-Zfyve19em1(IMPC)J/Mmjax)
|
increased circulating glucose level
|
J:211773
|
Zfyve21tm2c(EUCOMM)Wtsi/Zfyve21tm2c(EUCOMM)Wtsi Tg(Cdh5-cre/ERT2)1Rha/0 Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N)
|
decreased circulating serum albumin level
|
J:350543
|
increased circulating creatinine level
|
J:350543
|
Zfyve26em1(IMPC)J/Zfyve26em1(IMPC)J
(C57BL/6NJ-Zfyve26em1(IMPC)J/J)
|
decreased circulating calcium level
|
J:211773
|
Zfyve28tm1b(EUCOMM)Wtsi/Zfyve28tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfyve28tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating iron level
|
J:211773
|
Zg16tm1Lex/Zg16tm1Lex
(B6.129S-Zg16tm1Lex)
|
increased circulating interferon-gamma level
|
J:239095
|
increased circulating interleukin-6 level
|
J:239095
|
Zglp1tm1Eem/Zglp1tm1Eem
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating follicle stimulating hormone level
|
J:116977
|
increased circulating luteinizing hormone level
|
J:116977
|
Zgpattm1b(EUCOMM)Hmgu/Zgpattm1b(EUCOMM)Hmgu
(C57BL/6N-Zgpattm1b(EUCOMM)Hmgu/Tcp)
|
increased fasting circulating glucose level
|
J:211773
|
Zgrf1em1(IMPC)J/Zgrf1em1(IMPC)J
(C57BL/6NJ-Zgrf1em1(IMPC)J/Mmjax)
|
increased circulating aspartate transaminase level
|
J:211773
|
Zhx2BALB/cJ/Zhx2BALB/cJ
(BALB/cJ)
|
abnormal circulating protein level
|
J:5803
|
Zhx3tm1.1(KOMP)Vlcg/Zhx3tm1.1(KOMP)Vlcg
(C57BL/6N-Zhx3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating aspartate transaminase level
|
J:211773
|
Zkscan14tm1a(EUCOMM)Wtsi/Zkscan14+
(C57BL/6N-Zkscan14tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating alanine transaminase level
|
J:175295
|
decreased circulating aspartate transaminase level
|
J:175295
|
Zmat5em1(IMPC)Hmgu/Zmat5+
(C57BL/6NCrl-Zmat5em1(IMPC)Hmgu/Ieg)
|
increased circulating aspartate transaminase level
|
J:211773
|
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
|
increased circulating aspartate transaminase level
|
J:76209
|
increased circulating creatine kinase level
|
J:76209
|
increased circulating glutamate dehydrogenase level
|
J:76209
|
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/OlaHsd)
|
decreased circulating insulin-like growth factor I level
|
J:164373
|
increased circulating growth hormone level
|
J:164373
|
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating glucose level
|
J:79501
|
decreased circulating total protein level
|
J:79501
|
Zmym2em1(IMPC)J/Zmym2+
(C57BL/6NJ-Zmym2em1(IMPC)J/Mmjax)
|
increased circulating alkaline phosphatase level
|
J:211773
|
Zmym4em1(IMPC)Wtsi/Zmym4+
(C57BL/6N-Zmym4em1(IMPC)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:211773
|
increased circulating amylase level
|
J:211773
|
increased circulating calcium level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zmynd8tm1a(EUCOMM)Wtsi/Zmynd8+
(B6JTyr;B6N-Zmynd8tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating magnesium level
|
J:175295
|
decreased circulating serum albumin level
|
J:175295
|
Zmynd11em1(IMPC)Wtsi/Zmynd11+
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg)
|
increased circulating thyroxine level
|
J:211773
|
Zmynd12em1(IMPC)J/Zmynd12em1(IMPC)J
(C57BL/6NJ-Zmynd12em1(IMPC)J/Mmjax)
|
decreased circulating alanine transaminase level
|
J:211773
|
decreased circulating aspartate transaminase level
|
J:211773
|
decreased circulating bilirubin level
|
J:211773
|
Znhit1em1(IMPC)J/Znhit1+
(C57BL/6NJ-Znhit1em1(IMPC)J/Mmjax)
|
increased circulating phosphate level
|
J:211773
|
Znhit2em1(IMPC)J/Znhit2+
(C57BL/6NJ-Znhit2em1(IMPC)J/Mmjax)
|
decreased circulating bilirubin level
|
J:211773
|
increased circulating glucose level
|
J:211773
|
Zranb1tm1d(EUCOMM)Hmgu/Zranb1tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
decreased circulating interferon-gamma level
|
J:235701
|
decreased circulating interleukin-17 level
|
J:235701
|
Zranb2tm1a(EUCOMM)Wtsi/Zranb2+
(B6JTyr;B6N-Zranb2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating fructosamine level
|
J:175295
|
Zranb3em1(IMPC)Mbp/Zranb3em1(IMPC)Mbp
(C57BL/6N-Zranb3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating calcium level
|
J:221010
|
decreased circulating corticosterone level
|
J:221010
|
decreased circulating serum albumin level
|
J:221010
|
increased blood urea nitrogen level
|
J:221010
|
increased circulating creatinine level
|
J:221010
|
increased circulating lactate dehydrogenase level
|
J:221010
|
Zswim8em#Dpbl/Zswim8em#Dpbl
(C57BL/6J-Zswim8em#Dpbl)
|
cyanosis
|
J:338969
|
Zwilchtm1.1(KOMP)Vlcg/Zwilch+
(C57BL/6N-Zwilchtm1.1(KOMP)Vlcg/J)
|
decreased circulating iron level
|
J:211773
|
Zzef1tm2.1(KOMP)Vlcg/Zzef1tm2.1(KOMP)Vlcg
(B6N(Cg)-Zzef1tm2.1(KOMP)Vlcg/J)
|
decreased circulating calcium level
|
J:211773
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating alkaline phosphatase level
|
J:211773
|
increased circulating aspartate transaminase level
|
J:211773
|
increased circulating potassium level
|
J:211773
|
Zzef1tm2.1(KOMP)Vlcg/Zzef1tm2.1(KOMP)Vlcg
(C57BL/6N-Zzef1tm2.1(KOMP)Vlcg/Ucd)
|
increased circulating alkaline phosphatase level
|
J:211773
|